Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - olfactory bulb [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - olfactory bulb [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
AARD	"C8orf85, LOC441376"	ENSG00000205002	"Alanine and arginine rich domain containing protein"	Q4LEZ3	8	116938207-116944487	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 22.7;urinary bladder: 7.8"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 27.6;Breast glandular cells: 26.0;Breast myoepithelial cells: 29.0;granulocytes: 14.5;Late spermatids: 18.4;Proximal tubular cells: 14.9;Spermatocytes: 57.4"	"Cancer enriched"	"Detected in many"	8	"breast cancer: 27.0"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 21.7;JURKAT: 7.2;SK-BR-3: 11.8;U-2 OS: 5.5;U-266/84: 4.5"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in some"	4	"midbrain: 4.4"	HPA068290			Approved	"Lipid droplets"		NA	NA			"Lipid droplets"		"HPA068290: "	"unprognostic (5.81e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.28e-8)"	"unprognostic (3.42e-2)"	"unprognostic (4.32e-3)"	"unprognostic (4.34e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.52e-1)"	"unprognostic (8.29e-2)"	"unprognostic (8.57e-3)"	"unprognostic (4.20e-1)"	"unprognostic (2.23e-6)"	"unprognostic (1.67e-1)"	"unprognostic (9.78e-3)"	"unprognostic (3.77e-2)"	"unprognostic (5.27e-4)"	0.3	0.9	0.5	0.4	0.8	0.2	4.3	0.4	0.8	0.2	0.8	3.7	0.1	0.8	0.2	2.4	0.1	0.2	0.0	0.6	0.8	1.0	0.0	2.5	0.8	1.2	1.0	0.6	0.0	0.0	0.0	0.0	0.4	0.9	0.6	0.5	0.1	2.0	0.1	0.1	1.3	1.0	1.0	0.8	0.1	6.9	22.7	0.6	0.0	0.1	0.0	0.4	7.8	0.2	1.4	0.0	0.0	0.5	0.0	0.0	0.0	0.2	1.8	0.3	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.7	0.5	0.0	0.2	0.1	2.4	0.0	0.2	0.4	0.0	0.1	0.1	0.1	0.0	7.2	0.0	2.4	0.1	0.5	0.9	0.1	1.1	0.0	2.1	0.0	0.0	0.1	0.0	0.0	1.9	0.3	0.0	11.8	0.1	0.2	0.5	0.0	0.0	0.1	5.5	0.2	0.0	1.6	4.5	0.0	3.0	0.0	0.3	1.2	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.7	0.3	0.1	0.2	0.6	0.0	0.5	0.8	0.4	0.8	0.6	0.8	1.2	1.0	0.6	0.9	0.8	0.6	1.4	0.2	12.8	27.6	0.0	0.1	0.8	0.6	0.2	0.0	0.4	26.0	29.0	0.9	0.0	5.0	7.3	0.0	0.2	0.8	0.1	1.9	0.1	9.3	0.1	1.7	0.9	0.0	0.0	0.8	0.0	0.9	1.4	0.0	0.0	14.5	0.1	0.0	0.1	0.0	1.7	2.1	0.0	0.0	0.0	0.3	18.4	4.1	0.5	0.0	0.0	0.1	0.1	4.1	0.0	0.2	0.1	0.0	0.7	0.0	0.6	0.0	14.9	0.7	0.2	0.0	0.5	1.1	57.4	7.3	0.0	0.6	0.3	0.8	2.0	0.0	0.4
ABCC11	MRP8	ENSG00000121270	"ATP binding cassette subfamily C member 11"	Q96J66	16	48165773-48247568	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"breast: 46.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 3.3;Breast glandular cells: 4.4;Early spermatids: 3.3;Hepatocytes: 2.5;Late spermatids: 1.9;Spermatocytes: 4.0"	"Cancer enriched"	"Detected in some"	4	"breast cancer: 8.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"T-47d: 67.1"					"Not detected"	"Not detected"									NA	NA						"unprognostic (1.35e-1)"	"unprognostic (3.47e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.57e-1)"	"unprognostic (6.03e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.11e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.64e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.13e-2)"	"unprognostic (5.54e-4)"	0.1	0.0	0.2	0.0	0.2	0.1	46.9	0.3	0.3	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.5	0.1	0.0	0.2	0.2	0.0	1.6	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	3.6	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.4	0.6	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	16.0	0.1	0.0	67.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.3	0.2	0.2	0.2	0.1	0.1	0.2	0.0	0.1	0.3	0.1	0.0	0.5	3.3	0.2	0.0	0.0	0.0	0.0	0.4	4.4	0.9	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	3.3	0.3	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	2.5	0.0	0.0	0.6	0.0	0.0	0.3	0.0	1.9	0.0	0.2	0.0	0.0	0.0	0.5	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	4.0	0.4	0.5	0.0	0.3	0.2	0.1	0.0	0.1
ABCC12	MRP9	ENSG00000140798	"ATP binding cassette subfamily C member 12"	Q96J65	16	48081006-48156018	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"testis: 2.9"	"Group enriched"	"Detected in some"	4	"Early spermatids: 4.4;Excitatory neurons: 5.1;Late spermatids: 2.2;Spermatocytes: 6.0;Theca cells: 3.1"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA043100	Uncertain					NA	NA					"HPA043100: AB_10794922"	"unprognostic (1.53e-1)"			"unprognostic (6.87e-2)"	"unprognostic (2.37e-2)"			"unprognostic (4.62e-3)"		"unprognostic (1.88e-1)"		"unprognostic (1.59e-2)"		"unprognostic (2.65e-1)"	"unprognostic (7.53e-2)"	"unprognostic (4.23e-1)"		0.0	0.0	0.3	0.0	0.3	0.0	0.3	0.3	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	2.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.4	0.4	0.3	0.2	0.2	0.3	0.3	0.3	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.0	0.9	0.0	0.0	0.0	0.0	3.1	0.0	0.0
AC007325.1		ENSG00000276017			Unmapped	72411-74814	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in single"	48	"testis: 9.0"	"Cell type enriched"	"Detected in single"	13	"Spermatocytes: 2.7"					"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.0	0.1	0.0	0.0	0.0	0.0	0.0		0.1	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC023491.2		ENSG00000278633	"Putative POM121-like protein 1"		Unmapped	10598-13001	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in single"	200	"testis: 35.6"	"Cell type enriched"	"Detected in some"	27	"Spermatocytes: 38.3"					"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.6	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACR		ENSG00000100312	Acrosin	P10323	22	50738196-50745339	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"testis: 87.4"	"Group enriched"	"Detected in some"	33	"Early spermatids: 492.2;Late spermatids: 134.8;Spermatocytes: 216.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA048687	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA048687: AB_2680494"	"unprognostic (1.71e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.27e-3)"	"unprognostic (3.58e-2)"	"unprognostic (8.04e-2)"	"unprognostic (3.30e-3)"	"unprognostic (5.41e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.34e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.25e-1)"	2.0	0.2	0.3	0.0	0.5	0.0	2.0	0.4	0.5	0.7	2.1	0.5	0.1	1.1	0.7	0.4	1.1	0.2	0.7	0.4	0.4	0.8	0.8	2.0	0.0	0.3	0.3	0.3	0.3	0.2	0.0	0.5	0.1	0.5	0.6	0.0	0.1	0.6	0.2	0.8	0.7	0.5	0.2	0.4	3.0	0.3	87.4	0.4	0.0	0.6	0.0	0.0	0.6	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.4	0.5	0.4	0.4	0.3	0.3	0.3	0.5	0.4	0.4	0.4	8.4	0.0	0.0	0.3	0.0	0.1	0.0	0.0	2.2	0.0	0.3	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	492.2	0.4	0.1	4.7	3.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	7.5	0.1	0.1	0.0	0.2	0.8	0.0	0.0	0.0	134.8	3.4	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.8	2.6	0.0	0.0	1.2	0.4	0.0	0.0	6.6	0.3	0.1	216.9	2.5	0.3	0.0	0.0	0.0	0.1	1.5	0.2
ACTL6A	"Actl6, Arp4, BAF53A, INO80K"	ENSG00000136518	"Actin like 6A"	O96019	3	179562886-179588407	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Growth regulation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 243.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012188, HPA018671, HPA063149"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA		18000	Nucleoplasm	Cytosol	"CAB012188: AB_304125, HPA018671: AB_2669914, HPA063149: "	"unprognostic (2.13e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.24e-3)"	"unprognostic (7.79e-3)"	"unprognostic (1.51e-2)"	"prognostic unfavorable (1.89e-5)"	"unprognostic (3.36e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.13e-2)"	"prognostic unfavorable (5.44e-5)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (4.80e-5)"	"unprognostic (4.21e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.21e-3)"	"unprognostic (5.20e-2)"	19.0	20.6	9.1	23.7	10.4	18.0	33.3	10.8	12.5	24.8	11.3	31.4	24.9	27.8	26.1	25.5	25.2	15.7	18.8	8.6	10.9	22.5	22.0	19.2	32.2	11.1	10.4	8.1	32.2	20.8	24.5	13.2	23.7	11.2	21.5	38.2	16.4	21.5	21.6	12.4	27.0	24.0	26.5	10.4	20.1	22.5	63.1	9.7	46.5	20.7	14.0	41.8	25.0	20.8	12.7	196.4	59.5	142.2	75.7	53.4	58.0	111.7	78.1	60.2	142.3	119.8	126.6	94.8	154.0	136.8	73.5	164.7	88.7	126.3	95.7	174.6	156.7	105.0	125.5	58.2	101.9	61.0	157.4	75.2	40.7	96.1	91.5	76.6	44.5	82.5	90.7	100.1	85.1	103.6	135.6	140.1	96.8	127.6	178.0	129.5	128.7	118.0	284.4	113.4	76.2	116.9	83.2	119.1	118.5	125.2	71.2	231.5	128.8	62.5	101.0	87.1	104.1	237.8	54.6	86.5	231.3	55.6	165.0	113.5	5.7	19.3	14.7	24.5	25.5	32.4	29.2	27.8	28.5	34.1	24.1	30.2	31.3	2.6	26.7	30.1	19.3	39.1	24.3	9.1	10.4	10.8	12.5	8.6	10.9	11.1	10.4	8.1	11.2	10.4	9.7	12.7	31.1	22.4	23.1	6.2	27.1	47.2	48.0	60.4	29.0	6.1	24.5	23.9	6.7	30.0	38.1	27.6	8.4	51.2	21.6	13.4	35.2	51.1	53.5	27.1	28.8	26.7	30.5	62.3	2.8	44.7	67.5	28.1	23.4	20.8	14.5	31.0	13.6	16.8	34.9	0.0	3.8	26.7	48.8	17.1	18.7	17.7	32.3	15.4	30.2	3.7	27.1	16.7	18.6	6.6	19.0	38.8	18.8	30.1	25.8	45.4	18.2	25.8	35.6	14.9	26.3	25.0	49.0	243.2	92.1	42.7	45.9	30.6	21.6	35.1	40.4	38.5
ACTR5	"Arp5, FLJ12785, INO80M"	ENSG00000101442	"Actin related protein 5"	Q9H9F9	20	38748460-38772520	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 24.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042676	Approved					NA	NA					"HPA042676: AB_2678110"	"unprognostic (1.76e-1)"	"unprognostic (4.89e-2)"	"unprognostic (6.33e-2)"	"unprognostic (8.45e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (2.51e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.44e-2)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (4.83e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.01e-1)"	"unprognostic (5.95e-2)"	6.1	4.5	5.3	5.5	5.8	10.4	6.6	5.7	6.0	8.1	4.6	5.8	4.9	6.6	3.9	7.5	6.9	3.2	4.6	5.5	5.3	5.3	6.8	5.4	8.0	5.1	5.0	5.9	9.0	6.3	3.7	5.9	3.6	5.3	6.2	4.9	6.0	5.8	3.7	7.2	8.7	7.3	4.6	4.9	8.8	5.4	12.9	5.2	5.4	5.7	2.8	6.6	6.4	7.5	6.9	8.8	12.3	8.4	6.8	4.7	4.6	11.3	4.6	4.6	9.2	6.8	33.5	12.1	18.2	8.2	4.5	17.8	13.9	14.6	13.1	8.9	5.3	7.6	13.7	7.6	19.8	6.4	9.5	11.3	4.2	19.0	9.5	7.3	3.9	9.2	8.5	12.8	13.8	6.0	9.4	19.7	12.9	6.8	20.5	24.1	12.5	15.8	10.7	7.9	5.9	8.4	13.6	17.8	22.3	10.9	8.5	13.8	6.9	5.9	13.7	12.3	12.7	9.7	10.1	12.2	14.7	8.3	9.1	7.8	1.6	7.7	5.0	12.1	10.1	11.4	9.8	9.2	9.0	10.9	9.7	7.2	7.8	1.0	9.4	6.3	6.8	7.7	6.6	5.3	5.8	5.7	6.0	5.5	5.3	5.1	5.0	5.9	5.3	4.9	5.2	6.9	4.9	3.2	6.3	4.6	6.9	3.7	3.3	5.0	8.6	4.2	3.0	3.2	2.2	4.3	4.7	1.8	4.2	4.3	10.8	3.5	1.9	5.5	6.2	2.3	3.7	4.5	7.8	7.0	6.7	5.5	6.1	4.3	4.1	2.6	0.0	4.2	5.7	3.6	4.3	1.7	8.6	4.9	2.0	1.9	3.5	1.4	3.7	3.8	5.4	8.4	3.5	3.2	5.2	6.0	9.5	3.5	3.1	6.0	5.8	2.3	2.3	3.2	2.2	5.1	0.0	3.5	4.8	24.4	15.6	4.5	3.7	1.9	8.6	3.8	4.1	1.6
ACTR6	"ARP6, FLJ13433"	ENSG00000075089	"Actin related protein 6"	Q9GZN1	12	100199122-100241865	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 135.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038587, HPA038588"	Uncertain		Approved	"Plasma membrane,Cytosol"		No	No			"Plasma membrane, Cytosol"		"HPA038587: AB_10670781, HPA038588: AB_10672719"	"unprognostic (1.24e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (7.70e-9)"	"unprognostic (4.11e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.05e-1)"	"unprognostic (6.98e-2)"	"unprognostic (3.99e-1)"	"unprognostic (5.32e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.22e-1)"	"unprognostic (6.67e-3)"	"unprognostic (3.40e-2)"	15.2	16.8	20.0	12.9	20.4	7.5	29.2	20.7	24.4	14.0	20.1	14.7	15.4	15.3	18.3	13.9	14.3	10.4	17.6	20.8	22.0	22.3	19.7	12.3	21.0	20.7	21.1	19.2	18.0	5.0	20.9	4.5	17.1	21.7	17.0	15.5	20.8	15.4	16.1	14.4	13.7	14.5	14.5	20.6	16.2	10.7	21.5	20.4	20.6	16.4	15.9	19.4	17.2	4.6	23.3	60.2	23.5	27.1	35.9	22.4	28.3	63.3	26.0	22.6	25.0	18.2	15.2	17.8	32.9	24.7	19.5	18.8	23.0	36.5	22.5	34.3	48.9	33.8	22.8	22.2	17.7	23.6	33.7	17.7	17.4	27.7	20.2	25.8	38.5	28.9	38.0	36.9	10.5	29.2	15.5	33.7	50.8	31.6	22.5	34.2	27.0	27.3	41.4	27.3	35.8	24.8	47.0	35.3	62.5	36.5	22.4	40.6	39.5	18.8	18.4	12.3	20.5	23.7	23.6	55.6	42.8	12.1	21.2	21.7	5.7	6.4	10.0	15.2	11.5	19.3	12.6	17.9	20.3	8.2	12.1	19.4	19.6	3.0	19.4	13.2	12.0	20.5	12.1	20.0	20.4	20.7	24.4	20.8	22.0	20.7	21.1	19.2	21.7	20.6	20.4	23.3	33.5	16.0	17.7	6.5	25.8	22.9	36.2	72.4	29.6	32.7	26.5	23.9	34.8	8.6	38.1	23.9	18.8	55.6	36.9	9.9	46.9	21.4	135.2	56.8	27.7	20.7	12.5	21.7	20.9	12.0	68.4	25.0	12.2	28.9	33.0	19.1	16.1	16.4	23.7	33.7	23.2	11.3	73.2	19.1	13.4	34.3	20.2	17.5	32.0	13.1	19.5	27.0	25.7	17.1	17.4	13.2	10.0	22.6	19.7	24.7	11.7	67.9	67.9	32.8	32.9	27.8	36.8	80.8	19.9	23.8	19.7	96.0	36.6	23.8	13.3	33.8
ADAD2	"FLJ00337, TENRL"	ENSG00000140955	"Adenosine deaminase domain containing 2"	Q8NCV1	16	84191138-84197168	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"testis: 65.2"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 80.0;Late spermatids: 26.2;Spermatocytes: 111.8;Spermatogonia: 29.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"hippocampal formation: 2.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"SCLC-21H: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA079443	Enhanced					NA	NA					"HPA079443: "	"unprognostic (5.73e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.18e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.39e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.95e-2)"	"unprognostic (3.01e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.69e-1)"	"unprognostic (7.40e-2)"	"unprognostic (3.18e-1)"	"unprognostic (3.52e-1)"	"unprognostic (2.47e-2)"	0.6	0.3	0.4	0.0	0.4	0.0	0.5	0.0	1.5	0.3	0.0	0.1	0.0	0.5	0.0	0.7	0.1	0.1	0.4	2.1	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.7	0.2	0.1	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.1	0.0	0.1	0.6	0.3	0.0	0.0	3.7	0.2	65.2	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.7	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	1.5	2.1	0.1	0.1	0.0	0.7	0.4	0.0	0.0	0.3	3.9	0.0	0.0	0.0	0.3	0.8	3.1	0.6	1.2	0.0	0.1	0.3	0.9	0.0	0.6	0.0	0.0	0.1	0.0	0.0	5.9	0.0	80.0	0.1	0.1	2.0	0.0	0.0	0.8	0.0	0.1	0.1	0.0	0.3	0.0	0.4	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	26.2	1.5	0.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	111.8	29.2	7.8	1.8	0.0	0.1	0.2	0.0	3.8
ADAM18	"ADAM27, tMDCIII"	ENSG00000168619	"ADAM metallopeptidase domain 18"	Q9Y3Q7	8	39584489-39730065	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	73	"testis: 9.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 63.5;Late spermatids: 26.8;Spermatocytes: 141.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"								"Intracellular and membrane"	NA	NA																		"unprognostic (2.10e-4)"		"unprognostic (1.18e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	63.5	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	26.8	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.1	141.1	3.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0
ADAM2	"CT15, FTNB, PH-30b, PH30"	ENSG00000104755	"ADAM metallopeptidase domain 2"	Q99965	8	39743735-39838289	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	133	"testis: 38.5"	"Group enriched"	"Detected in some"	4	"Early spermatids: 28.2;Spermatocytes: 96.8"	"Cancer enriched"	"Detected in single"	5	"prostate cancer: 1.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB022390, HPA024621, HPA026581"	Enhanced					NA	NA					"CAB022390: , HPA024621: AB_1844576, HPA026581: AB_1844577"				"unprognostic (4.74e-2)"								"unprognostic (1.67e-3)"					"unprognostic (3.82e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	15.1	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	96.8	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0
ADAM30	svph4	ENSG00000134249	"ADAM metallopeptidase domain 30"	Q9UKF2	1	119893533-119896515	"Plasma proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	262	"testis: 26.1"	"Group enriched"	"Detected in some"	5	"Early spermatids: 77.4;Spermatocytes: 60.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA026080	Uncertain					NA	NA					"HPA026080: AB_1844581"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	77.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.8	0.0	60.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1
ADAM32		ENSG00000197140	"ADAM metallopeptidase domain 32"	Q8TC27	8	39106990-39284917	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 27.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 189.0;Excitatory neurons: 37.3;Late spermatids: 50.5;Spermatocytes: 99.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 1.0;MCF7: 1.1;U-2 OS: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA044156, HPA062151"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA044156: AB_10796798, HPA062151: AB_2684699"	"unprognostic (2.13e-1)"	"unprognostic (6.92e-2)"	"unprognostic (4.63e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.52e-2)"	"unprognostic (5.66e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.38e-2)"	"unprognostic (1.13e-7)"	"unprognostic (3.42e-1)"	"unprognostic (4.90e-2)"	"unprognostic (8.34e-3)"	"unprognostic (7.82e-2)"	0.8	1.0	0.9	0.2	1.0	0.4	1.0	2.8	1.5	0.6	0.1	0.4	0.0	0.5	0.6	0.2	0.5	0.4	0.5	0.9	1.1	0.2	0.0	0.4	0.1	0.3	0.9	1.0	0.6	1.8	0.0	0.4	0.1	0.8	0.6	0.4	0.9	0.5	0.4	0.2	0.7	0.2	0.1	0.5	0.7	0.3	27.6	0.9	0.0	0.3	0.1	0.1	0.5	0.4	1.4	0.2	0.4	0.0	0.2	0.6	0.0	0.0	0.4	0.1	0.4	0.2	0.1	0.9	0.0	0.1	0.7	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	1.0	0.1	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.2	0.5	1.1	0.1	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.7	1.3	0.0	0.5	0.0	0.1	0.0	0.2	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.9	1.0	2.8	1.5	0.9	1.1	0.3	0.9	1.0	0.8	0.5	0.9	1.4	1.0	0.0	0.0	11.8	0.0	0.9	1.1	0.7	0.6	8.2	2.5	2.3	1.7	1.5	0.4	1.8	18.8	0.3	0.1	0.4	0.0	0.4	189.0	5.7	3.6	1.0	4.2	0.0	37.3	1.3	0.2	2.4	0.0	9.8	0.0	3.3	0.7	0.4	0.5	0.0	29.8	1.1	0.0	0.0	1.0	50.5	2.8	0.6	0.0	9.4	0.1	1.0	0.0	18.6	17.6	2.8	0.1	3.0	0.1	1.7	0.0	0.2	1.4	3.8	0.0	3.4	0.9	99.9	2.9	0.5	0.0	0.1	0.2	3.7	1.4	1.5
AHRR	"AHH, AHHR, bHLHe77, KIAA1234"	ENSG00000063438	"Aryl-hydrocarbon receptor repressor"	A9YTQ3	5	321759-438291	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"testis: 46.7"	"Group enriched"	"Detected in some"	10	"Early spermatids: 299.1;Late spermatids: 168.8;Spermatocytes: 123.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 59.6;HMC-1: 76.8;NB-4: 91.1;WM-115: 53.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA021483			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA021483: AB_1855110"	"unprognostic (2.06e-4)"	"unprognostic (3.48e-2)"	"unprognostic (8.71e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.33e-4)"	"unprognostic (4.08e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-5)"	"unprognostic (1.87e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.65e-6)"	"unprognostic (1.70e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.55e-2)"	1.0	0.7	1.8	0.6	2.1	0.4	0.8	0.0	6.4	3.1	1.0	1.8	0.7	1.6	0.5	2.2	0.7	1.2	0.5	5.4	0.8	0.8	0.7	2.2	0.4	0.7	0.7	3.4	2.7	0.6	0.1	1.5	2.0	1.7	1.0	1.1	0.1	0.8	0.1	0.6	6.0	1.9	0.3	0.2	5.8	1.1	46.7	1.8	0.2	1.4	0.0	0.4	3.5	2.3	1.8	0.4	5.8	1.4	1.0	6.1	11.9	11.0	22.5	30.0	10.7	18.4	0.6	6.7	0.6	10.1	38.6	2.2	0.5	0.9	0.5	5.1	1.2	2.8	8.6	59.6	0.9	3.5	1.6	76.8	1.4	0.8	7.3	1.3	17.3	3.4	0.8	1.0	0.6	11.8	0.7	0.3	91.1	0.5	2.6	8.9	1.3	0.5	0.4	0.5	0.2	10.0	0.4	27.6	3.7	14.7	0.1	0.5	36.4	6.1	20.5	1.6	21.5	0.4	2.6	3.6	0.8	8.3	0.8	53.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	2.1	0.0	6.4	5.4	0.8	0.7	0.7	3.4	1.7	0.2	1.8	1.8	0.6	0.0	0.0	2.0	0.2	2.2	0.0	0.1	0.0	0.4	0.2	0.3	1.2	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.2	299.1	0.3	0.8	3.6	0.0	0.0	11.1	0.2	5.8	2.7	0.5	0.7	0.0	0.3	0.0	0.0	0.8	0.0	9.5	0.1	0.0	0.0	9.7	168.8	3.4	1.5	19.6	3.7	5.7	0.2	0.0	3.5	2.9	0.2	0.0	1.2	0.1	0.3	0.1	0.1	0.2	0.2	6.6	0.0	3.0	123.7	6.9	0.1	1.4	0.8	1.2	0.7	0.1	0.2
AIMP2	"JTV-1, JTV1, p38, PRO0992"	ENSG00000106305	"Aminoacyl tRNA synthetase complex interacting multifunctional protein 2"	Q13155	7	6009255-6023834	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Differentiation, Protein biosynthesis"	"Developmental protein"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 156.1;tongue: 103.4"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 134.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019098, HPA020057"	Supported		Approved	Cytosol		NA	Yes		35000	Cytosol		"HPA019098: AB_1852040, HPA020057: AB_1852042"	"unprognostic (1.24e-3)"	"unprognostic (1.66e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (9.29e-2)"	"unprognostic (3.41e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.13e-2)"	"unprognostic (3.96e-1)"	"prognostic favorable (1.38e-5)"	"unprognostic (7.44e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (3.09e-4)"	18.4	21.1	13.2	14.4	14.4	12.5	17.5	15.0	17.1	10.7	12.3	26.1	48.2	16.8	16.8	22.2	14.5	8.9	34.7	14.6	15.1	21.5	34.1	12.7	14.4	14.5	14.0	12.7	7.5	17.1	28.9	7.8	13.5	14.3	12.0	24.7	12.0	16.6	15.3	156.1	21.0	28.0	19.5	14.3	13.1	14.7	44.5	14.6	15.5	26.0	103.4	19.7	17.1	13.8	15.8	90.3	100.2	33.1	48.3	34.5	37.3	113.7	49.5	33.3	79.9	59.4	110.1	58.5	109.6	46.2	51.4	90.1	98.6	113.6	74.2	49.6	35.6	84.0	61.2	54.8	84.2	106.2	86.7	53.1	57.4	109.1	72.3	117.9	13.3	60.2	43.8	86.7	35.6	59.4	142.6	37.4	157.2	136.0	44.3	70.4	83.5	73.8	93.3	119.1	41.7	66.1	62.6	50.4	101.3	72.9	41.9	94.5	70.1	51.8	46.0	112.9	77.0	111.2	44.5	73.9	95.5	38.5	122.3	75.6	46.7	61.4	19.5	41.5	77.5	34.9	47.3	27.7	32.5	92.4	31.9	27.1	28.9	6.0	48.3	57.9	58.7	32.3	43.4	13.2	14.4	15.0	17.1	14.6	15.1	14.5	14.0	12.7	14.3	14.3	14.6	15.8	15.0	9.6	10.3	8.1	13.0	10.8	22.5	58.5	24.5	10.2	11.8	15.1	2.2	28.6	40.2	12.9	6.2	50.8	10.1	17.6	70.5	52.6	134.7	25.3	23.9	20.0	6.7	24.2	5.8	57.3	64.0	15.1	23.4	20.6	12.6	16.7	13.2	38.8	50.0	6.7	6.7	18.2	57.0	19.1	14.3	84.5	19.9	18.1	19.6	1.9	40.3	17.8	17.5	5.0	10.4	40.1	14.5	18.0	23.8	23.0	59.3	67.7	34.9	11.2	13.1	16.0	24.5	91.1	26.8	37.1	11.6	39.5	12.6	38.0	39.8	17.8
ALKBH1	"ABH, alkB, ALKBH, hABH"	ENSG00000100601	"AlkB homolog 1, histone H2A dioxygenase"	Q13686	14	77672404-77708023	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, RNA repair, Translation regulation"	"Dioxygenase, Lyase, Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044087, HPA060061"	Approved		Supported	"Nucleoplasm,Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Endoplasmic reticulum"	"HPA044087: AB_2678803, HPA060061: "	"unprognostic (1.92e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.41e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.74e-3)"	"unprognostic (7.45e-3)"	"unprognostic (2.68e-2)"	"unprognostic (3.95e-2)"	"unprognostic (5.05e-3)"	"unprognostic (2.16e-2)"	"prognostic favorable (1.80e-4)"	"unprognostic (1.65e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.44e-2)"	2.6	2.8	2.8	1.9	3.2	1.2	3.5	3.8	3.6	3.5	2.7	2.8	2.5	2.4	2.1	2.7	2.9	2.2	3.9	2.9	3.3	3.0	3.7	2.3	3.6	2.8	3.0	2.7	2.9	2.7	3.3	1.5	4.0	3.1	3.1	3.4	2.9	2.1	3.1	5.8	2.4	2.2	2.9	2.8	2.3	2.6	3.0	3.1	4.4	3.2	7.5	4.2	3.2	2.2	3.1	5.2	7.5	6.0	4.1	6.3	6.8	7.4	5.3	6.8	11.3	12.7	7.7	3.1	7.9	2.9	4.8	5.3	4.5	13.2	5.7	13.2	5.4	5.1	4.2	4.0	6.4	8.9	4.5	2.6	5.8	9.2	6.6	10.5	5.0	9.4	6.1	6.6	4.4	6.1	8.1	6.0	5.7	6.6	7.7	9.6	6.0	6.0	5.3	6.4	4.5	7.6	5.7	4.3	4.5	5.7	4.9	10.9	4.5	4.3	4.7	4.7	5.2	4.3	5.4	9.4	7.6	3.2	6.3	4.7	10.7	3.0	1.4	2.9	3.5	2.4	3.4	2.7	2.8	3.0	2.7	2.8	2.2	0.8	3.6	2.4	1.6	3.3	2.2	2.8	3.2	3.8	3.6	2.9	3.3	2.8	3.0	2.7	3.1	2.8	3.1	3.1	6.5	0.0	3.9	13.1	7.3	8.4	5.7	6.2	6.8	4.1	5.4	4.4	7.5	1.5	4.5	1.8	2.1	9.9	3.5	4.2	9.8	6.2	4.8	4.4	4.5	5.7	2.4	4.2	15.9	7.0	8.8	5.5	2.6	3.8	9.5	6.1	2.2	3.9	7.6	0.0	15.8	4.9	6.1	5.2	5.0	4.2	6.5	7.7	5.4	5.6	6.6	7.8	4.1	16.1	19.4	6.8	1.5	5.3	4.9	4.5	7.0	6.5	5.5	5.3	6.6	4.2	5.6	21.1	15.9	4.4	5.4	12.2	5.6	5.1	4.8	3.7
AMDHD2	CGI-14	ENSG00000162066	"Amidohydrolase domain containing 2"	Q9Y303	16	2520357-2531422	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 64.1;Hofbauer cells: 127.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041184, HPA041321"	Enhanced		Approved	Nucleoli,Cytosol		No	No		110000	"Nucleoli, Cytosol"		"HPA041184: AB_10803998, HPA041321: AB_10795588"	"unprognostic (1.20e-1)"	"prognostic favorable (5.19e-4)"	"unprognostic (7.86e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.88e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.30e-1)"	"unprognostic (8.37e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.20e-1)"	14.0	20.3	1.9	5.6	2.3	5.6	13.8	1.7	4.8	12.1	1.9	12.4	9.1	12.3	0.7	10.7	10.9	4.4	6.7	2.5	1.5	18.5	14.0	12.3	7.9	2.6	2.3	2.1	9.3	8.3	3.1	8.6	4.6	3.8	10.9	0.8	0.4	13.9	3.2	8.9	15.1	17.4	1.4	1.9	26.3	10.0	37.3	2.3	3.8	12.2	1.3	1.9	11.0	9.9	3.3	9.6	11.7	3.1	6.7	3.5	2.5	15.4	9.0	3.4	7.4	9.0	8.7	16.9	4.4	4.4	1.7	14.0	9.3	1.7	2.5	0.2	6.0	7.8	6.6	13.8	12.7	12.9	4.6	16.8	6.6	2.5	4.9	0.8	1.8	4.0	12.5	14.3	9.3	3.1	19.0	7.8	11.7	6.7	0.8	10.1	29.6	4.4	14.0	2.4	5.4	10.3	9.9	5.7	13.1	21.4	0.5	13.1	1.5	6.9	7.4	11.3	14.3	4.7	15.7	14.1	8.9	8.1	9.5	7.4	9.5	3.3	9.6	4.8	7.5	3.8	6.4	3.5	2.9	1.2	4.1	2.7	2.4	8.4	3.1	9.9	9.9	3.8	2.9	1.9	2.3	1.7	4.8	2.5	1.5	2.6	2.3	2.1	3.8	1.9	2.3	3.3	8.0	3.2	11.6	1.3	16.7	8.9	5.2	3.2	4.0	10.3	13.6	11.6	2.5	10.0	5.2	5.5	6.2	16.7	16.4	16.2	5.9	30.3	64.1	6.0	4.1	8.3	12.6	11.0	1.6	17.0	27.1	9.9	7.1	5.2	7.0	13.1	18.2	11.9	127.0	23.5	1.1	12.8	6.1	47.6	12.1	27.4	10.5	28.9	19.6	1.9	26.9	11.0	20.6	0.5	0.8	14.5	26.4	6.4	11.5	4.1	59.4	48.9	9.1	13.0	0.0	7.8	8.4	52.9	16.3	5.1	8.9	27.9	13.2	7.6	10.4	4.2
AMN1		ENSG00000151743	"Antagonist of mitotic exit network 1 homolog"	Q8IY45	12	31671142-31729121	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 57.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 384.0;Late spermatids: 156.1;Spermatocytes: 232.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 51.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046157, HPA062290"	Approved		Approved	Centrosome		NA	NA			Centrosome		"HPA046157: AB_10965846, HPA062290: AB_2684739"	"unprognostic (2.11e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.80e-1)"	"unprognostic (5.93e-2)"	"unprognostic (8.60e-3)"	"unprognostic (4.08e-2)"	"unprognostic (6.48e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.30e-1)"	6.2	10.9	27.8	7.0	31.0	3.4	9.7	27.1	34.7	9.9	20.2	5.2	4.0	11.8	8.5	6.3	18.9	7.6	11.9	31.3	30.4	12.1	6.3	6.9	13.0	27.0	27.1	29.0	17.3	8.8	13.8	12.6	5.6	27.1	9.4	4.3	46.4	6.8	7.8	18.5	6.3	6.1	7.5	27.4	10.3	9.4	57.2	28.3	19.7	8.6	20.2	10.2	9.0	6.9	34.7	5.4	11.6	8.5	0.7	8.5	10.8	5.2	5.7	8.2	3.7	7.1	6.0	19.8	2.6	11.9	4.8	28.1	2.8	4.3	6.4	7.6	4.6	5.4	9.7	3.9	8.7	15.4	5.0	4.8	7.1	10.5	6.3	8.9	28.4	21.4	13.9	8.4	8.0	14.3	3.3	2.9	4.0	12.5	11.2	5.1	4.2	14.7	4.5	8.7	11.9	14.7	11.2	7.3	1.5	11.7	19.3	16.9	5.6	11.5	6.1	5.1	5.2	9.9	9.1	9.5	9.0	8.2	4.5	11.9	8.2	5.0	6.4	7.4	3.7	7.5	22.1	7.7	7.9	4.0	19.3	16.9	10.5	51.8	9.4	3.2	12.4	12.8	5.9	27.8	31.0	27.1	34.7	31.3	30.4	27.0	27.1	29.0	27.1	27.4	28.3	34.7	13.2	6.4	2.7	25.5	25.7	9.3	25.6	35.3	12.5	11.7	10.5	6.7	4.0	7.2	22.3	16.5	27.1	7.1	3.1	2.1	27.4	10.5	384.0	20.0	4.7	11.5	14.4	1.7	48.6	7.2	5.3	7.7	7.1	12.1	7.6	8.1	11.4	3.2	9.0	30.3	58.5	1.9	42.7	6.0	6.8	156.1	10.2	7.7	16.0	13.1	4.1	15.9	11.3	22.1	67.3	11.1	1.0	13.5	5.4	16.9	2.0	11.4	22.9	43.2	0.0	6.1	11.2	232.9	31.1	6.9	12.6	7.3	9.5	10.8	2.1	32.3
ANAPC10	"APC10, DKFZP564L0562, DOC1"	ENSG00000164162	"Anaphase promoting complex subunit 10"	Q9UM13	4	144831908-145098541	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 126.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044547	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA044547: AB_2678979"	"unprognostic (2.96e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.66e-3)"	"unprognostic (1.02e-2)"	"unprognostic (6.69e-2)"	"prognostic unfavorable (8.22e-4)"	"unprognostic (2.80e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.99e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.55e-2)"	11.3	9.5	8.2	6.2	8.6	10.2	14.5	10.0	11.3	11.1	8.5	8.1	4.5	11.7	13.4	7.7	10.8	7.8	14.0	8.4	9.3	13.0	13.7	9.9	10.4	8.8	9.0	7.6	12.0	7.6	9.1	7.6	12.4	8.8	9.0	9.9	9.3	8.2	9.3	15.0	8.1	6.7	11.9	9.2	8.5	7.5	19.2	8.6	14.0	11.9	15.3	10.8	11.1	9.0	9.5	14.3	7.8	20.0	7.8	19.5	21.2	13.0	17.1	16.9	21.6	15.7	18.9	18.6	19.6	11.1	11.8	15.6	8.4	17.6	22.6	23.1	19.0	14.0	12.1	6.0	15.6	24.5	23.9	13.7	17.2	15.9	17.7	28.8	18.0	17.1	23.0	32.2	28.2	22.8	10.3	40.5	29.1	14.1	17.0	15.7	20.5	15.5	11.8	24.1	9.0	14.0	10.4	11.1	10.4	23.1	18.6	9.4	19.7	15.6	14.7	8.9	13.7	21.7	22.3	25.2	31.3	19.2	30.2	18.7	25.5	7.8	9.7	13.0	10.3	13.4	15.1	13.5	13.2	11.5	12.4	13.4	13.7	2.2	16.4	9.6	15.6	18.1	7.4	8.2	8.6	10.0	11.3	8.4	9.3	8.8	9.0	7.6	8.8	9.2	8.6	9.5	30.7	12.8	17.0	31.3	16.7	16.3	22.0	61.6	10.8	9.9	16.9	26.0	14.8	4.3	34.3	14.7	0.0	38.9	20.2	7.6	46.9	25.8	83.3	26.4	21.0	22.2	3.0	8.6	61.2	26.1	35.8	20.7	9.2	15.6	26.0	15.3	19.6	15.6	35.1	5.0	58.0	13.0	40.7	12.7	18.2	22.8	33.8	17.6	10.6	36.5	27.8	19.0	22.6	55.8	62.3	27.3	15.5	27.1	10.5	26.9	14.3	49.8	27.6	9.8	32.9	21.0	36.2	126.8	41.5	14.2	19.9	29.6	19.5	26.1	13.7	29.4
ANKRD18B	bA255A11.3	ENSG00000230453	"Ankyrin repeat domain 18B"	A2A2Z9	9	33524394-33573009	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 31.5;choroid plexus: 8.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 34.4;Excitatory neurons: 13.8;Muller glia cells: 22.3;Spermatocytes: 41.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NB-4: 27.5"									"HPA046346, HPA046695, HPA049923, HPA051288"	Uncertain		Uncertain	"Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Nucleoli, Nucleoli rim"	Cytosol	"HPA046346: AB_2679631, HPA046695: , HPA049923: AB_2680954, HPA051288: AB_2681421"	"unprognostic (4.71e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.85e-3)"	"unprognostic (1.00e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.29e-4)"	"unprognostic (1.45e-2)"	"unprognostic (9.84e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.54e-4)"	"unprognostic (1.01e-2)"	"unprognostic (6.43e-5)"	"unprognostic (4.89e-2)"	"unprognostic (9.75e-4)"	"unprognostic (8.25e-2)"	"unprognostic (5.18e-2)"	0.4	0.2	14.4	0.0	15.1	0.1	0.1	31.5	30.4	0.2	8.7	0.0	0.0	0.1	0.1	1.9	0.2	0.4	0.0	15.1	12.6	0.0	0.0	0.1	0.1	18.9	13.4	13.5	0.0	0.0	0.0	0.4	0.2	20.6	1.2	0.0	1.9	0.1	0.0	0.7	2.2	0.0	0.0	10.2	0.3	0.0	3.9	11.8	0.0	0.2	0.1	0.1	0.7	0.9	17.4	10.0	8.8	0.6	0.1	0.2	1.5	0.9	2.1	2.1	2.7	2.9	2.1	0.2	0.2	0.4	0.3	2.9	2.2	5.9	2.1	3.6	0.1	5.2	10.2	13.1	1.5	0.0	3.5	0.6	0.8	3.6	3.7	9.3	0.7	5.0	0.0	5.5	0.5	3.0	1.7	0.0	27.5	9.1	0.2	4.8	0.0	13.0	2.0	1.6	2.4	0.3	8.5	4.2	0.3	0.4	5.5	7.5	13.4	4.6	1.5	5.8	4.4	3.9	1.5	0.8	0.0	0.8	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	15.1	31.5	30.4	15.1	12.6	18.9	13.4	13.5	20.6	10.2	11.8	17.4	0.0	0.0	0.0	0.7	0.0	2.0	5.4	2.9	1.2	8.5	0.5	0.9	3.1	4.3	2.8	1.8	0.0	0.0	0.0	0.6	0.0	0.8	34.4	12.1	0.2	0.3	0.0	0.0	13.8	0.5	0.4	0.1	0.0	4.0	0.0	12.1	0.4	0.1	0.2	0.0	9.0	2.0	4.1	0.0	0.3	3.7	0.6	0.2	0.0	1.9	0.0	22.3	0.0	4.0	0.8	0.4	1.7	0.7	0.0	2.5	0.3	0.1	9.8	5.5	0.0	0.5	0.5	41.4	2.1	6.2	3.3	0.0	0.2	0.0	1.3	3.9
ANKRD62	DKFZp779B1634	ENSG00000181626	"Ankyrin repeat domain 62"	A6NC57	18	12093843-12129764	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	6	"brain: 1.1;pancreas: 1.0;testis: 1.6"	"Cell type enriched"	"Detected in some"	5	"Spermatocytes: 92.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA059835	Enhanced		Uncertain	"Nucleoplasm,Nuclear bodies,Actin filaments"		NA	NA			"Nucleoplasm, Nuclear bodies"	"Actin filaments"	"HPA059835: AB_2684136"	"unprognostic (2.45e-2)"	"unprognostic (1.18e-1)"		"unprognostic (2.37e-3)"	"unprognostic (9.46e-2)"	"unprognostic (3.01e-1)"		"unprognostic (1.98e-1)"		"unprognostic (6.61e-2)"	"unprognostic (7.95e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.55e-4)"	"unprognostic (1.13e-1)"	"unprognostic (3.28e-2)"	"unprognostic (4.52e-3)"	"unprognostic (8.70e-2)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.4	0.1	0.6	0.3	0.0	0.8	0.0	0.0	0.6	0.1	0.0	1.3	0.3	0.1	0.4	0.3	0.0	0.0	1.7	0.4	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	2.2	0.1	0.2	0.5	0.0	0.0	16.5	1.7	0.6	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.6	0.8	2.6	0.6	0.2	0.0	1.0	0.0	0.1	1.0	1.0	0.2	0.5	1.1	0.4	0.0	0.8	0.2	0.0	0.0	0.9	0.0	1.3	0.3	92.8	15.8	0.5	1.1	0.0	0.2	0.1	0.2	0.5
ANKRD7	TSA806	ENSG00000106013	"Ankyrin repeat domain 7"	Q92527	7	118214669-118496171	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	431	"testis: 867.8"	"Group enriched"	"Detected in some"	61	"Early spermatids: 3367.0;Late spermatids: 861.1;Spermatocytes: 3073.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.9"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 4.3;JURKAT: 4.6;SCLC-21H: 7.8;U-266/70: 9.8;WM-115: 3.1"									"HPA043489, HPA052941"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043489: AB_10959304, HPA052941: "	"unprognostic (1.29e-1)"	"unprognostic (7.22e-4)"		"unprognostic (3.13e-3)"	"unprognostic (6.16e-2)"	"unprognostic (8.49e-2)"		"unprognostic (1.69e-1)"	"unprognostic (5.51e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.63e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.57e-4)"	"unprognostic (3.32e-2)"	0.1	0.5	0.2	0.1	0.4	0.0	0.5	0.0	0.7	0.3	0.1	0.2	0.5	0.1	2.0	0.1	0.4	0.1	0.3	0.4	1.4	0.7	0.2	0.1	0.2	0.7	0.6	0.4	0.3	0.7	0.1	0.7	0.0	1.0	0.6	0.1	0.3	0.1	0.1	0.3	0.1	0.2	0.2	0.0	0.2	0.1	867.8	0.7	0.1	0.9	0.1	0.2	0.1	0.1	0.9	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	4.3	1.2	0.0	2.3	0.0	0.0	0.2	0.1	1.2	0.8	0.0	0.0	0.0	1.4	0.0	0.0	1.7	0.3	0.5	0.0	0.3	0.0	4.6	0.0	1.7	1.1	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	2.0	0.0	0.0	1.5	0.0	0.0	1.0	0.3	0.0	0.8	0.2	0.0	9.8	0.5	0.4	1.4	0.0	3.1	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.7	0.4	1.4	0.7	0.6	0.4	1.0	0.0	0.7	0.9	0.3	0.0	0.0	0.3	0.3	0.0	0.3	0.4	0.0	0.9	0.1	0.3	0.5	1.5	0.1	0.0	0.0	0.1	0.0	0.1	5.9	0.2	3367.0	0.5	0.3	1.6	0.0	0.4	2.8	0.2	0.1	0.2	0.0	0.0	0.0	1.2	0.4	0.0	0.1	3.3	2.8	0.0	0.0	0.0	0.0	861.1	39.4	2.7	1.8	1.0	0.0	1.8	0.0	0.0	1.0	0.1	0.0	29.3	0.1	0.1	0.0	2.0	0.2	0.0	26.3	0.2	0.2	3073.6	29.9	0.0	0.1	0.0	0.1	2.5	0.0	0.1
AP4S1	"AP47B, CLA20, SPG52"	ENSG00000100478	"Adaptor related protein complex 4 subunit sigma 1"	Q9Y587	14	31025106-31130996	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 36.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039963	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA039963: AB_10795240"	"unprognostic (4.03e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.00e-3)"	"unprognostic (1.03e-1)"	"prognostic favorable (7.44e-4)"	"unprognostic (3.79e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.15e-2)"	"unprognostic (3.02e-1)"	"prognostic favorable (2.87e-6)"	"unprognostic (2.20e-3)"	"unprognostic (5.44e-2)"	"unprognostic (7.75e-2)"	"unprognostic (5.59e-2)"	4.8	6.4	9.0	6.7	10.8	6.1	5.7	13.9	12.9	6.1	5.3	6.9	3.9	7.7	7.0	4.9	7.3	5.5	8.8	9.7	9.2	7.5	6.2	5.5	8.2	6.8	7.2	10.5	10.8	8.0	6.6	8.6	6.8	9.0	6.2	4.2	12.0	5.2	6.8	12.7	4.6	4.4	7.9	4.5	8.0	4.4	18.5	8.4	6.6	8.9	7.3	7.8	6.3	4.9	10.9	9.0	12.6	11.0	3.2	4.4	7.9	8.5	6.0	10.4	9.6	9.5	12.2	14.5	10.6	5.5	7.3	7.2	9.7	7.6	9.4	15.9	9.1	4.4	16.4	5.5	19.0	9.5	14.1	9.2	6.3	5.9	9.6	12.0	6.4	11.7	8.0	8.4	7.0	10.3	12.5	9.7	7.8	13.1	10.5	10.9	10.3	9.8	1.4	10.5	12.4	6.1	6.1	10.7	5.1	16.3	7.3	10.8	6.5	8.8	7.3	6.5	5.0	5.2	8.6	17.0	15.9	4.2	4.4	5.7	3.4	1.3	2.4	2.5	3.5	3.7	3.3	3.8	3.0	1.2	3.4	3.7	4.5	2.6	5.8	2.8	3.3	6.6	1.7	9.0	10.8	13.9	12.9	9.7	9.2	6.8	7.2	10.5	9.0	4.5	8.4	10.9	7.1	9.6	7.7	10.7	8.1	3.4	6.5	6.5	1.2	12.1	4.0	4.3	16.5	4.3	3.1	5.5	31.3	9.1	7.6	3.9	5.9	7.6	21.9	5.2	8.8	6.7	6.0	3.8	29.4	4.8	5.3	6.2	7.1	5.8	7.6	7.8	10.8	4.0	7.4	6.7	24.9	3.8	4.1	5.4	4.1	17.0	6.8	6.0	3.6	12.2	7.5	9.3	5.2	25.1	16.4	2.8	6.2	8.6	4.2	4.0	5.0	7.7	8.1	24.4	6.6	8.5	8.1	36.0	8.3	3.0	2.8	11.5	7.3	8.2	4.0	5.2
AP5S1	"C20orf29, FLJ11168"	ENSG00000125843	"Adaptor related protein complex 5 subunit sigma 1"	Q9NUS5	20	3820524-3828838	"Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034200, HPA043533, HPA048244"	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			"Nucleoplasm, Cytosol"		"CAB034200: AB_1564201, HPA043533: AB_2732507, HPA048244: AB_2680328"	"unprognostic (1.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.52e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.05e-2)"	"unprognostic (5.49e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.91e-2)"	"unprognostic (5.15e-3)"	"unprognostic (8.17e-2)"	"prognostic favorable (5.53e-5)"	"unprognostic (2.92e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.09e-3)"	"unprognostic (5.08e-2)"	6.0	11.6	6.5	5.5	7.1	7.4	5.8	6.0	8.2	4.8	7.0	5.6	6.4	5.7	3.0	7.4	4.8	4.6	10.2	6.9	6.2	9.5	14.7	5.4	5.6	6.5	6.1	6.9	5.9	7.5	7.9	7.5	5.4	7.1	6.9	4.4	3.5	8.7	3.6	19.4	5.2	6.4	4.0	5.8	8.3	6.5	11.3	6.2	4.3	9.5	10.1	3.8	5.4	5.1	6.1	18.1	33.8	4.6	3.1	6.2	8.0	5.7	10.8	8.6	10.4	8.3	28.5	18.9	10.4	11.3	11.4	19.7	15.9	3.9	17.4	3.6	5.7	10.9	17.3	10.1	25.3	10.7	12.0	10.0	13.7	9.7	13.0	10.3	7.0	12.4	12.4	12.4	19.8	14.0	29.4	28.0	10.5	4.2	13.0	27.3	11.7	7.8	10.8	11.8	14.4	14.2	5.7	10.6	32.4	18.2	3.1	15.9	5.9	16.9	21.7	10.3	11.3	20.6	10.6	12.6	5.7	7.5	10.6	19.0	2.2	7.5	4.6	10.2	11.9	7.8	5.4	8.5	8.4	9.9	7.0	7.8	7.3	1.7	6.2	6.7	7.7	9.9	6.5	6.5	7.1	6.0	8.2	6.9	6.2	6.5	6.1	6.9	7.1	5.8	6.2	6.1	4.0	0.0	10.6	2.3	5.9	1.7	4.4	8.0	7.4	15.3	4.9	4.3	11.2	11.5	5.9	3.7	10.4	19.4	3.8	8.4	11.7	11.1	3.7	5.1	6.2	8.6	12.6	9.9	1.9	12.7	13.3	6.8	14.8	5.2	14.0	6.6	6.1	9.4	15.5	25.2	2.1	7.3	8.2	6.9	2.0	3.6	5.9	7.3	5.4	4.7	11.0	12.8	8.2	2.5	1.7	10.2	8.8	4.1	8.6	3.6	11.2	8.5	4.5	20.8	13.1	5.8	4.5	19.4	10.9	6.8	1.0	18.5	6.2	10.9	7.4	3.0
APH1B	"APH-1B, DKFZp564D0372, PSFL"	ENSG00000138613	"Aph-1 homolog B, gamma-secretase subunit"	Q8WW43	15	63276018-63309126	"Predicted membrane proteins, Transporters"	"Notch signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"testis: 123.8"	"Group enriched"	"Detected in many"	15	"Early spermatids: 1363.2;Late spermatids: 359.9;Spermatocytes: 838.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 107.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (9.92e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.55e-2)"	"unprognostic (3.57e-1)"	"unprognostic (7.86e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.86e-1)"	"unprognostic (4.56e-2)"	"prognostic favorable (1.05e-4)"	"unprognostic (8.44e-2)"	"prognostic favorable (2.25e-4)"	"unprognostic (4.29e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.62e-1)"	10.2	12.2	9.8	9.8	11.2	8.2	10.7	10.6	10.6	8.4	10.7	5.6	3.8	7.0	11.7	3.8	16.4	7.6	5.6	8.6	11.1	7.8	3.5	8.9	10.1	12.4	12.5	8.7	14.7	4.5	7.5	7.0	8.1	10.8	11.8	4.5	12.3	8.3	8.0	4.0	5.1	7.8	6.5	12.2	13.7	5.1	123.8	10.5	9.8	19.7	5.6	7.9	7.8	6.7	13.5	1.3	8.8	9.3	7.5	20.7	36.2	3.3	11.2	22.6	8.3	13.9	8.1	12.3	11.1	5.2	12.4	15.4	1.2	15.8	4.4	15.5	7.6	2.5	19.6	1.9	0.3	17.1	4.3	30.9	22.8	7.0	12.3	8.3	14.1	17.6	13.9	6.7	8.0	26.1	3.9	5.9	13.2	8.8	2.8	4.6	5.7	5.1	0.2	4.3	8.9	8.1	4.4	4.5	3.7	0.1	9.8	13.6	25.1	11.8	24.5	9.4	4.0	1.6	19.6	35.3	15.2	17.8	25.1	14.6	32.0	31.8	41.4	10.7	63.1	9.0	24.1	10.8	9.7	15.3	18.0	11.8	12.0	44.1	6.2	107.5	5.5	11.7	18.6	9.8	11.2	10.6	10.6	8.6	11.1	12.4	12.5	8.7	10.8	12.2	10.5	13.5	8.4	9.6	18.8	16.3	21.7	5.2	12.4	15.5	5.7	6.8	16.2	13.7	6.1	11.5	15.9	22.0	2.1	6.3	10.4	1.0	1.9	36.9	1363.2	25.6	12.7	12.0	20.4	5.0	18.1	6.2	38.7	18.1	4.6	4.5	22.8	12.5	17.9	1.7	55.7	1.7	22.9	4.1	22.4	52.0	17.7	359.9	24.5	41.8	10.6	16.9	29.6	21.4	6.2	27.2	28.9	11.1	0.8	16.6	16.3	8.9	0.7	6.8	38.6	14.8	13.1	12.6	15.5	838.0	20.0	2.3	3.4	6.0	14.5	16.4	2.8	9.0
ARL14EP	"ARF7EP, C11orf46, FLJ38968"	ENSG00000152219	"ADP ribosylation factor like GTPase 14 effector protein"	Q8N8R7	11	30323104-30338223	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 130.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039634, HPA048127"	Approved		Supported	"Nucleoplasm,Vesicles,Focal adhesion sites,Cytosol"		NA	NA			"Vesicles, Focal adhesion sites, Cytosol"	Nucleoplasm	"HPA039634: AB_2676606, HPA048127: AB_2680277"	"prognostic favorable (2.50e-5)"	"unprognostic (8.93e-2)"	"unprognostic (6.19e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (5.26e-4)"	"unprognostic (2.50e-2)"	"unprognostic (6.50e-3)"	"unprognostic (5.76e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.57e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.47e-1)"	"unprognostic (4.50e-2)"	"prognostic favorable (7.49e-4)"	14.0	22.7	15.2	13.3	16.5	8.1	20.2	17.2	17.1	17.2	15.7	10.5	9.6	19.1	23.4	11.7	16.6	13.2	23.1	16.3	15.2	17.5	19.9	11.0	22.6	14.2	15.0	15.6	20.7	13.1	26.3	12.1	11.6	13.9	19.8	10.9	16.0	19.2	20.1	20.8	12.7	9.8	14.6	14.6	21.0	15.8	14.8	14.2	15.7	25.0	20.9	21.6	14.6	8.2	15.3	10.8	15.4	16.9	14.8	27.1	29.2	8.5	20.8	26.0	18.4	20.2	8.5	4.1	43.8	13.9	15.0	20.5	17.8	24.8	17.5	25.9	35.2	30.7	13.3	12.0	15.0	42.6	24.0	14.7	30.5	34.7	8.7	32.8	26.7	20.6	17.9	21.4	23.2	32.5	10.4	21.9	19.6	19.6	24.1	21.3	18.8	41.2	18.0	24.7	14.8	19.2	20.4	16.2	21.4	25.8	15.0	22.8	13.4	18.1	20.8	11.2	41.7	20.1	36.0	21.9	28.5	20.0	14.8	20.4	12.7	19.2	6.4	23.3	20.0	55.5	35.9	28.2	25.9	26.3	28.9	25.7	25.0	3.5	52.9	15.5	18.9	20.3	23.1	15.2	16.5	17.2	17.1	16.3	15.2	14.2	15.0	15.6	13.9	14.6	14.2	15.3	27.3	28.9	33.6	14.4	39.7	12.4	46.6	35.1	8.0	34.0	19.9	30.4	68.1	24.3	23.8	25.8	14.6	19.1	29.2	5.9	76.3	27.3	130.1	25.8	41.0	29.2	14.5	13.2	31.1	22.5	12.7	33.4	12.8	19.0	27.8	33.5	15.4	29.8	25.7	32.0	26.4	11.7	32.6	27.1	29.3	66.3	27.4	28.4	26.6	18.7	45.4	36.1	38.1	27.6	19.9	21.9	8.4	25.2	25.4	46.0	9.4	42.1	27.5	32.4	13.1	33.1	29.8	111.4	37.6	13.8	11.1	11.1	29.6	33.0	12.6	28.4
ART3	ARTC3	ENSG00000156219	"ADP-ribosyltransferase 3 (inactive)"	Q13508	4	76011184-76112802	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"heart muscle: 61.5;skeletal muscle: 222.2;testis: 97.3;tongue: 102.5"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 76.2;Spermatocytes: 262.8"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"NB-4: 5.5;NTERA-2: 14.1;SK-MEL-30: 6.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA011268	Enhanced				"Intracellular and membrane"	NA	NA		48000000			"HPA011268: AB_1845059"	"unprognostic (2.45e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.77e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.34e-1)"	"unprognostic (9.85e-4)"	"unprognostic (2.35e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.58e-2)"	"unprognostic (6.61e-3)"	0.8	0.4	4.0	1.1	4.7	0.0	0.9	7.6	7.9	2.0	4.3	2.8	0.3	0.3	0.5	4.8	0.9	0.2	61.5	5.0	5.5	0.2	0.2	0.4	0.3	3.5	3.3	4.2	0.4	7.9	0.1	2.5	0.1	5.2	2.0	2.3	0.2	3.1	1.3	222.2	0.8	2.3	0.4	3.9	2.7	1.9	97.3	3.6	0.6	0.3	102.5	0.1	0.7	1.7	10.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	5.5	14.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.6	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	4.7	7.6	7.9	5.0	5.5	3.5	3.3	4.2	5.2	3.9	3.6	10.3	0.4	0.0	0.0	0.7	0.1	0.5	0.5	1.1	0.0	0.5	0.2	0.3	76.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	23.3	2.1	0.4	0.8	0.0	0.0	37.9	0.0	0.1	2.6	0.0	5.9	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.4	13.5	1.8	0.2	1.8	0.0	0.0	0.3	0.0	5.0	7.3	0.0	0.0	1.2	0.0	1.0	0.0	0.0	0.1	0.3	0.0	21.7	2.7	262.8	24.2	0.0	0.3	0.0	0.2	0.1	0.8	0.4
ART5	ARTC5	ENSG00000167311	"ADP-ribosyltransferase 5"	Q96L15	11	3638512-3642316	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 13.6;testis: 29.6"	"Group enriched"	"Detected in some"	8	"Early spermatids: 18.3;Late spermatids: 18.5;Spermatocytes: 64.9"	"Cancer enriched"	"Detected in some"	4	"testis cancer: 4.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SuSa: 13.9"	"Not detected"	"Not detected"							"HPA041637, HPA044099"	Uncertain				"Secreted in other tissues"	NA	NA					"HPA041637: AB_2677589, HPA044099: AB_2678808"	"unprognostic (6.32e-2)"	"unprognostic (3.26e-5)"	"unprognostic (4.09e-3)"	"unprognostic (2.06e-4)"	"unprognostic (1.53e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.21e-2)"	"unprognostic (5.65e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (1.85e-4)"	"unprognostic (3.10e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.18e-1)"	0.7	0.2	0.3	0.0	0.3	0.0	1.0	0.3	0.5	4.1	0.5	0.2	0.0	3.6	0.7	0.6	1.5	1.4	1.5	0.3	0.7	0.8	0.9	0.9	0.1	0.3	0.4	0.2	8.4	0.4	2.9	0.7	0.1	0.6	1.1	0.0	0.6	1.6	0.9	13.6	0.4	0.2	1.1	0.2	0.0	0.5	29.6	0.4	0.3	2.9	10.6	0.0	0.7	2.2	0.3	0.0	0.1	1.6	2.0	0.0	0.0	3.2	0.2	1.6	0.7	1.8	0.0	0.0	0.0	0.8	0.2	0.0	0.0	1.5	0.0	0.4	0.0	2.2	0.0	0.3	0.1	0.0	0.0	1.4	0.5	0.0	0.0	0.0	0.2	0.0	0.1	0.6	0.0	0.2	0.3	0.0	0.0	1.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.5	0.0	13.9	0.5	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.5	0.3	0.7	0.3	0.4	0.2	0.6	0.2	0.4	0.3	0.1	0.0	1.8	0.0	0.0	0.3	2.2	0.0	2.8	0.8	0.3	1.3	2.5	0.0	0.6	0.0	0.0	0.6	0.0	0.1	0.0	0.6	18.3	0.1	0.2	0.4	0.0	0.0	0.0	0.2	0.5	1.3	0.0	0.2	0.0	3.3	0.0	1.8	0.1	0.0	0.0	0.2	0.0	0.3	0.0	18.5	3.4	0.1	0.0	1.0	0.0	3.6	0.0	0.0	0.0	0.2	0.0	1.2	0.1	0.8	0.0	0.6	0.0	0.9	0.0	1.3	0.2	64.9	3.9	0.1	0.3	2.9	0.0	1.2	0.0	0.3
ARV1		ENSG00000173409	"ARV1 homolog, fatty acid homeostasis modulator"	Q9H2C2	1	230978981-231000733	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 116.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035709	Approved		Uncertain	Vesicles		NA	NA			Vesicles		"HPA035709: AB_2674744"	"unprognostic (2.32e-1)"	"unprognostic (4.69e-2)"	"prognostic favorable (1.33e-4)"	"unprognostic (3.29e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.95e-2)"	"unprognostic (5.66e-2)"	"prognostic favorable (3.27e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.12e-2)"	"unprognostic (9.57e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.82e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.12e-3)"	10.7	18.6	24.9	10.3	26.3	14.0	19.2	27.5	33.0	12.4	26.3	24.9	16.6	9.8	23.1	15.9	14.5	16.5	30.4	25.9	26.8	25.4	26.4	15.2	14.9	26.6	26.0	25.1	11.3	17.6	33.6	20.3	11.8	26.6	16.4	26.1	29.2	22.2	15.4	21.9	17.9	17.5	13.2	27.4	13.7	17.3	31.6	26.5	15.2	22.1	25.0	15.4	15.4	11.3	29.2	40.8	43.6	20.8	25.1	29.6	26.4	20.1	19.0	34.0	33.5	38.3	16.3	31.4	11.4	22.7	21.3	20.5	32.3	40.6	25.5	39.2	30.4	55.7	36.8	28.9	22.1	30.5	53.6	27.9	28.0	25.8	18.1	20.9	21.9	22.5	34.7	53.7	30.7	22.2	14.3	22.3	16.4	27.1	43.0	27.1	25.2	32.1	33.1	47.1	33.0	21.2	32.6	22.6	26.6	57.9	5.3	46.6	46.6	13.9	13.4	8.7	23.6	45.9	47.4	44.6	28.9	36.8	45.9	36.7	9.1	8.1	8.5	10.0	12.2	13.9	18.1	11.2	12.4	10.1	11.2	13.7	13.0	2.0	12.7	21.2	14.9	15.4	9.0	24.9	26.3	27.5	33.0	25.9	26.8	26.6	26.0	25.1	26.6	27.4	26.5	29.2	13.6	16.0	31.7	10.7	12.6	12.9	22.0	75.8	11.4	18.9	14.8	15.6	32.2	21.5	38.9	29.5	2.1	37.9	12.7	15.8	60.7	24.1	52.6	12.7	10.9	12.7	7.7	58.1	20.2	40.8	14.5	14.5	11.7	9.7	17.1	14.4	15.0	17.3	24.9	38.7	25.6	18.5	34.6	13.3	5.5	22.9	9.3	13.5	24.9	8.4	9.8	33.6	7.2	8.5	19.3	21.5	11.5	16.6	14.7	11.6	17.9	32.5	27.3	20.0	0.0	11.4	15.6	116.7	21.0	20.3	15.2	15.6	11.4	22.0	26.4	20.9
ASH2L	"ASH2, ASH2L1, ASH2L2, Bre2"	ENSG00000129691	"ASH2 like, histone lysine methyltransferase complex subunit"	Q9UBL3	8	38105493-38144076	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 69.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 200.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042289	Approved		Supported	"Nucleoplasm,Plasma membrane"		Yes	No			Nucleoplasm	"Plasma membrane"	"HPA042289: AB_10795608"	"unprognostic (9.39e-2)"	"unprognostic (5.58e-3)"	"unprognostic (2.67e-3)"	"unprognostic (5.40e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.04e-1)"	"unprognostic (9.15e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.10e-2)"	"unprognostic (9.73e-3)"	"prognostic favorable (4.25e-4)"	"unprognostic (9.95e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.69e-3)"	"unprognostic (2.54e-1)"	29.2	19.0	18.9	18.0	21.5	31.9	21.6	20.4	21.6	20.0	15.8	22.7	18.3	22.2	17.3	24.1	20.3	17.5	21.5	20.6	19.8	23.5	23.8	18.7	28.1	18.0	17.7	18.9	26.4	17.8	25.0	12.1	22.2	17.7	20.0	22.5	21.9	20.8	21.2	32.7	20.5	18.4	24.4	16.5	19.1	22.3	41.7	19.3	34.0	21.3	28.0	28.6	18.7	16.2	19.9	45.6	23.3	39.8	39.8	26.3	34.0	49.8	44.1	45.7	53.5	47.0	24.9	21.1	51.4	38.2	37.1	27.2	27.5	49.0	24.8	50.4	20.3	22.4	200.3	22.9	51.7	39.4	32.0	41.3	28.6	22.9	25.0	27.7	28.1	43.9	48.0	138.2	40.0	53.7	26.1	91.9	40.7	51.7	39.3	15.6	38.2	42.9	23.4	28.9	33.1	18.3	32.4	33.5	22.5	38.4	37.1	27.4	40.4	33.5	35.3	35.0	50.4	37.6	37.8	48.7	44.9	35.2	44.7	49.7	39.9	23.0	55.9	16.8	26.8	18.1	19.6	18.8	20.0	27.7	19.2	19.3	18.4	19.2	26.1	25.8	15.8	21.3	21.6	18.9	21.5	20.4	21.6	20.6	19.8	18.0	17.7	18.9	17.7	16.5	19.3	19.9	11.1	12.8	15.8	18.3	14.3	6.9	9.3	13.3	10.8	12.9	9.6	8.0	18.1	8.6	15.9	12.9	10.4	37.0	15.9	11.5	7.9	21.2	10.8	12.7	13.2	14.0	10.8	62.1	19.7	28.7	37.2	17.3	8.6	10.8	19.6	38.2	12.8	11.9	24.2	6.7	21.4	11.6	12.2	17.2	5.7	13.0	23.3	17.0	23.2	15.9	29.2	17.8	19.6	17.6	16.5	21.3	8.9	20.7	8.4	6.2	12.8	17.1	18.0	15.5	13.1	14.6	20.7	69.6	33.9	11.6	6.8	30.9	11.9	37.3	10.9	7.4
ATP8B3	ATPIK	ENSG00000130270	"ATPase phospholipid transporting 8B3"	O60423	19	1782075-1812276	"Enzymes, Predicted membrane proteins"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"bone marrow: 5.9;testis: 22.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 9.5;Late spermatids: 11.7;Spermatocytes: 20.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 3.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 12.5;Karpas-707: 22.4;U-266/70: 18.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"									NA	NA						"unprognostic (6.50e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.05e-5)"	"unprognostic (6.66e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.28e-2)"	"unprognostic (6.15e-3)"	"prognostic unfavorable (4.80e-9)"	"unprognostic (8.05e-2)"	"unprognostic (3.20e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.19e-1)"	0.4	1.9	0.3	0.6	0.2	5.9	0.4	0.2	0.4	0.6	0.2	0.3	0.3	1.2	0.3	0.4	0.4	0.2	0.2	0.2	0.3	0.2	0.6	0.5	0.7	0.3	0.2	0.2	0.6	0.2	0.1	0.3	0.3	0.3	0.3	0.3	0.4	0.3	0.3	0.1	0.6	0.4	0.8	0.2	3.3	0.2	22.1	0.4	2.4	0.5	0.3	0.8	0.4	0.6	0.5	0.8	6.3	0.7	0.9	0.7	0.6	0.0	2.5	3.7	2.4	2.2	0.1	2.5	2.7	2.7	1.9	0.3	0.2	0.5	0.1	1.1	2.7	0.1	0.8	3.2	1.2	0.2	1.7	12.5	0.3	0.2	0.0	2.5	3.7	0.6	8.0	2.1	22.4	4.0	0.3	1.7	5.0	0.2	0.3	2.9	2.7	0.5	0.3	3.4	0.1	0.0	0.8	0.7	0.0	0.4	0.6	0.7	8.0	5.9	0.1	4.7	0.9	2.6	18.5	9.8	0.7	4.7	8.0	3.1	0.0	0.9	0.8	0.8	3.1	0.3	0.0	0.5	0.5	0.5	0.0	0.2	0.7	0.3	1.1	0.9	0.2	1.3	0.6	0.3	0.2	0.2	0.4	0.2	0.3	0.3	0.2	0.2	0.3	0.2	0.4	0.5	1.5	0.0	0.6	1.0	0.5	0.8	0.5	0.9	4.6	2.4	1.0	1.8	1.6	4.3	0.3	0.0	2.1	0.1	1.2	0.1	0.0	1.0	9.5	3.9	1.8	2.1	0.0	0.8	0.6	0.2	1.2	2.0	0.5	5.1	1.3	3.9	4.6	0.8	1.4	0.0	0.5	0.1	0.0	4.1	1.9	11.7	0.3	2.0	1.8	1.0	1.1	0.7	2.1	0.5	0.2	0.2	0.0	0.4	0.9	0.3	0.5	0.1	0.2	0.7	0.0	0.3	0.7	20.9	3.7	2.5	1.4	0.4	2.7	4.2	0.1	0.2
AURKA	"AIK, ARK1, AurA, BTAK, PPP1R47, STK15, STK6, STK7"	ENSG00000087586	"Aurora kinase A"	O14965	20	56369389-56392337	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 22.3;testis: 31.1"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 81.6;Extravillous trophoblasts: 67.1;granulocytes: 54.1;Spermatocytes: 168.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB001454, HPA002636"	Enhanced		Approved	"Nucleoplasm,Mitotic spindle,Centrosome,Cytosol"		Yes	Yes			"Nucleoplasm, Centrosome"	"Mitotic spindle, Cytosol"	"CAB001454: AB_563420, HPA002636: AB_1845217"	"unprognostic (7.73e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (9.40e-5)"	"unprognostic (1.92e-1)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (4.69e-3)"	"unprognostic (2.42e-1)"	"unprognostic (6.88e-2)"	"prognostic unfavorable (6.13e-4)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.47e-8)"	"unprognostic (1.67e-1)"	"unprognostic (6.83e-2)"	"unprognostic (9.00e-2)"	"unprognostic (5.14e-2)"	1.3	2.3	2.0	10.5	1.7	15.4	2.2	2.4	1.5	1.0	0.8	10.9	11.8	1.5	0.8	7.6	1.2	2.1	5.3	1.1	1.1	2.3	5.0	2.2	21.1	1.5	1.3	0.4	8.5	2.1	1.8	0.6	8.1	1.3	1.1	13.0	3.0	1.9	1.3	8.8	3.5	9.4	5.0	1.5	5.3	4.9	31.1	1.5	20.4	1.4	8.3	22.3	3.0	2.6	2.8	179.9	127.2	84.5	61.2	4.9	10.8	106.3	145.2	66.8	339.7	142.9	361.4	124.8	58.4	96.2	59.2	176.2	142.2	152.4	96.4	360.0	52.4	57.5	102.6	128.9	229.8	2.8	140.4	140.4	5.1	10.1	117.3	104.5	26.7	80.7	93.2	121.8	45.3	146.9	182.1	85.3	108.9	78.3	145.6	129.8	62.9	163.4	65.9	56.0	46.8	73.9	39.6	200.5	228.8	94.2	77.3	137.9	86.1	47.1	149.7	145.3	83.0	208.6	62.3	78.9	100.5	80.5	80.9	127.0	0.2	3.5	4.3	1.2	5.9	1.8	2.5	2.0	1.1	3.7	0.8	0.9	0.9	2.3	1.4	3.4	0.8	4.7	1.7	2.0	1.7	2.4	1.5	1.1	1.1	1.5	1.3	0.4	1.3	1.5	1.5	2.8	2.5	0.0	2.8	0.3	7.4	1.1	1.2	5.6	0.6	1.0	4.3	6.2	5.6	1.5	2.3	3.7	2.1	34.5	8.3	8.3	1.9	4.0	33.9	2.0	2.3	3.1	6.0	81.6	1.1	4.9	67.1	7.0	13.7	3.4	54.1	12.3	3.6	2.6	17.5	1.7	1.5	10.8	2.0	3.5	7.6	16.3	1.5	11.7	0.0	1.0	12.0	3.7	3.1	1.0	2.0	5.2	2.8	0.4	10.1	2.0	5.1	4.2	1.5	2.7	6.6	2.2	7.7	168.2	30.8	8.3	1.1	8.2	8.0	8.7	15.5	1.5
AURKC	"ARK3, AurC, STK13"	ENSG00000105146	"Aurora kinase C"	Q9UQB9	19	57230802-57235548	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"testis: 47.3"	"Group enriched"	"Detected in many"	4	"Early spermatids: 150.2;Spermatocytes: 116.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"NTERA-2: 38.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA034859	Uncertain					NA	NA					"HPA034859: AB_10670298"	"unprognostic (7.27e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.45e-2)"	"unprognostic (8.07e-3)"	"unprognostic (3.29e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.11e-2)"	"unprognostic (7.02e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.20e-5)"	"unprognostic (4.26e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.46e-4)"	1.2	1.1	3.8	1.3	3.9	1.4	2.1	4.1	6.3	0.6	3.3	0.9	0.2	1.3	1.8	1.0	1.1	1.4	1.7	3.8	4.2	1.3	2.7	1.1	3.5	4.0	3.9	3.6	0.5	0.9	0.6	1.4	1.9	4.2	0.9	1.3	1.2	0.8	1.4	2.0	1.1	0.9	1.1	4.0	5.0	0.8	47.3	3.9	1.2	1.2	0.5	2.2	1.4	0.8	4.6	0.3	0.1	0.9	0.4	0.3	0.9	0.5	1.7	0.8	1.2	4.4	1.3	0.2	0.1	0.2	0.6	1.0	0.0	0.0	0.9	0.8	0.0	4.9	0.2	0.4	0.0	1.4	0.0	0.3	1.2	0.9	0.9	0.7	1.5	0.8	0.5	0.2	0.0	1.6	0.0	1.5	0.9	38.4	0.2	1.0	0.1	0.3	0.8	0.9	1.7	1.9	0.6	0.0	0.3	0.2	0.1	0.1	1.8	0.4	0.3	5.1	0.4	1.0	1.9	2.7	0.8	1.1	0.0	0.1	0.0	0.0	0.4	0.1	0.2	0.0	0.3	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	3.8	3.9	4.1	6.3	3.8	4.2	4.0	3.9	3.6	4.2	4.0	3.9	4.6	1.9	0.0	0.5	0.7	0.1	1.1	0.8	0.9	0.0	2.4	1.2	3.8	1.2	0.0	2.5	1.8	0.0	0.4	0.9	0.7	1.9	2.1	150.2	0.8	0.4	0.8	1.8	0.4	1.3	1.0	0.9	1.0	0.0	0.6	0.0	0.5	1.8	0.6	4.1	0.0	1.3	0.3	0.0	2.6	0.8	28.9	1.5	1.2	5.4	0.0	1.0	1.8	1.0	0.0	0.9	1.3	1.4	0.4	0.6	1.3	0.0	0.5	2.7	1.0	6.6	0.4	0.7	116.8	22.9	0.5	1.1	0.3	0.9	0.5	0.4	1.6
B3GALT4	"beta3Gal-T4, GalT4"	ENSG00000235863	"Beta-1,3-galactosyltransferase 4"	O96024	6	33277123-33284832	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 28.1"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 71.8;Spermatocytes: 81.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 4.0;MOLT-4: 1.1;SCLC-21H: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043001	Approved					NA	NA					"HPA043001: AB_2678265"	"unprognostic (3.71e-2)"	"unprognostic (1.33e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.66e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.17e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.22e-2)"	"unprognostic (3.75e-2)"	8.2	8.8	0.3	0.0	0.8	0.0	8.0	1.6	0.8	7.6	0.2	10.9	0.0	8.1	0.0	19.7	6.5	0.0	7.9	0.2	0.6	7.0	1.5	7.7	0.0	1.0	1.3	0.2	3.5	3.5	0.0	5.7	0.0	1.9	9.0	0.0	0.0	12.5	0.0	2.5	14.9	10.9	0.0	1.1	12.9	9.6	28.1	0.8	0.0	7.4	0.0	0.0	9.8	11.3	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	7.7	4.6	2.4	1.8	1.8	1.8	3.1	2.5	8.8	1.8	2.4	2.8	5.0	5.7	4.7	4.5	2.0	0.3	0.8	1.6	0.8	0.2	0.6	1.0	1.3	0.2	1.9	1.1	0.8	2.3	12.6	12.8	4.8	1.3	12.0	3.2	6.3	18.9	4.0	14.5	7.6	4.2	3.8	15.7	18.9	14.7	4.2	18.4	20.2	38.2	5.9	17.7	36.8	12.1	3.1	11.1	12.6	5.2	1.0	18.4	12.9	8.2	13.3	11.0	10.2	5.0	15.0	0.4	20.3	11.8	1.4	15.8	16.2	22.3	8.6	71.8	7.8	15.2	8.8	4.7	27.2	9.8	54.6	1.5	2.1	20.0	32.6	6.0	6.2	9.1	35.5	6.1	26.0	15.0	6.6	3.3	5.9	81.2	2.7	13.2	4.8	32.0	14.2	5.1	11.2	17.0
BBIP1	"bA348N5.3, BBIP10, BBS18, NCRNA00081"	ENSG00000214413	"BBSome interacting protein 1"	A8MTZ0	10	110898730-110919201	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"		"Bardet-Biedl syndrome, Ciliopathy, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 103.8"	"Group enriched"	"Detected in all"	4	"Early spermatids: 597.4;Late spermatids: 501.6;Spermatocytes: 399.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA055206	Approved					NA	NA					"HPA055206: AB_2682737"	"unprognostic (6.05e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.25e-3)"	"unprognostic (3.08e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.65e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.00e-2)"	"unprognostic (6.79e-3)"	"unprognostic (3.90e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.85e-2)"	17.2	25.1	28.1	16.1	32.2	10.2	15.7	32.6	41.5	18.2	26.2	14.5	10.4	16.7	25.5	10.5	20.2	12.4	20.2	28.3	31.6	28.6	23.7	14.3	16.5	30.6	30.2	26.8	19.7	13.9	19.1	25.8	13.9	31.6	19.4	10.8	50.5	10.6	16.3	15.6	7.1	12.5	16.2	29.6	16.9	14.4	103.8	29.6	17.9	21.9	10.2	16.7	16.3	13.0	40.0	22.1	28.9	33.0	34.0	41.4	51.0	9.8	27.2	56.4	30.9	42.7	14.4	26.9	13.3	19.2	44.9	31.4	21.5	23.9	30.1	47.5	26.9	28.6	22.0	28.3	18.9	54.4	18.9	37.0	31.8	27.1	42.4	75.7	68.9	50.3	23.7	16.5	49.8	37.0	13.9	23.8	27.0	14.0	15.3	18.1	10.5	59.7	18.8	48.6	13.9	24.9	39.6	20.7	9.1	45.4	21.1	10.4	16.9	36.5	22.3	27.2	27.3	38.2	27.9	26.0	19.9	63.4	33.5	17.6	25.5	11.2	47.6	9.7	15.0	11.5	8.2	14.5	12.0	9.5	7.2	17.6	14.9	53.6	7.8	13.0	8.4	18.8	7.4	28.1	32.2	32.6	41.5	28.3	31.6	30.6	30.2	26.8	31.6	29.6	29.6	40.0	32.3	25.6	10.0	25.8	24.2	11.2	36.2	41.4	17.1	32.3	13.9	16.3	18.5	22.8	24.3	22.0	31.3	19.3	21.4	9.5	105.7	35.8	597.4	60.4	27.1	26.4	16.9	18.3	58.8	34.5	25.6	27.7	14.3	24.4	16.5	21.0	25.4	22.1	20.0	45.4	52.6	18.4	50.8	22.4	15.8	501.6	46.6	22.4	23.2	14.0	27.1	52.4	26.8	27.6	67.5	36.0	12.0	33.8	32.2	21.6	13.5	69.4	75.7	63.8	52.6	46.0	32.7	399.5	36.5	12.5	11.9	12.3	27.2	21.0	10.0	29.7
BBS12	"C4orf24, FLJ35630, FLJ41559"	ENSG00000181004	"Bardet-Biedl syndrome 12"	Q6ZW61	4	122732702-122744942	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Bardet-Biedl syndrome, Ciliopathy, Disease variant, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 17.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 57.0;Rod photoreceptor cells: 37.1;Spermatocytes: 33.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061856	Approved					NA	NA					"HPA061856: AB_2684626"	"unprognostic (9.59e-2)"	"unprognostic (2.27e-1)"	"unprognostic (8.55e-2)"	"prognostic favorable (5.69e-4)"	"unprognostic (7.61e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.52e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.99e-1)"	"prognostic favorable (9.89e-6)"	"unprognostic (1.36e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.46e-1)"	2.2	2.5	2.9	1.4	3.1	0.3	2.7	2.1	3.2	3.0	4.2	2.2	2.5	2.8	4.7	1.5	5.0	1.9	3.7	2.7	3.4	9.5	0.9	2.3	1.5	2.5	2.8	2.7	2.7	1.8	8.0	3.7	2.0	2.5	1.7	2.0	17.7	1.8	2.9	0.6	1.2	2.5	2.6	2.6	1.8	1.5	7.9	3.0	1.8	9.4	1.0	1.6	1.9	1.5	2.5	1.8	1.8	2.8	3.3	8.3	10.1	1.1	2.5	4.6	3.3	3.4	1.2	2.9	1.1	2.0	3.7	3.6	1.4	2.2	3.2	3.3	4.0	1.9	0.4	2.6	1.2	5.6	1.2	1.8	7.2	8.2	4.3	6.1	11.4	3.6	2.0	4.2	1.3	4.5	1.2	2.3	0.8	1.6	1.2	1.5	1.4	7.7	0.6	7.8	0.5	1.7	3.2	3.7	0.8	2.9	5.8	1.1	1.1	3.4	2.8	1.5	2.6	1.4	2.2	1.2	0.8	4.2	0.9	4.6	0.9	1.2	2.0	1.4	1.6	1.7	2.1	1.8	2.1	1.2	0.9	1.9	1.8	0.0	1.2	2.1	1.2	1.9	1.2	2.9	3.1	2.1	3.2	2.7	3.4	2.5	2.8	2.7	2.5	2.6	3.0	2.5	1.3	6.4	1.1	1.6	0.7	1.0	1.2	1.9	0.6	6.1	1.5	1.4	3.9	1.5	2.5	0.0	2.1	6.8	0.4	3.5	3.9	5.5	57.0	7.5	3.1	2.4	3.0	2.7	5.4	2.7	1.7	2.4	1.5	1.9	1.3	3.4	3.3	0.9	1.9	3.3	4.1	2.0	4.1	1.6	1.4	12.0	4.1	0.9	5.4	1.9	1.4	11.7	1.0	4.5	0.9	4.5	5.9	6.8	0.6	1.0	7.4	17.4	12.7	37.1	6.6	1.2	2.3	33.2	4.4	0.9	1.0	4.4	1.2	5.8	2.0	0.7
BLZF1	JEM-1	ENSG00000117475	"Basic leucine zipper nuclear factor 1"	Q9H2G9	1	169367970-169396540	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 131.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 85.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025703, HPA027331, HPA067113"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA025703: AB_1845379, HPA027331: AB_1845380, HPA067113: AB_2685781"	"unprognostic (5.25e-2)"	"unprognostic (9.03e-2)"	"unprognostic (9.31e-3)"	"unprognostic (1.48e-2)"	"unprognostic (4.66e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.34e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.81e-3)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (2.33e-4)"	"unprognostic (3.28e-1)"	"unprognostic (3.06e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.18e-1)"	15.0	13.2	9.2	12.6	11.4	25.8	19.6	12.2	10.9	14.8	10.5	14.0	12.4	15.7	14.5	32.7	11.4	16.5	16.1	9.7	12.1	17.2	15.0	13.1	11.9	10.5	10.5	9.5	14.6	9.5	15.2	8.8	18.4	10.3	15.7	15.7	23.0	12.8	16.1	11.4	18.2	12.8	18.0	10.1	12.6	13.2	35.3	10.0	13.9	18.9	11.1	16.4	16.7	14.9	15.2	52.8	16.6	16.5	13.6	24.9	37.6	26.2	46.6	32.0	48.1	52.5	19.5	33.3	7.5	26.8	31.6	30.7	38.6	16.6	30.3	37.4	16.8	16.1	13.7	20.0	13.6	26.4	27.2	18.9	27.6	36.9	35.8	31.7	27.3	25.1	14.9	25.6	20.0	46.0	10.8	12.1	12.7	19.9	38.2	25.2	6.8	26.0	16.6	48.1	17.5	9.3	30.6	30.3	41.3	36.9	28.3	44.8	20.4	30.5	28.9	22.5	26.7	39.6	20.4	26.1	19.5	22.1	11.7	44.6	85.6	12.2	51.5	12.2	16.2	16.0	11.3	15.0	14.1	10.8	10.4	13.2	14.4	25.1	19.8	15.8	8.2	23.9	10.9	9.2	11.4	12.2	10.9	9.7	12.1	10.5	10.5	9.5	10.3	10.1	10.0	15.2	14.7	22.4	16.4	34.9	11.7	18.4	46.7	22.6	16.5	14.3	18.0	12.1	29.6	11.5	24.4	11.0	14.6	18.3	15.2	18.2	23.5	24.2	131.4	28.0	18.6	11.9	12.6	16.0	30.2	13.2	17.3	18.7	22.4	28.5	26.0	12.3	12.5	4.8	14.3	33.7	32.8	11.7	14.2	10.7	6.8	72.8	14.6	11.6	14.2	17.8	10.3	21.2	17.5	30.2	57.8	36.7	11.6	17.7	13.9	17.0	15.4	22.4	31.6	27.9	0.0	23.0	21.7	84.9	25.8	16.7	15.6	20.1	18.8	17.1	11.6	65.3
BOLL	BOULE	ENSG00000152430	"Boule homolog, RNA binding protein"	Q8N9W6	2	197726879-197786762	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Translation regulation"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"testis: 49.4"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 178.2;Late spermatids: 129.3;Spermatocytes: 327.7;Spermatogonia: 63.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	9	"T-reg: 1.5"	"Lineage enriched"	"Detected in single"	9	"T-cells: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA018678, HPA048813"	Enhanced					NA	NA					"HPA018678: AB_1845411, HPA048813: AB_2680529"	"unprognostic (3.55e-2)"	"unprognostic (1.69e-1)"		"unprognostic (6.05e-2)"	"unprognostic (3.08e-2)"	"unprognostic (7.93e-2)"		"unprognostic (3.20e-1)"		"unprognostic (3.73e-1)"		"unprognostic (1.77e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.08e-1)"	"unprognostic (9.49e-2)"		"unprognostic (1.77e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	49.4	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	178.2	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.2	129.3	4.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	3.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.3	327.7	63.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1
BRD8	"p120, SMAP"	ENSG00000112983	"Bromodomain containing 8"	Q9H0E9	5	138139770-138178953	"Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 120.8;Spermatocytes: 226.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001841	Supported		Supported	Nucleoplasm,Mitochondria		NA	Yes			Nucleoplasm	Mitochondria	"HPA001841: AB_1845438"	"unprognostic (1.25e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.81e-3)"	"unprognostic (2.31e-2)"	"unprognostic (9.01e-2)"	"unprognostic (3.56e-2)"	"prognostic unfavorable (1.09e-6)"	"unprognostic (1.73e-1)"	"unprognostic (7.01e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.87e-2)"	"prognostic unfavorable (7.80e-4)"	"unprognostic (4.29e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.07e-2)"	21.2	21.7	25.7	15.5	25.9	22.6	25.4	29.1	28.8	29.5	22.6	28.2	15.6	28.6	41.7	23.7	26.8	16.5	19.2	23.9	25.8	25.2	25.6	19.6	20.8	23.6	23.5	23.4	33.0	30.8	26.4	47.0	25.1	24.6	27.5	25.1	39.0	25.3	24.1	28.0	23.8	23.5	25.3	22.8	27.8	25.1	83.8	24.4	38.3	34.6	25.3	22.3	24.5	25.0	31.3	28.7	36.8	63.1	101.8	45.0	42.0	57.0	43.4	47.9	61.6	64.4	55.4	62.6	28.6	42.2	40.3	62.9	32.9	67.4	41.5	65.9	50.3	50.1	38.5	93.6	38.0	25.0	23.6	39.2	31.4	27.2	48.7	44.1	49.3	39.7	52.2	35.2	35.8	41.3	31.8	48.4	37.6	28.6	32.9	18.8	46.4	52.2	35.1	41.4	41.3	55.7	27.9	51.9	22.4	40.1	85.0	38.5	43.2	25.0	30.2	34.7	21.2	38.1	31.5	37.9	39.1	23.1	34.7	28.5	16.2	10.8	14.1	14.6	8.0	15.8	10.7	12.7	13.2	12.0	11.0	15.9	16.0	20.2	23.8	8.8	8.4	13.0	9.8	25.7	25.9	29.1	28.8	23.9	25.8	23.6	23.5	23.4	24.6	22.8	24.4	31.3	21.0	25.6	38.3	28.1	17.8	6.9	10.6	16.4	31.9	33.7	19.8	20.3	44.8	14.3	27.0	27.6	37.5	27.7	19.0	17.0	19.6	19.5	120.8	30.1	51.1	24.3	31.2	26.5	26.2	12.4	13.2	32.5	20.9	29.7	24.0	43.2	13.6	17.2	11.9	30.3	23.7	23.3	14.2	14.8	9.8	43.9	31.4	14.3	24.9	12.2	31.3	27.1	19.6	27.6	30.8	16.0	16.8	24.0	21.8	18.1	15.4	22.4	29.0	34.9	26.3	23.2	31.7	226.9	65.0	23.2	7.0	25.3	19.1	41.9	18.6	10.1
BRDT	"BRD6, CT9"	ENSG00000137948	"Bromodomain testis associated"	Q58F21	1	91949343-92014426	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Meiosis, mRNA processing, mRNA splicing, Spermatogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	48	"testis: 132.6"	"Group enriched"	"Detected in some"	4	"Early spermatids: 1313.5;Spermatocytes: 561.9"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 6.4"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	30	"BEWO: 21.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			CAB012237	Approved					NA	NA					"CAB012237: AB_304756"	"unprognostic (5.00e-2)"	"unprognostic (2.86e-1)"		"unprognostic (2.22e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.49e-1)"		"unprognostic (5.25e-2)"		"unprognostic (2.53e-3)"	"unprognostic (6.26e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.22e-13)"	"unprognostic (2.70e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.00e-3)"	0.0	0.0	0.4	0.5	0.4	2.7	0.3	0.7	0.7	0.1	0.4	0.1	0.4	0.1	0.2	0.0	0.0	0.4	0.0	0.4	0.2	0.0	0.1	0.2	0.4	0.5	0.1	0.3	0.1	0.0	0.0	0.0	0.9	0.4	0.1	0.0	0.3	0.2	0.1	0.0	0.6	0.0	0.1	0.1	0.2	0.1	132.6	0.3	0.2	0.2	0.0	0.0	0.2	0.0	0.8	0.2	0.0	0.0	0.1	0.0	0.0	21.3	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.1	0.4	0.0	0.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.3	0.4	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.7	0.2	0.1	0.1	0.0	0.0	0.1	0.2	0.3	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	1.5	0.3	0.2	0.3	0.1	0.3	0.1	0.1	0.1	0.0	0.2	0.2	0.2	0.8	0.3	0.1	0.2	0.1	0.2	0.4	0.4	0.7	0.7	0.4	0.2	0.5	0.1	0.3	0.4	0.1	0.3	0.8	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.0	0.0	1.2	1.1	0.6	0.0	0.0	0.0	0.0	38.0	1.7	0.0	0.0	0.0	1313.5	0.0	0.0	1.8	0.0	0.0	1.2	0.0	22.2	3.2	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.9	0.0	0.0	0.0	0.0	228.7	7.8	0.8	0.0	0.0	0.0	0.0	1.0	1.0	0.3	0.0	0.0	6.8	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.2	2.3	561.9	19.9	0.0	0.0	19.4	1.1	0.1	0.0	0.1
BTBD1		ENSG00000064726	"BTB domain containing 1"	Q9H0C5	15	83016423-83067252	"Predicted intracellular proteins"	"Differentiation, Myogenesis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 328.1;tongue: 232.9"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 84.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024263, HPA067671"	Enhanced		Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA			"Cytoplasmic bodies"	"Nucleoplasm, Cytosol"	"HPA024263: , HPA067671: AB_2685882"	"unprognostic (1.63e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.17e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (6.21e-7)"	"unprognostic (8.94e-3)"	"unprognostic (8.27e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.89e-2)"	37.2	27.0	43.2	25.2	43.1	36.6	29.1	43.4	48.6	25.0	30.0	33.7	32.8	24.5	25.9	30.7	31.7	28.9	108.2	44.9	45.8	38.1	34.6	24.1	37.0	43.7	44.5	40.8	23.8	17.3	46.8	22.2	24.3	42.1	30.4	35.8	28.7	21.2	24.3	328.1	16.6	30.2	26.7	47.5	26.1	24.2	58.9	47.8	35.8	37.5	232.9	34.5	36.5	18.3	49.2	45.8	43.1	37.3	37.0	57.5	98.2	19.5	64.9	88.0	54.8	60.6	27.4	46.4	91.0	78.4	73.2	45.6	56.4	82.7	52.0	64.4	73.4	67.1	77.7	62.6	39.6	67.6	74.2	82.9	80.6	45.8	37.2	55.4	71.0	82.0	35.2	70.2	49.9	117.2	24.1	55.8	38.5	52.2	39.9	47.0	57.1	94.4	45.5	55.0	106.7	64.9	46.6	75.1	61.6	111.2	50.7	46.5	61.6	82.9	61.9	46.1	86.0	91.2	50.6	84.0	88.4	66.7	123.6	43.8	1.3	2.9	5.7	3.1	3.2	2.7	2.7	2.9	4.0	5.2	3.4	3.2	3.2	1.6	2.4	4.2	2.2	3.0	1.3	43.2	43.1	43.4	48.6	44.9	45.8	43.7	44.5	40.8	42.1	47.5	47.8	49.2	24.2	16.0	5.8	30.7	22.0	15.2	13.7	9.6	13.6	9.4	11.4	6.9	84.9	8.6	18.1	11.0	6.2	8.4	23.6	20.8	17.6	14.2	35.8	19.9	16.6	16.8	23.3	18.7	36.0	10.5	13.5	15.8	18.8	14.5	17.7	11.0	17.2	11.0	18.0	11.8	38.4	10.8	14.2	23.6	24.6	24.5	8.7	21.2	12.4	37.5	22.8	11.1	9.2	32.2	28.6	15.1	19.8	11.3	22.6	11.8	15.8	15.7	24.7	8.6	6.6	21.0	15.3	46.2	14.9	16.0	12.1	8.1	18.8	22.0	18.4	18.7
BTD		ENSG00000169814	Biotinidase	P43251	3	15601341-15722311	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 96.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052275	Uncertain				"Secreted to blood"	NA	NA		2800000000			"HPA052275: AB_2681782"	"unprognostic (6.04e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.37e-3)"	"unprognostic (5.84e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.95e-2)"	"unprognostic (6.37e-3)"	"unprognostic (4.26e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (2.60e-9)"	"unprognostic (2.44e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.67e-3)"	"unprognostic (3.73e-2)"	25.5	16.9	10.6	8.1	12.5	13.3	16.6	19.0	12.7	13.8	10.2	16.1	46.6	13.3	62.9	10.0	18.5	20.0	10.3	11.1	11.3	38.0	96.7	16.0	9.6	12.1	10.4	11.2	25.5	44.5	27.9	6.0	17.1	12.6	19.7	17.1	35.5	16.2	21.3	7.9	9.6	30.9	14.2	10.3	11.4	24.7	18.4	10.5	10.7	27.0	11.5	10.5	14.4	7.5	19.0	9.2	22.0	7.8	7.3	51.7	15.3	39.6	15.4	18.4	16.2	28.3	10.1	21.5	4.1	16.3	31.6	7.1	9.7	5.3	16.7	18.7	7.6	11.7	12.9	28.8	24.8	12.7	8.8	14.7	18.3	16.9	42.9	5.1	39.7	30.5	5.9	8.7	32.3	44.7	11.1	4.5	8.2	8.5	16.9	13.0	5.9	18.4	27.9	16.5	17.7	5.3	11.8	17.9	5.2	24.4	15.1	19.9	11.3	24.3	20.5	13.6	19.1	10.1	8.9	11.4	4.1	21.4	7.7	14.4	74.1	20.7	44.9	22.9	19.6	21.0	14.7	23.3	19.2	21.4	13.1	19.7	15.4	19.8	15.0	15.8	24.9	28.8	16.5	10.6	12.5	19.0	12.7	11.1	11.3	12.1	10.4	11.2	12.6	10.3	10.5	19.0	14.9	6.4	11.0	11.8	11.7	5.9	12.4	25.0	6.2	13.5	9.1	7.9	6.0	45.8	16.7	18.4	18.8	25.3	19.7	9.9	5.9	21.1	31.0	9.5	6.0	9.1	7.2	4.0	6.6	28.5	22.4	14.5	9.7	5.7	5.1	8.9	20.3	63.3	14.9	5.0	12.2	8.5	16.2	8.2	5.9	17.9	32.3	9.2	10.6	5.6	8.7	19.2	6.2	27.2	23.9	12.0	17.9	18.0	16.6	6.3	52.1	32.0	19.8	54.1	13.1	8.5	8.6	45.3	7.5	7.7	5.5	23.1	13.6	17.4	8.9	9.5
BUD13	"Cwc26, fSAP71, MGC13125"	ENSG00000137656	"BUD13 homolog"	Q9BRD0	11	116748170-116772987	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 51.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038340, HPA038341"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA038340: AB_2675967, HPA038341: AB_10671528"	"unprognostic (1.89e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (5.07e-5)"	"unprognostic (1.77e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.23e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.63e-1)"	10.6	7.6	7.6	12.3	8.8	12.8	13.6	10.5	9.4	11.9	8.4	11.5	11.1	15.5	10.6	11.5	13.8	8.2	8.0	7.4	8.4	9.2	9.8	12.3	16.5	8.6	8.2	7.1	16.2	11.3	10.6	8.1	11.1	8.9	10.3	13.5	10.7	10.2	10.7	12.4	11.3	12.9	12.9	7.6	12.8	11.4	21.8	8.6	25.8	12.1	14.1	18.9	11.1	11.3	10.5	22.4	12.0	33.3	20.1	10.4	12.5	16.6	21.6	23.9	24.3	23.5	28.6	33.0	47.1	26.8	17.9	25.4	30.7	27.2	16.8	26.6	27.8	11.1	55.1	8.8	21.8	12.7	46.9	31.6	11.3	19.2	20.6	20.8	15.6	24.0	46.1	36.0	22.8	20.2	17.7	57.5	41.0	20.0	31.6	19.0	42.9	28.6	36.3	17.0	25.5	19.7	26.2	25.3	18.3	10.0	21.0	25.1	30.6	13.7	27.7	17.5	14.3	29.0	9.3	12.4	39.1	9.0	42.6	25.3	15.8	7.6	20.2	10.0	7.8	10.8	10.4	8.6	7.9	8.2	7.4	9.5	8.1	9.1	7.5	8.7	7.2	8.1	5.7	7.6	8.8	10.5	9.4	7.4	8.4	8.6	8.2	7.1	8.9	7.6	8.6	10.5	11.7	9.6	5.6	6.2	14.3	7.6	10.8	7.1	11.4	6.8	6.6	6.0	4.9	2.8	6.5	9.2	12.5	9.2	9.5	11.7	7.9	8.5	13.5	10.4	8.7	8.5	9.6	17.7	7.2	8.1	10.5	7.8	7.1	9.3	11.4	9.6	7.1	8.0	8.2	3.3	6.8	6.9	2.0	12.0	6.7	5.3	9.0	7.8	7.2	3.7	9.4	7.3	26.8	9.0	11.2	6.4	8.5	10.9	16.6	6.4	15.4	5.8	10.9	7.3	6.6	8.5	7.7	51.2	21.8	11.0	4.8	9.9	13.1	7.9	11.3	7.0
C11orf91		ENSG00000205177	"Chromosome 11 open reading frame 91"	Q3C1V1	11	33698261-33700801	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 4.8;testis: 9.6"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 16.6;Late spermatids: 4.0;Sertoli cells: 6.6;Spermatocytes: 12.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 16.2;hTERT-HME1: 10.0;HUVEC TERT2: 8.2;TIME: 12.6;U-2197: 10.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA047064, HPA050487"	Uncertain		Supported	Vesicles		NA	NA			Vesicles		"HPA047064: AB_2679920, HPA050487: AB_2681142"	"unprognostic (9.22e-3)"	"unprognostic (1.51e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.62e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.31e-1)"	"unprognostic (5.68e-3)"	"unprognostic (7.41e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.01e-1)"	"unprognostic (8.33e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.95e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.21e-1)"	4.8	0.2	0.5	0.6	0.4	1.0	1.6	1.3	2.2	0.1	0.1	0.4	0.0	0.2	0.1	3.0	0.3	4.7	0.6	0.4	1.0	0.7	0.2	1.1	0.2	0.6	0.5	0.1	0.2	1.5	0.0	0.1	0.5	0.6	0.2	0.0	0.2	0.5	0.2	0.5	1.0	0.3	0.8	0.4	0.0	2.1	9.6	0.5	0.2	0.4	0.0	0.4	1.4	0.3	0.8	0.2	0.0	0.2	1.5	0.0	0.0	0.0	1.8	0.0	0.9	0.4	0.3	0.6	0.0	0.1	1.9	0.2	0.7	0.5	16.2	1.3	0.5	0.0	0.0	4.0	0.9	0.3	0.0	0.0	0.0	0.1	1.2	10.0	0.5	8.2	0.2	0.0	2.5	3.9	0.0	0.0	0.3	0.0	0.1	5.0	0.0	0.0	0.0	1.1	2.1	0.0	0.3	0.0	1.6	0.1	0.5	0.0	0.0	12.6	1.2	0.3	10.3	0.3	0.7	0.6	0.0	2.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	1.3	2.2	0.4	1.0	0.6	0.5	0.1	0.6	0.4	0.5	0.8	1.2	0.0	0.0	0.3	0.0	0.0	2.2	0.0	0.0	0.0	0.4	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	16.6	0.4	0.2	0.6	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.3	0.1	0.0	6.6	0.1	0.3	12.3	0.4	0.3	0.0	0.1	0.0	0.0	0.0	1.5
C12orf40	FLJ40126	ENSG00000180116	"Chromosome 12 open reading frame 40"	Q86WS4	12	39626167-39908300	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	40	"testis: 8.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 11.5;Late spermatids: 5.2;Spermatocytes: 33.2;Spermatogonia: 7.6"	"Cancer enriched"	"Detected in single"	12	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"K-562: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039032			Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA039032: AB_2676316"					"unprognostic (1.75e-1)"								"unprognostic (2.76e-6)"	"unprognostic (3.45e-1)"	"unprognostic (1.96e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.2	7.6	0.0	0.0	0.0	0.3	0.1	0.0	0.0
C12orf56		ENSG00000185306	"Chromosome 12 open reading frame 56"	Q8IXR9	12	64264762-64390758	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 5.3;testis: 7.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 59.8;Late spermatids: 33.9;Oligodendrocytes: 13.5;Spermatocytes: 19.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"hTEC/SVTERT24-B: 5.2;SCLC-21H: 4.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA056986	Enhanced					NA	NA					"HPA056986: AB_2683300"	"unprognostic (5.85e-3)"	"unprognostic (2.53e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.24e-2)"	"unprognostic (9.35e-4)"	"unprognostic (1.79e-4)"	"unprognostic (9.63e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.51e-2)"	"unprognostic (6.22e-3)"	"unprognostic (4.00e-2)"	"unprognostic (2.38e-4)"	"unprognostic (8.86e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.69e-2)"	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.1	0.5	0.4	5.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.1	0.0	1.4	0.2	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	7.5	0.4	1.9	0.0	0.0	0.0	0.0	1.6	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.3	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.1	4.4	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.1	0.5	0.2	0.3	0.4	0.5	0.0	0.7	0.2	0.4	1.7	0.1	0.0	0.0	3.9	0.5	0.4	1.5	0.4	1.8	0.2	0.0	0.0	1.2	0.0	0.4	0.0	0.0	5.6	0.0	0.7	5.9	0.0	59.8	1.2	0.0	0.2	0.0	0.0	2.0	0.0	4.3	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.9	0.0	2.2	1.7	0.0	0.0	2.2	33.9	0.0	0.2	0.0	0.0	0.0	10.4	0.0	1.5	13.5	0.4	1.0	0.4	0.0	1.0	0.0	9.7	0.5	0.7	0.0	0.0	0.0	19.0	2.3	3.1	0.3	1.8	0.0	0.0	1.4	2.4
C15orf61	LOC145853	ENSG00000189227	"Chromosome 15 open reading frame 61"	A6NNL5	15	67521131-67530146	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 24.0"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 222.6;Spermatocytes: 258.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062820			Approved	Nucleoli,Vesicles,Cytosol	"Secreted - unknown location"	NA	NA			"Nucleoli, Vesicles"	Cytosol	"HPA062820: AB_2684874"	"unprognostic (1.35e-1)"	"unprognostic (9.42e-3)"	"unprognostic (2.11e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.87e-3)"	"unprognostic (8.95e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.04e-2)"	"unprognostic (8.45e-2)"	"prognostic favorable (5.31e-5)"	"unprognostic (2.42e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.32e-2)"	3.9	3.8	2.5	1.6	6.1	5.4	3.6	7.5	4.5	2.7	0.0	2.2	2.8	2.4	1.9	2.1	2.9	1.5	5.0	3.8	2.6	3.1	2.5	2.3	1.3	1.3	3.0	3.8	2.8	4.2	4.4	5.1	2.0	2.3	2.5	2.2	10.9	2.6	2.1	24.0	4.0	1.9	1.4	0.6	1.7	2.4	7.8	1.8	1.4	2.8	8.4	1.0	2.3	2.4	2.5	4.2	4.4	1.1	4.9	5.0	7.2	3.1	1.8	3.2	3.3	2.6	3.4	2.9	3.5	3.8	2.0	3.9	4.9	4.4	1.2	2.7	2.1	10.4	3.7	3.3	4.6	3.2	4.6	3.0	7.5	3.4	1.1	4.0	2.4	1.6	10.6	4.3	7.6	1.0	2.4	3.8	7.6	1.8	3.3	5.6	5.1	2.5	13.0	2.3	2.9	6.4	4.8	3.2	3.0	6.1	2.1	2.7	7.1	1.6	4.4	6.8	5.5	4.7	7.1	11.2	8.5	1.9	9.0	2.2	7.9	4.3	7.8	4.5	3.7	5.2	5.3	5.9	4.5	4.8	3.6	6.2	5.0	0.5	3.8	3.2	4.9	4.0	3.5	2.5	6.1	7.5	4.5	3.8	2.6	1.3	3.0	3.8	2.3	0.6	1.8	2.5	28.0	22.4	13.5	4.9	23.1	67.2	32.6	32.3	120.7	75.5	55.7	82.3	74.5	18.6	14.3	16.5	37.5	42.6	23.8	38.6	80.3	25.1	222.6	17.5	24.2	26.8	27.1	11.8	14.8	29.8	31.9	56.8	15.8	17.1	34.8	15.2	22.9	44.7	30.5	13.5	15.7	47.5	48.8	24.8	25.6	42.6	41.0	19.9	37.4	3.7	15.6	97.1	23.7	5.0	8.5	27.6	48.4	25.6	37.4	63.3	49.0	77.1	8.4	93.9	32.9	38.2	38.7	258.9	52.1	62.7	60.9	20.5	34.4	28.9	39.2	20.0
C16orf71	"DKFZp686H2240, FLJ43261"	ENSG00000166246	"Chromosome 16 open reading frame 71"	Q8IYS4	16	4734344-4749396	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"fallopian tube: 22.7;testis: 74.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 37.1;Late spermatids: 62.0;Respiratory ciliated cells: 22.6;Spermatocytes: 122.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"MCF7: 4.6;U-2197: 5.0"					"Low region specificity"	"Detected in all"			HPA049468	Enhanced		Uncertain	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA049468: AB_2680779"	"unprognostic (1.24e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.39e-1)"	"prognostic favorable (7.49e-4)"	"unprognostic (7.06e-2)"	"unprognostic (2.17e-2)"	"unprognostic (5.36e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.15e-2)"	"unprognostic (6.79e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.56e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.54e-5)"	"unprognostic (1.65e-1)"	0.7	1.3	2.2	0.7	1.8	0.2	0.7	2.4	1.6	1.5	7.2	0.7	0.6	1.0	2.7	0.7	22.7	1.4	0.6	1.5	2.2	1.8	1.4	2.9	0.4	3.7	3.2	0.7	1.2	1.1	0.9	4.1	0.2	2.7	1.1	0.3	1.7	1.2	0.8	1.0	0.6	0.4	0.8	3.4	0.4	0.8	74.5	2.4	0.6	2.0	1.1	0.4	0.7	0.5	1.9	0.3	2.0	0.4	1.1	2.6	1.1	0.8	1.1	0.9	0.9	1.1	0.9	0.8	0.0	1.0	1.6	2.6	0.9	0.9	1.1	0.2	0.4	0.6	0.2	1.5	0.1	0.8	0.9	0.3	0.3	0.2	3.4	0.9	0.7	0.4	0.8	0.7	0.5	0.9	4.6	0.2	0.8	0.6	1.3	1.0	0.3	0.4	1.4	2.3	0.4	3.0	1.1	1.1	0.9	0.3	0.7	4.0	0.2	0.4	0.7	0.8	5.0	0.5	2.0	1.7	0.5	0.4	0.2	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.1	0.1	0.0	0.0	0.3	1.1	0.0	0.1	2.2	1.8	2.4	1.6	1.5	2.2	3.7	3.2	0.7	2.7	3.4	2.4	1.9	0.1	0.0	1.1	1.0	0.1	0.0	0.2	1.0	0.6	0.9	0.6	0.5	1.2	0.0	3.9	0.0	4.2	0.3	0.2	0.2	0.0	0.6	37.1	15.6	0.6	0.2	0.0	0.0	1.0	0.0	0.1	0.3	3.6	0.6	0.0	0.2	0.0	0.3	0.2	0.0	0.9	0.1	0.0	0.0	0.0	62.0	1.2	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.0	1.5	0.0	0.1	0.0	2.4	22.6	1.7	0.0	0.2	0.7	122.1	7.2	0.5	0.0	0.1	0.2	0.3	0.3	0.0
C16orf86	FLJ41802	ENSG00000159761	"Chromosome 16 open reading frame 86"	Q6ZW13	16	67666814-67668757	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"testis: 40.1"	"Group enriched"	"Detected in many"	4	"Early spermatids: 136.7;Spermatocytes: 100.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HSkMC: 3.3;T-47d: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA073475	Enhanced					NA	NA					"HPA073475: AB_2686607"	"unprognostic (1.01e-2)"	"unprognostic (1.38e-2)"	"unprognostic (6.33e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.68e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.87e-2)"	"unprognostic (4.05e-1)"	"unprognostic (8.35e-3)"	"prognostic favorable (1.47e-4)"	"unprognostic (1.59e-1)"	"prognostic favorable (2.12e-7)"	"unprognostic (1.34e-1)"	"unprognostic (4.22e-1)"	"unprognostic (5.92e-2)"	"unprognostic (3.05e-1)"	3.3	2.8	1.9	0.9	1.8	0.6	3.4	1.7	2.8	2.9	1.7	3.1	0.3	3.5	0.3	1.4	3.6	2.2	3.1	1.4	2.0	3.9	2.2	2.0	1.5	2.3	1.8	1.2	2.1	2.4	2.6	2.4	1.2	1.9	2.4	0.5	0.7	1.7	1.5	4.7	1.7	1.8	0.6	1.8	2.4	2.0	40.1	1.9	1.9	2.6	2.8	0.5	3.3	2.1	2.3	0.1	0.3	0.6	0.2	0.9	0.8	0.6	0.8	1.8	0.4	0.6	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.0	1.7	0.0	0.9	3.3	0.0	0.5	0.1	0.6	0.7	1.2	0.1	2.0	0.9	0.0	0.1	0.4	0.3	0.3	0.0	1.3	0.0	1.5	1.8	0.1	0.4	0.2	0.0	0.0	0.0	0.1	2.1	0.3	0.0	0.1	0.0	0.4	0.0	0.3	0.6	0.6	0.7	0.1	0.1	1.1	2.3	3.0	0.7	0.7	1.2	1.9	1.8	1.0	3.8	3.6	0.5	1.1	0.8	0.8	0.7	7.4	1.2	1.8	1.9	1.8	1.7	2.8	1.4	2.0	2.3	1.8	1.2	1.9	1.8	1.9	2.3	6.2	0.0	3.7	5.5	5.8	1.5	2.4	2.6	3.4	7.5	3.6	4.1	1.9	4.3	2.7	5.5	6.2	1.5	5.2	0.3	7.9	3.3	136.7	1.3	3.5	4.8	3.0	0.8	1.1	0.7	0.4	5.6	0.0	0.9	11.4	2.6	5.7	3.1	6.2	5.0	1.9	0.8	2.0	6.0	4.7	25.7	5.6	5.9	3.6	4.7	5.4	13.5	5.2	2.0	2.3	0.9	0.2	7.5	4.5	0.7	0.2	17.8	1.7	8.4	0.0	5.4	4.0	100.9	3.0	1.1	1.6	0.8	2.5	9.2	0.3	0.9
C16orf95		ENSG00000260456	"Chromosome 16 open reading frame 95"	Q9H693	16	87083562-87317420	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"testis: 102.2"	"Group enriched"	"Detected in many"	4	"Early spermatids: 94.6;Late spermatids: 96.2;Spermatocytes: 127.9"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA040850, HPA067924"	Supported		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA040850: AB_10794882, HPA067924: AB_2685924"	"unprognostic (3.51e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.77e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.92e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.23e-1)"	2.5	3.8	1.9	1.2	1.8	3.3	2.2	2.2	3.3	1.1	1.4	1.5	1.4	1.2	0.4	1.5	1.2	0.9	2.6	2.0	1.9	2.6	7.0	1.3	1.3	1.9	2.1	1.8	1.5	3.2	1.3	2.2	0.5	2.1	1.2	0.8	0.6	1.5	0.6	4.3	1.2	1.5	0.4	1.8	1.6	2.2	102.2	2.2	1.7	1.2	3.1	0.8	1.4	1.2	1.8	3.4	9.2	3.2	3.9	3.7	2.1	5.4	3.1	1.3	3.0	2.3	4.4	5.4	8.3	8.6	0.6	3.3	2.7	3.0	2.1	1.4	4.2	5.4	7.9	3.5	6.5	3.2	0.9	1.5	3.7	0.7	3.5	1.1	1.5	2.9	6.1	7.2	4.2	3.6	8.7	3.0	7.4	3.0	2.1	5.5	6.7	1.4	4.8	1.9	1.4	4.0	3.3	7.6	0.4	2.5	1.1	4.5	4.2	3.3	5.5	2.3	3.3	3.0	12.5	10.9	16.2	7.4	8.0	3.8	0.0	2.5	0.6	2.6	2.7	1.8	1.7	2.1	2.3	2.4	1.4	1.7	2.9	0.4	0.7	3.4	3.3	2.9	1.8	1.9	1.8	2.2	3.3	2.0	1.9	1.9	2.1	1.8	2.1	1.8	2.2	1.8	1.9	0.0	1.5	1.0	1.9	1.7	0.5	0.6	6.2	2.5	2.0	2.9	2.4	1.5	0.3	0.0	2.1	2.6	0.4	6.0	1.9	2.8	94.6	0.5	0.4	1.3	0.0	6.9	1.5	3.4	3.4	1.3	4.1	0.4	0.0	0.7	2.2	5.9	2.9	1.7	1.5	3.4	0.0	1.6	1.8	96.2	3.4	0.9	0.0	1.9	2.7	3.7	2.1	1.0	1.8	4.0	2.4	5.3	6.4	0.6	6.4	3.4	1.0	2.2	26.3	0.4	1.8	127.9	8.0	3.0	0.6	1.1	1.1	0.6	5.3	0.4
C17orf64		ENSG00000141371	"Chromosome 17 open reading frame 64"	Q86WR6	17	60392429-60431426	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	173	"testis: 136.3"	"Group enriched"	"Detected in some"	25	"Early spermatids: 1057.0;Late spermatids: 524.2;Spermatocytes: 287.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 2.5"	"Group enriched"	"Detected in many"	4	"dendritic cells: 2.5;granulocytes: 1.0"	"Cell line enriched"	"Detected in some"	4	"MCF7: 5.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA044415	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA044415: AB_10797148"	"unprognostic (3.00e-1)"	"unprognostic (2.60e-2)"		"unprognostic (2.36e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.68e-6)"	"unprognostic (3.30e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.80e-2)"	"unprognostic (5.46e-2)"	0.3	0.1	0.3	0.0	0.2	0.6	0.2	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.4	0.1	0.0	0.1	0.1	0.6	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.5	0.1	136.3	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.3	0.4	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.3	0.8	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.3	0.0	5.8	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.8	0.7	0.1	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.4	0.1	0.0	0.8	0.0	0.0	0.2	1.0	0.0	0.0	2.5	0.0	0.0	0.3	0.2	0.3	0.7	0.2	0.4	0.6	0.2	0.1	0.4	0.3	0.3	0.6	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1057.0	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.4	524.2	9.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	287.9	24.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0
C17orf80	"FLJ20721, HLC-8, MIG3, SPEP1"	ENSG00000141219	"Chromosome 17 open reading frame 80"	Q9BSJ5	17	73232233-73248947	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 170.0;Late spermatids: 100.8;Spermatocytes: 67.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012896	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA012896: AB_1850766"	"unprognostic (9.22e-2)"	"unprognostic (1.62e-1)"	"prognostic favorable (1.43e-4)"	"unprognostic (5.55e-3)"	"unprognostic (8.58e-2)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (9.02e-6)"	"unprognostic (1.08e-1)"	"unprognostic (1.00e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.20e-3)"	"unprognostic (6.09e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.36e-3)"	"unprognostic (1.37e-1)"	8.7	10.2	10.1	9.6	10.5	3.2	11.3	13.2	12.2	12.0	9.3	10.1	10.6	14.6	9.8	8.9	12.4	8.9	15.9	9.9	10.1	12.9	10.0	9.2	13.8	9.3	9.3	9.2	17.3	9.3	16.8	10.7	12.6	10.3	12.7	10.1	23.5	10.8	12.1	24.8	8.8	9.8	12.9	9.4	10.9	10.4	40.0	9.4	18.0	16.2	22.0	12.3	9.2	6.9	10.4	20.0	20.6	28.1	17.2	20.2	17.2	27.2	25.6	22.2	35.6	33.6	19.7	16.1	37.7	17.8	13.2	24.2	19.5	39.4	14.7	41.4	13.8	26.8	34.6	21.5	23.3	17.6	37.0	19.7	13.5	18.1	23.8	19.5	17.8	30.9	25.1	38.3	21.9	24.0	11.5	43.1	17.5	22.3	22.1	22.1	25.7	77.2	19.3	18.4	14.9	34.3	30.8	13.7	24.7	30.0	44.0	27.1	23.0	17.1	37.1	34.0	12.1	24.8	24.7	31.9	35.8	14.9	16.5	24.1	17.3	3.3	4.8	6.6	4.0	6.6	4.9	4.9	5.9	3.8	4.7	4.5	6.6	1.6	4.4	4.4	5.8	7.2	3.4	10.1	10.5	13.2	12.2	9.9	10.1	9.3	9.3	9.2	10.3	9.4	9.4	10.4	10.3	6.4	15.1	10.7	6.4	5.0	2.1	3.0	8.6	10.3	6.1	7.2	20.2	5.7	7.9	5.5	20.9	9.5	14.9	4.6	9.8	6.1	170.0	8.9	12.3	11.0	5.4	1.3	10.8	3.8	5.8	9.6	5.6	7.0	7.6	11.8	5.0	4.6	5.0	8.4	10.9	3.8	6.1	5.1	2.6	100.8	5.3	4.8	1.8	9.4	5.9	10.6	4.1	10.1	9.0	4.5	5.1	7.5	5.9	2.1	6.6	7.5	15.8	15.8	0.0	10.5	7.7	67.1	13.6	7.1	4.4	16.8	5.5	17.9	4.8	1.4
C18orf21	"HsT3108, PNAS-124, PNAS-131"	ENSG00000141428	"Chromosome 18 open reading frame 21"	Q32NC0	18	35972625-35979286	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 145.2;Late spermatids: 76.3;Spermatocytes: 124.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065505, HPA067322"	Uncertain		Approved	"Nucleoli,Plasma membrane"		NA	NA			"Nucleoli, Plasma membrane"		"HPA065505: AB_2685498, HPA067322: AB_2685822"	"unprognostic (7.31e-2)"	"unprognostic (2.14e-3)"	"unprognostic (9.88e-2)"	"unprognostic (8.66e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (1.38e-6)"	"unprognostic (2.53e-3)"	"unprognostic (1.83e-2)"	"prognostic favorable (1.81e-6)"	"unprognostic (2.88e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.21e-2)"	"unprognostic (5.15e-3)"	"unprognostic (2.35e-3)"	"unprognostic (5.97e-2)"	15.8	18.4	16.3	12.9	17.3	72.5	20.7	20.3	19.8	12.9	16.0	14.9	16.3	15.5	18.6	14.8	15.0	12.4	18.5	16.8	17.4	15.2	17.0	12.3	21.9	16.5	16.9	16.8	17.2	23.4	18.1	13.0	14.8	17.1	14.5	13.2	19.4	19.4	13.1	34.3	15.8	15.3	13.1	17.0	18.2	20.0	36.1	17.3	22.1	14.2	26.6	19.0	16.5	12.4	18.0	24.9	17.2	35.3	27.0	25.4	36.2	25.9	34.3	34.9	42.3	44.7	15.8	17.8	22.4	33.7	27.4	26.9	26.2	28.2	28.8	45.7	33.4	30.4	22.5	21.2	35.5	35.3	65.4	26.3	37.9	46.7	38.2	39.3	36.8	37.0	30.6	39.7	34.0	29.4	29.5	42.4	48.0	30.4	11.6	18.9	28.0	30.7	43.0	29.2	29.5	25.5	36.0	25.4	18.8	58.3	32.7	28.2	31.2	24.3	43.3	19.1	15.8	31.0	43.2	41.4	46.0	21.4	37.3	22.1	97.5	28.8	34.2	24.5	30.7	24.2	34.7	25.9	23.2	27.1	30.9	19.8	25.9	28.0	28.8	30.0	26.6	41.5	19.8	16.3	17.3	20.3	19.8	16.8	17.4	16.5	16.9	16.8	17.1	17.0	17.3	18.0	9.6	19.2	6.1	3.9	13.7	11.9	8.9	17.4	18.2	9.6	13.1	16.5	12.7	10.0	12.1	1.8	6.2	19.0	23.0	10.4	11.7	20.2	145.2	13.7	14.7	10.8	7.2	12.4	5.5	28.8	32.0	12.4	8.6	14.4	14.0	12.9	10.0	9.6	21.3	8.4	6.0	12.9	16.2	20.1	10.3	76.3	22.4	14.4	12.4	5.6	24.4	13.1	20.6	4.5	5.1	20.0	14.0	17.0	13.5	11.7	17.8	20.1	5.1	12.1	0.0	14.1	11.3	124.0	35.9	12.8	12.4	13.1	13.6	17.3	15.9	9.3
C19orf67		ENSG00000188032	"Chromosome 19 open reading frame 67"	A6NJJ6	19	14081624-14085875	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	27	"testis: 6.6"	"Group enriched"	"Detected in some"	28	"Early spermatids: 30.0;Late spermatids: 28.2;Spermatocytes: 9.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA046351			Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Cytosol	"Nucleoplasm, Nucleoli"	"HPA046351: "	"unprognostic (1.21e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.40e-1)"	"unprognostic (6.45e-4)"	"unprognostic (1.25e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.76e-3)"	"unprognostic (9.22e-2)"	"unprognostic (1.65e-3)"	"unprognostic (4.20e-3)"	"unprognostic (3.74e-1)"	"unprognostic (1.63e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.94e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.3	0.3	0.0	0.1	0.0	0.0	0.6	0.0	0.5	0.0	0.5	30.0	0.4	0.2	0.1	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	28.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.2	0.1	9.9	0.5	0.0	0.0	0.4	0.0	0.0	0.2	0.2
C1GALT1C1L		ENSG00000223658	"C1GALT1 specific chaperone 1 like"	P0DN25	2	43675151-43676429	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Endometrial stromal cells: 7.0;Muller glia cells: 5.1;Spermatocytes: 18.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 13.1;U-2 OS: 8.2"															NA	NA						"unprognostic (2.18e-1)"	"unprognostic (3.71e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.32e-1)"	"unprognostic (5.71e-3)"	"unprognostic (2.19e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.73e-2)"	"unprognostic (3.81e-3)"	"unprognostic (8.88e-2)"	"unprognostic (1.39e-2)"	"unprognostic (8.86e-2)"	1.4	1.8	0.9	0.4	1.1	0.0	2.1	1.2	1.1	1.7	0.9	1.8	0.3	4.1	6.0	0.3	1.1	0.6	2.3	0.9	1.6	1.8	0.1	0.3	0.2	1.1	1.1	0.8	1.1	1.0	2.0	0.7	0.9	1.0	1.5	0.7	3.9	1.2	2.4	0.5	0.4	0.5	3.2	1.1	0.3	0.5	5.9	0.9	0.2	1.2	0.8	0.3	1.0	0.7	1.1	0.0	0.3	0.0	0.0	2.4	1.2	0.1	0.2	0.4	0.8	1.0	0.5	3.8	0.0	3.7	0.3	3.3	0.3	0.0	0.2	2.0	0.0	2.9	1.7	1.1	0.8	0.8	0.0	0.0	1.6	0.6	2.5	0.1	1.3	2.6	0.0	2.0	0.0	0.2	4.0	0.0	3.7	0.0	0.0	0.0	0.0	1.4	0.0	3.2	0.8	0.1	13.1	0.0	0.2	2.7	0.3	0.9	2.7	0.0	3.3	8.2	0.2	0.8	0.0	2.0	0.0	2.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.1	1.2	1.1	0.9	1.6	1.1	1.1	0.8	1.0	1.1	0.9	1.1	0.9	0.0	0.5	0.0	0.0	0.0	0.5	0.0	1.8	1.0	0.5	1.0	0.5	2.8	0.6	0.0	0.0	0.3	0.1	0.0	0.0	1.3	2.8	1.0	7.0	0.5	0.0	0.0	0.0	0.6	0.3	2.4	0.0	0.3	0.0	1.6	0.7	0.1	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.8	2.5	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.2	0.1	1.9	0.0	0.1	0.1	0.2	1.5	3.7	0.0	1.9	2.1	18.8	2.4	0.2	0.0	0.1	0.0	2.2	0.3	0.1
C1orf167	"DKFZp434E1410, RP11-56N19.2"	ENSG00000215910	"Chromosome 1 open reading frame 167"	Q5SNV9	1	11761787-11789585	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	47	"testis: 28.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 22.4;Early spermatids: 18.0;Late spermatids: 18.7;Spermatocytes: 20.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	54	"U-698: 32.0"					"Not detected"	"Not detected"			HPA039114	Enhanced					NA	NA					"HPA039114: AB_10673606"	"unprognostic (2.93e-3)"	"unprognostic (1.34e-2)"		"unprognostic (7.48e-3)"	"unprognostic (3.96e-1)"	"unprognostic (2.38e-4)"	"unprognostic (2.71e-1)"	"unprognostic (5.55e-3)"	"unprognostic (3.92e-2)"	"unprognostic (5.10e-2)"	"unprognostic (4.90e-3)"	"unprognostic (3.96e-2)"	"unprognostic (8.38e-5)"	"unprognostic (5.46e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.38e-2)"	0.2	0.2	0.1	0.0	0.0	0.0	0.3	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.1	0.1	0.5	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.1	0.3	0.1	28.4	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	32.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	4.5	22.4	2.6	0.0	0.8	1.1	1.4	0.3	0.0	0.5	2.8	1.1	0.6	0.0	0.9	3.7	0.0	0.7	0.3	1.3	1.9	1.2	18.0	1.1	1.9	2.5	0.0	0.0	0.4	8.2	0.3	4.8	4.6	2.4	0.0	0.2	5.0	0.0	0.5	5.0	0.4	0.4	0.0	0.3	1.2	18.7	6.2	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.3	3.8	2.3	3.8	0.6	1.4	1.2	4.2	0.2	0.3	0.0	4.2	3.6	20.0	4.0	0.5	1.7	0.3	0.4	1.8	0.5	3.6
C1orf94	MGC15882	ENSG00000142698	"Chromosome 1 open reading frame 94"	Q6P1W5	1	34166883-34219131	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	21	"testis: 19.8"	"Group enriched"	"Detected in some"	28	"Early spermatids: 65.2;Late spermatids: 27.9;Spermatocytes: 34.6"	"Cancer enriched"	"Detected in single"	10	"glioma: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"NTERA-2: 17.0;U-87 MG: 48.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA045805			Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA045805: AB_10969626"					"unprognostic (1.17e-1)"	"unprognostic (1.38e-1)"				"unprognostic (9.77e-2)"	"unprognostic (4.09e-2)"			"unprognostic (1.65e-2)"	"unprognostic (2.31e-1)"			0.0	0.1	0.5	0.0	0.3	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.5	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	19.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.0	0.0	1.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	48.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.4	0.5	0.3	0.6	0.5	0.5	0.3	0.5	0.7	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	65.2	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	27.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	34.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C22orf23	"EVG1, FLJ32787, LOC84645"	ENSG00000128346	"Chromosome 22 open reading frame 23"	Q9BZE7	22	37943050-37953669	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 96.2"	"Group enriched"	"Detected in some"	7	"Early spermatids: 292.5;Late spermatids: 312.9;Spermatocytes: 241.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 31.8;U-138 MG: 31.4;U-87 MG: 46.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000650			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA000650: AB_2732391"	"unprognostic (6.09e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.42e-5)"	"unprognostic (1.50e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.80e-2)"	"unprognostic (8.18e-3)"	"unprognostic (4.21e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.82e-2)"	"unprognostic (8.46e-2)"	2.9	2.6	4.2	5.6	7.8	3.1	0.8	8.6	4.0	1.6	3.4	2.4	2.9	8.4	1.3	14.1	12.5	6.4	5.2	4.2	5.5	2.3	0.4	5.0	3.6	10.2	9.7	0.7	2.5	8.7	1.1	4.9	5.4	10.0	5.1	0.1	3.5	10.4	0.2	5.7	26.2	3.8	0.1	8.8	2.3	9.0	96.2	8.4	0.2	8.3	0.0	0.1	6.3	1.2	15.6	6.6	5.3	11.1	10.3	0.2	0.4	13.7	18.4	0.5	0.5	0.7	6.3	5.9	3.5	5.0	0.4	11.7	31.8	0.4	0.1	0.6	6.7	13.4	2.0	4.6	4.3	0.5	5.4	4.4	0.4	0.2	2.2	0.2	15.4	0.1	2.6	2.3	2.0	0.1	4.1	0.3	3.2	1.6	6.6	4.6	6.0	16.1	1.3	0.1	29.4	5.6	4.0	8.2	3.2	10.3	17.5	3.6	7.3	27.8	31.4	10.2	25.1	10.0	4.6	2.0	1.6	46.9	2.5	18.3	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	7.8	8.6	4.0	4.2	5.5	10.2	9.7	0.7	10.0	8.8	8.4	15.6	0.2	0.0	2.4	1.3	0.0	0.3	0.1	1.8	0.0	0.2	0.3	0.8	0.1	1.5	1.9	0.0	0.0	0.1	0.1	0.1	1.9	0.4	292.5	16.8	0.6	0.6	0.0	0.0	0.5	0.4	0.1	0.5	0.0	0.5	0.0	0.2	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	312.9	6.8	0.5	0.0	1.0	0.0	2.2	0.0	1.0	5.6	0.3	0.0	5.3	0.0	0.1	0.0	1.8	37.8	1.2	0.0	0.5	0.4	241.3	5.2	0.0	0.0	0.0	0.2	0.3	0.0	0.1
C2orf69	FLJ38973	ENSG00000178074	"Chromosome 2 open reading frame 69"	Q8N8R5	2	199911293-199955935	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 132.1;Spermatocytes: 124.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045225	Approved				"Secreted to blood"	NA	Yes					"HPA045225: AB_10960841"	"unprognostic (6.94e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.17e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.39e-3)"	"unprognostic (1.92e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.02e-2)"	"unprognostic (6.33e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.41e-3)"	"unprognostic (8.87e-2)"	"unprognostic (1.03e-2)"	"unprognostic (5.86e-2)"	9.8	14.2	9.6	6.8	10.7	22.3	7.5	9.6	11.9	5.7	8.0	8.1	8.5	6.4	6.6	6.9	3.9	6.3	6.8	11.2	10.9	9.0	10.1	6.1	7.4	9.8	10.3	10.0	4.8	8.3	9.3	4.2	5.4	9.9	6.5	8.1	10.5	6.2	4.7	9.1	6.5	7.5	7.7	9.8	7.0	7.2	14.8	11.0	5.3	6.8	9.9	7.5	6.9	4.1	12.0	16.1	7.2	13.2	18.0	18.2	22.8	22.3	22.6	13.5	15.0	17.7	16.3	11.4	13.2	12.9	16.0	15.9	12.8	14.1	12.0	25.1	19.8	12.8	20.4	12.4	20.8	10.6	20.7	24.2	11.8	10.5	17.2	14.9	8.1	17.0	8.8	14.9	25.5	25.6	13.9	11.6	18.1	19.4	7.1	19.1	11.0	17.2	11.9	14.8	16.4	21.5	9.4	10.9	8.1	17.4	16.9	12.0	17.7	14.9	23.3	19.0	26.2	18.2	16.7	29.0	13.0	18.6	13.1	12.0	5.4	2.7	7.2	3.6	3.5	5.2	3.1	4.0	3.4	2.4	3.0	4.2	4.5	2.3	2.0	2.7	1.3	4.1	2.8	9.6	10.7	9.6	11.9	11.2	10.9	9.8	10.3	10.0	9.9	9.8	11.0	12.0	13.5	3.2	5.1	12.4	22.9	38.0	29.8	8.8	9.1	21.8	10.1	3.7	11.4	12.8	7.6	16.5	29.2	13.3	11.0	16.4	27.4	12.8	132.1	7.9	10.2	16.1	18.6	27.8	19.4	18.3	18.0	17.0	13.7	7.1	8.2	14.8	23.6	19.7	11.8	13.5	13.9	16.9	10.2	18.0	32.1	78.1	13.4	13.4	16.0	12.2	14.0	56.5	12.3	12.5	27.0	14.6	9.3	21.8	8.6	24.6	18.1	20.4	11.8	26.5	19.7	14.0	14.9	124.3	44.1	15.7	44.9	9.9	18.1	11.1	17.5	19.5
C3orf62	FLJ43654	ENSG00000188315	"Chromosome 3 open reading frame 62"	Q6ZUJ4	3	49268596-49277232	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	8	"neutrophil: 40.0"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 40.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043328			Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA043328: AB_10795613"	"prognostic favorable (3.93e-4)"	"unprognostic (4.87e-3)"	"unprognostic (3.70e-3)"	"unprognostic (2.35e-2)"	"unprognostic (9.51e-2)"	"prognostic favorable (9.72e-4)"	"prognostic unfavorable (5.20e-4)"	"prognostic favorable (8.88e-4)"	"unprognostic (1.28e-1)"	"unprognostic (9.40e-3)"	"prognostic favorable (8.15e-4)"	"unprognostic (7.23e-2)"	"unprognostic (3.27e-2)"	"prognostic favorable (3.29e-5)"	"unprognostic (2.46e-1)"	"unprognostic (4.79e-1)"	"prognostic favorable (1.62e-5)"	6.0	10.5	3.8	4.5	4.5	8.6	5.5	4.8	5.5	5.8	6.6	6.5	3.1	5.7	4.6	7.0	8.0	4.8	6.3	3.9	3.3	4.7	5.6	7.4	4.9	4.2	3.6	3.1	11.4	3.3	3.1	7.8	2.7	5.1	7.6	2.6	9.0	4.2	2.1	4.0	5.5	5.5	2.8	2.9	11.8	4.0	17.4	4.0	4.2	6.1	3.6	3.5	6.4	6.2	4.7	4.3	2.5	5.9	7.4	4.7	4.0	3.3	2.5	4.2	2.2	3.2	3.6	3.2	8.5	3.8	3.9	4.6	3.3	2.9	2.8	2.4	7.5	3.4	5.6	5.8	4.0	1.4	8.0	10.0	3.3	8.1	3.2	6.0	3.8	2.5	4.9	6.5	6.3	1.8	2.7	5.9	5.8	4.2	3.6	3.6	4.4	3.1	4.5	3.6	9.8	4.5	6.1	6.8	5.2	9.1	4.3	2.6	8.8	3.1	3.0	7.3	5.2	4.7	5.5	10.2	7.1	2.2	7.4	4.2	1.0	5.1	5.3	1.2	1.7	1.0	1.9	1.1	1.2	0.6	1.2	0.8	1.0	40.0	0.3	1.7	2.5	1.4	1.3	3.8	4.5	4.8	5.5	3.9	3.3	4.2	3.6	3.1	5.1	2.9	4.0	4.7	8.6	9.6	16.1	4.6	4.4	6.8	3.5	7.9	1.8	12.6	5.7	6.0	9.1	7.2	10.3	11.0	22.9	7.0	7.8	7.6	0.0	4.9	12.4	6.6	9.2	8.1	5.4	7.0	7.3	3.9	4.3	7.3	5.6	10.1	2.5	8.5	9.7	6.3	9.8	5.0	6.1	9.8	2.0	18.0	7.1	17.3	8.7	11.3	8.8	9.4	14.2	7.3	9.2	4.5	7.0	6.0	3.8	8.6	4.6	7.0	4.9	5.2	11.1	13.7	0.0	14.9	6.4	51.8	6.8	4.2	8.7	4.1	6.9	12.1	7.4	2.7
C8orf37	"BBS21, CORD16, FAP418, FLJ30600, MOT25, RP64"	ENSG00000156172	"Chromosome 8 open reading frame 37"	Q96NL8	8	95244913-95269201	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Bardet-Biedl syndrome, Ciliopathy, Cone-rod dystrophy, Disease variant, Obesity, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024198	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			Cytosol	"Plasma membrane, Cell Junctions"	"HPA024198: AB_1845775"	"unprognostic (7.90e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.68e-2)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (2.72e-3)"	"unprognostic (4.20e-3)"	"unprognostic (2.04e-2)"	"unprognostic (8.94e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.11e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.29e-1)"	1.8	1.8	2.5	1.3	2.0	0.9	2.3	2.4	2.2	2.3	3.0	0.9	0.9	2.4	3.1	1.0	3.9	1.4	2.7	1.7	3.5	2.4	1.8	1.6	2.2	2.5	2.7	1.6	4.8	1.2	3.5	2.3	1.8	2.2	2.0	0.9	5.1	1.5	1.7	1.1	1.5	1.0	2.3	3.2	1.7	1.1	1.7	1.9	2.4	2.5	1.9	1.9	1.2	1.4	3.0	2.8	4.5	3.6	1.9	1.2	3.3	1.0	1.2	2.7	1.5	2.0	0.7	6.0	5.6	2.8	2.0	3.8	2.3	1.5	3.1	3.3	1.8	1.4	4.4	2.7	2.0	1.4	0.9	2.3	3.3	1.4	1.8	5.0	3.9	2.3	3.3	2.3	3.2	2.0	2.1	4.8	1.1	1.1	5.6	3.0	2.5	1.9	1.4	3.4	1.2	3.5	3.4	2.5	0.5	2.1	2.7	4.2	0.8	2.0	1.9	2.4	1.6	1.2	2.9	3.0	3.8	3.6	2.1	2.4	0.3	0.3	0.1	0.2	0.2	0.5	0.4	0.3	0.3	0.5	0.8	0.3	0.5	0.4	0.7	0.1	0.2	0.1	0.2	2.5	2.0	2.4	2.2	1.7	3.5	2.5	2.7	1.6	2.2	3.2	1.9	3.0	2.4	3.2	2.6	6.8	2.5	0.9	3.7	2.9	4.0	2.7	1.3	2.4	5.3	0.0	3.3	7.3	2.1	2.5	1.8	0.1	7.9	1.8	10.2	3.4	1.3	1.5	0.0	0.4	6.8	2.7	2.9	2.8	1.1	1.0	0.0	1.9	1.1	3.8	1.3	3.3	5.2	0.1	2.0	1.6	1.2	8.7	3.1	0.8	1.8	1.9	1.8	5.3	0.0	8.5	5.7	1.2	0.2	3.0	0.7	1.9	0.1	4.7	7.9	4.1	0.0	2.5	4.2	6.0	3.5	0.9	1.8	0.8	1.1	3.0	0.5	1.8
C8orf88		ENSG00000253250	"Chromosome 8 open reading frame 88"	P0DMB2	8	90958471-90985238	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 92.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 612.7;Late spermatids: 138.4;Spermatocytes: 329.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 3.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 63.4"					"Low region specificity"	"Detected in all"			HPA078486	Enhanced					NA	NA					"HPA078486: "	"unprognostic (2.17e-1)"	"unprognostic (7.00e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.95e-4)"	"unprognostic (4.07e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.44e-3)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (4.90e-4)"	"unprognostic (1.71e-2)"	"unprognostic (9.89e-2)"	"unprognostic (7.18e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.57e-2)"	"prognostic unfavorable (6.23e-6)"	7.9	3.9	2.2	4.2	2.9	11.1	6.7	2.5	3.0	10.5	4.8	24.1	2.1	21.6	13.2	8.7	12.0	7.2	37.2	2.2	5.7	4.6	1.0	4.8	1.7	3.3	3.0	1.9	13.4	1.3	0.4	4.1	3.5	2.9	14.0	5.8	1.6	2.5	23.7	1.4	6.9	6.6	31.1	3.1	3.0	13.4	92.4	2.8	13.2	11.0	1.8	1.4	19.2	7.9	4.5	0.1	2.4	13.4	1.2	15.4	13.4	0.2	14.6	22.8	19.8	29.7	0.1	3.8	0.3	1.3	14.9	20.6	0.1	0.2	1.1	36.7	0.0	38.6	41.7	11.5	0.0	63.4	0.0	1.3	14.1	0.3	22.3	37.0	28.9	2.1	13.6	25.0	23.9	30.3	0.0	39.7	14.9	3.3	0.0	0.7	0.0	26.1	0.1	16.3	0.1	11.4	19.8	0.6	0.0	19.6	15.1	0.0	1.9	8.5	22.8	38.0	0.3	15.5	33.3	33.4	21.2	22.6	0.0	10.5	0.0	0.0	0.0	0.9	0.0	1.2	1.1	0.8	1.0	0.2	0.9	0.7	1.4	0.0	3.8	0.0	3.2	0.6	0.4	2.2	2.9	2.5	3.0	2.2	5.7	3.3	3.0	1.9	2.9	3.1	2.8	4.5	6.4	0.0	1.1	1.3	2.9	18.9	9.3	1.0	19.4	0.0	0.5	8.6	12.4	2.8	0.1	3.7	0.0	0.2	0.8	0.0	5.9	1.1	612.7	0.3	9.0	4.7	0.0	55.6	3.1	0.0	0.9	13.7	0.0	0.2	2.5	4.9	5.0	0.0	0.6	0.0	6.4	0.0	0.0	0.8	3.8	138.4	19.0	1.7	10.6	1.9	0.6	0.9	0.0	2.0	4.0	3.6	0.0	21.8	3.0	6.6	0.0	1.4	0.1	0.2	19.7	8.2	21.1	329.5	30.7	6.9	26.6	0.0	2.8	2.0	0.0	1.2
C9orf57		ENSG00000204669	"Chromosome 9 open reading frame 57"	Q5W0N0	9	72051376-72072721	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	35	"testis: 13.1"	"Cell type enriched"	"Detected in some"	6	"Spermatocytes: 13.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA								"unprognostic (3.26e-2)"				"unprognostic (1.15e-1)"							"unprognostic (5.05e-2)"				0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CAPN11		ENSG00000137225	"Calpain 11"	Q9UMQ6	6	44158811-44184401	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"testis: 30.6"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 14.0;Breast myoepithelial cells: 11.8;Early spermatids: 24.7;Late spermatids: 9.8;Spermatocytes: 50.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"NTERA-2: 2.2;TIME: 5.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB018070, HPA030955"	Enhanced					NA	NA					"CAB018070: AB_2069481, HPA030955: AB_2673672"	"unprognostic (2.20e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.22e-2)"	"unprognostic (3.34e-2)"	"unprognostic (3.99e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.62e-6)"	"unprognostic (2.38e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.27e-2)"	"unprognostic (8.89e-2)"	1.5	0.4	0.1	0.3	0.2	0.5	2.3	0.4	0.5	0.6	0.1	0.2	0.0	0.3	0.5	0.2	0.3	0.3	0.2	0.3	0.3	0.2	0.1	0.2	0.4	0.2	0.2	0.2	0.0	0.1	0.1	0.1	0.5	0.2	0.3	0.1	0.1	0.4	0.0	0.1	0.8	0.4	0.3	0.1	0.1	0.2	30.6	0.2	2.2	0.3	0.2	0.3	0.5	0.5	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.2	0.2	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	5.8	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.4	0.5	0.3	0.3	0.2	0.2	0.2	0.2	0.1	0.2	0.4	14.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	11.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	24.7	0.0	0.0	3.9	0.0	2.7	0.5	0.0	0.0	0.7	0.0	0.2	0.0	0.1	1.1	0.0	1.3	0.0	0.3	0.1	0.0	0.3	0.3	9.8	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.7	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.2	50.0	0.9	0.1	0.0	0.0	0.1	0.1	0.1	0.1
CARTPT	CART	ENSG00000164326	"CART prepropeptide"	Q16568	5	71719275-71721048	"FDA approved drug targets, Human disease related genes, Predicted secreted proteins"		"Neuropeptide, Neurotransmitter"	"FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"adrenal gland: 119.8;brain: 251.1"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 47.4;Early spermatids: 25.4;Prostatic glandular cells: 39.5;Spermatocytes: 55.7"	"Cancer enriched"	"Detected in many"	9	"breast cancer: 117.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"hippocampal formation: 209.0"	"CAB025515, HPA046278, CAB079776"	Enhanced	Supported			"Secreted to blood"	NA	NA					"CAB025515: , CAB079776: , HPA046278: AB_10961570"			"unprognostic (1.37e-1)"		"unprognostic (1.43e-1)"					"unprognostic (2.27e-1)"	"unprognostic (3.45e-2)"	"unprognostic (6.67e-2)"		"prognostic unfavorable (4.36e-4)"		"unprognostic (1.14e-1)"		2.4	119.8	87.8	4.4	23.1	0.0	9.4	8.4	59.1	0.0	9.3	11.1	5.5	2.9	0.7	0.3	0.4	0.2	0.1	32.3	71.3	0.0	0.0	0.1	0.0	76.0	116.3	16.1	0.1	0.5	0.0	5.3	0.0	236.6	8.6	4.6	21.6	0.1	0.0	0.0	0.1	3.4	15.3	25.6	0.0	14.7	7.2	122.3	0.3	5.5	0.0	0.0	0.0	0.3	251.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.8	23.1	8.4	59.1	32.3	71.3	76.0	116.3	16.1	236.6	25.6	122.3	251.1	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	47.4	0.2	0.3	0.1	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	25.4	1.6	0.1	1.0	7.1	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.6	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.1	0.0	0.0	1.2	0.0	39.5	0.0	0.0	0.0	8.1	0.0	0.0	0.1	55.7	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2
CBARP	"BARP, C19orf26, DOS, MGC40084"	ENSG00000099625	"CACN subunit beta associated regulatory protein"	Q8N350	19	1228287-1238027	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 15.9;pituitary gland: 22.5"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 21.8;Early spermatids: 55.9;Late spermatids: 97.4;Spermatocytes: 54.8"	"Cancer enhanced"	"Detected in many"		"glioma: 4.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SH-SY5Y: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012777			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA012777: AB_2067005"	"unprognostic (1.31e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.54e-5)"	"unprognostic (3.48e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.86e-3)"	"unprognostic (3.03e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.40e-1)"	"unprognostic (7.42e-5)"	0.8	2.7	6.2	0.1	6.8	0.0	0.4	1.6	15.9	0.5	0.0	0.4	0.1	0.5	0.0	1.4	0.5	0.1	1.4	12.6	13.6	1.9	0.3	1.0	0.0	6.1	1.5	6.2	5.0	0.4	0.0	22.5	0.1	5.6	0.8	0.0	0.3	0.4	0.1	0.4	3.0	0.2	0.0	0.2	0.1	0.4	1.7	2.3	0.0	0.6	0.0	0.0	0.3	0.9	1.5	0.3	0.4	1.1	3.1	0.1	0.5	0.4	2.7	0.8	0.5	0.5	1.1	0.1	0.0	2.7	0.5	0.3	0.9	0.4	0.6	0.1	0.5	0.7	0.1	1.1	0.9	1.4	0.0	1.0	0.6	0.2	0.6	0.1	0.5	0.4	0.5	1.7	0.0	0.3	2.3	0.0	0.6	1.6	0.1	1.2	2.0	0.4	0.2	0.1	0.2	1.4	4.2	0.0	0.0	3.1	0.1	0.4	0.5	1.2	0.7	2.6	2.3	0.7	0.1	0.2	0.0	0.7	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	6.8	1.6	15.9	12.6	13.6	6.1	1.5	6.2	5.6	0.2	2.3	1.5	1.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	1.2	21.8	1.7	1.8	0.0	1.5	0.0	0.0	2.1	0.0	0.6	0.0	1.9	0.1	55.9	0.9	2.2	0.7	0.0	0.0	0.0	0.2	0.1	1.2	1.1	1.6	0.0	0.9	1.4	0.1	0.3	3.3	0.0	0.0	0.0	0.8	0.0	97.4	1.8	1.2	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.9	0.0	0.2	0.0	1.7	0.0	0.7	1.4	54.8	7.0	1.1	0.0	0.0	0.3	0.1	0.0	0.3
CCDC110	"CT52, KM-HN-1, MGC33607"	ENSG00000168491	"Coiled-coil domain containing 110"	Q8TBZ0	4	185445182-185471752	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"pancreas: 31.0;testis: 100.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 796.2;Late spermatids: 175.5;Spermatocytes: 552.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 8.4;U-266/70: 5.3;U-266/84: 8.8;U-87 MG: 4.0"					"Low region specificity"	"Detected in many"			HPA078808			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA078808: "	"unprognostic (1.18e-1)"	"unprognostic (7.26e-3)"	"unprognostic (5.42e-2)"	"unprognostic (9.84e-4)"	"unprognostic (3.72e-2)"	"unprognostic (3.08e-3)"	"unprognostic (1.95e-5)"	"unprognostic (4.92e-2)"	"unprognostic (5.81e-2)"	"unprognostic (9.94e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.64e-1)"	"prognostic favorable (1.08e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.21e-2)"	0.5	1.0	2.0	1.0	3.3	0.0	3.6	2.9	2.3	2.7	1.5	1.8	0.9	1.4	5.1	1.8	3.0	1.2	1.1	1.2	1.8	2.5	0.8	0.9	1.2	2.0	1.8	1.1	4.6	31.0	2.0	2.9	0.8	2.7	2.3	1.9	8.0	6.2	2.0	2.1	1.1	0.8	1.4	1.7	0.6	2.5	100.9	1.5	0.4	7.8	0.9	0.7	1.3	0.5	1.4	0.4	0.0	0.2	0.1	2.2	2.4	0.1	0.0	0.0	0.0	0.2	0.0	1.7	2.7	0.3	0.0	2.3	0.3	1.7	0.0	0.2	1.0	1.7	0.0	0.2	0.0	1.1	0.0	0.0	0.6	0.0	1.0	0.0	1.4	0.8	0.7	0.2	0.2	2.9	0.7	0.0	0.0	0.2	0.3	1.3	0.1	0.0	0.4	0.6	0.0	8.4	1.5	0.0	0.9	0.7	0.4	3.8	0.0	0.5	0.3	0.7	0.1	0.1	5.3	8.8	0.0	4.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	3.3	2.9	2.3	1.2	1.8	2.0	1.8	1.1	2.7	1.7	1.5	1.4	0.4	0.0	0.0	0.7	0.9	0.3	0.4	0.3	1.8	0.5	2.9	4.7	4.2	0.0	0.0	1.8	0.0	0.1	0.0	0.3	1.9	2.6	796.2	1.8	0.2	1.2	0.0	0.0	3.5	3.5	0.1	2.1	0.5	1.0	0.0	0.2	2.2	0.5	0.1	0.0	1.3	1.1	4.1	0.0	0.3	175.5	7.2	0.9	3.6	1.9	0.1	3.1	1.0	0.5	1.8	2.2	0.3	6.0	9.3	0.4	0.0	2.3	4.4	5.3	0.0	1.7	2.5	552.8	6.1	1.5	0.4	0.0	0.3	0.7	1.1	0.1
CCDC112	MGC39633	ENSG00000164221	"Coiled-coil domain containing 112"	Q8NEF3	5	115267190-115296693	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 41.0"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 201.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 113.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045120, HPA050621"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA045120: AB_2679222, HPA050621: AB_2681191"	"unprognostic (1.88e-2)"	"unprognostic (5.10e-2)"	"unprognostic (4.63e-2)"	"unprognostic (5.60e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.32e-6)"	"unprognostic (4.30e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.41e-2)"	"unprognostic (3.33e-1)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (1.51e-6)"	"unprognostic (7.00e-2)"	"unprognostic (2.79e-2)"	"unprognostic (8.61e-2)"	"unprognostic (4.10e-3)"	4.3	3.7	6.3	5.4	6.8	7.4	6.1	8.0	7.4	4.5	3.7	9.2	7.3	5.7	6.3	4.5	4.1	3.2	6.0	6.4	6.1	2.8	1.2	5.5	4.6	6.7	6.8	5.8	2.1	10.2	4.5	4.6	2.5	7.1	6.8	9.4	8.0	6.5	5.0	4.3	5.0	6.3	5.5	6.0	4.6	6.4	41.0	6.3	3.7	4.0	2.5	4.2	3.8	3.6	8.5	12.0	5.9	11.5	18.5	7.1	14.0	2.9	10.5	5.3	7.7	8.7	2.6	6.7	14.8	8.9	7.2	11.4	7.5	12.1	6.0	16.0	12.0	10.1	9.8	8.8	3.8	9.7	12.9	4.8	6.4	7.2	9.8	13.0	8.8	12.1	13.1	4.1	11.6	10.8	9.3	19.2	11.4	13.1	11.0	11.0	20.6	14.5	113.7	7.7	4.2	17.9	23.5	11.5	7.2	32.8	7.8	12.2	18.9	12.6	10.1	6.9	19.7	14.8	13.2	13.2	3.0	6.7	9.9	6.0	0.3	5.0	11.0	2.9	4.0	3.3	2.8	2.2	2.5	5.4	4.0	2.8	1.9	3.2	3.0	4.9	10.2	0.1	2.1	6.3	6.8	8.0	7.4	6.4	6.1	6.7	6.8	5.8	7.1	6.0	6.3	8.5	15.7	16.0	14.0	16.0	19.2	14.1	5.0	6.0	8.0	29.2	19.4	18.4	17.6	8.6	8.4	5.5	10.4	0.7	19.5	23.6	5.9	28.2	8.5	23.0	21.4	12.4	40.6	20.8	26.4	25.9	2.0	11.5	14.3	12.3	9.5	15.0	7.9	3.1	32.7	10.1	15.2	33.4	6.1	28.6	31.5	18.5	4.1	31.5	14.2	15.0	36.6	11.0	11.3	21.1	54.7	27.1	18.7	4.1	27.3	8.0	11.8	4.4	11.7	24.9	13.1	18.5	18.2	201.8	73.3	13.8	22.6	0.5	9.2	5.5	32.8	3.4
CCDC144A	"FLJ43983, KIAA0565"	ENSG00000170160	"Coiled-coil domain containing 144A"	A2RUR9	17	16689537-16777881	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"testis: 9.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 54.2;Early spermatids: 59.1;Rod photoreceptor cells: 49.4;Spermatocytes: 165.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 9.5;TIME: 8.5"									"HPA022996, HPA047220, HPA047851, HPA066260"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA022996: AB_1846136, HPA047220: AB_2679989, HPA047851: AB_2680182, HPA066260: "	"unprognostic (8.54e-2)"	"unprognostic (4.49e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.69e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.54e-1)"	"unprognostic (9.49e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.74e-1)"	1.3	1.3	0.8	2.1	2.8	4.2	1.5	6.7	4.8	1.1	0.0	1.5	0.8	3.6	2.5	0.8	1.6	1.2	1.1	4.5	5.9	0.5	1.1	1.3	1.7	2.8	2.2	0.3	4.6	2.8	0.4	1.6	2.7	6.8	1.5	0.9	7.4	1.2	1.0	1.1	2.5	1.0	1.6	2.1	1.8	1.5	9.2	1.2	3.4	0.8	2.3	1.2	1.7	0.9	4.8	0.5	3.4	0.8	2.1	3.0	9.5	0.4	0.2	0.0	0.2	0.2	4.4	0.1	0.5	2.8	6.2	0.2	5.3	4.4	0.3	0.2	3.2	0.2	0.4	0.5	0.3	0.2	0.7	2.7	1.7	0.1	2.1	0.2	0.9	0.1	0.1	0.4	0.3	2.0	0.1	0.0	1.1	0.6	0.9	0.4	1.4	0.2	0.1	0.1	4.1	1.1	1.2	0.6	0.2	1.2	1.5	3.4	0.1	8.5	0.7	0.4	4.6	1.4	5.7	6.3	0.2	0.3	6.2	1.6	0.2	0.1	0.0	0.5	0.1	0.3	0.2	0.5	0.3	0.1	0.1	0.9	0.5	0.2	0.2	0.4	0.2	0.5	0.0	0.8	2.8	6.7	4.8	4.5	5.9	2.8	2.2	0.3	6.8	2.1	1.2	4.8	5.9	0.0	14.9	15.7	3.1	4.0	6.4	1.9	0.0	40.8	4.5	2.5	2.8	2.8	2.9	0.0	54.2	4.9	6.4	1.7	0.0	1.8	59.1	8.0	25.8	9.1	1.2	1.7	21.2	0.0	7.1	9.7	2.0	10.4	26.0	6.2	3.6	2.0	4.2	33.7	19.8	2.4	2.0	6.8	7.7	6.5	7.2	6.3	5.4	1.0	3.6	7.1	6.2	17.1	4.0	1.7	3.8	9.1	1.7	8.6	1.2	1.1	3.9	49.4	6.6	11.7	10.2	165.9	36.1	0.2	3.7	1.9	6.9	22.2	2.1	4.6
CCDC158	FLJ25770	ENSG00000163749	"Coiled-coil domain containing 158"	Q5M9N0	4	76312997-76421868	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"testis: 33.8"	"Group enriched"	"Detected in some"	7	"Early spermatids: 88.5;Late spermatids: 81.7;Spermatocytes: 66.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.31e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.49e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.60e-3)"	"unprognostic (6.99e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.18e-1)"	"unprognostic (9.77e-3)"	"unprognostic (6.22e-2)"	"unprognostic (3.65e-2)"	"unprognostic (9.29e-2)"	"unprognostic (2.68e-1)"	0.5	0.1	0.2	0.0	0.1	0.0	1.1	0.3	0.4	0.1	0.0	0.1	0.0	0.2	0.9	0.1	0.2	0.2	0.4	0.1	0.6	0.5	1.6	0.1	0.0	0.3	0.4	0.0	0.0	0.3	0.0	0.5	0.0	0.4	0.5	0.0	0.2	0.5	0.3	0.0	0.0	0.0	0.4	0.5	0.0	0.0	33.8	0.3	0.0	1.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.4	0.1	0.6	0.3	0.4	0.0	0.4	0.5	0.3	0.4	0.0	0.0	0.0	1.3	0.0	0.1	0.2	0.0	0.0	0.7	1.0	2.4	0.8	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	88.5	2.3	0.1	0.1	0.0	0.0	10.9	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	1.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	81.7	0.6	0.3	0.0	0.0	0.0	1.1	0.0	3.0	3.0	0.1	0.0	0.7	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.3	0.2	66.7	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1
CCDC171	"bA536D16.1, bA778P13.1, C9orf93, Em:AL513423.1, FLJ39267, FLJ46740"	ENSG00000164989	"Coiled-coil domain containing 171"	Q6TFL3	9	15553043-16061663	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 11.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 194.5;Excitatory neurons: 92.4;Inhibitory neurons: 70.6;Late spermatids: 172.4;Spermatocytes: 148.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Daudi: 7.5;HEL: 11.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA019803, HPA019806, HPA024133"	Uncertain		Approved	Nucleoplasm,Nucleoli		Yes	No			Nucleoplasm	Nucleoli	"HPA019803: AB_1845846, HPA019806: AB_1845847, HPA024133: AB_1845848"	"unprognostic (1.35e-2)"	"unprognostic (2.03e-4)"	"unprognostic (7.22e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.76e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.92e-3)"	"unprognostic (7.80e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.91e-3)"	0.8	1.1	2.4	0.7	3.1	2.1	1.6	4.1	3.5	1.4	0.1	0.9	0.8	5.9	1.1	1.0	2.0	1.5	1.0	2.7	0.8	1.2	0.4	1.1	1.1	1.9	1.1	2.2	3.0	1.3	1.4	1.1	0.9	2.4	1.2	1.1	5.5	0.8	1.3	0.8	2.4	1.0	3.3	0.4	0.6	1.4	11.4	0.8	4.9	2.0	1.1	1.0	0.8	0.9	3.8	1.4	0.7	1.6	1.6	0.9	1.9	1.0	1.0	0.8	1.0	1.1	0.4	0.6	7.5	0.5	0.6	1.9	0.3	0.7	1.0	1.1	1.6	0.7	11.7	1.2	1.0	1.3	1.6	1.4	1.1	1.9	0.8	1.5	0.8	0.5	4.1	0.3	2.0	1.2	0.5	3.3	1.5	1.3	0.6	1.6	3.8	1.2	0.2	0.7	1.1	2.3	1.1	2.1	0.7	2.8	1.3	0.9	1.1	0.8	2.1	1.2	0.6	0.7	1.1	1.4	4.8	0.9	1.0	1.5	2.4	0.2	0.0	0.2	0.2	0.6	0.2	0.2	0.2	0.2	0.6	0.1	0.2	0.1	0.1	0.1	0.2	0.2	0.0	2.4	3.1	4.1	3.5	2.7	0.8	1.9	1.1	2.2	2.4	0.4	0.8	3.8	4.4	0.0	7.5	56.8	2.6	2.8	5.8	1.8	7.4	27.7	5.0	8.0	8.5	0.0	5.9	3.7	16.7	6.7	1.4	3.6	5.9	2.9	194.5	24.3	7.8	3.8	1.2	3.8	92.4	3.5	4.1	5.7	8.2	12.9	1.3	7.6	3.3	0.8	1.9	10.1	70.6	3.5	6.1	1.0	1.1	172.4	5.9	2.1	0.0	16.9	1.6	12.5	5.2	54.8	63.1	2.5	1.0	6.0	1.9	0.8	2.8	2.1	12.0	44.0	13.1	11.6	5.7	148.2	40.6	5.4	3.3	5.6	3.6	10.7	4.9	3.7
CCDC174	"C3orf19, FLJ33839"	ENSG00000154781	"Coiled-coil domain containing 174"	Q6PII3	3	14651746-14672659	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 152.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043468, HPA060129"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043468: AB_2678493, HPA060129: AB_2684208"	"unprognostic (6.10e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.26e-2)"	"unprognostic (6.58e-3)"	"unprognostic (5.06e-2)"	"unprognostic (6.48e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.86e-2)"	"prognostic unfavorable (4.75e-4)"	"unprognostic (1.15e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.64e-1)"	"prognostic favorable (3.81e-5)"	8.7	7.0	8.1	7.0	8.9	17.4	9.3	9.2	8.6	10.8	7.3	9.5	9.4	10.5	7.6	8.9	9.4	6.9	8.3	8.2	8.4	9.0	8.8	7.1	9.6	9.2	8.7	7.7	14.8	10.2	12.0	8.6	8.6	8.6	9.8	7.4	6.8	8.7	8.0	11.2	9.8	9.6	8.0	8.1	10.7	10.4	9.1	8.7	11.8	9.1	10.8	10.3	9.7	9.6	10.0	6.2	6.7	10.0	10.7	13.6	11.1	25.3	8.1	11.6	10.0	7.8	7.5	7.0	12.8	5.8	7.2	6.8	5.3	7.3	6.8	7.8	9.7	8.9	13.0	8.1	8.1	19.7	12.9	14.5	12.9	17.0	13.5	16.5	14.0	8.6	13.4	13.2	11.4	7.6	10.9	13.6	11.3	13.5	10.1	10.9	10.1	9.3	10.6	10.4	10.8	4.8	13.1	9.5	7.4	13.4	11.6	11.2	18.1	8.0	8.0	7.8	7.4	9.5	15.0	14.3	14.7	8.0	9.8	11.1	25.4	10.7	22.2	12.9	11.3	15.2	17.4	16.1	15.1	9.7	16.4	17.4	13.8	20.5	18.8	12.2	10.9	12.5	10.0	8.1	8.9	9.2	8.6	8.2	8.4	9.2	8.7	7.7	8.6	8.1	8.7	10.0	29.5	9.6	34.5	11.4	48.0	16.2	31.3	38.0	26.7	32.8	25.0	28.4	37.0	32.9	35.7	12.9	20.9	32.1	42.3	27.3	56.7	34.7	152.5	27.3	35.4	31.0	18.5	43.4	12.8	34.9	25.2	33.7	20.4	34.7	52.0	22.0	38.6	29.3	26.5	15.2	16.6	34.1	32.6	27.2	16.5	59.1	33.5	30.5	14.2	5.6	45.2	22.2	34.0	11.1	15.8	38.2	34.9	40.3	34.9	28.8	36.8	46.4	31.1	24.9	32.9	28.4	37.2	78.7	33.5	19.9	13.5	65.7	41.6	23.5	23.1	31.8
CCDC178	"C18orf34, FLJ44050"	ENSG00000166960	"Coiled-coil domain containing 178"	Q5BJE1	18	32937402-33441101	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 9.6;testis: 15.4"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 29.2;Early spermatids: 89.0;Late spermatids: 76.8;Spermatocytes: 49.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	17	"HUVEC TERT2: 5.1;U-87 MG: 4.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.15e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.69e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.58e-3)"	"unprognostic (2.92e-1)"	"unprognostic (5.95e-4)"	"unprognostic (4.12e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.94e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.42e-3)"	"unprognostic (9.03e-3)"	9.6	0.3	0.2	0.2	0.3	0.0	7.9	0.1	0.5	2.7	0.2	0.8	0.5	1.3	2.2	0.6	1.6	2.5	0.4	0.3	0.3	2.8	0.1	0.7	0.2	0.4	0.5	0.3	4.0	0.2	0.1	0.6	0.0	0.3	3.5	0.5	0.1	0.5	2.0	0.3	0.6	0.6	1.6	0.4	7.7	0.6	15.4	0.2	0.1	0.8	0.0	0.6	2.1	2.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.5	0.3	0.3	0.4	0.5	0.3	0.3	0.4	0.2	0.2	29.2	0.0	0.0	0.3	0.0	0.4	0.4	0.0	2.2	0.0	0.1	0.4	0.3	0.0	0.0	1.8	0.0	0.0	0.1	0.0	9.8	0.0	89.0	0.6	0.3	12.8	0.0	0.0	7.9	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	6.1	0.0	0.0	0.0	0.0	76.8	1.8	0.2	0.0	2.8	0.0	0.0	0.0	1.0	1.1	0.0	0.0	0.7	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.2	49.4	16.3	0.1	0.3	0.0	0.0	6.1	0.0	0.0
CCDC38	FLJ40089	ENSG00000165972	"Coiled-coil domain containing 38"	Q502W7	12	95867048-95942635	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 17.0"	"Group enriched"	"Detected in some"	31	"Early spermatids: 93.8;Late spermatids: 33.8;Spermatocytes: 60.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.76e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.54e-3)"	"unprognostic (2.00e-2)"	"unprognostic (3.62e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.61e-3)"	"unprognostic (3.29e-1)"	"unprognostic (5.11e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.25e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.96e-5)"	"unprognostic (1.08e-2)"	0.1	0.7	0.3	0.2	0.2	0.7	0.1	1.1	0.4	0.1	0.2	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.3	0.2	0.3	2.8	0.1	0.2	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.4	0.1	0.0	0.5	0.2	0.0	0.8	0.2	0.1	0.1	0.0	0.7	0.1	17.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.6	0.1	0.3	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.4	0.2	0.1	0.0	0.1	0.3	0.2	0.2	0.2	0.1	0.0	0.3	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.5	0.0	0.2	0.0	0.1	0.1	0.2	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.3	0.7	0.2	0.2	0.4	0.1	0.1	0.2	0.0	0.2	0.2	0.3	0.0	0.3	0.4	0.2	0.2	0.1	0.2	0.3	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.5	0.1	0.0	0.1	0.1	0.0	0.3	0.2	1.1	0.4	0.3	0.2	0.2	0.1	0.1	0.4	0.0	0.1	0.6	0.4	0.0	0.0	0.3	0.3	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	93.8	0.1	0.1	0.4	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	2.0	0.1	0.0	1.3	0.0	0.0	0.3	0.0	33.8	1.2	0.2	0.0	0.0	0.0	0.5	0.0	1.5	0.9	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.0	0.4	0.0	0.0	0.0	60.7	1.8	0.0	0.0	0.1	0.3	0.1	0.0	0.1
CCDC42	"CCDC42A, FLJ32734"	ENSG00000161973	"Coiled-coil domain containing 42"	Q96M95	17	8729935-8745219	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	292	"testis: 95.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 103.6;Late spermatids: 52.2;Spermatocytes: 284.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.66e-1)"	"unprognostic (2.92e-2)"		"unprognostic (2.30e-2)"	"unprognostic (3.60e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.13e-4)"	"unprognostic (8.35e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.36e-3)"	"unprognostic (6.08e-2)"	"unprognostic (1.04e-5)"	"unprognostic (5.74e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.32e-2)"	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.3	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	95.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.3	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	103.6	0.0	0.0	0.2	0.0	2.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	52.2	4.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.1	284.7	3.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0
CCDC62	"CT109, ERAP75, FLJ40344, TSP-NY"	ENSG00000130783	"Coiled-coil domain containing 62"	Q6P9F0	12	122774526-122827528	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	32	"testis: 70.7"	"Group enriched"	"Detected in some"	13	"Early spermatids: 259.2;Late spermatids: 75.0;Spermatocytes: 188.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"U-2 OS: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA039021, HPA058741"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA039021: AB_10673604, HPA058741: AB_2683805"	"unprognostic (3.39e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.46e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.21e-4)"	"unprognostic (5.23e-1)"	"unprognostic (6.39e-6)"	"unprognostic (2.78e-2)"	"unprognostic (6.18e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.25e-4)"	0.2	0.4	1.4	0.2	1.4	0.2	0.1	0.9	1.6	0.3	0.0	0.1	0.2	0.1	0.1	0.2	0.1	0.2	0.1	1.4	0.6	0.1	0.1	0.1	0.3	0.8	0.7	1.8	0.1	0.1	0.3	0.7	0.0	1.1	0.1	0.1	1.4	0.1	0.1	0.7	0.4	0.2	0.1	0.6	0.6	0.1	70.7	0.7	0.2	0.1	0.3	0.3	0.1	0.1	2.2	0.1	0.1	0.1	0.3	0.0	0.3	0.3	0.0	0.1	0.3	0.1	0.0	0.2	0.8	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.2	0.3	0.9	0.1	0.0	0.0	0.6	0.8	0.1	0.3	0.4	0.1	0.1	0.0	0.7	0.3	0.2	0.4	0.1	0.0	1.2	0.1	0.0	0.5	0.8	0.2	0.0	0.2	0.1	0.5	0.0	0.0	0.3	0.4	0.2	0.0	0.6	0.1	0.2	2.9	0.1	0.1	0.3	0.3	0.2	0.0	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.3	0.0	1.4	1.4	0.9	1.6	1.4	0.6	0.8	0.7	1.8	1.1	0.6	0.7	2.2	0.5	0.0	0.0	9.1	2.1	0.5	0.2	0.1	0.6	1.4	0.4	0.5	1.0	0.0	0.0	0.0	4.2	0.1	0.6	0.1	0.0	0.3	259.2	0.5	0.4	0.4	0.0	0.0	11.7	0.2	0.6	0.2	0.0	0.7	0.0	0.2	0.0	0.0	0.1	1.7	8.1	0.2	0.0	0.3	1.7	75.0	3.1	1.3	1.8	3.7	0.2	0.5	1.0	5.0	8.0	0.1	0.0	2.6	0.3	0.5	0.1	0.0	0.0	1.3	13.1	0.5	0.2	188.2	2.9	0.4	0.9	0.0	0.3	0.2	0.3	0.2
CCDC83	"CT148, FLJ42119, KP-CoT-23, MGC34732"	ENSG00000150676	"Coiled-coil domain containing 83"	Q8IWF9	11	85855101-85920021	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	132	"testis: 35.8"	"Group enriched"	"Detected in some"	46	"Early spermatids: 222.2;Late spermatids: 194.2;Spermatocytes: 160.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"MCF7: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA039707, HPA039882"			Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane, Cytosol"		"HPA039707: AB_10795259, HPA039882: AB_10795410"	"unprognostic (1.14e-1)"				"unprognostic (4.09e-1)"					"unprognostic (1.49e-2)"		"unprognostic (4.43e-2)"	"unprognostic (7.05e-6)"	"unprognostic (3.52e-1)"			"unprognostic (2.17e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	222.2	0.1	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	194.2	4.1	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	160.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CCDC86	MGC2574	ENSG00000110104	"Coiled-coil domain containing 86"	Q9H6F5	11	60842113-60851081	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"parathyroid gland: 380.6"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 74.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041117, HPA041540"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA041117: AB_10794984, HPA041540: AB_10794299"	"unprognostic (2.93e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.47e-3)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (7.36e-5)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (1.65e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.12e-2)"	"unprognostic (4.47e-1)"	"unprognostic (3.76e-2)"	"unprognostic (7.54e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.25e-2)"	23.2	26.9	11.7	14.5	13.0	10.3	20.9	12.7	14.3	13.0	10.4	14.0	11.5	16.8	3.6	19.6	15.3	7.0	14.3	12.3	12.9	13.1	13.8	11.9	11.7	13.0	12.8	11.2	13.9	24.1	380.6	25.1	11.7	13.1	24.2	5.8	8.3	12.3	8.7	35.0	22.7	12.4	10.5	12.5	12.8	16.6	49.3	12.3	8.9	13.0	13.8	8.6	20.4	14.6	14.0	83.4	110.2	26.5	76.1	21.8	35.7	36.3	54.3	42.4	98.1	52.4	95.0	53.7	98.9	100.7	31.0	69.7	73.3	94.2	65.7	48.2	35.7	101.3	51.0	45.8	133.2	70.7	80.7	82.6	39.5	48.7	90.2	61.8	14.3	75.8	53.5	166.0	46.9	50.3	97.3	125.2	122.6	107.0	48.6	156.3	81.4	39.6	253.5	37.2	33.8	59.9	38.9	34.7	79.5	64.6	17.6	80.8	30.3	45.9	93.6	59.6	131.6	118.2	41.0	66.5	109.2	78.2	86.0	118.6	1.7	13.5	4.2	9.1	29.4	9.7	9.4	9.6	8.3	29.8	9.0	11.5	10.2	1.0	6.9	9.3	16.6	9.7	10.1	11.7	13.0	12.7	14.3	12.3	12.9	13.0	12.8	11.2	13.1	12.5	12.3	14.0	9.3	0.0	2.2	2.0	8.9	37.0	22.2	5.7	28.5	12.1	9.9	10.3	0.6	4.3	4.0	1.8	8.4	17.2	5.7	5.3	7.9	18.6	25.6	6.8	9.4	12.7	7.2	8.8	2.0	12.2	20.4	10.2	9.7	7.7	5.1	7.9	3.6	3.1	18.4	3.3	1.7	5.7	6.1	2.5	16.5	15.0	11.5	7.3	16.0	1.0	5.3	3.9	4.1	1.0	1.3	19.2	3.6	6.0	8.6	24.0	4.4	7.3	1.3	8.3	19.7	10.7	19.1	74.6	18.8	21.2	31.0	8.2	7.0	12.5	11.3	18.8
CCDC87	FLJ10786	ENSG00000182791	"Coiled-coil domain containing 87"	Q9NVE4	11	66590176-66593063	"Predicted intracellular proteins"	"Differentiation, Fertilization, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 13.9"	"Group enriched"	"Detected in some"	4	"Early spermatids: 32.1;Spermatocytes: 19.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.3;SCLC-21H: 2.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (3.48e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.96e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.71e-2)"	"unprognostic (8.59e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.16e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.97e-3)"	"unprognostic (8.25e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.42e-1)"	0.0	0.2	0.2	0.1	0.2	0.0	0.2	0.1	0.2	0.2	0.3	0.1	0.1	0.2	1.8	0.1	0.3	0.1	0.2	0.2	0.2	0.3	0.2	0.1	0.0	0.1	0.1	0.2	0.0	0.1	1.1	0.5	0.0	0.1	0.2	0.1	1.4	0.1	0.5	0.1	0.1	0.0	0.2	0.0	0.0	0.1	13.9	0.1	0.2	0.9	0.1	0.0	0.1	0.0	0.2	0.4	1.3	0.2	0.3	0.3	0.1	0.1	0.1	0.3	0.2	0.1	0.8	0.3	0.0	0.5	0.2	0.5	0.6	0.2	0.0	0.1	0.2	0.0	0.2	0.2	0.1	0.3	0.0	0.2	0.1	0.2	0.0	0.0	0.2	0.2	0.2	0.1	0.1	0.2	0.5	0.2	0.2	0.4	0.8	0.2	0.4	0.3	0.0	0.5	0.0	2.3	0.3	0.5	0.5	0.1	0.3	0.6	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.2	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.2	0.1	0.2	0.2	0.2	0.1	0.1	0.2	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.5	0.0	0.1	1.8	2.1	0.0	0.0	0.0	0.0	0.5	32.1	0.2	0.2	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	1.6	0.0	0.0	0.0	19.5	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1
CCNA1	CT146	ENSG00000133101	"Cyclin A1"	P78396	13	36431520-36442870	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 22.4;testis: 82.1"	"Group enriched"	"Detected in some"	5	"Early spermatids: 162.4;Endometrial ciliated cells: 119.1;Late spermatids: 91.1;Spermatocytes: 285.7"	"Group enriched"	"Detected in many"	4	"endometrial cancer: 20.7;head and neck cancer: 6.2;ovarian cancer: 18.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	103	"basophil: 49.2"	"Lineage enriched"	"Detected in single"	301	"granulocytes: 49.2"	"Cell line enhanced"	"Detected in many"		"HMC-1: 350.9;NB-4: 71.4;THP-1: 71.5;U-937: 90.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA060646, HPA077614"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA060646: AB_2684336, HPA077614: "	"unprognostic (1.92e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.69e-3)"	"unprognostic (1.89e-3)"	"unprognostic (5.46e-2)"	"prognostic unfavorable (1.70e-4)"		"unprognostic (1.51e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.01e-3)"	"unprognostic (1.64e-1)"	"unprognostic (4.04e-6)"	"unprognostic (7.04e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.63e-2)"	0.4	0.9	7.0	0.5	6.6	2.1	0.7	3.2	7.6	5.9	4.1	0.5	0.4	3.8	7.1	0.4	18.2	0.7	0.3	6.0	7.5	0.5	0.1	1.4	0.3	5.6	6.5	6.4	0.5	0.1	22.4	8.2	0.0	8.6	0.5	0.1	1.0	0.6	0.1	1.2	0.3	0.3	8.2	4.5	0.6	0.4	82.1	5.6	0.4	0.6	0.4	0.6	0.6	1.1	6.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	15.2	0.1	15.5	1.2	12.9	1.4	0.1	0.0	0.7	0.0	0.4	0.0	0.6	8.0	350.9	0.3	34.1	0.7	2.8	5.5	0.9	1.7	0.0	0.5	0.2	4.4	0.4	71.4	2.5	0.0	8.8	0.0	8.3	0.0	2.3	0.0	2.5	5.8	0.0	8.4	0.2	1.8	0.0	71.5	4.5	0.0	0.0	0.1	2.9	0.8	0.0	0.0	0.3	90.3	0.6	49.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	7.0	6.6	3.2	7.6	6.0	7.5	5.6	6.5	6.4	8.6	4.5	5.6	6.1	0.1	0.0	0.6	0.3	0.3	0.6	0.6	19.1	0.0	0.4	0.5	1.4	0.4	0.0	10.3	0.0	0.0	0.1	0.0	0.1	0.0	0.2	162.4	119.1	1.8	0.4	0.0	0.0	3.5	0.0	0.8	1.1	0.0	31.9	5.1	2.2	0.0	0.0	0.2	0.0	3.0	0.0	6.1	0.0	1.8	91.1	3.1	1.1	0.0	0.0	0.0	1.4	0.0	0.5	0.4	0.0	0.0	2.6	0.0	0.7	0.0	0.1	29.3	0.8	6.6	0.5	1.5	285.7	2.4	0.0	0.4	0.3	0.9	0.0	0.1	1.1
CCT6B	"Cctz2, TSA303"	ENSG00000132141	"Chaperonin containing TCP1 subunit 6B"	Q92526	17	34927859-34981078	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	23	"testis: 127.3"	"Group enriched"	"Detected in many"	27	"Early spermatids: 448.5;Late spermatids: 185.2;Spermatocytes: 490.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 12.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042996, HPA045576, HPA049949"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA042996: AB_2678261, HPA045576: AB_2679372, HPA049949: AB_2680968"	"unprognostic (1.56e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.99e-3)"	"unprognostic (6.11e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.12e-3)"	"unprognostic (3.61e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.44e-3)"	"unprognostic (9.56e-3)"	"unprognostic (3.61e-2)"	"unprognostic (4.82e-7)"	"unprognostic (1.24e-1)"	"unprognostic (4.30e-1)"	"unprognostic (4.23e-4)"	"unprognostic (1.49e-1)"	2.3	3.3	2.3	0.8	2.6	3.9	5.6	2.5	2.4	2.2	1.9	1.5	1.4	1.9	5.5	1.8	2.7	0.9	1.8	1.9	2.6	4.1	5.0	1.2	1.4	2.8	2.4	1.8	2.4	2.7	2.5	2.8	0.6	2.6	2.7	1.2	2.3	3.4	2.6	5.1	2.5	1.4	1.6	2.7	1.6	2.1	127.3	2.3	1.6	2.9	3.8	1.7	1.9	1.5	3.1	0.7	1.0	2.6	1.1	3.3	2.0	0.9	1.3	5.3	2.2	3.1	0.7	2.1	5.0	0.5	2.4	1.6	1.0	0.1	0.7	0.7	0.5	1.9	0.7	0.3	0.6	4.5	2.4	0.7	2.7	1.3	0.2	2.6	0.4	0.6	0.8	0.5	5.0	2.4	1.9	0.5	5.2	1.4	0.4	0.6	2.4	1.2	12.2	1.4	0.8	3.0	1.5	2.4	0.9	4.1	0.6	1.9	2.4	0.5	1.0	0.1	1.2	0.6	4.4	1.0	4.7	1.1	1.5	1.3	0.0	1.1	0.9	0.6	1.1	0.6	0.9	0.7	0.4	2.6	0.8	1.0	1.0	0.0	1.6	1.1	0.6	0.3	0.6	2.3	2.6	2.5	2.4	1.9	2.6	2.8	2.4	1.8	2.6	2.7	2.3	3.1	2.4	0.0	3.1	4.6	2.6	2.4	2.8	3.2	6.2	1.5	8.7	7.0	4.2	4.3	3.9	1.8	0.0	1.8	4.0	0.9	3.9	3.4	448.5	8.8	3.7	2.1	0.0	0.8	3.9	8.0	0.5	3.5	1.5	3.6	2.5	4.6	0.7	3.1	1.5	0.0	3.7	2.3	6.1	2.2	4.0	185.2	10.8	2.9	5.4	4.7	1.6	8.7	4.1	7.1	10.7	2.7	1.6	4.1	3.9	2.1	0.7	6.9	8.8	2.5	0.0	3.7	3.0	490.2	13.5	3.1	2.6	0.8	2.7	6.9	1.8	3.6
CDKL2	"KKIAMRE, P56"	ENSG00000138769	"Cyclin dependent kinase like 2"	Q92772	4	75576496-75630716	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 9.4;choroid plexus: 8.2;retina: 9.7;testis: 11.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 76.4;Early spermatids: 57.8;Excitatory neurons: 32.8;Inhibitory neurons: 40.9;Oligodendrocytes: 46.4;Spermatocytes: 101.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 2.1;HHSteC: 1.9;RPTEC TERT1: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040672			Approved	Nucleoplasm,Centrosome		NA	NA			"Nucleoplasm, Centrosome"		"HPA040672: AB_10794744"	"unprognostic (2.07e-1)"	"unprognostic (9.96e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.80e-5)"	"unprognostic (3.43e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.14e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (6.88e-15)"	"unprognostic (5.91e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.52e-2)"	0.0	1.0	7.2	0.3	7.9	0.0	0.3	5.3	8.0	0.6	8.2	0.7	0.1	0.6	0.9	0.8	1.6	0.4	0.3	7.0	7.3	6.0	0.0	4.8	0.4	7.0	6.7	7.0	1.6	0.5	2.5	1.5	0.0	7.7	0.6	0.9	9.7	0.3	0.6	0.0	0.2	0.1	0.4	5.5	0.1	0.6	11.7	6.8	0.0	3.2	0.0	0.6	0.2	0.3	9.4	2.1	0.3	0.1	0.0	0.1	0.1	0.0	0.1	0.8	1.0	0.9	0.1	0.5	0.0	0.3	0.0	1.0	0.2	0.0	0.2	0.9	0.1	1.5	0.0	0.1	0.0	1.9	0.0	0.0	0.6	1.0	0.1	0.3	0.9	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	4.2	0.1	1.1	0.9	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.2	7.9	5.3	8.0	7.0	7.3	7.0	6.7	7.0	7.7	5.5	6.8	9.4	0.2	25.6	76.4	5.9	0.4	0.1	0.5	0.6	0.6	17.7	0.7	3.0	0.9	1.5	4.7	9.2	4.2	0.1	0.3	3.0	7.9	1.9	57.8	11.6	1.4	0.2	1.8	0.0	32.8	0.2	0.6	1.2	1.1	2.5	1.3	1.0	0.4	0.0	0.1	10.1	40.9	2.3	0.0	0.0	0.4	20.7	1.8	0.5	1.8	3.7	0.0	11.6	0.0	5.5	46.4	0.1	1.0	1.2	0.3	0.2	0.0	29.5	18.6	20.2	0.0	0.4	1.1	101.7	4.1	0.8	0.3	0.3	2.7	0.2	2.7	0.2
CDRT1	"FBXW10B, FBXW10P1, HREP, SM25H2"	ENSG00000241322	"CMT1A duplicated region transcript 1"	O95170	17	15565483-15619704	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"esophagus: 8.6;testis: 12.7"	"Group enriched"	"Detected in some"	4	"Early spermatids: 22.9;Late spermatids: 11.8;Spermatocytes: 8.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 19.6;HaCaT: 35.7;HeLa: 14.3;OE19: 9.3"									"HPA013332, HPA047457"			Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA013332: AB_1848471, HPA047457: "	"unprognostic (2.25e-1)"	"unprognostic (2.78e-1)"	"unprognostic (7.03e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.45e-2)"	"unprognostic (5.93e-2)"	"unprognostic (5.04e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.38e-1)"	"unprognostic (9.31e-8)"	"unprognostic (1.55e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.86e-1)"	1.3	2.4	1.0	1.0	1.0	0.4	1.0	1.2	1.0	1.3	0.5	0.5	2.3	0.2	0.9	8.6	0.7	0.6	1.0	0.8	0.9	0.5	1.4	1.3	0.8	1.1	1.0	0.7	0.2	0.3	0.1	0.5	1.4	1.0	0.6	0.7	0.4	2.6	0.3	2.6	3.5	1.2	0.2	0.8	0.4	2.2	12.7	1.5	0.3	2.1	0.8	2.3	1.8	4.3	1.3	3.0	8.4	0.3	2.8	0.4	0.8	0.2	0.7	2.0	0.3	1.0	7.7	19.6	0.3	0.5	1.8	2.1	35.7	0.6	0.4	0.4	3.2	0.3	0.2	14.3	0.4	0.3	0.1	0.3	0.6	1.2	0.9	0.6	0.1	0.2	0.5	0.0	1.5	1.1	0.2	0.6	0.5	0.3	9.3	1.1	0.1	0.6	0.0	2.4	5.1	0.2	0.1	2.7	2.5	0.2	0.9	0.2	0.2	1.8	0.6	1.8	0.2	0.5	1.0	4.0	0.1	2.1	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.0	1.0	1.2	1.0	0.8	0.9	1.1	1.0	0.7	1.0	0.8	1.5	1.3	0.9	0.0	0.5	1.3	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.2	22.9	0.5	0.1	0.3	0.0	0.0	2.5	0.2	0.0	0.2	3.6	0.8	0.0	0.2	0.4	0.2	0.1	0.0	2.3	0.2	0.0	0.0	0.0	11.8	0.6	0.2	0.0	1.0	0.0	0.1	0.0	1.5	2.2	1.8	0.0	0.0	0.0	0.2	0.0	0.0	2.2	0.2	0.0	0.1	0.0	8.6	0.5	0.6	0.0	0.0	0.0	2.5	0.0	0.3
CDRT15		ENSG00000223510	"CMT1A duplicated region transcript 15"	Q96T59	17	14235673-14236862	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 21.1"	"Group enriched"	"Detected in some"	24	"Early spermatids: 117.5;Late spermatids: 88.5;Spermatocytes: 43.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 3.8"									HPA055952	Uncertain		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA055952: AB_2682983"	"unprognostic (3.27e-2)"	"unprognostic (1.77e-2)"	"unprognostic (8.61e-2)"	"unprognostic (9.33e-2)"	"unprognostic (5.15e-3)"	"unprognostic (2.90e-1)"	"unprognostic (6.16e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.15e-3)"	"unprognostic (2.66e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.30e-7)"	"unprognostic (1.55e-1)"	"unprognostic (1.52e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.38e-2)"	0.1	0.4	0.3	1.2	0.1	0.6	0.1	1.3	0.4	0.2	0.2	0.2	0.8	0.2	0.2	0.3	0.1	0.4	0.3	0.3	0.0	0.1	0.4	0.3	2.7	0.5	0.2	0.0	0.4	0.2	0.0	0.1	0.1	1.0	0.2	0.0	0.4	0.7	0.0	0.1	3.4	0.8	0.0	0.0	0.9	0.4	21.1	0.4	0.0	0.5	0.0	0.0	0.1	0.2	0.6	0.7	1.3	0.9	2.0	0.0	0.0	0.5	0.8	0.0	0.0	0.0	2.5	0.3	2.1	0.4	0.0	0.3	0.9	0.0	0.0	0.0	2.1	3.8	1.2	2.6	1.8	0.0	1.0	1.5	0.0	0.0	0.0	0.0	0.7	0.0	1.0	1.0	0.4	0.0	0.5	1.0	1.6	0.8	1.5	1.2	0.8	0.3	0.8	0.0	1.0	1.0	1.8	0.2	0.5	0.3	2.7	0.4	0.5	1.1	3.2	0.4	0.8	0.9	0.7	0.8	0.9	0.5	1.6	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.1	1.3	0.4	0.3	0.0	0.5	0.2	0.0	1.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	117.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	88.5	3.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CEBPZ	"CBF2, CTF2"	ENSG00000115816	"CCAAT enhancer binding protein zeta"	Q03701	2	37201612-37231596	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 282.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052065	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA052065: AB_2681715"	"unprognostic (1.64e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.00e-3)"	"prognostic unfavorable (5.07e-4)"	"unprognostic (2.88e-1)"	"unprognostic (1.72e-2)"	"prognostic unfavorable (2.94e-5)"	"unprognostic (8.84e-2)"	"unprognostic (3.85e-3)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (8.13e-4)"	"unprognostic (2.65e-2)"	"unprognostic (5.36e-2)"	"unprognostic (4.19e-2)"	"unprognostic (8.76e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.01e-2)"	21.2	28.1	10.9	19.1	12.2	31.5	26.5	16.5	12.9	18.1	12.8	19.7	17.6	20.3	20.1	20.7	17.3	16.8	15.4	10.6	13.1	25.6	27.3	19.5	24.8	12.1	13.0	9.1	24.1	20.8	22.5	10.3	23.2	12.5	19.9	20.2	24.6	16.4	15.7	36.6	18.0	18.2	17.1	12.0	20.1	17.6	38.7	11.5	24.2	22.6	24.6	24.6	26.8	12.7	14.9	61.2	46.6	46.9	26.1	45.2	48.6	39.9	57.0	39.2	47.2	50.5	74.5	45.1	111.5	49.4	33.8	64.4	51.0	122.8	58.5	60.2	71.8	53.9	104.0	47.5	60.9	35.8	105.7	44.9	37.3	56.4	62.8	63.4	31.1	43.3	27.8	114.8	49.8	48.6	31.8	61.5	82.4	153.3	81.0	43.2	48.6	76.3	84.3	45.3	56.9	49.9	80.7	47.5	57.6	65.5	67.6	41.8	45.9	35.5	45.8	52.3	41.3	79.1	55.5	62.0	88.1	40.8	95.6	51.2	34.8	16.8	16.3	23.8	21.7	30.0	29.6	24.7	23.4	17.6	30.0	31.1	26.1	6.1	26.1	22.3	25.6	21.4	14.6	10.9	12.2	16.5	12.9	10.6	13.1	12.1	13.0	9.1	12.5	12.0	11.5	14.9	73.4	86.6	82.9	15.0	91.6	107.1	109.2	64.4	83.1	45.5	50.4	54.1	34.4	47.1	81.9	49.7	43.8	54.7	93.4	36.7	107.6	56.1	282.1	56.0	87.2	60.5	44.2	66.7	15.6	62.5	37.4	67.4	52.5	67.5	73.4	44.7	43.9	76.4	35.1	43.7	19.3	56.6	44.7	37.0	36.1	43.3	60.9	44.6	21.4	15.0	54.1	57.1	63.8	18.6	21.4	54.9	30.2	50.8	67.7	79.0	30.2	89.1	54.2	95.5	52.6	94.3	68.3	186.7	99.3	56.8	101.2	45.0	87.7	62.1	64.2	80.9
CEP19	"C3orf34, MGC14126"	ENSG00000174007	"Centrosomal protein 19"	Q96LK0	3	196706277-196712250	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		Obesity	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 54.8;Spermatocytes: 66.3;Spermatogonia: 39.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	8	"basophil: 51.5;eosinophil: 59.0;neutrophil: 144.2"	"Lineage enriched"	"Detected in all"	13	"granulocytes: 144.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047614, HPA071138"	Enhanced		Supported	Centrosome		NA	NA			Centrosome		"HPA047614: AB_2680103, HPA071138: AB_2686348"	"unprognostic (3.00e-1)"	"unprognostic (5.45e-2)"	"unprognostic (5.11e-2)"	"unprognostic (9.31e-2)"	"unprognostic (5.51e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.56e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.33e-2)"	1.7	2.6	5.4	3.1	5.2	1.2	1.1	4.7	6.4	1.7	5.3	1.2	0.9	1.6	3.1	1.6	4.2	1.9	1.3	5.6	5.6	2.7	1.1	1.6	2.9	5.1	5.3	5.1	1.8	0.7	3.4	3.9	2.0	5.5	1.7	1.0	6.6	1.2	2.1	0.6	1.6	1.2	1.4	5.1	3.4	0.9	10.0	5.2	7.7	2.3	1.8	3.5	1.8	1.5	5.5	6.0	4.1	5.6	3.5	12.6	9.6	1.6	4.8	9.0	5.1	6.6	2.1	3.9	4.4	13.3	2.4	11.1	2.6	3.8	1.1	5.9	6.2	3.8	6.8	2.0	0.6	5.0	3.1	8.3	4.4	5.5	6.6	1.8	9.3	2.0	5.4	3.8	5.4	5.2	3.1	7.8	5.6	2.9	2.6	6.9	9.0	3.4	2.9	5.4	0.5	5.6	4.0	6.4	0.8	7.6	4.7	5.0	5.9	1.7	5.8	1.3	9.1	3.2	16.2	16.6	9.1	8.4	7.9	5.8	51.5	4.0	59.0	5.4	3.2	6.0	3.8	8.0	7.3	2.6	4.4	10.3	6.6	144.2	7.3	3.7	11.0	4.8	3.9	5.4	5.2	4.7	6.4	5.6	5.6	5.1	5.3	5.1	5.5	5.1	5.2	5.5	2.6	0.0	2.0	3.6	4.5	2.0	1.3	2.2	5.2	5.8	2.7	3.0	2.0	2.8	2.1	1.8	0.0	1.8	5.1	0.6	5.9	2.0	54.8	14.8	5.2	3.7	0.0	1.3	8.4	0.8	1.5	3.4	0.0	1.3	1.3	5.0	5.0	0.3	3.1	5.0	6.6	0.4	4.1	2.2	4.7	6.3	6.5	2.4	0.0	1.0	15.3	9.5	14.4	1.5	1.4	0.8	0.0	5.3	7.1	0.8	0.1	4.9	21.4	8.3	0.0	2.9	2.2	66.3	39.6	2.1	0.9	0.4	3.9	8.8	0.4	0.5
CEP57L1	"bA487F23.2, C6orf182, MGC21731"	ENSG00000183137	"Centrosomal protein 57 like 1"	Q8IYX8	6	109095110-109174418	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 50.3;Spermatocytes: 75.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040378	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA040378: AB_10794028"	"unprognostic (5.93e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.41e-2)"	"unprognostic (4.69e-3)"	"unprognostic (3.63e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.33e-1)"	"unprognostic (9.97e-2)"	"unprognostic (2.42e-5)"	"unprognostic (2.37e-1)"	"unprognostic (2.00e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.72e-1)"	10.6	7.6	5.5	7.9	6.4	10.3	10.3	11.4	7.9	8.2	5.1	8.6	8.8	9.4	10.5	6.3	6.0	9.5	7.6	6.0	5.1	8.1	10.1	6.7	8.9	5.7	5.0	6.1	6.6	7.6	17.0	5.6	10.2	6.4	6.5	11.0	12.1	5.3	6.4	6.1	6.9	7.9	10.9	4.3	7.8	7.4	26.4	5.2	14.6	8.7	6.7	7.4	6.5	6.6	8.5	17.9	7.9	23.1	22.9	21.2	35.2	18.1	40.3	22.1	35.8	39.8	11.9	15.3	16.0	18.4	20.9	30.8	9.1	16.1	15.4	56.1	20.3	16.1	34.8	18.9	12.3	19.6	28.5	14.5	21.2	11.0	30.3	29.9	19.2	32.4	52.5	63.9	52.5	32.4	11.8	32.0	24.6	7.6	14.7	14.6	25.7	17.4	15.7	17.0	7.4	17.4	14.4	19.8	14.7	12.9	15.0	18.2	43.9	14.7	23.1	13.6	24.4	42.9	15.4	19.1	25.3	21.8	43.1	18.9	15.9	5.2	6.6	4.7	6.1	5.1	3.3	4.8	6.7	5.7	6.3	4.5	6.7	3.6	11.6	9.6	6.0	6.9	4.6	5.5	6.4	11.4	7.9	6.0	5.1	5.7	5.0	6.1	6.4	4.3	5.2	8.5	12.9	6.4	5.3	12.4	6.3	3.3	7.6	7.4	7.4	6.6	6.8	7.2	10.3	2.8	6.8	5.5	20.9	9.8	9.7	4.2	7.9	7.0	50.3	12.8	18.5	10.6	5.4	18.1	31.9	5.4	13.2	15.5	8.2	6.9	5.1	20.5	8.2	6.3	10.2	5.0	31.1	3.1	8.2	4.1	6.8	39.3	17.4	7.7	8.8	27.2	7.7	10.4	8.2	26.2	36.1	6.0	4.5	12.4	13.2	4.4	5.7	13.4	9.8	12.3	13.1	21.8	14.1	75.7	13.0	5.8	4.4	8.5	6.7	13.6	6.1	5.0
CEP63	FLJ13386	ENSG00000182923	"Centrosomal protein 63"	Q96MT8	3	134485721-134575017	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, Mitosis"		"Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 139.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 179.4"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 179.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058154, HPA058313"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA058154: AB_2683624, HPA058313: "	"unprognostic (1.80e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.08e-2)"	"unprognostic (5.24e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.33e-1)"	24.1	15.3	8.1	14.1	9.3	30.4	16.3	10.5	13.8	13.2	7.3	14.9	10.1	13.1	17.0	12.5	12.3	11.4	25.4	8.3	8.5	15.2	22.1	11.9	18.7	10.0	10.6	6.5	16.3	17.2	19.0	12.8	14.5	11.0	14.6	14.4	22.2	16.1	16.1	41.9	14.8	11.3	16.5	8.4	16.3	14.9	45.6	9.5	27.8	19.1	29.3	17.6	15.8	12.6	12.3	32.9	12.6	26.2	17.5	36.9	30.7	24.6	35.1	29.1	26.7	21.9	11.8	13.7	36.5	21.0	24.4	26.0	18.6	14.5	18.0	32.3	41.7	7.4	47.9	15.0	16.1	25.3	30.5	22.0	26.4	23.3	14.8	47.1	28.8	27.9	48.2	14.7	31.3	32.4	20.1	37.7	34.5	18.4	20.1	16.9	23.5	38.7	52.8	23.7	20.3	14.8	14.6	31.2	12.1	47.3	30.2	24.7	38.1	30.1	30.1	18.4	30.3	26.9	27.1	21.9	46.7	33.4	30.8	39.2	72.7	20.1	34.3	12.7	20.6	16.9	15.9	12.2	16.5	24.6	22.2	17.2	13.1	179.4	20.3	29.5	16.3	16.8	12.7	8.1	9.3	10.5	13.8	8.3	8.5	10.0	10.6	6.5	11.0	8.4	9.5	12.3	19.9	19.2	27.6	39.2	25.5	10.7	14.6	22.6	13.6	31.6	16.8	22.5	84.7	22.8	23.1	7.3	20.9	25.3	16.5	11.8	31.3	25.8	93.2	21.8	23.6	21.0	13.1	26.5	63.5	20.0	26.0	25.8	14.8	17.9	52.6	25.2	14.6	17.3	29.4	32.0	58.3	16.0	16.2	27.7	12.8	54.9	23.9	25.1	17.8	28.1	30.2	26.3	19.6	71.4	67.8	21.0	16.2	25.9	27.3	19.2	12.5	29.6	31.1	43.8	19.7	31.7	25.1	139.1	51.7	17.3	9.8	17.4	20.6	18.8	16.2	16.2
CETN1	"CEN1, CETN"	ENSG00000177143	"Centrin 1"	Q12798	18	580380-582114	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1083	"testis: 135.4"	"Group enriched"	"Detected in some"	34	"Early spermatids: 930.9;Late spermatids: 435.6;Spermatocytes: 675.9"	"Cancer enriched"	"Detected in single"	10	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001470, HPA028956, CAB037244, HPA069157"	Enhanced		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Nucleoplasm, Centriolar satellite, Cytosol"		"CAB037244: AB_476871, HPA001470: , HPA028956: AB_10601798, HPA069157: "															"unprognostic (1.51e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	135.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	930.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	435.6	12.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	19.7	0.0	0.0	675.9	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CETN3	CEN3	ENSG00000153140	"Centrin 3"	O15182	5	90392257-90409766	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 131.5"	"Cell type enriched"	"Detected in all"	4	"Spermatocytes: 469.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035608, HPA063704"	Enhanced		Supported	Centrosome		NA	NA			Centrosome		"HPA035608: AB_10601098, HPA063704: AB_2685097"	"unprognostic (2.08e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.58e-2)"	"prognostic unfavorable (2.22e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.18e-2)"	"unprognostic (8.77e-2)"	"unprognostic (5.03e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.53e-1)"	"unprognostic (5.21e-2)"	"unprognostic (2.35e-1)"	17.6	21.8	20.1	14.8	21.5	7.7	24.3	20.5	26.5	20.8	20.0	17.1	9.7	20.2	22.0	13.6	22.8	10.4	22.3	19.3	19.9	20.0	13.6	13.5	19.3	21.8	22.3	18.4	31.2	9.3	24.6	16.9	19.4	22.3	19.2	19.8	35.6	15.3	14.9	14.5	15.5	10.7	14.0	20.6	15.2	13.0	131.5	21.3	20.8	15.3	14.2	21.1	11.4	11.8	28.8	38.4	18.7	66.2	13.4	38.8	49.2	39.5	41.2	25.4	39.7	47.1	25.5	45.3	71.7	40.4	20.2	76.9	26.2	58.5	57.4	63.5	59.6	27.2	36.4	26.9	32.6	27.3	26.9	22.2	32.7	36.6	29.4	49.1	42.5	24.1	56.8	47.2	30.9	44.3	26.5	46.2	42.6	23.2	14.0	42.6	40.6	45.7	37.0	35.1	14.5	36.0	37.2	40.2	19.9	31.7	59.1	37.7	36.6	28.0	22.6	32.7	32.0	55.7	28.6	55.5	63.6	26.9	60.5	23.3	19.7	9.9	14.8	12.9	13.1	13.7	27.3	14.3	14.6	11.3	21.8	20.4	16.3	1.2	17.3	16.6	30.6	13.3	6.9	20.1	21.5	20.5	26.5	19.3	19.9	21.8	22.3	18.4	22.3	20.6	21.3	28.8	19.5	19.2	38.7	13.4	17.8	14.3	34.3	70.3	22.2	19.3	23.5	25.7	53.0	27.1	37.5	36.8	18.8	69.4	13.4	11.9	95.9	21.8	20.2	41.4	26.6	22.4	24.0	54.1	8.4	10.0	69.5	33.0	6.1	24.4	6.3	19.6	48.5	42.2	26.0	21.9	12.6	21.2	48.8	19.2	5.1	38.5	44.1	10.3	19.6	8.4	19.6	84.0	17.5	15.1	34.1	12.8	21.4	32.4	8.4	16.5	8.5	46.2	75.9	24.4	59.2	14.2	23.8	469.5	66.3	19.6	15.8	41.7	15.0	17.2	24.8	21.6
CFAP97	"DKFZp434F1728, hmw, KIAA1430"	ENSG00000164323	"Cilia and flagella associated protein 97"	Q9P2B7	4	185159665-185209504	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 276.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049446, HPA053335"	Uncertain		Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA049446: AB_2680770, HPA053335: AB_2682117"	"unprognostic (6.74e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.40e-2)"	"unprognostic (3.63e-1)"	"unprognostic (6.01e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.96e-2)"	"unprognostic (6.74e-3)"	"unprognostic (2.49e-1)"	"unprognostic (4.44e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.81e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.29e-1)"	17.1	12.0	8.1	14.8	8.4	5.3	21.0	10.4	10.0	17.7	10.6	10.1	7.6	19.0	9.4	19.3	15.9	15.2	9.1	7.4	8.6	16.3	18.9	13.8	17.7	8.7	7.8	6.3	22.3	10.3	20.5	6.4	14.0	9.0	17.7	11.4	18.1	12.3	17.7	6.8	11.5	9.8	17.5	8.3	18.7	11.3	37.8	7.6	11.9	27.5	7.1	16.3	14.7	9.8	11.9	29.5	17.9	23.6	40.8	27.1	47.8	14.2	38.3	34.7	28.1	22.2	11.2	36.2	73.1	12.6	44.2	21.0	15.8	26.9	33.3	37.2	65.3	17.7	29.5	10.5	26.1	33.5	40.5	22.4	31.0	45.9	30.6	66.6	34.9	24.6	33.7	53.1	66.8	39.9	14.0	21.5	20.0	13.6	9.1	14.2	31.9	11.7	45.8	34.4	15.6	15.8	42.3	28.3	27.2	53.9	13.6	18.2	24.4	35.8	26.4	16.4	10.4	30.4	26.4	12.5	22.4	33.0	34.5	53.8	9.5	6.4	2.9	27.8	11.5	32.8	30.7	27.0	27.4	8.5	29.7	27.0	18.9	1.3	19.9	18.9	29.3	21.0	10.0	8.1	8.4	10.4	10.0	7.4	8.6	8.7	7.8	6.3	9.0	8.3	7.6	11.9	84.0	64.1	41.3	17.0	50.5	0.0	64.7	0.0	58.6	61.5	68.5	75.4	29.6	52.9	22.9	46.0	52.1	29.5	54.4	2.8	70.5	57.2	276.4	66.9	81.7	49.9	12.2	30.1	10.8	51.5	33.8	53.0	34.7	39.3	27.8	39.7	41.4	65.1	20.7	69.0	19.3	11.6	0.0	26.3	0.0	156.3	81.7	25.7	0.0	15.0	41.0	61.9	63.8	26.2	20.3	49.1	6.6	87.6	41.9	73.0	15.0	109.2	36.5	69.6	72.3	75.5	51.4	171.7	109.3	48.3	0.0	15.7	47.7	122.0	14.8	37.8
CGRRF1	"CGR19, RNF197"	ENSG00000100532	"Cell growth regulator with ring finger domain 1"	Q99675	14	54509812-54539292	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 145.4;Spermatocytes: 112.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002930	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA002930: AB_1078507"	"unprognostic (1.81e-1)"	"unprognostic (3.76e-1)"	"unprognostic (5.61e-2)"	"unprognostic (4.38e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (6.84e-4)"	"unprognostic (2.25e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.63e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.64e-3)"	"prognostic favorable (2.57e-8)"	"unprognostic (2.94e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.74e-1)"	9.8	9.3	20.4	3.9	20.7	8.0	12.1	22.1	26.0	9.2	20.8	10.8	5.4	11.1	13.9	6.0	11.3	5.9	11.8	20.2	21.7	14.7	7.9	7.6	6.1	21.2	21.3	19.7	10.1	13.2	12.9	12.8	7.1	20.7	11.4	6.9	13.7	8.5	11.0	19.4	4.1	8.5	8.7	21.8	8.6	9.8	22.5	20.8	5.7	12.8	12.6	5.3	10.2	7.5	22.2	10.4	8.6	9.7	8.6	16.7	10.6	7.3	9.5	10.2	14.6	15.2	8.7	11.7	5.9	11.9	8.2	15.8	9.1	10.8	8.4	18.5	11.9	8.7	8.3	1.7	10.6	20.1	4.6	4.4	10.9	16.7	11.0	18.1	9.6	10.6	9.3	3.3	7.6	13.6	19.0	4.9	7.2	6.0	9.5	15.3	10.8	12.3	2.9	11.8	13.3	6.4	6.3	8.3	3.9	16.1	8.7	11.3	4.2	9.3	18.2	14.3	7.2	8.7	5.0	6.4	8.5	10.0	5.6	12.0	61.9	12.4	22.6	19.1	15.4	18.7	18.2	19.9	20.2	10.4	19.4	20.0	18.6	12.5	20.3	19.0	9.0	22.3	19.7	20.4	20.7	22.1	26.0	20.2	21.7	21.2	21.3	19.7	20.7	21.8	20.8	22.2	20.3	9.6	11.5	21.5	22.6	7.6	17.4	26.7	16.5	18.6	18.3	18.7	22.1	14.3	17.3	16.5	10.4	14.7	21.8	17.5	23.5	21.6	145.4	13.7	15.1	20.3	10.7	4.2	14.2	16.9	11.5	22.3	5.6	13.1	29.2	12.7	18.9	10.6	17.0	11.8	13.8	9.1	28.5	14.8	10.3	41.5	16.8	24.8	16.0	12.2	15.5	29.4	16.5	17.1	24.3	17.7	13.1	22.6	11.5	16.8	15.6	27.3	22.6	15.9	19.7	17.0	25.0	112.2	36.0	10.0	3.4	12.0	24.0	12.3	11.0	14.0
CHST13	C4ST3	ENSG00000180767	"Carbohydrate sulfotransferase 13"	Q8NET6	3	126524155-126543291	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"liver: 60.1;testis: 18.5"	"Group enriched"	"Detected in some"	5	"Early spermatids: 104.0;Hepatocytes: 40.3;Spermatocytes: 126.2"	"Group enriched"	"Detected in many"	4	"liver cancer: 25.0;renal cancer: 6.3"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	5	"eosinophil: 155.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 155.2"	"Group enriched"	"Detected in some"	8	"CACO-2: 15.6;Hep G2: 28.4;NB-4: 19.0;THP-1: 11.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA067960			Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"		"HPA067960: "	"unprognostic (5.68e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.32e-2)"	"unprognostic (6.42e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.45e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.98e-1)"	"unprognostic (5.75e-2)"	"unprognostic (5.16e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.59e-2)"	0.3	0.4	0.2	0.4	0.2	0.6	0.1	0.1	0.4	0.0	0.0	0.5	0.6	0.1	0.0	0.0	0.2	0.0	0.3	0.2	0.3	3.2	60.1	0.6	0.1	0.2	0.4	0.2	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.1	1.0	0.0	0.4	3.6	0.4	18.5	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.6	0.7	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.7	0.3	28.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	0.9	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.1	33.0	155.2	0.0	20.5	0.0	0.0	0.0	0.0	22.0	0.0	0.0	0.0	30.7	0.0	17.5	0.0	0.0	13.1	0.2	0.2	0.1	0.4	0.2	0.3	0.2	0.4	0.2	0.2	0.4	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	10.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	104.0	0.6	0.0	0.1	1.2	5.5	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.7	40.3	13.1	0.0	0.0	1.0	0.0	7.5	1.3	16.9	1.5	6.2	0.0	1.9	7.2	0.0	0.0	0.0	0.1	0.0	2.8	1.2	0.3	0.0	8.5	9.9	0.1	0.0	0.0	0.0	0.0	126.2	2.8	0.0	0.0	0.3	0.2	0.0	1.8	0.0
CIAPIN1	"Anamorsin, CIAE2"	ENSG00000005194	"Cytokine induced apoptosis inhibitor 1"	Q6FI81	16	57428187-57447420	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 259.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041350, HPA042182"	Enhanced		Supported	Nucleoplasm,Mitochondria		No	No		21000	Mitochondria	Nucleoplasm	"HPA041350: AB_10796665, HPA042182: AB_10794646"	"unprognostic (1.78e-2)"	"unprognostic (9.62e-2)"	"unprognostic (6.44e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (4.35e-4)"	"unprognostic (1.41e-3)"	"unprognostic (8.15e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.48e-2)"	"unprognostic (4.70e-3)"	"unprognostic (1.62e-1)"	"prognostic favorable (4.42e-4)"	"unprognostic (5.61e-2)"	"unprognostic (3.86e-2)"	"unprognostic (8.90e-3)"	"unprognostic (1.16e-1)"	19.0	33.1	21.6	19.9	22.8	20.8	19.0	23.4	27.3	15.2	24.8	29.7	21.5	16.4	15.7	30.5	16.2	16.7	38.2	22.6	24.1	30.1	27.5	20.1	24.4	25.0	24.1	22.7	13.0	19.7	37.8	17.9	31.8	24.5	18.1	26.1	21.1	19.9	16.5	41.6	27.9	21.1	22.2	20.8	21.7	22.5	68.6	24.4	31.3	18.6	38.8	34.6	24.6	20.3	25.6	51.8	77.8	80.4	61.4	46.5	31.8	67.5	52.7	51.2	102.6	48.1	87.6	40.3	55.0	75.8	46.9	32.4	95.9	113.2	82.2	86.5	32.7	68.2	71.4	63.6	91.6	74.6	88.2	67.7	48.8	88.7	74.9	94.5	40.5	101.9	69.3	101.4	30.7	60.9	51.5	81.1	71.1	100.8	60.3	114.8	146.0	93.6	112.7	69.6	57.7	68.7	85.8	126.4	86.2	56.6	64.6	61.7	76.5	63.2	42.3	52.1	42.4	64.7	76.8	113.4	175.0	51.1	78.9	68.0	53.6	80.5	54.2	74.2	79.2	68.1	65.7	60.8	78.4	94.6	72.6	128.5	115.1	19.8	91.1	64.7	79.8	74.5	153.8	21.6	22.8	23.4	27.3	22.6	24.1	25.0	24.1	22.7	24.5	20.8	24.4	25.6	25.3	16.0	22.0	7.8	16.0	14.3	13.9	59.4	8.6	29.2	17.5	18.3	36.1	20.0	28.4	22.0	10.4	90.4	21.8	17.0	39.2	55.4	19.3	14.4	19.1	28.5	18.6	21.9	15.7	51.8	50.0	19.2	19.4	15.1	10.8	28.1	17.9	20.3	40.0	23.5	16.4	17.8	52.9	13.9	13.2	33.6	14.0	17.4	24.9	7.5	42.9	27.9	23.7	11.1	10.6	54.6	23.9	20.7	14.4	23.2	25.5	37.4	14.1	17.8	39.5	11.8	21.3	259.9	69.8	23.2	15.9	106.2	19.3	43.4	28.0	15.2
CILP2	MGC45771	ENSG00000160161	"Cartilage intermediate layer protein 2"	Q8IUL8	19	19538248-19546659	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 5.6"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 26.2;Late spermatids: 21.8;Sertoli cells: 6.6;Spermatocytes: 27.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 4.6;HEK 293: 2.8;NB-4: 2.2;THP-1: 2.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"medulla oblongata: 2.7;spinal cord: 7.3"	HPA041847	Uncertain				"Secreted to extracellular matrix"	NA	NA		22000000			"HPA041847: AB_10795599"	"unprognostic (6.51e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.42e-4)"	"prognostic unfavorable (3.22e-6)"	"unprognostic (4.81e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.31e-2)"	"unprognostic (4.13e-3)"	"unprognostic (4.48e-2)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (5.09e-2)"	"unprognostic (1.41e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.59e-2)"	"unprognostic (3.19e-2)"	"unprognostic (3.12e-3)"	"unprognostic (1.36e-2)"	0.7	0.0	0.3	0.2	0.5	1.0	0.3	0.1	0.5	0.3	0.0	0.1	0.0	0.2	0.1	0.0	0.4	1.6	0.3	0.4	0.9	0.0	0.2	0.4	0.3	0.9	0.1	0.4	1.6	0.0	0.1	0.3	0.1	0.2	0.2	0.0	0.0	0.1	0.0	0.3	0.3	0.1	0.1	0.1	0.2	0.0	5.6	0.6	0.0	1.0	0.0	0.1	0.3	0.2	0.3	0.0	0.1	0.1	0.1	4.6	0.1	0.6	0.6	0.0	0.3	0.0	1.3	0.5	0.0	1.2	0.2	0.0	0.5	0.1	0.0	0.0	0.3	2.8	0.0	0.1	0.1	0.2	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.2	1.7	1.5	0.9	0.3	0.0	0.0	0.0	0.0	0.1	1.2	0.3	1.5	0.1	0.2	0.3	2.8	0.0	0.0	0.5	0.2	0.1	0.4	1.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.1	0.5	0.4	0.9	0.9	0.1	0.4	0.2	0.1	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.4	0.4	0.2	0.0	0.0	0.5	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	26.2	0.3	0.3	0.1	0.0	0.0	0.2	0.0	0.2	1.5	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.3	21.8	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	1.4	0.0	0.1	0.0	0.0	6.6	0.4	0.3	27.8	4.0	0.7	0.6	0.0	0.2	0.1	0.0	0.5
CINP	MGC849	ENSG00000100865	"Cyclin dependent kinase 2 interacting protein"	Q9BW66	14	102341102-102362916	"Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, DNA replication"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.47e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.50e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.71e-1)"	20.6	24.1	26.2	13.5	28.8	29.0	20.0	29.8	32.4	14.4	22.7	18.2	13.7	11.6	22.0	25.4	14.4	15.1	26.4	24.6	27.2	22.7	33.8	15.8	20.5	28.3	27.9	22.8	13.8	44.5	19.4	12.7	15.1	29.1	16.1	16.0	4.5	30.1	13.8	32.2	16.2	15.2	17.3	29.8	17.2	23.8	29.4	27.9	19.7	18.5	27.3	17.9	18.4	14.5	32.5	32.1	75.1	29.1	33.3	54.5	71.6	33.4	47.0	61.1	63.3	52.3	50.8	49.6	36.3	45.8	59.4	31.6	52.7	52.0	64.7	57.6	41.6	40.2	26.2	48.0	60.4	46.7	67.2	25.7	54.7	47.5	46.1	52.6	41.9	67.7	34.2	38.5	44.0	57.9	161.2	39.8	36.4	31.2	90.2	74.5	26.2	41.3	47.8	61.5	73.2	30.9	30.2	36.6	60.0	33.6	25.7	71.3	31.5	47.3	36.1	22.0	108.7	42.1	84.9	70.9	63.3	60.4	42.5	41.9	46.1	58.3	55.0	37.5	58.4	34.4	44.1	33.4	35.1	54.3	37.6	31.9	31.5	49.8	38.0	50.8	50.7	41.6	46.4	26.2	28.8	29.8	32.4	24.6	27.2	28.3	27.9	22.8	29.1	29.8	27.9	32.5	27.5	28.9	16.2	3.3	19.1	14.0	26.0	37.5	14.2	18.2	25.2	28.1	39.7	15.7	29.0	20.2	12.5	48.5	18.4	19.1	56.7	39.6	59.4	15.4	24.9	28.8	19.7	29.5	4.1	45.2	53.7	27.8	16.3	16.7	19.6	25.8	28.5	43.9	59.8	15.2	3.6	27.1	18.3	25.5	22.2	111.2	29.8	28.1	17.8	0.0	65.8	25.2	35.0	4.0	10.0	42.6	21.9	20.3	36.5	25.9	43.9	82.2	19.8	20.1	32.9	18.0	21.4	90.1	16.1	33.6	15.8	37.1	20.5	33.9	32.9	25.4
CIR1	CIR	ENSG00000138433	"Corepressor interacting with RBPJ, CIR1"	Q86X95	2	174348022-174395712	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 187.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 187.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015784, HPA061442"	Approved		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA015784: AB_1846782, HPA061442: AB_2732664"	"unprognostic (3.17e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (9.56e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (2.52e-4)"	"unprognostic (1.00e-2)"	"unprognostic (4.39e-2)"	"prognostic favorable (9.80e-4)"	"unprognostic (1.27e-1)"	"unprognostic (3.66e-2)"	"prognostic unfavorable (1.04e-7)"	"unprognostic (2.23e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.10e-3)"	"prognostic favorable (2.04e-5)"	24.5	24.0	39.0	23.7	40.4	67.9	36.3	40.8	61.6	26.8	41.8	25.5	26.0	27.6	43.9	20.5	28.6	23.6	28.9	38.4	38.3	26.2	27.7	26.9	31.4	39.1	39.2	37.4	34.0	25.1	27.6	25.3	30.1	39.3	26.4	26.6	23.9	25.1	26.3	31.0	30.6	26.9	20.8	38.5	35.3	25.7	31.7	38.2	32.6	29.3	25.4	29.8	24.2	24.4	42.3	20.4	11.4	26.5	21.2	36.3	50.4	39.2	32.9	46.5	32.3	39.5	21.5	30.7	14.1	30.3	32.4	28.3	24.0	22.1	23.4	38.6	26.1	29.1	29.4	17.8	34.9	35.1	35.2	26.0	41.7	41.9	35.5	26.5	55.6	32.4	24.9	30.7	30.8	31.0	19.5	44.1	55.6	24.5	33.2	31.6	24.7	38.1	42.2	38.4	32.1	30.7	36.1	22.7	28.7	52.9	45.7	21.6	51.6	33.6	26.1	19.0	24.9	17.3	34.6	31.4	5.2	37.4	18.2	23.3	71.0	33.8	55.9	28.4	31.7	28.4	41.2	32.2	30.5	21.4	40.5	33.4	30.9	187.8	45.3	33.9	39.5	37.2	28.3	39.0	40.4	40.8	61.6	38.4	38.3	39.1	39.2	37.4	39.3	38.5	38.2	42.3	82.0	118.6	79.8	30.0	80.8	28.6	52.2	118.6	39.3	51.7	40.6	66.8	61.4	61.5	101.2	42.3	31.3	72.7	116.5	69.1	119.3	67.3	201.5	192.2	79.7	58.7	51.4	102.5	30.4	78.7	58.1	69.9	30.1	79.6	81.6	59.1	75.7	58.6	63.8	45.4	33.7	81.9	85.5	93.0	30.3	43.4	107.2	75.3	33.8	22.5	108.2	85.7	111.2	30.2	37.3	57.7	79.8	82.4	49.1	37.5	91.6	114.0	202.3	56.2	72.3	71.4	72.1	219.5	54.7	25.4	32.0	116.0	80.5	62.6	53.5	45.7
CIZ1	"LSFR1, ZNF356"	ENSG00000148337	"CDKN1A interacting zinc finger protein 1"	Q9ULV3	9	128161251-128204383	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020380, HPA020387"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA020380: , HPA020387: AB_2670425"	"unprognostic (1.28e-1)"	"unprognostic (5.77e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (1.43e-4)"	"unprognostic (6.14e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.49e-3)"	"unprognostic (3.13e-3)"	"unprognostic (8.05e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.24e-1)"	"unprognostic (8.47e-3)"	51.3	39.2	36.2	28.7	35.2	55.7	48.7	34.6	46.8	60.1	20.2	58.0	34.8	53.9	24.6	46.6	48.1	34.2	44.1	36.1	27.5	31.8	21.6	38.3	35.4	36.5	32.4	30.3	70.4	71.3	35.3	34.0	28.2	40.0	41.2	27.0	27.1	45.0	33.9	91.2	65.6	42.2	37.2	25.3	35.8	51.7	56.9	34.4	35.6	37.3	42.8	29.7	58.3	50.4	45.5	72.2	85.5	70.7	67.5	71.8	85.6	69.9	55.6	82.2	99.5	56.1	79.1	60.4	84.1	46.1	93.7	82.0	102.1	55.3	59.4	53.9	76.7	64.2	80.2	106.7	51.2	82.5	75.1	91.0	83.7	104.5	109.1	91.9	71.7	68.1	52.9	199.0	70.4	60.5	169.6	98.2	76.1	61.6	96.2	87.4	83.4	74.8	86.5	45.0	48.7	88.4	68.5	123.3	85.8	73.7	31.5	89.7	96.4	72.9	105.7	74.4	120.4	105.6	81.3	99.1	80.2	74.4	49.9	115.1	2.6	2.2	2.6	2.4	3.1	2.2	2.7	2.9	3.1	2.4	3.9	3.0	2.6	0.5	4.9	2.3	2.4	4.8	1.9	36.2	35.2	34.6	46.8	36.1	27.5	36.5	32.4	30.3	40.0	25.3	34.4	45.5	15.4	3.2	12.9	14.0	19.4	23.2	23.2	12.3	21.6	25.9	16.7	17.0	10.8	18.6	11.7	18.4	29.2	23.3	23.6	20.8	13.7	26.0	77.3	10.1	19.9	18.7	22.8	31.5	20.6	44.7	28.8	22.6	25.0	14.8	9.5	25.3	18.5	6.1	22.6	16.8	19.3	19.1	16.2	20.7	18.2	79.2	34.8	17.7	19.6	19.7	19.1	19.6	16.5	11.6	15.9	28.0	15.6	31.2	25.5	15.4	31.6	18.0	8.4	25.0	13.1	23.9	19.1	37.5	26.0	23.8	24.9	20.8	18.2	15.7	25.4	20.0
CLGN		ENSG00000153132	Calmegin	O14967	4	140388453-140427661	"Predicted intracellular proteins, Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 60.0;testis: 114.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 313.3;Early spermatids: 162.4;Endometrial ciliated cells: 93.4;Muller glia cells: 176.4;Spermatocytes: 465.5"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 19.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 53.0;MOLT-4: 47.8;U-251 MG: 73.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020709, HPA048761, HPA058627"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB020709: , HPA048761: AB_2680514, HPA058627: AB_2683782"	"unprognostic (6.74e-2)"	"unprognostic (8.28e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.73e-3)"	"unprognostic (6.14e-2)"	"unprognostic (4.80e-2)"	"unprognostic (3.11e-1)"	"unprognostic (5.38e-3)"	"unprognostic (2.29e-2)"	"unprognostic (2.45e-3)"	"unprognostic (3.00e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.01e-1)"	0.4	6.7	1.4	1.0	0.9	2.4	2.7	3.9	1.7	0.9	1.8	2.0	0.5	1.6	0.6	1.2	13.8	0.4	60.0	1.0	2.0	0.4	3.2	0.5	0.7	2.6	2.0	0.9	0.3	2.2	0.6	11.3	0.2	2.8	22.7	1.3	17.4	1.0	0.7	0.4	0.2	1.3	1.5	1.4	0.2	2.1	114.6	1.7	2.4	2.7	1.6	1.2	0.6	0.1	3.5	0.2	10.2	10.3	6.9	4.0	21.1	2.4	0.1	9.4	10.0	18.6	0.3	0.9	0.0	27.8	0.9	8.4	0.2	7.5	0.1	16.2	0.4	9.0	3.0	9.8	7.4	41.4	38.9	0.6	2.2	39.2	1.0	0.9	53.0	0.2	9.6	2.0	0.0	0.0	0.5	47.8	0.5	12.0	0.2	28.1	31.5	0.0	0.4	0.0	0.3	16.8	29.8	6.5	4.1	1.8	3.8	1.9	5.6	0.0	27.4	4.7	9.7	73.6	14.4	31.7	19.9	43.4	1.6	2.9	0.9	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.9	3.9	1.7	1.0	2.0	2.6	2.0	0.9	2.8	1.4	1.7	3.5	0.8	0.0	2.2	0.3	0.1	0.0	0.9	8.5	1.2	9.2	3.3	1.8	313.3	0.0	6.4	0.0	4.2	0.5	0.0	0.5	0.0	1.2	162.4	93.4	1.3	11.9	5.3	8.6	7.2	4.2	0.1	10.2	0.0	11.3	0.0	10.1	0.7	3.7	0.1	25.2	6.7	0.4	30.5	0.0	0.0	60.2	5.0	0.7	1.8	0.0	0.1	176.4	0.0	6.6	0.6	0.9	3.9	4.5	0.1	33.8	0.2	0.1	24.6	16.3	0.0	0.6	2.0	465.5	23.9	2.8	0.1	0.3	0.7	0.2	0.8	1.3
CMTM2	"CKLFSF2, FLJ25732, MGC39436"	ENSG00000140932	"CKLF like MARVEL transmembrane domain containing 2"	Q8TAZ6	16	66579448-66588275	"Predicted membrane proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	429	"testis: 654.0"	"Group enriched"	"Detected in some"	73	"Early spermatids: 3619.3;Late spermatids: 3073.4;Spermatocytes: 1347.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	5	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.1"	"Cell line enriched"	"Detected in some"	20	"REH: 32.1"					"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.81e-1)"	"unprognostic (3.75e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.23e-1)"	"unprognostic (8.71e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.91e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.02e-4)"	"unprognostic (1.80e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.32e-1)"	0.2	0.1	0.5	0.4	0.2	1.1	0.5	0.7	0.9	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.5	0.1	0.4	0.3	0.5	0.0	0.2	0.0	0.1	0.2	0.2	0.0	0.3	0.2	0.4	0.7	0.0	0.3	0.2	0.0	0.2	0.2	0.3	0.0	0.0	1.5	0.2	654.0	0.0	1.1	0.4	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.2	0.0	0.4	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.5	0.1	0.1	1.5	0.5	0.1	0.0	0.0	32.1	0.2	0.3	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.1	0.7	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.8	0.5	0.2	0.7	0.9	0.5	0.1	0.2	0.0	0.1	0.4	0.0	0.0	0.1	0.3	12.8	21.9	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.2	0.0	5.0	0.0	0.0	0.1	1.5	0.2	0.0	0.3	3619.3	0.1	0.1	2.3	0.0	0.0	1.1	0.2	0.2	1.8	0.0	0.1	18.9	0.1	1.1	0.3	1.4	0.0	0.6	0.0	0.0	0.9	0.3	3073.4	36.4	5.5	0.0	0.0	7.7	0.0	1.0	0.0	0.6	0.8	0.0	30.5	0.0	0.0	0.0	0.4	0.7	0.6	19.7	0.7	0.1	1347.5	20.4	0.0	0.0	0.1	1.7	0.4	0.0	0.0
CNOT10	"FLJ12890, FLJ13165"	ENSG00000182973	"CCR4-NOT transcription complex subunit 10"	Q9H9A5	3	32685145-32773875	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 181.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035614, HPA041450"	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Nucleoplasm, Centrosome"	Cytosol	"HPA035614: AB_10669975, HPA041450: AB_2677487"	"unprognostic (3.75e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.45e-3)"	"unprognostic (6.01e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.60e-2)"	"prognostic unfavorable (1.03e-6)"	"unprognostic (1.88e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.84e-2)"	"unprognostic (8.75e-3)"	"unprognostic (3.43e-1)"	8.5	7.8	6.0	11.5	6.6	17.6	12.7	7.9	7.2	11.0	7.1	11.7	9.9	10.8	11.6	9.9	14.2	8.7	7.8	5.9	6.7	10.7	12.6	9.9	14.7	6.3	6.2	5.5	12.4	9.5	13.1	10.4	8.6	6.3	9.1	14.0	6.5	8.6	7.6	9.6	13.4	10.7	10.2	5.9	14.7	9.2	40.2	6.4	19.9	12.4	5.9	16.6	9.9	8.8	7.7	24.4	26.7	27.2	25.9	12.9	14.8	181.2	20.1	20.0	28.0	31.3	20.5	20.5	39.6	13.0	14.4	18.1	20.9	32.5	26.5	27.8	34.5	33.3	51.0	23.2	20.0	37.6	42.3	18.9	10.9	23.3	30.9	40.4	18.7	23.2	36.4	54.1	30.1	16.6	20.1	38.0	20.4	41.2	28.0	25.3	37.9	18.5	39.8	18.0	28.1	15.5	29.9	29.5	41.1	24.4	19.3	40.0	47.4	14.3	17.3	24.6	23.0	33.7	30.8	67.8	39.6	17.7	31.7	21.4	18.5	12.0	17.7	11.4	17.1	12.4	15.3	18.6	13.7	15.1	17.4	18.1	16.0	9.6	10.2	25.2	8.4	16.0	12.3	6.0	6.6	7.9	7.2	5.9	6.7	6.3	6.2	5.5	6.3	5.9	6.4	7.7	11.6	16.0	22.8	28.4	19.6	10.5	7.2	13.0	9.1	16.8	9.4	9.0	13.2	14.3	15.3	14.7	33.3	14.8	21.0	15.3	5.9	12.9	60.3	23.4	12.9	14.1	15.6	21.2	37.7	13.5	17.1	12.0	15.3	14.1	10.8	17.2	12.8	9.8	11.9	15.2	36.5	10.6	10.2	18.8	14.3	34.3	9.6	14.5	12.4	20.6	37.2	7.4	10.3	29.1	35.3	11.7	16.4	10.5	17.5	6.6	15.2	7.0	29.9	20.9	6.6	14.9	12.5	63.0	33.1	10.2	14.5	8.2	20.1	17.8	14.4	7.3
CNTRL	"CEP1, CEP110"	ENSG00000119397	Centriolin	Q7Z7A1	9	121074753-121177610	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 28.2;testis: 35.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 131.7;Spermatocytes: 385.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 81.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020468, HPA020480, HPA051583"	Approved		Approved	"Centriolar satellite,Centrosome,Cytosol"		NA	Yes			"Centrosome, Cytosol"	"Centriolar satellite"	"HPA020468: AB_2670455, HPA020480: AB_2670457, HPA051583: AB_2681542"	"unprognostic (4.33e-3)"	"unprognostic (2.89e-3)"	"unprognostic (2.09e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.17e-2)"	"prognostic favorable (9.21e-5)"	"unprognostic (1.05e-2)"	"unprognostic (3.22e-3)"	"unprognostic (3.74e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.78e-2)"	"unprognostic (5.47e-2)"	"unprognostic (3.60e-3)"	"unprognostic (9.83e-3)"	"unprognostic (2.43e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.13e-2)"	5.3	3.7	3.8	13.9	3.3	28.2	5.0	3.8	2.8	4.4	6.4	4.6	4.0	6.7	2.7	4.1	7.8	5.4	2.8	1.9	3.7	2.9	4.1	6.8	23.5	4.6	4.7	1.2	7.6	3.9	2.9	3.1	6.3	3.6	4.6	5.7	7.5	3.6	3.8	1.1	5.0	5.2	5.0	4.2	12.8	7.9	35.6	3.5	24.1	4.8	1.8	21.9	6.5	2.8	5.2	12.6	8.3	22.5	16.4	3.3	4.9	4.2	8.4	6.2	6.6	5.6	4.7	13.2	55.7	3.3	6.3	11.8	25.2	7.6	5.2	10.4	34.3	5.5	29.4	15.2	6.1	4.5	81.0	34.1	3.1	3.8	6.9	16.5	2.8	14.6	22.7	19.2	31.0	6.5	7.9	31.2	21.5	8.1	16.0	6.6	30.1	33.4	17.4	3.1	5.7	8.5	12.9	28.4	5.2	6.3	3.9	11.0	36.0	10.3	6.7	11.6	10.8	15.8	22.0	25.6	37.8	5.6	32.2	16.1	16.2	7.0	17.0	7.2	4.3	5.5	11.7	7.5	5.5	3.7	11.9	9.0	6.4	2.7	5.0	6.5	10.6	11.5	2.8	3.8	3.3	3.8	2.8	1.9	3.7	4.6	4.7	1.2	3.6	4.2	3.5	5.2	19.8	28.9	32.8	34.9	78.7	3.3	13.8	6.8	9.1	33.5	7.4	12.2	8.9	10.0	29.5	3.7	37.5	2.7	58.2	2.7	3.9	5.1	131.7	61.8	12.3	14.8	8.4	33.2	35.4	6.0	3.0	15.1	14.8	10.9	53.0	20.6	14.6	3.9	27.2	30.3	43.8	8.4	4.1	33.9	16.5	44.3	13.7	50.7	8.8	52.5	55.2	8.2	49.4	37.2	53.1	6.3	4.5	12.0	39.1	4.3	2.2	1.4	114.6	59.6	39.5	33.8	14.5	385.0	114.1	10.9	5.7	0.8	57.0	13.1	6.4	6.2
CNTROB	"LIP8, PP1221"	ENSG00000170037	"Centrobin, centriole duplication and spindle assembly protein"	Q8N137	17	7932101-7949920	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 44.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023319, HPA023320, HPA023321, HPA023325"	Approved		Supported	Centrosome,Cytosol		NA	NA			Centrosome	Cytosol	"HPA023319: AB_1852886, HPA023320: AB_1852888, HPA023321: AB_1852890, HPA023325: AB_1852892"	"unprognostic (5.73e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.26e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (9.88e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.47e-3)"	"unprognostic (1.48e-2)"	"unprognostic (8.63e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.79e-1)"	"unprognostic (2.16e-2)"	16.9	14.8	18.7	13.7	19.1	32.5	17.5	19.2	20.6	25.4	17.8	23.3	10.8	38.3	18.2	20.2	20.2	12.9	14.7	19.0	19.6	18.7	18.2	28.9	15.3	19.9	19.4	18.0	20.9	16.9	20.0	18.2	12.1	20.1	19.6	19.1	18.1	16.6	12.6	12.7	26.4	17.4	25.8	18.2	19.1	16.8	66.0	20.1	29.5	19.8	9.8	17.8	18.9	19.7	20.1	51.1	31.0	48.7	25.5	19.1	26.7	15.0	43.9	40.5	59.8	44.0	26.5	18.0	50.2	22.4	38.5	26.9	41.2	36.8	29.9	64.9	50.6	27.4	33.6	58.6	21.5	28.6	31.9	52.8	24.2	21.1	42.0	41.7	28.5	36.6	53.0	24.6	25.9	40.8	15.9	49.5	29.6	10.4	18.5	25.6	51.9	32.6	20.2	26.5	16.1	16.2	29.4	34.3	17.8	14.8	25.2	24.6	20.0	33.2	32.8	27.6	45.2	61.0	38.7	27.1	35.1	28.4	39.6	47.2	6.4	1.8	0.7	1.8	2.5	1.7	1.4	1.4	2.4	1.3	0.9	0.9	1.6	0.2	2.5	1.1	5.3	2.0	2.1	18.7	19.1	19.2	20.6	19.0	19.6	19.9	19.4	18.0	20.1	18.2	20.1	20.1	4.2	6.4	19.6	6.5	4.2	7.9	7.5	5.2	4.6	6.6	6.7	6.5	3.4	7.2	6.9	12.9	8.4	4.4	7.4	5.9	1.9	5.8	3.1	5.8	18.0	5.4	3.0	14.1	3.8	6.9	4.7	6.4	6.6	5.4	18.4	10.9	5.7	3.5	6.5	3.3	5.5	7.0	2.0	6.7	9.1	4.8	5.3	9.2	3.6	5.6	1.9	6.4	6.2	4.5	4.3	6.6	3.1	7.9	7.5	5.5	4.4	3.5	5.7	6.2	0.0	5.8	5.4	44.4	8.1	9.0	8.7	2.5	5.7	5.5	8.4	4.5
COPRS	"C17orf79, COPR5, HSA272196, TTP1"	ENSG00000172301	"Coordinator of PRMT5 and differentiation stimulator"	Q9NQ92	17	31851871-31859291	"Predicted intracellular proteins"	"Myogenesis, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 243.3"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 253.2;Late spermatids: 288.9;Spermatocytes: 575.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA052552	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA052552: AB_2681868"	"unprognostic (1.65e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.01e-3)"	"unprognostic (3.12e-2)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (6.88e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.44e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.11e-2)"	50.3	46.9	128.9	20.3	132.2	14.4	50.2	127.6	174.2	43.0	128.7	73.2	16.2	43.8	118.6	26.6	52.2	32.3	60.6	128.9	136.1	56.2	68.6	34.2	21.2	127.3	127.8	125.7	52.1	42.2	49.4	67.9	19.9	129.2	60.7	27.7	56.5	35.7	46.8	54.0	29.7	31.3	44.8	125.1	25.3	52.1	243.3	131.1	13.3	63.7	53.8	28.1	57.5	33.6	127.8	101.5	132.9	64.4	66.6	104.3	99.5	45.2	109.7	140.3	125.8	127.8	83.4	27.0	53.0	58.8	135.1	245.0	58.5	116.0	67.6	142.3	18.7	153.8	15.4	79.7	99.5	105.5	53.2	43.4	64.2	87.4	169.3	92.4	135.7	68.6	75.2	75.0	46.9	139.6	89.9	79.6	170.7	49.1	65.2	62.8	61.8	120.8	104.4	74.5	62.8	58.4	44.2	65.9	32.6	107.1	56.1	104.4	57.9	37.0	327.8	85.9	116.6	156.3	76.2	77.2	58.3	170.8	50.1	44.9	1.8	2.0	0.0	0.6	2.0	1.6	1.9	0.5	0.1	2.6	3.6	0.3	0.3	0.6	0.0	0.9	1.0	0.8	0.3	128.9	132.2	127.6	174.2	128.9	136.1	127.3	127.8	125.7	129.2	125.1	131.1	127.8	54.2	22.4	8.3	13.7	20.9	34.4	69.0	15.3	29.6	43.1	79.2	88.4	78.9	68.6	13.4	86.5	10.4	31.9	10.7	12.1	225.0	99.6	253.2	142.2	38.5	53.5	19.7	18.7	14.6	80.8	54.9	65.7	14.3	40.5	3.8	39.9	62.4	95.4	87.6	26.9	14.8	15.9	40.7	30.3	34.7	288.9	62.4	36.5	58.7	7.5	47.9	136.3	9.2	3.5	9.2	70.7	8.4	65.1	27.4	127.4	6.4	212.0	55.8	43.0	19.7	46.9	63.5	575.6	63.8	21.4	31.7	27.4	11.2	49.6	21.3	39.6
COPS4	CSN4	ENSG00000138663	"COP9 signalosome subunit 4"	Q9BT78	4	83034447-83075818	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036894, HPA042828"	Approved		Supported	"Nuclear speckles"		NA	NA		100000	"Nuclear speckles"		"HPA036894: AB_10670929, HPA042828: AB_2678191"	"unprognostic (1.82e-3)"	"unprognostic (1.01e-2)"	"prognostic favorable (4.14e-4)"	"unprognostic (7.97e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.96e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.10e-2)"	"unprognostic (9.21e-2)"	"prognostic favorable (5.21e-6)"	"unprognostic (5.84e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.80e-1)"	25.7	39.0	28.3	22.2	31.4	41.4	32.3	27.5	33.8	32.0	26.7	25.5	23.3	31.1	29.0	30.8	26.2	22.7	60.3	30.1	34.4	39.2	29.4	22.4	30.2	29.4	29.3	28.9	32.2	24.8	44.0	39.5	30.5	31.5	30.6	25.3	46.0	23.9	30.8	105.8	26.4	22.1	33.6	28.4	22.6	22.6	45.4	30.9	36.5	38.8	84.9	33.0	32.1	23.7	32.7	51.7	30.4	64.1	59.0	56.0	71.7	34.8	67.2	85.7	74.8	66.0	43.7	51.8	86.9	57.3	140.5	41.3	37.7	80.6	68.9	101.1	55.6	56.9	50.4	43.5	42.1	46.3	86.8	135.6	54.4	47.0	55.8	47.8	56.2	101.1	53.5	65.2	48.0	91.9	43.4	105.0	63.6	35.3	81.1	40.6	74.0	48.8	48.1	59.8	47.2	67.7	39.6	45.0	69.4	43.5	43.8	52.7	46.4	66.7	52.2	55.1	39.7	48.6	49.8	32.7	96.8	50.3	55.2	52.8	91.4	37.0	55.2	43.0	50.4	53.9	39.7	47.1	49.7	45.3	38.9	44.7	48.1	8.2	54.6	59.8	29.0	47.6	52.3	28.3	31.4	27.5	33.8	30.1	34.4	29.4	29.3	28.9	31.5	28.4	30.9	32.7	25.6	12.8	20.1	21.9	34.1	42.8	42.2	94.5	23.3	38.7	20.1	23.4	81.3	20.0	51.5	20.2	31.3	82.5	36.5	14.5	90.1	42.4	130.6	24.9	27.6	31.9	31.2	26.5	34.7	33.2	62.7	39.9	15.3	21.3	34.2	38.2	20.0	22.4	49.0	26.9	32.9	22.0	67.1	29.2	29.2	38.3	30.7	27.2	33.8	18.7	37.8	62.5	37.0	28.6	32.9	28.2	22.1	42.9	28.6	20.5	22.6	75.7	37.9	44.6	32.9	34.1	42.5	121.2	50.2	29.7	35.2	95.0	32.8	53.3	26.3	34.3
COX6B2	"COXVIB2, CT59, FLJ32865"	ENSG00000160471	"Cytochrome c oxidase subunit 6B2"	Q6YFQ2	19	55349306-55354719	"Metabolic proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"testis: 91.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 36.0;Late spermatids: 27.4;Respiratory ciliated cells: 12.6;Spermatocytes: 61.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"CAPAN-2: 24.9;SCLC-21H: 10.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA035014			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane, Cytosol"		"HPA035014: AB_10601261"	"unprognostic (7.43e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.59e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.88e-2)"	"unprognostic (6.45e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.82e-2)"	"prognostic unfavorable (9.70e-5)"	"unprognostic (8.11e-2)"	"unprognostic (1.81e-6)"	"unprognostic (9.91e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.02e-1)"	0.4	0.1	0.4	1.1	0.3	1.1	0.9	0.9	0.5	0.3	0.4	4.7	0.2	0.2	1.2	1.2	0.7	0.2	0.1	0.3	0.3	0.8	0.1	0.3	0.2	0.3	0.6	0.3	0.5	0.2	0.0	0.9	0.2	0.5	0.7	4.9	0.4	1.4	0.2	0.3	2.5	0.3	0.2	0.1	0.4	0.2	91.2	0.5	3.3	0.1	0.0	1.9	0.5	1.0	0.6	3.1	0.4	0.1	0.1	0.0	0.0	0.2	0.4	0.1	0.3	0.5	0.2	24.9	0.1	0.2	0.3	0.3	1.8	0.7	0.2	0.2	0.9	0.7	0.0	2.0	0.1	0.3	0.2	1.8	0.2	2.7	0.5	0.6	1.7	0.0	0.1	0.4	0.2	0.0	0.6	0.1	0.2	0.6	2.6	0.5	0.1	0.0	0.2	0.1	0.4	10.1	0.3	0.4	0.1	0.0	0.6	0.4	0.0	0.5	0.2	0.5	0.1	0.3	1.6	1.4	0.1	0.1	0.3	0.1	0.8	0.2	0.3	0.2	0.1	0.1	0.2	0.2	0.1	0.0	0.3	0.2	0.2	1.5	0.5	0.2	0.4	0.2	0.3	0.4	0.3	0.9	0.5	0.3	0.3	0.3	0.6	0.3	0.5	0.1	0.5	0.6	0.2	0.0	0.5	0.0	0.0	0.5	0.7	3.5	1.2	2.4	0.9	1.3	0.6	0.0	2.1	0.0	4.2	0.5	1.8	8.0	0.0	0.5	36.0	1.3	0.5	0.2	1.2	0.0	0.0	0.6	0.3	0.6	0.0	0.8	0.0	0.2	0.0	0.0	0.1	3.3	0.1	1.3	4.1	0.0	0.0	27.4	0.6	0.3	0.0	0.0	0.0	1.4	2.1	0.0	0.1	9.6	4.1	0.0	0.3	0.7	3.4	0.1	12.6	5.4	0.0	0.4	0.5	61.1	1.7	0.3	0.4	0.4	0.6	0.1	6.5	2.3
COX7B2		ENSG00000170516	"Cytochrome c oxidase subunit 7B2"	Q8TF08	4	46734827-46909245	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	70	"testis: 86.4"	"Group enriched"	"Detected in some"	9	"Early spermatids: 519.2;Late spermatids: 211.0;Spermatocytes: 391.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 7.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"Karpas-707: 33.9"	"Low region specificity"	"Detected in many"													NA	NA												"unprognostic (2.82e-1)"								"unprognostic (2.42e-1)"			0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	86.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	33.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.9	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	519.2	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	211.0	9.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	391.5	38.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CRBN	"MRT2, MRT2A"	ENSG00000113851	Cereblon	Q96SW2	3	3144628-3179727	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Transporters"	"Ubl conjugation pathway"		"Disease variant, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 314.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045910	Approved					NA	NA					"HPA045910: AB_10960409"	"unprognostic (1.26e-1)"	"unprognostic (4.14e-2)"	"unprognostic (4.27e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.40e-3)"	"unprognostic (2.15e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.17e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.47e-2)"	25.3	21.1	26.9	17.3	30.2	44.4	34.2	34.9	42.8	23.1	43.1	20.5	22.0	26.4	24.1	20.8	21.9	21.2	31.2	30.9	29.8	31.3	35.6	24.7	28.8	33.0	34.3	35.1	32.4	22.1	30.1	11.2	29.7	37.5	23.7	23.2	27.0	36.6	23.8	42.2	25.0	23.0	25.0	31.9	30.8	23.1	48.6	31.6	23.7	32.2	38.8	21.8	20.2	14.7	49.6	12.9	10.5	32.5	14.4	38.8	37.3	13.6	14.3	23.9	18.4	24.6	15.6	18.7	13.9	19.4	17.8	22.3	12.2	19.9	24.1	20.0	24.0	30.9	35.9	20.1	19.4	26.0	32.5	22.4	28.7	31.1	19.9	15.1	36.1	25.2	29.9	21.5	29.4	16.1	18.7	28.6	32.5	27.3	17.8	24.8	25.9	19.5	30.5	21.8	20.0	16.3	23.7	15.9	21.6	35.7	24.1	28.9	24.0	16.3	18.8	9.8	30.0	18.6	33.2	55.8	35.2	29.2	29.5	23.5	314.2	44.3	99.3	61.6	53.6	65.2	46.4	82.6	66.8	39.8	36.9	84.3	72.4	28.1	103.6	58.1	21.4	63.0	96.1	26.9	30.2	34.9	42.8	30.9	29.8	33.0	34.3	35.1	37.5	31.9	31.6	49.6	89.7	44.8	39.1	30.3	46.5	36.1	35.5	70.9	33.0	61.5	30.6	43.4	73.5	38.6	45.2	38.6	27.1	52.6	81.2	21.4	72.4	33.3	184.2	23.9	31.7	72.0	15.6	54.5	72.6	21.2	35.3	47.9	17.3	22.3	140.4	50.2	68.6	35.0	36.0	43.7	74.1	24.6	54.9	52.7	33.4	56.6	62.7	54.8	33.8	28.1	68.8	66.4	121.5	42.7	74.0	20.4	33.5	66.5	34.1	26.0	53.4	73.2	36.4	64.5	59.2	58.0	46.2	206.2	96.2	19.2	38.5	50.2	70.9	49.4	30.5	24.7
CRYZL1	"4P11, QOH-1"	ENSG00000205758	"Crystallin zeta like 1"	O95825	21	33589341-33643926	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 139.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019120, HPA029399, CAB034129"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB034129: AB_2084755, HPA019120: AB_1847264, HPA029399: AB_10600865"	"unprognostic (1.54e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.19e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.57e-3)"	"unprognostic (2.90e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.59e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.28e-3)"	22.6	18.8	24.9	16.5	27.8	22.6	21.3	32.7	33.7	18.6	23.9	24.5	15.2	22.8	19.2	19.0	20.4	16.4	20.2	26.1	25.7	23.7	18.1	16.3	17.9	25.9	27.1	25.4	22.2	15.3	22.5	14.3	21.8	26.8	18.4	20.5	29.5	18.1	22.5	19.4	23.1	16.0	21.4	24.0	15.7	17.8	34.3	26.1	18.3	24.7	15.6	14.1	21.2	18.1	35.4	38.0	16.4	45.7	33.8	24.3	35.0	24.0	26.3	37.8	33.0	29.1	24.5	29.0	26.4	23.0	32.5	25.6	20.5	24.6	27.2	30.0	24.6	24.8	49.9	35.5	22.2	38.4	31.0	29.8	32.7	23.4	34.9	27.2	43.1	42.4	42.6	36.8	26.6	31.3	19.3	30.2	31.8	32.3	38.8	21.9	28.5	36.8	36.6	47.1	33.7	19.8	31.2	34.6	17.5	39.7	37.8	34.3	23.1	44.8	26.3	25.3	22.0	20.5	43.4	64.7	29.1	34.4	22.7	30.1	36.1	34.5	36.2	31.7	37.5	34.3	38.2	33.4	29.9	43.3	40.4	43.3	35.3	18.3	47.1	35.6	34.3	29.9	26.8	24.9	27.8	32.7	33.7	26.1	25.7	25.9	27.1	25.4	26.8	24.0	26.1	35.4	25.6	32.1	17.3	40.1	25.9	23.6	43.9	58.9	19.9	47.8	22.1	25.1	28.0	31.5	36.0	31.3	31.3	70.4	21.3	20.2	49.0	37.6	90.4	19.6	14.4	29.9	21.0	25.4	42.4	29.1	40.5	28.1	13.3	14.4	65.2	34.5	27.5	15.0	33.5	47.1	47.2	22.5	46.8	26.0	25.7	28.0	44.1	24.6	37.4	26.2	36.1	49.4	41.2	32.2	56.7	28.6	30.3	41.0	11.3	23.3	33.7	44.8	35.0	51.1	19.7	23.7	41.5	139.4	19.4	15.9	21.5	44.6	28.4	27.3	29.4	40.5
CSTF1		ENSG00000101138	"Cleavage stimulation factor subunit 1"	Q05048	20	56392371-56406362	"Predicted intracellular proteins"	"mRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 84.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019270, HPA047275, HPA065000"	Supported		Enhanced	Nucleoplasm		NA	NA		210000	Nucleoplasm		"CAB019270: , HPA047275: AB_2680008, HPA065000: AB_2685400"	"unprognostic (2.51e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.13e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.57e-3)"	"unprognostic (3.08e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.05e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.60e-1)"	6.3	6.5	4.3	8.2	5.0	5.2	11.2	6.3	5.0	7.4	5.0	7.9	5.4	8.2	8.1	8.9	9.6	7.8	8.1	4.6	4.6	9.6	11.0	8.6	12.5	4.4	4.9	4.4	11.9	10.1	11.5	4.8	9.4	5.0	8.6	8.1	15.0	10.4	7.1	9.5	8.4	5.9	8.9	4.1	7.7	7.9	17.7	5.4	14.4	10.1	14.8	14.6	9.0	5.8	6.4	18.9	17.4	22.1	15.6	22.6	20.2	23.7	25.2	27.8	49.2	36.7	37.6	26.9	39.1	26.7	19.1	31.5	31.2	35.7	43.4	57.8	12.4	12.6	38.1	29.3	23.3	13.4	32.2	23.6	19.4	24.5	27.6	23.8	19.1	30.2	24.3	32.6	18.5	30.2	44.6	36.2	17.0	20.3	37.2	23.2	26.5	47.7	34.6	23.9	19.3	24.5	17.0	34.5	93.1	25.6	25.3	37.1	22.9	17.1	39.9	25.3	16.9	24.9	13.0	21.5	42.0	32.0	21.3	19.4	11.4	16.9	13.6	20.7	14.6	26.0	21.1	25.9	23.4	21.5	24.3	28.4	24.9	13.3	31.2	13.1	23.7	33.3	20.4	4.3	5.0	6.3	5.0	4.6	4.6	4.4	4.9	4.4	5.0	4.1	5.4	6.4	8.4	9.6	13.1	4.2	11.6	9.2	10.8	29.3	12.5	9.2	9.9	8.3	8.9	14.3	16.8	18.4	14.6	30.9	11.5	7.3	19.6	17.9	25.9	7.1	9.4	13.3	4.9	21.0	4.2	14.7	21.1	12.1	9.7	6.0	17.7	12.6	11.7	22.6	15.3	5.0	4.2	9.4	14.2	16.7	7.8	7.5	13.7	8.4	5.4	9.4	18.4	14.2	12.3	5.5	6.7	11.9	11.8	12.8	10.8	12.3	8.5	21.1	12.9	14.7	19.7	11.1	9.9	84.3	30.5	11.3	8.8	21.1	14.9	16.7	9.8	8.8
CTAGE6	"CTAGE6P, MGC41943"	ENSG00000271321	"CTAGE family member 6"	Q86UF2	7	143755089-143757696	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	36	"testis: 14.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 4.1;Microglial cells: 1.0;Spermatocytes: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA000387, HPA000922"	Uncertain					NA	NA					"HPA000387: AB_1078582, HPA000922: AB_1078581"		"unprognostic (1.51e-2)"											"unprognostic (8.90e-12)"	"unprognostic (1.73e-2)"			"unprognostic (2.86e-1)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	14.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0
CTAGE9		ENSG00000236761	"CTAGE family member 9"	A4FU28	6	131708441-131711017	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	30	"testis: 8.4"	"Group enriched"	"Detected in some"	5	"Early spermatids: 8.6;Spermatocytes: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA000387, HPA000922"	Uncertain					NA	NA					"HPA000387: AB_1078582, HPA000922: AB_1078581"	"unprognostic (3.92e-2)"	"unprognostic (6.84e-2)"	"unprognostic (3.48e-2)"			"unprognostic (1.92e-1)"	"unprognostic (9.89e-3)"	"unprognostic (2.36e-1)"		"unprognostic (5.55e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.52e-2)"	"unprognostic (5.74e-4)"	"unprognostic (3.15e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.41e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.5	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0
CYB5D2	MGC32124	ENSG00000167740	"Cytochrome b5 domain containing 2"	Q8WUJ1	17	4143168-4187310	"Predicted intracellular proteins, Predicted secreted proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 130.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 74.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011032, HPA042299"	Approved		Approved	"Endoplasmic reticulum,Plasma membrane"	"Secreted to blood"	NA	NA			"Endoplasmic reticulum, Plasma membrane"		"HPA011032: , HPA042299: AB_10793879"	"unprognostic (2.57e-2)"	"unprognostic (2.89e-2)"	"unprognostic (4.16e-2)"	"prognostic favorable (6.19e-4)"	"unprognostic (1.88e-2)"	"unprognostic (1.75e-2)"	"prognostic favorable (4.98e-6)"	"unprognostic (1.57e-1)"	"unprognostic (2.47e-1)"	"unprognostic (9.71e-3)"	"prognostic favorable (7.76e-5)"	"unprognostic (2.04e-1)"	"prognostic favorable (2.03e-10)"	"unprognostic (2.01e-3)"	"unprognostic (8.73e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.97e-1)"	17.6	21.9	17.9	6.1	17.5	4.3	18.4	18.0	20.3	16.1	14.2	10.5	15.3	15.7	28.7	11.0	18.9	16.4	12.3	16.9	19.3	25.7	29.2	9.8	9.4	18.7	18.1	16.9	20.9	19.9	31.1	24.3	10.9	18.4	13.6	7.4	9.3	20.1	17.7	16.3	13.5	12.2	8.4	17.6	9.7	16.1	29.5	17.5	10.3	22.9	15.0	7.2	13.0	11.7	19.0	16.2	21.6	11.8	12.7	74.7	22.5	5.2	15.7	31.5	11.0	10.9	6.3	10.3	5.3	13.6	17.4	9.2	22.5	4.9	7.1	4.4	17.9	25.7	5.0	13.5	10.5	13.7	2.1	9.5	28.8	17.0	6.2	11.7	22.3	20.1	11.5	5.1	31.2	8.3	20.6	7.8	3.4	4.3	13.7	11.5	9.2	10.6	12.5	25.1	8.5	9.3	8.1	17.2	9.9	23.5	13.1	25.6	3.2	28.5	15.7	4.0	14.5	8.0	5.8	4.9	3.9	19.9	4.5	6.2	0.6	10.8	13.6	5.9	9.2	6.7	8.1	9.3	7.4	10.5	7.1	8.6	8.0	9.5	5.5	8.7	11.3	11.2	8.2	17.9	17.5	18.0	20.3	16.9	19.3	18.7	18.1	16.9	18.4	17.6	17.5	19.0	57.4	12.8	10.3	9.1	17.2	53.7	18.4	36.0	12.5	26.9	35.4	36.7	9.8	45.8	21.8	31.3	58.4	55.7	11.4	18.5	52.8	34.3	28.5	36.6	20.0	34.4	13.8	33.3	7.6	27.0	29.1	23.8	19.4	23.4	11.4	22.3	41.0	32.9	21.4	40.4	10.4	16.0	36.7	24.0	23.8	30.6	28.9	17.3	14.2	4.7	15.4	37.6	15.5	8.5	10.0	26.9	18.9	28.6	17.6	8.3	39.7	55.7	38.5	30.4	0.0	15.2	20.1	130.3	29.2	9.5	42.9	38.6	15.8	39.3	16.6	15.8
DBF4	"ASK, chif, DBF4A, ZDBF1"	ENSG00000006634	"DBF4 zinc finger"	Q9UBU7	7	87876216-87909553	"Predicted intracellular proteins"	"Cell cycle, DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	19	"testis: 15.3"	"Group enriched"	"Detected in all"	4	"Early spermatids: 468.6;Spermatocytes: 569.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042923			Supported	"Nucleoplasm,Nuclear bodies"		Yes	Yes			"Nucleoplasm, Nuclear bodies"		"HPA042923: AB_2678222"	"unprognostic (2.48e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.86e-3)"	"unprognostic (2.81e-2)"	"unprognostic (3.63e-1)"	"prognostic unfavorable (4.45e-6)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (6.86e-4)"	"unprognostic (1.46e-3)"	"unprognostic (1.05e-3)"	"unprognostic (2.78e-3)"	"prognostic unfavorable (6.42e-7)"	"unprognostic (1.98e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.30e-1)"	0.0	0.2	0.3	0.2	0.5	0.6	0.2	0.8	0.5	0.2	0.3	0.2	0.2	0.2	0.3	0.1	0.1	0.4	0.1	0.3	0.3	0.2	0.2	0.1	0.5	0.3	0.4	0.4	0.2	0.1	0.1	0.0	0.1	0.4	0.2	0.2	0.2	0.1	0.1	0.1	0.2	0.3	0.0	0.2	0.3	0.2	15.3	0.3	0.6	0.3	0.0	0.5	0.1	0.1	0.5	0.9	0.8	2.0	2.5	0.4	0.4	0.5	1.0	0.2	1.0	2.1	1.4	0.6	2.1	0.6	0.6	1.7	0.9	2.2	0.5	1.0	1.6	1.3	1.3	1.0	0.4	0.1	1.7	1.0	0.4	0.6	1.2	1.0	0.3	0.9	1.9	1.2	4.2	1.4	1.7	2.8	2.0	2.0	2.1	1.9	0.7	3.1	2.5	0.8	0.1	3.0	1.8	1.2	2.2	1.0	1.6	0.9	1.6	0.1	1.2	1.4	3.1	2.0	2.3	5.2	2.1	0.8	3.1	2.5	1.0	0.1	0.1	0.3	0.0	0.1	0.2	0.2	0.1	0.0	0.2	0.2	0.3	0.2	0.2	0.0	0.2	0.4	0.1	0.3	0.5	0.8	0.5	0.3	0.3	0.3	0.4	0.4	0.4	0.2	0.3	0.5	13.3	3.2	12.6	5.5	38.4	15.6	16.4	10.7	12.0	6.6	13.0	16.8	3.7	2.8	7.7	9.2	12.5	19.6	59.2	9.7	3.9	8.3	468.6	12.1	23.6	11.1	14.9	40.8	14.7	14.7	36.4	12.4	14.3	17.7	31.0	19.4	6.4	6.5	16.1	3.3	9.1	20.6	16.2	9.1	15.5	116.0	15.5	20.8	12.4	2.8	11.0	2.1	24.7	6.0	6.7	14.1	8.5	9.4	48.9	18.4	4.2	5.8	10.2	16.6	13.1	9.7	11.4	569.4	74.6	20.5	12.6	9.6	44.4	13.5	22.3	11.7
DCTN5	"MGC3248, p25"	ENSG00000166847	"Dynactin subunit 5"	Q9BTE1	16	23641466-23677472	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042003, HPA063710"	Approved		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA042003: AB_10796468, HPA063710: AB_2685101"	"unprognostic (5.90e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.28e-2)"	"prognostic unfavorable (4.02e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.36e-2)"	"unprognostic (6.78e-2)"	"unprognostic (9.28e-2)"	"prognostic favorable (4.48e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.59e-2)"	"unprognostic (9.55e-2)"	14.0	11.4	13.4	18.3	18.3	41.9	14.3	10.4	15.2	13.7	4.3	19.4	20.9	15.0	12.1	25.4	13.7	14.3	14.8	17.0	14.9	21.2	10.7	14.1	22.3	11.6	13.5	17.0	12.1	16.0	19.9	8.5	21.0	11.3	14.3	25.1	21.7	12.9	14.1	14.0	14.2	22.4	21.9	11.2	15.2	16.8	20.8	12.4	21.1	19.0	14.4	32.5	20.8	11.0	13.5	30.0	58.5	56.0	46.9	39.0	28.9	39.2	51.9	32.1	32.9	39.3	66.5	40.3	42.1	41.2	54.8	34.6	30.6	93.4	50.2	40.5	48.1	37.1	51.9	67.2	93.9	26.5	63.7	38.4	24.3	35.3	40.5	42.8	36.5	52.8	52.0	100.7	31.6	53.3	82.4	49.4	18.4	66.3	43.3	25.5	59.8	48.6	45.9	26.2	62.6	46.8	48.5	45.6	36.7	30.5	49.0	51.2	53.2	71.8	44.0	20.0	34.9	36.6	42.6	68.6	66.2	42.0	31.4	48.8	14.3	16.6	20.3	15.5	14.0	17.1	13.9	14.2	17.0	17.5	10.5	12.0	14.3	7.3	22.0	22.0	12.4	19.0	17.2	13.4	18.3	10.4	15.2	17.0	14.9	11.6	13.5	17.0	11.3	11.2	12.4	13.5	19.7	16.0	26.2	12.1	19.1	14.7	14.5	12.9	22.8	52.1	15.5	14.5	27.1	15.7	15.6	20.2	91.8	32.9	16.1	36.2	11.7	23.8	23.2	11.9	22.4	22.5	22.1	27.6	13.4	25.2	36.3	16.3	20.9	20.8	27.8	37.3	17.2	14.2	28.4	52.2	13.2	18.9	12.2	19.1	11.4	23.4	13.1	17.1	7.2	6.5	34.4	32.3	30.9	11.1	12.0	45.7	19.4	18.0	17.4	14.4	31.9	23.3	11.2	45.0	13.1	22.4	18.1	70.4	30.6	20.9	14.2	48.2	18.7	17.9	26.2	22.0
DDX19B	"DBP5, DDX19"	ENSG00000157349	"DEAD-box helicase 19B"	Q9UMR2	16	70289663-70335305	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 207.8;Spermatocytes: 101.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037229, CAB037284, HPA046380, HPA066668"	Approved		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"CAB037229: AB_1840791, CAB037284: AB_1840792, HPA046380: AB_2679645, HPA066668: "	"unprognostic (2.91e-2)"	"unprognostic (5.37e-2)"	"unprognostic (6.48e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.05e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.05e-1)"	"unprognostic (6.33e-2)"	"unprognostic (4.07e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.32e-2)"	24.4	20.6	7.4	14.9	7.9	29.8	24.0	12.8	9.3	15.1	8.5	19.0	19.0	16.5	13.3	18.7	16.7	15.3	17.4	7.4	9.7	20.7	40.3	19.3	22.2	7.8	7.9	6.7	15.8	21.2	19.1	14.5	14.9	9.2	16.2	23.5	19.6	19.1	17.7	31.9	29.6	19.6	20.3	7.7	18.3	22.3	46.3	7.6	23.2	20.2	23.2	25.9	20.2	16.4	9.3	5.3	31.8	44.3	40.3	23.9	31.6	38.0	25.3	36.0	54.6	56.6	67.7	38.5	41.9	23.5	32.2	22.3	31.2	0.2	14.7	56.1	17.7	28.5	25.0	20.0	56.5	51.4	53.7	22.9	39.3	28.0	41.5	31.2	22.5	42.5	12.7	25.1	17.3	33.7	37.1	0.1	77.0	27.6	19.9	13.1	73.9	23.8	59.9	33.2	29.5	29.0	37.1	60.0	13.7	33.1	19.3	30.5	47.1	25.8	25.8	22.6	21.6	23.6	37.6	20.7	96.4	8.7	41.1	33.8	80.6	46.4	42.0	46.5	61.1	45.0	45.8	41.3	50.6	44.6	45.3	36.4	35.1	8.7	52.6	40.2	14.2	77.8	54.6	7.4	7.9	12.8	9.3	7.4	9.7	7.8	7.9	6.7	9.2	7.7	7.6	9.3	16.7	12.8	21.8	7.5	21.4	9.4	16.5	20.3	11.4	18.4	12.4	11.2	8.0	14.3	20.8	11.0	12.5	19.7	19.5	25.4	31.3	42.3	207.8	10.6	8.1	19.6	22.0	8.6	11.7	66.1	24.4	16.7	13.7	10.6	11.4	13.8	12.5	15.5	29.3	10.1	12.4	18.4	16.2	21.0	21.6	46.7	20.8	17.1	3.6	6.5	33.6	17.0	28.8	7.5	11.0	45.8	35.3	15.8	13.2	28.6	49.3	23.5	24.4	17.9	13.1	9.7	13.7	101.7	7.4	9.2	10.4	31.6	19.0	13.9	22.2	20.4
DDX25	GRTH	ENSG00000109832	"DEAD-box helicase 25"	Q9UHL0	11	125903348-125943702	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, mRNA transport, Spermatogenesis, Translation regulation, Transport"	"Developmental protein, Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 92.2"	"Group enriched"	"Detected in some"	4	"Early spermatids: 332.1;Spermatocytes: 266.3"	"Cancer enhanced"	"Detected in some"		"glioma: 1.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"JURKAT: 16.1;NTERA-2: 10.8;SCLC-21H: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020137	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA020137: AB_1847552"	"unprognostic (5.78e-3)"	"unprognostic (9.75e-3)"	"unprognostic (7.93e-2)"	"unprognostic (5.09e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.91e-3)"	"unprognostic (6.24e-5)"	"unprognostic (2.57e-1)"	"unprognostic (2.44e-3)"	"unprognostic (3.89e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.69e-1)"	0.3	2.8	13.0	0.1	16.3	0.3	0.3	12.7	17.1	0.3	4.2	0.3	0.4	0.3	0.2	0.1	0.6	0.1	0.0	13.6	14.9	2.6	0.3	0.2	0.1	10.2	9.9	14.8	0.6	1.4	1.7	15.0	0.2	11.1	0.2	0.2	22.0	0.2	0.4	0.1	1.2	0.1	0.0	6.7	0.3	0.4	92.2	12.7	0.6	4.8	0.1	0.1	0.0	0.2	13.9	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.2	0.1	1.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	16.1	0.0	0.2	0.0	0.5	1.7	0.0	10.8	0.5	0.0	0.4	0.0	0.0	0.0	0.1	8.7	1.9	0.1	0.0	1.7	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.6	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	13.0	16.3	12.7	17.1	13.6	14.9	10.2	9.9	14.8	11.1	6.7	12.7	13.9	0.2	0.0	0.5	16.0	0.5	0.1	0.8	0.0	2.2	18.0	0.1	0.8	1.1	0.0	0.0	0.0	16.7	0.1	0.0	0.0	3.9	0.3	332.1	0.2	0.0	1.0	0.0	0.0	18.0	0.2	0.2	0.4	0.0	0.1	0.0	2.3	0.4	0.5	0.1	16.8	23.1	0.0	0.0	0.0	0.3	66.0	3.7	0.4	0.0	1.9	0.0	20.2	0.0	15.6	3.1	0.1	0.0	4.9	0.0	0.5	0.0	2.7	0.0	16.6	0.0	0.2	0.3	266.3	28.6	0.4	0.0	0.0	0.1	4.0	0.0	0.2
DEFB121	DEFB-21	ENSG00000204548	"Defensin beta 121"	Q5J5C9	20	31404845-31412838	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	11882	"epididymis: 2628.1"	"Group enriched"	"Detected in some"	22	"Early spermatids: 14.5;Late spermatids: 5.4;Spermatocytes: 7.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"NB-4: 3.1"					"Not detected"	"Not detected"			HPA079460	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA079460: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2628.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB125	DEFB-25	ENSG00000178591	"Defensin beta 125"	Q8N687	20	87250-97094	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	10	"epididymis: 1.5;seminal vesicle: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in male reproductive system"	NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEPDC4	"DEP.4, FLJ33505"	ENSG00000166153	"DEP domain containing 4"	Q8N2C3	12	100203669-100267079	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"testis: 4.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 13.7;Late spermatids: 19.2"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA039323	Uncertain		Approved	Microtubules		NA	NA			Microtubules		"HPA039323: AB_10674283"	"unprognostic (8.89e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.33e-2)"	"unprognostic (3.62e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.53e-1)"	"unprognostic (9.09e-4)"	"unprognostic (5.02e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.37e-2)"	0.2	0.3	0.2	0.3	0.2	0.6	0.8	0.2	0.6	0.3	0.0	0.6	1.3	0.4	0.5	0.7	0.4	0.4	0.3	0.2	0.4	1.7	1.3	0.3	0.3	0.2	0.2	0.1	0.7	0.7	0.5	0.5	0.7	0.2	0.7	0.8	0.4	0.7	1.0	0.2	0.4	0.5	0.2	0.3	0.2	0.6	4.0	0.2	0.6	0.5	0.2	0.3	0.3	0.3	0.3	1.3	1.8	3.4	0.9	0.1	0.4	2.1	1.8	1.2	3.7	2.2	2.9	0.7	1.4	1.1	0.9	1.1	2.0	2.9	1.5	4.0	1.5	3.2	4.9	0.8	3.3	0.4	1.6	1.9	0.3	0.9	1.3	0.3	0.7	0.9	2.5	2.9	0.6	1.7	1.3	1.0	2.9	1.6	1.6	1.9	2.0	3.4	3.3	1.7	0.8	0.9	2.0	1.0	1.4	1.1	2.0	2.8	1.7	0.2	2.5	1.0	1.0	1.4	1.5	1.7	3.0	0.7	1.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.6	0.2	0.4	0.2	0.2	0.1	0.2	0.3	0.2	0.3	0.5	0.0	4.4	6.2	0.7	0.9	1.4	1.8	3.4	2.1	1.0	1.5	0.9	0.0	2.2	5.5	4.2	3.5	0.2	0.5	5.9	0.6	13.7	0.9	0.9	0.7	0.0	2.1	3.3	1.3	2.0	3.6	0.0	0.9	0.0	1.1	0.4	1.1	1.1	0.0	3.4	0.5	0.0	0.3	1.1	19.2	1.2	0.5	1.8	1.0	0.1	1.3	0.0	3.5	6.5	0.5	0.3	0.0	0.2	0.6	1.4	5.3	1.8	4.8	0.0	1.4	1.2	8.0	6.2	0.7	0.3	1.2	0.7	2.4	1.5	0.9
DESI2	"C1orf121, CGI-146, DESI-2, FAM152A, FLJ21998, PNAS-4, PPPDE1"	ENSG00000121644	"Desumoylating isopeptidase 2"	Q9BSY9	1	244653103-244709033	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 171.8;Spermatocytes: 192.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049950			Approved	Vesicles		NA	NA			Vesicles		"HPA049950: AB_2680969"	"unprognostic (1.13e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.95e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.51e-1)"	"unprognostic (4.47e-3)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (4.25e-5)"	"unprognostic (4.52e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.27e-2)"	"unprognostic (9.49e-2)"	17.3	13.7	8.1	13.7	11.1	17.3	14.1	13.6	8.3	18.5	12.8	16.6	16.2	22.9	13.8	16.3	13.4	18.0	16.5	7.8	9.3	11.9	12.9	23.4	18.0	8.2	8.8	7.6	13.7	9.4	14.0	7.2	18.7	9.5	14.5	18.3	16.4	11.2	15.7	24.3	15.3	13.4	22.5	8.6	11.8	15.8	55.3	8.5	19.9	23.5	23.8	19.2	18.6	12.1	8.6	68.1	24.3	47.0	40.8	52.8	54.8	61.7	40.8	65.9	36.9	33.9	43.8	31.0	121.8	53.8	47.7	21.5	29.5	58.1	43.1	50.5	43.1	53.6	31.0	17.5	33.0	46.2	52.8	36.1	38.4	57.3	49.3	61.6	35.6	52.8	52.8	48.4	63.7	56.2	11.7	49.6	28.0	109.0	62.7	67.7	36.9	71.9	46.0	28.4	27.6	42.5	57.2	55.4	26.4	47.7	37.7	27.6	39.0	59.7	41.7	45.4	57.4	68.5	69.4	94.1	69.8	33.8	55.7	78.0	2.5	1.7	5.6	2.1	2.1	2.1	5.2	2.2	3.0	2.7	2.7	2.9	2.8	1.4	2.2	2.3	2.4	3.2	0.7	8.1	11.1	13.6	8.3	7.8	9.3	8.2	8.8	7.6	9.5	8.6	8.5	8.6	32.7	86.6	60.4	17.9	31.0	55.3	41.3	23.0	38.7	43.2	21.5	26.3	22.1	27.1	25.5	18.4	20.9	29.8	36.1	28.1	21.5	19.8	171.8	32.0	39.6	36.2	15.6	21.7	18.4	33.4	40.0	44.2	28.5	25.0	7.0	28.7	25.7	21.5	23.8	40.4	23.1	19.0	26.4	23.3	27.1	101.5	34.8	27.2	16.0	18.7	25.5	23.8	28.8	35.7	26.9	34.3	28.6	51.9	34.5	69.5	17.0	16.5	17.6	25.1	39.5	41.7	50.2	192.7	105.4	42.4	41.3	43.2	31.2	38.4	25.4	55.5
DHRS7B	"CGI-93, DKFZp566O084, MGC8916, SDR32C1"	ENSG00000109016	"Dehydrogenase/reductase 7B"	Q6IAN0	17	21123364-21193265	"Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012132, HPA016873"	Uncertain		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Plasma membrane, Cell Junctions, Cytosol"		"HPA012132: AB_1847658, HPA016873: AB_1847657"	"unprognostic (1.90e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.71e-1)"	"prognostic favorable (1.98e-8)"	"unprognostic (9.83e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.02e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.81e-1)"	"prognostic favorable (3.95e-5)"	"unprognostic (1.20e-2)"	"unprognostic (6.26e-2)"	"unprognostic (9.20e-2)"	"unprognostic (3.97e-1)"	18.9	18.9	19.1	8.2	19.0	3.0	19.4	19.9	28.5	17.9	19.6	15.3	15.7	11.5	25.9	12.9	16.1	12.0	21.0	19.0	19.5	23.1	20.3	13.6	7.8	19.8	19.8	18.8	8.4	20.4	33.2	8.0	13.3	19.4	15.2	15.9	10.9	18.4	10.3	31.0	18.8	14.6	9.7	19.8	9.3	18.3	24.2	19.0	6.8	16.8	19.7	9.0	12.5	11.2	21.3	17.2	19.9	7.1	15.6	18.5	12.7	12.4	16.0	8.9	11.4	20.7	25.2	17.6	7.2	23.8	13.7	9.0	23.7	10.6	26.2	16.1	13.8	33.9	9.9	13.8	21.8	10.2	5.5	7.0	10.0	17.0	14.6	22.1	5.6	11.3	12.5	6.0	8.6	13.5	35.2	6.0	21.6	9.9	55.4	8.5	10.0	18.8	12.7	39.1	20.5	3.9	8.3	19.8	17.4	17.9	56.8	11.7	11.2	5.6	9.4	6.4	28.7	18.3	4.7	7.9	13.6	14.9	20.3	14.4	19.2	34.3	29.3	6.7	33.9	6.0	7.6	6.5	4.6	21.6	5.9	7.0	6.1	25.0	8.4	40.8	9.4	10.9	14.4	19.1	19.0	19.9	28.5	19.0	19.5	19.8	19.8	18.8	19.4	19.8	19.0	21.3	31.1	16.0	18.1	29.4	11.9	16.3	26.7	59.0	11.4	21.3	19.8	17.4	14.1	25.8	38.5	29.5	31.3	52.9	11.3	25.9	17.6	47.2	69.5	38.1	13.6	23.7	7.2	21.9	32.9	39.0	31.8	18.9	14.3	22.2	8.8	13.8	27.5	20.5	29.4	18.5	37.3	28.5	48.8	17.9	15.5	24.4	22.4	14.3	19.6	14.0	20.8	27.6	22.6	36.7	36.2	30.0	24.8	35.0	10.5	29.0	44.4	25.2	50.7	40.1	6.6	15.1	18.2	71.5	22.3	10.7	18.6	51.6	11.2	27.3	22.2	25.1
DHX16	"DBP2, DDX16, Prp2, PRPF2"	ENSG00000204560	"DEAH-box helicase 16"	O60231	6	30653119-30673006	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"	"Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 92.7;Spermatocytes: 86.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051455	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA051455: AB_2681491"	"unprognostic (7.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.29e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.11e-1)"	"unprognostic (8.58e-2)"	"unprognostic (1.24e-2)"	"unprognostic (9.77e-3)"	"unprognostic (4.42e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.64e-1)"	"unprognostic (8.73e-3)"	24.5	28.5	5.1	13.9	6.1	11.4	26.2	6.0	6.9	27.9	7.4	27.0	19.0	25.7	8.6	27.4	26.9	11.4	24.8	5.0	5.9	35.1	36.8	25.7	18.3	6.0	5.4	4.9	26.4	35.3	16.2	28.8	10.6	6.3	30.3	10.4	14.5	32.3	12.9	45.4	28.4	37.8	12.6	4.8	40.6	28.5	47.2	6.1	17.2	38.5	17.8	12.8	25.0	27.0	5.8	31.9	17.9	20.3	38.7	26.8	15.7	27.0	33.0	30.7	47.6	44.3	35.8	15.9	25.5	24.2	31.1	39.6	34.0	47.0	24.1	35.5	35.4	15.5	27.2	25.5	17.9	21.4	65.9	40.4	17.6	22.7	47.3	30.1	16.5	16.9	36.9	44.4	29.3	26.7	29.0	22.4	20.8	21.4	20.9	12.1	38.5	17.4	28.2	18.4	24.0	27.9	19.7	30.8	37.4	32.0	20.3	29.5	24.7	11.8	31.2	21.3	27.4	46.3	29.9	49.9	20.2	15.7	36.8	40.4	10.5	11.2	18.6	7.4	14.7	9.5	7.7	9.1	7.9	11.1	5.9	7.4	5.8	11.4	14.8	16.4	9.8	7.4	7.5	5.1	6.1	6.0	6.9	5.0	5.9	6.0	5.4	4.9	6.3	4.8	6.1	5.8	13.0	22.4	20.9	4.6	16.9	10.8	11.7	11.3	16.5	13.9	10.0	9.9	14.6	10.0	20.2	5.5	39.6	19.2	14.4	18.3	9.8	15.7	92.7	25.2	18.0	11.8	6.0	14.9	4.3	18.6	20.1	11.6	26.5	15.8	42.3	11.1	8.6	9.7	13.9	5.0	4.1	14.6	8.2	12.6	12.8	49.3	14.3	14.4	5.4	5.6	20.3	11.6	15.5	2.5	5.2	22.9	23.1	12.4	22.1	9.3	18.0	9.8	31.4	51.1	19.7	16.2	19.2	86.9	32.6	14.7	10.7	19.2	19.5	11.4	12.8	9.5
DHX30	"DDX30, FLJ11214, KIAA0890"	ENSG00000132153	"DExH-box helicase 30"	Q7L2E3	3	47802909-47850195	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Ribosome biogenesis"	"Helicase, Hydrolase, RNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034806	Supported		Supported	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA034806: AB_10601364"	"unprognostic (2.00e-1)"	"unprognostic (8.37e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.42e-2)"	"prognostic favorable (1.37e-6)"	"unprognostic (4.12e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.22e-1)"	22.6	24.8	20.5	17.2	20.7	22.4	23.1	18.8	26.5	26.2	20.0	25.0	16.3	27.9	10.5	23.8	25.0	15.0	27.3	20.8	19.4	24.8	25.4	21.5	20.3	21.6	21.9	21.5	28.1	24.3	29.1	32.4	17.7	22.5	26.8	11.0	12.9	21.8	18.3	37.4	27.8	22.5	16.0	17.2	27.5	25.4	54.6	21.0	23.5	25.1	21.2	14.4	25.4	23.0	22.0	21.9	52.3	54.5	56.2	24.6	20.2	35.3	39.0	33.4	65.1	46.5	56.9	42.6	66.4	32.0	37.0	51.2	30.3	73.7	52.1	23.1	49.6	86.1	59.6	76.0	58.6	40.7	56.0	58.3	33.0	33.4	68.1	49.7	28.4	44.0	57.5	82.0	40.6	31.8	57.1	82.2	59.3	60.7	30.2	84.0	44.6	30.6	62.2	32.0	53.6	41.6	61.6	39.6	54.1	31.1	25.0	38.5	58.8	32.2	40.6	51.0	46.7	73.9	56.2	75.3	61.8	42.8	48.3	49.9	14.1	10.7	7.8	16.2	10.6	12.4	10.4	12.4	16.3	13.9	8.7	11.7	12.7	1.6	9.6	11.6	7.9	15.3	14.7	20.5	20.7	18.8	26.5	20.8	19.4	21.6	21.9	21.5	22.5	17.2	21.0	22.0	31.1	38.5	46.7	30.7	34.7	18.1	25.7	38.7	39.3	49.0	34.6	35.6	38.1	32.9	34.1	51.5	43.8	41.7	33.1	37.6	66.5	37.8	129.5	59.2	31.7	32.4	40.1	38.5	32.8	36.3	22.8	26.7	42.3	33.2	23.5	40.7	27.5	50.8	35.9	58.9	36.6	25.8	40.7	29.6	17.6	123.8	24.8	24.4	19.6	13.1	32.5	46.3	28.8	22.1	28.7	46.0	41.0	30.1	39.9	28.6	40.5	83.5	49.9	52.8	32.9	27.3	28.6	145.4	50.2	33.5	19.9	29.6	29.7	36.6	38.5	26.3
DNAH8	hdhc9	ENSG00000124721	"Dynein axonemal heavy chain 8"	Q96JB1	6	38715311-39030792	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 2.6;prostate: 2.2;testis: 7.9"	"Group enriched"	"Detected in some"	4	"Early spermatids: 35.4;Late spermatids: 13.2;Spermatocytes: 33.3"	"Cancer enriched"	"Detected in single"	7	"prostate cancer: 2.5"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	8	"basophil: 2.5"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 2.5"	"Cell line enriched"	"Detected in some"	8	"HMC-1: 47.1"	"Not detected"	"Not detected"							HPA028447	Uncertain					NA	NA					"HPA028447: AB_10599600"	"unprognostic (2.83e-1)"	"unprognostic (4.46e-4)"	"unprognostic (1.27e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.47e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.17e-9)"	"unprognostic (1.46e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.48e-3)"	0.0	0.0	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.2	0.0	0.0	0.0	0.1	0.0	1.6	0.1	0.0	0.0	0.9	0.1	7.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	47.1	0.0	0.0	0.0	0.0	0.0	5.9	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	35.4	0.0	0.0	0.2	0.0	0.0	2.7	0.0	0.1	0.2	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	13.2	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	1.7	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	33.3	5.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0
DNAJC21	"DNAJA5, GS3, JJJ1"	ENSG00000168724	"DnaJ heat shock protein family (Hsp40) member C21"	Q5F1R6	5	34929559-34958964	"Disease related genes, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA040789	Approved		Supported	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA040789: AB_10794147"	"unprognostic (1.37e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (2.36e-5)"	"unprognostic (1.77e-3)"	"unprognostic (3.04e-2)"	"unprognostic (6.68e-3)"	"unprognostic (5.99e-2)"	"unprognostic (6.02e-2)"	"unprognostic (9.27e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.26e-1)"	"unprognostic (2.57e-1)"	"unprognostic (6.02e-2)"	18.4	12.8	11.1	13.9	12.0	24.3	16.3	11.0	11.5	22.4	11.0	17.8	15.3	16.5	14.5	20.9	11.5	13.7	32.3	9.5	11.7	23.3	23.2	17.6	18.6	12.0	11.6	9.0	11.9	20.2	19.6	8.2	24.7	11.9	18.2	18.6	9.4	15.9	17.7	58.9	15.3	16.0	18.4	11.6	12.8	19.0	61.9	11.7	18.1	18.1	42.7	19.8	21.0	16.9	12.1	36.2	25.3	32.0	41.6	39.1	46.4	57.1	47.4	38.9	37.7	25.2	41.6	42.8	75.9	20.1	44.3	46.6	24.3	37.9	49.0	43.8	45.2	27.8	41.7	90.7	35.2	64.6	60.7	37.7	33.2	44.8	41.6	67.7	26.2	35.3	27.8	65.6	59.7	28.1	30.4	51.3	45.2	22.6	39.8	21.4	45.5	79.2	33.7	37.9	44.9	16.5	17.5	128.1	59.4	40.2	35.2	40.1	64.4	43.4	46.5	44.7	27.8	37.7	40.2	40.0	51.0	37.6	71.8	25.1	2.2	1.5	4.7	1.7	1.2	2.5	3.1	2.5	1.6	2.5	2.0	2.5	2.5	0.4	4.0	2.0	2.3	3.4	1.0	11.1	12.0	11.0	11.5	9.5	11.7	12.0	11.6	9.0	11.9	11.6	11.7	12.1	53.5	76.9	111.3	23.8	42.0	37.0	73.9	22.4	33.6	52.6	57.0	56.6	151.1	47.1	36.1	36.8	43.8	51.2	59.1	34.6	88.0	21.5	117.5	49.2	77.8	44.9	18.0	40.0	26.9	30.5	25.7	44.4	32.6	68.4	8.2	42.0	37.5	59.5	24.3	75.7	40.4	36.9	6.1	31.4	32.9	47.7	40.4	38.8	37.4	15.0	50.8	31.2	45.3	20.1	32.1	26.6	27.7	38.0	41.4	85.8	28.2	62.5	22.8	73.0	13.1	57.0	44.0	117.4	50.3	43.4	46.7	65.7	52.7	51.4	41.4	77.1
DNAJC27	"RabJS, RBJ"	ENSG00000115137	"DnaJ heat shock protein family (Hsp40) member C27"	Q9NZQ0	2	24943636-24972094	"Predicted intracellular proteins"			Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 22.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 59.8;Spermatocytes: 70.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036815, HPA036816"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA036815: , HPA036816: AB_10673506"	"unprognostic (1.67e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.53e-2)"	"unprognostic (3.09e-1)"	"unprognostic (5.17e-3)"	"unprognostic (5.41e-2)"	"unprognostic (5.58e-3)"	"unprognostic (2.13e-1)"	"unprognostic (4.60e-2)"	"unprognostic (7.44e-4)"	"unprognostic (8.84e-2)"	"prognostic favorable (8.48e-5)"	"unprognostic (3.35e-1)"	"unprognostic (3.66e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.78e-3)"	4.3	3.4	4.6	2.1	5.8	3.8	3.7	7.2	7.2	3.6	4.0	3.3	2.0	4.2	5.1	2.2	4.6	3.0	5.0	4.9	8.9	3.8	2.0	2.7	2.8	7.8	6.7	4.5	7.1	2.8	5.2	6.2	2.9	8.4	3.3	2.8	13.4	2.2	3.1	4.7	2.9	2.7	3.0	6.3	2.9	2.9	22.4	6.1	3.6	3.3	7.0	2.4	3.2	3.0	8.4	2.8	1.2	2.6	2.6	3.6	3.0	2.0	2.1	3.2	2.2	1.9	1.3	1.3	2.6	0.5	1.5	1.8	2.2	1.9	1.3	2.3	1.1	1.6	1.6	1.6	1.2	2.3	1.5	2.2	2.3	2.2	1.7	3.5	2.5	0.9	3.1	1.1	2.4	2.4	1.0	2.7	2.6	1.7	1.0	1.1	1.6	5.1	1.4	2.1	1.5	0.9	3.2	2.0	1.5	3.0	2.7	1.3	1.1	0.8	2.9	2.0	1.5	2.0	6.1	2.3	3.1	1.5	2.4	1.3	0.0	0.2	0.9	0.2	0.1	0.5	0.4	0.3	0.2	0.2	0.3	0.4	0.5	0.0	1.3	0.3	0.1	0.3	0.2	4.6	5.8	7.2	7.2	4.9	8.9	7.8	6.7	4.5	8.4	6.3	6.1	8.4	7.8	9.6	10.0	19.2	11.2	2.0	5.6	3.6	8.0	24.1	9.8	8.5	25.4	4.3	3.0	7.3	37.5	3.6	10.8	4.5	3.9	2.6	59.8	12.5	9.7	7.7	15.5	11.8	18.2	2.5	2.0	8.8	8.2	5.2	10.8	9.5	6.1	3.4	3.3	37.0	22.1	5.9	6.1	3.2	4.6	32.5	8.7	5.9	1.8	7.5	4.3	12.2	4.1	12.1	24.1	1.7	0.9	6.4	8.8	4.6	4.3	3.1	17.3	25.1	0.0	12.8	23.9	70.7	17.0	8.3	3.3	4.2	11.3	23.2	5.4	3.8
DNAJC28	"C21orf55, C21orf78"	ENSG00000177692	"DnaJ heat shock protein family (Hsp40) member C28"	Q9NX36	21	33485530-33491716	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 7.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 14.0;Early spermatids: 33.3;Proximal tubular cells: 10.4;Spermatocytes: 13.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018003, HPA030076"	Approved					NA	NA					"HPA018003: AB_1845695, HPA030076: AB_10602218"	"unprognostic (9.63e-3)"	"unprognostic (4.44e-1)"	"unprognostic (5.66e-3)"	"unprognostic (2.05e-1)"	"unprognostic (4.00e-2)"	"unprognostic (4.92e-3)"	"unprognostic (2.89e-2)"	"unprognostic (6.61e-3)"	"unprognostic (1.45e-1)"	"unprognostic (7.23e-4)"	"unprognostic (1.20e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.14e-9)"	"unprognostic (1.84e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.24e-2)"	0.6	2.2	0.9	0.1	0.9	0.4	0.7	1.0	1.2	0.5	0.7	0.9	0.3	0.5	1.2	1.1	0.3	0.5	2.1	0.9	0.8	2.6	2.6	0.6	0.2	0.9	0.8	0.9	0.4	1.4	1.4	1.5	0.6	1.0	0.8	0.7	1.7	1.4	0.6	2.8	0.6	1.1	0.3	0.6	1.2	1.5	7.0	0.8	0.1	2.5	2.0	0.1	0.7	0.6	1.0	0.3	0.1	1.2	0.4	3.1	0.8	0.3	0.6	0.6	1.2	0.5	0.1	0.5	0.3	0.1	0.0	0.6	0.1	0.1	0.1	0.3	0.1	1.3	0.7	0.2	0.8	0.7	0.0	1.2	0.6	0.6	0.6	0.1	1.0	0.7	0.6	0.4	0.1	0.4	0.4	0.1	0.3	0.6	0.4	0.0	0.3	1.3	0.1	0.6	0.1	0.9	0.6	0.1	0.0	0.3	0.4	1.1	0.2	0.2	0.5	0.2	0.1	0.1	0.5	0.5	0.1	1.1	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.9	0.9	1.0	1.2	0.9	0.8	0.9	0.8	0.9	1.0	0.6	0.8	1.0	1.3	0.0	2.2	0.3	0.7	0.4	0.3	1.1	1.8	1.7	1.2	0.9	14.0	1.5	0.5	3.7	0.0	1.3	0.9	1.3	3.9	2.2	33.3	0.7	0.8	1.4	1.2	4.0	2.5	1.3	0.4	1.1	1.1	0.9	3.8	0.8	1.4	4.7	1.0	1.7	2.3	1.1	0.0	2.4	0.3	7.6	0.6	0.9	0.0	1.9	1.3	0.9	0.0	1.0	1.2	1.7	1.2	1.2	2.0	0.6	1.8	10.4	2.4	2.2	0.0	1.1	1.2	13.4	2.0	0.6	0.0	2.3	0.8	3.0	0.6	0.2
DNAJC5G	"CSP-gamma, FLJ40417"	ENSG00000163793	"DnaJ heat shock protein family (Hsp40) member C5 gamma"	Q8N7S2	2	27275433-27281499	"Predicted membrane proteins"		Chaperone		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	15	"epididymis: 47.3;testis: 23.0"	"Group enriched"	"Detected in some"	4	"Early spermatids: 69.1;Late spermatids: 83.6;Spermatocytes: 105.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HAP1: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041445	Approved					NA	NA					"HPA041445: AB_2677485"	"unprognostic (1.43e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.99e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.75e-4)"	"unprognostic (2.08e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.97e-2)"	0.1	0.8	0.6	0.0	0.2	0.0	0.0	0.0	2.3	0.3	0.0	0.1	0.0	0.4	47.3	0.0	0.4	0.0	1.3	1.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.7	0.2	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	23.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	1.7	0.7	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.3	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.6	0.2	0.0	2.3	1.0	0.0	0.2	0.0	0.7	1.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.1	0.0	0.0	0.3	0.0	0.0	8.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	83.6	0.9	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	105.1	19.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1
DPP8	"DP8, DPRP1, FLJ14920, FLJ20283, MGC26191, MSTP141"	ENSG00000074603	"Dipeptidyl peptidase 8"	Q6V1X1	15	65442463-65517704	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Aminopeptidase, Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008706	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA008706: AB_1078665"	"unprognostic (3.65e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.60e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.58e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.59e-1)"	12.8	10.3	8.2	12.2	8.8	15.1	12.0	9.6	11.4	11.9	5.6	11.5	14.6	11.8	9.8	10.1	8.4	9.8	15.0	7.9	9.0	12.8	8.0	11.2	13.0	9.1	9.0	7.2	10.9	7.4	15.3	5.7	11.3	8.2	10.9	13.0	15.5	9.6	11.6	27.8	9.8	13.7	13.2	7.6	14.9	11.1	26.3	9.9	13.9	14.2	30.8	11.4	11.3	8.3	10.3	14.1	24.4	15.7	15.8	17.4	25.2	12.8	22.5	28.4	21.1	20.3	10.6	12.6	25.1	16.3	30.3	14.5	25.9	30.6	17.6	26.0	20.9	17.2	24.2	18.1	10.4	17.9	34.3	23.8	18.6	18.3	17.0	16.0	18.5	23.2	19.2	16.4	24.1	26.5	12.5	17.1	12.0	9.9	15.7	11.1	22.6	27.9	24.7	19.8	32.7	10.5	17.0	14.3	15.8	25.3	15.6	14.4	22.5	28.6	28.2	19.2	12.7	25.5	26.9	42.2	25.8	21.3	32.8	20.4	30.5	11.7	15.1	12.1	11.7	12.6	11.8	10.0	11.2	10.9	12.2	9.5	10.6	20.9	8.2	15.8	8.6	11.3	7.2	8.2	8.8	9.6	11.4	7.9	9.0	9.1	9.0	7.2	8.2	7.6	9.9	10.3	39.1	35.3	27.9	65.6	30.0	13.4	15.0	20.4	15.9	24.1	21.1	14.2	43.4	21.5	25.4	14.7	37.5	20.4	35.3	25.8	23.5	22.7	57.4	17.3	19.3	39.5	25.9	17.9	50.1	30.0	15.2	22.3	31.1	17.5	27.8	24.7	46.1	18.2	21.5	28.6	58.6	27.0	16.2	36.0	15.1	59.7	29.2	31.9	23.2	38.4	47.6	32.3	45.3	36.2	57.1	38.4	25.8	29.3	24.7	19.3	24.2	27.5	25.9	28.1	19.7	29.9	22.1	69.3	24.4	21.9	20.2	17.6	28.5	46.5	26.7	23.6
DR1	"NC2-BETA, NC2B, NCB2"	ENSG00000117505	"Down-regulator of transcription 1"	Q01658	1	93345907-93369493	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050785, HPA055308"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA050785: AB_2681237, HPA055308: AB_2682779"	"unprognostic (1.46e-1)"	"unprognostic (9.62e-2)"	"prognostic favorable (4.79e-4)"	"unprognostic (1.03e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (9.95e-7)"	"unprognostic (8.70e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.44e-2)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (4.30e-2)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (2.07e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.97e-1)"	"unprognostic (1.60e-1)"	22.0	19.0	9.6	29.1	9.2	59.7	17.0	12.3	9.2	16.7	20.8	18.3	27.5	21.2	11.2	30.2	14.3	23.3	27.2	8.3	9.6	22.0	20.5	19.8	43.7	9.1	9.9	6.6	16.1	18.9	17.1	12.2	32.3	9.1	17.3	16.5	14.2	19.7	14.1	50.9	28.0	22.6	19.3	10.5	27.2	30.4	56.2	10.6	48.1	18.9	43.3	31.1	27.5	22.8	10.3	97.1	29.8	46.8	60.6	42.3	47.9	57.5	76.5	46.6	50.9	54.0	34.9	34.1	101.9	86.4	56.7	69.3	50.1	56.7	53.0	74.6	86.4	53.0	85.8	58.7	38.4	67.3	102.1	60.6	33.7	62.4	71.2	102.2	53.1	45.9	60.0	90.0	95.7	61.0	29.8	97.6	32.1	78.1	33.4	72.1	83.5	103.2	104.0	36.3	58.0	45.3	57.6	65.1	59.7	80.6	42.2	42.2	79.4	72.1	91.5	73.0	90.7	116.0	54.9	65.6	105.5	26.3	80.3	38.2	95.2	46.2	82.1	35.3	52.7	39.2	36.9	38.8	40.4	55.9	31.5	38.6	37.8	62.8	35.5	47.4	45.4	57.1	41.3	9.6	9.2	12.3	9.2	8.3	9.6	9.1	9.9	6.6	9.1	10.5	10.6	10.3	36.2	28.9	22.1	10.1	43.5	171.3	38.0	38.7	47.3	32.0	29.1	24.1	33.9	22.8	27.9	36.8	25.0	74.5	84.6	42.8	45.0	31.4	183.1	18.4	33.7	37.5	20.8	59.3	8.4	27.7	73.6	34.3	38.2	24.2	48.9	19.7	29.3	27.6	53.0	50.5	8.7	42.6	10.2	50.8	82.8	106.2	28.3	55.2	44.4	15.0	68.0	16.0	69.0	7.5	10.8	52.9	25.9	26.4	31.9	51.6	29.8	40.7	17.6	25.3	32.9	27.7	42.0	163.2	41.2	69.4	160.5	109.9	59.8	26.2	26.9	79.2
DRC7	"C16orf50, CCDC135, CFAP50, DKFZp434I099, FAP50"	ENSG00000159625	"Dynein regulatory complex subunit 7"	Q8IY82	16	57694793-57731805	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 21.3;testis: 46.5"	"Group enriched"	"Detected in some"	4	"Early spermatids: 119.1;Late spermatids: 134.4;Spermatocytes: 48.2"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.1"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	8	"basophil: 10.9"	"Lineage enriched"	"Detected in single"	43	"granulocytes: 10.9"	"Cell line enhanced"	"Detected in some"		"Hep G2: 3.0;HMC-1: 1.6;JURKAT: 1.8;NB-4: 1.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (4.04e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.11e-2)"	"prognostic favorable (3.61e-4)"	"unprognostic (9.96e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.34e-4)"	"unprognostic (2.18e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.80e-2)"	"unprognostic (5.53e-2)"	0.0	0.0	4.8	0.3	1.9	1.0	0.0	2.9	1.8	0.5	9.5	0.0	0.0	0.6	0.8	0.0	21.3	0.7	0.0	1.6	6.8	0.8	0.3	1.9	0.1	4.8	6.6	0.6	0.2	1.2	0.7	1.0	0.1	4.2	0.1	0.0	0.2	0.0	0.7	0.0	0.0	0.1	0.1	5.0	0.2	0.2	46.5	2.9	0.2	0.1	0.0	0.1	0.0	0.0	3.0	0.0	0.7	0.3	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.4	1.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	3.0	0.3	0.3	1.6	0.6	0.0	0.2	0.0	0.6	0.2	1.8	0.7	0.0	0.0	0.0	0.3	1.4	0.1	0.0	0.0	0.9	0.0	0.0	0.7	0.0	0.7	0.8	0.0	0.0	0.0	0.1	0.1	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.2	10.9	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.1	4.8	1.9	2.9	1.8	1.6	6.8	4.8	6.6	0.6	4.2	5.0	2.9	3.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.4	119.1	25.1	0.2	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	134.4	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.1	0.0	0.8	21.9	0.0	0.0	0.1	0.1	48.2	4.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1
DRG1	NEDD3	ENSG00000185721	"Developmentally regulated GTP binding protein 1"	Q9Y295	22	31399604-31530634	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 161.7"	"Group enriched"	"Detected in all"	5	"Early spermatids: 798.4;Late spermatids: 651.5;Spermatocytes: 469.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001218	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No		22000	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA001218: AB_1078704"	"unprognostic (4.94e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.17e-3)"	"unprognostic (5.26e-2)"	"unprognostic (4.66e-2)"	"unprognostic (3.49e-3)"	"prognostic unfavorable (7.71e-4)"	"unprognostic (3.68e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.32e-3)"	"unprognostic (8.69e-3)"	"unprognostic (1.55e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.25e-1)"	31.7	32.8	24.3	21.6	25.6	32.6	35.5	28.7	31.9	27.6	24.6	25.0	22.8	28.1	39.0	27.6	33.0	19.7	45.0	25.0	26.5	36.2	38.2	21.0	29.4	26.0	25.4	24.0	35.3	34.4	38.7	18.8	36.0	26.5	25.2	30.3	30.4	30.8	29.1	101.3	23.7	21.5	34.4	25.9	20.3	24.4	161.7	24.9	40.8	34.9	85.8	38.6	31.0	20.8	28.0	80.3	61.3	73.9	63.3	64.4	75.2	61.5	70.2	81.7	125.7	104.4	100.3	38.3	111.2	38.6	86.9	60.3	64.5	128.5	82.8	134.4	52.0	152.0	71.9	64.9	99.6	91.4	174.2	65.1	65.6	60.9	103.7	152.9	64.6	87.5	61.6	93.9	48.1	97.2	88.0	75.7	88.4	62.1	114.0	65.9	98.7	118.9	97.3	82.1	68.6	80.8	50.4	78.5	79.8	107.2	70.8	59.7	77.2	50.6	57.7	79.3	59.1	81.3	67.2	78.5	108.6	57.0	77.7	77.4	25.0	43.3	46.0	34.3	49.7	39.6	53.6	36.6	43.0	45.2	39.4	40.5	39.8	9.8	46.7	37.5	39.6	50.9	47.0	24.3	25.6	28.7	31.9	25.0	26.5	26.0	25.4	24.0	26.5	25.9	24.9	28.0	22.0	19.2	15.4	3.9	29.4	38.6	40.8	77.2	29.6	18.7	27.2	27.2	52.4	35.8	37.6	27.6	25.0	126.4	20.6	22.5	64.6	56.4	798.4	23.7	24.4	34.4	11.4	37.8	10.3	45.4	104.5	33.2	21.4	21.1	33.7	27.1	35.7	36.9	60.4	15.2	11.2	31.0	48.8	31.1	24.0	651.5	35.8	22.9	17.8	7.5	39.2	27.6	33.0	9.5	11.1	42.7	27.0	37.2	27.1	48.7	42.9	60.3	28.7	18.4	59.2	35.4	36.1	469.3	92.1	33.1	32.1	117.1	25.5	26.2	41.0	45.3
DUS3L	"DUS3, FLJ13896"	ENSG00000141994	"Dihydrouridine synthase 3 like"	Q96G46	19	5784832-5791225	"Predicted intracellular proteins"	"tRNA processing"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041854, HPA041944, HPA062846"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA041854: AB_10794493, HPA041944: AB_10794163, HPA062846: AB_2684879"	"unprognostic (1.25e-2)"	"unprognostic (7.27e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.64e-3)"	"unprognostic (6.08e-2)"	"unprognostic (6.98e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.19e-1)"	"unprognostic (3.55e-2)"	"unprognostic (7.35e-3)"	"unprognostic (4.25e-3)"	"unprognostic (7.73e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.89e-2)"	14.0	15.5	5.9	8.5	6.2	20.9	15.8	5.6	10.3	16.7	5.6	14.8	11.5	16.4	1.6	20.8	17.3	4.1	13.2	5.9	5.6	16.8	25.4	11.8	9.6	7.6	6.1	5.2	18.3	24.3	4.0	13.8	5.4	7.4	19.1	2.8	3.0	17.9	5.0	16.9	24.4	18.5	2.8	6.1	19.8	17.1	40.5	6.3	8.2	18.7	3.8	3.7	15.6	16.9	8.2	29.9	28.3	8.1	29.0	2.3	3.7	26.9	9.8	5.7	9.9	7.6	44.4	13.9	30.2	36.1	3.9	11.5	18.9	7.3	9.5	1.5	22.7	63.6	20.3	15.4	16.9	14.2	45.0	56.2	8.6	10.0	11.3	7.8	1.3	6.8	19.8	53.2	0.0	5.4	38.0	38.8	45.9	28.4	10.7	76.9	19.4	17.0	38.1	4.2	20.7	27.9	28.6	10.3	17.0	19.7	1.9	12.1	36.1	9.4	14.3	25.2	43.1	42.6	83.4	66.9	29.3	13.9	46.1	16.4	8.3	20.1	5.8	21.5	30.2	24.7	15.2	16.4	20.3	29.8	19.0	21.2	21.5	2.2	27.9	25.3	30.9	20.1	16.3	5.9	6.2	5.6	10.3	5.9	5.6	7.6	6.1	5.2	7.4	6.1	6.3	8.2	7.2	9.6	10.0	2.6	19.9	14.7	19.3	16.7	25.6	6.6	7.7	10.2	3.0	7.2	9.7	1.8	12.5	18.3	9.3	14.4	7.9	12.4	48.8	6.7	8.3	9.2	7.7	25.2	4.2	22.4	17.7	10.9	18.3	8.2	35.5	7.7	4.6	7.5	14.8	11.8	5.0	12.8	4.1	7.2	9.1	10.9	12.8	10.6	5.4	1.9	6.9	4.3	14.4	1.5	4.8	12.0	10.3	6.4	12.3	8.6	12.8	7.2	6.2	11.1	19.7	15.8	9.8	55.0	10.7	16.1	12.8	21.8	13.5	9.8	15.9	12.7
DYDC1	"bA36D19.5, DPY30D1"	ENSG00000170788	"DPY30 domain containing 1"	Q8WWB3	10	80336105-80356755	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"testis: 127.6"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 222.4;Late spermatids: 83.5;Spermatocytes: 349.2"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.6"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	6	"basophil: 2.0"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA037790, HPA037791"	Uncertain					NA	NA					"HPA037790: AB_10805351, HPA037791: AB_10796215"	"unprognostic (8.95e-2)"	"unprognostic (8.28e-3)"		"unprognostic (7.11e-2)"			"unprognostic (3.12e-1)"	"unprognostic (1.87e-1)"		"unprognostic (1.90e-1)"				"unprognostic (9.96e-2)"	"unprognostic (7.95e-2)"			0.0	0.0	0.6	0.0	0.5	0.2	0.0	0.1	0.3	0.3	1.9	0.0	0.0	0.2	1.5	0.0	5.7	0.0	0.0	0.2	0.6	0.0	0.0	1.0	0.0	0.4	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	127.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.3	0.0	0.2	0.0	0.0	0.6	0.5	0.1	0.3	0.2	0.6	0.4	0.8	0.2	0.2	0.9	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	222.4	15.1	0.1	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	1.3	0.2	0.0	0.0	0.0	0.0	0.3	0.0	2.0	0.0	0.0	83.5	4.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.1	0.0	0.1	0.0	0.0	36.3	0.0	6.6	0.0	0.3	349.2	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DYRK3	"hYAK3-2, RED, REDK"	ENSG00000143479	"Dual specificity tyrosine phosphorylation regulated kinase 3"	O43781	1	206635536-206684419	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 48.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 235.3;Late spermatids: 48.1;Spermatocytes: 108.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 2.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 73.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA075041			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA075041: AB_2686730"	"unprognostic (6.51e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.20e-4)"	"unprognostic (2.69e-1)"	"unprognostic (3.91e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.79e-3)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (9.41e-7)"	"unprognostic (2.38e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.99e-2)"	"unprognostic (7.62e-3)"	7.0	2.4	4.4	4.2	3.7	8.9	5.7	1.8	3.7	5.6	5.1	2.0	1.0	5.3	3.2	2.8	5.7	13.6	7.0	5.1	9.9	3.3	4.1	5.5	1.7	3.5	4.2	3.0	5.0	3.9	3.0	6.6	1.2	3.6	2.9	1.5	6.5	4.3	3.0	0.8	1.5	1.7	8.2	2.8	1.3	3.1	48.4	4.1	6.0	8.4	1.9	1.8	7.5	2.8	3.5	5.0	6.7	1.6	9.8	16.7	15.9	0.4	15.4	36.7	15.0	19.6	0.4	2.7	7.6	2.2	20.1	25.8	1.5	8.6	14.1	15.8	0.1	4.8	10.5	8.9	1.7	26.9	7.5	6.8	10.9	8.9	25.6	73.6	15.1	11.8	11.6	20.1	1.4	23.2	2.0	16.9	4.4	13.2	0.5	10.8	41.1	4.9	0.1	4.8	0.4	9.3	6.9	13.6	0.6	20.3	2.0	2.0	1.9	8.1	31.1	11.2	14.8	13.2	5.6	2.2	9.1	17.7	8.3	2.9	0.7	0.0	0.2	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.5	0.0	0.0	2.7	0.0	0.0	4.4	3.7	1.8	3.7	5.1	9.9	3.5	4.2	3.0	3.6	2.8	4.1	3.5	13.9	3.2	8.2	4.2	1.0	6.5	10.7	9.6	3.4	0.2	4.7	3.3	10.8	1.5	4.2	1.8	10.4	0.0	1.5	0.3	0.0	5.1	235.3	12.6	8.0	8.5	2.4	23.6	3.6	2.2	0.1	12.7	1.1	5.9	0.0	3.4	3.9	1.1	1.0	0.0	1.5	0.4	2.0	1.0	4.6	48.1	4.1	2.9	8.8	1.0	1.0	3.4	0.0	2.5	0.3	1.2	1.2	1.9	2.1	3.8	0.2	1.7	10.5	8.2	6.6	10.2	10.4	108.7	6.4	1.3	3.7	0.4	2.4	3.0	0.6	5.3
EFCAB5	FLJ46247	ENSG00000176927	"EF-hand calcium binding domain 5"	A4FU69	17	29929200-30108452	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 8.6"	"Group enriched"	"Detected in some"	4	"Early spermatids: 136.5;Late spermatids: 101.0;Spermatocytes: 65.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.4;eosinophil: 3.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"MOLT-4: 2.1;RPTEC TERT1: 2.9;SK-MEL-30: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (5.75e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.74e-1)"	"unprognostic (8.52e-2)"	"unprognostic (2.40e-1)"	"unprognostic (5.08e-4)"	"unprognostic (3.13e-1)"	"unprognostic (3.22e-2)"	"unprognostic (6.77e-3)"	"unprognostic (9.86e-4)"	"unprognostic (7.93e-2)"	"unprognostic (2.11e-1)"	"unprognostic (6.74e-2)"	"unprognostic (3.11e-5)"	0.0	0.1	0.2	0.2	0.0	1.3	0.0	0.9	0.4	0.0	0.1	0.8	0.1	0.0	0.1	0.0	0.1	0.1	0.3	0.1	0.4	0.4	0.0	0.1	0.4	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	1.1	0.1	0.0	0.0	0.1	0.3	0.4	0.2	0.0	0.1	0.3	8.6	0.3	0.1	0.2	0.0	0.4	0.0	0.0	0.8	0.3	0.4	0.3	0.0	0.4	0.6	0.0	0.6	0.1	0.0	0.4	0.0	0.9	0.5	0.3	0.9	0.3	0.4	0.1	0.6	0.5	0.2	1.7	0.0	1.1	0.4	0.2	0.5	0.3	0.0	0.0	0.1	0.0	0.7	0.2	0.7	0.0	0.1	0.0	0.0	2.1	1.0	0.1	0.4	0.0	0.7	0.8	0.8	2.9	1.2	1.3	0.2	0.8	0.5	2.3	0.3	0.0	0.2	0.6	0.1	0.3	0.4	0.0	0.0	0.0	0.8	0.2	0.2	1.1	2.4	0.0	3.2	0.1	0.1	0.0	0.5	0.1	0.2	0.0	0.9	0.2	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.2	0.0	0.9	0.4	0.1	0.4	0.2	0.3	0.0	0.3	0.0	0.3	0.8	0.3	0.0	2.0	0.7	1.5	0.3	0.2	0.1	0.0	0.8	0.7	0.6	0.7	1.5	0.1	3.7	0.0	0.3	1.7	1.4	1.9	0.0	136.5	1.7	0.2	0.4	0.0	0.4	23.3	0.2	0.2	0.3	0.5	1.1	5.1	0.2	1.4	0.4	0.2	0.0	15.0	0.8	0.0	0.0	0.2	101.0	1.8	0.6	7.2	2.8	0.1	0.0	0.0	10.6	11.1	0.3	0.2	0.7	0.2	0.2	1.3	1.4	0.6	0.2	0.0	3.1	0.8	65.9	5.0	0.4	0.0	0.0	0.7	0.5	0.8	0.3
EID3	"FLJ25832, NSE4B, NSMCE4B"	ENSG00000255150	"EP300 interacting inhibitor of differentiation 3"	Q8N140	12	104303739-104305205	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 61.8"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 78.5;Early spermatids: 72.8;Spermatocytes: 306.8"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 9.1;BJ: 8.5;BJ hTERT+: 6.9;BJ hTERT+ SV40 Large T+ RasG12V: 6.8;HeLa: 8.9"	"Not detected"	"Not detected"							HPA059367	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA059367: AB_2683992"	"unprognostic (1.25e-1)"	"unprognostic (5.41e-3)"	"unprognostic (5.82e-2)"	"unprognostic (8.21e-2)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (8.02e-2)"	"unprognostic (5.88e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.66e-2)"	"unprognostic (5.38e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (5.96e-5)"	"unprognostic (8.70e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.04e-3)"	"unprognostic (2.87e-2)"	2.8	3.1	1.9	3.6	1.9	5.3	2.4	2.2	2.4	3.0	2.8	2.5	0.8	2.8	2.7	1.8	3.1	2.7	1.9	2.1	10.6	1.8	1.4	3.0	6.2	7.0	2.6	1.8	4.1	2.5	1.2	3.7	1.7	2.3	3.3	0.9	6.7	1.4	5.6	0.6	2.4	2.7	2.3	2.6	3.0	2.2	61.8	2.4	3.8	1.5	1.0	3.9	2.4	2.1	3.8	0.3	9.1	0.3	0.9	2.0	2.0	1.7	8.5	6.9	4.0	6.8	0.2	0.5	0.1	0.0	1.9	1.8	0.2	0.3	0.7	5.9	0.5	0.1	1.7	8.9	1.4	2.9	0.1	0.5	2.7	0.0	2.5	0.5	0.4	0.6	0.4	0.1	0.5	2.5	0.1	3.1	1.3	0.4	0.1	1.8	0.2	0.0	0.1	2.2	0.3	0.1	0.0	5.6	0.4	0.2	0.2	0.0	0.0	1.3	0.1	0.3	2.0	0.4	0.4	0.2	0.1	0.2	0.0	0.9	0.0	0.3	0.5	4.4	1.4	4.6	2.3	5.6	5.4	0.2	2.3	7.9	5.0	0.7	6.2	0.9	0.5	7.3	2.2	1.9	1.9	2.2	2.4	2.1	10.6	7.0	2.6	1.8	2.3	2.6	2.4	3.8	4.7	0.0	6.0	0.0	5.9	13.4	78.5	5.9	1.8	4.9	2.4	3.9	1.4	2.8	2.7	1.8	27.1	2.4	11.1	2.4	0.0	3.5	72.8	13.8	9.6	14.0	0.0	6.6	0.0	1.3	1.6	12.7	5.1	21.1	1.3	6.1	5.3	3.0	1.9	11.8	0.0	1.2	4.1	4.7	26.8	23.5	8.7	6.8	1.8	0.0	4.0	7.5	6.2	0.0	0.0	4.9	4.5	4.5	4.3	47.6	1.2	1.7	7.5	18.6	6.6	7.6	8.4	306.8	44.3	1.4	7.7	2.5	11.1	15.6	1.0	46.9
ERLIN1	"C10orf69, Erlin-1, KE04, SPFH1, SPG62"	ENSG00000107566	"ER lipid raft associated 1"	O75477	10	100150094-100186033	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"		"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 115.0"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 77.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA011252	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"HPA011252: AB_1853965"	"unprognostic (3.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.57e-1)"	"unprognostic (6.98e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.30e-1)"	"prognostic unfavorable (7.63e-4)"	"unprognostic (1.26e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.99e-3)"	"unprognostic (9.09e-2)"	"unprognostic (1.32e-3)"	"unprognostic (6.10e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.93e-1)"	29.6	14.3	8.4	21.6	10.1	76.9	21.6	9.2	10.2	27.7	9.8	37.3	40.7	22.0	17.8	33.1	31.8	16.5	11.1	9.0	10.0	27.4	115.0	19.3	14.6	8.7	8.1	8.5	30.6	19.4	19.6	5.5	42.6	8.6	17.9	38.5	10.9	15.2	16.6	8.7	22.7	30.4	22.6	8.5	16.7	37.1	28.2	8.7	15.7	26.5	13.7	21.4	28.9	19.2	9.2	97.4	95.3	46.9	86.3	113.5	107.9	96.8	148.7	138.3	120.2	137.5	64.0	109.9	42.6	59.7	139.9	100.5	98.5	42.6	90.0	164.1	26.1	38.8	36.7	38.5	83.5	47.6	128.4	39.4	62.6	53.6	105.8	129.2	114.9	90.1	43.5	36.8	25.2	130.2	40.7	33.5	65.9	33.8	66.2	40.4	28.3	77.2	31.6	53.9	37.6	19.1	31.1	85.6	23.6	56.0	53.8	59.3	109.0	101.7	118.7	92.4	72.4	160.8	19.6	35.2	57.1	105.6	204.8	60.6	8.1	20.4	24.4	10.5	15.1	9.3	7.4	7.9	8.6	16.3	6.7	8.1	10.9	15.0	9.9	11.9	4.1	5.6	9.7	8.4	10.1	9.2	10.2	9.0	10.0	8.7	8.1	8.5	8.6	8.5	8.7	9.2	28.2	0.0	11.5	5.2	6.4	15.8	11.3	16.1	12.5	4.6	13.4	12.3	4.8	5.7	14.6	14.7	6.2	20.6	6.4	31.5	0.0	9.9	28.9	16.3	19.5	18.8	13.2	19.1	16.2	10.9	62.7	17.1	20.4	20.9	8.2	19.7	13.6	77.6	14.3	3.3	14.8	27.5	0.0	14.4	7.2	12.9	15.2	12.9	10.6	12.2	13.3	5.9	6.2	15.6	21.0	9.5	19.8	7.9	4.7	12.7	25.6	12.6	30.2	6.2	0.0	14.3	11.8	50.9	15.4	20.6	20.3	24.8	6.6	19.6	27.6	15.6
ERMARD	"C6orf70, dJ266L20.3, FLJ11152"	ENSG00000130023	"ER membrane associated RNA degradation"	Q5T6L9	6	169751622-169781600	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 49.9;Late spermatids: 48.5;Spermatocytes: 37.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA041741	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA041741: AB_10804116"	"unprognostic (2.66e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.41e-3)"	"unprognostic (1.96e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.66e-3)"	"unprognostic (4.74e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.31e-2)"	12.2	14.7	6.4	8.5	7.4	10.2	13.2	5.8	6.8	13.3	5.8	10.7	6.4	13.9	20.6	10.6	13.3	7.8	6.8	5.7	7.0	11.8	18.8	9.8	14.0	7.6	6.6	5.5	17.5	11.5	6.9	15.5	7.5	7.0	12.8	7.5	14.7	11.1	8.7	15.0	18.8	13.8	6.5	6.9	17.4	10.9	22.3	6.4	10.0	13.3	2.5	13.7	11.3	10.9	9.5	5.1	7.5	9.7	14.8	6.9	11.4	5.1	5.3	7.7	5.0	6.3	2.0	8.3	8.0	4.8	6.5	6.1	13.3	4.0	10.3	4.4	8.6	4.4	11.5	9.9	3.0	13.7	16.1	7.6	13.4	10.4	6.1	15.5	12.8	3.4	14.0	8.0	11.4	6.5	7.7	6.8	14.4	3.2	5.7	5.4	7.5	6.0	13.0	6.2	4.0	3.8	7.0	9.0	9.0	4.9	6.3	7.1	12.8	5.3	5.7	3.4	9.1	6.5	13.1	17.5	6.7	7.2	9.7	6.6	1.6	4.2	1.8	5.2	7.9	5.2	5.1	6.0	5.9	4.4	6.0	4.7	4.4	0.4	5.2	9.7	3.7	7.6	3.9	6.4	7.4	5.8	6.8	5.7	7.0	7.6	6.6	5.5	7.0	6.9	6.4	9.5	8.5	3.2	11.1	20.2	6.2	4.1	4.4	7.7	5.2	12.0	5.9	5.1	2.8	5.7	7.7	5.5	10.4	12.2	4.7	3.0	11.7	9.8	49.9	10.8	9.4	5.0	6.0	4.6	9.3	8.5	8.3	7.0	5.6	6.9	2.5	11.7	7.9	10.1	5.9	5.0	11.8	2.9	6.1	5.7	4.4	48.5	4.4	6.1	3.6	8.4	5.6	14.6	5.2	17.1	20.7	5.3	2.4	4.5	4.4	2.5	5.7	9.5	15.5	10.8	6.6	5.5	5.8	37.8	18.0	5.5	3.1	7.1	4.7	10.3	3.4	3.4
EXD1	"EXDL1, MGC33637"	ENSG00000178997	"Exonuclease 3'-5' domain containing 1"	Q8NHP7	15	41182725-41230757	"Predicted intracellular proteins"	"Meiosis, RNA-mediated gene silencing"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 15.1"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 3.7;Early spermatids: 13.4;Late spermatids: 5.7;Spermatocytes: 23.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"pons: 1.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.12e-1)"	"unprognostic (6.33e-3)"	"unprognostic (2.51e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.21e-2)"	"unprognostic (6.50e-2)"	"unprognostic (4.57e-2)"	"unprognostic (4.54e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.11e-6)"	"unprognostic (2.15e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.71e-2)"	0.3	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	15.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.4	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.3	0.1	0.2	0.3	0.2	0.0	1.5	0.2	0.2	0.3	0.1	0.0	1.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.3	0.3	0.5	0.0	0.6	3.7	0.0	0.0	0.1	0.0	0.0	0.0	13.4	0.2	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.0	1.6	5.7	0.0	0.2	1.8	1.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.2	0.1	23.6	2.5	0.0	0.1	0.0	0.1	0.1	0.0	0.0
EXD2	"C14orf114, EXDL2, FLJ10738"	ENSG00000081177	"Exonuclease 3'-5' domain containing 2"	Q9NVH0	14	69191511-69244020	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 36.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002906, HPA005848"	Uncertain		Approved	"Intermediate filaments,Mitochondria"		NA	NA			Mitochondria	"Intermediate filaments"	"HPA002906: AB_1078767, HPA005848: AB_1078768"	"unprognostic (3.36e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (9.91e-2)"	"unprognostic (8.03e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.64e-2)"	"unprognostic (8.97e-2)"	"prognostic favorable (2.08e-9)"	"unprognostic (1.16e-1)"	"unprognostic (3.06e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.14e-2)"	8.1	6.9	16.4	5.1	17.7	2.5	9.8	16.9	19.0	13.7	14.5	9.2	6.9	9.6	12.2	10.5	13.2	8.2	8.7	15.9	16.1	10.5	6.0	8.6	4.2	17.4	16.6	16.0	11.1	18.2	16.1	10.1	7.6	17.0	10.3	9.3	13.1	15.5	10.6	11.1	6.7	6.6	10.2	17.3	5.9	9.8	20.1	16.5	7.3	11.6	9.8	4.5	8.5	7.4	19.2	29.6	13.6	10.3	15.3	6.2	7.4	13.0	14.4	12.1	13.1	17.3	11.6	20.3	0.0	10.4	15.1	8.0	16.4	11.5	14.5	14.7	7.4	13.7	8.6	5.2	6.8	24.2	6.4	7.9	15.1	23.5	13.4	8.7	8.1	18.9	7.4	5.5	11.0	12.7	14.8	3.6	9.6	11.2	15.8	13.5	0.0	9.9	10.4	19.5	10.8	20.0	17.8	10.8	22.2	10.6	11.0	29.8	5.5	15.0	12.2	8.5	9.9	7.5	8.3	12.0	0.1	0.1	6.9	9.3	12.2	2.5	2.2	2.2	1.4	4.2	2.9	2.3	2.3	5.4	1.5	2.8	4.1	0.3	2.9	1.4	4.2	1.8	2.3	16.4	17.7	16.9	19.0	15.9	16.1	17.4	16.6	16.0	17.0	17.3	16.5	19.2	7.2	12.8	10.9	15.7	4.3	3.2	4.9	6.2	14.2	9.9	9.9	7.2	12.1	7.2	9.0	0.0	8.4	8.5	2.5	4.7	5.9	10.7	3.2	7.7	8.4	6.0	6.1	7.8	27.4	8.8	4.4	6.5	8.2	11.1	1.3	9.6	10.8	5.4	6.8	10.1	22.6	8.4	8.2	6.3	2.2	2.3	6.2	3.3	3.6	11.2	6.8	7.5	2.1	21.6	19.1	8.8	6.2	12.0	5.6	5.6	3.6	4.8	11.0	9.3	0.0	7.2	7.4	36.1	8.1	12.6	4.3	2.9	2.6	6.1	7.9	4.3
EXOSC3	"CGI-102, hRrp-40, hRrp40p, p10, RRP40, Rrp40p"	ENSG00000107371	"Exosome component 3"	Q9NQT5	9	37759234-37832117	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"rRNA processing"	RNA-binding	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 132.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020485	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA020485: AB_10960685"	"unprognostic (7.07e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.69e-1)"	"unprognostic (4.95e-2)"	"prognostic unfavorable (7.01e-5)"	"unprognostic (3.06e-1)"	"prognostic unfavorable (7.39e-4)"	"unprognostic (1.71e-3)"	"unprognostic (5.38e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.20e-2)"	"unprognostic (9.25e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.04e-1)"	9.4	12.4	5.6	9.8	5.9	6.5	9.2	9.0	6.5	10.2	5.4	9.1	7.3	9.8	4.3	14.5	8.9	4.2	7.8	5.5	6.8	8.9	10.2	7.6	11.2	5.3	5.7	4.6	10.4	7.9	6.9	8.6	6.7	6.1	9.5	6.2	5.3	9.4	6.6	11.5	8.2	9.0	5.2	5.7	10.9	9.0	21.8	6.3	13.0	8.5	5.4	11.9	10.3	11.6	7.3	69.2	46.8	25.1	32.5	16.5	13.4	33.7	38.5	15.0	31.7	29.6	63.0	11.1	52.3	29.0	14.3	36.2	26.2	28.3	27.3	35.7	75.1	46.9	43.4	57.5	59.3	19.4	66.7	38.5	9.1	13.5	24.0	15.2	10.2	17.0	38.1	108.7	24.7	22.8	40.9	59.3	53.1	69.6	61.7	53.9	53.9	31.2	29.2	17.9	22.0	36.8	36.4	21.9	18.0	26.3	19.8	23.7	48.0	19.7	25.4	47.1	32.0	62.2	16.5	45.4	70.7	25.7	51.2	28.9	34.1	44.4	36.8	35.6	53.9	45.7	53.1	42.9	47.8	42.4	49.1	43.0	41.3	27.8	40.2	49.3	50.4	51.2	55.6	5.6	5.9	9.0	6.5	5.5	6.8	5.3	5.7	4.6	6.1	5.7	6.3	7.3	14.7	22.4	19.9	3.3	25.8	54.2	32.7	47.2	8.6	7.4	17.1	19.3	7.8	22.8	24.0	7.3	0.0	58.0	22.6	13.5	33.2	40.6	74.3	19.2	20.1	14.6	10.7	29.5	4.3	34.9	76.7	20.9	8.6	13.2	29.2	23.7	12.8	13.1	45.4	6.7	4.1	14.9	22.4	19.9	17.9	16.4	16.8	17.6	19.6	1.9	26.3	11.2	20.6	2.5	5.9	34.9	17.7	13.2	19.9	27.6	15.7	32.7	21.9	7.5	26.3	17.6	30.6	132.4	53.1	20.0	54.1	31.5	19.6	28.9	20.2	27.2
EXOSC8	"bA421P11.3, CIP3, EAP2, OIP2, p9, RRP43, Rrp43p"	ENSG00000120699	"Exosome component 8"	Q96B26	13	36998816-37009614	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"rRNA processing"	RNA-binding	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 163.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034240, HPA039702, HPA043942, HPA075230"	Uncertain		Supported	"Nucleoli fibrillar center,Mitotic chromosome,Vesicles"		Yes	NA			"Nucleoli fibrillar center, Mitotic chromosome, Vesicles"		"CAB034240: AB_2101977, HPA039702: AB_2676634, HPA043942: AB_2678742, HPA075230: "	"unprognostic (8.67e-2)"	"unprognostic (9.39e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.01e-2)"	"unprognostic (3.24e-3)"	"unprognostic (2.45e-2)"	"unprognostic (2.35e-2)"	"unprognostic (7.32e-3)"	"prognostic unfavorable (8.39e-7)"	"unprognostic (9.58e-3)"	"unprognostic (7.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.51e-1)"	15.0	14.3	17.7	19.3	18.5	27.8	19.0	19.0	24.5	16.5	17.7	17.1	12.7	14.4	14.5	18.4	17.0	8.5	17.9	17.8	18.6	15.1	20.0	13.7	21.3	18.5	18.3	17.5	16.6	14.0	11.7	10.9	15.7	18.9	14.4	19.2	15.4	11.4	13.4	24.4	16.8	14.2	16.7	18.1	17.7	15.4	28.0	18.0	31.7	12.4	25.0	25.3	16.3	14.9	20.7	47.5	33.5	97.7	66.4	28.4	30.1	73.8	68.9	48.8	93.2	74.2	72.7	93.6	65.1	29.8	38.2	91.4	64.7	92.7	67.1	111.5	96.3	73.9	174.8	34.2	87.4	37.0	148.3	58.9	17.4	51.3	62.6	100.2	24.1	72.8	93.6	86.6	41.3	66.4	59.1	78.6	116.6	101.4	113.2	44.0	48.5	98.6	53.5	51.1	30.8	23.8	46.1	38.1	44.5	65.3	51.1	35.4	117.6	37.2	35.5	49.1	42.9	95.5	23.3	29.4	135.7	56.0	104.1	66.8	28.9	29.8	23.5	42.8	39.6	44.8	66.0	54.1	50.5	33.9	57.2	67.1	62.7	6.0	46.2	41.7	54.8	54.6	52.4	17.7	18.5	19.0	24.5	17.8	18.6	18.5	18.3	17.5	18.9	18.1	18.0	20.7	43.5	32.1	38.9	15.7	40.1	36.1	51.6	109.6	25.0	20.8	25.0	50.0	50.2	18.6	69.5	11.0	8.4	86.8	46.8	13.1	56.7	58.1	115.7	21.5	31.4	39.4	13.2	57.9	7.0	52.1	92.3	41.8	19.4	20.6	103.6	46.2	18.5	17.4	46.8	28.6	8.6	19.1	79.3	13.6	34.2	54.6	40.7	26.0	26.6	10.3	32.6	27.1	35.0	17.1	22.0	36.1	16.4	36.5	38.8	29.0	18.0	26.6	53.4	32.0	26.3	38.8	52.1	163.3	85.9	29.0	36.2	67.0	38.7	42.7	30.2	37.7
EXOSC9	"p5, p6, PM/Scl-75, PMSCL1, RRP45, Rrp45p"	ENSG00000123737	"Exosome component 9"	Q06265	4	121801318-121817021	"Disease related genes, Predicted intracellular proteins"	"rRNA processing"	RNA-binding	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 154.0;Spermatocytes: 170.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041838, HPA048257, CAB070171"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"CAB070171: AB_11026964, HPA041838: AB_10794492, HPA048257: AB_2680331"	"unprognostic (7.36e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.36e-2)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (7.89e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.25e-2)"	"unprognostic (9.85e-3)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (3.28e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.21e-2)"	14.3	14.4	9.4	16.9	10.2	38.2	14.5	11.1	15.4	12.0	9.1	11.6	9.4	13.0	14.5	12.4	13.0	8.2	15.8	9.8	9.9	11.9	16.2	13.7	26.0	10.6	9.6	9.0	13.0	11.3	14.8	11.1	14.2	10.1	10.5	12.7	10.0	11.9	9.4	21.7	14.0	12.1	10.3	9.5	15.9	11.8	43.8	9.9	33.1	10.2	18.8	21.3	15.0	12.0	10.7	66.3	29.9	76.7	44.4	10.7	20.6	39.2	83.7	45.4	114.6	84.5	32.5	53.2	113.9	20.1	50.5	35.7	23.2	83.1	38.1	95.6	51.1	39.9	56.8	43.4	43.0	26.0	98.5	51.1	16.1	20.1	77.8	20.3	23.7	56.0	72.6	102.2	42.3	110.0	38.9	154.6	78.6	42.7	25.2	34.7	80.6	134.4	52.4	41.4	21.0	51.3	53.7	28.8	45.5	52.3	38.9	38.2	64.2	35.2	50.4	76.5	44.4	80.9	63.0	49.7	132.5	52.4	67.8	34.2	15.8	14.5	23.4	17.6	21.1	18.5	20.7	20.9	25.4	17.9	22.4	22.1	22.6	3.8	14.4	21.3	15.9	24.9	14.0	9.4	10.2	11.1	15.4	9.8	9.9	10.6	9.6	9.0	10.1	9.5	9.9	10.7	20.4	44.8	19.1	4.9	20.8	12.7	15.5	31.7	18.8	10.7	6.7	10.7	13.2	17.2	25.4	3.7	10.4	31.4	21.5	5.7	1.9	23.7	154.0	10.9	15.6	17.6	6.0	27.0	10.4	30.5	31.3	15.8	7.7	11.8	31.0	25.4	10.0	5.5	24.5	16.8	8.8	9.8	28.5	11.9	10.1	21.8	13.1	16.3	8.8	11.2	22.2	15.3	16.5	6.6	10.9	20.2	9.2	10.9	22.9	8.4	6.5	8.5	16.8	17.7	6.6	23.4	21.8	170.4	62.8	14.1	14.8	10.9	26.2	16.5	11.6	12.1
FAM118B	FLJ21103	ENSG00000197798	"Family with sequence similarity 118 member B"	Q9BPY3	11	126211724-126262984	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 46.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041644, HPA042100"	Approved					NA	NA					"HPA041644: AB_10794303, HPA042100: AB_10795394"	"unprognostic (8.11e-2)"	"unprognostic (9.87e-3)"	"unprognostic (4.05e-3)"	"unprognostic (3.13e-2)"	"unprognostic (9.55e-3)"	"unprognostic (4.04e-2)"	"prognostic unfavorable (6.67e-7)"	"unprognostic (1.85e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.43e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.49e-2)"	"unprognostic (3.82e-1)"	"unprognostic (7.44e-2)"	9.4	10.6	15.0	10.4	18.7	4.3	7.6	15.5	20.6	10.4	18.7	24.2	18.7	10.0	12.4	7.7	6.8	10.6	15.0	15.4	21.8	10.3	9.0	16.4	12.8	15.6	15.0	15.3	6.3	5.7	7.7	9.1	11.1	15.0	7.4	23.9	9.1	8.1	9.4	22.2	5.4	13.2	14.3	15.9	10.6	15.0	21.6	15.1	14.2	10.3	16.5	14.1	13.7	6.3	16.0	11.7	14.3	31.5	23.6	43.4	28.5	14.0	18.5	33.2	20.4	21.2	29.0	18.5	13.0	19.2	23.5	42.4	15.2	33.5	19.7	24.8	21.2	14.5	41.3	6.8	19.5	33.7	20.7	13.0	23.7	19.9	25.0	23.0	20.5	46.8	24.9	25.8	17.8	29.6	10.9	27.8	16.2	25.6	63.3	26.4	24.1	25.1	11.6	34.4	18.3	14.5	15.2	21.5	14.0	26.8	36.8	27.3	12.4	29.2	20.7	15.2	17.9	16.3	9.3	11.7	22.0	8.9	31.0	26.9	33.8	43.4	21.9	14.6	58.8	18.6	15.2	14.4	18.9	48.1	15.9	12.9	16.0	9.0	18.9	59.6	21.9	18.0	25.2	15.0	18.7	15.5	20.6	15.4	21.8	15.6	15.0	15.3	15.0	15.9	15.1	16.0	8.6	3.2	16.4	14.4	5.6	4.1	4.2	21.9	1.2	3.1	3.3	3.6	10.4	4.3	9.6	12.9	4.2	9.3	5.0	21.9	5.9	16.0	7.5	5.0	6.0	12.4	3.6	8.6	19.1	17.2	12.4	8.3	21.4	4.1	10.8	9.1	9.7	5.5	24.2	1.7	17.6	11.4	12.2	16.7	9.4	9.2	7.8	11.0	3.6	12.2	16.9	13.5	13.4	16.1	12.7	14.0	12.8	21.8	9.5	4.1	11.4	12.9	6.8	5.7	6.6	3.4	10.2	46.0	20.6	3.5	3.4	13.0	5.3	11.0	16.6	5.7
FAM126A	"DRCTNNB1A, HCC, HYCC1, hyccin"	ENSG00000122591	"Family with sequence similarity 126 member A"	Q9BYI3	7	22889371-23014130	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cataract, Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 133.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042873	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA042873: AB_2678207"	"unprognostic (7.94e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.38e-2)"	"unprognostic (3.54e-4)"	"unprognostic (1.35e-1)"	"unprognostic (9.76e-3)"	"unprognostic (1.30e-2)"	"unprognostic (7.23e-2)"	"unprognostic (6.19e-2)"	"prognostic unfavorable (6.04e-7)"	"prognostic unfavorable (5.99e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.40e-2)"	"prognostic unfavorable (9.03e-4)"	14.8	4.8	5.6	8.6	7.4	4.2	12.4	5.1	6.6	9.8	8.5	7.8	9.5	8.8	1.4	12.3	6.8	11.5	10.1	11.6	10.3	4.7	8.5	13.8	11.6	6.2	6.4	4.8	6.6	6.2	2.3	5.0	14.9	6.9	5.9	4.4	4.9	6.9	4.8	25.3	4.7	6.9	11.6	5.2	11.9	4.6	12.1	6.5	4.3	6.6	15.4	9.2	9.5	11.3	8.5	22.4	12.4	63.6	22.3	61.3	100.9	10.6	103.0	101.8	41.6	63.9	19.8	10.6	13.3	15.9	82.6	87.2	7.7	44.3	14.7	72.6	6.6	22.4	14.7	18.1	13.0	48.0	19.3	15.7	41.1	9.2	85.0	61.3	83.4	42.5	7.5	30.4	58.6	77.5	7.9	10.8	24.2	63.0	0.1	22.9	15.7	63.5	9.5	13.1	11.2	10.4	0.1	38.1	0.4	19.2	52.5	8.2	20.4	51.0	150.0	18.3	71.8	37.4	67.2	30.6	60.9	91.1	12.5	112.6	4.7	2.9	13.7	1.4	7.8	1.3	6.4	2.6	1.3	3.9	7.4	0.9	1.5	0.3	2.1	9.8	1.6	4.0	2.5	5.6	7.4	5.1	6.6	11.6	10.3	6.2	6.4	4.8	6.9	5.2	6.5	8.5	27.8	3.2	15.1	19.6	29.1	25.5	5.1	8.3	15.9	60.3	5.4	32.4	21.9	2.8	4.2	3.7	2.1	11.8	28.8	0.5	0.0	6.8	49.0	12.5	22.4	31.4	7.7	19.8	13.6	4.8	15.5	42.9	2.6	11.3	8.2	8.6	26.0	17.7	15.2	16.8	13.6	3.0	2.0	25.1	55.2	22.4	20.2	31.5	35.6	47.8	24.0	6.8	11.3	23.6	133.2	3.6	1.4	19.5	26.4	4.7	8.3	5.7	2.4	4.6	19.7	24.0	31.7	72.2	11.1	35.0	24.0	6.0	20.6	12.2	4.7	6.5
FAM170A	ZNFD	ENSG00000164334	"Family with sequence similarity 170 member A"	A1A519	5	119629559-119635822	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	49	"testis: 11.7"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 30.5;Late spermatids: 11.7;Sertoli cells: 6.6;Spermatocytes: 54.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA037900, HPA037902"	Enhanced					NA	NA					"HPA037900: AB_2675728, HPA037902: AB_2675730"	"unprognostic (2.26e-1)"	"unprognostic (1.13e-1)"		"unprognostic (9.70e-3)"			"unprognostic (1.89e-1)"					"unprognostic (1.06e-1)"	"unprognostic (1.02e-4)"	"unprognostic (2.12e-1)"		"unprognostic (2.25e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.5	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	54.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM181A	C14orf152	ENSG00000140067	"Family with sequence similarity 181 member A"	Q8N9Y4	14	93918894-93929608	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 9.1;testis: 32.8"	"Group enriched"	"Detected in some"	4	"Early spermatids: 48.9;Spermatocytes: 35.4"	"Group enriched"	"Detected in some"	6	"endometrial cancer: 3.1;glioma: 9.7;ovarian cancer: 5.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"AF22: 4.3"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 31.9"	HPA001603	Enhanced					NA	NA					"HPA001603: AB_1078326"		"unprognostic (8.19e-2)"		"unprognostic (6.78e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.31e-1)"		"unprognostic (2.05e-2)"		"unprognostic (1.84e-2)"					"unprognostic (6.27e-2)"	"unprognostic (4.44e-2)"	"unprognostic (5.37e-2)"	0.0	0.0	5.5	0.0	5.1	0.0	0.0	5.6	7.6	0.0	3.5	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	4.9	9.1	0.0	0.0	0.9	0.0	6.8	5.3	4.5	0.0	0.0	0.0	2.3	0.0	5.8	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	6.0	0.0	0.0	32.8	5.5	0.0	1.2	0.0	0.0	0.0	0.0	5.5	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	5.1	5.6	7.6	4.9	9.1	6.8	5.3	4.5	5.8	6.0	5.5	5.5	0.0	3.2	3.1	8.8	0.0	0.0	0.0	1.6	0.0	0.1	0.1	0.4	0.4	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.9	6.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	8.7	0.6	0.1	0.0	0.0	0.0	0.9	0.0	0.5	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	3.7	0.2	0.0	0.0	0.1	35.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM186B	"C12orf25, DKFZP434J0113"	ENSG00000135436	"Family with sequence similarity 186 member B"	Q8IYM0	12	49582885-49605639	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"testis: 46.4"	"Group enriched"	"Detected in some"	17	"Early spermatids: 85.1;Late spermatids: 101.5;Spermatocytes: 38.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039736, HPA040028"	Uncertain					NA	NA					"HPA039736: AB_10795295, HPA040028: AB_10795684"	"unprognostic (2.96e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.00e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.11e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.42e-5)"	"unprognostic (1.56e-1)"	"unprognostic (6.18e-2)"	"unprognostic (2.10e-5)"	"unprognostic (7.23e-2)"	0.2	0.5	0.4	0.5	0.4	0.5	0.3	0.8	0.6	0.3	0.0	0.2	0.3	0.3	0.3	0.2	0.4	0.2	0.3	0.4	0.2	0.5	0.8	0.2	0.6	0.6	0.2	0.4	0.8	1.6	0.9	0.3	0.1	0.9	0.3	0.1	0.6	0.4	0.2	0.6	1.2	0.3	0.1	0.1	0.3	0.4	46.4	0.2	0.1	1.0	0.3	0.2	0.3	0.3	0.5	0.3	1.4	0.1	0.4	0.1	0.0	0.7	0.0	0.1	0.0	0.1	1.8	0.5	1.0	0.3	0.1	0.3	0.5	0.2	0.2	0.1	0.3	0.4	0.6	0.9	0.2	0.1	1.1	0.3	0.0	0.3	0.2	0.7	0.1	0.1	0.4	1.0	0.8	0.2	1.0	0.1	0.1	0.2	0.4	0.5	0.4	0.1	0.4	0.5	0.4	1.1	0.3	0.5	0.2	0.8	0.3	0.6	0.5	0.5	0.1	0.5	0.4	0.3	0.5	0.4	1.8	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.4	0.8	0.6	0.4	0.2	0.6	0.2	0.4	0.9	0.1	0.2	0.5	0.1	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.0	0.4	0.2	0.0	0.4	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	85.1	0.2	0.1	0.2	0.0	0.0	0.7	0.2	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.9	0.1	0.0	0.7	0.0	0.0	0.0	0.0	101.5	1.2	0.2	0.0	1.0	0.0	0.1	0.0	0.0	1.0	0.1	0.1	0.7	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.5	0.2	38.2	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0
FAM204A	"bA319I23.1, C10orf84, FLJ13188"	ENSG00000165669	"Family with sequence similarity 204 member A"	Q9H8W3	10	118297925-118342328	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038182, HPA062025"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA038182: AB_10669519, HPA062025: AB_2684663"	"unprognostic (1.60e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.45e-2)"	"unprognostic (8.52e-3)"	"unprognostic (4.47e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.13e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (8.59e-4)"	"unprognostic (5.55e-2)"	"unprognostic (8.33e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.76e-3)"	27.7	19.5	17.4	22.7	19.1	54.9	31.7	15.4	23.8	22.4	14.2	23.7	21.0	26.9	32.5	26.4	20.2	22.0	35.7	18.8	17.9	27.9	29.3	25.2	27.6	19.7	17.3	17.0	28.7	25.0	30.5	14.2	21.1	17.0	20.9	24.4	16.1	25.5	22.3	37.0	18.9	18.7	26.7	16.8	25.0	21.9	49.6	17.6	28.6	29.6	27.9	28.1	26.1	17.3	17.9	56.4	24.9	40.2	56.2	39.1	42.4	22.8	43.6	81.4	61.6	55.4	29.4	51.2	39.7	26.3	47.2	27.7	47.3	34.0	45.5	55.6	62.8	42.0	33.0	23.4	26.2	58.4	86.7	44.9	29.4	54.8	45.3	94.3	51.7	53.3	50.2	35.3	45.5	51.6	31.5	53.6	80.1	28.6	24.7	22.0	45.2	77.7	29.3	56.0	28.2	25.8	40.5	29.9	27.7	66.8	19.6	44.0	61.7	37.4	32.2	30.1	28.8	67.4	32.4	31.0	57.0	62.8	92.2	33.3	73.5	57.5	70.4	36.9	64.2	39.0	50.6	41.8	34.4	59.6	35.2	35.6	41.8	32.0	34.4	69.3	43.0	51.5	57.1	17.4	19.1	15.4	23.8	18.8	17.9	19.7	17.3	17.0	17.0	16.8	17.6	17.9	71.9	60.9	55.7	54.5	66.0	55.6	63.0	60.9	63.7	38.8	61.0	67.4	78.6	52.9	47.3	44.1	73.0	39.5	84.8	30.2	135.0	85.5	255.8	62.5	79.4	67.8	41.9	59.5	49.9	113.7	49.8	72.4	41.8	60.3	68.4	140.6	64.6	49.8	62.4	33.7	48.3	56.0	63.1	69.4	76.2	132.0	76.4	73.0	60.5	27.2	77.2	62.5	92.7	53.3	45.4	95.3	68.9	70.0	62.9	54.6	35.4	115.7	44.2	55.4	26.3	73.7	78.3	258.5	170.3	55.6	50.6	30.6	62.8	62.6	48.4	61.6
FAM216A	"C12orf24, HSU79274"	ENSG00000204856	"Family with sequence similarity 216 member A"	Q8WUB2	12	110468415-110490385	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"brain: 16.6;testis: 59.9"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 54.7;Spermatocytes: 215.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038286	Enhanced		Approved	"Actin filaments"		NA	NA			"Actin filaments"		"HPA038286: AB_2675931"	"unprognostic (7.91e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.56e-1)"	"unprognostic (6.02e-3)"	"unprognostic (3.04e-1)"	"unprognostic (2.76e-1)"	"prognostic unfavorable (4.49e-5)"	"unprognostic (8.49e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.04e-3)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (4.18e-10)"	"unprognostic (7.60e-2)"	"unprognostic (4.35e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.05e-1)"	3.2	7.5	9.9	6.7	10.8	4.1	3.9	14.3	16.6	4.8	6.1	3.0	1.1	5.9	2.0	3.2	4.5	4.3	9.2	11.0	13.7	3.0	3.2	2.1	7.4	11.2	10.9	9.1	7.1	2.0	5.5	5.2	3.6	11.7	3.9	2.2	8.9	1.7	4.5	3.4	1.4	3.3	6.0	9.4	4.0	2.3	59.9	12.0	7.3	3.3	4.4	4.5	4.9	3.2	13.9	31.1	25.8	21.6	28.5	13.7	25.9	3.5	57.3	14.4	63.9	28.3	27.5	8.5	101.2	13.1	24.2	18.1	19.9	38.1	33.3	77.9	30.0	72.8	49.9	17.6	23.4	22.8	68.3	39.1	25.1	7.8	32.5	71.6	47.8	20.5	39.5	63.1	26.7	48.4	11.2	50.4	106.4	64.6	13.6	41.9	24.4	29.6	68.9	24.7	0.9	77.4	27.5	24.4	18.4	14.2	7.8	43.6	49.2	18.9	22.4	7.5	19.9	58.8	41.7	38.9	79.7	31.7	61.0	37.7	0.9	3.6	1.0	1.9	3.1	3.7	7.3	3.7	3.6	4.5	8.2	9.3	5.6	2.9	2.8	2.6	2.4	2.4	3.9	9.9	10.8	14.3	16.6	11.0	13.7	11.2	10.9	9.1	11.7	9.4	12.0	13.9	2.4	0.0	1.5	7.8	9.6	1.7	6.0	8.7	7.4	11.6	3.0	7.5	20.1	0.0	3.6	3.7	2.1	0.7	1.4	0.1	0.0	4.1	38.6	3.2	17.5	4.4	1.2	17.2	20.4	0.9	3.0	10.8	1.1	0.7	10.2	6.6	3.9	3.4	8.1	13.5	21.6	0.1	2.0	4.4	2.1	54.7	9.6	3.7	3.6	5.6	4.2	4.2	6.2	14.1	8.9	2.8	0.0	5.7	3.9	8.0	0.1	4.4	5.1	5.1	13.1	8.4	9.3	215.9	21.6	5.1	2.0	0.5	3.6	12.2	0.4	1.5
FAM222B	"C17orf63, FLJ10700"	ENSG00000173065	"Family with sequence similarity 222 member B"	Q8WU58	17	28755978-28855232	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 73.8;Inhibitory neurons: 84.7;Oligodendrocytes: 79.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051840, HPA062239"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA051840: AB_2681633, HPA062239: AB_2684722"	"unprognostic (4.11e-2)"	"unprognostic (9.72e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.40e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.12e-2)"	"prognostic unfavorable (3.45e-4)"	"unprognostic (1.18e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.28e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.61e-2)"	"unprognostic (7.18e-2)"	8.5	6.4	6.5	7.0	6.5	7.1	8.4	13.0	9.6	8.6	14.7	11.3	12.4	7.6	7.8	11.1	7.1	8.7	9.9	6.3	4.2	10.5	7.8	8.1	6.6	8.3	6.4	3.6	8.5	8.1	10.6	10.3	9.9	8.0	9.4	10.1	10.0	14.3	8.9	43.8	7.8	11.1	7.1	2.7	6.7	8.5	27.7	8.9	7.9	8.6	16.3	7.2	10.8	9.9	10.2	13.1	25.1	21.2	24.4	17.7	12.3	23.2	9.1	8.5	12.5	12.6	32.4	12.6	13.3	17.9	10.2	16.0	16.2	17.7	20.4	10.4	18.7	24.1	15.0	12.9	24.9	20.4	9.9	23.1	12.9	19.8	17.7	15.7	12.6	25.2	15.5	29.1	9.2	26.4	16.5	16.9	7.9	24.3	17.5	9.4	7.9	20.1	13.4	22.4	16.4	23.0	16.1	12.9	24.8	31.8	44.0	18.9	9.3	28.8	8.3	17.1	9.4	14.5	18.5	24.9	8.8	11.4	6.8	15.5	15.9	3.9	9.5	6.4	5.0	7.6	6.2	5.4	6.6	5.4	4.6	7.3	6.3	4.5	3.9	7.9	4.9	5.2	4.2	6.5	6.5	13.0	9.6	6.3	4.2	8.3	6.4	3.6	8.0	2.7	8.9	10.2	10.3	3.2	7.3	49.3	12.0	9.4	7.7	14.7	9.1	14.8	14.7	10.3	13.6	31.5	9.1	7.3	27.1	7.9	6.5	22.9	3.9	18.1	56.9	11.0	10.8	13.7	25.9	14.7	73.8	13.3	10.6	7.9	11.7	17.1	10.1	8.1	31.4	11.4	8.7	25.2	84.7	17.3	20.3	8.4	5.7	45.3	12.5	6.8	7.2	41.2	8.3	6.2	8.2	64.3	79.0	24.1	12.7	7.9	8.6	14.0	18.3	11.2	10.0	8.0	0.0	9.5	6.5	51.9	34.8	9.2	6.7	6.0	10.7	8.1	19.0	10.4
FAM227B	"C15orf33, FLJ32800"	ENSG00000166262	"Family with sequence similarity 227 member B"	Q96M60	15	49326962-49620929	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 39.5;Early spermatids: 41.0;Oligodendrocytes: 55.1;Spermatocytes: 48.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA049774, HPA061695"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA049774: AB_2680873, HPA061695: AB_2684588"	"unprognostic (1.19e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.89e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.28e-4)"	"unprognostic (3.32e-2)"	"unprognostic (9.21e-2)"	"unprognostic (6.57e-3)"	"unprognostic (6.32e-3)"	"unprognostic (6.41e-2)"	"unprognostic (7.48e-5)"	"unprognostic (2.70e-1)"	"unprognostic (9.01e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.76e-1)"	1.0	5.1	5.0	1.9	5.4	1.5	6.7	4.8	4.7	4.8	4.8	3.4	2.8	6.3	7.3	3.5	7.8	3.4	7.3	4.2	5.4	7.8	7.6	2.8	4.9	5.6	5.1	3.8	10.0	6.5	5.7	6.5	1.3	5.5	5.8	2.9	8.0	5.3	5.1	8.0	3.9	2.3	3.9	5.6	2.8	3.6	10.5	4.6	6.9	7.5	9.0	4.4	3.5	2.2	6.8	0.8	0.7	5.1	2.8	1.5	3.0	0.6	2.1	2.8	3.2	5.1	0.7	2.4	1.5	4.9	3.5	3.7	0.8	1.8	3.1	3.7	3.7	1.5	3.2	1.3	1.7	4.2	1.5	1.3	3.1	4.0	1.8	2.0	6.2	3.0	7.7	5.4	2.4	7.1	3.5	3.2	1.3	2.0	1.2	1.3	2.7	4.5	8.1	4.8	1.0	3.8	5.3	1.9	2.5	6.2	3.7	3.1	1.1	2.2	2.2	1.7	3.0	1.3	12.2	9.8	4.8	2.4	3.9	2.4	5.8	0.2	1.7	3.4	0.5	4.5	2.8	3.5	4.6	0.3	3.5	5.8	5.6	0.3	2.7	0.6	3.4	3.4	2.0	5.0	5.4	4.8	4.7	4.2	5.4	5.6	5.1	3.8	5.5	5.6	4.6	6.8	1.1	9.6	4.8	39.5	5.8	2.8	5.4	5.4	3.4	4.3	6.2	7.6	10.8	1.5	9.4	3.7	0.0	1.7	3.3	1.3	25.4	3.9	41.0	19.1	3.1	2.8	8.4	2.1	12.8	3.2	1.5	3.7	3.6	3.2	3.8	1.8	1.8	4.1	0.6	5.0	12.1	1.8	6.1	0.6	2.0	21.1	4.1	2.0	3.6	5.6	0.6	11.7	4.1	16.1	55.1	2.5	1.6	3.0	6.1	2.6	1.9	12.5	21.3	8.0	0.0	4.7	2.0	48.7	13.2	2.5	4.3	0.4	5.7	6.3	2.2	2.6
FAM228A	"C2orf84, FLJ30851"	ENSG00000186453	"Family with sequence similarity 228 member A"	Q86W67	2	24175053-24200849	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 35.4"	"Group enriched"	"Detected in some"	5	"Early spermatids: 119.7;Spermatocytes: 176.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 2.5;hTERT-RPE1: 1.1;TIME: 4.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA075817			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA075817: "	"unprognostic (2.57e-1)"	"unprognostic (7.14e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.98e-3)"	"unprognostic (7.13e-4)"	"unprognostic (2.19e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.05e-1)"	"unprognostic (9.57e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.44e-5)"	"unprognostic (1.73e-2)"	"unprognostic (1.04e-4)"	"unprognostic (1.96e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.33e-2)"	1.9	0.9	1.4	0.6	1.7	0.0	1.6	1.4	2.9	0.8	0.0	0.7	0.3	0.7	0.9	0.9	0.6	1.1	1.2	1.3	0.9	0.5	0.3	0.8	0.6	1.4	0.9	1.9	0.7	0.4	0.1	0.5	1.0	1.2	0.8	0.3	0.9	0.2	0.9	0.4	0.4	0.4	0.5	0.2	0.4	0.7	35.4	0.9	0.3	0.7	0.4	0.2	0.9	0.5	2.0	0.1	0.0	0.3	0.0	0.2	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.5	0.0	0.1	0.1	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.4	0.0	0.0	0.2	0.2	0.0	0.1	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.1	0.0	0.1	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.7	0.0	0.1	1.4	1.7	1.4	2.9	1.3	0.9	1.4	0.9	1.9	1.2	0.2	0.9	2.0	0.4	3.2	0.5	3.3	0.0	0.5	0.1	0.0	0.0	0.4	0.1	0.0	0.7	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.7	119.7	0.0	0.4	0.5	0.0	0.0	5.5	0.5	0.2	1.6	0.0	0.0	0.0	0.6	1.1	0.1	0.5	1.7	5.8	0.0	0.0	0.8	0.4	24.8	2.8	0.3	0.0	2.8	0.1	0.3	1.0	3.0	3.1	0.7	0.0	4.5	0.0	0.1	0.0	0.0	0.1	0.2	6.6	1.0	0.8	176.0	10.4	0.0	0.1	0.1	0.1	0.5	0.0	0.2
FAM72A	"LMPIP, MGC57827, p17, RP11-312O7.1, UGENE"	ENSG00000196550	"Family with sequence similarity 72 member A"	Q5TYM5	1	206186179-206204414	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 11.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 29.5;Kupffer cells: 18.2;Late spermatids: 30.2;Spermatocytes: 28.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							"HPA043271, HPA067321"	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	Yes			Vesicles	"Plasma membrane, Cytosol"	"HPA043271: AB_2678402, HPA067321: "	"unprognostic (3.61e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.20e-5)"	"unprognostic (3.61e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.01e-5)"	"unprognostic (7.70e-3)"	"unprognostic (1.45e-2)"	"unprognostic (5.58e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.44e-16)"	"unprognostic (1.82e-1)"	"unprognostic (1.94e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.89e-1)"	3.9	3.1	2.5	5.9	2.9	8.5	3.6	8.1	2.9	1.3	1.3	2.3	3.1	0.9	0.4	2.5	1.8	2.7	1.1	3.1	3.7	1.3	2.0	2.7	11.0	4.1	4.5	1.9	1.1	1.4	1.6	0.8	3.5	4.9	1.1	2.4	0.2	1.0	0.7	0.6	5.9	2.9	2.0	4.8	6.3	1.6	7.1	5.2	8.6	0.9	1.0	7.5	1.5	1.5	4.6	21.1	16.4	17.7	7.7	2.6	3.1	21.1	14.6	6.3	17.1	12.7	9.9	31.1	54.2	12.3	3.8	18.8	24.7	20.9	8.1	20.2	29.5	16.3	24.3	16.4	13.9	1.8	42.9	27.0	4.4	1.4	15.1	26.7	5.1	10.7	45.7	50.1	36.7	10.7	12.9	26.9	38.3	32.1	15.1	22.1	29.5	30.6	41.4	9.8	3.2	17.7	10.2	10.6	9.7	9.3	20.1	20.5	23.2	5.5	13.5	15.5	17.7	24.9	29.1	44.8	48.4	11.1	34.9	18.8	0.0	5.9	0.0	0.7	8.0	0.2	1.7	1.4	1.4	4.6	0.5	0.1	0.3	1.0	0.6	4.8	1.9	2.9	2.1	2.5	2.9	8.1	2.9	3.1	3.7	4.1	4.5	1.9	4.9	4.8	5.2	4.6	5.9	0.0	1.5	0.0	2.4	1.8	0.4	1.2	1.2	0.3	0.8	0.6	1.5	0.0	0.9	0.0	0.0	0.8	3.7	4.9	0.0	1.0	29.5	1.5	1.5	8.4	0.0	0.4	0.1	0.8	3.8	1.8	0.5	0.7	0.0	0.3	7.1	0.4	9.4	0.0	0.2	3.6	0.0	18.2	5.8	30.2	0.0	6.9	3.6	0.0	9.6	0.6	2.1	0.0	0.1	0.6	0.0	0.0	1.6	0.4	1.3	0.3	2.1	0.2	0.0	0.9	2.2	28.0	4.1	2.0	1.0	0.7	1.4	0.8	1.6	0.8
FASTKD5	FLJ13149	ENSG00000215251	"FAST kinase domains 5"	Q7L8L6	20	3146519-3159865	"Predicted intracellular proteins"	"mRNA processing"	"RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043833	Approved					NA	NA					"HPA043833: AB_10962718"	"unprognostic (1.10e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.49e-2)"	"prognostic unfavorable (4.05e-5)"	"unprognostic (1.13e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.96e-1)"	"unprognostic (4.06e-1)"	"unprognostic (6.95e-2)"	"prognostic favorable (8.19e-8)"	"unprognostic (6.80e-2)"	"unprognostic (2.36e-1)"	"unprognostic (7.84e-2)"	"unprognostic (5.04e-2)"	8.0	14.1	6.1	9.1	6.5	37.3	8.0	9.4	8.3	7.3	8.3	9.1	9.7	7.1	5.4	9.7	6.6	7.5	15.9	6.3	6.7	16.5	12.7	8.3	11.7	7.0	6.6	6.3	7.1	5.6	12.8	5.4	8.4	7.3	7.1	9.1	10.4	8.9	6.6	35.0	7.4	9.0	8.9	6.3	9.3	8.0	10.2	6.9	12.8	7.4	27.2	12.7	10.3	5.7	8.5	25.7	28.7	18.4	22.9	17.8	12.0	18.1	14.7	15.3	20.0	16.9	41.3	14.5	36.0	11.1	19.0	26.6	31.9	45.3	35.6	25.0	10.0	23.2	31.4	12.7	50.5	15.4	36.1	28.9	17.0	29.7	19.2	7.6	12.0	19.2	23.5	35.2	17.6	23.6	12.1	21.2	26.2	26.7	33.2	24.6	21.4	24.5	32.6	28.0	29.1	17.5	20.4	17.4	55.1	36.6	21.5	20.1	27.7	20.4	12.8	17.5	12.0	21.3	19.4	36.0	27.0	8.5	22.6	20.3	30.2	12.4	20.5	10.1	14.7	18.1	10.9	13.3	13.5	12.1	8.5	16.5	18.2	10.2	8.4	17.7	6.1	17.8	13.1	6.1	6.5	9.4	8.3	6.3	6.7	7.0	6.6	6.3	7.3	6.3	6.9	8.5	5.8	16.0	8.9	0.0	9.0	9.4	10.7	10.0	5.7	5.7	6.1	4.6	17.7	14.3	9.7	7.3	14.6	13.4	9.2	8.4	7.9	11.2	13.8	9.5	5.3	6.1	5.4	3.6	0.0	6.5	8.9	6.1	4.1	10.0	5.7	6.8	5.7	10.7	7.0	15.2	0.0	5.8	8.2	6.3	8.4	4.0	4.7	8.1	3.6	0.0	11.4	8.9	5.2	0.0	0.0	8.7	4.4	6.0	4.9	4.7	11.5	12.9	12.4	16.6	0.0	8.3	6.9	25.3	11.6	7.7	9.2	19.7	10.0	9.0	6.7	10.9
FBXO25	FBX25	ENSG00000147364	"F-box protein 25"	Q8TCJ0	8	406428-477967	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 98.7"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 625.7;Late spermatids: 312.5;Spermatocytes: 640.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 58.7;SK-MEL-30: 61.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.63e-1)"	"prognostic favorable (5.38e-5)"	"unprognostic (2.74e-2)"	"unprognostic (5.11e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.86e-1)"	"unprognostic (9.23e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.39e-3)"	"unprognostic (3.30e-1)"	"prognostic favorable (1.41e-4)"	"unprognostic (1.71e-1)"	"unprognostic (3.94e-2)"	"unprognostic (2.11e-3)"	"unprognostic (2.41e-1)"	14.6	20.6	8.2	7.6	9.0	9.2	14.0	13.0	11.9	9.2	7.5	16.8	15.6	8.5	16.9	10.1	8.7	9.3	15.5	8.7	8.8	15.9	30.3	10.5	12.1	8.4	8.8	7.9	8.9	28.9	14.3	12.2	6.8	9.2	25.2	18.9	7.3	16.4	10.6	18.4	12.4	11.2	11.1	8.0	8.2	15.2	98.7	8.7	20.9	18.8	19.8	12.2	11.4	9.0	10.9	13.4	10.6	4.5	8.8	6.9	4.4	18.6	12.6	18.5	11.8	18.1	6.0	12.7	0.3	3.4	19.4	17.8	8.5	8.7	24.5	16.1	10.0	14.5	7.1	6.3	28.3	20.5	11.4	13.7	12.7	37.6	3.6	18.7	17.9	5.0	58.7	8.4	0.1	13.9	12.8	50.8	13.6	2.1	29.0	4.6	2.4	3.4	18.1	15.4	22.5	13.7	14.4	12.7	4.2	61.5	11.2	9.0	8.1	7.5	4.8	4.1	0.8	10.1	9.2	14.4	13.6	13.0	4.7	14.7	1.6	9.1	6.6	9.0	10.8	11.1	16.2	10.7	8.5	9.1	10.9	9.5	9.4	0.7	9.9	9.9	9.0	12.5	6.9	8.2	9.0	13.0	11.9	8.7	8.8	8.4	8.8	7.9	9.2	8.0	8.7	10.9	21.3	19.2	28.5	15.3	24.2	34.8	19.6	28.0	19.9	31.8	35.9	21.7	36.6	42.9	20.4	35.0	10.4	20.0	26.8	30.4	72.4	53.3	625.7	20.0	17.8	25.7	43.3	12.6	20.5	102.6	18.9	18.2	16.3	27.4	20.3	15.4	28.2	77.0	25.4	53.8	20.0	58.2	42.7	32.7	24.2	312.5	38.8	17.4	39.2	11.2	36.2	22.1	38.1	8.5	28.3	51.5	41.2	29.3	21.4	39.1	34.9	58.3	13.2	36.3	26.3	17.8	16.2	640.9	142.1	17.4	40.5	16.1	19.5	14.4	47.2	21.8
FBXO43	Fbx43	ENSG00000156509	"F-box protein 43"	Q4G163	8	100133351-100145817	"Predicted intracellular proteins"	"Meiosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	12	"testis: 3.6"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 11.6;Erythroid cells: 9.9;Late spermatids: 6.9;Spermatocytes: 43.8"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 3.6"	"Not detected"	"Not detected"							"HPA024292, HPA024295, HPA024824"	Uncertain					NA	NA					"HPA024292: AB_1848462, HPA024295: AB_1848463, HPA024824: AB_1848464"	"unprognostic (4.94e-2)"	"unprognostic (4.35e-2)"	"unprognostic (2.09e-2)"	"unprognostic (4.34e-2)"	"unprognostic (5.06e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.07e-5)"	"unprognostic (4.31e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.46e-1)"	"unprognostic (0.00e+0)"	"unprognostic (7.97e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.91e-2)"	"unprognostic (8.09e-2)"	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	3.6	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.3	0.7	0.0	0.0	0.0	0.1	0.4	0.3	1.0	0.0	0.1	1.1	0.7	0.1	0.0	0.0	0.0	0.1	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.5	0.6	0.0	0.3	0.6	0.0	0.9	0.2	0.0	0.1	1.4	0.0	0.0	1.5	1.1	0.0	0.1	0.2	0.0	0.6	0.0	0.3	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	1.2	0.5	0.6	0.8	1.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.2	1.8	1.6	0.3	0.9	0.6	0.3	0.6	1.4	0.5	0.6	0.4	0.0	3.2	0.0	0.0	0.6	0.4	0.2	0.0	0.0	11.6	1.5	0.4	0.6	1.2	9.9	0.3	0.4	0.3	1.4	0.0	0.3	1.3	6.2	0.0	0.2	0.5	0.0	0.4	0.1	2.0	0.3	1.1	6.9	0.0	0.7	0.0	1.0	0.1	0.6	1.0	0.5	0.5	0.1	0.1	0.4	0.8	0.3	0.2	0.2	1.2	0.8	0.0	1.4	0.5	43.8	4.5	0.7	0.4	0.3	1.6	0.3	0.4	0.2
FEZF1	ZNF312B	ENSG00000128610	"FEZ family zinc finger 1"	A0PJY2	7	122301303-122310691	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"brain: 80.2"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 5.1;Spermatocytes: 5.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"thalamus: 80.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"NTERA-2: 152.1;SCLC-21H: 66.0"	"Region enriched"	"Detected in some"	11	"hypothalamus: 11.7"	"Region enriched"	"Detected in single"	14	"hypothalamus: 7.4"	"HPA064639, HPA073693"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA064639: AB_2685308, HPA073693: AB_2686626"		"unprognostic (8.48e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.43e-2)"	"unprognostic (4.17e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.64e-3)"			"unprognostic (2.54e-1)"	"unprognostic (1.34e-1)"		"unprognostic (2.96e-2)"	"unprognostic (2.55e-1)"		"unprognostic (1.48e-2)"	0.1	0.0	4.5	0.0	2.6	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	18.3	0.0	0.0	0.0	0.0	1.0	2.3	0.9	0.0	0.0	0.0	3.0	0.0	0.9	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.6	80.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	152.1	3.8	2.7	0.0	0.0	0.0	0.0	0.2	66.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	7.2	0.3	0.0	0.1	2.0	0.0	0.0	0.9	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	2.6	0.2	1.5	0.7	18.3	1.0	2.3	0.9	0.9	0.1	80.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	5.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FGF4	"HBGF-4, HST, HST-1, HSTF1, K-FGF, KFGF"	ENSG00000075388	"Fibroblast growth factor 4"	P08620	11	69771022-69775341	"Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins"	Differentiation	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 1.1;Early spermatids: 3.1;Late spermatids: 1.4;Spermatocytes: 1.5"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 13.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	62	"NTERA-2: 16.1;SuSa: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA011209	Uncertain				"Secreted in other tissues"	NA	NA	326000				"HPA011209: AB_1848527"			"unprognostic (1.47e-2)"	"unprognostic (6.22e-2)"										"unprognostic (7.77e-2)"	"unprognostic (8.56e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FKRP	"FKTR, LGMD2I, MDC1C"	ENSG00000181027	"Fukutin related protein"	Q9H9S5	19	46746046-46776988	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Transferase	"Cardiomyopathy, Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043115, HPA060454"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Secreted to blood"	NA	NA			"Nucleoplasm, Golgi apparatus, Cytosol"		"HPA043115: AB_2678324, HPA060454: AB_2684281"	"unprognostic (4.44e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.19e-2)"	"unprognostic (8.37e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.85e-1)"	"unprognostic (2.99e-2)"	"unprognostic (4.59e-3)"	"prognostic favorable (8.98e-4)"	"unprognostic (3.53e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.53e-2)"	10.0	9.2	8.5	8.2	8.1	8.9	10.0	4.0	11.7	11.4	4.0	11.9	4.8	15.4	5.0	8.9	12.7	6.0	14.8	8.6	9.9	11.4	12.0	10.5	7.5	10.3	7.2	8.9	12.8	11.2	7.5	16.9	10.2	9.0	13.6	4.3	5.8	11.2	7.5	19.8	7.1	10.6	5.9	4.6	14.9	11.0	9.4	8.5	5.7	13.7	9.9	4.9	13.1	10.6	9.7	12.7	26.5	17.8	12.5	15.4	16.9	15.8	31.7	21.0	12.6	19.9	17.0	21.4	11.7	17.0	18.2	20.9	13.0	6.6	14.8	11.5	21.9	22.2	11.7	14.4	10.7	13.3	9.3	19.8	19.4	12.5	15.6	15.2	14.6	16.7	6.0	12.2	11.0	12.7	5.8	6.8	22.8	17.2	7.8	6.5	18.3	11.1	4.0	8.0	26.4	12.0	23.1	15.8	7.6	10.6	11.7	8.9	7.3	16.8	18.4	19.8	6.7	25.7	11.6	15.4	11.0	15.0	7.5	25.6	1.3	1.8	0.8	1.5	1.0	0.9	1.7	1.1	1.7	1.1	2.4	1.2	1.6	2.2	2.0	1.1	1.9	0.6	1.2	8.5	8.1	4.0	11.7	8.6	9.9	10.3	7.2	8.9	9.0	4.6	8.5	9.7	4.7	9.6	7.4	6.8	3.9	0.8	4.8	3.0	1.2	9.8	5.3	5.2	15.5	4.3	5.6	5.5	6.2	9.6	9.1	4.5	5.9	4.2	12.0	7.9	7.3	6.0	7.8	7.8	6.8	2.4	5.9	6.6	3.6	5.1	1.3	6.7	11.4	16.6	7.6	3.3	8.2	4.2	2.0	10.0	1.2	13.2	5.6	4.3	5.4	3.7	6.1	7.8	2.1	8.0	6.2	4.1	4.7	4.1	3.6	4.3	4.2	8.2	9.7	11.0	6.6	7.2	7.0	12.2	4.0	2.4	1.6	18.7	4.3	4.5	4.0	4.3
FRA10AC1	C10orf4	ENSG00000148690	"FRA10A associated CGG repeat 1"	Q70Z53	10	93667883-93702592	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 151.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039204	Approved					NA	NA					"HPA039204: AB_10794426"	"unprognostic (3.21e-3)"	"unprognostic (1.61e-1)"	"unprognostic (5.03e-2)"	"unprognostic (9.91e-2)"	"unprognostic (9.24e-2)"	"unprognostic (8.30e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.89e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.13e-1)"	9.3	8.7	21.4	6.4	22.7	7.1	8.7	22.4	24.1	10.2	16.8	8.8	5.9	10.8	8.5	6.6	10.2	5.3	11.8	20.6	21.0	8.5	8.4	6.4	8.3	21.5	21.3	19.2	12.3	10.4	8.4	10.3	6.0	22.1	9.1	6.4	12.4	12.5	7.5	12.3	9.9	6.7	6.8	21.6	7.3	7.9	10.6	21.4	7.4	9.2	12.8	7.4	8.9	8.6	23.3	15.9	11.6	10.7	29.4	14.3	17.1	6.9	13.4	9.5	7.3	8.4	5.3	12.9	11.9	9.7	8.9	11.6	19.1	13.0	10.0	11.5	22.4	14.4	8.9	9.0	12.0	20.1	17.5	5.8	11.7	5.9	7.9	18.8	23.1	15.3	13.6	13.0	14.3	13.1	7.6	16.2	17.9	8.5	8.3	11.1	10.6	13.4	5.1	8.8	5.5	10.5	10.0	6.8	6.1	28.1	11.1	24.2	14.2	15.9	5.3	9.5	4.4	15.6	11.5	16.2	11.6	13.5	28.4	3.9	4.7	2.7	5.6	4.4	3.1	6.0	5.7	6.5	5.9	2.2	6.3	7.8	6.7	2.0	4.0	4.1	3.6	5.5	1.4	21.4	22.7	22.4	24.1	20.6	21.0	21.5	21.3	19.2	22.1	21.6	21.4	23.3	39.6	16.0	45.4	28.1	25.5	20.6	29.6	37.7	32.5	36.2	24.1	43.6	109.7	34.3	28.9	14.7	22.9	29.0	18.7	13.4	37.2	35.2	75.8	29.0	35.8	35.1	43.0	24.6	44.2	43.7	21.0	37.1	21.4	24.6	25.3	34.5	29.6	77.1	19.6	50.5	45.6	51.7	20.3	20.0	14.6	26.2	30.7	18.4	16.0	34.7	26.9	47.9	29.9	44.7	48.2	36.0	16.1	28.2	19.0	32.5	14.8	43.1	23.7	33.0	13.1	57.2	43.0	151.3	69.0	20.3	22.3	14.1	23.1	33.6	25.3	21.8
GBX1		ENSG00000164900	"Gastrulation brain homeobox 1"	Q14549	7	151148589-151174745	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"skeletal muscle: 13.0;testis: 5.2"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"cervical cancer: 1.0"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HMC-1: 1.5"	"Region enhanced"	"Detected in some"		"basal ganglia: 3.3"	"Low region specificity"	"Detected in single"			HPA055783	Approved					NA	NA					"HPA055783: AB_2682919"		"unprognostic (4.24e-2)"			"unprognostic (3.87e-2)"			"unprognostic (3.58e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.95e-1)"				"unprognostic (1.87e-1)"	"unprognostic (1.91e-1)"		"unprognostic (3.14e-1)"	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.0	1.0	0.0	0.0	5.2	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.5	0.2	0.7	0.9	0.0	0.2	0.3	1.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GDF9		ENSG00000164404	"Growth differentiation factor 9"	O60383	5	132861181-132866884	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Cytokine, Growth factor"	"Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 9.0"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 19.9;Late spermatids: 5.2;Spermatocytes: 15.2"	"Cancer enriched"	"Detected in some"	5	"breast cancer: 2.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 3.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA069146	Supported		Approved	"Golgi apparatus,Cytosol"	"Secreted in female reproductive system"	NA	NA			"Golgi apparatus"	Cytosol	"HPA069146: AB_2686094"	"unprognostic (4.64e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.61e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.70e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.75e-3)"	"unprognostic (3.10e-2)"	0.3	0.6	1.5	0.2	1.5	0.3	0.8	1.4	2.0	0.4	0.9	0.3	0.4	0.3	4.1	0.3	0.8	0.2	0.3	1.4	1.4	1.0	0.7	0.3	0.5	1.4	1.5	1.3	0.5	1.0	0.7	1.7	0.2	1.4	0.6	0.3	1.3	0.8	0.5	0.7	1.1	0.4	0.2	1.4	0.4	1.0	9.0	1.3	0.7	1.0	0.7	0.4	0.6	0.3	1.5	0.2	0.1	0.5	1.1	0.7	0.3	0.1	0.0	0.1	0.1	0.1	0.3	0.8	0.2	0.6	0.1	0.9	0.2	0.4	0.4	0.1	0.4	0.7	0.5	0.5	0.1	0.1	0.1	0.0	0.3	0.6	0.0	0.3	0.1	0.0	3.9	0.0	1.2	0.2	0.2	0.7	0.8	0.2	0.1	0.0	0.6	0.0	0.2	0.3	0.2	1.0	0.9	0.2	0.1	0.5	0.7	0.5	0.1	0.1	0.9	0.4	0.2	0.1	1.3	1.7	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	1.5	1.4	2.0	1.4	1.4	1.4	1.5	1.3	1.4	1.4	1.3	1.5	0.9	0.0	0.0	1.6	0.1	0.1	0.4	0.1	0.0	0.4	1.9	2.2	0.6	0.0	0.1	0.0	4.2	0.4	0.3	0.7	3.9	0.1	19.9	1.4	0.9	0.5	0.0	0.0	0.5	0.2	0.3	0.4	0.0	1.9	0.0	0.5	0.4	0.2	0.1	0.0	0.8	0.9	0.0	0.3	0.0	5.2	0.6	0.5	0.0	0.0	0.0	1.0	0.0	2.0	0.9	0.1	0.1	0.4	0.1	0.6	0.3	0.4	0.6	1.0	0.0	1.6	0.8	15.2	2.5	1.1	0.1	0.7	0.2	0.2	0.5	0.2
GEMIN4	"DKFZP434B131, DKFZP434D174, HC56, HCAP1, HHRF-1, p97"	ENSG00000179409	"Gem nuclear organelle associated protein 4"	P57678	17	744421-753999	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 148.3;Late spermatids: 157.2;Spermatocytes: 57.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065699, HPA067891"	Uncertain		Supported	"Nuclear bodies,Cytosol"		NA	NA			"Nuclear bodies, Cytosol"		"HPA065699: AB_2685534, HPA067891: AB_2685918"	"unprognostic (1.85e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.60e-1)"	"unprognostic (7.41e-3)"	"unprognostic (2.00e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.89e-2)"	"unprognostic (8.67e-3)"	"unprognostic (4.65e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.74e-2)"	"unprognostic (8.56e-3)"	12.3	7.7	2.9	8.2	3.0	15.7	12.4	10.1	6.4	13.0	5.0	9.3	8.1	12.2	5.7	14.9	12.4	13.2	9.9	2.8	3.0	4.8	8.7	9.9	13.7	2.5	2.7	3.0	15.8	9.8	6.3	5.7	6.7	5.2	14.5	6.4	3.5	11.8	8.2	14.0	39.2	9.8	8.6	2.1	10.1	14.6	49.2	2.6	13.3	15.7	10.2	12.4	11.9	12.5	2.6	44.8	77.8	25.5	38.3	15.8	19.9	31.7	25.0	17.4	44.4	39.1	44.5	23.6	77.9	32.5	21.6	23.6	55.4	48.3	47.0	35.3	29.6	72.3	28.0	40.9	25.1	11.3	30.1	36.8	19.3	23.3	36.5	25.6	15.4	25.3	44.9	39.6	31.7	24.0	31.7	49.8	17.0	24.7	37.4	33.0	53.1	12.1	36.6	18.9	32.5	26.4	21.4	25.7	26.1	11.7	18.2	27.8	21.7	20.2	27.3	24.6	35.6	61.4	5.3	12.4	44.8	23.5	41.9	31.8	1.6	7.0	0.3	7.9	9.6	13.6	11.8	8.6	8.4	9.3	12.3	10.1	10.2	0.9	8.7	11.6	5.2	6.0	10.0	2.9	3.0	10.1	6.4	2.8	3.0	2.5	2.7	3.0	5.2	2.1	2.6	2.6	2.9	16.0	6.7	1.3	8.5	20.4	14.3	6.6	9.1	2.9	4.6	4.7	38.4	4.3	8.5	0.0	0.0	8.4	4.4	3.1	3.9	7.5	148.3	2.6	3.9	5.8	1.2	3.0	1.2	6.4	8.3	6.4	7.7	2.9	1.3	11.1	4.6	5.2	5.4	5.0	1.5	7.0	8.2	3.9	5.7	157.2	11.5	2.6	5.4	1.0	4.8	2.4	2.1	0.0	0.5	8.4	1.8	6.8	4.3	7.4	2.3	2.2	4.4	1.4	0.0	6.2	6.4	57.0	11.2	8.7	16.1	4.0	3.2	7.4	8.7	9.8
GFY	Goofy	ENSG00000261949	"Golgi associated olfactory signaling regulator"	I3L273	19	49423749-49428987	"Predicted membrane proteins"	"Olfaction, Sensory transduction"			"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 1.1;testis: 1.3"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"testis cancer: 1.0"	"Region enhanced"	"Detected in single"		"cerebellum: 1.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HEK 293: 1.8;SCLC-21H: 4.0;T-47d: 1.1;U-266/84: 2.7"	"Region enriched"	"Detected in single"	13	"olfactory bulb: 1.4"	"Region enriched"	"Detected in some"	6	"cerebellum: 6.6"							NA	NA						"unprognostic (8.04e-2)"	"unprognostic (8.21e-2)"		"unprognostic (1.16e-1)"	"unprognostic (2.43e-1)"	"unprognostic (4.50e-2)"		"unprognostic (8.99e-2)"		"unprognostic (8.85e-2)"				"unprognostic (1.42e-1)"	"unprognostic (1.82e-1)"		"unprognostic (9.62e-3)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.1	0.5	0.2	0.0	0.3	0.1	0.1	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GGA1		ENSG00000100083	"Golgi associated, gamma adaptin ear containing, ARF binding protein 1"	Q9UJY5	22	37608725-37633564	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 180.7"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 221.2;Spermatocytes: 193.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048280, HPA051016"	Supported		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA048280: AB_2680338, HPA051016: AB_2681312"	"unprognostic (1.64e-1)"	"unprognostic (1.42e-2)"	"unprognostic (4.08e-1)"	"unprognostic (9.23e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (6.29e-4)"	"unprognostic (2.32e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (4.86e-4)"	"unprognostic (1.42e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.16e-3)"	25.2	49.7	34.5	23.5	36.5	37.5	27.5	36.4	42.6	38.2	37.3	34.5	24.5	32.4	21.7	41.4	37.7	20.6	27.7	33.0	33.0	40.1	42.4	34.0	29.4	38.6	35.2	30.6	46.7	34.8	33.4	53.1	19.2	40.8	40.4	18.0	23.0	35.2	19.8	43.5	35.4	41.0	17.0	35.0	56.1	35.2	180.7	35.9	27.1	45.0	24.8	21.2	31.9	33.7	42.4	37.4	28.3	32.9	31.1	28.0	23.0	35.4	30.8	25.0	27.0	29.6	23.3	21.8	59.9	20.6	22.9	17.0	35.0	29.4	35.6	24.8	51.0	53.6	24.0	52.3	27.3	28.1	56.1	42.6	28.4	31.3	38.9	24.2	45.1	26.5	30.3	48.0	36.8	27.8	37.7	24.8	64.2	26.2	39.2	28.7	28.5	25.8	25.2	28.8	31.0	30.4	54.0	18.7	39.0	48.9	31.3	42.4	42.0	31.0	36.8	35.2	32.1	24.4	81.1	35.3	62.5	39.9	33.6	30.8	8.1	10.7	6.1	18.0	10.2	22.1	8.3	7.2	23.3	6.7	5.0	5.1	16.5	4.5	11.6	7.9	5.8	8.0	11.5	34.5	36.5	36.4	42.6	33.0	33.0	38.6	35.2	30.6	40.8	35.0	35.9	42.4	17.9	25.6	38.5	26.8	50.9	24.2	31.1	36.5	21.1	57.6	26.5	20.8	19.2	20.0	34.5	44.1	83.4	38.8	34.7	67.3	5.9	34.9	148.2	27.6	19.8	32.6	32.4	38.3	18.4	20.1	37.4	18.8	44.4	26.5	49.4	33.3	40.7	20.4	77.1	25.2	19.3	40.4	32.6	66.9	40.3	221.2	26.4	50.5	16.0	20.6	47.9	37.0	73.2	16.6	28.7	36.6	51.6	22.6	24.4	24.7	55.4	13.2	46.7	74.1	26.3	26.9	22.1	193.4	50.4	19.7	28.6	56.8	59.6	44.4	42.8	33.6
GGNBP2	"DIF-3, DIF3, FLJ21230, FLJ22561, LZK1, ZFP403, ZNF403"	ENSG00000278311	"Gametogenetin binding protein 2"	Q9H3C7	17	36544912-36589848	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 467.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018914, HPA073392"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA018914: AB_2294667, HPA073392: AB_2686599"	"unprognostic (2.68e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.41e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.88e-3)"	"unprognostic (2.83e-1)"	"unprognostic (7.29e-2)"	"unprognostic (3.29e-2)"	"unprognostic (3.82e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.28e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.95e-2)"	39.4	30.8	25.7	29.8	26.1	80.6	35.6	28.2	30.3	32.4	26.9	39.1	34.1	34.3	26.9	34.2	35.0	25.4	30.7	25.6	27.2	31.5	36.9	33.7	50.2	26.5	27.2	24.0	40.3	35.6	31.8	26.9	27.3	27.6	28.1	31.0	27.0	33.5	24.2	53.1	40.4	44.4	27.8	25.9	39.7	35.1	60.6	26.2	36.9	29.7	32.5	46.9	37.5	35.0	27.8	48.0	49.4	45.8	38.9	53.5	63.9	33.0	60.0	48.1	44.4	44.2	48.6	34.5	64.5	37.2	47.7	44.4	46.9	37.2	55.6	58.1	38.9	36.1	36.2	55.1	43.7	55.1	63.1	47.1	62.3	68.4	45.2	61.4	56.6	38.9	46.2	51.2	62.0	62.5	29.5	65.6	51.2	13.9	31.0	26.1	44.3	60.9	42.8	58.6	93.2	37.1	32.3	58.1	33.5	97.1	46.2	63.0	64.2	39.9	62.4	43.0	41.5	62.4	42.2	50.0	48.7	40.9	34.6	38.6	42.8	31.6	67.8	37.1	35.9	43.6	56.6	46.9	41.5	42.0	48.5	66.0	62.0	44.9	40.4	39.9	84.1	50.1	20.8	25.7	26.1	28.2	30.3	25.6	27.2	26.5	27.2	24.0	27.6	25.9	26.2	27.8	85.0	67.3	84.2	38.5	110.2	96.0	98.9	128.8	111.5	70.2	58.9	46.9	81.1	60.1	118.6	31.3	37.5	82.4	132.3	94.7	52.8	74.0	467.4	87.3	84.2	82.2	57.4	71.1	46.9	68.5	77.4	86.6	56.1	104.3	97.5	52.2	65.0	64.7	73.5	57.2	43.3	79.6	101.7	77.9	66.7	130.6	79.6	84.7	58.7	33.7	103.0	71.8	94.7	29.1	48.6	73.2	74.2	72.2	84.4	83.9	124.9	63.6	107.0	71.5	59.2	99.0	114.9	335.2	98.7	91.9	96.5	95.6	117.8	53.5	97.4	102.4
GGTLC2	GGTL4	ENSG00000100121	"Gamma-glutamyltransferase light chain 2"	Q14390	22	22644475-22647903	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"testis: 18.2"	"Group enriched"	"Detected in some"	14	"Alveolar cells type 1: 22.4;Early spermatids: 24.6;Late spermatids: 28.4;Spermatocytes: 14.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 1.6;U-2 OS: 3.3"									"HPA045635, HPA047534"	Uncertain					NA	NA					"HPA045635: AB_2679400, HPA047534: AB_2680079"				"unprognostic (2.58e-2)"			"unprognostic (2.35e-2)"	"unprognostic (7.17e-2)"		"unprognostic (2.96e-1)"	"unprognostic (4.31e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.48e-2)"		"unprognostic (1.55e-1)"		0.1	0.0	0.0	0.0	0.2	0.0	0.1	1.0	0.2	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.1	0.5	0.1	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	18.2	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	1.6	0.5	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.9	0.0	0.0	3.3	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.2	0.2	0.1	0.1	0.0	0.0	0.4	0.0	0.2	0.4	0.0	22.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	24.6	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	28.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	14.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GJA8	"CAE, CAE1, CX50, CZP1"	ENSG00000121634	"Gap junction protein alpha 8"	P48165	1	147902795-147909269	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	46	"testis: 5.9"	"Group enriched"	"Detected in some"	4	"Early spermatids: 14.6;Spermatocytes: 39.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA014715, HPA062940"	Enhanced					NA	NA					"HPA014715: AB_2732411, HPA062940: AB_2732693"										"unprognostic (3.73e-2)"					"unprognostic (2.35e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GK2	"GKP2, GKTA"	ENSG00000196475	"Glycerol kinase 2"	Q14410	4	79406361-79408228	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Glycerol metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	301	"testis: 90.3"	"Group enriched"	"Detected in some"	92	"Early spermatids: 589.0;Late spermatids: 163.3;Spermatocytes: 194.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	40	"SCLC-21H: 3.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA060687	Uncertain					NA	NA					"HPA060687: AB_2684343"															"unprognostic (1.31e-1)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	90.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.2	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	589.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	163.3	3.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	194.7	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GKAP1	"FKSG21, GKAP42"	ENSG00000165113	"G kinase anchoring protein 1"	Q5VSY0	9	83739425-83829516	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"skeletal muscle: 50.5;testis: 201.3"	"Group enriched"	"Detected in all"	6	"Early spermatids: 1339.6;Late spermatids: 481.5;Spermatocytes: 642.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/84: 34.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035117, HPA035118, HPA066173"	Enhanced	Supported	Approved	"Centriolar satellite,Cytosol"		NA	NA			"Centriolar satellite, Cytosol"		"HPA035117: AB_2674473, HPA035118: AB_10671100, HPA066173: AB_2732740"	"unprognostic (1.91e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.52e-3)"	"unprognostic (7.66e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.86e-2)"	"prognostic favorable (6.96e-5)"	"unprognostic (4.18e-1)"	"prognostic favorable (1.05e-6)"	"unprognostic (9.73e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.24e-3)"	7.9	6.4	21.3	2.7	20.4	4.0	6.2	27.5	23.7	7.3	24.8	9.4	4.4	8.9	6.7	3.8	8.3	5.0	13.8	19.0	20.6	6.7	9.5	4.2	4.0	21.3	19.8	16.9	13.0	8.5	10.3	12.6	2.4	21.5	8.9	3.6	22.7	5.2	9.1	50.5	2.0	5.4	6.2	20.5	4.1	7.7	201.3	21.0	9.2	10.0	26.7	3.9	7.9	4.7	26.0	7.2	8.4	6.0	8.0	0.8	0.0	9.0	2.6	2.1	4.1	4.2	1.1	3.7	10.8	2.7	1.2	13.7	1.4	6.0	0.7	7.0	13.2	5.6	6.4	4.1	6.2	8.7	2.9	0.6	0.2	4.8	2.1	2.2	11.9	3.8	10.2	5.3	8.6	1.2	6.6	16.1	9.8	5.1	3.3	4.9	10.9	13.7	3.7	4.3	1.1	20.3	11.9	6.0	2.7	4.8	9.2	1.2	5.8	1.3	1.4	10.0	0.9	4.7	14.6	34.5	4.3	3.0	2.0	1.6	1.2	0.2	0.2	0.5	0.0	0.5	0.7	0.5	0.5	0.2	0.6	0.3	0.7	1.1	2.0	0.1	0.1	0.6	0.0	21.3	20.4	27.5	23.7	19.0	20.6	21.3	19.8	16.9	21.5	20.5	21.0	26.0	14.2	6.4	11.2	32.0	17.9	7.0	14.7	2.7	2.8	54.1	21.1	17.3	51.7	20.0	2.6	14.7	45.9	8.8	13.1	5.4	13.7	13.4	1339.6	18.4	5.4	12.6	13.1	14.3	19.7	6.6	2.9	8.6	5.1	13.6	2.5	28.9	10.0	21.3	4.1	121.1	32.6	10.8	4.1	4.4	6.2	481.5	26.4	7.7	10.6	27.2	2.3	51.1	8.2	36.2	42.0	4.9	7.4	21.4	15.0	17.5	9.0	14.3	5.4	85.2	26.3	32.0	11.0	642.9	79.4	4.2	4.5	2.9	13.7	15.4	12.2	8.9
GLB1L	MGC10771	ENSG00000163521	"Galactosidase beta 1 like"	Q6UWU2	2	219236598-219245478	"Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 52.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 41.5;Spermatocytes: 117.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 19.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA043058	Enhanced				"Secreted - unknown location"	NA	NA					"HPA043058: AB_10806375"	"unprognostic (4.30e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.08e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.67e-3)"	"unprognostic (3.32e-2)"	"unprognostic (4.77e-1)"	"unprognostic (2.39e-1)"	"unprognostic (8.48e-3)"	"unprognostic (3.27e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.23e-3)"	"unprognostic (1.33e-1)"	"unprognostic (8.50e-2)"	4.5	4.9	4.2	4.1	3.1	4.5	5.3	3.1	2.8	5.3	12.1	3.1	3.1	6.0	11.5	2.5	23.3	9.1	2.2	2.6	7.1	13.7	3.2	5.4	3.0	4.8	5.4	2.2	7.2	3.1	14.5	6.8	8.6	4.7	5.6	3.7	8.0	4.5	4.8	0.9	4.7	4.2	5.9	4.8	4.9	2.9	52.8	3.2	3.4	8.5	1.0	3.4	6.0	2.2	4.9	2.8	4.8	7.4	5.9	8.0	9.8	3.7	4.6	9.7	5.7	5.3	1.9	7.7	0.9	4.1	4.1	4.3	1.5	1.9	4.6	4.5	2.6	3.6	2.9	6.9	4.5	19.7	1.1	4.4	11.4	2.9	5.4	3.3	13.5	5.3	4.3	1.8	5.3	5.4	4.0	2.5	2.7	1.3	1.0	1.3	2.5	4.1	4.0	11.5	1.6	4.7	4.2	3.9	5.3	4.3	4.9	8.4	2.6	4.1	4.7	5.8	2.8	2.6	5.0	1.7	1.5	8.8	1.2	12.3	1.9	5.1	0.3	0.7	6.4	0.4	0.4	0.5	0.7	2.1	1.0	1.1	0.7	2.1	1.0	5.4	0.9	0.2	1.7	4.2	3.1	3.1	2.8	2.6	7.1	4.8	5.4	2.2	4.7	4.8	3.2	4.9	3.2	3.2	5.1	3.3	1.3	1.8	2.6	3.6	0.6	4.7	4.9	5.6	1.9	1.5	6.3	3.7	12.5	3.4	1.9	1.1	3.9	3.8	41.5	15.7	3.9	4.2	4.9	1.3	0.9	1.8	2.2	8.4	1.1	2.2	0.0	2.7	8.6	1.3	14.5	3.3	1.1	3.2	2.0	5.6	2.4	25.6	10.8	4.4	8.8	1.9	2.7	5.0	3.1	1.0	0.5	2.1	3.3	6.4	1.8	2.7	6.5	16.5	23.9	10.2	6.6	3.8	2.2	117.4	9.7	1.8	1.7	1.4	2.0	7.0	2.4	1.7
GLE1	"GLE1L, hGLE1, LCCS1"	ENSG00000119392	"GLE1 RNA export mediator"	Q53GS7	9	128504719-128542288	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 77.0;Late spermatids: 58.1;Spermatocytes: 51.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041689, HPA043538, HPA061560"	Supported		Supported	"Nuclear membrane,Nucleoli"		NA	NA			"Nuclear membrane"	Nucleoli	"HPA041689: AB_2677617, HPA043538: AB_2678539, HPA061560: AB_2684560"	"unprognostic (8.74e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (7.49e-4)"	"unprognostic (1.75e-1)"	"unprognostic (5.58e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.95e-2)"	"unprognostic (4.00e-2)"	"prognostic favorable (7.04e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.99e-3)"	"unprognostic (5.64e-2)"	11.1	14.1	9.7	15.9	9.4	15.2	15.9	12.8	11.4	13.1	12.9	17.6	16.3	11.7	10.9	16.6	14.3	7.8	15.0	9.1	9.9	14.3	16.4	12.4	20.6	9.0	9.2	9.2	16.3	9.6	17.8	14.2	9.3	10.5	11.9	18.5	16.6	11.2	12.5	22.7	19.2	15.9	13.0	9.0	15.3	13.1	32.3	9.6	26.1	13.4	12.5	22.4	12.9	12.4	9.2	29.6	54.5	26.2	44.9	25.3	25.5	34.6	29.2	24.9	40.2	28.4	36.8	20.1	59.6	23.0	33.0	38.6	101.4	45.9	41.7	34.5	56.9	29.8	30.6	57.8	34.6	28.5	49.9	38.8	18.1	39.7	45.6	48.5	22.3	22.9	54.7	44.7	51.0	46.7	68.6	49.5	35.2	22.2	79.1	46.7	49.8	64.2	79.0	27.3	26.1	30.9	23.1	71.3	42.7	25.9	21.1	78.9	34.9	17.0	42.5	28.1	50.2	41.2	50.9	131.9	45.9	39.9	37.5	46.8	40.0	21.1	24.4	22.1	26.0	18.1	13.4	17.2	20.0	22.1	20.5	15.2	17.7	18.0	27.4	27.5	13.0	22.3	19.8	9.7	9.4	12.8	11.4	9.1	9.9	9.0	9.2	9.2	10.5	9.0	9.6	9.2	4.0	9.6	9.0	11.1	11.4	6.5	5.3	10.4	8.6	7.6	8.8	7.6	13.0	5.7	7.2	7.3	8.4	16.1	6.9	13.2	5.9	11.7	77.0	12.2	7.4	3.6	5.4	12.0	14.0	6.2	11.7	7.6	10.2	9.4	9.5	10.9	4.6	14.2	15.7	10.1	15.5	12.7	8.2	15.1	5.7	58.1	10.2	13.5	3.6	10.3	20.0	8.9	15.5	18.1	15.5	8.3	8.0	6.4	13.4	6.1	16.3	13.7	12.6	8.6	13.1	7.7	7.3	51.3	25.5	14.4	6.8	13.3	12.1	7.1	14.1	5.4
GLIPR1L1	MGC26856	ENSG00000173401	"GLIPR1 like 1"	Q6UWM5	12	75334670-75370560	"Predicted intracellular proteins, Predicted secreted proteins"	Fertilization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 34.0"	"Group enriched"	"Detected in some"	7	"Early spermatids: 226.7;Spermatocytes: 179.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"NTERA-2: 109.1"					"Low region specificity"	"Detected in many"			HPA042095	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA042095: AB_10796898"	"unprognostic (2.45e-3)"	"unprognostic (1.56e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.47e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.70e-1)"	"unprognostic (4.79e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.89e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.08e-1)"	"unprognostic (9.13e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.11e-2)"	0.2	0.9	0.3	0.1	1.5	0.3	0.1	3.5	1.1	0.1	0.3	0.1	0.2	0.5	0.0	0.8	0.2	0.8	1.4	0.3	1.3	0.6	0.1	0.4	0.4	1.4	1.1	0.1	0.6	0.2	0.0	0.5	0.0	1.4	0.3	0.0	1.1	0.6	0.0	0.5	1.1	0.3	0.0	0.6	0.4	0.3	34.0	1.9	0.0	0.3	0.0	0.0	0.2	0.1	1.7	0.5	0.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.9	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.2	109.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.7	0.3	0.0	0.0	0.2	14.5	0.1	0.2	0.0	0.4	0.2	0.2	0.1	0.2	0.0	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.3	1.5	3.5	1.1	0.3	1.3	1.4	1.1	0.1	1.4	0.6	1.9	1.7	0.1	0.0	0.0	2.6	0.0	0.0	0.1	0.0	0.6	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	226.7	0.1	0.3	0.5	0.0	0.0	4.4	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	28.3	5.3	0.3	0.0	1.9	0.0	0.3	0.0	5.0	5.1	0.0	0.0	2.6	0.0	0.0	0.0	0.3	0.0	0.3	6.6	0.2	0.2	179.3	2.2	0.1	0.0	0.0	0.2	0.2	0.0	0.0
GLIPR1L2	MGC39497	ENSG00000180481	"GLIPR1 like 2"	Q4G1C9	12	75391089-75432688	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"testis: 47.2"	"Group enriched"	"Detected in many"	7	"Early spermatids: 254.0;Spermatocytes: 306.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"Hep G2: 4.2;SK-BR-3: 5.6;U-2 OS: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA039795, HPA039866"	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	Vesicles	"HPA039795: AB_10805595, HPA039866: AB_10795235"	"unprognostic (1.23e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.27e-1)"	"unprognostic (7.74e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.78e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.82e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.91e-2)"	"unprognostic (2.57e-2)"	1.0	2.7	5.3	0.8	5.4	0.3	2.4	6.6	6.1	1.9	2.7	0.7	0.6	2.3	3.7	1.0	3.1	1.0	2.3	5.5	5.0	2.0	1.5	1.2	0.7	4.6	4.9	5.1	7.1	2.6	4.1	2.6	0.9	5.3	1.5	0.4	3.0	1.0	3.0	2.3	1.9	0.8	1.1	4.0	1.6	0.7	47.2	4.7	1.3	2.4	1.6	0.4	0.9	0.9	6.5	0.2	0.4	0.2	0.4	2.9	1.6	0.5	0.4	0.3	0.1	0.2	0.1	0.3	0.2	1.0	0.3	0.7	0.1	0.0	0.1	0.3	0.6	0.2	0.1	0.6	4.2	2.1	0.4	0.0	0.5	0.9	0.4	1.5	2.5	0.1	0.1	0.2	0.5	0.8	0.1	0.4	0.3	0.1	0.9	0.1	0.1	0.0	0.2	0.0	0.3	0.7	0.3	0.5	5.6	1.7	0.2	1.7	0.1	0.8	0.6	7.6	0.9	0.3	0.7	0.7	0.2	0.2	0.2	0.5	0.7	0.0	0.1	0.3	0.0	0.1	0.3	0.3	0.5	0.1	0.3	0.5	0.9	0.6	0.3	0.1	0.7	1.0	0.2	5.3	5.4	6.6	6.1	5.5	5.0	4.6	4.9	5.1	5.3	4.0	4.7	6.5	1.5	0.0	3.1	15.0	0.3	0.9	4.6	1.7	3.4	5.6	2.9	3.0	4.0	1.5	1.8	0.0	0.0	1.7	1.5	0.1	9.8	0.6	254.0	4.9	1.4	1.5	0.0	0.4	7.4	0.0	0.2	3.0	1.1	0.5	1.3	1.4	0.0	0.2	0.6	1.7	13.3	0.1	0.0	0.3	0.3	39.0	7.5	0.7	0.0	10.3	0.0	6.7	0.0	27.2	28.1	0.1	0.0	5.7	0.1	1.2	0.1	1.4	14.1	2.0	6.6	5.6	1.9	306.8	19.4	0.3	0.4	0.4	0.6	2.1	0.3	2.1
GLT8D1	"AD-017, FLJ14611"	ENSG00000016864	"Glycosyltransferase 8 domain containing 1"	Q68CQ7	3	52694486-52706032	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 149.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010588	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA010588: AB_1078098"	"unprognostic (1.37e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.38e-2)"	"prognostic favorable (2.76e-4)"	"unprognostic (3.17e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.82e-3)"	"unprognostic (7.12e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.82e-3)"	"unprognostic (2.42e-3)"	"unprognostic (3.97e-1)"	"unprognostic (3.34e-2)"	"unprognostic (6.21e-2)"	31.7	40.1	27.0	22.7	26.9	9.3	36.0	26.4	29.5	47.9	34.5	28.0	26.1	35.4	41.6	18.5	54.8	30.0	31.1	27.3	28.5	40.8	70.1	29.9	25.5	25.7	26.3	26.1	54.3	36.0	46.4	65.3	48.7	25.9	30.8	32.7	32.5	30.2	33.0	21.0	22.1	23.6	32.5	26.4	24.8	29.1	65.1	26.1	29.5	64.6	24.9	27.1	31.9	28.8	29.7	28.7	33.2	65.7	52.0	142.6	179.8	36.8	70.3	107.8	60.6	69.1	15.5	52.6	24.0	19.7	122.7	73.3	31.9	42.1	72.0	79.5	43.5	30.6	22.8	61.4	71.7	68.3	34.0	68.5	104.1	62.9	52.1	66.8	139.8	91.3	40.6	29.4	53.6	80.6	29.2	23.4	51.8	33.8	49.8	61.5	17.4	37.3	81.9	71.3	30.8	26.9	46.5	58.6	27.9	48.9	61.2	47.7	44.2	67.1	43.7	33.9	63.9	39.6	60.2	73.7	26.4	76.0	53.2	56.2	38.4	13.0	21.8	19.1	8.5	18.3	14.1	22.2	20.0	11.8	9.8	22.3	15.6	6.9	30.3	9.3	23.1	16.8	10.9	27.0	26.9	26.4	29.5	27.3	28.5	25.7	26.3	26.1	25.9	26.4	26.1	29.7	25.8	0.0	9.6	16.0	16.0	12.1	16.1	40.3	13.6	41.5	18.1	19.7	15.3	17.2	23.8	18.4	12.5	58.4	26.5	9.4	23.5	34.4	71.4	38.5	38.4	22.7	18.6	8.6	17.9	27.1	63.5	59.2	14.8	15.2	5.7	35.6	34.2	38.2	26.9	21.9	16.8	21.1	30.5	13.6	12.0	23.0	53.7	12.3	24.9	8.4	26.5	37.0	34.0	15.6	14.6	23.3	16.9	48.5	39.1	14.7	22.8	21.5	44.4	21.3	26.3	31.6	25.2	149.5	50.0	10.3	8.0	26.1	21.4	74.2	17.3	10.0
GOLGA8F	DKFZp434P162	ENSG00000153684	"Golgin A8 family member F"	Q08AF8	15	28378621-28392018	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in single"	203	"testis: 20.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 1.7;Spermatocytes: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"NB-4: 2.1"															NA	NA																			"unprognostic (4.96e-2)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GOLGA8G	DKFZp434K052	ENSG00000183629	"Golgin A8 family member G"		15	28519611-28533014	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in single"	92	"testis: 9.2"	"Group enriched"	"Detected in some"	14	"Early spermatids: 11.8;Spermatocytes: 19.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																			"unprognostic (7.17e-2)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPANK1	"ANKRD59, BAT4, D6S54E, G5, GPATCH10"	ENSG00000204438	"G-patch domain and ankyrin repeats 1"	O95872	6	31661228-31666283	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 180.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006301	Approved		Approved	"Endoplasmic reticulum"		NA	Yes			"Endoplasmic reticulum"		"HPA006301: AB_1078267"	"unprognostic (2.03e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.81e-2)"	"prognostic favorable (5.89e-4)"	"unprognostic (2.29e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.51e-1)"	13.8	11.9	1.5	2.7	1.7	4.0	14.8	3.6	2.6	14.9	1.2	14.8	1.6	16.1	2.6	11.5	15.1	2.1	19.4	1.5	1.4	14.6	16.1	13.3	3.8	2.4	2.5	1.4	17.4	15.2	3.3	13.6	1.8	2.8	14.1	2.4	2.4	13.9	2.0	28.7	15.6	15.7	1.1	1.4	16.8	15.6	36.7	1.6	6.7	12.9	2.8	2.3	15.1	13.4	2.3	3.3	3.3	1.7	5.6	8.3	6.6	4.4	3.2	5.2	3.1	4.2	0.2	4.8	10.8	5.2	3.4	4.2	3.9	0.0	8.1	2.3	6.4	5.6	11.3	0.0	3.7	5.7	3.7	4.3	3.2	4.3	10.4	6.9	6.1	3.8	10.9	3.0	8.8	4.2	2.6	13.1	4.4	0.0	5.1	1.2	5.4	7.5	7.9	5.1	2.6	12.6	8.4	4.3	1.9	5.4	4.6	5.1	9.2	4.8	7.3	7.0	0.5	0.0	6.5	10.8	4.1	8.6	7.9	4.2	11.8	3.1	9.9	4.1	2.5	4.1	2.0	3.2	2.5	3.1	2.9	3.7	3.3	9.5	4.5	2.6	3.8	4.6	2.7	1.5	1.7	3.6	2.6	1.5	1.4	2.4	2.5	1.4	2.8	1.4	1.6	2.3	22.6	38.5	21.7	5.9	30.5	25.0	24.2	27.6	23.3	29.1	25.0	23.4	35.9	30.0	21.6	18.4	35.5	30.1	28.3	26.4	45.0	31.6	55.4	21.9	21.4	29.1	27.1	33.0	3.2	23.6	39.7	23.8	13.3	22.9	35.4	21.9	27.8	30.3	27.7	11.8	3.5	29.9	22.4	27.0	18.5	51.5	34.5	21.0	19.6	3.7	43.5	37.8	47.4	5.0	7.3	21.9	43.3	24.8	29.2	32.3	90.5	74.5	20.1	47.3	19.7	21.6	29.7	180.8	87.2	16.2	34.2	47.1	26.9	17.3	26.9	19.9
GPN3	"ATPBD1C, MGC14560"	ENSG00000111231	"GPN-loop GTPase 3"	Q9UHW5	12	110452486-110469268	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 187.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039764, HPA047793"	Uncertain		Approved	"Nuclear speckles,Cytosol"		Yes	No			"Nuclear speckles"	Cytosol	"HPA039764: AB_2676669, HPA047793: AB_2680157"	"unprognostic (1.68e-3)"	"unprognostic (1.11e-2)"	"unprognostic (9.82e-2)"	"unprognostic (4.96e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.27e-3)"	"prognostic unfavorable (3.98e-5)"	"unprognostic (5.50e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.56e-2)"	"prognostic favorable (2.65e-6)"	"unprognostic (5.81e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.27e-1)"	25.8	19.1	11.3	16.5	12.4	15.5	24.6	13.6	13.0	15.9	12.7	13.8	8.2	18.0	15.4	16.5	18.7	13.9	34.6	11.1	14.2	31.7	32.3	17.0	23.1	13.2	12.9	10.3	23.5	20.1	29.5	11.1	21.5	13.3	22.4	13.2	23.6	24.4	18.1	48.4	11.1	10.7	19.7	14.9	16.4	15.7	41.7	12.0	18.3	21.4	51.5	18.2	17.8	13.9	15.9	42.3	65.8	43.2	42.8	47.5	30.1	57.6	57.1	34.1	62.2	50.3	59.7	24.6	81.5	38.5	31.0	46.0	37.9	54.2	50.5	83.9	46.9	50.6	47.7	33.8	50.5	33.2	75.2	42.2	32.2	31.4	61.1	39.5	34.9	45.6	67.0	82.1	17.9	44.3	28.2	69.8	142.8	53.4	58.6	64.8	23.5	59.9	62.2	39.3	37.8	34.7	34.8	57.7	39.0	49.9	55.0	66.7	87.7	25.4	51.6	38.0	51.3	66.6	24.7	68.0	85.1	38.2	68.5	60.3	41.0	54.4	79.4	30.0	71.9	32.8	46.5	32.0	34.2	51.1	47.9	40.5	26.9	27.4	28.4	75.3	62.5	30.1	41.6	11.3	12.4	13.6	13.0	11.1	14.2	13.2	12.9	10.3	13.3	14.9	12.0	15.9	23.8	25.6	34.5	3.3	24.5	29.8	49.3	57.9	15.9	18.8	28.8	32.5	43.8	20.0	36.0	33.1	14.6	62.4	26.6	3.8	107.6	30.4	111.1	24.9	24.6	20.8	8.3	26.9	4.3	21.3	74.0	25.4	8.2	21.5	31.0	18.6	18.2	38.1	94.7	21.9	5.6	9.1	40.7	19.1	17.7	22.6	19.9	33.2	16.0	14.0	39.6	25.7	19.6	3.5	6.4	22.4	11.0	23.7	20.9	55.5	5.3	72.1	34.2	33.0	26.3	31.0	35.3	187.2	77.6	20.8	25.4	46.7	19.2	22.1	13.7	40.2
GPR150	PGR11	ENSG00000178015	"G protein-coupled receptor 150"	Q8NGU9	5	95620087-95622142	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.8;pancreas: 7.0"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 4.0;Extravillous trophoblasts: 5.3;granulocytes: 5.7;Hofbauer cells: 3.5;NK-cells: 2.1;Spermatocytes: 2.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 1.4;SiHa: 1.2;TIME: 2.7"					"Low region specificity"	"Detected in some"			HPA026635	Uncertain					NA	NA					"HPA026635: AB_1849266"	"unprognostic (3.03e-2)"	"unprognostic (6.88e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.01e-2)"	"unprognostic (5.95e-2)"	"unprognostic (5.34e-4)"	"unprognostic (1.98e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.23e-2)"	"unprognostic (4.42e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.26e-1)"	0.6	0.1	1.6	0.0	2.8	0.0	0.7	0.0	2.4	0.3	0.0	0.2	0.1	0.2	0.1	0.1	0.3	0.1	0.1	2.3	0.8	0.0	0.1	0.3	0.3	0.6	0.2	2.4	0.0	7.0	1.3	0.6	0.1	0.3	0.4	0.1	0.0	0.2	0.2	0.2	0.5	0.4	0.0	0.0	0.4	1.6	0.2	1.5	0.1	0.1	0.0	0.1	0.3	0.2	1.6	0.0	0.0	0.0	0.0	1.4	0.6	0.0	0.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.8	0.5	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.5	1.2	0.0	0.3	0.0	0.0	0.4	2.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.6	2.8	0.0	2.4	2.3	0.8	0.6	0.2	2.4	0.3	0.0	1.5	1.6	0.5	0.0	0.6	0.0	0.9	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	4.0	0.1	0.1	0.2	0.0	0.4	0.0	0.2	5.3	0.9	0.0	0.0	5.7	0.0	0.4	0.5	3.5	0.0	0.0	0.3	0.0	0.3	0.3	1.1	0.0	0.9	0.0	0.0	0.7	0.0	2.1	0.0	0.0	0.2	0.7	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	1.8	0.3	2.5	0.5	0.1	0.3	0.0	1.4	0.0	0.8	0.1
GPR39		ENSG00000183840	"G protein-coupled receptor 39"	O43194	2	132416805-132646582	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 6.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 16.0;Astrocytes: 12.1;Early spermatids: 20.6;Late spermatids: 19.4;Oligodendrocyte precursor cells: 18.6;Spermatocytes: 32.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"plasmacytoid DC: 1.4"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 1.4"	"Cell line enhanced"	"Detected in many"		"A-431: 32.0;CAPAN-2: 26.9;hTEC/SVTERT24-B: 30.8;RT4: 27.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA022111	Approved					NA	NA					"HPA022111: AB_1849298"	"unprognostic (4.06e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.54e-3)"	"unprognostic (3.81e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (7.50e-4)"	"unprognostic (2.28e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.72e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.58e-3)"	0.1	0.0	1.6	0.9	0.6	0.0	2.1	0.7	0.6	4.4	1.0	6.8	4.7	0.4	0.8	0.9	3.6	2.2	0.0	0.4	0.8	2.7	3.3	4.0	0.0	1.2	1.4	0.3	0.0	3.9	5.1	0.1	0.1	1.9	0.5	5.7	0.0	0.5	1.0	0.0	1.0	3.7	0.3	1.4	0.0	6.1	0.2	0.4	0.0	1.3	0.0	0.2	2.6	0.6	0.4	32.0	18.1	0.3	0.0	0.5	3.6	0.0	2.8	11.1	5.8	3.3	17.7	26.9	0.0	9.7	1.9	13.1	18.6	0.0	12.9	5.7	0.1	0.0	0.0	1.9	0.7	0.6	0.0	0.0	1.1	9.7	30.8	3.1	7.0	0.1	0.0	0.0	0.0	4.2	3.0	0.0	0.0	0.3	7.3	10.5	0.0	0.5	0.0	21.2	27.9	0.0	0.1	2.0	10.3	0.1	1.1	5.8	0.0	5.6	12.4	12.2	4.2	16.8	0.0	0.0	0.1	18.9	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	1.6	0.6	0.7	0.6	0.4	0.8	1.2	1.4	0.3	1.9	1.4	0.4	0.4	0.0	16.0	8.7	12.1	0.0	0.1	0.7	2.4	0.0	0.2	1.5	0.9	0.2	2.8	6.7	0.0	0.0	0.0	2.7	10.3	0.0	5.6	20.6	2.6	0.2	0.1	2.4	0.0	3.9	3.1	0.0	0.2	4.1	1.8	0.0	0.0	0.0	3.6	0.0	0.0	4.9	1.6	0.0	0.6	0.3	19.4	0.3	0.3	0.0	1.0	0.6	1.4	0.0	18.6	1.8	5.9	3.0	0.4	0.1	0.3	1.9	0.7	6.1	0.0	0.0	0.1	0.3	32.4	1.2	0.5	0.0	0.0	0.0	0.0	4.9	1.2
GRXCR1	"DFNB25, PPP1R88"	ENSG00000215203	"Glutaredoxin and cysteine rich domain containing 1"	A8MXD5	4	42892713-43030658	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Hearing		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"seminal vesicle: 2.6"	"Group enriched"	"Detected in some"	4	"Early spermatids: 3.2;Spermatocytes: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA040824	Uncertain					NA	NA					"HPA040824: AB_10794863"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GTF2A1L	ALF	ENSG00000242441	"General transcription factor IIA subunit 1 like"	Q9UNN4	2	48617798-48733148	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"testis: 60.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 9.2;Late spermatids: 2.3;Spermatocytes: 5.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 1.6;hTERT-RPE1: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA													"unprognostic (3.59e-1)"		"unprognostic (7.00e-2)"	"unprognostic (2.63e-1)"	"unprognostic (4.77e-1)"		"unprognostic (5.02e-2)"				1.8	0.5	1.2	0.0	0.7	0.0	1.2	1.5	0.7	2.5	0.7	5.9	0.4	4.2	0.5	0.7	3.0	1.1	0.7	0.4	0.6	1.1	0.2	1.2	0.2	3.8	1.2	0.2	2.1	0.2	0.0	0.5	0.2	2.4	2.1	0.1	0.1	0.2	0.2	0.6	0.4	1.7	0.6	2.0	1.3	2.6	60.5	1.5	0.1	0.5	0.1	0.0	4.3	1.6	3.1	0.0	0.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.1	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.7	1.5	0.7	0.4	0.6	3.8	1.2	0.2	2.4	2.0	1.5	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1
GTF2A2	"HsT18745, TFIIA"	ENSG00000140307	"General transcription factor IIA subunit 2"	P52657	15	59638062-59657541	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 1134.9;Late spermatids: 732.8;Spermatocytes: 1264.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056239			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA056239: AB_2683074"	"unprognostic (2.18e-2)"	"unprognostic (3.21e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.31e-2)"	"unprognostic (7.35e-2)"	"unprognostic (6.29e-2)"	"unprognostic (3.47e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.90e-2)"	51.5	57.5	36.3	55.0	38.2	72.6	50.1	40.8	44.4	50.7	37.1	63.4	40.6	49.1	55.1	61.5	46.6	44.0	64.6	36.3	44.6	60.1	50.2	40.0	53.1	40.2	40.2	34.0	52.4	43.5	66.0	58.8	43.7	39.8	46.4	51.6	42.2	58.7	34.6	75.7	39.5	42.3	45.7	40.5	43.6	46.7	213.6	38.2	60.6	41.5	55.6	52.2	62.0	66.1	42.7	149.1	206.4	136.8	130.9	83.8	70.5	157.7	164.0	79.8	134.6	133.3	224.4	58.9	136.5	149.5	107.9	197.6	124.3	138.7	100.6	95.4	242.2	112.9	157.4	146.5	143.4	107.5	171.5	134.1	66.0	95.1	112.3	94.9	95.3	87.6	105.6	226.7	136.1	113.6	103.8	112.9	130.8	181.7	49.6	120.0	104.4	142.9	166.5	133.7	172.2	148.0	157.1	152.1	171.5	160.1	180.5	120.7	179.2	121.5	126.4	224.7	142.5	297.7	134.1	426.3	303.8	143.2	284.0	157.2	174.0	129.8	170.3	88.1	140.7	92.4	126.9	103.1	98.9	174.2	100.2	87.4	96.7	70.0	117.5	135.1	201.0	132.7	134.9	36.3	38.2	40.8	44.4	36.3	44.6	40.2	40.2	34.0	39.8	40.5	38.2	42.7	109.4	41.7	58.5	17.0	89.8	98.7	184.6	213.0	83.1	51.1	107.3	155.8	120.4	62.9	132.2	64.4	47.9	217.8	99.9	122.4	211.3	148.8	1134.9	129.9	85.8	96.6	82.1	121.4	22.4	148.8	199.7	103.7	51.5	92.4	82.2	87.9	74.6	78.4	148.3	50.5	27.5	100.8	195.3	100.1	107.7	732.8	125.9	101.9	80.0	16.9	158.9	173.8	107.1	24.1	35.4	181.6	104.6	137.3	109.6	210.7	83.5	149.2	129.7	62.2	65.7	102.9	133.7	1264.3	166.3	89.8	106.8	151.9	87.3	120.8	120.5	236.2
GTF2H1	"BTF2, P62, TFIIH"	ENSG00000110768	"General transcription factor IIH subunit 1"	P32780	11	18322295-18367045	"Cancer-related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004637, HPA046660"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB004637: AB_425470, HPA046660: AB_2679743"	"unprognostic (2.25e-1)"	"unprognostic (2.33e-1)"	"unprognostic (9.78e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (5.98e-9)"	"unprognostic (7.71e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.42e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.90e-2)"	"unprognostic (2.94e-1)"	18.9	18.4	6.3	7.7	6.8	4.8	18.3	8.1	7.3	16.2	9.7	16.5	7.5	15.8	8.2	19.6	14.7	9.4	14.4	6.9	6.7	15.0	17.4	14.0	10.9	5.9	6.1	6.6	19.3	18.1	8.2	13.9	10.0	6.5	15.9	8.3	13.2	18.8	10.1	16.8	19.9	14.8	8.5	6.0	17.3	15.3	26.7	6.4	8.9	16.1	8.4	11.2	17.9	17.1	7.7	14.7	13.3	11.0	15.5	25.1	20.1	13.7	21.8	23.6	19.0	21.9	13.9	5.6	24.9	8.4	22.4	27.2	19.8	19.1	20.1	24.1	11.0	18.5	15.9	13.4	14.1	35.8	30.7	16.5	22.4	23.8	11.7	37.3	15.7	17.3	12.8	25.2	12.6	27.7	13.6	15.6	23.3	9.8	24.7	19.8	16.1	23.4	11.3	15.3	19.6	12.5	13.5	17.8	17.1	27.0	9.4	8.8	17.5	12.6	24.9	12.2	45.3	17.8	6.3	16.0	17.7	21.5	24.0	24.4	11.0	5.0	5.4	3.8	5.0	4.2	5.4	4.8	4.3	5.4	5.7	5.8	4.7	3.5	7.5	6.0	2.9	5.2	4.2	6.3	6.8	8.1	7.3	6.9	6.7	5.9	6.1	6.6	6.5	6.0	6.4	7.7	27.8	16.0	18.2	19.2	26.1	48.3	22.7	22.2	39.9	17.3	23.4	20.6	28.3	22.8	21.9	11.0	20.9	26.1	26.8	14.7	7.9	25.2	50.2	19.0	17.7	21.6	7.7	26.1	32.1	30.5	27.5	27.1	21.4	20.2	18.3	20.0	22.1	13.9	25.2	21.9	29.9	12.9	14.2	20.8	27.2	46.1	17.1	28.8	23.2	20.6	25.9	23.4	25.7	24.1	29.4	28.8	10.5	16.1	25.7	23.4	18.6	25.1	23.6	21.2	6.6	23.4	23.2	84.8	30.1	37.6	51.7	28.2	20.4	29.2	16.8	26.8
GTPBP8	HSPC135	ENSG00000163607	"GTP binding protein 8 (putative)"	Q8N3Z3	3	112990984-113015060	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 79.8;Spermatocytes: 79.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034831, HPA058631"	Approved		Enhanced	Mitochondria		No	No			Mitochondria		"HPA034831: AB_10671506, HPA058631: AB_2683783"	"unprognostic (1.98e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.99e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.18e-3)"	"unprognostic (1.80e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.21e-2)"	"prognostic favorable (3.07e-5)"	"unprognostic (7.10e-2)"	"unprognostic (7.21e-2)"	"unprognostic (4.57e-1)"	"unprognostic (2.69e-1)"	5.3	5.8	4.0	6.2	4.6	8.5	5.7	5.0	5.0	4.6	4.6	6.1	6.6	5.7	3.7	7.5	4.4	5.2	12.0	4.3	4.4	7.3	6.0	4.4	11.3	4.7	4.5	3.8	6.8	6.9	9.0	4.5	6.1	4.7	5.8	7.2	4.3	6.6	3.7	20.2	4.8	6.0	5.5	4.6	4.9	7.5	14.5	4.6	9.8	10.2	18.5	8.2	5.9	4.8	6.8	25.5	10.8	15.7	16.5	9.2	15.6	11.5	17.9	14.7	17.0	20.5	18.6	10.4	16.8	9.7	10.0	14.2	17.1	21.0	17.1	23.5	7.0	13.4	46.5	11.4	11.6	8.4	28.9	10.5	11.9	11.9	9.6	7.0	19.2	16.1	19.9	16.4	19.5	18.0	8.8	18.5	14.4	32.8	13.2	20.8	16.1	14.7	10.4	14.4	16.3	17.5	18.2	14.2	11.3	25.7	13.7	12.3	19.6	9.8	12.7	19.4	4.5	16.0	13.1	17.4	24.0	12.7	23.6	14.0	7.9	4.3	2.9	6.4	3.0	5.7	4.2	7.8	6.3	8.1	3.6	9.9	6.5	0.7	8.7	2.7	3.7	5.4	4.5	4.0	4.6	5.0	5.0	4.3	4.4	4.7	4.5	3.8	4.7	4.6	4.6	6.8	13.1	16.0	15.4	2.9	16.9	13.5	15.9	28.8	8.0	11.5	12.9	12.4	25.8	10.0	19.5	5.5	6.2	28.3	27.1	10.4	23.5	16.3	79.8	17.7	12.9	11.6	10.2	22.7	5.5	18.3	25.1	13.3	12.8	18.3	19.7	20.0	17.9	7.7	22.7	10.1	6.3	10.3	28.5	16.7	14.8	35.5	11.8	13.6	10.6	4.7	18.3	10.4	13.4	7.1	6.9	16.5	12.2	5.7	17.1	12.8	17.7	29.6	16.0	14.0	0.0	17.4	15.8	79.7	28.1	16.1	12.1	15.2	22.5	34.9	12.0	18.9
GYG1	GYG	ENSG00000163754	"Glycogenin 1"	P46976	3	148991408-149031775	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Glycogen biosynthesis"	Transferase	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 564.6;tongue: 360.8"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 229.8;Early spermatids: 251.2;Late spermatids: 368.8;Spermatocytes: 296.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030497, HPA073229"	Supported		Approved	Vesicles		NA	NA		30000	Vesicles		"HPA030497: AB_10602326, HPA073229: "	"unprognostic (2.68e-2)"	"unprognostic (6.31e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (6.15e-5)"	"unprognostic (2.55e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.75e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.79e-2)"	39.3	31.4	30.6	31.6	32.2	221.8	34.1	33.6	39.8	35.4	29.8	113.1	16.8	64.6	39.0	54.1	53.1	24.1	118.6	30.1	52.2	26.1	18.7	41.4	25.0	38.3	38.8	28.3	44.1	43.0	25.4	31.7	23.2	41.0	47.8	25.9	34.6	40.1	65.0	564.6	19.7	38.1	68.7	36.0	59.6	51.1	116.2	34.2	18.1	21.3	360.8	23.2	86.9	31.1	38.9	62.7	39.8	29.0	32.6	78.5	81.7	39.5	90.2	74.4	128.3	119.2	52.3	62.2	0.1	43.5	105.1	68.4	18.8	76.7	39.8	128.6	21.1	33.3	47.6	16.7	59.9	70.7	49.1	68.8	45.1	63.8	42.7	53.3	66.8	74.7	30.7	29.8	109.8	74.7	110.3	9.6	38.9	34.9	48.3	32.2	26.7	43.8	89.3	35.7	57.6	23.7	11.3	47.6	64.6	54.4	27.3	64.4	51.4	62.9	65.4	19.4	47.4	66.9	98.7	59.1	44.4	55.1	74.3	21.7	22.7	58.1	42.4	39.4	59.6	73.1	15.9	25.7	41.3	64.0	14.0	13.8	23.5	27.0	44.3	67.9	25.3	39.4	50.1	30.6	32.2	33.6	39.8	30.1	52.2	38.3	38.8	28.3	41.0	36.0	34.2	38.9	27.7	12.8	11.1	16.3	28.3	12.1	22.4	27.7	12.5	9.4	22.5	17.1	229.8	15.7	21.9	33.1	18.8	36.5	50.4	9.9	27.4	43.4	251.2	7.9	15.2	32.6	14.4	12.2	9.8	77.6	47.2	45.0	17.3	9.5	18.3	19.7	45.3	13.5	95.3	6.7	11.3	19.0	26.4	87.1	26.3	368.8	53.1	56.2	40.9	6.5	56.2	132.1	36.0	11.6	5.4	31.6	14.3	76.8	104.1	45.9	15.0	17.3	16.1	7.0	65.7	35.8	50.3	296.7	52.2	23.1	14.9	29.3	61.2	33.8	15.2	19.6
HCFC2	HCF-2	ENSG00000111727	"Host cell factor C2"	Q9Y5Z7	12	104064531-104106524	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 250.3;Spermatocytes: 130.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006227	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA006227: AB_1079042"	"unprognostic (4.22e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.08e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.71e-2)"	"unprognostic (4.54e-2)"	"unprognostic (4.23e-3)"	"unprognostic (1.16e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.19e-2)"	"unprognostic (7.23e-2)"	5.7	6.8	4.3	3.6	5.6	2.7	5.2	4.8	5.5	7.4	2.6	7.3	5.2	7.9	5.0	6.3	5.4	5.7	5.1	4.1	4.6	5.8	7.3	4.7	4.6	5.5	5.6	3.9	7.8	6.0	6.7	4.2	6.5	5.4	7.2	4.3	8.1	4.5	9.5	9.8	4.5	5.0	7.3	5.2	5.1	5.2	9.6	5.2	5.2	7.0	11.3	3.7	6.0	6.0	7.3	2.0	2.3	2.3	2.0	12.7	12.5	1.7	9.1	4.1	6.8	3.9	1.1	0.9	2.1	3.1	7.1	2.5	2.2	2.9	1.6	7.3	3.5	2.8	2.1	2.3	1.0	8.5	1.7	3.3	7.8	4.3	4.2	3.5	9.8	5.3	3.1	2.5	4.2	12.3	1.8	3.1	4.0	0.5	1.3	4.7	2.5	7.6	1.3	3.1	1.4	3.3	2.5	4.4	3.2	3.5	1.5	5.0	1.9	8.0	10.7	1.4	5.6	3.1	5.3	1.7	1.8	5.1	2.3	4.4	0.4	0.6	0.9	0.8	1.1	0.9	0.5	0.7	0.9	0.7	0.5	0.8	0.9	0.1	0.8	1.8	0.4	0.9	0.5	4.3	5.6	4.8	5.5	4.1	4.6	5.5	5.6	3.9	5.4	5.2	5.2	7.3	19.3	12.8	14.1	18.9	10.0	8.0	6.6	5.4	8.6	19.6	6.1	5.0	12.5	1.5	9.6	5.5	20.9	5.0	8.8	7.4	9.8	6.2	250.3	7.9	18.5	14.4	8.4	7.4	31.8	3.3	5.0	16.0	6.6	6.5	17.1	9.8	15.7	11.5	7.4	23.5	33.9	4.7	8.2	11.4	5.7	59.4	21.8	8.6	7.2	16.9	9.3	13.7	7.2	30.7	45.6	3.1	6.0	27.8	12.2	2.7	7.7	8.6	10.4	22.2	13.1	18.7	17.4	130.9	16.4	8.5	7.2	10.8	11.3	17.9	3.8	3.3
HDGFL1	"dJ309H15.1, Hdgfrp1, HRP-1, PWWP1"	ENSG00000112273	"HDGF like 1"	Q5TGJ6	6	22569566-22571666	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	215	"testis: 91.8"	"Group enriched"	"Detected in some"	5	"Early spermatids: 130.5;Late spermatids: 120.2;Spermatocytes: 165.6"	"Cancer enriched"	"Detected in some"	41	"testis cancer: 21.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"K-562: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045679, HPA063707"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA045679: AB_2679415, HPA063707: AB_2685099"						"unprognostic (1.55e-1)"									"unprognostic (6.18e-2)"		"unprognostic (4.03e-2)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	91.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	130.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	120.2	5.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	6.6	0.0	0.0	165.6	24.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HHIPL2	"FLJ13840, KIAA1822L"	ENSG00000143512	"HHIP like 2"	Q6UWX4	1	222522258-222548104	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 4.9;thyroid gland: 2.0"	"Group enriched"	"Detected in some"	9	"Early spermatids: 16.7;Late spermatids: 25.5;Spermatocytes: 13.6"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 18.7;Hep G2: 5.7;RH-30: 21.3;SuSa: 7.8;U-87 MG: 10.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA059673	Enhanced		Uncertain	Mitochondria,Cytosol	"Secreted in other tissues"	No	NA			Mitochondria	Cytosol	"HPA059673: AB_2684100"	"unprognostic (1.35e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.91e-1)"	"unprognostic (9.21e-2)"	"unprognostic (3.58e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.74e-3)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (8.07e-2)"	"unprognostic (3.64e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.14e-2)"	"unprognostic (0.00e+0)"	"unprognostic (6.52e-2)"	"unprognostic (4.21e-4)"	"unprognostic (2.30e-3)"	"unprognostic (8.38e-2)"	0.2	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.1	0.1	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	2.0	0.0	0.0	0.0	0.3	0.0	0.0	4.2	0.1	0.1	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.8	18.7	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.9	5.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.8	0.1	0.3	0.0	21.3	0.0	0.2	0.0	0.3	0.1	0.1	0.1	0.0	7.8	0.0	0.0	0.0	1.0	0.3	0.0	0.2	0.0	0.1	0.0	10.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.1	0.1	0.0	1.8	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	25.5	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.2	13.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1
HIGD2B	HIGD2BP	ENSG00000175202	"HIG1 hypoxia inducible domain family member 2B"	Q4VC39	15	72675798-72686182	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in single"	10	"testis: 3.6"	"Group enriched"	"Detected in some"	10	"Early spermatids: 18.3;Late spermatids: 8.6;Spermatocytes: 20.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA019016, HPA042715"	Uncertain		Supported	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA019016: AB_1850711, HPA042715: AB_2678127"	"unprognostic (1.22e-1)"	"unprognostic (1.09e-1)"		"unprognostic (2.24e-3)"	"unprognostic (5.09e-2)"	"unprognostic (3.34e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.98e-2)"	"unprognostic (3.90e-1)"	"unprognostic (8.80e-2)"	"unprognostic (6.11e-4)"	"unprognostic (6.95e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.18e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.2	0.1	0.0	0.0	0.1	0.4	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	18.3	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.0	8.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.4	0.0	0.3	0.0	0.2	0.4	0.0	0.0	0.1	0.0	20.1	1.5	0.0	0.1	0.1	0.1	0.0	0.1	0.2
HOXD8	"HOX4, HOX4E"	ENSG00000175879	"Homeobox D8"	P13378	2	176129694-176132695	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 100.5;kidney: 76.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 51.8;Collecting duct cells: 60.7;Distal tubular cells: 213.2;Early spermatids: 124.6;Leydig cells: 51.3;Peritubular cells: 53.8;Spermatocytes: 82.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"white matter: 6.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 45.4;RPTEC TERT1: 74.8;TIME: 32.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	70	"spinal cord: 34.6"							NA	NA						"unprognostic (1.22e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.19e-3)"	"unprognostic (2.68e-2)"	"unprognostic (3.35e-1)"	"unprognostic (3.49e-1)"	"unprognostic (2.56e-3)"	"prognostic unfavorable (3.78e-4)"	"unprognostic (2.79e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.93e-1)"	"unprognostic (3.05e-1)"	"unprognostic (3.63e-2)"	"unprognostic (4.80e-2)"	"unprognostic (5.21e-2)"	"unprognostic (8.31e-2)"	"unprognostic (2.80e-2)"	15.0	20.8	0.1	4.8	0.2	0.0	19.0	0.0	0.0	12.2	0.0	10.2	1.2	19.6	100.5	2.7	17.4	3.1	0.8	0.0	0.0	76.9	0.3	0.9	4.9	1.2	0.0	0.0	34.5	1.4	1.1	0.0	0.7	0.7	6.1	5.0	0.0	1.7	24.2	7.8	4.7	8.7	13.2	4.0	10.6	1.6	20.3	0.2	1.0	3.5	1.5	1.4	6.6	9.2	6.1	13.7	2.1	0.0	0.0	8.8	14.1	0.3	1.7	7.2	2.2	0.2	0.1	0.1	0.0	16.7	10.8	1.7	0.1	4.7	0.5	5.4	0.0	6.4	2.3	0.8	0.0	2.9	1.3	0.8	24.7	45.4	0.3	6.7	0.0	22.9	4.4	0.2	0.1	3.7	0.1	0.1	0.4	0.2	0.0	2.6	0.0	4.9	0.2	74.8	9.6	14.2	26.4	4.3	0.0	28.4	1.2	0.0	0.1	32.5	1.1	8.9	15.4	9.1	0.0	0.0	0.0	21.1	0.0	26.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.7	4.0	0.2	6.1	51.8	0.0	1.1	0.0	0.5	2.7	2.1	0.0	0.6	0.0	0.7	0.6	2.3	0.0	0.0	60.7	0.0	0.0	0.2	2.7	213.2	0.0	124.6	0.7	9.4	36.4	4.8	0.0	0.0	0.0	0.0	14.9	0.0	0.3	0.0	0.0	2.5	0.0	0.1	0.0	0.0	1.8	0.0	0.0	3.4	29.9	51.3	0.5	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	53.8	0.0	1.3	0.5	25.1	0.7	0.0	32.9	14.1	9.8	82.1	20.4	0.2	2.8	0.1	1.0	31.9	3.4	1.1
HSF1	HSTF1	ENSG00000185122	"Heat shock transcription factor 1"	Q00613	8	144291591-144314720	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"DNA damage, DNA repair, Host-virus interaction, mRNA processing, mRNA transport, Stress response, Transcription, Transcription regulation, Transport"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 248.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004239, HPA008888"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB004239: AB_627753, HPA008888: AB_1079088"	"unprognostic (7.08e-2)"	"unprognostic (1.89e-2)"	"unprognostic (6.07e-2)"	"prognostic unfavorable (8.93e-4)"	"unprognostic (1.55e-1)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (4.95e-4)"	"unprognostic (5.69e-3)"	"unprognostic (1.05e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.12e-1)"	48.8	56.1	18.2	14.8	16.5	18.2	48.3	16.0	24.2	48.9	14.7	60.0	14.3	52.1	7.4	48.5	52.5	12.5	118.5	16.4	16.8	50.5	46.4	50.0	14.7	20.2	18.3	15.5	57.8	69.3	18.9	48.4	17.1	17.8	53.6	10.9	7.7	40.1	17.2	126.1	48.3	40.0	15.5	16.3	43.1	58.3	108.7	19.4	14.8	46.1	32.5	12.7	59.2	46.6	20.2	40.8	53.8	22.9	19.6	37.6	35.0	37.9	29.7	26.6	28.8	25.0	36.3	34.6	46.7	42.5	41.5	28.2	28.9	35.2	42.7	18.3	29.9	40.7	58.4	51.8	50.1	59.1	17.1	43.4	34.2	39.3	40.6	74.2	30.6	39.4	41.9	39.6	27.1	29.4	82.0	58.0	26.2	29.4	52.6	154.2	37.2	19.9	59.2	20.6	40.5	34.3	27.9	45.4	35.9	52.8	23.8	40.5	34.5	40.2	29.5	66.3	46.8	49.5	18.8	15.4	39.9	41.8	31.4	28.8	14.2	23.2	26.3	16.7	24.9	17.2	19.2	17.8	21.1	24.6	17.3	17.1	15.9	9.7	16.3	32.2	12.6	22.9	19.2	18.2	16.5	16.0	24.2	16.4	16.8	20.2	18.3	15.5	17.8	16.3	19.4	20.2	46.5	6.4	11.2	8.5	40.4	51.4	73.8	53.8	39.9	67.8	37.0	30.5	46.4	22.8	34.7	29.5	62.6	69.9	38.2	43.3	150.6	39.2	248.7	35.1	20.5	44.4	40.9	120.8	12.1	41.1	80.6	34.7	44.9	34.6	37.5	51.1	40.7	63.8	49.5	69.0	14.7	36.8	42.7	25.7	45.6	106.7	37.3	32.7	33.8	12.2	59.7	24.9	34.0	6.0	12.9	45.3	49.3	42.9	40.4	76.6	63.8	34.9	25.9	33.1	59.2	41.3	39.2	84.4	47.7	36.3	45.5	111.0	39.0	105.9	45.8	76.4
HSF5	FLJ40311	ENSG00000176160	"Heat shock transcription factor 5"	Q4G112	17	58420167-58488408	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	41	"testis: 49.2"	"Group enriched"	"Detected in some"	4	"Early spermatids: 53.8;Spermatocytes: 68.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"B-cells: 1.3;T-cells: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA016440, HPA063613"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA016440: AB_1851142, HPA063613: AB_2685060"	"unprognostic (2.13e-1)"	"unprognostic (1.21e-4)"	"unprognostic (1.71e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.09e-3)"	"unprognostic (4.17e-2)"	"unprognostic (7.48e-3)"	"unprognostic (7.40e-2)"	"unprognostic (8.85e-3)"	"unprognostic (2.13e-3)"	"unprognostic (2.58e-2)"	"unprognostic (6.65e-4)"	"unprognostic (1.21e-1)"	"unprognostic (7.39e-2)"	"unprognostic (8.75e-2)"	"unprognostic (3.64e-2)"	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	49.2	0.0	0.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	1.1	0.6	0.5	0.0	1.3	1.1	0.8	0.0	0.2	0.0	0.0	0.9	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.0	3.9	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	53.8	0.0	0.0	0.1	0.0	0.4	3.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	3.2	0.0	0.0	0.0	0.0	14.6	3.1	0.1	0.0	0.0	0.0	0.2	2.1	0.5	2.4	0.0	0.0	1.9	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	68.8	3.3	0.0	0.0	0.0	1.3	0.1	0.0	0.0
HSPA2		ENSG00000126803	"Heat shock protein family A (Hsp70) member 2"	P54652	14	64535905-64546173	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Stress response"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 318.0;skeletal muscle: 172.0"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 342.0;Distal tubular cells: 238.7;Extravillous trophoblasts: 509.9;Spermatocytes: 578.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A549: 75.4;BEWO: 114.4;BJ hTERT+: 99.0;CAPAN-2: 52.9;SCLC-21H: 101.4"	"Low region specificity"	"Detected in all"							"HPA000798, HPA052504"	Enhanced	Supported	Approved	Nucleoplasm,Vesicles		NA	NA		63000000	Vesicles	Nucleoplasm	"HPA000798: AB_1079090, HPA052504: AB_2681854"	"prognostic favorable (1.78e-4)"	"unprognostic (1.72e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.90e-2)"	"unprognostic (7.11e-2)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (1.31e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.60e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.25e-1)"	9.0	6.6	78.2	7.6	146.0	0.8	6.5	140.1	128.1	9.8	77.7	71.9	5.6	52.0	18.7	42.6	17.1	5.4	40.1	82.6	107.0	37.8	4.2	14.3	3.9	170.3	122.5	62.1	5.6	8.9	7.9	15.3	62.0	159.2	10.9	9.6	1.2	16.5	4.5	172.0	31.5	29.8	29.0	124.8	20.3	18.6	121.9	124.8	3.0	2.7	61.1	5.0	43.2	16.2	318.0	30.4	75.4	11.4	0.2	8.1	0.7	114.4	42.3	99.0	16.6	27.3	2.9	52.9	7.4	16.8	46.4	3.6	33.6	0.0	2.2	10.1	4.3	5.8	0.1	4.0	0.2	7.9	0.2	10.0	3.7	1.7	2.4	0.1	4.1	1.1	0.5	0.0	6.0	8.4	13.5	0.5	0.4	8.4	11.7	9.1	6.0	0.0	0.1	26.1	4.6	101.4	5.8	1.8	3.7	0.1	3.9	2.9	3.1	1.6	0.3	0.2	3.7	0.2	7.6	0.2	0.2	9.2	0.1	11.4	0.3	0.0	0.0	0.5	0.1	0.0	0.2	0.4	0.2	0.0	0.1	0.1	0.1	0.6	0.2	0.1	0.0	1.0	0.1	78.2	146.0	140.1	128.1	82.6	107.0	170.3	122.5	62.1	159.2	124.8	124.8	318.0	74.7	0.0	5.2	18.6	21.1	54.0	31.2	35.1	342.0	1.9	37.5	57.1	39.1	5.7	8.8	132.4	0.0	42.5	30.8	29.2	238.7	8.3	35.7	56.4	63.8	59.6	28.1	0.0	0.5	5.6	509.9	40.7	83.6	54.5	13.3	1.4	32.2	0.8	15.7	0.0	1.1	63.4	24.4	3.1	25.7	27.3	8.7	24.0	30.2	6.5	0.0	14.2	0.0	2.5	157.4	5.5	15.6	7.5	7.1	7.5	8.5	1.5	4.6	2.4	26.3	48.6	66.2	578.6	77.1	175.8	42.3	75.9	29.8	4.5	12.9	11.3
HSPBAP1	"FLJ22623, PASS1"	ENSG00000169087	"HSPB1 associated protein 1"	Q96EW2	3	122739999-122793831	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 60.5;Microglial cells: 52.5;Syncytiotrophoblasts: 48.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044930	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA044930: AB_10961122"	"unprognostic (3.40e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.98e-2)"	"unprognostic (6.70e-3)"	"unprognostic (3.40e-3)"	"unprognostic (3.40e-2)"	"unprognostic (8.61e-4)"	"unprognostic (2.68e-2)"	"unprognostic (6.95e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.36e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.24e-3)"	"unprognostic (4.29e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.34e-1)"	"unprognostic (4.12e-3)"	4.2	5.4	3.1	4.3	3.4	3.1	3.9	3.6	4.2	3.7	4.3	3.4	2.5	3.8	1.9	2.8	3.2	3.6	2.9	3.5	3.5	4.3	3.5	4.6	6.2	4.1	3.7	2.7	3.0	3.8	3.7	2.7	6.0	4.2	3.3	3.5	4.6	3.2	3.2	16.1	4.2	3.8	3.9	3.8	7.4	3.0	10.8	3.6	6.5	6.3	8.8	5.5	4.3	3.2	4.0	5.4	4.1	5.8	5.2	6.8	5.1	11.3	2.6	6.7	6.1	8.6	5.6	4.1	6.9	4.2	1.8	15.4	6.4	9.0	5.0	7.1	4.3	2.5	4.6	4.8	3.3	15.4	4.2	6.1	7.7	18.0	5.1	16.3	5.8	5.8	6.9	3.1	5.8	5.6	3.5	6.1	5.3	6.6	4.2	8.2	6.2	7.8	6.8	6.4	2.1	6.4	6.5	6.2	2.4	23.3	5.5	2.9	8.8	5.8	7.1	4.2	2.3	3.7	5.7	6.1	8.1	4.4	6.2	7.1	23.0	16.5	12.0	6.1	12.2	7.6	11.0	8.0	6.1	13.0	8.3	8.6	8.4	30.6	6.3	24.1	4.5	10.3	8.2	3.1	3.4	3.6	4.2	3.5	3.5	4.1	3.7	2.7	4.2	3.8	3.6	4.0	10.2	6.4	5.3	10.7	20.8	10.7	3.9	5.0	6.8	6.6	3.9	5.7	5.7	4.3	3.9	5.5	60.5	16.8	11.4	4.9	3.9	5.5	35.7	7.3	5.1	6.4	0.0	7.2	15.2	6.0	11.0	6.5	5.6	4.4	6.3	6.4	11.0	3.6	12.9	8.4	24.7	3.1	4.1	24.1	14.1	8.0	9.6	20.1	5.4	52.5	29.4	3.7	14.4	8.0	22.9	4.3	3.5	4.9	6.4	3.2	6.3	4.5	5.9	12.8	6.6	7.1	4.9	36.8	8.4	5.0	7.5	48.6	10.3	7.4	3.5	1.7
IAH1		ENSG00000134330	"Isoamyl acetate hydrolyzing esterase 1 (putative)"	Q2TAA2	2	9473658-9496543	"Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 433.4;Late spermatids: 503.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040523, HPA076040"	Approved		Approved	Nucleoplasm		NA	NA		240000	Nucleoplasm		"HPA040523: AB_2677021, HPA076040: "	"unprognostic (1.51e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.41e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.98e-2)"	"unprognostic (5.40e-2)"	"unprognostic (7.39e-2)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (3.64e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.42e-2)"	"unprognostic (3.91e-2)"	38.8	47.9	28.0	17.0	29.2	27.6	34.3	33.1	37.6	32.7	31.8	37.3	20.2	30.6	31.6	26.9	28.5	23.2	52.2	27.8	30.5	39.6	46.4	31.5	27.2	28.5	28.1	28.6	35.9	23.4	45.9	31.3	24.4	29.4	26.8	29.4	22.5	22.5	29.6	43.4	22.7	26.5	27.6	27.9	26.1	30.1	66.3	29.3	28.8	29.1	73.3	31.2	30.9	30.2	32.5	41.0	40.8	4.7	0.5	73.4	140.7	0.9	33.4	76.8	48.7	46.4	0.5	44.2	21.1	17.6	106.7	35.2	27.8	15.4	32.2	48.5	81.2	26.8	26.7	16.1	27.5	139.6	0.1	21.2	85.1	92.9	36.6	42.6	93.6	49.2	37.8	0.4	13.3	100.1	39.4	106.6	4.2	6.4	53.6	20.6	26.0	0.1	6.1	79.4	21.1	29.0	56.2	26.0	37.2	52.6	2.4	37.9	46.4	38.6	38.7	17.0	17.5	52.6	10.6	0.7	8.2	53.4	16.6	44.3	33.3	38.0	31.9	30.2	35.3	33.8	38.5	35.2	34.6	49.6	32.7	27.2	30.9	23.0	37.6	42.8	52.4	46.0	25.6	28.0	29.2	33.1	37.6	27.8	30.5	28.5	28.1	28.6	29.4	27.9	29.3	32.5	44.4	32.1	26.2	25.1	53.7	89.9	100.5	92.4	21.6	33.6	41.3	51.2	45.4	52.9	40.1	49.7	12.5	74.2	65.0	36.2	92.0	68.9	433.4	49.9	56.9	30.1	25.7	41.4	43.2	76.9	109.8	73.5	16.8	50.1	36.8	74.0	36.4	53.1	87.4	42.1	35.1	28.6	42.7	78.2	95.2	503.0	93.8	66.3	92.5	19.7	116.8	44.0	80.3	23.1	44.4	90.5	37.3	73.0	38.5	75.6	68.0	138.8	42.7	57.4	98.6	82.8	75.2	243.2	48.8	41.4	95.8	44.5	64.9	87.0	47.5	89.5
IDE		ENSG00000119912	"Insulin degrading enzyme"	P14735	10	92451684-92574096	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction"	"Allosteric enzyme, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063478	Approved				"Secreted in other tissues"	NA	NA		310000			"HPA063478: AB_2685020"	"unprognostic (1.70e-1)"	"unprognostic (6.40e-2)"	"prognostic favorable (3.69e-4)"	"prognostic favorable (3.53e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.79e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.58e-2)"	"unprognostic (7.79e-2)"	"unprognostic (6.81e-2)"	"unprognostic (9.24e-3)"	"unprognostic (6.13e-2)"	"unprognostic (3.89e-2)"	"unprognostic (3.91e-1)"	6.5	10.2	3.6	2.8	3.8	3.6	6.1	3.9	4.3	7.5	5.6	8.2	3.4	7.5	9.8	9.9	6.6	2.9	11.0	3.6	4.3	5.9	11.5	6.0	3.4	4.0	3.9	3.5	5.5	12.4	9.5	4.7	2.7	4.1	9.2	3.9	10.4	7.9	4.2	29.0	34.1	6.8	3.7	3.9	6.4	8.3	26.0	3.8	2.5	6.8	9.8	4.1	9.0	8.0	4.0	12.1	22.9	6.2	15.1	10.5	5.8	8.5	10.4	13.3	6.1	5.2	19.4	9.5	12.5	16.4	14.3	7.2	16.3	14.6	10.0	3.9	14.7	8.8	5.1	13.7	25.9	11.5	14.9	6.5	5.4	6.6	9.1	14.0	7.8	8.6	3.3	10.0	8.1	5.4	18.0	6.6	8.8	10.2	10.4	5.2	10.2	10.8	9.0	10.9	19.3	2.2	5.6	14.3	6.4	6.7	6.8	12.6	6.3	15.3	4.4	8.2	5.0	10.4	11.2	12.2	14.5	6.9	10.9	4.4	0.3	3.5	1.4	2.0	4.2	2.2	2.9	2.6	2.9	4.6	2.1	1.9	2.0	0.0	3.7	5.9	1.3	3.9	2.3	3.6	3.8	3.9	4.3	3.6	4.3	4.0	3.9	3.5	4.1	3.9	3.8	4.0	12.9	9.6	14.1	20.9	11.1	5.2	6.1	10.5	5.2	15.0	8.7	4.3	45.7	7.2	10.6	7.3	47.9	11.2	10.0	14.0	1.9	14.0	46.4	14.9	19.3	10.8	10.8	19.6	43.3	20.2	5.7	9.1	22.4	16.5	1.3	9.9	11.7	24.1	11.9	6.7	42.6	12.7	18.3	16.6	5.4	12.0	6.5	12.5	8.8	23.4	7.8	7.8	4.1	20.6	24.0	16.5	5.7	10.1	24.2	12.2	9.0	10.7	23.3	26.9	6.6	7.6	13.2	51.5	11.0	19.6	16.3	3.8	8.5	9.8	9.8	9.6
IFT122	"FAP80, SPG, WDR10, WDR10p, WDR140"	ENSG00000163913	"Intraflagellar transport 122"	Q9HBG6	3	129440036-129520507	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein"	"Ciliopathy, Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 73.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 81.7;Late spermatids: 70.3;Spermatocytes: 120.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041815	Uncertain		Uncertain	Cytosol		NA	NA			Cytosol		"HPA041815: AB_10804118"	"unprognostic (7.16e-2)"	"unprognostic (3.71e-3)"	"unprognostic (3.67e-1)"	"unprognostic (7.61e-3)"	"unprognostic (5.29e-2)"	"unprognostic (5.33e-3)"	"unprognostic (4.68e-2)"	"unprognostic (1.82e-1)"	"unprognostic (7.90e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.67e-2)"	"unprognostic (5.33e-1)"	"unprognostic (9.91e-2)"	"unprognostic (4.20e-3)"	9.3	7.5	6.1	5.3	7.3	10.2	12.6	6.4	9.3	13.2	12.7	7.0	4.7	12.7	12.8	7.2	24.9	6.7	11.3	6.9	6.1	11.8	9.3	8.8	6.7	4.5	5.7	5.4	25.6	13.4	14.0	14.5	10.8	4.6	7.5	7.0	11.3	8.0	8.6	3.9	14.0	5.3	9.0	4.3	4.5	9.1	73.4	5.9	9.0	13.2	3.0	5.8	6.7	8.5	6.2	16.5	24.6	21.0	13.5	29.7	21.0	10.5	8.5	12.9	14.8	14.1	11.9	10.7	10.6	10.0	11.3	14.5	10.4	8.2	7.7	13.3	5.8	8.8	8.2	21.8	10.3	8.1	22.2	7.2	24.7	5.7	11.4	8.8	12.9	20.3	21.8	8.4	22.1	12.1	18.2	18.2	11.6	14.1	12.3	7.0	16.3	8.0	7.7	15.7	3.0	25.9	10.6	24.8	8.2	7.5	7.9	22.6	17.9	9.0	10.1	8.7	13.6	10.2	15.0	11.4	9.3	9.2	11.3	8.1	4.5	3.1	3.7	0.9	2.2	1.6	1.9	1.6	2.3	3.2	2.1	1.8	2.2	1.4	1.5	0.9	0.8	3.0	2.1	6.1	7.3	6.4	9.3	6.9	6.1	4.5	5.7	5.4	4.6	4.3	5.9	6.2	7.5	9.6	8.2	28.1	4.3	2.7	5.8	4.5	2.8	9.7	18.0	13.3	6.4	15.7	5.6	25.8	37.5	6.7	4.5	6.2	7.9	5.2	81.7	43.4	11.0	9.7	3.0	7.4	35.1	8.9	5.2	9.8	19.9	10.2	5.1	8.7	20.7	6.0	9.3	5.0	23.1	10.2	4.1	7.2	2.2	70.3	18.6	4.1	3.6	15.0	3.8	11.8	3.1	12.1	15.9	3.4	4.2	13.9	3.4	3.6	6.2	8.2	37.3	21.4	0.0	12.8	7.7	120.4	38.0	5.4	2.8	2.6	4.1	10.6	8.7	3.4
IFT74	"CCDC2, CMG-1, CMG1, FLJ22621"	ENSG00000096872	"Intraflagellar transport 74"	Q96LB3	9	26947039-27066134	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Bardet-Biedl syndrome, Ciliopathy, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 49.4"	"Cell type enhanced"	"Detected in all"		"Endometrial ciliated cells: 93.2;Respiratory ciliated cells: 97.4;Spermatocytes: 208.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020247, HPA026684"	Approved					NA	NA					"HPA020247: AB_1846140, HPA026684: AB_1846141"	"unprognostic (3.84e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.43e-1)"	7.4	12.9	5.8	6.5	4.7	6.7	15.1	5.8	5.7	13.5	12.8	9.0	4.6	12.5	22.6	8.4	22.0	6.7	8.4	4.8	6.0	12.3	11.9	7.9	6.2	6.0	5.6	4.3	12.6	8.4	16.8	12.6	9.8	5.3	11.8	9.0	14.8	7.7	13.4	9.2	7.2	6.0	10.5	5.2	8.2	6.8	49.4	5.3	10.1	20.5	9.0	7.5	8.4	7.8	5.5	15.3	26.2	24.3	18.8	17.5	29.4	6.1	16.8	26.8	20.7	17.8	2.9	10.3	6.7	13.9	17.9	21.8	12.8	18.6	23.6	22.8	17.3	8.6	17.0	10.5	12.0	27.8	10.6	16.3	22.9	32.9	24.8	42.6	25.6	13.4	1.4	12.0	22.8	31.4	6.3	12.4	25.9	15.4	11.7	10.7	7.5	9.8	17.0	31.1	9.3	21.0	21.2	11.0	15.2	9.1	14.8	23.2	14.6	9.1	0.0	20.0	5.1	15.6	7.5	24.5	5.4	9.8	12.6	9.5	2.3	6.2	2.0	5.8	7.3	4.7	12.4	6.1	5.8	9.2	12.6	10.3	7.7	0.4	12.1	7.0	7.8	6.1	3.9	5.8	4.7	5.8	5.7	4.8	6.0	6.0	5.6	4.3	5.3	5.2	5.3	5.5	10.1	32.1	27.4	27.4	8.2	7.8	15.8	24.4	10.2	23.9	12.1	16.0	29.1	7.2	28.4	16.5	22.9	23.1	3.4	17.2	21.5	26.5	84.5	93.2	27.6	12.1	13.2	10.7	15.5	22.7	10.6	14.8	7.1	23.1	16.5	19.2	8.9	8.6	15.8	28.6	17.8	13.5	8.2	49.6	4.5	36.1	20.2	9.3	5.4	19.7	8.3	25.2	1.0	23.1	24.2	11.7	10.5	18.0	7.7	6.0	10.2	33.1	97.4	43.5	19.7	18.1	25.4	208.2	29.9	9.7	8.4	10.9	8.3	35.9	17.2	7.3
IGHMBP2	"CATF1, CMT2S, HCSA, HMN6, SMARD1, SMUBP2, ZFAND7"	ENSG00000132740	"Immunoglobulin mu DNA binding protein 2"	P38935	11	68903863-68940602	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Helicase, Hydrolase, Ribonucleoprotein, RNA-binding, tRNA-binding"	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 94.6;Late spermatids: 46.9;Spermatocytes: 51.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA004092, HPA060994"			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA004092: , HPA060994: AB_2684406"	"unprognostic (1.17e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.17e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.59e-3)"	"unprognostic (4.31e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (5.89e-4)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (1.29e-8)"	"unprognostic (1.69e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.18e-2)"	5.1	4.0	0.9	2.5	1.2	6.0	5.5	0.7	1.7	6.7	0.1	9.7	1.5	7.9	0.6	5.5	6.7	1.7	4.7	1.3	0.8	4.4	6.3	5.2	3.3	0.8	0.5	1.1	6.1	5.3	2.8	4.0	2.0	0.8	6.3	1.5	1.4	6.5	3.1	8.5	7.5	6.3	2.7	0.4	5.8	6.3	15.5	0.7	4.3	5.0	3.8	1.8	6.3	5.9	1.1	5.1	7.3	4.0	7.4	3.6	3.1	5.2	5.8	3.9	7.8	4.6	14.5	7.0	7.3	9.7	3.3	6.9	8.0	5.8	4.9	1.8	8.3	6.2	6.6	9.6	5.6	5.5	6.5	7.4	1.8	4.9	9.2	4.6	4.5	4.6	11.1	10.6	4.6	2.3	5.1	11.1	8.9	2.3	7.9	10.3	9.4	5.7	7.6	3.3	5.9	8.6	5.4	7.4	6.1	16.6	3.0	9.3	6.0	6.6	5.3	3.8	7.7	6.6	6.0	6.3	6.9	5.3	6.1	5.1	0.0	2.0	0.8	1.5	1.8	1.3	1.0	0.9	1.0	1.8	0.6	0.5	0.7	0.6	0.1	1.1	0.3	0.6	1.3	0.9	1.2	0.7	1.7	1.3	0.8	0.8	0.5	1.1	0.8	0.4	0.7	1.1	6.6	6.4	7.7	7.5	5.7	5.7	3.8	3.5	6.2	9.1	5.6	3.8	6.3	8.6	6.1	1.8	20.9	4.9	10.2	6.0	1.9	5.1	94.6	7.0	8.1	6.4	3.0	9.3	7.4	5.1	4.4	5.5	6.1	14.0	7.0	10.7	3.3	6.1	5.8	11.8	6.4	4.1	2.0	3.5	4.3	46.9	7.8	7.2	1.8	5.6	7.3	6.6	9.2	6.0	5.2	6.5	8.4	7.2	5.8	7.5	3.9	2.9	3.8	10.1	0.0	5.1	10.1	51.6	7.1	5.3	6.7	6.7	8.0	4.6	7.1	6.3
IL31RA	"CRL, CRL3, GLM-R, Glmr, IL-31RA"	ENSG00000164509	"Interleukin 31 receptor A"	Q8NI17	5	55851357-55922854	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	Immunity	Receptor	"Amyloidosis, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 1.6;lymphoid tissue: 2.2;testis: 1.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 2.2;Late spermatids: 1.2;Spermatocytes: 2.5;Syncytiotrophoblasts: 1.1"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 26.3;HBEC3-KT: 10.3;HHSteC: 9.5;hTERT-HME1: 11.5;U-2 OS: 16.8;U-87 MG: 20.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.2"	"HPA051532, HPA068114"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA051532: , HPA068114: AB_2732779"	"unprognostic (1.14e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.13e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.95e-3)"	"unprognostic (7.34e-2)"	"unprognostic (3.54e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.95e-3)"	"unprognostic (7.75e-5)"	"unprognostic (5.55e-2)"	"unprognostic (2.65e-6)"	"unprognostic (7.73e-2)"	"unprognostic (7.68e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.76e-2)"	0.0	0.0	0.1	0.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.0	0.4	0.5	0.0	0.1	0.0	0.0	0.1	1.9	0.0	2.2	0.0	0.6	0.1	0.1	0.0	0.1	0.1	1.4	0.0	0.0	0.1	0.4	0.5	0.2	0.5	0.3	0.1	0.0	0.2	0.0	0.0	0.4	26.3	0.0	0.0	10.3	2.2	0.0	0.1	0.0	0.0	0.0	9.5	0.0	0.0	7.3	2.9	4.8	11.5	0.6	4.1	0.1	0.0	0.4	1.4	0.0	0.0	1.2	0.0	0.0	6.8	0.0	1.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	3.5	2.0	0.5	16.8	0.0	0.8	0.0	0.0	0.0	20.8	0.0	2.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.1	0.3	0.3	0.0	0.0	0.3	0.2	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.2	0.1	2.5	0.6	0.0	0.1	1.1	0.0	0.7	0.0	0.0
IL5	"EDF, IL-5, TRF"	ENSG00000113525	"Interleukin 5"	P05113	5	132541445-132556838	"Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.4;testis: 5.1"	"Cell type enriched"	"Detected in some"	7	"Spermatocytes: 19.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in single"	8	"memory B-cell: 1.4"	"Lineage enriched"	"Detected in single"	8	"B-cells: 1.4"	"Cell line enhanced"	"Detected in some"		"Hep G2: 2.8;TIME: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			CAB010304	Approved				"Secreted to blood"	NA	NA	4130				"CAB010304: AB_2296159"	"unprognostic (1.66e-1)"	"unprognostic (4.76e-2)"	"unprognostic (5.30e-3)"	"unprognostic (2.35e-1)"	"unprognostic (9.07e-2)"		"unprognostic (7.98e-2)"	"unprognostic (2.03e-2)"		"unprognostic (3.51e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.27e-2)"	"unprognostic (5.84e-3)"	"unprognostic (1.91e-1)"	0.1	0.0	0.4	0.1	0.1	0.0	0.0	1.3	1.1	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.3	0.5	0.2	1.4	0.0	0.0	0.2	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.9	0.1	0.1	0.0	0.2	5.1	0.2	0.0	0.4	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	2.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.1	0.3	0.1	0.4	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	1.3	1.1	1.4	0.0	0.9	0.5	0.0	0.7	0.1	0.2	1.2	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	1.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.7	1.2	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.1	0.0	0.1	0.0	19.5	1.2	0.0	0.1	0.0	1.6	0.0	0.0	0.0
INO80C	"C18orf37, FLJ38183, hIes6, IES6"	ENSG00000153391	"INO80 complex subunit C"	Q6PI98	18	35452230-35497979	"Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 184.7;Pancreatic endocrine cells: 165.1;Spermatocytes: 209.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049060	Approved		Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA049060: AB_2680617"	"unprognostic (3.40e-1)"	"prognostic favorable (3.58e-4)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (2.62e-5)"	"unprognostic (5.56e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.72e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.08e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.94e-3)"	"unprognostic (1.18e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.44e-2)"	"unprognostic (5.14e-3)"	"unprognostic (5.38e-2)"	16.3	17.5	23.4	14.6	24.6	46.6	16.1	25.1	24.0	14.9	29.6	21.3	18.6	12.1	13.7	46.1	13.8	13.1	25.8	23.3	28.5	22.0	19.3	17.6	26.4	22.7	22.9	23.1	9.9	13.4	8.0	29.4	20.9	23.4	14.0	22.0	33.9	20.8	9.3	42.8	40.8	18.8	11.1	20.5	31.4	30.7	93.1	28.7	22.1	15.3	30.9	29.5	21.6	21.0	24.1	46.5	30.1	27.1	14.9	9.5	23.6	29.7	17.5	13.2	27.3	36.5	37.5	38.7	77.4	36.6	11.9	41.6	31.3	52.4	112.7	24.8	22.9	28.3	97.8	36.0	40.7	21.0	57.4	60.1	10.7	31.9	70.7	37.9	33.7	80.0	32.3	30.4	27.8	44.7	49.3	36.4	48.5	34.6	32.2	18.0	28.5	19.2	26.5	58.4	58.9	37.3	25.8	27.9	31.6	23.4	41.8	31.5	46.1	51.5	30.9	13.5	24.0	32.3	24.1	28.4	137.8	25.2	52.7	19.2	21.3	14.8	35.6	12.3	20.6	12.2	24.9	17.0	16.3	22.2	17.8	17.2	14.2	23.0	12.4	18.3	33.5	21.7	11.8	23.4	24.6	25.1	24.0	23.3	28.5	22.7	22.9	23.1	23.4	20.5	28.7	24.1	40.2	6.4	10.1	5.9	19.5	24.0	22.1	72.3	18.8	4.4	16.3	15.2	17.8	18.6	31.6	12.9	4.2	59.8	14.0	81.4	31.3	43.9	184.7	16.7	6.6	30.5	15.0	29.0	15.6	40.0	105.1	14.1	41.8	14.4	20.3	9.0	22.1	16.6	52.2	5.0	11.3	20.4	36.7	17.9	15.0	49.6	6.2	16.4	23.2	6.5	14.1	22.8	14.4	9.0	10.9	165.1	76.0	7.2	26.4	20.7	48.8	80.9	31.5	14.1	0.0	18.5	15.6	209.0	40.3	35.3	39.9	73.2	16.4	11.9	35.9	34.7
IPP	KLHL27	ENSG00000197429	"Intracisternal A particle-promoted polypeptide"	Q9Y573	1	45694324-45750653	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 40.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075545	Approved					NA	NA					"HPA075545: "	"unprognostic (8.45e-3)"	"unprognostic (1.35e-1)"	"prognostic favorable (9.11e-4)"	"unprognostic (1.63e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.84e-3)"	"prognostic unfavorable (2.27e-4)"	"unprognostic (2.99e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.03e-2)"	"prognostic favorable (1.11e-4)"	"unprognostic (2.68e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.11e-1)"	5.6	4.5	3.1	3.8	4.6	3.4	6.2	4.0	2.9	4.9	3.4	5.7	4.9	6.6	5.4	6.3	6.6	5.0	7.1	2.6	4.8	7.1	6.9	4.3	4.4	4.0	3.9	2.5	7.6	6.6	9.6	2.3	4.0	3.6	7.1	5.7	7.4	5.7	6.5	14.4	5.1	5.4	5.7	3.7	3.8	5.1	10.2	3.7	6.6	9.8	9.1	5.0	3.8	2.9	5.0	9.6	9.1	8.0	11.8	9.8	18.2	6.2	9.9	7.1	6.9	7.0	5.6	6.8	5.2	10.1	12.3	7.9	6.7	8.8	7.3	9.9	12.2	5.2	7.3	7.7	6.9	9.8	2.1	6.2	15.5	8.3	15.0	8.1	8.0	6.8	9.4	9.0	10.3	12.2	6.4	7.3	0.4	4.8	7.0	4.9	3.1	14.7	4.3	5.7	10.4	11.5	7.5	19.1	10.3	9.5	9.1	10.0	1.8	7.9	7.5	9.2	5.3	7.9	8.3	10.4	9.2	12.0	3.1	11.9	4.1	0.6	3.5	4.6	0.4	3.4	3.1	2.7	3.7	0.7	2.6	3.4	4.0	2.6	3.7	0.8	0.6	4.7	2.5	3.1	4.6	4.0	2.9	2.6	4.8	4.0	3.9	2.5	3.6	3.7	3.7	5.0	7.6	12.8	10.0	11.1	7.9	2.5	5.6	7.6	6.8	12.4	6.5	4.8	18.8	5.7	8.1	5.5	12.5	7.8	4.7	10.1	3.9	6.5	26.0	10.7	10.1	5.2	5.4	3.0	5.4	7.3	6.9	9.6	9.7	6.7	12.7	15.9	3.3	5.9	1.4	18.5	7.1	6.8	6.1	1.3	1.1	7.6	7.2	2.8	1.8	4.7	3.4	19.0	18.6	6.0	11.9	5.8	4.6	6.4	7.4	3.9	9.5	8.4	10.1	16.8	0.0	14.0	9.3	40.8	14.7	6.7	4.7	7.7	8.4	23.5	5.8	4.9
ITGB6		ENSG00000115221	"Integrin subunit beta 6"	P18564	2	160099667-160200313	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Amelogenesis imperfecta, Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 80.7;tongue: 65.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 153.8;Alveolar cells type 2: 202.5;Basal prostatic cells: 153.5;Basal respiratory cells: 125.9;Pancreatic endocrine cells: 195.2;Spermatocytes: 286.0;Urothelial cells: 129.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 139.2;RPTEC TERT1: 269.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023626, CAB073536"	Approved		Approved	"Nucleoplasm,Cell Junctions,Centrosome"		NA	NA			"Nucleoplasm, Cell Junctions"	Centrosome	"CAB073536: , HPA023626: AB_2671267"	"unprognostic (1.27e-1)"	"unprognostic (1.57e-2)"	"unprognostic (6.90e-2)"	"unprognostic (8.22e-3)"	"unprognostic (3.61e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.72e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.06e-2)"	"prognostic unfavorable (5.03e-6)"	"unprognostic (1.04e-1)"	"unprognostic (2.73e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.00e-1)"	0.1	0.0	0.0	1.9	0.0	0.0	20.4	0.0	0.0	1.4	0.0	8.1	8.5	5.5	1.7	14.3	3.4	14.9	0.5	0.0	0.0	29.4	0.1	45.7	0.0	0.0	0.0	0.0	0.0	3.3	32.5	1.8	5.6	0.0	5.1	7.5	0.0	3.9	9.0	80.7	2.2	6.4	0.3	0.0	0.0	18.9	0.1	0.0	0.0	4.8	65.1	3.1	45.3	6.5	0.0	14.5	0.2	0.0	0.1	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.1	139.2	0.1	0.8	0.1	0.0	28.7	0.0	45.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	31.4	0.0	0.1	0.4	0.1	0.0	0.0	0.0	3.8	4.3	0.0	0.0	0.0	9.0	0.0	0.0	10.9	0.0	269.9	45.7	0.0	0.1	0.1	43.7	0.0	1.6	0.5	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	153.8	202.5	0.0	0.0	10.5	153.5	125.9	46.1	0.0	35.5	31.0	38.7	10.0	60.4	71.7	0.0	13.6	0.5	30.3	0.0	57.5	89.4	9.6	0.7	2.6	0.0	0.0	0.3	105.4	7.0	2.6	37.8	24.4	3.8	0.0	1.1	1.0	2.2	0.0	0.2	11.6	24.4	0.3	0.4	48.3	2.8	2.2	1.8	0.0	2.0	1.7	0.0	0.5	0.1	195.2	25.6	1.2	0.0	57.3	10.0	1.9	17.7	0.1	0.0	5.7	3.8	286.0	3.0	42.2	8.5	4.7	2.1	0.0	12.4	129.3
KAT7	"HBO1, HBOA, MYST2, ZC2HC7"	ENSG00000136504	"Lysine acetyltransferase 7"	O95251	17	49788648-49835026	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transcription factors"	"DNA damage, DNA repair, DNA replication, Transcription, Transcription regulation"	"Acyltransferase, Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044470, HPA071116"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA044470: AB_10965785, HPA071116: "	"unprognostic (1.30e-1)"	"unprognostic (3.15e-2)"	"unprognostic (6.20e-3)"	"unprognostic (2.20e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.33e-3)"	"unprognostic (2.75e-1)"	"unprognostic (5.03e-2)"	"unprognostic (6.23e-2)"	"unprognostic (7.68e-2)"	16.1	14.3	13.9	8.2	16.5	41.2	16.7	22.6	21.7	20.1	13.3	18.8	7.2	22.8	12.4	20.6	20.4	6.7	22.2	15.1	14.5	16.5	11.8	14.6	10.5	13.6	12.3	15.3	21.1	12.5	23.7	17.2	10.1	15.4	17.6	10.1	19.4	17.9	14.1	38.1	24.7	16.1	12.5	9.1	16.0	16.1	38.9	13.7	17.5	21.2	20.3	13.7	22.7	19.1	18.3	17.1	22.6	22.5	17.3	10.1	14.3	27.2	11.2	16.5	24.7	18.7	35.9	11.5	17.8	21.8	13.7	24.7	16.7	23.0	12.8	32.5	18.6	20.3	20.7	14.8	17.8	15.0	21.6	17.2	13.3	16.6	21.1	25.3	14.4	22.7	16.0	23.6	18.9	27.4	28.8	26.4	23.2	79.0	38.4	20.2	20.6	34.7	18.2	12.8	17.6	25.7	15.7	7.6	9.2	14.9	40.5	38.6	22.9	8.8	24.5	13.3	16.0	19.4	21.4	32.7	23.3	17.3	13.6	23.3	17.1	6.8	9.5	8.3	5.4	10.6	5.8	7.8	8.5	7.0	6.1	9.3	8.5	10.1	11.7	7.1	4.3	8.5	7.9	13.9	16.5	22.6	21.7	15.1	14.5	13.6	12.3	15.3	15.4	9.1	13.7	18.3	16.0	25.6	21.3	9.4	23.6	16.8	11.7	10.1	25.0	32.6	18.5	16.6	28.5	20.0	15.6	27.6	31.3	22.7	27.6	11.7	9.8	11.9	23.1	22.4	21.0	18.7	25.1	25.4	14.8	7.5	14.5	15.3	15.3	29.9	24.1	18.2	15.4	10.4	13.3	45.4	16.7	13.4	12.2	22.6	13.2	16.5	16.8	15.9	14.2	10.3	19.1	16.5	25.7	13.0	18.3	10.0	8.9	18.4	18.6	15.4	12.8	10.2	18.6	25.1	39.5	21.2	24.2	73.7	31.6	17.9	20.0	33.8	28.4	15.2	12.1	10.2
KATNAL1	MGC2599	ENSG00000102781	"Katanin catalytic subunit A1 like 1"	Q9BW62	13	30202630-30307551	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 144.3;Excitatory neurons: 80.6;Oligodendrocytes: 78.5;Spermatocytes: 59.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 63.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046205			Uncertain	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA046205: AB_10965325"	"unprognostic (3.34e-1)"	"unprognostic (6.44e-3)"	"unprognostic (2.08e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.43e-1)"	"unprognostic (4.68e-3)"	"unprognostic (4.54e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.84e-3)"	"unprognostic (7.41e-2)"	"unprognostic (6.42e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.83e-3)"	8.8	3.9	7.9	5.0	9.5	6.5	4.8	8.4	10.0	9.7	0.1	6.5	1.4	9.4	2.7	5.8	4.9	3.9	18.1	8.1	10.4	4.1	3.9	5.0	6.6	7.5	7.4	6.8	4.3	1.9	2.2	3.0	3.0	8.9	4.6	4.1	7.9	2.2	5.9	5.1	2.6	2.8	15.1	9.0	3.4	2.8	21.0	8.9	9.3	3.0	6.7	7.1	5.0	5.3	12.5	11.7	9.6	16.5	8.8	12.3	26.0	0.4	47.5	15.2	24.9	19.4	1.9	11.6	18.8	5.5	63.7	31.3	3.2	11.8	12.2	37.5	16.3	4.4	13.4	11.2	4.4	6.5	6.7	8.7	10.1	6.0	28.0	6.8	23.3	26.4	10.2	7.3	8.1	30.8	2.4	15.2	6.1	7.1	0.2	6.1	16.8	19.4	1.9	8.8	0.8	6.8	14.3	12.6	2.6	9.0	13.6	4.1	4.1	24.2	21.8	32.7	12.1	19.3	4.2	8.2	25.8	8.7	6.5	32.1	1.5	0.7	2.9	4.4	0.4	2.1	1.9	3.4	4.4	1.9	4.5	0.8	1.8	0.2	7.7	0.9	5.5	5.8	1.2	7.9	9.5	8.4	10.0	8.1	10.4	7.5	7.4	6.8	8.9	9.0	8.9	12.5	12.9	9.6	1.8	30.3	7.2	5.9	3.9	4.7	6.2	10.2	4.0	5.6	41.4	2.8	2.3	5.5	27.1	0.4	6.6	0.3	3.9	6.5	144.3	10.3	26.5	9.3	10.2	16.4	80.6	1.5	0.8	12.3	1.5	3.6	10.1	10.3	7.9	10.6	2.9	21.9	34.5	1.0	0.0	2.8	8.9	50.7	9.0	5.9	17.8	21.5	21.9	9.6	13.4	29.1	78.5	5.7	0.0	5.3	6.4	1.9	0.3	8.4	14.7	18.7	6.6	11.9	13.7	59.0	24.6	5.2	5.7	0.3	9.8	19.2	0.7	1.7
KBTBD3	BKLHD3	ENSG00000182359	"Kelch repeat and BTB domain containing 3"	Q8NAB2	11	106051098-106077459	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 103.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047385	Uncertain					NA	NA					"HPA047385: AB_2680023"	"unprognostic (9.57e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.43e-2)"	"unprognostic (4.09e-2)"	"unprognostic (8.73e-3)"	"unprognostic (6.35e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.63e-2)"	"unprognostic (2.43e-1)"	"prognostic favorable (3.42e-7)"	"unprognostic (2.36e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.55e-2)"	2.2	2.6	4.3	1.7	5.3	1.2	2.9	9.5	7.0	2.7	2.2	2.4	1.9	2.5	4.4	1.9	2.4	1.1	3.2	4.3	5.2	4.3	2.8	2.3	1.7	5.7	5.2	4.1	3.7	3.8	2.8	3.9	1.0	6.6	2.4	1.7	10.4	3.9	2.9	3.5	2.2	2.3	1.9	5.4	2.0	2.4	3.7	5.5	2.2	4.0	3.1	1.9	2.4	2.4	9.1	1.9	1.3	2.6	3.1	3.3	3.4	0.6	1.6	2.0	1.4	0.9	1.1	3.6	1.0	4.2	0.5	1.9	1.2	1.3	1.3	1.0	2.0	0.5	2.7	0.8	1.0	1.5	1.1	2.4	1.3	3.9	1.2	1.2	2.9	1.9	1.8	1.0	2.6	1.3	0.3	2.6	2.7	1.1	2.2	1.7	1.2	1.6	4.7	4.9	0.4	2.1	2.6	2.4	2.4	2.0	1.9	3.0	1.5	1.6	0.7	1.1	0.6	0.6	0.9	0.6	2.4	1.4	2.4	1.2	30.8	5.6	18.5	12.1	3.2	11.0	13.2	13.7	12.6	7.5	10.9	12.9	11.6	3.6	15.0	3.4	4.5	15.5	7.2	4.3	5.3	9.5	7.0	4.3	5.2	5.7	5.2	4.1	6.6	5.4	5.5	9.1	13.0	9.6	12.8	11.1	10.8	6.2	16.5	38.6	12.5	17.6	13.3	16.0	28.5	18.6	18.9	12.9	20.9	10.8	9.3	8.8	37.2	14.4	103.5	11.5	5.3	12.7	6.0	5.7	23.5	29.5	8.8	14.3	6.1	14.3	16.5	6.9	15.7	19.2	9.7	16.8	22.6	15.0	40.7	6.3	10.4	22.8	11.8	6.4	19.6	10.3	14.5	21.4	18.6	23.1	44.3	13.4	14.1	17.0	5.6	6.2	19.0	34.3	17.8	19.3	13.1	10.9	10.2	21.5	4.6	5.2	9.8	2.6	15.4	10.3	13.5	10.1
KCTD19	FLJ40162	ENSG00000168676	"Potassium channel tetramerization domain containing 19"	Q17RG1	16	67289428-67326760	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 33.2"	"Group enriched"	"Detected in some"	8	"Early spermatids: 49.2;Spermatocytes: 72.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 1.6;neutrophil: 2.9;plasmacytoid DC: 2.7"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.7;granulocytes: 2.9"	"Cell line enhanced"	"Detected in some"		"JURKAT: 6.4;U-266/70: 5.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA049310, HPA053321"	Uncertain					NA	NA					"HPA049310: AB_2680706, HPA053321: AB_2682110"	"unprognostic (2.44e-1)"	"unprognostic (2.14e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.60e-2)"	"unprognostic (9.01e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.88e-4)"	"unprognostic (4.44e-1)"	"unprognostic (2.76e-3)"	"unprognostic (1.19e-2)"	"unprognostic (2.91e-2)"	"unprognostic (9.71e-2)"	"unprognostic (8.44e-2)"	0.1	0.0	2.2	0.8	3.0	3.3	0.1	3.3	3.3	0.2	0.8	0.1	0.3	0.5	1.3	0.5	0.4	0.8	0.0	2.5	1.8	0.2	0.1	0.2	0.1	3.7	2.4	2.0	0.0	0.1	0.1	0.2	0.3	5.5	0.1	0.2	0.3	0.3	0.1	0.6	1.5	0.3	0.2	1.5	0.4	0.4	33.2	2.8	0.5	0.4	0.1	0.1	0.4	0.0	5.2	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.6	0.4	0.6	0.3	0.6	0.3	0.5	0.3	0.0	0.0	0.0	0.6	0.0	2.0	0.4	1.5	0.6	0.4	0.0	0.3	0.2	0.2	0.4	0.5	0.6	0.3	0.0	0.1	6.4	0.4	0.1	0.0	0.0	0.5	0.5	0.0	0.4	0.0	0.1	0.2	0.0	0.0	0.2	0.4	0.8	0.1	0.3	0.1	0.6	0.1	0.3	0.6	0.0	0.4	1.7	0.0	5.6	1.1	0.3	0.6	0.0	0.5	1.6	0.4	0.4	0.2	0.2	0.2	0.3	0.2	0.2	0.1	0.4	0.2	0.2	2.9	0.4	0.2	2.7	0.2	0.4	2.2	3.0	3.3	3.3	2.5	1.8	3.7	2.4	2.0	5.5	1.5	2.8	5.2	0.1	0.0	2.3	0.7	0.1	0.4	1.5	0.0	0.0	1.1	0.3	0.1	1.3	0.0	1.3	0.0	6.2	0.2	4.2	0.0	0.0	0.1	49.2	0.1	0.1	0.3	0.0	0.0	0.6	0.0	0.2	0.6	0.0	0.1	0.0	0.8	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	1.3	7.5	0.9	0.5	3.6	0.0	0.6	0.2	0.0	1.0	0.4	0.0	0.0	0.7	0.1	1.0	0.1	0.1	0.0	2.5	0.0	1.2	0.6	72.7	6.1	0.0	0.3	0.1	0.4	0.2	0.2	1.4
KDM4D	"FLJ10251, JMJD2D"	ENSG00000186280	"Lysine demethylase 4D"	Q6B0I6	11	94973709-94999519	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"testis: 33.6"	"Group enriched"	"Detected in many"	7	"Early spermatids: 115.7;Late spermatids: 43.7;Spermatocytes: 102.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 2.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA055854, HPA064037"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA055854: AB_2682944, HPA064037: AB_2685180"	"unprognostic (1.98e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.83e-1)"	"unprognostic (9.65e-3)"	"unprognostic (3.19e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.16e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-2)"	"unprognostic (5.62e-2)"	"unprognostic (4.49e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.88e-1)"	0.4	0.6	0.5	0.3	0.5	0.0	0.8	0.5	0.6	0.5	0.4	0.2	0.1	0.5	0.8	0.3	1.0	0.4	1.0	0.5	0.5	0.5	0.3	0.4	0.7	0.6	0.5	0.5	0.9	0.3	0.9	0.5	0.4	0.5	0.6	0.3	2.1	0.6	0.6	0.6	0.7	0.3	0.5	0.5	0.6	0.3	33.6	0.5	0.6	0.7	0.7	0.6	0.4	0.3	0.6	0.5	0.8	3.3	2.4	0.7	0.8	1.5	1.1	1.2	3.0	2.6	0.9	1.0	1.2	3.5	0.9	2.9	1.0	2.1	2.3	2.3	1.4	2.2	1.1	0.4	1.3	0.6	0.5	0.3	1.5	1.2	3.0	2.7	0.4	1.1	4.4	1.2	0.5	1.2	1.0	1.9	1.2	1.4	0.8	4.0	2.6	1.4	0.9	0.7	0.3	1.9	2.3	1.3	1.1	0.9	1.7	1.2	0.4	0.9	2.0	1.2	3.2	1.7	0.7	2.5	0.2	0.7	0.6	2.3	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.2	0.3	0.0	0.0	0.2	0.0	0.0	0.0	2.1	0.4	0.6	0.1	0.5	0.5	0.5	0.6	0.5	0.5	0.6	0.5	0.5	0.5	0.5	0.5	0.6	0.8	0.0	0.0	2.6	0.2	0.0	0.2	0.8	0.6	7.0	0.8	0.9	1.1	1.5	0.4	0.0	2.1	0.9	1.6	0.0	3.9	0.8	115.7	1.3	1.4	1.1	0.0	0.4	1.8	0.6	0.9	0.9	0.5	0.4	0.0	2.6	2.2	1.3	0.7	3.3	2.6	0.1	0.0	0.6	0.3	43.7	2.1	0.8	0.0	4.7	0.7	3.9	1.0	3.5	4.3	0.2	0.1	1.2	0.5	0.2	0.0	1.3	1.0	3.3	0.0	0.8	0.7	102.5	11.4	0.7	0.0	0.3	0.3	2.5	0.3	0.2
KDM5B	"CT31, JARID1B, PLU-1, PPP1R98, RBBP2H1A"	ENSG00000117139	"Lysine demethylase 5B"	Q9UGL1	1	202724495-202808487	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase, Repressor"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 62.8"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 243.6;Spermatocytes: 390.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027179, HPA053723, CAB068193"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"CAB068193: AB_2665696, HPA027179: AB_1851987, HPA053723: AB_2682241"	"unprognostic (1.19e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.49e-3)"	"unprognostic (3.02e-2)"	"unprognostic (3.23e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.61e-2)"	"unprognostic (4.79e-2)"	"unprognostic (8.25e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.56e-2)"	"unprognostic (4.13e-1)"	8.9	7.7	2.3	2.6	3.0	14.2	10.0	5.6	4.4	13.9	7.0	10.5	2.1	12.7	3.4	21.2	10.0	2.9	5.5	5.4	2.6	5.8	4.7	10.9	2.2	1.2	1.2	4.2	13.0	8.3	2.6	7.0	4.8	2.8	10.7	2.3	17.9	12.6	2.4	4.8	24.3	8.7	3.2	0.9	7.5	8.8	62.8	1.6	4.2	8.5	0.8	2.1	11.0	15.8	4.7	9.9	2.4	14.0	9.8	7.2	6.6	23.7	6.2	9.4	6.2	6.4	2.2	8.8	0.1	5.7	7.9	2.3	11.8	9.0	8.3	5.4	0.5	12.8	7.7	2.4	1.9	5.5	17.7	8.9	9.4	12.1	7.0	7.2	10.1	11.7	7.3	20.9	0.3	4.9	6.3	5.8	16.4	21.9	4.3	28.0	18.7	0.1	0.4	6.5	10.7	10.7	23.4	14.7	7.9	8.7	15.7	16.6	10.5	12.8	8.2	5.8	1.4	5.2	2.3	1.1	8.2	6.0	5.5	4.1	44.6	6.4	19.6	7.7	4.8	4.6	10.9	8.9	4.3	4.2	17.4	9.6	6.0	34.4	12.9	10.4	6.6	7.2	3.9	2.3	3.0	5.6	4.4	5.4	2.6	1.2	1.2	4.2	2.8	0.9	1.6	4.7	24.5	89.8	38.5	46.7	22.2	64.4	34.8	53.0	84.2	35.5	57.1	50.0	9.5	11.5	53.6	16.5	62.6	41.8	12.4	23.7	5.9	47.6	191.6	65.2	71.8	31.9	43.6	50.2	75.8	22.3	34.3	42.7	47.9	69.5	27.1	28.6	17.2	10.9	7.7	15.2	53.5	38.1	44.7	15.1	21.9	243.6	36.4	15.5	26.6	40.3	11.3	69.8	10.3	39.7	42.5	45.4	21.8	32.7	25.8	43.1	15.2	8.2	61.9	138.6	32.9	22.8	40.2	390.9	71.0	95.9	116.2	82.4	21.2	61.5	30.2	55.6
KIF4B		ENSG00000226650	"Kinesin family member 4B"	Q2VIQ3	5	155013755-155018141	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	19	"testis: 3.5"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 2.1;Early spermatids: 5.4;Late spermatids: 4.3;Spermatocytes: 9.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA034745, HPA034746, HPA061583"	Uncertain		Uncertain	Nucleoplasm,Midbody		Yes	NA			"Nucleoplasm, Midbody"		"HPA034745: AB_10670978, HPA034746: AB_10670173, HPA061583: AB_2684564"	"unprognostic (9.87e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.91e-3)"	"unprognostic (1.71e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.71e-1)"		"unprognostic (4.76e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.37e-2)"		"unprognostic (6.48e-9)"	"unprognostic (7.24e-2)"	"unprognostic (5.10e-2)"		"unprognostic (1.71e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	4.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	9.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0
KLB		ENSG00000134962	"Klotho beta"	Q86Z14	4	39406930-39451533	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adipose tissue: 19.8;liver: 17.9;pancreas: 6.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 19.6;Enteroendocrine cells: 17.4;Hepatocytes: 51.4;Intestinal goblet cells: 12.1;Spermatocytes: 39.5"	"Cancer enriched"	"Detected in some"	16	"liver cancer: 11.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	24	"ASC diff: 6.7;Hep G2: 25.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA021136	Uncertain					NA	NA		320000			"HPA021136: AB_1852616"	"unprognostic (1.03e-2)"	"unprognostic (1.61e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.30e-2)"	"unprognostic (7.02e-3)"	"unprognostic (2.46e-1)"	"unprognostic (9.92e-2)"	"unprognostic (6.99e-3)"	"unprognostic (4.51e-3)"	"unprognostic (3.02e-3)"	"unprognostic (8.90e-3)"	"unprognostic (1.73e-1)"	"unprognostic (5.03e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.09e-2)"	19.8	0.1	0.2	0.2	0.4	0.3	3.5	0.9	0.6	0.0	0.0	0.6	0.2	0.0	0.0	0.3	0.2	0.2	0.1	0.2	0.3	0.2	17.9	1.6	0.0	0.4	0.2	0.2	0.0	6.1	0.1	0.0	0.0	0.3	0.1	0.5	0.1	0.4	0.0	0.0	0.6	0.6	0.0	0.1	0.0	1.4	2.8	0.2	0.0	0.0	0.2	0.1	0.1	0.1	0.5	0.0	0.3	0.1	0.0	6.7	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	25.7	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.1	0.3	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.6	0.0	0.0	0.2	0.4	0.9	0.6	0.2	0.3	0.4	0.2	0.2	0.3	0.1	0.2	0.5	0.6	3.2	19.6	0.0	0.7	0.5	1.1	1.4	0.0	1.6	0.7	1.1	1.2	0.0	1.2	0.0	0.0	0.4	0.5	1.6	0.0	1.1	8.5	4.4	1.5	0.4	17.4	0.0	0.5	4.3	1.5	0.5	2.6	2.2	0.0	0.2	0.4	51.4	0.2	1.7	0.6	12.1	2.0	1.0	0.6	3.2	1.5	0.4	1.8	0.0	0.1	0.4	0.0	0.5	0.2	0.9	4.8	0.7	0.0	1.2	2.1	1.1	0.4	2.3	0.0	1.2	0.5	39.5	0.9	2.0	0.9	1.4	0.8	0.5	1.1	1.1
KRBOX1		ENSG00000240747	"KRAB box domain containing 1"	C9JBD0	3	42809483-42942792	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in many"	24	"testis: 199.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 250.9;Late spermatids: 111.3;Spermatocytes: 883.9;Spermatogonia: 176.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 4.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 22.2;CAPAN-2: 50.0;EFO-21: 22.6;GAMG: 35.2;hTEC/SVTERT24-B: 33.7;hTERT-HME1: 23.0;U-2197: 67.7"									HPA046901			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA046901: AB_2797232"	"unprognostic (2.62e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.53e-3)"	"unprognostic (7.63e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.27e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.95e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.28e-1)"	2.9	4.8	2.9	0.2	2.9	0.6	4.0	3.1	3.9	4.8	2.8	3.8	1.7	5.3	8.1	4.4	3.9	1.2	3.0	3.0	3.0	3.6	0.6	1.6	0.9	3.0	2.9	2.9	7.0	3.9	0.8	4.1	1.3	3.0	3.7	2.0	2.0	2.4	5.4	1.6	5.2	1.8	4.7	2.9	1.2	2.8	199.4	3.0	1.5	5.2	1.1	1.6	3.8	3.3	3.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	8.7	22.2	0.2	0.0	0.1	50.0	0.0	22.6	1.8	35.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	9.7	0.0	33.7	23.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.9	0.0	0.0	0.0	0.0	0.0	17.0	0.0	67.7	0.0	7.4	2.6	0.0	3.8	0.0	1.4	0.0	0.3	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.4	0.0	4.0	0.7	1.0	0.3	0.0	2.9	2.9	3.1	3.9	3.0	3.0	3.0	2.9	2.9	3.0	2.9	3.0	3.1	2.2	0.0	2.6	1.6	0.1	0.0	2.6	0.0	0.6	8.8	4.2	11.3	5.6	2.8	1.8	5.5	2.1	12.0	0.2	0.4	19.6	4.2	250.9	4.4	7.7	1.6	0.0	0.0	0.8	12.0	10.1	6.1	0.0	2.5	0.0	3.8	1.4	1.0	2.2	1.7	1.4	1.4	0.0	0.0	0.0	111.3	20.2	1.0	0.0	1.0	0.0	18.3	1.0	1.5	1.0	6.8	3.2	13.5	0.0	1.8	1.2	3.1	0.7	8.8	13.1	5.2	6.9	883.9	176.0	0.6	0.0	9.0	0.2	14.3	2.8	1.0
KRT72	"K6irs, K6IRS2, KRT6, KRT6IRS2"	ENSG00000170486	"Keratin 72"	Q14CN4	12	52585589-52601538	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"skin 1: 10.5;testis: 23.9"	"Group enriched"	"Detected in some"	4	"Early spermatids: 26.3;Late spermatids: 67.5;Spermatocytes: 55.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA065523	Enhanced					NA	NA					"HPA065523: AB_2685504"	"unprognostic (3.36e-1)"	"unprognostic (7.20e-2)"				"unprognostic (3.41e-2)"		"unprognostic (1.02e-1)"			"unprognostic (6.97e-2)"	"unprognostic (4.38e-3)"	"unprognostic (4.82e-3)"	"unprognostic (2.88e-2)"	"unprognostic (9.16e-2)"		"unprognostic (1.19e-1)"	0.1	0.1	0.0	0.7	0.0	1.2	0.1	0.1	0.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.7	2.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	10.5	2.2	0.0	0.0	2.3	0.0	23.9	0.0	0.5	0.1	0.0	0.7	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	26.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.5	1.5	0.1	0.0	0.0	0.1	0.0	12.3	0.0	0.1	0.0	2.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	55.9	0.2	0.0	0.4	0.0	0.3	0.0	0.1	0.0
LCA5L	"C21orf13, MGC33295"	ENSG00000157578	"Lebercilin LCA5 like"	O95447	21	39405728-39445805	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"testis: 111.4"	"Group enriched"	"Detected in many"	11	"Early spermatids: 1312.6;Late spermatids: 472.4;Spermatocytes: 465.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 3.7;T-47d: 3.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA019790, HPA032010"	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA019790: AB_1845690, HPA032010: AB_2674110"	"unprognostic (1.02e-1)"	"unprognostic (3.81e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.54e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.15e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.85e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.37e-1)"	"unprognostic (7.53e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.04e-2)"	"unprognostic (9.68e-3)"	"unprognostic (1.95e-1)"	0.4	1.7	2.3	0.4	0.8	0.3	1.7	1.4	0.8	1.8	2.6	0.5	0.4	1.2	7.7	0.4	7.3	0.8	0.5	0.7	0.8	2.5	0.7	1.5	0.3	1.5	1.7	0.1	0.9	1.3	2.3	2.0	0.3	1.3	0.8	0.5	10.9	0.9	0.9	2.2	0.9	0.4	0.6	2.3	0.4	0.8	111.4	0.9	0.3	4.4	1.5	0.2	0.5	0.5	1.8	0.9	1.0	0.6	1.7	0.8	0.7	0.1	0.2	0.4	0.5	0.0	0.5	1.0	0.7	0.7	0.9	0.2	0.2	0.1	0.5	0.3	0.3	0.8	0.4	0.8	0.1	0.7	1.1	0.0	0.6	2.3	1.6	1.7	1.1	0.3	1.0	1.7	0.6	0.6	3.7	0.3	0.4	3.2	0.6	1.0	0.2	0.2	0.7	1.7	0.3	1.1	0.5	2.0	0.8	1.4	0.3	3.9	0.1	0.1	0.3	0.2	0.9	0.2	1.8	1.1	0.1	1.4	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.8	1.4	0.8	0.7	0.8	1.5	1.7	0.1	1.3	2.3	0.9	1.8	1.1	3.2	0.5	5.5	0.3	0.5	0.9	2.7	1.2	2.0	4.5	5.0	2.6	1.5	16.8	7.3	6.2	1.1	0.1	0.4	19.6	3.5	1312.6	34.9	2.4	1.6	4.2	0.0	3.8	2.2	0.2	2.2	0.5	2.8	0.0	1.8	1.4	1.6	0.5	1.7	2.6	1.4	0.0	0.6	0.7	472.4	6.5	1.3	1.8	1.0	0.6	3.2	0.0	0.5	2.1	1.6	0.5	7.9	0.0	0.6	0.2	12.0	68.0	17.4	19.7	3.6	1.7	465.8	26.7	0.3	0.6	0.3	0.3	3.2	0.9	0.7
LDHAL6A	"LDH6A, MGC23940"	ENSG00000166800	"Lactate dehydrogenase A like 6A"	Q6ZMR3	11	18455824-18479601	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 9.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 13.3;Excitatory neurons: 3.5;Late spermatids: 7.4;Spermatocytes: 19.3;Spermatogonia: 3.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 1.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HL-60: 11.0"															NA	NA						"unprognostic (1.41e-1)"	"unprognostic (4.84e-2)"	"unprognostic (8.95e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.31e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.35e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.31e-3)"	"unprognostic (1.48e-1)"	0.1	0.5	0.1	0.3	0.2	1.0	0.1	1.5	0.4	0.0	0.0	0.1	0.6	0.2	0.2	0.2	0.1	0.2	0.1	0.2	0.1	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.3	0.3	0.0	0.1	0.2	0.6	0.1	0.1	1.1	0.2	0.2	0.1	1.0	0.5	0.0	0.0	0.3	0.3	9.9	0.1	0.1	0.5	0.0	0.2	0.0	0.0	0.5	0.1	0.3	0.7	0.5	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.2	0.3	0.6	0.1	0.0	0.1	0.3	0.0	0.2	0.3	0.5	0.5	0.4	0.7	0.3	0.0	11.0	0.5	0.1	0.2	0.0	0.1	0.1	0.0	0.7	0.3	0.7	0.0	0.2	0.3	0.8	0.2	0.1	0.4	0.5	0.3	0.2	0.1	0.7	0.3	0.3	0.3	0.2	0.1	0.3	0.2	1.5	0.5	0.4	0.1	0.6	0.2	0.2	0.2	0.1	0.2	0.4	0.2	0.6	0.0	0.1	0.4	0.0	0.0	0.2	0.0	0.1	0.1	0.2	0.2	0.2	0.7	0.3	0.1	0.0	0.3	0.1	0.1	0.2	1.5	0.4	0.2	0.1	0.1	0.0	0.1	0.6	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	13.3	0.1	0.1	0.1	0.0	0.0	3.5	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	7.4	0.9	0.1	0.0	0.0	0.0	0.9	1.0	1.5	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.2	0.0	19.3	3.5	0.0	0.0	0.3	0.0	0.3	0.0	0.0
LDHAL6B	"LDH6B, LDHAL6, LDHL"	ENSG00000171989	"Lactate dehydrogenase A like 6B"	Q9BYZ2	15	59206843-59208588	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"testis: 41.0"	"Cell type enriched"	"Detected in some"	13	"Spermatocytes: 101.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HeLa: 1.1"	"Region enriched"	"Detected in single"	6	"olfactory bulb: 1.3"					HPA053962	Enhanced					NA	NA					"HPA053962: AB_2682324"	"unprognostic (1.59e-1)"	"unprognostic (9.41e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.46e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.13e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.12e-7)"	"unprognostic (3.47e-2)"	"unprognostic (1.49e-2)"	"unprognostic (8.53e-2)"	"unprognostic (7.80e-2)"	0.2	0.0	0.5	0.2	0.7	0.0	0.2	0.5	0.8	0.2	2.0	0.2	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.2	0.4	0.2	0.3	0.1	0.1	0.8	0.5	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.1	0.0	0.1	0.3	0.3	0.0	0.6	0.0	0.1	41.0	0.7	0.0	0.1	0.0	0.0	0.1	0.2	1.8	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.5	0.8	0.2	0.4	0.8	0.5	0.0	1.0	0.6	0.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	101.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LDHC	CT32	ENSG00000166796	"Lactate dehydrogenase C"	P07864	11	18412318-18452063	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	177	"testis: 267.6"	"Group enriched"	"Detected in many"	7	"Early spermatids: 1441.7;Spermatocytes: 1584.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"SK-BR-3: 2.1;U-2197: 5.1;U-266/70: 4.5;U-266/84: 4.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA045442	Enhanced					NA	NA					"HPA045442: AB_10966720"	"unprognostic (2.32e-2)"	"unprognostic (3.42e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.19e-1)"	"unprognostic (8.56e-4)"	"unprognostic (1.35e-1)"	"unprognostic (5.74e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.30e-2)"	"unprognostic (3.00e-1)"	"unprognostic (4.25e-1)"	"unprognostic (1.93e-1)"	0.1	0.2	0.6	0.0	0.6	0.4	0.4	1.2	1.0	0.1	0.4	0.4	0.3	0.0	0.6	0.3	0.6	0.0	0.3	0.7	0.3	0.6	1.5	0.2	0.4	0.4	0.4	0.7	0.4	1.4	0.0	0.2	0.1	0.7	0.3	0.0	0.6	0.5	0.0	0.7	0.4	0.7	0.1	0.2	0.1	0.1	267.6	0.6	0.3	0.6	0.2	0.7	0.2	0.0	0.5	0.0	0.0	0.1	1.2	0.9	0.9	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.1	0.7	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.6	0.1	0.1	0.3	0.0	0.2	0.1	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.3	2.1	0.3	0.0	0.1	0.0	0.5	0.2	1.6	5.1	0.0	4.5	4.2	0.2	0.1	0.0	0.0	0.6	0.2	0.3	0.1	0.3	0.6	0.2	0.5	0.6	0.0	0.7	1.0	0.7	1.1	0.0	0.3	0.9	0.6	0.3	0.6	0.6	1.2	1.0	0.7	0.3	0.4	0.4	0.7	0.7	0.2	0.6	0.5	1.9	0.0	0.0	1.3	1.3	0.1	0.8	0.4	1.2	0.1	2.5	3.2	0.9	0.0	1.0	1.8	0.0	0.0	0.1	0.4	3.9	1.6	1441.7	3.7	0.8	2.0	0.0	0.4	1.0	6.3	0.1	1.3	0.5	1.9	0.0	0.3	0.4	0.2	0.2	0.0	0.9	0.2	0.0	0.0	0.4	209.5	23.3	2.7	0.0	1.9	0.0	1.5	0.0	1.0	2.0	2.0	0.0	18.0	0.9	0.3	0.0	3.5	1.2	0.6	19.7	1.2	1.2	1584.7	30.7	1.0	0.6	0.0	1.4	0.1	0.0	0.3
LEKR1	FLJ16641	ENSG00000197980	"Leucine, glutamate and lysine rich 1"		3	156825481-157046129	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"testis: 12.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 96.8;Late spermatids: 47.7;Respiratory ciliated cells: 28.0;Spermatocytes: 65.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 3.3;U-266/70: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044039, HPA047774"	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA044039: AB_10794288, HPA047774: "	"unprognostic (5.42e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.22e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.98e-2)"	"unprognostic (7.55e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.66e-3)"	"unprognostic (3.50e-2)"	"unprognostic (5.99e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.80e-2)"	0.9	1.0	1.2	0.3	0.9	0.2	1.6	1.0	0.7	0.4	1.6	0.6	1.1	0.7	3.4	0.3	3.9	0.4	0.9	0.9	1.7	1.4	0.7	0.6	1.1	1.7	1.6	0.6	0.9	1.0	1.5	1.5	0.2	1.4	0.9	0.6	1.8	0.6	0.6	0.2	0.4	0.6	0.4	2.0	0.5	0.9	12.9	0.9	0.7	2.4	0.2	0.4	0.5	0.2	1.0	3.3	1.2	0.0	0.7	0.4	0.2	0.1	0.1	0.5	0.6	0.5	0.1	1.7	0.0	0.9	0.4	1.2	1.2	0.0	0.3	1.3	0.5	0.3	1.0	0.1	0.0	0.0	1.0	0.2	1.5	0.8	0.1	0.9	0.3	0.3	0.0	0.7	0.6	1.2	1.2	0.0	0.7	1.0	0.9	0.7	0.0	0.8	0.8	1.0	0.2	1.9	0.7	1.0	0.7	0.0	0.2	2.2	1.8	0.0	0.1	0.3	0.2	0.5	2.9	0.5	0.0	0.5	0.7	1.0	0.6	0.0	0.0	0.2	0.0	0.4	0.8	0.4	0.0	0.3	0.9	0.4	0.2	0.0	0.7	0.0	0.5	0.6	0.1	1.2	0.9	1.0	0.7	0.9	1.7	1.7	1.6	0.6	1.4	2.0	0.9	1.0	0.5	0.0	1.1	19.9	6.3	1.3	1.1	1.4	2.8	1.2	2.7	3.9	1.5	1.5	2.8	3.7	2.1	0.3	0.7	1.5	3.9	0.7	96.8	20.7	1.4	0.6	0.0	2.1	6.5	1.6	0.1	1.1	9.7	2.8	1.3	1.4	0.0	1.8	0.2	3.3	11.8	0.9	0.0	1.6	1.3	47.7	1.5	1.8	1.8	3.7	1.1	1.7	0.0	8.0	8.0	1.0	0.6	1.9	2.5	0.7	1.2	5.4	28.0	4.8	0.0	0.6	1.4	65.2	4.3	2.2	0.9	0.1	2.3	1.1	0.9	0.8
LETM2	"FLJ25409, SLC55A2"	ENSG00000165046	"Leucine zipper and EF-hand containing transmembrane protein 2"	Q2VYF4	8	38386207-38409527	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 24.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 76.9;Late spermatids: 57.6;Pancreatic endocrine cells: 48.6;Spermatocytes: 54.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"neutrophil: 21.5"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 21.5"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 25.2;hTERT-HME1: 26.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 24.0"	HPA025032	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		Yes	No			Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA025032: AB_1852808"	"unprognostic (3.37e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.27e-4)"	"unprognostic (3.20e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.27e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.25e-2)"	0.8	1.0	3.9	1.1	3.7	5.4	0.7	5.4	5.0	1.6	2.8	0.7	0.8	1.4	1.1	1.2	1.4	1.2	0.8	3.2	3.0	2.4	0.7	2.0	1.3	2.6	3.0	3.2	2.1	0.7	1.6	1.3	1.8	3.5	1.1	0.9	4.3	0.4	0.8	0.2	1.1	0.5	0.6	2.0	1.6	2.7	24.0	3.2	2.4	1.0	0.3	1.5	1.9	0.7	4.4	21.2	4.5	3.0	2.9	2.3	7.0	2.5	7.5	9.2	10.6	6.2	1.5	8.3	2.8	16.5	1.5	3.1	2.2	5.9	25.2	11.7	1.2	2.9	3.2	2.3	4.2	2.7	0.7	2.8	1.7	7.2	11.7	26.9	5.9	10.7	3.4	2.6	3.9	9.3	4.2	7.5	1.8	0.8	1.6	18.2	2.9	4.8	1.6	16.8	1.1	2.4	2.3	2.5	0.4	0.9	1.8	2.4	1.2	20.0	3.3	22.5	7.4	1.7	2.6	1.6	2.0	5.6	3.3	2.5	1.3	4.1	0.7	0.9	1.6	2.0	1.5	0.9	1.5	1.7	1.8	1.7	1.7	21.5	1.4	5.0	0.7	5.2	1.3	3.9	3.7	5.4	5.0	3.2	3.0	2.6	3.0	3.2	3.5	2.0	3.2	4.4	3.0	3.2	6.4	2.3	10.3	0.5	13.9	7.6	6.8	6.6	2.1	3.3	1.8	4.3	3.2	5.5	6.2	2.6	10.1	1.4	1.9	4.0	76.9	21.8	7.1	4.2	0.0	0.8	3.6	20.5	7.9	5.0	16.8	20.5	9.5	1.1	1.4	0.0	1.4	6.7	7.3	1.9	2.0	2.2	2.3	57.6	2.1	3.6	1.8	1.0	2.0	3.6	1.0	1.5	1.6	48.6	0.1	1.5	4.5	2.9	0.3	3.0	4.9	8.4	0.0	4.5	3.3	54.8	3.3	2.5	0.9	8.1	9.1	1.5	1.3	4.5
LIPT1	"MGC12290, MGC13378"	ENSG00000144182	"Lipoyltransferase 1"	Q9Y234	2	99154955-99163157	"Disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 41.0;Spermatocytes: 40.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA034802	Approved					NA	NA					"HPA034802: AB_10669851"	"unprognostic (1.13e-2)"	"unprognostic (7.21e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.32e-2)"	"unprognostic (7.46e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.13e-3)"	"prognostic favorable (5.70e-4)"	"unprognostic (1.49e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.72e-1)"	"unprognostic (4.92e-2)"	"unprognostic (3.16e-1)"	"prognostic favorable (9.60e-8)"	7.0	7.8	6.8	6.9	7.7	12.5	11.0	7.5	8.4	7.2	6.4	6.8	8.5	8.2	14.2	5.1	8.2	6.6	7.9	7.3	7.2	9.0	8.2	5.7	10.8	7.5	7.6	6.5	11.9	7.3	6.3	6.7	4.9	7.4	9.2	7.3	7.6	9.0	6.0	9.2	7.1	8.4	5.7	7.3	12.0	7.0	13.6	7.1	5.4	11.4	9.0	7.4	6.3	5.7	10.6	6.2	4.0	5.4	9.2	9.3	11.0	13.0	4.0	4.7	3.1	3.4	9.8	10.3	9.9	8.4	2.4	8.4	5.4	6.6	5.0	6.1	10.6	12.0	10.3	5.1	8.7	9.9	7.0	5.1	6.5	8.0	5.6	12.7	6.3	8.8	11.4	10.0	5.8	5.4	5.0	6.9	13.4	13.8	6.0	9.9	11.7	5.8	10.4	10.1	9.2	5.2	5.0	5.6	6.2	14.8	9.8	6.6	14.2	6.4	4.6	6.4	4.1	3.8	9.1	12.9	10.7	4.8	11.4	6.7	15.4	10.3	16.1	16.8	9.6	20.9	14.2	18.9	18.5	5.6	12.4	23.6	19.9	2.7	18.4	9.5	5.6	12.3	11.6	6.8	7.7	7.5	8.4	7.3	7.2	7.5	7.6	6.5	7.4	7.3	7.1	10.6	9.3	3.2	6.7	6.5	7.5	3.6	10.8	14.5	6.2	5.2	3.9	7.9	6.6	2.8	8.5	12.9	2.1	7.6	9.7	3.3	13.7	5.1	41.0	3.6	6.5	7.8	6.1	3.2	5.3	3.4	4.3	7.2	3.1	3.4	5.1	8.3	12.8	2.2	7.2	11.8	5.5	6.1	6.1	7.9	2.2	25.4	9.6	4.6	1.8	1.9	8.5	12.1	18.6	9.5	14.3	3.4	6.9	7.5	2.7	5.6	15.9	11.8	9.0	10.6	6.6	13.1	5.8	40.6	12.8	3.0	4.3	5.3	8.9	5.0	6.2	6.2
LIPT2		ENSG00000175536	"Lipoyl(octanoyl) transferase 2"	A6NK58	11	74490519-74493724	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Ligase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 12.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 55.4;Late spermatids: 29.4;Proximal tubular cells: 17.7;Spermatocytes: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA040249	Approved					NA	NA					"HPA040249: AB_10795275"	"unprognostic (8.80e-2)"	"unprognostic (9.67e-2)"	"unprognostic (5.12e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.74e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.50e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.11e-2)"	"prognostic favorable (1.63e-4)"	"unprognostic (6.11e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.17e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.35e-1)"	1.3	2.0	1.9	1.6	2.0	2.1	2.5	2.0	1.8	1.5	1.2	2.1	3.7	1.6	3.2	1.8	3.2	1.9	1.5	1.9	2.1	4.7	3.2	1.7	2.2	2.6	1.8	1.6	3.4	2.9	2.1	2.1	2.2	2.9	1.9	2.3	1.9	2.1	2.8	8.1	1.6	3.6	0.6	1.9	2.1	3.5	12.4	2.7	2.8	3.1	7.1	2.3	1.7	1.2	2.9	2.1	3.3	6.6	3.1	2.1	0.4	6.9	0.8	1.5	3.3	2.3	9.8	3.0	11.5	4.0	0.6	8.0	3.2	2.8	1.9	1.2	2.2	2.6	4.0	3.2	2.9	2.9	4.4	5.0	1.4	2.2	2.2	2.2	1.5	0.2	12.7	3.0	4.1	1.3	4.0	6.6	6.1	4.9	13.0	2.6	4.3	7.0	3.7	2.6	7.3	5.5	3.6	5.6	2.0	8.1	6.2	5.6	3.2	0.6	1.0	2.1	1.5	1.8	5.7	5.8	9.3	0.6	2.7	2.9	0.1	4.7	7.5	5.5	3.0	7.6	10.6	7.3	6.6	5.3	10.5	13.3	10.9	1.1	8.4	3.4	6.3	3.7	4.8	1.9	2.0	2.0	1.8	1.9	2.1	2.6	1.8	1.6	2.9	1.9	2.7	2.9	0.6	0.0	0.0	1.0	2.5	0.8	1.1	2.9	4.0	0.9	1.7	1.9	1.1	2.8	1.4	3.7	0.0	13.2	0.7	0.9	5.9	2.6	55.4	1.5	0.7	1.0	0.0	4.0	0.3	4.4	14.1	1.4	2.0	1.1	0.0	1.9	2.2	4.2	5.4	3.3	0.2	3.1	4.1	1.3	0.0	29.4	1.8	2.3	1.8	0.0	0.7	9.8	2.1	0.5	1.1	2.8	0.5	1.2	0.8	1.0	4.3	17.7	1.9	1.6	0.0	1.3	0.9	46.7	10.7	2.9	0.6	8.1	1.4	3.0	3.1	0.3
LLPH	"C12orf31, hLLP, MGC14817"	ENSG00000139233	"LLP homolog, long-term synaptic facilitation factor"	Q9BRT6	12	66116555-66130750	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048920, HPA058786"			Enhanced	"Nucleoli,Mitotic chromosome"		Yes	No			Nucleoli	"Mitotic chromosome"	"HPA048920: AB_2680556, HPA058786: AB_2683820"	"unprognostic (3.60e-3)"	"unprognostic (4.94e-2)"	"unprognostic (4.07e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.31e-2)"	"prognostic unfavorable (6.44e-7)"	"unprognostic (7.15e-2)"	"unprognostic (1.30e-2)"	"unprognostic (8.49e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.87e-2)"	"unprognostic (9.65e-3)"	"unprognostic (2.49e-2)"	"unprognostic (3.37e-1)"	"unprognostic (2.94e-2)"	21.8	34.6	12.8	24.6	13.8	50.7	18.8	13.3	16.1	13.4	12.3	20.3	19.3	15.3	18.8	19.6	13.3	14.8	23.3	13.3	13.8	21.1	21.4	15.6	26.5	14.1	13.9	11.9	17.7	17.4	17.1	10.8	17.6	14.3	15.4	20.5	7.5	14.6	14.3	29.9	13.9	18.3	19.5	13.6	18.4	19.3	22.2	13.9	22.3	17.5	25.6	25.8	27.5	14.1	15.6	77.0	61.1	36.4	44.2	42.6	40.8	44.5	87.0	56.4	63.9	53.6	52.8	31.0	87.0	70.6	58.6	50.7	63.6	57.2	52.9	85.7	78.4	48.8	94.5	41.7	47.3	49.8	162.5	61.8	41.9	53.6	53.7	58.3	50.1	56.6	44.1	81.5	60.9	76.1	81.3	74.1	110.4	77.9	61.6	63.0	61.9	67.2	62.7	63.3	90.8	36.3	45.1	57.0	58.3	97.4	38.0	77.4	89.5	60.5	48.3	71.3	60.9	80.4	45.7	77.6	130.2	65.4	76.0	76.8	34.3	32.0	35.5	27.8	38.0	32.0	29.2	32.3	30.6	31.3	27.5	27.4	29.2	43.8	27.4	48.4	27.0	38.9	28.8	12.8	13.8	13.3	16.1	13.3	13.8	14.1	13.9	11.9	14.3	13.6	13.9	15.6	34.2	12.8	33.9	2.9	47.6	27.1	53.9	86.3	30.1	15.9	24.5	28.4	25.1	41.5	64.3	31.3	4.2	66.3	49.4	34.1	66.5	68.3	63.3	40.5	45.4	32.5	13.8	33.4	5.0	71.3	70.4	34.8	35.7	46.6	89.4	61.2	35.7	60.2	64.2	21.9	4.4	31.1	85.5	50.4	26.5	17.0	43.8	45.6	35.6	3.7	84.1	30.8	59.8	3.0	5.8	96.3	43.3	30.1	27.3	46.3	44.0	86.5	35.8	15.2	26.3	29.7	36.8	126.6	48.6	30.6	30.5	72.7	43.8	126.4	36.1	60.6
LRR1	"LRR-1, MGC20689, PPIL5"	ENSG00000165501	"Leucine rich repeat protein 1"	Q96L50	14	49598761-49614672	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 29.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 129.5;Spermatocytes: 151.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA065703, HPA069364"	Approved		Approved	"Nucleoplasm,Nuclear membrane,Vesicles"		No	No			"Nucleoplasm, Nuclear membrane"	Vesicles	"HPA065703: AB_2685537, HPA069364: AB_2686129"	"unprognostic (2.73e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.85e-2)"	"unprognostic (9.34e-2)"	"prognostic unfavorable (2.97e-4)"	"unprognostic (7.34e-2)"	"unprognostic (2.50e-2)"	"unprognostic (8.30e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (4.90e-7)"	"unprognostic (6.86e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.04e-2)"	5.3	5.5	1.6	9.1	1.6	22.8	5.6	1.7	2.1	3.0	1.6	12.3	9.7	3.7	2.4	6.7	3.3	3.6	3.1	1.5	1.9	3.1	6.2	4.2	14.1	1.8	1.7	1.4	2.4	4.4	2.9	1.2	4.1	1.8	3.2	10.1	3.3	4.1	3.5	4.0	4.8	10.2	6.1	1.8	7.5	4.6	29.3	1.7	23.4	3.4	4.9	13.4	5.4	3.5	2.0	66.5	39.3	34.2	38.4	15.1	10.6	38.2	35.0	30.8	72.5	68.7	38.4	49.1	60.9	25.1	22.9	23.2	41.7	42.2	29.8	64.1	56.5	31.3	27.4	29.4	24.6	8.5	64.5	34.2	6.9	11.3	33.9	19.4	9.2	35.8	49.2	29.3	45.4	49.2	55.2	87.2	60.1	22.5	31.7	53.0	54.8	56.2	41.4	25.4	27.1	36.9	21.7	33.1	35.3	25.4	12.1	49.9	49.6	13.1	50.6	83.1	24.8	44.4	23.6	35.9	69.0	23.6	47.7	42.9	22.4	14.2	25.4	10.1	22.7	13.5	16.1	13.3	14.8	15.0	12.6	10.8	12.3	8.2	11.1	16.9	17.7	15.7	10.5	1.6	1.6	1.7	2.1	1.5	1.9	1.8	1.7	1.4	1.8	1.8	1.7	2.0	6.4	3.2	6.5	2.0	12.1	15.6	5.7	12.0	4.6	3.8	6.5	5.6	3.6	5.7	9.3	3.7	2.1	12.6	9.2	11.8	1.9	16.8	129.5	3.4	5.3	8.9	4.8	48.4	0.9	22.7	34.2	7.8	6.6	2.9	14.5	9.5	6.8	6.6	21.6	1.7	1.1	11.0	12.2	10.4	19.2	41.6	7.5	11.5	10.6	2.8	16.7	8.1	13.4	1.0	2.0	14.1	3.7	3.4	31.3	11.2	8.7	7.5	4.3	5.2	6.6	5.5	8.0	151.7	14.0	8.8	14.9	7.7	10.5	7.5	14.5	7.0
LRRC37B		ENSG00000185158	"Leucine rich repeat containing 37B"	Q96QE4	17	32007872-32053504	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 25.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 101.9;Excitatory neurons: 45.4;Spermatocytes: 66.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 3.8"	"Group enriched"	"Detected in many"	4	"granulocytes: 1.5;NK-cells: 3.8;T-cells: 2.6"	"Low cell line specificity"	"Detected in all"											HPA015135	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA015135: AB_1853309"	"unprognostic (5.46e-3)"	"unprognostic (2.56e-2)"	"unprognostic (5.08e-2)"	"unprognostic (5.30e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.60e-2)"	"unprognostic (9.65e-3)"	"unprognostic (5.06e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.72e-4)"	"unprognostic (6.99e-2)"	"unprognostic (5.72e-3)"	"unprognostic (6.94e-2)"	"unprognostic (3.35e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.36e-3)"	4.4	3.7	8.7	3.7	7.9	25.4	5.2	14.5	10.3	6.7	2.0	4.5	3.4	6.3	4.7	4.2	6.8	3.6	2.5	9.3	4.7	3.6	2.1	5.7	4.7	7.6	5.4	7.1	9.1	3.3	5.7	8.3	3.5	8.4	4.8	4.7	7.0	4.8	2.9	3.6	10.6	5.1	5.3	3.6	6.2	5.0	18.0	5.7	11.0	4.1	1.4	4.5	4.7	5.9	8.3	2.7	5.0	15.6	8.9	3.9	4.7	4.8	2.4	9.0	6.9	8.7	6.8	2.6	7.1	5.0	5.5	8.5	3.6	9.3	1.9	5.4	2.2	7.6	3.4	8.1	2.6	5.8	13.3	5.8	5.1	5.9	6.3	15.9	6.6	5.9	12.1	8.2	6.8	2.6	2.5	23.4	20.5	4.8	2.5	3.3	16.2	3.7	5.9	3.9	6.6	2.9	5.0	6.1	3.8	8.8	5.2	10.4	20.9	5.0	4.8	3.2	10.8	6.1	6.8	10.4	7.5	3.4	13.2	3.4	0.0	0.2	1.5	0.5	0.2	1.0	0.1	1.0	1.4	0.4	0.4	1.4	0.4	0.5	3.8	0.1	0.6	2.6	0.3	8.7	7.9	14.5	10.3	9.3	4.7	7.6	5.4	7.1	8.4	3.6	5.7	8.3	7.4	6.4	9.1	39.2	5.1	4.1	6.9	3.8	2.8	10.0	7.3	5.6	4.7	7.2	7.1	1.8	0.0	2.3	10.0	2.9	9.8	8.9	101.9	7.9	6.3	6.0	1.8	7.4	45.4	10.5	2.3	6.0	1.5	4.7	3.8	7.0	8.2	2.9	9.7	3.3	33.4	5.7	4.1	8.7	6.9	22.9	6.8	7.9	8.8	14.0	9.3	14.5	20.6	39.7	28.3	9.2	1.8	7.2	3.8	9.1	6.8	8.3	7.8	9.7	0.0	8.9	7.8	66.7	13.0	1.6	5.1	2.2	9.0	4.6	4.8	7.7
LRRCC1	"CLERC, KIAA1764, VFL1"	ENSG00000133739	"Leucine rich repeat and coiled-coil centrosomal protein 1"	Q9C099	8	85107215-85146080	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 33.8"	"Group enriched"	"Detected in all"	5	"Early spermatids: 192.2;Late spermatids: 166.0;Spermatocytes: 224.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 41.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012893, HPA075880"	Uncertain		Supported	Centrosome		NA	NA			Centrosome		"HPA012893: AB_1852434, HPA075880: "	"unprognostic (1.01e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.68e-3)"	"unprognostic (2.37e-2)"	"unprognostic (7.67e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.45e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.67e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.52e-1)"	5.0	4.9	6.8	3.9	7.5	7.4	6.5	7.1	9.0	4.9	5.7	9.0	6.8	6.3	3.9	3.8	4.5	4.2	3.4	6.5	7.1	5.5	4.0	5.3	4.9	7.7	7.3	5.8	8.1	3.7	3.8	1.8	2.1	7.7	5.1	9.1	3.0	2.7	5.1	0.8	5.9	6.5	4.6	7.3	4.4	6.0	33.8	7.2	6.6	8.8	2.0	3.7	4.4	4.2	8.0	7.3	1.6	13.4	3.1	6.3	5.6	10.4	7.4	4.8	1.6	2.9	3.5	10.2	5.4	1.2	4.6	8.6	9.8	16.0	4.5	2.6	41.9	1.4	21.2	4.0	5.4	1.9	8.1	5.5	3.1	1.2	4.6	1.0	3.0	1.8	13.7	24.1	4.8	8.5	2.6	24.9	6.3	4.6	28.0	3.3	18.2	8.3	3.7	4.5	5.5	1.7	4.5	3.7	7.1	2.8	8.6	15.8	17.5	2.4	6.3	8.5	6.8	10.3	6.4	6.9	10.5	5.1	20.6	12.5	0.0	0.2	0.0	0.4	0.3	0.2	0.4	0.3	0.5	0.8	0.2	0.4	0.7	0.0	0.7	0.3	0.5	1.1	0.1	6.8	7.5	7.1	9.0	6.5	7.1	7.7	7.3	5.8	7.7	7.3	7.2	8.0	12.2	32.1	32.8	6.5	5.8	9.3	11.8	7.7	13.1	7.2	11.3	9.8	12.6	11.5	22.1	25.8	12.5	8.0	9.9	9.3	33.2	7.7	192.2	14.1	12.6	12.0	7.8	33.6	5.3	7.6	11.7	13.9	12.8	8.1	15.2	13.1	11.4	6.8	6.9	25.2	8.3	14.4	2.0	4.1	8.7	166.0	10.2	10.1	5.4	5.6	6.3	10.8	12.3	22.1	13.8	2.9	5.9	14.3	9.1	5.6	7.7	7.9	20.7	5.0	19.7	13.3	15.5	224.3	38.3	14.1	6.5	1.1	6.5	9.8	20.6	10.8
LRRIQ3	"LRRC44, MGC22773"	ENSG00000162620	"Leucine rich repeats and IQ motif containing 3"	A6PVS8	1	74026015-74198187	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"testis: 20.6"	"Group enriched"	"Detected in many"	5	"Early spermatids: 258.5;Late spermatids: 103.6;Spermatocytes: 204.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 7.9;JURKAT: 4.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA030799	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA030799: AB_10601337"	"unprognostic (5.94e-3)"	"unprognostic (6.00e-2)"	"unprognostic (6.49e-3)"	"unprognostic (1.63e-1)"	"unprognostic (6.62e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.27e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.88e-2)"	"unprognostic (4.65e-2)"	1.6	0.7	0.7	0.7	0.6	0.1	0.7	0.7	0.7	0.1	1.1	0.3	0.2	0.2	0.3	0.1	2.2	0.4	0.3	0.5	0.7	2.0	0.9	0.3	0.7	0.7	0.9	0.4	0.3	0.2	1.2	0.5	0.2	0.8	0.4	0.2	0.5	0.7	0.4	0.1	0.1	0.2	0.0	0.7	0.4	0.3	20.6	0.8	1.0	1.5	0.5	0.6	0.2	0.1	1.6	0.2	1.0	0.1	0.4	1.0	0.4	0.6	0.6	0.4	0.8	0.9	0.1	1.4	1.4	1.2	0.1	7.9	0.1	2.1	2.0	1.0	3.5	0.0	1.3	0.3	0.7	0.1	2.3	0.7	0.7	1.0	1.4	0.5	0.3	0.4	4.8	1.1	1.9	1.4	0.0	0.9	0.3	1.1	2.5	0.6	1.1	0.8	1.4	1.2	0.1	1.0	0.7	0.1	0.1	3.1	0.2	0.9	1.3	0.1	0.1	0.7	0.5	1.2	2.0	0.7	1.1	1.5	0.2	1.1	0.0	0.0	0.8	0.9	0.5	1.1	1.6	1.0	1.1	0.1	0.7	0.9	1.3	0.0	0.4	0.1	0.4	1.6	0.3	0.7	0.6	0.7	0.7	0.5	0.7	0.7	0.9	0.4	0.8	0.7	0.8	1.6	1.0	0.0	1.5	2.0	2.8	1.1	1.2	4.0	0.0	1.0	2.0	2.8	1.2	2.8	2.6	0.0	4.2	1.7	0.5	0.3	13.7	1.5	258.5	21.6	0.8	0.8	3.0	0.4	4.1	1.7	1.5	0.3	0.0	1.5	0.0	3.2	0.7	1.8	1.3	0.0	3.9	0.6	0.0	0.6	0.2	103.6	1.8	0.5	0.0	1.9	0.8	1.2	2.1	2.0	4.0	0.9	0.1	1.5	0.6	0.9	0.1	6.3	36.0	0.7	0.0	0.2	1.5	204.8	31.3	0.0	0.1	0.3	1.5	3.6	0.7	1.2
LRWD1	"CENP-33, DKFZp434K1815, ORCA"	ENSG00000161036	"Leucine rich repeats and WD repeat domain containing 1"	Q9UFC0	7	102464956-102473168	"Predicted intracellular proteins"	"DNA replication"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	11	"testis: 277.4"	"Group enriched"	"Detected in many"	4	"Early spermatids: 1002.6;Spermatocytes: 677.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021320	Enhanced		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Vesicles"		NA	NA			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Vesicles"	"HPA021320: AB_1853372"	"unprognostic (1.50e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.31e-2)"	"unprognostic (7.66e-3)"	"unprognostic (1.60e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.72e-3)"	"unprognostic (4.97e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.04e-2)"	"prognostic favorable (8.71e-5)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (1.46e-2)"	"unprognostic (4.14e-2)"	"unprognostic (7.82e-2)"	"unprognostic (9.20e-2)"	7.9	16.9	11.0	6.9	9.4	15.1	8.0	10.8	13.2	9.6	8.7	8.7	5.4	10.1	2.3	7.7	13.9	4.0	9.2	11.2	10.1	10.4	15.1	10.2	8.2	10.9	10.5	9.9	9.4	9.4	8.8	17.8	3.1	10.6	8.6	2.3	3.4	7.6	6.1	13.3	6.7	17.2	4.3	9.7	24.5	9.1	277.4	10.8	8.8	10.1	5.3	7.4	9.0	7.4	9.5	18.6	24.6	13.0	36.8	9.4	7.2	21.0	19.6	11.9	30.5	20.9	23.7	10.3	44.8	27.5	13.9	36.3	19.2	18.7	16.4	9.0	16.6	39.2	10.0	11.1	14.8	12.7	17.6	17.4	6.7	9.9	35.4	7.5	10.2	16.2	33.9	44.5	13.3	16.8	54.3	53.4	42.1	28.7	22.0	37.8	28.2	12.2	48.5	9.2	11.3	17.7	50.7	21.0	20.1	19.3	14.6	11.2	14.4	11.1	17.3	37.7	54.8	30.8	50.5	94.3	43.6	19.3	17.1	31.4	10.6	2.6	9.9	9.7	4.0	9.0	10.0	8.4	8.4	2.7	11.8	5.2	6.9	5.5	10.5	3.8	9.7	9.3	6.0	11.0	9.4	10.8	13.2	11.2	10.1	10.9	10.5	9.9	10.6	9.7	10.8	9.5	9.1	0.0	1.1	5.5	10.6	10.5	6.4	16.5	3.4	11.7	5.5	5.0	0.8	2.8	12.8	12.9	2.1	9.2	10.8	8.6	7.9	12.3	1002.6	54.4	7.3	6.5	7.8	13.7	4.7	10.5	12.4	7.0	10.7	13.7	0.0	14.8	5.7	7.2	8.8	5.0	5.0	9.8	18.3	3.4	4.0	172.3	19.0	5.0	5.4	2.8	7.2	7.9	10.3	4.5	2.8	12.4	11.2	15.8	20.2	3.9	8.6	15.9	65.3	11.4	0.0	5.4	13.6	677.0	38.3	4.5	9.8	6.2	9.3	22.2	7.5	3.4
LYAR	"ZC2HC2, ZLYAR"	ENSG00000145220	"Ly1 antibody reactive"	Q9NX58	4	4267701-4290154	"Predicted intracellular proteins, Transcription factors"	"Immunity, Innate immunity, rRNA processing, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"testis: 103.0"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 223.1;NK-cells: 197.8;Spermatocytes: 718.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035880, HPA035881"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA035880: , HPA035881: AB_10669980"	"unprognostic (2.81e-1)"	"unprognostic (3.79e-1)"	"unprognostic (2.64e-2)"	"unprognostic (6.22e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (3.20e-5)"	"unprognostic (1.08e-3)"	"unprognostic (2.92e-2)"	"prognostic favorable (8.82e-4)"	"unprognostic (5.05e-2)"	"unprognostic (1.59e-2)"	"prognostic unfavorable (4.36e-10)"	"unprognostic (4.94e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.72e-1)"	13.5	8.5	8.0	20.0	8.4	20.5	11.3	8.1	13.1	9.8	7.2	10.3	8.9	9.2	5.7	16.1	10.4	8.2	15.7	7.9	8.3	5.7	10.5	11.9	24.5	8.7	8.5	7.2	12.5	9.7	5.3	8.5	11.2	8.9	7.9	10.2	11.2	7.4	6.8	21.4	9.3	9.4	9.1	8.0	18.9	8.0	103.0	8.3	13.0	6.8	11.8	18.0	19.0	10.9	9.3	59.9	30.8	26.7	39.3	22.9	26.0	46.1	53.2	18.1	53.7	37.1	97.1	75.6	158.9	37.5	23.0	86.2	37.0	100.6	55.4	69.8	28.6	74.8	159.2	29.5	109.0	38.7	184.4	41.4	20.5	34.4	61.8	103.9	13.9	47.2	89.1	217.9	51.2	37.8	60.5	63.4	236.6	134.0	62.1	99.2	96.2	48.6	76.4	24.4	40.7	63.4	27.4	29.0	31.0	55.8	34.0	32.3	54.4	44.7	53.3	42.7	70.2	169.1	36.2	59.1	250.4	36.5	154.7	44.2	37.3	26.4	24.4	73.5	26.8	85.5	21.7	48.2	80.3	19.5	15.0	22.1	47.9	7.6	30.3	39.2	14.3	25.4	30.2	8.0	8.4	8.1	13.1	7.9	8.3	8.7	8.5	7.2	8.9	8.0	8.3	9.3	29.1	16.0	23.5	6.8	26.9	120.1	59.2	19.9	27.9	10.1	15.7	32.9	20.9	14.3	25.6	1.8	8.4	47.7	128.9	11.5	9.8	24.9	223.1	17.7	29.4	32.3	10.7	46.3	3.6	19.8	55.6	31.9	9.7	12.7	21.5	31.5	14.3	11.2	35.8	15.2	4.2	16.1	4.1	30.4	34.0	113.4	34.2	44.7	21.4	2.8	35.2	14.1	197.8	6.0	9.3	30.0	11.4	26.7	36.1	117.5	3.0	7.4	19.2	30.2	39.5	34.4	27.9	718.6	36.6	36.0	115.8	20.2	135.3	46.8	28.9	64.1
LYRM7	"C5orf31, FLJ20796, MZM1L"	ENSG00000186687	"LYR motif containing 7"	Q5U5X0	5	131170944-131205428	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Chaperone	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 34.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 161.3;Late spermatids: 209.3;Spermatocytes: 135.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050053	Approved					NA	NA					"HPA050053: AB_2680999"	"unprognostic (1.88e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.90e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.03e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.50e-2)"	"unprognostic (3.03e-1)"	"prognostic favorable (9.84e-6)"	"unprognostic (6.61e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.20e-1)"	8.4	5.2	6.3	6.9	7.1	6.2	5.4	6.8	8.2	4.1	4.4	9.5	7.7	5.6	2.9	6.5	3.9	3.6	12.3	6.6	7.3	8.5	8.6	3.8	8.6	6.8	6.8	6.6	7.1	2.6	8.0	3.1	3.8	7.3	6.0	6.4	9.0	4.0	4.0	27.4	6.9	6.3	5.3	6.1	6.7	5.3	23.2	8.0	7.8	8.4	34.0	6.6	4.0	3.6	9.6	15.1	5.3	7.7	21.0	17.3	16.1	28.1	20.0	4.2	9.7	9.7	13.5	22.5	37.9	23.4	5.5	27.2	20.4	13.5	17.1	17.4	34.3	13.6	20.4	13.7	7.3	7.8	20.7	10.8	10.1	21.7	9.4	20.8	4.3	7.0	19.3	28.1	17.0	12.3	7.9	23.4	17.0	10.2	18.4	9.6	23.0	28.9	28.9	6.8	13.3	17.2	13.5	13.6	11.5	17.7	12.9	19.8	17.0	7.0	20.1	21.8	15.2	26.0	15.9	51.4	50.9	12.5	37.1	16.0	2.5	8.0	6.4	11.9	10.7	16.0	21.0	16.9	14.8	12.4	22.3	22.5	21.8	4.8	13.5	10.8	17.3	13.3	11.6	6.3	7.1	6.8	8.2	6.6	7.3	6.8	6.8	6.6	7.3	6.1	8.0	9.6	15.9	3.2	11.2	15.0	28.6	13.8	10.3	19.8	17.1	40.0	13.4	11.4	82.6	12.8	19.6	16.5	20.9	15.1	19.9	21.9	43.0	9.9	161.3	15.0	18.3	16.7	13.1	30.3	20.6	8.9	30.5	17.6	6.1	9.7	17.7	20.0	22.9	28.2	18.1	30.3	27.7	16.3	14.2	18.1	19.2	209.3	27.1	15.3	8.8	8.4	17.5	32.3	27.8	14.6	27.5	8.0	12.3	27.1	15.5	7.7	31.4	28.8	34.4	34.2	0.0	21.0	16.1	135.6	22.2	22.8	18.6	5.5	21.6	21.4	25.4	7.1
MAGEB18	MGC33889	ENSG00000176774	"MAGE family member B18"	Q96M61	X	26138343-26140736	"Predicted intracellular proteins"	"Ubl conjugation pathway"	"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"Spermatocytes: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	28	"Karpas-707: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA046141	Enhanced					NA	NA					"HPA046141: AB_2679554"															"unprognostic (1.66e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MBD1	"CXXC3, PCM1"	ENSG00000141644	"Methyl-CpG binding domain protein 1"	Q9UIS9	18	50266882-50281774	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 97.4;Spermatocytes: 136.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009017, CAB036003, HPA068850"	Approved		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"CAB009017: AB_2095559, CAB036003: , HPA068850: AB_2732121"	"unprognostic (2.12e-2)"	"unprognostic (5.05e-2)"	"unprognostic (6.88e-2)"	"unprognostic (5.01e-3)"	"unprognostic (9.20e-2)"	"unprognostic (6.85e-2)"	"prognostic unfavorable (5.08e-6)"	"unprognostic (5.91e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.96e-3)"	"prognostic unfavorable (1.70e-6)"	"unprognostic (7.06e-3)"	"unprognostic (7.70e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.31e-1)"	28.2	40.1	23.3	26.4	24.5	44.5	29.3	24.1	28.4	32.6	18.5	34.3	25.0	32.4	20.7	39.6	31.9	19.8	34.6	26.1	21.7	32.3	36.0	30.1	30.4	23.1	21.7	25.5	35.1	34.8	32.7	43.1	24.8	24.5	33.3	17.8	24.2	30.8	23.8	51.4	43.1	34.0	20.6	19.4	41.3	33.9	88.8	22.5	29.9	35.7	28.8	24.4	35.6	32.5	25.2	30.9	28.6	31.5	35.9	33.2	26.9	33.9	36.2	41.4	49.2	37.7	21.6	23.9	48.5	25.8	35.3	28.8	54.4	36.3	63.4	28.4	54.7	23.2	30.6	43.8	23.1	63.9	74.8	62.1	31.5	100.4	56.2	127.2	31.1	40.9	47.4	39.3	73.8	38.3	28.5	63.3	38.9	29.8	16.1	22.7	57.8	23.3	53.2	24.4	13.8	41.5	39.5	27.0	25.5	33.2	25.4	32.4	67.4	44.7	53.0	24.1	17.3	37.2	135.8	62.2	51.6	34.3	56.8	49.0	16.0	11.2	22.7	15.3	9.7	14.6	11.6	13.5	12.9	11.2	11.4	13.8	11.4	14.5	14.3	7.8	10.2	13.8	12.6	23.3	24.5	24.1	28.4	26.1	21.7	23.1	21.7	25.5	24.5	19.4	22.5	25.2	17.7	9.6	24.6	19.6	20.1	22.7	13.9	18.2	23.3	15.1	16.5	14.5	28.1	14.3	20.5	16.5	18.8	31.1	25.0	24.5	13.7	15.7	85.1	17.1	16.1	17.6	13.1	9.7	20.4	13.8	24.2	16.5	28.1	17.3	8.8	17.7	13.9	18.1	18.7	15.2	17.3	19.5	24.4	15.8	11.1	97.4	15.5	17.5	16.0	9.4	15.7	17.4	14.4	12.1	16.4	21.1	24.5	19.2	34.6	14.4	21.3	9.7	16.9	20.3	13.1	14.8	18.9	136.0	32.5	21.6	29.3	51.4	20.0	28.1	18.6	17.0
MBTD1	"FLJ20055, SA49P01"	ENSG00000011258	"Mbt domain containing 1"	Q05BQ5	17	51177425-51260163	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 78.4;Oligodendrocytes: 94.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.6"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021876	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA021876: AB_2140367"	"unprognostic (1.95e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.91e-3)"	"unprognostic (3.39e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.30e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.61e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.50e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.25e-3)"	6.7	5.3	5.5	5.5	6.6	10.9	11.5	8.9	6.9	8.5	5.2	7.2	8.0	8.6	7.8	7.2	7.0	5.1	4.5	5.6	5.5	6.2	9.8	6.2	8.7	5.9	6.1	5.4	11.9	8.7	5.7	5.6	8.7	6.2	6.9	7.9	10.1	7.0	4.9	6.4	14.5	8.2	5.7	5.5	8.8	8.4	25.6	5.8	14.6	8.4	6.9	8.0	6.9	8.3	7.7	6.6	6.1	32.0	12.9	7.5	8.8	16.7	5.0	6.2	5.3	6.4	7.2	8.3	25.7	11.5	3.8	3.9	6.3	14.8	3.7	9.8	7.4	13.4	26.7	7.5	11.1	5.0	18.0	7.7	7.5	7.0	4.0	7.2	10.5	9.4	22.3	21.0	6.3	4.3	6.7	24.8	18.8	18.1	14.0	5.5	28.4	19.3	12.9	8.0	12.4	20.1	30.7	4.5	8.6	10.7	26.6	12.2	35.0	5.7	5.7	5.8	4.2	5.4	15.4	10.5	22.8	3.4	11.8	3.3	2.6	0.1	0.7	0.2	0.1	0.0	0.4	0.2	0.1	0.2	0.2	0.1	0.2	0.3	0.1	0.1	0.3	0.3	0.0	5.5	6.6	8.9	6.9	5.6	5.5	5.9	6.1	5.4	6.2	5.5	5.8	7.7	11.2	16.0	15.0	47.7	10.3	17.2	6.5	5.4	17.1	9.0	14.7	11.7	7.3	17.2	7.1	7.3	16.7	7.9	9.6	7.8	1.9	5.4	51.6	11.8	15.0	11.3	13.8	17.7	61.5	5.1	5.1	10.8	17.9	16.0	5.1	18.8	10.4	12.8	5.8	10.1	59.9	13.5	6.1	12.3	8.5	12.4	14.6	11.5	10.6	56.2	16.4	4.1	11.3	78.4	94.9	6.4	9.0	10.5	5.1	10.8	10.1	4.6	6.2	12.0	0.0	10.2	13.0	47.8	19.2	10.5	22.0	8.6	8.6	15.6	12.1	9.7
METTL23	"C17orf95, LOC124512"	ENSG00000181038	"Methyltransferase like 23"	Q86XA0	17	76726830-76733936	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 182.5;Spermatocytes: 198.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022889			Approved	Vesicles		No	No			Vesicles		"HPA022889: "	"unprognostic (5.45e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.70e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (4.18e-6)"	"unprognostic (5.22e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.03e-3)"	"unprognostic (3.21e-2)"	"prognostic unfavorable (3.93e-7)"	"unprognostic (1.13e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.65e-1)"	30.0	32.9	21.7	24.4	23.7	27.5	31.0	23.6	28.1	28.0	24.9	26.3	22.8	26.1	35.0	24.1	27.9	20.0	27.7	21.4	23.7	37.4	47.7	27.0	43.1	23.1	23.0	20.6	29.6	42.6	35.3	33.5	19.9	23.2	28.3	27.6	23.1	29.3	22.1	35.0	29.3	30.9	23.7	23.0	48.5	30.3	52.0	22.7	37.3	42.5	26.2	40.8	26.3	25.0	27.3	68.3	58.4	32.6	30.0	79.2	66.5	31.3	33.7	68.2	43.5	41.9	29.5	47.1	38.0	32.2	43.0	56.7	37.6	23.8	61.0	48.9	19.2	55.8	49.5	38.0	56.6	77.4	35.1	41.7	64.0	57.3	54.0	74.6	68.5	69.1	46.5	48.1	46.0	53.1	38.5	44.3	30.1	24.2	75.2	65.3	29.9	54.5	106.5	63.0	33.9	30.9	44.5	33.8	51.6	123.3	78.8	72.3	43.7	25.8	49.8	24.9	48.9	59.9	63.2	26.0	38.6	47.5	25.0	46.3	23.0	28.9	34.1	48.0	30.3	53.6	51.3	53.0	53.5	32.1	44.7	50.2	51.1	9.4	51.8	27.9	48.3	57.6	34.5	21.7	23.7	23.6	28.1	21.4	23.7	23.1	23.0	20.6	23.2	23.0	22.7	27.3	39.5	28.9	14.5	8.5	49.6	16.4	47.2	64.8	42.1	13.9	34.9	48.4	17.7	27.1	35.6	20.2	10.4	42.9	50.7	11.7	119.3	42.0	182.5	31.7	23.4	28.0	22.8	22.3	4.2	39.5	41.1	26.6	24.5	25.9	31.1	21.8	25.7	49.9	57.0	6.7	5.4	24.5	40.7	33.3	23.5	54.5	32.6	33.9	24.9	8.4	50.1	38.6	81.4	7.5	13.4	33.2	26.3	25.9	49.2	33.2	27.5	87.8	32.7	23.7	52.6	28.1	43.0	198.9	49.5	32.2	16.2	17.2	55.3	53.3	32.1	34.1
MFSD6L	FLJ35773	ENSG00000185156	"Major facilitator superfamily domain containing 6 like"	Q8IWD5	17	8797110-8799365	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"pancreas: 9.4;testis: 25.7"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 125.7;Ionocytes: 28.5;Late spermatids: 46.1;Spermatocytes: 45.0"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 6.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HMC-1: 8.3"	"Not detected"	"Not detected"							HPA023164	Uncertain					NA	NA					"HPA023164: AB_2142777"	"prognostic favorable (1.84e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.07e-4)"	"unprognostic (3.31e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.37e-1)"	"unprognostic (7.40e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.98e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.84e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.25e-1)"	0.0	0.0	0.1	0.4	0.2	0.0	0.5	0.0	0.1	1.8	0.1	2.7	2.4	0.1	1.3	0.6	2.0	0.8	0.1	0.1	0.2	1.2	0.0	0.3	0.0	0.1	0.1	0.0	0.0	9.4	4.2	4.9	0.4	0.1	0.4	3.1	0.0	6.8	2.1	0.0	0.3	1.5	0.0	0.2	0.2	4.0	25.7	0.2	0.2	3.4	0.0	0.2	0.7	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.6	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	1.7	0.8	0.2	4.3	1.1	1.8	0.0	2.9	0.0	1.7	0.0	7.2	125.7	1.2	0.1	0.1	1.2	0.0	0.0	7.6	0.3	0.0	3.6	2.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	5.9	28.5	0.6	0.0	46.1	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	1.7	1.2	0.1	0.8	0.2	0.0	0.8	0.0	0.0	0.0	0.2	45.0	0.3	0.6	0.0	1.5	0.0	0.0	4.5	1.0
MGAT4D	GnT1IP	ENSG00000205301	"MGAT4 family member D"	A6NG13	4	140442262-140498377	"Metabolic proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	37	"testis: 22.9"	"Group enriched"	"Detected in some"	19	"Early spermatids: 19.5;Late spermatids: 26.7;Spermatocytes: 64.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA036523	Enhanced					NA	NA					"HPA036523: AB_10670110"										"unprognostic (2.70e-1)"		"unprognostic (3.16e-2)"						0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	26.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MIP	"AQP0, LIM1, MP26"	ENSG00000135517	"Major intrinsic protein of lens fiber"	P30301	12	56449502-56469166	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Sensory transduction, Transport, Vision"	"Eye lens protein"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Early spermatids: 2.6;Horizontal cells: 1.7;Late spermatids: 2.8;Spermatocytes: 7.3;Spermatogonia: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA014940	Supported					NA	NA					"HPA014940: AB_2669122"	"unprognostic (6.48e-2)"	"unprognostic (6.12e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.14e-2)"	"unprognostic (3.96e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.72e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.51e-5)"	"unprognostic (4.56e-3)"	"unprognostic (6.75e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.62e-1)"	"unprognostic (8.82e-2)"	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	2.6	0.1	0.1	0.3	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	1.7	0.1	0.2	0.0	0.0	0.3	2.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.1	7.3	1.6	0.0	0.0	0.3	0.0	0.3	0.0	0.1
MLH1	"COCA2, FCC2, HNPCC, HNPCC2"	ENSG00000076242	"MutL homolog 1"	P40692	3	36993350-37050846	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"		"Cancer-related genes, Disease variant, Hereditary nonpolyposis colorectal cancer, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013294, HPA052707, HPA060714, CAB070868"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB013294: AB_2533406, CAB070868: , HPA052707: AB_2681923, HPA060714: AB_2684348"	"unprognostic (1.26e-2)"	"unprognostic (3.88e-3)"	"unprognostic (2.36e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (8.24e-5)"	"unprognostic (3.36e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.32e-1)"	"unprognostic (8.54e-2)"	"unprognostic (8.63e-3)"	"unprognostic (2.10e-3)"	"unprognostic (4.37e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.86e-2)"	15.5	18.1	7.0	17.6	7.5	22.3	15.6	6.9	9.1	16.7	7.4	16.5	12.1	16.4	14.1	14.4	15.1	11.2	32.2	6.6	8.0	16.2	19.3	15.9	22.0	7.6	7.5	6.5	15.2	16.7	22.6	22.9	14.9	8.6	16.4	14.7	9.7	12.2	14.1	49.6	13.3	13.5	19.4	7.1	18.9	15.6	25.6	7.7	28.6	19.3	42.6	24.5	17.3	14.1	9.5	37.1	56.7	66.7	0.2	25.9	34.5	30.7	54.7	44.4	64.1	62.3	43.4	40.1	92.2	25.0	44.1	33.6	24.7	65.2	45.8	68.5	42.2	32.1	68.1	42.3	54.9	23.2	81.9	40.5	28.4	29.0	54.8	57.8	21.9	37.6	55.0	86.0	32.0	66.2	27.6	81.0	22.2	49.4	38.4	31.6	4.6	90.6	40.2	35.1	39.3	14.2	36.1	52.1	56.9	32.7	33.3	79.9	55.6	28.8	46.0	50.5	44.0	65.9	29.1	93.7	88.1	37.8	71.9	45.7	12.6	12.5	15.1	12.7	22.6	9.8	11.3	7.7	11.4	14.3	9.7	8.4	9.6	2.6	7.8	29.2	5.9	15.0	11.0	7.0	7.5	6.9	9.1	6.6	8.0	7.6	7.5	6.5	8.6	7.1	7.7	9.5	10.8	25.6	15.8	22.9	18.5	7.1	12.4	18.7	7.4	18.5	9.6	9.7	41.8	12.8	15.8	11.0	10.4	33.4	16.0	6.1	19.6	14.6	31.3	12.5	11.3	10.7	5.4	19.0	18.5	14.7	26.9	14.4	12.2	9.5	7.6	13.0	13.6	14.9	20.1	3.3	21.6	8.6	16.2	16.3	8.9	13.2	11.1	13.8	8.8	10.3	18.2	15.9	11.3	27.2	31.3	9.3	7.4	13.9	22.1	6.4	5.3	12.9	16.5	18.1	13.1	10.0	14.0	58.6	29.3	9.3	5.5	20.0	15.9	14.8	8.4	6.5
MLLT10	AF10	ENSG00000078403	"MLLT10 histone lysine methyltransferase DOT1L cofactor"	P55197	10	21524646-21743630	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 93.8"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 201.3;Spermatocytes: 233.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005736, HPA005747, HPA072790"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA005736: , HPA005747: AB_1079393, HPA072790: "	"unprognostic (6.58e-2)"	"unprognostic (1.57e-1)"	"unprognostic (7.32e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.31e-2)"	"prognostic favorable (8.75e-4)"	"unprognostic (1.03e-3)"	"unprognostic (9.56e-3)"	"unprognostic (9.29e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.69e-2)"	"unprognostic (7.85e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.67e-1)"	15.4	13.1	12.5	12.1	14.5	30.7	14.6	22.0	16.1	17.7	16.2	17.7	9.2	18.9	16.1	16.3	17.5	11.5	15.8	12.6	15.6	15.2	15.7	14.8	15.4	14.4	14.0	11.8	25.0	13.7	18.7	12.7	16.6	14.9	13.2	12.9	20.8	13.8	11.9	15.8	25.6	13.3	17.0	12.7	12.9	12.4	93.8	13.5	23.4	22.0	14.3	14.7	19.3	16.6	19.4	32.1	29.6	38.3	22.2	23.3	25.0	44.1	19.6	10.6	21.7	21.6	29.5	31.3	34.9	10.8	20.7	21.1	24.1	43.3	25.1	22.2	25.0	21.9	59.2	24.5	44.5	29.6	1.6	33.4	21.3	28.6	17.7	19.2	21.8	30.1	34.3	65.4	26.5	19.3	28.1	44.1	28.5	17.3	17.5	9.2	36.6	23.5	31.7	23.2	12.6	13.8	39.6	24.7	29.0	45.8	30.7	13.3	37.1	29.8	14.7	24.6	26.7	18.9	23.5	32.2	43.4	15.4	21.5	9.9	10.3	6.5	13.5	5.0	4.1	4.6	5.3	6.1	6.1	5.1	4.3	6.6	6.0	4.8	4.6	4.7	7.5	5.5	2.5	12.5	14.5	22.0	16.1	12.6	15.6	14.4	14.0	11.8	14.9	12.7	13.5	19.4	33.3	28.9	40.4	155.7	25.1	37.7	17.4	22.4	44.3	38.4	19.9	20.7	31.5	18.6	19.6	18.4	43.8	34.0	24.9	13.3	13.7	14.6	66.1	16.1	26.6	28.7	3.5	30.9	201.3	12.8	58.6	26.6	21.9	21.3	25.2	28.6	26.0	22.7	28.9	30.3	169.6	16.3	26.4	36.1	23.0	109.0	39.4	28.6	48.0	107.7	29.7	17.8	21.6	148.3	160.0	13.2	14.6	48.2	23.5	22.7	18.8	23.1	18.7	53.7	39.5	31.4	35.7	233.8	57.4	48.5	43.9	50.2	29.5	24.2	18.0	13.5
MORF4L1	"Eaf3, HsT17725, MEAF3, MORFRG15, MRG15"	ENSG00000185787	"Mortality factor 4 like 1"	Q9UBU8	15	78810487-78898139	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Growth regulation, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA042360, HPA062010"	Approved		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA042360: AB_10794275, HPA062010: AB_2684655"	"unprognostic (5.36e-2)"	"unprognostic (4.30e-1)"	"unprognostic (3.68e-1)"	"unprognostic (9.69e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.83e-3)"	"unprognostic (3.61e-3)"	"unprognostic (8.61e-3)"	"unprognostic (3.15e-1)"	"unprognostic (3.58e-2)"	"unprognostic (6.96e-2)"	"unprognostic (3.69e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.60e-3)"	275.2	309.2	194.3	239.8	202.8	431.4	244.0	206.6	287.9	286.2	199.5	236.8	170.9	308.0	214.9	202.9	260.2	258.8	400.2	196.7	236.5	335.3	261.0	245.6	253.8	242.1	217.4	178.8	321.0	166.9	265.8	176.5	303.4	243.5	230.7	227.9	267.9	197.6	285.3	564.6	138.4	188.9	334.4	218.5	219.3	188.6	594.0	217.6	300.4	272.7	429.0	281.9	268.7	185.8	261.0	362.0	480.3	863.5	355.4	603.2	620.4	453.2	644.3	636.0	570.7	554.0	436.9	532.7	446.7	517.2	649.1	376.0	442.1	1054.3	432.8	534.3	446.0	420.3	493.5	483.5	406.5	617.9	410.4	424.3	436.7	482.5	323.1	447.6	550.1	689.1	309.7	526.3	398.2	659.2	335.3	392.9	301.6	930.7	472.9	208.5	431.8	673.0	431.0	459.2	488.1	443.6	457.7	578.1	367.2	825.7	871.1	441.7	533.9	543.1	667.2	471.6	359.0	549.6	256.4	770.6	499.2	412.3	647.4	501.4	118.5	195.0	197.5	123.0	188.4	149.4	172.7	176.9	141.6	225.5	163.7	241.9	174.2	154.9	145.1	155.8	214.4	214.2	318.6	194.3	202.8	206.6	287.9	196.7	236.5	242.1	217.4	178.8	243.5	218.5	217.6	261.0	374.2	301.3	249.0	38.2	300.0	418.1	624.1	724.2	256.6	104.5	236.1	198.9	372.2	286.0	512.3	290.6	62.6	611.9	309.4	173.4	686.7	545.5	740.6	377.8	352.6	391.1	275.2	298.0	69.6	312.8	815.0	468.2	153.4	282.5	465.8	179.5	372.3	328.6	379.1	200.2	68.5	263.6	451.6	310.9	601.3	504.6	389.5	325.7	501.6	52.5	450.8	322.0	306.9	40.2	80.0	407.4	185.5	464.9	232.0	489.8	178.6	805.1	582.5	97.5	315.5	368.3	500.6	1322.3	467.9	185.3	370.4	663.0	338.2	279.9	199.0	597.1
MOS		ENSG00000172680	"MOS proto-oncogene, serine/threonine kinase"	P00540	8	56112942-56113982	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Proto-oncogene	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"Early spermatids: 6.5;Spermatocytes: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA																				"unprognostic (3.28e-1)"			0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MROH2A	HEATR7B1	ENSG00000185038	"Maestro heat like repeat family member 2A"	A6NES4	2	233775679-233833423	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 1.8;thyroid gland: 1.6"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 3.4;Early spermatids: 1.3;Hepatocytes: 1.0;Late spermatids: 1.7;Spermatocytes: 1.5"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 2.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"RT4: 6.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052107	Uncertain		Uncertain	Cytosol		NA	NA			Cytosol		"HPA052107: AB_2681729"	"unprognostic (7.00e-2)"	"unprognostic (3.37e-3)"	"unprognostic (4.77e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.32e-2)"	"unprognostic (5.05e-2)"	"unprognostic (4.06e-9)"	"unprognostic (5.65e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.41e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.8	0.1	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.4	3.4	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	1.5	0.6	0.6	0.1	0.0	0.0	0.0	0.0	0.3
MROH8	"C20orf131, C20orf132, dJ621N11.3, dJ621N11.4"	ENSG00000101353	"Maestro heat like repeat family member 8"		20	37101226-37179588	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"testis: 9.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 25.4;Breast myoepithelial cells: 33.9;Early spermatids: 33.9;Late spermatids: 31.4;Spermatocytes: 23.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 4.5"	"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.16e-2)"	"unprognostic (6.65e-3)"	"unprognostic (5.88e-3)"	"unprognostic (1.04e-2)"	"unprognostic (2.17e-2)"	"unprognostic (6.92e-2)"	"unprognostic (3.31e-3)"	"unprognostic (2.50e-4)"	"unprognostic (1.98e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.11e-3)"	"unprognostic (9.70e-3)"	"unprognostic (5.00e-9)"	"unprognostic (1.39e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.62e-1)"	0.8	0.6	2.0	0.3	2.3	1.4	0.8	3.1	3.1	0.6	2.5	0.8	0.2	1.0	4.0	0.5	1.0	0.6	1.2	2.2	2.2	0.7	1.4	0.4	0.5	1.9	2.2	2.3	0.9	0.8	0.4	2.6	0.4	2.2	1.0	0.6	4.0	1.1	0.9	2.5	1.9	0.6	0.9	1.5	0.8	0.5	9.8	2.3	0.7	0.7	2.5	1.0	0.6	0.5	2.4	0.6	0.0	0.9	0.3	1.3	0.6	0.6	0.3	0.2	0.3	0.3	1.3	0.7	1.0	0.2	0.0	0.7	0.6	0.5	0.0	0.5	0.0	0.0	0.7	1.3	0.3	0.4	0.2	0.6	0.3	0.1	0.3	0.0	0.8	0.9	0.7	0.6	0.6	0.0	0.0	0.5	1.6	0.3	0.0	0.3	0.7	0.0	0.2	0.5	0.7	0.5	0.5	0.5	0.0	0.4	0.7	0.0	0.1	1.7	1.0	0.3	0.2	0.1	0.9	0.2	1.0	0.9	0.1	0.9	1.3	0.9	0.5	0.3	0.7	0.2	0.7	0.3	0.4	0.3	0.6	0.2	0.2	4.5	0.1	0.6	1.1	0.2	0.3	2.0	2.3	3.1	3.1	2.2	2.2	1.9	2.2	2.3	2.2	1.5	2.3	2.4	25.4	3.2	0.6	17.3	2.0	0.6	1.1	0.5	1.8	6.2	6.6	33.9	3.0	7.2	0.2	0.0	8.4	3.7	0.7	1.6	0.0	0.3	33.9	2.2	6.5	4.0	1.2	3.2	15.0	0.2	1.1	5.3	6.1	2.6	0.0	11.9	1.8	3.9	2.7	0.0	17.5	1.2	0.0	1.6	1.1	31.4	1.5	3.2	1.8	3.7	1.0	5.8	1.0	7.1	8.5	0.1	1.4	3.0	3.5	0.6	4.0	2.6	1.5	4.9	0.0	1.1	11.7	23.6	5.9	1.5	0.4	1.4	1.5	3.4	1.3	0.4
MRPL39	"C21orf92, FLJ20451, L39mt, MGC104174, MGC3400, MRP-L5, MSTP003, PRED22, PRED66, RPML5"	ENSG00000154719	"Mitochondrial ribosomal protein L39"	Q9NYK5	21	25585656-25607517	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 241.5;Spermatocytes: 103.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018331	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA018331: AB_1854111"	"unprognostic (3.81e-3)"	"unprognostic (5.34e-2)"	"unprognostic (8.55e-3)"	"unprognostic (4.61e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.32e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (5.84e-4)"	"unprognostic (7.48e-2)"	"unprognostic (7.32e-3)"	"unprognostic (9.81e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.45e-2)"	"unprognostic (6.89e-2)"	23.3	35.9	19.6	19.9	21.0	22.9	27.0	23.7	28.9	16.3	19.8	29.5	25.7	18.2	42.1	26.7	20.6	13.6	51.9	20.1	20.5	40.8	55.8	15.4	34.5	20.5	21.6	20.0	17.7	25.4	71.6	13.5	26.4	21.4	20.2	32.5	21.7	22.0	18.0	59.2	20.5	23.3	22.2	20.1	17.8	23.1	55.2	19.8	25.1	20.2	57.2	37.6	22.5	19.0	23.1	89.6	43.0	60.1	38.1	29.7	42.9	92.3	56.1	50.0	77.0	64.7	85.2	49.2	97.9	30.9	35.4	69.8	25.5	128.5	76.4	85.9	49.1	66.3	100.1	43.0	91.4	34.6	102.4	31.7	34.8	66.7	76.3	62.2	42.7	58.2	99.6	112.3	78.4	77.1	56.0	67.5	55.5	95.6	88.9	65.4	77.8	97.0	103.1	80.6	35.7	37.9	36.3	51.6	94.5	76.3	42.3	68.3	57.6	36.4	40.8	61.0	43.9	69.6	54.9	74.6	121.9	61.2	109.1	62.5	41.9	16.9	20.7	37.0	30.3	46.9	62.0	45.0	42.3	31.0	49.1	43.9	39.3	2.8	36.7	21.6	43.2	56.4	18.6	19.6	21.0	23.7	28.9	20.1	20.5	20.5	21.6	20.0	21.4	20.1	19.8	23.1	18.3	25.6	10.5	9.8	17.6	20.0	20.3	71.0	7.4	20.4	14.0	23.5	78.2	10.0	36.2	25.8	10.4	46.8	14.1	8.7	31.3	36.0	241.5	20.9	12.7	22.2	7.8	22.3	11.4	33.8	41.7	19.4	7.1	11.8	15.2	11.3	18.9	19.8	30.8	10.1	11.7	11.4	30.5	10.6	15.7	37.0	14.9	11.3	19.6	9.4	17.1	19.0	11.3	9.5	13.2	26.5	9.3	23.3	13.6	13.2	20.4	46.8	41.8	15.0	46.0	18.1	25.4	103.0	29.4	10.7	16.9	36.9	14.9	25.7	20.1	17.3
MRPL43	bMRP36a	ENSG00000055950	"Mitochondrial ribosomal protein L43"	Q8N983	10	100969458-100987515	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073022			Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA073022: "	"unprognostic (2.65e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.01e-2)"	"unprognostic (4.11e-3)"	"unprognostic (6.07e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.03e-1)"	"unprognostic (6.04e-3)"	"unprognostic (3.02e-1)"	"unprognostic (3.53e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.53e-2)"	58.8	85.6	22.5	21.2	25.5	25.6	62.1	29.2	37.9	63.2	22.9	65.5	28.9	56.8	7.5	64.2	58.2	19.1	62.3	21.3	26.9	79.9	83.5	45.4	23.8	26.4	25.5	19.5	72.0	77.0	27.8	52.1	21.8	26.4	63.1	7.0	9.3	66.3	31.1	119.0	72.0	51.1	7.5	26.8	51.1	68.6	41.4	26.1	12.7	65.8	18.4	7.5	67.1	58.0	30.4	102.5	113.6	23.3	41.5	24.0	30.6	72.4	69.7	62.2	52.9	53.4	65.1	78.0	87.1	92.8	29.3	28.9	62.8	8.5	58.1	7.0	66.4	146.1	68.9	76.6	102.6	51.1	55.1	53.2	47.8	44.6	45.1	19.8	25.2	50.0	54.7	34.9	43.3	16.3	107.7	51.4	124.5	37.9	27.7	105.8	54.7	77.8	59.4	29.4	51.9	26.1	67.6	51.0	24.5	80.7	7.5	130.9	26.1	62.4	49.4	65.9	53.4	74.4	89.9	73.5	44.5	63.1	101.5	36.4	100.4	62.2	70.8	58.0	58.8	59.4	67.1	63.5	57.7	69.7	62.8	59.9	54.9	20.9	72.3	58.7	54.3	77.0	68.0	22.5	25.5	29.2	37.9	21.3	26.9	26.4	25.5	19.5	26.4	26.8	26.1	30.4	84.3	44.8	49.6	9.8	64.5	55.7	70.6	97.2	60.3	44.0	93.6	130.8	34.3	88.6	74.7	75.4	41.7	135.3	63.7	47.2	180.0	101.1	114.1	74.3	53.2	58.8	61.1	52.6	8.9	127.2	140.6	68.9	53.5	44.5	46.9	64.8	69.3	75.7	98.4	18.5	13.4	77.7	67.1	51.5	43.6	51.5	85.4	47.6	64.0	7.5	67.6	91.5	71.1	12.1	31.0	91.0	77.4	73.7	70.8	72.0	94.3	221.0	79.7	62.4	52.6	66.1	82.2	277.1	76.6	82.6	68.5	103.7	61.6	98.1	80.6	79.2
MRPL47	"CGI-204, NCM1"	ENSG00000136522	"Mitochondrial ribosomal protein L47"	Q9HD33	3	179588285-179604649	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 399.7;Spermatocytes: 301.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037553, HPA047779"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA037553: AB_10671375, HPA047779: AB_2680154"	"unprognostic (6.37e-2)"	"prognostic favorable (6.44e-4)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (3.15e-4)"	"unprognostic (1.53e-1)"	"unprognostic (8.55e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.03e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.29e-2)"	"unprognostic (5.64e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.71e-1)"	"unprognostic (8.84e-2)"	25.3	35.1	32.1	24.2	32.7	49.2	27.5	35.3	41.4	19.0	34.8	32.4	23.9	23.2	23.0	32.1	19.1	18.7	52.2	30.6	35.6	41.1	35.8	20.3	30.2	33.6	33.2	29.7	16.7	17.6	34.1	24.2	22.4	34.1	20.8	32.1	26.9	21.3	19.0	53.0	21.2	22.8	24.9	34.5	24.5	26.5	53.5	33.9	33.6	21.2	57.5	30.7	32.3	21.8	35.5	128.6	48.6	83.0	76.7	51.5	53.5	95.2	73.2	65.1	112.3	93.2	198.6	51.8	104.7	140.6	62.5	137.2	94.5	103.5	76.9	120.5	121.0	90.9	99.8	46.1	112.5	99.8	182.2	54.2	49.6	65.7	83.4	84.7	53.1	77.2	95.9	59.5	81.4	88.1	98.9	98.4	168.4	144.3	115.4	114.6	102.7	81.1	175.3	120.4	79.6	71.8	83.5	80.7	128.6	151.2	61.9	198.6	136.6	61.6	60.7	87.4	77.1	204.5	102.1	182.4	229.3	70.7	147.4	75.8	38.2	32.4	44.2	31.7	43.8	32.2	35.1	35.1	34.7	48.4	31.8	30.4	31.7	8.5	41.5	54.4	41.9	48.9	35.8	32.1	32.7	35.3	41.4	30.6	35.6	33.6	33.2	29.7	34.1	34.5	33.9	35.5	45.3	22.4	21.7	5.5	51.4	74.9	82.0	179.7	38.7	20.2	36.4	33.4	89.7	54.3	78.6	57.0	10.4	100.0	61.2	46.3	258.2	112.3	399.7	72.8	56.0	55.5	54.9	62.9	7.1	115.9	109.6	51.8	36.2	50.0	56.4	34.0	44.3	62.5	99.3	10.1	9.2	52.8	105.8	42.4	55.7	95.4	42.9	53.5	48.0	4.7	80.3	43.4	39.1	7.1	12.4	118.7	53.6	49.2	54.6	72.6	45.2	201.7	85.5	26.0	59.2	57.9	68.2	301.2	54.0	52.2	70.5	104.1	57.8	102.3	71.9	83.8
MRPS22	"C3orf5, GIBT, GK002, MRP-S22"	ENSG00000175110	"Mitochondrial ribosomal protein S22"	P82650	3	139005806-139357223	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006083, HPA007830"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA006083: AB_1854122, HPA007830: AB_1854123"	"unprognostic (8.38e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.04e-2)"	"prognostic unfavorable (1.35e-5)"	"unprognostic (5.22e-3)"	"unprognostic (5.45e-3)"	"unprognostic (4.85e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.78e-2)"	"unprognostic (4.49e-3)"	"prognostic unfavorable (1.55e-5)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (3.22e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.40e-1)"	25.7	56.1	23.8	20.8	24.3	38.2	25.4	27.1	31.7	22.1	22.7	35.3	37.3	20.4	19.5	37.8	20.7	17.5	61.9	23.6	26.9	38.3	57.8	17.1	23.0	25.9	24.8	22.2	22.8	32.2	32.0	13.8	25.8	25.8	17.2	32.2	18.1	22.2	20.4	83.8	22.0	33.4	24.1	25.2	17.2	25.2	35.7	24.9	23.7	23.0	78.0	24.6	27.6	21.8	27.6	101.2	40.4	40.0	44.5	49.1	41.7	79.1	58.9	72.3	97.1	80.7	130.0	68.3	66.5	106.9	67.1	98.9	109.9	64.6	76.5	96.4	39.0	64.1	105.2	35.8	97.2	56.2	99.3	58.1	45.2	59.6	58.3	61.8	49.2	61.0	76.2	149.2	41.7	61.2	72.4	51.9	85.9	64.4	102.3	73.3	65.0	61.3	98.9	75.0	61.4	43.4	40.4	94.2	141.4	154.6	37.0	97.1	93.7	47.5	42.4	42.3	82.4	55.9	66.3	38.5	119.5	56.9	70.6	42.3	42.8	38.4	36.1	34.9	53.4	43.0	40.3	37.5	39.4	45.8	36.1	41.0	38.9	9.2	38.1	53.6	29.7	47.6	36.3	23.8	24.3	27.1	31.7	23.6	26.9	25.9	24.8	22.2	25.8	25.2	24.9	27.6	30.7	19.2	13.4	8.8	21.8	22.8	29.7	63.3	19.4	19.9	15.3	18.0	50.3	25.8	33.3	18.4	14.6	62.9	24.9	26.5	68.4	47.5	84.3	19.9	30.5	26.6	15.6	31.2	8.7	60.3	48.0	27.7	16.3	22.0	27.3	24.9	18.2	38.9	48.6	20.2	13.8	26.5	32.6	21.9	16.1	14.3	23.3	22.5	16.0	4.7	38.0	21.8	24.7	10.1	10.1	42.0	27.1	23.7	38.4	16.6	45.4	59.4	35.5	26.2	39.5	32.2	39.1	102.2	51.4	34.8	20.5	75.4	24.7	74.1	46.5	31.2
MRPS30	"PAP, PDCD9"	ENSG00000112996	"Mitochondrial ribosomal protein S30"	Q9NP92	5	44808947-44820428	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018686, HPA021149"	Approved					NA	NA					"HPA018686: AB_1854127, HPA021149: AB_1854128"	"unprognostic (1.56e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.48e-1)"	"unprognostic (2.94e-2)"	"unprognostic (5.47e-2)"	"unprognostic (3.54e-2)"	"prognostic unfavorable (5.91e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.45e-2)"	"prognostic favorable (2.87e-9)"	"unprognostic (2.20e-2)"	"unprognostic (5.04e-1)"	"unprognostic (7.01e-2)"	"unprognostic (8.70e-3)"	13.1	13.5	4.1	8.6	6.2	25.6	14.3	7.8	9.1	9.5	2.4	12.4	13.5	10.3	6.0	16.8	10.5	5.9	22.5	5.9	3.0	15.3	21.6	8.6	11.8	1.4	2.5	4.5	9.5	13.0	12.8	6.4	7.5	2.8	8.8	10.9	6.4	11.7	6.4	35.9	19.6	12.1	7.4	2.3	11.4	12.1	11.6	3.4	10.2	12.1	27.0	9.7	11.5	11.0	5.9	33.2	32.5	19.2	36.9	14.0	16.3	61.9	16.2	17.4	22.8	16.1	51.9	40.5	50.4	55.1	10.7	52.6	30.6	37.7	24.2	20.3	32.7	64.5	37.5	67.8	40.8	31.1	51.5	29.8	16.2	24.4	23.9	29.4	17.2	21.7	27.4	58.5	45.6	21.4	28.3	33.3	67.7	32.4	26.0	57.6	31.3	32.1	67.6	34.6	24.1	29.3	22.9	75.1	40.1	52.2	14.5	36.2	38.0	21.4	26.8	39.6	22.3	51.0	24.4	31.0	41.0	22.6	68.4	27.7	26.0	24.0	18.7	30.9	27.2	32.3	37.8	34.2	34.2	25.6	31.7	40.0	33.9	4.4	35.2	33.3	19.4	46.1	33.6	4.1	6.2	7.8	9.1	5.9	3.0	1.4	2.5	4.5	2.8	2.3	3.4	5.9	22.1	25.6	16.5	4.6	31.7	48.8	38.8	63.3	26.7	31.3	23.6	21.1	60.2	17.2	31.5	5.5	18.8	40.0	37.6	21.4	33.2	36.5	105.1	21.3	29.4	23.9	28.7	18.7	14.4	33.1	38.0	24.1	21.4	22.5	19.0	24.1	17.9	26.9	32.5	32.0	8.0	24.5	30.5	16.6	15.7	14.3	20.8	18.9	17.8	3.7	26.3	20.4	26.8	3.5	6.9	29.6	22.8	18.0	20.1	27.6	25.6	35.4	21.9	26.3	13.1	24.9	28.7	43.4	26.4	28.6	75.0	18.6	32.6	32.6	37.0	42.3
MRPS9	"MRP-S9, RPMS9, S9mt"	ENSG00000135972	"Mitochondrial ribosomal protein S9"	P82933	2	105038069-105099960	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043476, HPA048479"	Supported		Supported	Mitochondria		No	No			Mitochondria		"HPA043476: AB_2678498, HPA048479: AB_2680412"	"unprognostic (8.10e-3)"	"unprognostic (4.75e-3)"	"unprognostic (3.69e-1)"	"unprognostic (3.80e-3)"	"unprognostic (5.25e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.78e-1)"	"unprognostic (2.62e-3)"	"unprognostic (4.62e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.12e-1)"	17.3	33.8	23.1	18.0	24.5	24.8	23.6	25.6	26.7	18.3	26.8	30.0	29.8	20.9	19.4	24.0	24.4	13.5	64.7	23.2	24.9	33.0	32.1	15.6	24.9	25.5	24.8	23.0	31.1	24.4	33.1	19.7	13.0	25.7	23.6	33.6	22.5	23.5	21.8	99.5	22.1	23.6	20.0	24.3	18.7	26.1	33.8	24.5	31.0	21.6	97.9	27.3	20.4	18.1	26.8	68.2	28.9	59.4	55.1	30.6	31.5	69.6	42.6	40.6	66.2	59.2	155.0	46.4	70.6	41.1	33.9	68.9	59.8	118.0	62.1	69.9	44.0	77.5	69.7	42.4	94.4	51.0	52.2	29.9	37.9	41.5	54.6	45.4	38.3	51.6	84.8	101.5	35.9	45.7	54.9	70.6	68.6	93.9	57.4	62.6	88.9	50.9	98.3	83.2	47.3	51.4	30.9	49.4	71.5	59.9	58.0	58.9	52.2	34.0	38.8	78.2	38.9	46.6	32.6	41.5	56.3	33.6	79.1	33.3	21.7	23.8	10.1	39.3	31.5	43.3	44.4	43.0	41.7	43.0	35.3	42.9	42.4	2.8	46.0	39.9	32.1	49.9	31.7	23.1	24.5	25.6	26.7	23.2	24.9	25.5	24.8	23.0	25.7	24.3	24.5	26.8	18.2	22.4	28.2	28.1	21.0	19.5	25.3	56.4	22.2	24.7	15.4	22.2	110.2	22.8	30.4	22.0	12.5	39.9	29.1	17.7	107.6	40.7	51.7	35.9	18.6	22.5	19.7	47.5	43.4	42.7	40.7	21.2	18.8	12.9	22.8	34.6	18.2	31.2	28.8	8.4	54.2	27.9	24.4	15.2	9.9	14.6	23.9	15.9	30.2	17.8	26.2	21.2	29.9	49.3	69.4	22.6	18.3	27.1	25.0	17.4	23.1	72.3	42.1	32.0	39.5	24.8	28.1	112.8	40.7	23.4	13.2	20.4	25.2	62.9	40.5	19.0
MTERF2	"FLJ14062, MTERFD3"	ENSG00000120832	"Mitochondrial transcription termination factor 2"	Q49AM1	12	106977277-106987160	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003526	Approved					NA	NA					"HPA003526: AB_1079423"	"unprognostic (1.54e-2)"	"prognostic favorable (8.50e-4)"	"unprognostic (1.17e-1)"	"unprognostic (4.87e-2)"	"unprognostic (7.62e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.60e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.24e-3)"	14.1	25.0	24.4	6.3	24.6	6.5	17.5	32.5	27.9	19.1	24.3	21.9	17.6	16.1	13.3	9.6	17.1	13.0	28.0	24.2	25.0	22.4	29.3	15.2	8.1	24.0	25.1	24.2	21.6	34.3	12.8	20.4	7.2	26.8	22.7	9.9	30.4	15.7	11.9	23.2	22.5	16.7	11.8	23.2	15.2	22.6	17.7	25.4	6.6	30.7	16.5	5.6	16.2	13.5	24.6	10.3	13.0	14.5	20.6	16.7	8.5	7.0	10.0	5.2	8.1	8.5	8.2	7.2	7.0	10.5	6.7	6.6	10.0	11.1	5.4	6.7	14.2	13.2	23.9	18.4	14.5	12.6	0.0	7.8	15.2	9.7	8.1	5.9	13.0	10.5	0.5	31.8	6.9	9.8	7.8	3.3	10.6	7.4	4.2	13.0	10.3	13.0	4.4	14.6	11.9	14.3	16.5	13.4	18.0	18.4	13.4	26.0	9.3	10.0	9.1	6.1	7.3	8.3	14.7	19.4	6.7	3.5	2.4	13.8	0.3	0.7	3.0	11.8	2.1	10.1	2.8	11.1	9.3	5.2	2.8	9.1	9.8	5.0	7.2	1.3	11.0	10.7	5.8	24.4	24.6	32.5	27.9	24.2	25.0	24.0	25.1	24.2	26.8	23.2	25.4	24.6	11.7	35.3	11.4	24.8	4.3	0.0	20.2	0.0	8.0	0.0	23.6	21.7	20.1	27.1	4.3	14.7	0.0	10.8	19.3	1.8	39.2	6.3	32.3	10.7	16.6	9.1	3.6	12.4	13.9	6.4	8.7	12.7	10.2	10.7	5.1	15.0	10.4	16.8	7.0	0.0	20.6	4.4	0.0	3.2	0.0	12.1	20.2	3.8	0.0	2.8	4.3	0.0	16.5	16.1	15.3	3.6	7.6	24.8	4.8	6.7	8.5	27.1	6.6	0.0	13.1	27.1	10.3	17.7	10.7	5.7	0.0	4.2	10.8	20.6	8.1	7.3
MTRF1	"MGC47721, MTTRF1, RF1"	ENSG00000120662	"Mitochondrial translation release factor 1"	O75570	13	41216369-41263577	"Predicted intracellular proteins"	"Protein biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 28.6;Spermatocytes: 26.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043316	Uncertain					NA	NA					"HPA043316: AB_10795038"	"unprognostic (3.87e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.89e-3)"	"unprognostic (7.27e-3)"	"unprognostic (5.07e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.84e-2)"	"unprognostic (9.55e-2)"	"unprognostic (7.74e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.46e-2)"	5.2	9.8	6.7	8.8	6.5	10.9	7.0	7.3	8.2	6.2	9.9	8.5	10.9	6.2	12.1	8.6	5.1	11.1	6.8	6.4	6.7	11.8	11.5	5.9	12.6	7.1	6.5	6.2	6.2	12.5	7.5	6.8	6.0	7.9	7.4	12.0	5.1	6.8	6.3	13.9	10.1	9.3	6.9	6.4	11.4	10.9	14.1	6.9	10.3	7.1	12.8	11.7	7.2	6.3	7.3	9.2	12.1	14.8	12.6	16.2	18.7	10.0	13.0	9.3	15.4	15.2	29.0	23.1	25.3	8.6	10.5	25.4	26.3	21.7	14.0	20.6	15.6	18.0	23.8	17.9	23.7	10.3	21.3	21.6	10.6	12.7	14.0	8.3	11.7	22.3	26.0	15.9	5.9	18.9	9.1	18.9	21.8	13.8	33.6	9.1	14.8	12.4	12.0	16.0	7.8	3.7	8.9	11.9	10.7	12.6	17.8	7.3	11.2	9.8	12.4	5.3	11.7	12.9	6.8	12.0	22.4	17.3	14.8	13.2	3.3	2.5	4.9	3.9	3.3	5.2	5.0	2.8	4.0	5.4	2.8	5.4	7.9	1.5	3.2	2.5	3.4	4.8	2.5	6.7	6.5	7.3	8.2	6.4	6.7	7.1	6.5	6.2	7.9	6.4	6.9	7.3	3.7	3.2	3.6	5.5	8.3	3.6	5.3	8.8	5.2	0.0	4.6	4.7	9.4	10.0	9.5	9.2	0.0	7.2	10.0	4.3	11.7	6.2	28.6	5.0	4.7	4.8	4.2	7.4	10.1	7.5	9.2	5.1	7.1	4.4	5.1	5.7	5.7	4.6	6.1	0.0	9.4	4.6	14.2	3.5	1.6	8.0	1.5	6.2	1.8	6.5	5.4	0.0	3.1	10.1	11.7	7.2	4.4	3.8	7.5	3.7	5.2	15.5	3.9	0.0	0.0	5.6	5.4	26.6	8.7	6.4	3.4	4.2	7.6	7.3	5.7	6.2
MTX2		ENSG00000128654	"Metaxin 2"	O75431	2	176269395-176338025	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 201.5;Spermatocytes: 247.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031550, HPA031551, HPA031552"	Approved	Approved	Supported	Nucleoli,Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria	Nucleoli	"HPA031550: AB_10599733, HPA031551: AB_10601442, HPA031552: AB_10794616"	"unprognostic (2.61e-1)"	"unprognostic (9.86e-2)"	"unprognostic (6.54e-2)"	"prognostic unfavorable (5.06e-4)"	"unprognostic (1.92e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.80e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.92e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.33e-2)"	20.6	37.8	34.8	15.3	36.2	9.3	27.3	35.0	47.1	19.7	37.4	31.5	23.0	18.8	39.7	38.4	29.2	14.7	48.9	35.5	37.9	46.8	31.1	15.8	14.3	36.8	34.5	34.1	21.3	26.6	48.5	29.7	26.0	36.0	26.6	35.9	47.7	20.6	22.8	75.1	22.1	20.3	25.9	35.8	15.7	24.6	64.9	36.7	18.3	20.6	71.5	21.0	25.4	24.9	38.0	52.2	31.0	60.8	37.8	40.0	45.9	58.3	54.5	52.0	49.8	58.3	53.1	55.8	66.4	91.4	49.1	79.9	34.5	67.1	67.6	67.9	66.6	49.4	63.9	39.1	94.9	62.7	98.9	20.7	51.1	83.5	52.2	89.1	60.3	72.0	64.3	86.8	50.2	59.6	47.4	34.9	102.9	58.3	101.8	45.5	0.0	44.0	60.8	142.4	93.3	87.0	74.4	45.7	60.9	120.7	116.4	33.7	64.0	63.5	49.2	43.5	52.1	57.9	55.4	62.1	79.8	61.1	49.7	60.8	8.0	9.3	4.1	9.6	15.8	13.1	18.9	12.4	11.1	14.8	13.7	14.9	15.4	0.0	19.6	14.4	12.1	16.9	9.9	34.8	36.2	35.0	47.1	35.5	37.9	36.8	34.5	34.1	36.0	35.8	36.7	38.0	34.4	19.2	22.6	50.6	20.8	31.1	36.2	130.9	37.5	0.0	38.2	43.8	69.2	31.5	63.6	57.0	0.0	78.8	11.1	38.8	201.5	51.8	22.3	60.9	25.7	31.4	41.5	19.5	106.0	39.5	63.3	30.2	28.1	33.9	43.1	25.7	16.4	33.7	47.8	0.0	106.3	47.7	103.7	21.7	15.7	18.8	35.4	19.6	35.6	43.1	26.1	0.0	12.3	93.5	180.2	49.8	26.1	32.7	23.1	48.2	39.6	106.3	63.8	0.0	39.5	24.9	52.4	247.8	127.1	56.5	41.9	65.0	18.8	55.8	52.6	53.7
NAA11	"ARD1B, ARD2, hARD2"	ENSG00000156269	"N-alpha-acetyltransferase 11, NatA catalytic subunit"	Q9BSU3	4	79225694-79326061	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"brain: 2.7;placenta: 4.2;testis: 6.2"	"Group enriched"	"Detected in some"	12	"Cytotrophoblasts: 19.4;Early spermatids: 30.6;Extravillous trophoblasts: 16.4;Late spermatids: 23.9;Spermatocytes: 25.1;Spermatogonia: 15.9;Syncytiotrophoblasts: 13.3"	"Cancer enriched"	"Detected in some"	4	"testis cancer: 2.1"	"Region enriched"	"Detected in single"	5	"cerebellum: 2.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"GAMG: 19.3;K-562: 12.3;U-266/70: 32.9;U-266/84: 11.3"					"Not detected"	"Not detected"			HPA035922	Approved		Supported	"Nucleoplasm,Golgi apparatus,Centrosome,Cytosol"		NA	NA			Nucleoplasm	"Golgi apparatus, Centrosome, Cytosol"	"HPA035922: AB_10673490"					"unprognostic (7.37e-2)"							"unprognostic (7.58e-2)"		"unprognostic (1.36e-1)"	"unprognostic (1.20e-1)"		"unprognostic (4.67e-1)"	0.0	0.0	0.2	0.0	0.2	0.0	0.0	2.7	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.1	0.0	0.0	0.0	4.2	0.5	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	6.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	3.3	0.0	0.3	0.3	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.2	0.0	32.9	11.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	2.7	0.1	0.1	0.2	0.4	0.3	0.0	0.5	0.3	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	19.4	0.0	0.0	0.0	0.0	30.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	16.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	23.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.1	15.9	0.0	0.0	13.3	0.0	0.0	0.0	0.0
NAA30	"C14orf35, FLJ35355, MAK3, Mak3p, NAT12"	ENSG00000139977	"N-alpha-acetyltransferase 30, NatC catalytic subunit"	Q147X3	14	57390544-57415906	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 107.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057824	Uncertain		Supported	Cytosol		NA	NA			Cytosol		"HPA057824: AB_2683539"	"unprognostic (5.13e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.52e-2)"	"unprognostic (5.22e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.84e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.21e-2)"	"prognostic favorable (1.25e-8)"	"unprognostic (1.77e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.75e-3)"	"unprognostic (1.63e-1)"	9.7	7.7	10.0	7.2	12.0	15.1	9.7	11.3	12.1	7.8	7.2	8.5	10.0	9.2	7.2	11.4	7.5	7.1	14.3	11.5	11.7	12.5	16.8	6.5	9.1	9.5	10.3	10.1	15.0	9.1	12.6	5.7	13.5	9.9	10.2	8.0	12.1	8.1	10.2	32.1	8.4	8.7	10.2	10.2	8.4	7.0	18.6	12.1	9.0	10.7	27.6	9.2	8.3	6.0	10.1	19.4	18.2	10.2	16.7	16.8	21.9	17.1	22.1	21.3	16.5	15.0	16.5	13.9	14.1	19.0	18.4	12.5	20.1	18.5	14.3	27.4	24.7	9.4	11.4	10.1	14.5	17.5	23.1	12.8	15.0	20.7	15.0	24.9	18.4	25.8	17.3	11.3	13.6	22.1	22.1	19.5	13.4	11.0	17.8	20.0	15.3	29.4	11.0	16.9	17.4	21.8	11.5	18.7	18.3	23.0	18.2	23.6	11.9	22.7	25.7	27.0	14.2	14.3	10.1	13.2	16.9	17.1	11.5	18.7	0.8	0.4	0.2	1.2	0.9	1.2	1.0	1.1	1.8	0.3	1.1	1.2	1.2	0.2	2.4	2.8	0.6	1.7	0.4	10.0	12.0	11.3	12.1	11.5	11.7	9.5	10.3	10.1	9.9	10.2	12.1	10.1	11.8	9.6	6.3	10.1	16.7	41.0	11.8	8.6	25.0	13.5	16.5	10.9	34.9	17.2	8.0	3.7	18.8	18.3	20.1	11.6	9.8	12.5	107.1	9.0	13.1	17.0	21.0	9.0	20.3	11.6	15.6	13.1	12.8	10.8	7.0	14.9	11.0	25.5	9.9	10.1	20.3	13.7	6.1	13.2	12.1	37.6	13.7	8.2	23.2	10.3	9.9	13.3	8.2	16.6	18.9	14.5	13.8	13.5	18.1	18.9	13.6	17.9	9.5	15.3	19.7	13.3	15.4	69.2	20.5	25.5	41.2	22.2	17.0	13.3	12.6	16.7
NAGS	"AGAS, ARGA, NAT7"	ENSG00000161653	"N-acetylglutamate synthase"	Q8N159	17	44004622-44009068	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Urea cycle"	"Acyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"intestine: 16.0;liver: 48.6"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 21.7;Proximal enterocytes: 44.2;Proximal tubular cells: 20.7;Spermatocytes: 16.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 12.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.5;HHSteC: 5.2;TIME: 7.1;U-87 MG: 10.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA027300			Supported	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA027300: AB_2672207"	"unprognostic (1.51e-3)"	"unprognostic (9.24e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.30e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.19e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.27e-1)"	0.7	0.7	1.9	0.5	1.2	0.0	1.4	0.9	2.0	0.7	0.0	1.4	16.0	0.8	1.8	1.5	0.7	0.4	0.7	0.9	2.6	4.8	48.6	1.9	0.3	2.0	1.2	0.6	0.6	0.3	3.3	0.5	0.1	1.8	1.2	0.5	0.0	1.0	1.4	0.2	0.9	13.7	0.1	1.0	0.4	0.4	0.6	2.8	0.1	4.5	0.2	0.1	0.4	1.0	1.7	2.9	0.1	0.0	0.4	0.0	5.5	0.1	0.5	0.1	0.1	0.2	1.7	0.7	0.0	1.1	0.0	0.1	1.3	0.1	1.5	0.3	0.2	0.7	0.1	0.2	2.2	5.2	0.0	0.0	3.2	0.0	0.7	0.0	0.6	1.4	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.4	1.5	2.7	0.0	0.3	0.0	0.1	0.0	2.1	0.0	0.9	0.0	0.0	0.2	0.2	0.0	7.1	2.5	0.7	0.2	0.6	0.1	0.1	0.1	10.0	0.0	0.3	0.8	0.5	0.7	0.9	0.4	0.7	0.3	0.6	0.8	0.5	0.3	0.3	0.4	0.3	0.2	0.8	0.1	0.5	0.3	1.9	1.2	0.9	2.0	0.9	2.6	2.0	1.2	0.6	1.8	1.0	2.8	1.7	1.8	3.2	4.2	0.0	0.9	1.5	0.9	1.9	6.8	0.4	3.5	4.8	2.6	2.8	2.9	12.9	0.0	0.9	1.1	10.5	7.9	1.9	5.8	0.5	0.2	2.3	7.2	0.0	0.0	4.2	1.9	0.9	2.0	0.2	0.0	0.3	0.7	21.7	1.1	0.0	0.3	3.8	4.1	1.9	5.3	5.3	1.5	2.1	0.0	1.0	6.1	1.0	3.1	0.0	0.0	5.1	11.1	0.7	0.0	0.6	44.2	20.7	1.1	0.5	0.0	0.2	0.9	16.0	2.5	1.0	0.9	0.4	1.4	0.7	6.6	0.6
NAIF1	"bA379C10.2, C9orf90, DKFZp762G199"	ENSG00000171169	"Nuclear apoptosis inducing factor 1"	Q69YI7	9	128061233-128068206	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA054898, HPA064931"			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA054898: AB_2682633, HPA064931: AB_2732725"	"unprognostic (7.09e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.56e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (1.60e-1)"	"unprognostic (6.15e-2)"	"unprognostic (9.41e-2)"	"prognostic favorable (1.02e-5)"	"unprognostic (3.08e-1)"	"prognostic favorable (8.30e-5)"	"unprognostic (8.48e-2)"	"unprognostic (2.47e-1)"	"unprognostic (6.67e-2)"	"unprognostic (3.92e-2)"	2.0	2.4	1.3	1.8	1.3	4.3	1.8	1.2	1.6	2.1	1.3	1.9	2.0	2.2	0.7	2.6	1.8	1.0	1.9	1.2	1.3	1.7	2.6	1.6	2.6	1.3	1.2	1.0	1.7	2.4	1.8	1.5	1.6	1.3	1.5	1.2	0.7	2.2	1.4	2.7	2.1	2.3	1.4	1.2	3.2	2.1	3.4	1.5	2.4	1.7	1.9	2.2	1.6	1.8	1.8	5.1	4.4	2.7	7.0	2.5	2.2	6.1	3.8	2.3	3.2	2.6	3.5	4.0	6.2	3.3	2.4	4.5	3.8	2.8	2.9	2.6	19.1	3.8	4.6	5.4	2.0	4.1	6.4	12.5	2.0	3.4	2.5	4.0	2.6	2.9	6.9	11.0	3.9	3.0	5.9	6.2	7.7	3.0	6.9	7.4	5.9	4.3	5.7	2.5	3.1	3.9	4.5	3.8	5.2	4.0	2.0	4.0	6.3	2.0	3.8	11.8	3.2	4.5	6.3	14.0	4.1	3.6	4.1	5.1	0.0	0.7	1.2	0.5	0.6	0.4	0.3	1.1	0.7	0.7	0.9	0.7	0.6	1.5	0.5	1.0	0.5	0.3	0.5	1.3	1.3	1.2	1.6	1.2	1.3	1.3	1.2	1.0	1.3	1.2	1.5	1.8	5.6	0.0	3.0	2.0	5.4	4.8	4.6	3.9	4.6	4.0	3.9	2.8	4.2	4.3	3.4	5.5	0.0	5.8	6.6	6.3	3.9	3.5	8.7	2.6	3.5	6.4	5.4	0.8	1.0	6.6	5.7	3.1	1.5	3.2	8.2	3.7	7.1	2.4	5.7	10.1	0.9	4.0	0.0	7.0	3.6	10.9	6.2	3.1	0.0	0.0	5.1	4.6	7.2	2.0	0.7	3.7	5.1	3.0	3.4	3.3	7.3	4.2	1.8	5.0	0.0	4.2	3.5	15.1	7.8	5.0	3.8	4.7	4.0	4.4	3.6	2.9
NBPF3	AE2	ENSG00000142794	"NBPF member 3"	Q9H094	1	21440128-21485005	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 9.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 33.8;Excitatory neurons: 17.6;Inhibitory neurons: 18.4;Oligodendrocyte precursor cells: 29.1;Oligodendrocytes: 17.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 12.0;HHSteC: 12.0"									"HPA042595, HPA043692, HPA044023, HPA046971, HPA058050"	Approved					NA	NA					"HPA042595: , HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (5.49e-2)"	"unprognostic (1.19e-2)"	"unprognostic (5.09e-3)"	"unprognostic (2.57e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.22e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.11e-3)"	"unprognostic (1.63e-1)"	"unprognostic (5.31e-5)"	"unprognostic (8.35e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.66e-2)"	1.4	2.0	1.3	0.7	1.3	0.7	1.8	1.3	2.1	1.5	1.2	1.5	0.1	0.9	1.3	1.2	1.4	0.1	1.1	1.2	1.4	1.9	1.7	0.9	0.9	1.4	1.2	1.3	1.5	1.4	1.4	2.2	1.6	1.3	1.5	0.9	1.5	1.5	0.9	0.7	1.7	1.6	1.0	1.2	1.5	2.0	9.9	1.5	1.1	1.7	0.0	1.4	1.5	1.2	1.2	1.6	1.6	0.0	4.3	2.9	1.1	4.9	3.7	12.0	3.3	2.9	2.9	4.3	3.0	1.2	6.9	0.8	0.2	2.2	2.6	0.3	1.7	3.0	2.3	0.2	0.9	12.0	1.1	1.3	0.8	0.8	3.1	0.1	1.2	0.4	0.0	0.2	0.6	0.4	5.3	0.0	2.6	0.7	2.1	3.3	0.0	0.0	2.4	0.3	1.5	3.4	3.7	5.2	1.0	3.5	1.0	1.3	1.7	3.5	1.1	2.2	4.6	1.1	0.0	1.8	4.7	0.3	2.2	1.4	0.0	0.2	1.0	1.7	0.3	2.4	0.4	0.7	1.4	0.1	0.2	1.2	1.6	0.1	0.7	0.0	0.0	0.8	0.9	1.3	1.3	1.3	2.1	1.2	1.4	1.4	1.2	1.3	1.3	1.2	1.5	1.2	1.6	0.0	3.7	14.0	1.9	1.3	2.8	1.2	2.8	1.8	3.8	2.8	2.9	1.5	1.3	1.8	6.2	3.7	2.7	0.8	0.0	1.2	33.8	1.9	1.5	2.3	0.0	2.1	17.6	2.5	1.1	3.4	4.1	3.2	2.5	1.8	3.6	1.1	0.9	0.0	18.4	2.8	4.1	1.6	6.7	4.3	2.8	3.0	0.0	6.5	1.9	1.0	0.0	29.1	17.2	2.4	0.2	1.9	0.9	1.6	1.4	2.2	5.9	2.0	0.0	2.8	2.3	15.7	8.0	2.2	3.0	2.5	3.4	4.0	1.1	2.2
NDUFAF1	"CGI-65, CIA30"	ENSG00000137806	"NADH:ubiquinone oxidoreductase complex assembly factor 1"	Q9Y375	15	41387218-41409403	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Chaperone	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 85.3;Spermatocytes: 84.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039933, HPA040064"	Supported		Approved	Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"		"HPA039933: AB_10795265, HPA040064: AB_10795687"	"unprognostic (2.02e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.10e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.20e-1)"	"prognostic favorable (2.88e-5)"	"unprognostic (3.01e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.46e-1)"	"prognostic favorable (3.34e-6)"	"unprognostic (1.68e-1)"	"unprognostic (3.23e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.05e-1)"	16.1	33.7	22.1	9.6	22.7	4.3	12.6	23.6	29.8	9.7	24.3	12.1	12.7	10.5	15.7	13.9	9.9	7.7	34.6	22.6	23.4	29.3	39.0	9.4	11.6	23.1	23.0	22.3	9.8	11.9	18.4	11.6	8.1	23.1	10.2	10.5	12.6	12.3	13.3	64.0	9.8	11.0	10.9	23.2	12.0	14.3	21.2	22.7	11.0	10.6	61.5	13.2	12.9	10.0	25.0	15.9	13.3	16.4	13.3	30.0	28.3	14.9	26.1	25.1	23.6	21.3	22.5	8.1	16.7	38.2	24.9	17.5	25.0	20.1	15.9	19.3	32.9	23.9	22.4	25.0	13.8	27.1	24.7	17.0	30.0	18.5	20.8	18.0	19.9	19.0	31.9	38.2	17.2	30.6	17.5	19.9	28.6	12.6	27.5	17.9	15.0	17.4	40.6	41.9	27.8	17.5	13.8	13.2	31.8	12.6	16.9	25.1	50.2	15.4	18.0	10.1	30.5	24.2	15.8	34.7	28.0	24.0	43.5	19.3	35.0	12.8	16.2	7.8	15.0	9.1	13.8	9.6	9.5	11.8	11.8	10.6	8.6	9.4	13.4	13.3	18.2	16.8	8.5	22.1	22.7	23.6	29.8	22.6	23.4	23.1	23.0	22.3	23.1	23.2	22.7	25.0	7.7	12.8	10.1	6.5	14.6	4.7	15.8	43.8	9.6	15.7	12.3	11.9	58.7	15.7	27.3	22.0	12.5	36.3	19.8	8.5	64.6	30.5	59.5	14.2	14.2	11.1	6.7	13.5	8.8	31.3	34.6	12.5	12.2	13.1	7.0	16.3	8.6	28.2	28.8	6.7	9.1	8.5	30.5	12.8	7.0	15.0	16.4	16.2	10.6	3.7	23.4	20.7	16.5	4.0	10.3	20.9	3.7	16.1	15.0	11.8	23.3	85.3	30.6	19.2	26.3	15.3	17.3	84.7	21.6	11.3	7.7	50.3	12.3	32.6	11.9	16.3
NDUFAF3	"2P1, C3orf60, DKFZP564J0123, E3-3, MGC10527"	ENSG00000178057	"NADH:ubiquinone oxidoreductase complex assembly factor 3"	Q9BU61	3	49020459-49023495	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 332.4"	"Group enriched"	"Detected in all"	4	"Distal tubular cells: 475.4;Early spermatids: 1124.6;Late spermatids: 1303.4;Proximal tubular cells: 658.1;Spermatocytes: 913.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035376, HPA035377"	Enhanced					NA	NA					"HPA035376: AB_2674597, HPA035377: AB_10673219"	"unprognostic (2.90e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.03e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.61e-1)"	"unprognostic (6.28e-3)"	"unprognostic (4.12e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.64e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (1.86e-5)"	"unprognostic (7.97e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.60e-1)"	62.6	122.9	104.4	36.7	109.6	52.1	61.2	115.6	124.5	57.2	105.0	43.3	35.2	59.1	48.1	48.9	62.2	32.6	155.7	100.6	111.4	88.7	85.8	52.7	45.7	113.8	108.2	99.4	59.9	49.2	84.8	99.7	30.2	111.4	57.7	27.3	26.4	71.3	52.0	128.1	31.8	41.8	30.9	113.4	54.3	50.2	332.4	110.0	52.5	71.8	100.5	38.0	51.5	46.1	119.6	47.7	68.4	60.6	59.9	78.5	66.6	35.0	59.6	57.5	82.8	64.5	98.9	75.1	55.1	68.5	92.1	113.4	34.9	43.3	95.4	29.6	72.9	76.8	109.5	129.9	124.8	110.4	92.2	50.8	68.5	72.5	116.6	85.8	98.9	73.0	169.4	31.4	136.0	90.8	73.9	134.1	46.5	20.1	78.1	183.0	41.1	24.3	169.3	136.7	97.4	52.9	61.6	55.0	115.1	59.1	27.3	66.5	177.6	64.4	76.4	52.0	108.0	100.1	110.8	79.3	86.6	93.2	48.4	121.8	144.3	164.6	143.9	157.6	175.3	168.4	244.1	172.6	160.6	144.9	234.0	223.3	170.2	51.8	154.9	201.2	297.8	180.5	250.4	104.4	109.6	115.6	124.5	100.6	111.4	113.8	108.2	99.4	111.4	113.4	110.0	119.6	117.4	93.0	95.2	7.2	95.3	53.3	143.7	113.6	66.0	60.4	119.4	125.5	198.0	104.4	109.6	150.8	2.1	135.2	81.9	124.6	475.4	171.7	1124.6	123.4	81.8	104.3	132.0	118.2	7.2	155.7	128.0	121.2	50.0	58.2	117.3	73.1	114.9	150.6	217.8	69.0	8.3	118.1	103.7	114.1	73.8	1303.4	170.2	129.5	136.9	11.2	149.6	171.5	103.0	6.6	19.6	139.5	148.0	120.7	151.1	175.5	176.9	658.1	199.2	52.8	72.3	87.5	106.4	913.0	88.6	108.4	54.8	106.9	91.2	105.6	109.4	154.9
NDUFAF7	"C2orf56, MidA, PRO1853"	ENSG00000003509	"NADH:ubiquinone oxidoreductase complex assembly factor 7"	Q7L592	2	37231631-37253403	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 39.1"	"Group enriched"	"Detected in all"	4	"Early spermatids: 196.6;Late spermatids: 109.6;Spermatocytes: 118.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045217	Uncertain					NA	NA					"HPA045217: AB_10960395"	"unprognostic (6.38e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.48e-4)"	"prognostic favorable (3.08e-4)"	"unprognostic (5.44e-2)"	"unprognostic (1.55e-2)"	"unprognostic (9.88e-2)"	"unprognostic (8.12e-3)"	"unprognostic (5.94e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.73e-2)"	"unprognostic (8.67e-3)"	6.1	12.8	6.4	5.5	7.4	6.0	6.1	7.9	8.1	7.8	6.5	10.0	4.6	7.9	8.1	5.6	6.0	6.0	15.2	7.6	7.1	9.4	10.7	5.5	6.9	6.9	6.8	7.0	7.0	5.7	8.2	6.9	6.0	7.6	6.7	5.9	10.0	5.7	5.4	20.5	4.8	5.7	7.4	6.0	6.6	6.3	39.1	6.7	8.3	5.1	24.6	6.0	6.8	6.2	7.4	20.2	10.6	13.2	11.6	8.3	17.6	7.3	6.6	10.5	11.1	14.1	22.9	8.5	17.1	8.1	6.0	18.9	14.8	16.2	8.3	13.1	11.9	12.1	12.6	13.1	21.1	10.2	12.6	6.1	13.8	13.6	9.1	5.6	11.8	17.4	6.4	15.5	11.1	6.7	7.4	12.6	13.5	17.3	15.9	9.5	11.3	10.2	14.4	15.4	7.4	13.7	11.0	8.2	13.9	14.3	18.6	8.4	4.9	3.4	9.2	12.3	11.6	12.1	9.7	6.0	19.8	13.4	16.9	7.9	3.0	4.3	2.6	4.1	3.7	1.8	4.7	3.6	3.5	5.3	4.1	3.5	3.1	2.7	4.1	2.7	4.2	4.6	2.0	6.4	7.4	7.9	8.1	7.6	7.1	6.9	6.8	7.0	7.6	6.0	6.7	7.4	10.9	9.6	10.0	12.7	15.5	4.8	9.5	12.3	11.4	18.1	6.4	5.6	13.4	2.8	8.4	11.0	22.9	15.0	16.1	3.7	17.6	10.5	196.6	6.6	12.1	9.4	2.4	6.5	30.5	6.3	10.8	9.7	8.6	7.2	7.6	11.9	7.5	5.6	9.4	11.8	26.9	5.5	12.2	7.3	7.8	109.6	13.4	9.4	3.6	15.0	10.5	7.6	10.3	13.6	15.4	8.8	2.0	16.6	9.3	5.9	7.7	14.8	11.3	21.8	6.6	10.1	18.0	118.4	14.4	7.4	4.0	11.5	13.6	16.1	6.2	6.3
NEK2	"NEK2A, NLK1, PPP1R111, RP67"	ENSG00000117650	"NIMA related kinase 2"	P51955	1	211658657-211675630	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Meiosis, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 18.0;lymphoid tissue: 19.4;testis: 67.7"	"Group enriched"	"Detected in many"	4	"Early spermatids: 76.1;Spermatocytes: 244.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 5.7"	"Low region specificity"	"Detected in all"			"CAB017530, HPA064967"	Enhanced		Supported	Nucleoplasm,Centrosome		NA	Yes			"Nucleoplasm, Centrosome"		"CAB017530: AB_1126558, HPA064967: AB_2685393"	"unprognostic (1.28e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (9.47e-6)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (1.95e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.09e-3)"	"unprognostic (8.49e-2)"	"unprognostic (0.00e+0)"	"unprognostic (8.21e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.71e-1)"	0.7	0.4	0.6	5.3	0.5	18.0	1.5	0.8	0.7	1.1	0.7	5.9	7.4	1.3	0.5	4.4	2.2	0.8	0.4	0.6	0.9	0.3	0.7	0.7	9.1	0.4	0.3	0.4	0.4	0.1	0.1	0.0	3.2	0.5	2.6	7.7	1.5	0.8	0.2	0.4	4.3	6.9	2.0	0.3	1.7	2.7	67.7	0.6	19.4	0.4	0.2	10.7	1.4	1.6	0.8	86.0	60.5	45.3	32.6	2.6	4.5	49.7	32.4	30.1	55.4	47.5	32.3	81.7	45.1	15.2	25.2	35.1	44.5	39.9	24.2	69.6	69.5	33.2	21.6	51.4	44.2	0.4	43.2	28.3	1.4	2.9	42.9	45.9	13.4	36.3	45.2	59.9	76.9	56.0	23.6	47.3	28.8	43.0	55.0	30.5	46.2	69.2	68.7	19.7	24.2	41.0	45.0	46.6	51.5	39.3	38.4	79.4	25.1	19.0	27.6	54.1	54.8	88.3	31.6	62.6	59.6	24.1	32.6	46.8	1.2	0.1	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.0	0.4	0.3	0.2	0.7	1.5	0.1	0.2	1.6	0.3	0.6	0.5	0.8	0.7	0.6	0.9	0.4	0.3	0.4	0.5	0.3	0.6	0.8	0.1	0.0	0.5	0.3	1.7	2.9	0.7	3.8	0.6	11.3	1.9	2.2	0.5	0.0	2.9	0.0	0.0	9.4	0.8	1.9	0.0	0.2	76.1	15.2	0.7	0.8	0.0	39.6	0.8	0.2	14.1	1.4	5.6	1.5	0.0	3.6	3.6	0.7	5.8	3.3	0.0	3.2	10.2	2.5	1.1	39.0	2.5	2.1	0.0	0.0	0.0	1.6	2.1	0.0	0.1	0.0	2.5	0.7	5.4	0.7	2.1	0.1	5.2	1.8	6.6	0.0	1.5	244.2	26.1	8.6	1.7	1.4	2.0	0.9	9.5	1.4
NEK3	"HSPK36, MGC29949"	ENSG00000136098	"NIMA related kinase 3"	P51956	13	52132639-52159861	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 87.0;Spermatocytes: 49.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019062, HPA043230"	Enhanced		Approved	Microtubules		NA	NA			Microtubules		"HPA019062: AB_2670037, HPA043230: AB_2678374"	"unprognostic (8.97e-2)"	"unprognostic (2.54e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.16e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.22e-2)"	"unprognostic (4.66e-2)"	"unprognostic (4.15e-2)"	"unprognostic (5.34e-2)"	10.7	3.9	14.2	6.3	19.2	8.7	10.7	13.6	22.0	10.2	13.0	16.4	9.4	10.0	6.9	4.2	8.8	7.4	7.7	14.3	16.6	9.3	7.3	9.1	5.1	18.8	19.2	11.8	8.3	8.4	3.8	5.2	17.5	20.7	8.3	17.0	4.7	7.0	5.1	6.0	7.2	12.8	8.6	13.9	8.1	6.7	18.3	17.0	3.2	6.4	3.3	5.4	8.4	7.4	28.0	0.3	2.7	20.2	11.4	6.2	10.8	0.3	6.5	6.2	7.6	8.3	8.6	11.1	0.0	0.4	8.4	6.3	1.5	0.4	4.8	4.8	15.1	11.8	1.9	2.7	23.0	7.6	19.4	10.9	7.2	9.5	4.2	17.6	5.6	13.5	1.0	3.1	7.1	9.0	5.1	1.1	23.4	19.7	4.4	0.5	0.5	1.7	7.6	11.4	1.9	2.2	14.0	2.9	6.4	12.8	19.6	2.5	26.3	12.2	1.0	5.9	6.0	6.7	7.5	2.5	13.1	1.8	6.8	10.8	7.1	6.3	5.1	1.6	5.8	1.0	3.6	1.9	1.0	6.7	1.9	1.4	0.4	0.4	1.6	1.2	5.8	2.9	1.4	14.2	19.2	13.6	22.0	14.3	16.6	18.8	19.2	11.8	20.7	13.9	17.0	28.0	28.8	6.4	6.5	9.1	5.9	2.8	4.4	2.8	5.7	3.9	5.5	6.7	7.7	5.7	5.8	7.3	0.0	13.0	8.3	20.1	13.7	7.9	11.5	9.8	14.0	22.7	6.0	3.4	0.6	17.3	14.4	8.7	10.2	11.0	10.1	11.6	18.2	7.4	19.1	3.3	3.4	13.7	6.1	12.4	8.1	4.6	7.2	10.4	12.4	18.7	25.4	3.0	7.2	9.0	87.0	15.6	17.9	6.8	6.0	3.3	22.4	6.8	7.1	5.8	0.0	7.1	9.0	49.7	25.5	3.5	3.4	4.8	4.0	3.9	20.1	5.2
NEK4	"NRK2, pp12301, STK2"	ENSG00000114904	"NIMA related kinase 4"	P51957	3	52708444-52770946	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 46.4"	"Cell type enhanced"	"Detected in all"		"Spermatocytes: 75.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015750, HPA058543"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"HPA015750: AB_1854367, HPA058543: AB_2732623"	"unprognostic (1.32e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (2.69e-5)"	"unprognostic (9.65e-3)"	"unprognostic (3.42e-1)"	"unprognostic (6.64e-2)"	"unprognostic (8.75e-3)"	"unprognostic (2.27e-1)"	"unprognostic (7.85e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.74e-3)"	"unprognostic (5.11e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.51e-2)"	"unprognostic (8.39e-2)"	6.4	8.2	7.6	7.5	7.2	7.0	9.5	9.7	7.4	8.6	7.9	7.4	6.6	8.8	8.9	6.8	13.8	6.3	6.2	6.1	9.0	9.8	10.9	6.7	8.4	7.5	8.9	5.9	13.4	8.2	11.6	7.4	7.6	6.5	7.8	8.3	17.0	7.4	9.1	8.0	3.5	5.7	8.2	7.6	7.3	9.7	46.4	6.9	9.5	13.6	6.1	9.5	8.0	5.0	6.5	19.9	15.2	20.5	16.2	18.2	13.1	22.1	13.9	18.6	25.3	25.4	13.5	14.4	20.4	6.4	13.6	27.9	9.2	25.2	16.3	33.8	20.4	10.6	16.0	18.4	17.3	11.4	39.4	15.4	8.1	14.8	32.5	21.5	13.5	9.6	17.4	20.2	16.1	16.1	17.1	21.4	14.4	17.7	20.9	14.9	18.5	17.8	15.1	14.3	28.3	15.0	9.0	29.1	17.7	14.1	15.7	16.5	23.4	8.9	16.9	17.1	27.3	26.0	17.8	27.9	19.7	19.3	18.2	18.7	13.6	9.8	5.0	3.5	6.1	3.7	2.8	3.0	3.6	5.2	3.5	3.6	3.1	1.4	4.0	4.2	2.6	2.6	5.2	7.6	7.2	9.7	7.4	6.1	9.0	7.5	8.9	5.9	6.5	7.6	6.9	6.5	6.2	12.8	8.2	19.2	11.8	4.1	5.3	3.4	4.6	14.1	10.6	6.2	4.6	2.8	11.6	5.5	12.5	7.0	4.8	6.5	9.8	7.0	20.7	24.0	10.6	7.3	4.8	13.3	30.5	9.6	8.1	7.8	12.8	9.9	7.6	14.0	6.8	14.5	8.2	6.7	29.4	9.3	6.1	16.8	4.6	19.5	14.6	10.4	1.8	7.5	14.0	19.4	10.3	16.6	19.3	8.5	2.9	12.4	10.6	5.3	5.4	17.1	22.4	18.9	6.6	12.6	7.3	75.9	27.9	6.9	4.1	6.7	5.8	11.8	9.1	5.2
NKAPL	"bA424I5.1, C6orf194"	ENSG00000189134	"NFKB activating protein like"	Q5M9Q1	6	28259297-28260958	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 12.7;testis: 32.6"	"Group enriched"	"Detected in many"	4	"Early spermatids: 401.2;Spermatocytes: 307.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.2;BJ: 1.4;fHDF/TERT166: 2.2;HHSteC: 4.6;HSkMC: 3.0;HUVEC TERT2: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.93e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.46e-2)"	"unprognostic (9.73e-2)"	"unprognostic (2.47e-1)"	"unprognostic (7.86e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.88e-2)"	"unprognostic (3.84e-3)"	"unprognostic (5.78e-2)"	"unprognostic (5.83e-5)"	"unprognostic (6.65e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.47e-2)"	1.9	1.3	6.9	0.7	6.4	0.2	1.5	6.9	9.0	0.7	5.5	1.6	0.3	1.1	1.1	0.9	0.7	0.7	5.1	6.1	6.4	1.0	0.8	0.7	0.7	7.1	6.7	5.8	2.0	1.6	0.3	2.1	0.8	7.5	1.4	0.4	12.7	1.6	2.5	5.7	0.7	0.7	1.4	6.7	1.4	1.1	32.6	7.2	0.5	1.0	4.0	0.5	2.0	0.5	8.3	0.0	0.0	0.0	0.0	3.2	0.9	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	3.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	1.6	0.1	1.3	0.3	1.2	0.0	0.2	0.9	0.1	0.2	0.2	2.2	0.3	1.0	2.5	0.0	0.2	6.9	6.4	6.9	9.0	6.1	6.4	7.1	6.7	5.8	7.5	6.7	7.2	8.3	4.2	0.0	0.0	2.6	1.1	1.0	1.6	2.5	0.0	29.5	1.8	3.7	13.0	1.5	2.6	1.8	43.8	0.1	4.7	0.0	9.8	2.1	401.2	0.4	2.5	4.8	0.0	0.0	3.3	0.7	0.0	4.1	0.0	0.2	0.0	1.4	3.9	3.5	3.2	33.7	3.3	0.1	10.2	5.1	3.1	49.2	5.6	2.7	5.4	1.9	3.6	15.7	2.1	1.0	2.1	1.4	0.0	6.4	0.4	1.6	0.1	4.1	1.3	77.4	0.0	3.1	5.7	307.1	28.1	1.1	0.9	0.3	1.9	3.2	0.1	0.6
NKX6-1	"Nkx6.1, NKX6A"	ENSG00000163623	"NK6 homeobox 1"	P78426	4	84491985-84499292	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 13.7;esophagus: 9.3;pancreas: 6.5"	"Group enriched"	"Detected in some"	5	"Ductal cells: 9.3;Early spermatids: 25.8;Spermatocytes: 16.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 13.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 4.4;HAP1: 6.2;HEK 293: 5.0;HMC-1: 4.1;PC-3: 3.0;U-2197: 6.8"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.6"	"Group enriched"	"Detected in many"	5	"hypothalamus: 2.5;medulla oblongata: 3.4;midbrain: 3.8;pons: 3.8;spinal cord: 7.9"	"HPA036774, CAB070169"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB070169: AB_10011794, HPA036774: AB_10673664"	"unprognostic (2.26e-1)"	"unprognostic (2.12e-2)"		"unprognostic (9.13e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.38e-2)"		"unprognostic (1.30e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.75e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.41e-2)"	"unprognostic (7.13e-3)"	"unprognostic (3.68e-1)"	0.0	0.0	1.7	0.0	1.0	0.0	0.2	0.7	1.0	0.0	0.8	0.0	0.1	0.0	0.0	9.3	0.0	0.0	0.0	0.5	2.7	0.0	0.0	0.1	0.0	4.3	13.7	0.3	0.1	6.5	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.7	2.2	1.7	0.0	3.2	0.0	0.0	0.0	0.0	2.0	0.2	0.1	4.4	0.8	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.1	2.0	0.0	6.2	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	3.0	0.0	2.0	0.0	0.0	0.3	1.1	0.0	0.7	0.0	0.0	1.3	0.0	0.5	0.0	0.0	1.8	6.8	2.0	0.0	0.0	0.0	1.3	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.0	0.7	1.0	0.5	2.7	4.3	13.7	0.3	3.2	5.3	1.7	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	25.8	0.2	1.0	0.1	0.0	0.0	0.0	0.4	0.1	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	1.9	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	16.7	1.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0
NME8	"CILD6, NM23-H8, SPTRX2, TXNDC3"	ENSG00000086288	"NME/NM23 family member 8"	Q8N427	7	37848597-37900397	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"	"Ciliopathy, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"bone marrow: 12.4;testis: 10.5"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 22.8;Early spermatids: 46.3;Late spermatids: 23.4;NK-cells: 17.5;Oligodendrocytes: 9.8;Spermatocytes: 26.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 4.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.2;NB-4: 2.0;NTERA-2: 1.7;THP-1: 1.7;U-937: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016416, HPA019259, HPA029572"	Enhanced		Supported	"Nuclear speckles,Cytosol"		NA	NA			Cytosol	"Nuclear speckles"	"CAB016416: , HPA019259: AB_1858475, HPA029572: "	"unprognostic (7.44e-3)"	"unprognostic (2.32e-2)"	"unprognostic (9.11e-2)"	"unprognostic (2.97e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.20e-2)"	"unprognostic (6.56e-2)"	"unprognostic (4.22e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.34e-2)"	"unprognostic (8.13e-8)"	"unprognostic (5.90e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.86e-1)"	0.1	0.1	0.5	0.6	0.8	12.4	0.1	0.6	0.7	0.1	0.6	0.3	0.1	0.1	0.1	0.2	0.1	0.5	0.0	0.4	0.7	0.0	0.1	0.4	0.5	1.0	0.7	0.3	0.0	0.0	0.0	0.0	0.2	1.0	0.1	0.1	0.0	0.1	0.1	0.0	0.4	0.2	0.1	0.8	1.0	0.2	10.5	0.9	0.3	0.0	0.0	0.3	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	1.1	0.9	0.3	0.2	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.3	2.1	0.1	0.0	4.6	0.0	0.4	0.5	0.8	0.6	0.7	0.4	0.7	1.0	0.7	0.3	1.0	0.8	0.9	1.1	0.1	0.0	2.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.1	22.8	0.0	0.0	0.0	46.3	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	5.1	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	1.9	5.1	23.4	0.0	3.3	0.0	0.0	2.6	0.0	17.5	0.0	9.8	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	26.5	0.7	0.0	0.0	0.0	2.2	0.0	0.0	0.0
NUDCD3	"KIAA1068, NudCL"	ENSG00000015676	"NudC domain containing 3"	Q8IVD9	7	44379119-44490658	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019136, HPA019528, HPA019529"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA019136: AB_1852370, HPA019528: AB_1852372, HPA019529: AB_1852374"	"unprognostic (3.72e-2)"	"unprognostic (9.28e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.05e-3)"	"unprognostic (2.18e-3)"	"unprognostic (2.05e-2)"	"unprognostic (4.73e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.62e-2)"	"prognostic favorable (9.16e-4)"	"unprognostic (3.51e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.50e-2)"	2.9	2.8	6.1	1.3	8.1	2.8	2.8	2.9	6.9	2.5	0.0	2.2	1.2	2.3	2.4	2.8	3.5	2.2	7.6	6.4	5.0	2.2	1.8	2.5	2.2	4.5	5.4	6.4	3.1	3.3	3.8	1.9	1.7	5.4	2.8	1.8	4.8	2.4	3.3	8.3	3.0	2.0	3.1	3.3	1.9	2.7	3.9	5.0	2.1	2.8	5.7	2.3	2.3	1.8	6.1	2.6	4.9	3.4	6.3	4.2	3.4	1.3	4.1	4.0	4.8	4.9	3.3	1.8	8.1	3.0	5.5	6.6	3.0	4.8	5.6	2.8	4.8	4.9	2.2	2.9	2.3	3.8	3.9	1.3	3.1	3.7	3.6	4.1	2.8	5.9	2.4	6.1	2.6	3.6	2.3	1.6	3.7	4.3	2.5	6.3	2.3	3.7	3.0	2.7	4.0	3.6	10.6	2.4	4.5	1.8	3.4	3.4	5.7	5.7	3.3	3.4	2.2	3.3	7.3	8.1	4.0	3.6	4.5	5.9	0.6	0.8	0.9	1.0	0.8	1.1	1.0	0.9	0.9	0.7	1.0	0.9	0.9	0.5	0.8	1.0	0.6	1.0	0.9	6.1	8.1	2.9	6.9	6.4	5.0	4.5	5.4	6.4	5.4	3.3	5.0	6.1	30.5	12.8	19.2	35.9	26.4	11.3	13.0	16.5	20.5	40.9	29.3	25.3	44.5	17.2	16.0	38.6	54.2	19.6	21.9	22.7	23.5	29.6	87.7	27.4	34.4	25.3	17.4	22.3	59.6	21.6	18.1	23.9	23.9	30.9	9.5	35.8	22.5	32.8	18.3	48.8	58.8	25.1	26.4	17.9	9.5	98.3	30.4	13.9	16.0	46.9	21.2	24.8	34.0	36.2	61.2	27.4	18.8	28.2	14.3	15.9	27.2	26.8	21.9	40.2	32.9	17.8	25.2	106.6	21.1	25.5	16.2	14.4	26.2	18.9	27.8	13.3
NUP210L		ENSG00000143552	"Nucleoporin 210 like"	Q5VU65	1	153992685-154155116	"Cancer-related genes, Metabolic proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 26.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 20.3;Inhibitory neurons: 8.4;Late spermatids: 8.5;Oligodendrocytes: 19.2;Spermatocytes: 28.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	47	"MCF7: 15.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA047195, HPA064245, HPA066707"	Enhanced		Approved	"Nuclear bodies"		No	No			"Nuclear bodies"		"HPA047195: AB_2679980, HPA064245: AB_2685224, HPA066707: AB_2685706"	"unprognostic (2.11e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.72e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.79e-3)"	"unprognostic (3.45e-2)"	"unprognostic (5.57e-2)"	"unprognostic (4.51e-4)"	"unprognostic (1.15e-1)"	"unprognostic (9.35e-10)"	"unprognostic (4.20e-2)"	"unprognostic (3.78e-2)"	"unprognostic (7.45e-2)"	"unprognostic (4.09e-2)"	0.1	0.0	0.6	0.0	1.0	0.1	0.0	2.4	1.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	1.3	0.1	0.0	0.1	0.0	0.8	0.7	0.3	0.1	0.1	0.0	0.3	0.0	1.1	0.1	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.2	0.6	0.0	0.0	26.8	1.1	0.0	0.2	0.0	0.0	0.3	0.0	2.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	15.8	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.6	1.0	2.4	1.1	0.7	1.3	0.8	0.7	0.3	1.1	0.6	1.1	2.5	0.6	0.0	0.0	6.2	0.5	0.3	0.1	0.1	0.0	0.0	0.3	0.3	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	20.3	0.7	0.6	0.9	0.0	0.4	7.0	0.2	0.1	0.5	0.0	1.5	0.0	0.1	0.0	0.0	0.2	0.0	8.4	0.1	0.0	0.0	0.6	8.5	0.9	0.8	0.0	2.8	0.0	0.0	0.0	4.5	19.2	0.0	0.0	1.2	1.7	0.1	0.0	0.1	0.1	0.0	6.6	1.8	0.3	28.2	5.1	0.3	0.6	0.0	0.4	0.1	0.1	0.3
ODF4	"CT136, OPPO1"	ENSG00000184650	"Outer dense fiber of sperm tails 4"	Q2M2E3	17	8339840-8346048	"Predicted membrane proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	132	"testis: 13.1"	"Group enriched"	"Detected in some"	48	"Early spermatids: 32.1;Late spermatids: 36.0;Spermatocytes: 47.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA072129	Enhanced					NA	NA					"HPA072129: "	"unprognostic (5.16e-2)"				"unprognostic (5.13e-1)"	"unprognostic (3.54e-4)"						"unprognostic (3.64e-1)"					"unprognostic (5.40e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	36.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OOEP	"C6orf156, Em:AC019205.2, KHDC2"	ENSG00000203907	"Oocyte expressed protein"	A6NGQ2	6	73368555-73395133	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 14.3"	"Group enriched"	"Detected in some"	6	"Early spermatids: 29.4;Spermatocytes: 74.1;Spermatogonia: 56.8"	"Cancer enriched"	"Detected in single"	26	"testis cancer: 10.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.8;CAPAN-2: 8.3;MCF7: 2.9;U-2 OS: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055165	Approved					NA	NA					"HPA055165: AB_2682722"	"unprognostic (7.95e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.50e-1)"	"unprognostic (4.68e-1)"	"unprognostic (2.20e-3)"	"unprognostic (6.86e-2)"	"unprognostic (3.99e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.52e-1)"	"unprognostic (6.04e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.86e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.98e-2)"	0.2	0.2	0.1	0.1	0.1	0.0	0.3	0.1	0.6	0.1	0.3	0.1	0.1	0.1	0.0	0.3	0.0	0.1	0.1	0.2	0.2	0.1	0.3	0.2	0.1	0.3	0.2	0.0	0.2	0.9	0.0	0.1	1.4	0.2	0.2	0.0	0.0	1.8	0.4	0.0	0.9	0.1	0.0	0.1	0.2	0.5	14.3	0.2	0.0	0.4	0.2	0.1	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.1	0.2	0.0	8.3	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.3	0.5	0.2	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.6	0.2	0.2	0.3	0.2	0.0	0.2	0.1	0.2	0.3	0.3	0.0	0.0	0.0	0.3	1.1	0.3	3.8	0.0	0.0	0.4	0.6	0.0	1.5	0.5	0.0	0.0	8.6	0.2	0.2	0.0	0.1	29.4	1.8	0.1	0.7	0.0	2.7	0.0	0.6	2.4	0.5	0.0	0.8	0.0	0.0	0.0	0.7	1.2	0.0	0.0	0.5	2.0	0.3	0.7	7.2	0.6	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.7	0.0	1.2	0.4	0.3	0.2	1.2	0.5	0.6	0.0	0.5	0.2	74.1	56.8	0.0	1.0	4.5	0.4	0.0	0.0	0.3
OR7A5	HTPCR2	ENSG00000188269	"Olfactory receptor family 7 subfamily A member 5"	Q15622	19	14826241-14835185	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"brain: 9.7;epididymis: 4.5;parathyroid gland: 7.1"	"Cell type enhanced"	"Detected in single"		"Spermatocytes: 1.3"	"Cancer enriched"	"Detected in single"	8	"melanoma: 2.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA053823	Uncertain					NA	NA					"HPA053823: AB_2682274"	"unprognostic (3.26e-4)"	"unprognostic (1.44e-1)"		"unprognostic (7.46e-2)"	"unprognostic (6.19e-3)"	"unprognostic (4.89e-2)"		"unprognostic (1.49e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.01e-7)"	"unprognostic (6.45e-2)"	"unprognostic (9.64e-2)"	"unprognostic (6.44e-2)"	"unprognostic (2.47e-3)"	0.0	0.1	1.2	0.0	3.3	0.0	0.7	3.1	4.8	0.1	0.7	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	1.3	3.1	0.0	0.0	0.0	0.0	3.9	4.3	1.0	0.0	0.0	7.1	1.3	0.0	3.7	0.5	0.0	0.0	0.2	0.6	0.0	0.7	0.0	0.0	1.2	0.0	0.0	1.3	3.0	0.0	0.0	0.0	0.0	0.0	0.2	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	3.3	3.1	4.8	1.3	3.1	3.9	4.3	1.0	3.7	1.2	3.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2
ORC2	ORC2L	ENSG00000115942	"Origin recognition complex subunit 2"	Q13416	2	200908977-200963680	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 107.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003693, HPA073881"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB003693: AB_425574, HPA073881: AB_2686640"	"unprognostic (3.04e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.89e-1)"	"unprognostic (8.12e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.37e-3)"	"unprognostic (3.28e-1)"	"prognostic unfavorable (8.42e-4)"	"unprognostic (6.18e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.63e-3)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (9.67e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.42e-1)"	"unprognostic (5.31e-3)"	5.6	5.0	2.3	6.8	3.5	5.7	8.1	7.6	5.0	5.6	4.0	7.2	9.2	6.0	6.1	5.9	5.2	4.4	8.9	3.3	2.3	5.7	5.3	5.0	8.6	3.0	2.8	3.1	6.8	6.9	7.3	5.1	5.6	3.6	6.4	6.9	7.8	7.2	5.9	6.8	8.4	7.7	4.8	1.6	6.6	7.1	21.0	2.6	9.5	8.4	6.0	8.5	5.4	5.9	4.6	17.8	12.3	13.9	13.9	5.6	9.5	23.4	18.1	11.4	16.3	16.1	26.3	14.2	11.2	12.6	10.7	18.3	14.3	30.6	20.6	24.7	24.9	28.2	26.1	22.1	32.4	11.0	20.7	17.7	8.9	12.0	16.7	20.4	12.8	19.1	18.3	42.5	13.3	14.6	16.9	29.1	19.5	33.6	17.2	29.6	20.6	14.1	16.3	17.2	14.1	22.0	16.5	15.9	14.0	10.4	27.2	10.0	10.2	14.7	14.2	14.6	12.3	18.3	9.4	24.1	17.9	11.3	19.9	13.6	0.3	2.5	3.9	3.2	1.0	4.3	5.5	4.5	3.2	2.1	4.6	5.7	4.1	1.2	3.2	1.9	4.9	3.3	1.6	2.3	3.5	7.6	5.0	3.3	2.3	3.0	2.8	3.1	3.6	1.6	2.6	4.6	12.9	9.6	18.5	30.7	16.5	19.1	9.0	7.7	23.9	14.6	12.3	7.6	18.0	14.3	14.8	9.2	25.0	20.6	17.5	12.8	7.9	10.0	56.0	11.5	14.1	12.7	4.2	26.7	54.6	12.3	18.5	10.0	14.8	13.3	10.8	27.5	13.2	10.9	8.9	6.7	61.4	13.1	4.1	7.0	7.1	11.6	12.2	7.0	10.6	24.4	11.4	7.0	20.6	41.7	55.9	10.5	9.0	8.2	16.3	9.7	15.2	9.1	12.1	14.9	19.7	13.1	9.1	107.2	22.1	16.1	15.5	10.8	14.7	6.9	14.7	8.4
OVOL2	"bA504H3.3, CHED, CHED1, HOVO2, ZNF339"	ENSG00000125850	"Ovo like zinc finger 2"	Q9BRP0	20	17956979-18059188	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Corneal dystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 7.2;stomach 1: 8.0"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 24.4;Spermatocytes: 37.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 5.6;CACO-2: 4.1;CAPAN-2: 7.3;HaCaT: 5.4;OE19: 10.0;SCLC-21H: 8.3;SK-BR-3: 5.4"	"Region enhanced"	"Detected in many"		"cerebral cortex: 10.3"	"Group enriched"	"Detected in some"	5	"cerebral cortex: 3.9;hippocampal formation: 3.3"	HPA038531	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA038531: AB_10673012"	"unprognostic (2.85e-2)"	"unprognostic (5.13e-2)"	"unprognostic (2.41e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.84e-4)"	"unprognostic (4.77e-3)"	"unprognostic (2.92e-1)"	"unprognostic (2.57e-2)"	"unprognostic (3.76e-2)"	0.0	0.0	0.0	0.1	0.1	0.0	2.8	0.0	0.2	1.0	0.0	3.3	3.0	0.3	0.5	5.4	1.0	0.3	0.0	0.1	0.0	1.2	0.0	1.5	0.0	0.0	0.0	0.1	0.0	4.5	0.4	1.2	0.1	0.0	4.1	1.3	0.0	7.2	0.7	0.0	6.6	2.3	0.1	0.0	0.0	8.0	1.4	0.0	0.1	3.4	0.0	0.2	1.2	3.7	0.1	5.6	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	4.1	7.3	0.0	1.0	0.0	0.3	5.4	1.0	1.3	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.0	0.3	0.0	2.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	10.0	0.1	0.0	0.0	2.1	0.1	2.6	8.3	0.0	0.0	5.4	0.0	0.1	2.8	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	6.4	8.4	0.3	0.1	8.3	11.4	4.8	4.0	0.0	14.6	11.7	1.4	8.6	8.8	1.8	0.0	1.7	0.2	17.1	0.0	8.4	18.6	24.4	1.3	0.3	3.6	0.0	3.3	10.9	3.2	0.2	17.9	18.4	0.0	0.0	0.0	0.0	0.1	1.7	1.7	15.5	10.2	0.0	0.7	7.4	0.3	0.5	0.0	0.0	0.0	0.7	0.0	1.0	0.3	16.9	10.5	0.4	0.0	12.9	12.0	1.6	6.4	0.0	0.0	0.0	0.7	37.9	0.7	4.9	9.8	0.1	0.4	0.0	12.3	15.1
OXLD1	"C17orf90, MGC104712"	ENSG00000204237	"Oxidoreductase like domain containing 1"	Q5BKU9	17	81665036-81666635	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 56.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056878, HPA057019"	Uncertain		Approved	Vesicles,Cytosol		NA	NA		12000	"Vesicles, Cytosol"		"HPA056878: AB_2683265, HPA057019: AB_2683310"	"unprognostic (1.08e-1)"	"prognostic favorable (2.91e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.03e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.60e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.06e-2)"	"unprognostic (3.64e-1)"	"unprognostic (8.71e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.30e-2)"	11.3	16.8	6.3	3.2	6.2	6.3	12.7	6.5	15.3	7.2	5.8	9.9	4.6	7.9	0.0	11.1	8.4	1.2	13.5	6.0	6.6	14.1	18.1	7.5	3.9	6.9	6.9	6.2	5.5	14.9	1.5	6.7	1.7	6.6	11.2	0.2	0.1	10.6	1.9	16.6	13.8	9.9	1.3	6.8	11.8	15.5	29.9	6.9	0.6	8.9	0.0	0.7	10.1	7.6	7.3	15.2	56.0	0.5	12.6	3.2	0.3	9.5	7.3	0.2	0.1	1.4	14.9	14.1	4.7	12.6	0.0	7.8	13.1	0.0	10.0	0.0	7.7	29.4	4.2	26.1	37.2	22.9	3.0	11.1	4.8	6.8	2.9	3.1	0.7	5.3	22.3	7.3	7.2	1.1	38.3	10.7	12.4	6.9	7.9	24.9	9.7	0.4	20.5	2.9	8.2	2.4	11.2	3.1	19.0	27.6	0.2	27.4	17.1	4.5	10.8	7.2	12.2	8.4	19.8	7.9	6.5	14.6	11.3	11.0	18.6	23.6	18.4	23.5	20.8	25.1	26.4	31.9	27.0	22.9	28.6	33.5	26.0	17.1	35.5	22.6	31.2	30.6	23.8	6.3	6.2	6.5	15.3	6.0	6.6	6.9	6.9	6.2	6.6	6.8	6.9	7.3	17.9	32.1	17.1	7.5	26.1	8.5	21.5	48.6	21.6	19.9	40.3	40.0	16.2	30.0	26.1	23.9	6.2	37.1	24.8	43.4	72.4	38.1	85.7	29.9	25.6	19.2	21.7	38.1	8.3	47.9	28.8	20.6	28.1	26.9	14.0	26.1	23.6	55.0	44.2	23.5	7.7	35.5	50.8	34.2	11.1	34.6	33.2	21.0	16.0	5.6	41.2	41.3	47.4	7.5	12.6	43.9	41.5	23.7	19.7	40.4	63.4	89.3	36.0	30.9	26.3	11.9	18.5	95.7	20.4	35.8	8.5	27.9	29.5	56.5	31.6	26.6
OXSM	"CEM1, FASN2D, FLJ20604, KS"	ENSG00000151093	"3-oxoacyl-ACP synthase, mitochondrial"	Q9NWU1	3	25782917-25794534	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 59.5;Spermatocytes: 48.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021293, HPA021300, HPA021337"	Enhanced		Approved	Mitochondria,Cytosol		No	No			"Mitochondria, Cytosol"		"HPA021293: AB_1848772, HPA021300: AB_1848774, HPA021337: AB_1848776"	"unprognostic (2.20e-2)"	"unprognostic (3.28e-1)"	"prognostic favorable (1.35e-4)"	"prognostic favorable (5.51e-4)"	"unprognostic (1.01e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.83e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (4.18e-9)"	"unprognostic (1.79e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.73e-2)"	6.2	11.1	3.6	5.6	3.9	4.1	9.3	4.0	4.7	4.9	5.4	11.2	9.5	4.6	14.0	8.6	6.9	3.9	13.1	3.8	4.0	13.8	22.2	4.9	7.9	3.7	3.8	3.7	5.0	10.6	10.1	5.8	6.0	4.0	6.0	12.4	10.3	10.2	6.0	14.8	7.8	7.8	5.3	3.9	8.0	8.3	11.8	3.8	7.1	8.6	15.8	8.9	5.6	5.3	3.9	11.0	18.1	3.8	10.5	10.7	11.6	10.9	8.6	12.4	15.8	11.2	13.8	12.9	20.4	11.5	8.0	9.2	11.3	15.7	16.6	14.9	12.3	16.0	22.5	15.2	16.9	13.1	18.4	13.7	11.0	20.4	12.7	13.3	10.3	13.8	18.9	23.5	16.0	13.7	16.6	13.6	14.4	0.7	8.8	20.6	17.8	9.9	33.7	23.3	6.8	5.4	9.7	13.8	23.6	18.3	6.0	25.5	16.9	8.5	10.0	11.9	13.1	12.7	15.1	18.8	6.6	13.9	16.0	10.4	2.1	5.1	3.7	8.6	6.0	10.1	7.9	8.8	10.8	8.4	8.9	10.2	10.7	0.8	11.4	6.8	8.8	6.0	6.3	3.6	3.9	4.0	4.7	3.8	4.0	3.7	3.8	3.7	4.0	3.9	3.8	3.9	5.9	0.0	9.4	3.9	9.3	3.1	5.9	23.0	4.0	6.5	8.7	13.2	13.3	10.0	12.0	11.0	4.2	19.5	7.1	5.4	11.7	13.5	59.5	7.8	7.2	4.9	2.4	2.1	4.5	6.8	16.9	5.9	4.6	6.4	10.1	13.0	7.5	17.4	8.5	5.0	5.1	9.8	14.2	3.8	3.2	15.1	7.2	6.8	5.4	1.0	5.2	9.1	6.2	3.5	3.8	7.5	8.9	4.1	7.8	6.5	10.6	18.4	9.2	7.4	0.0	5.3	5.8	48.0	12.6	7.2	4.4	14.1	5.9	19.2	8.8	3.6
PABPC3	"PABP3, PABPL3, tPABP"	ENSG00000151846	"Poly(A) binding protein cytoplasmic 3"	Q9H361	13	25096136-25099254	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	42	"testis: 37.1"	"Group enriched"	"Detected in many"	14	"Early spermatids: 217.6;Late spermatids: 135.4;Spermatocytes: 190.8"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	15	"U-266/84: 6.8"									"HPA045423, HPA067156"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA045423: AB_2679320, HPA067156: AB_2685793"	"unprognostic (2.17e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.98e-1)"	"unprognostic (8.76e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (8.00e-4)"	"unprognostic (5.26e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.17e-2)"	"unprognostic (5.18e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.61e-3)"	0.4	0.2	0.1	0.0	0.2	0.0	0.4	0.2	0.2	0.3	0.0	0.3	0.0	0.3	0.0	0.8	0.2	0.0	0.1	0.2	0.1	0.1	0.2	0.4	0.0	0.2	0.2	0.1	0.5	0.4	0.0	0.1	0.0	0.2	0.3	0.0	0.1	0.7	0.0	0.1	0.5	0.3	0.0	0.2	0.2	0.3	37.1	0.2	0.0	0.2	0.0	0.0	0.3	0.6	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.4	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.4	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.2	6.8	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.4	0.3	0.3	0.3	0.2	0.4	0.2	0.4	0.4	0.1	0.3	0.4	0.2	0.3	0.5	0.1	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.1	0.2	0.2	0.2	0.3	0.1	0.0	0.0	0.0	1.3	11.7	9.9	2.8	0.0	0.1	0.4	0.0	5.3	0.0	1.3	0.0	0.0	2.0	4.0	0.9	0.0	0.3	217.6	0.2	0.4	2.5	4.2	2.7	0.0	0.4	1.8	2.0	0.0	0.1	4.5	0.1	2.5	1.0	1.6	1.7	0.0	1.6	2.0	5.7	12.7	135.4	3.1	1.9	5.4	0.0	2.1	1.3	0.0	0.0	0.0	0.1	3.0	4.9	0.0	4.5	0.5	2.0	1.0	0.0	6.6	4.8	10.5	190.8	5.1	0.0	12.9	2.9	2.5	0.2	2.7	5.0
PANK2	"C20orf48, FLJ11729, HARP, HSS, NBIA1, PKAN"	ENSG00000125779	"Pantothenate kinase 2"	Q9BZ23	20	3888839-3929887	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Coenzyme A biosynthesis"	"Kinase, Transferase"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008440	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA008440: AB_1079559"	"unprognostic (4.50e-2)"	"unprognostic (7.96e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.00e-2)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (2.75e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.01e-3)"	"unprognostic (1.73e-2)"	"unprognostic (2.18e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.81e-1)"	13.2	12.4	15.8	16.9	14.9	21.1	12.3	16.4	16.2	12.0	15.5	11.5	8.5	11.1	11.4	20.2	16.4	12.2	8.8	16.6	15.1	15.8	18.5	14.2	18.6	14.0	15.6	15.5	13.0	10.4	11.0	9.0	15.4	14.4	12.1	14.3	10.4	12.0	10.8	9.7	11.8	11.7	13.9	14.3	15.0	9.1	26.2	15.3	17.0	15.5	11.3	22.2	15.7	10.0	14.9	39.3	29.4	33.7	18.6	39.3	32.6	15.0	25.6	34.2	38.3	48.3	40.8	25.4	34.6	10.6	34.9	70.2	34.9	34.7	57.3	49.3	8.8	9.8	47.4	22.7	80.2	33.3	33.6	15.9	28.7	26.4	39.7	28.7	17.0	36.0	23.3	34.7	30.5	42.5	11.7	30.0	30.3	28.8	22.9	19.5	20.3	46.0	22.4	26.2	45.7	36.2	16.7	30.0	44.3	78.1	32.6	23.6	28.1	24.6	47.7	17.8	60.7	43.3	14.0	50.8	23.3	15.0	30.7	34.2	3.0	10.5	3.4	3.6	11.1	3.5	3.8	3.7	3.4	8.5	4.5	4.1	3.4	5.9	6.8	9.4	3.0	5.9	4.0	15.8	14.9	16.4	16.2	16.6	15.1	14.0	15.6	15.5	14.4	14.3	15.3	14.9	23.8	19.2	11.7	23.8	29.2	25.5	17.5	12.0	41.5	22.0	15.8	17.3	9.8	7.2	13.4	14.7	25.0	29.4	38.6	14.4	23.5	19.4	83.1	24.1	20.6	26.7	20.3	42.7	28.6	17.8	36.0	21.1	24.5	24.1	7.6	20.1	26.0	14.0	33.8	35.3	25.3	12.7	10.2	52.8	37.9	17.3	21.1	34.3	19.6	29.0	55.0	14.1	35.0	23.1	17.7	15.9	12.8	22.6	33.2	20.9	15.1	20.6	20.2	21.1	6.6	14.1	23.1	54.6	25.9	37.7	24.3	18.6	31.6	21.2	15.0	20.0
PBK	"CT84, FLJ14385, Nori-3, SPK, TOPK"	ENSG00000168078	"PDZ binding kinase"	Q96KB5	8	27809624-27838082	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 23.0;testis: 70.9"	"Group enriched"	"Detected in many"	5	"Early spermatids: 364.9;Spermatocytes: 436.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 282.8"	"Group enriched"	"Detected in many"	4	"basal ganglia: 4.7;white matter: 13.9"	"Not detected"	"Not detected"			"HPA005753, HPA050656"	Enhanced	Supported	Approved	Cytosol		NA	Yes			Cytosol		"HPA005753: AB_1855018, HPA050656: AB_2681205"	"unprognostic (7.17e-2)"	"unprognostic (7.21e-3)"	"unprognostic (1.04e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (8.29e-5)"	"unprognostic (3.65e-3)"	"unprognostic (7.38e-2)"	"unprognostic (2.88e-3)"	"prognostic unfavorable (6.56e-4)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (1.18e-12)"	"unprognostic (9.61e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.30e-2)"	"unprognostic (8.68e-2)"	1.1	0.6	0.1	6.7	0.1	9.2	2.3	0.1	0.1	1.1	0.1	8.9	8.4	1.2	0.0	6.6	0.6	0.7	0.2	0.1	0.3	0.4	1.1	0.7	12.9	0.1	0.3	0.1	0.2	0.4	0.2	0.0	5.2	0.1	0.4	10.2	0.0	0.9	0.0	0.2	4.9	8.2	2.7	0.1	1.5	3.7	70.9	0.3	23.0	0.6	0.1	12.5	1.6	2.1	1.0	282.8	94.2	94.4	57.9	8.3	15.7	36.9	129.5	63.0	133.2	112.3	33.7	51.2	156.4	43.3	51.7	150.2	76.4	87.6	44.7	145.7	35.8	48.0	35.0	64.6	49.2	0.6	25.7	54.1	4.4	36.0	62.6	32.8	24.3	68.5	75.9	54.3	100.6	160.4	34.5	87.7	29.1	15.6	80.1	80.0	54.4	126.9	41.2	51.2	44.9	36.1	53.2	48.2	56.0	75.0	26.2	58.0	37.3	40.6	85.6	207.3	111.5	141.5	15.4	39.4	70.1	54.0	43.4	188.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.3	0.1	0.1	0.1	0.3	1.0	0.2	0.0	0.0	0.0	4.2	8.9	2.8	10.8	0.0	0.0	2.9	2.4	0.5	2.8	2.6	0.0	0.0	29.8	1.3	5.5	0.0	0.6	364.9	2.5	2.2	2.4	0.0	61.7	0.1	0.0	49.3	6.7	6.6	3.5	0.0	13.5	5.7	1.7	5.0	0.0	0.1	9.4	6.1	1.9	1.6	76.8	8.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	3.0	14.0	2.0	1.5	0.3	0.1	0.0	6.6	0.1	5.8	436.4	38.1	9.4	2.4	6.7	1.9	2.4	18.7	3.8
PCDHA7	"CNR4, CNRS4, CRNR4"	ENSG00000204963	"Protocadherin alpha 7"	Q9UN72	5	140834248-141012347	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 3.2"	"Cell type enhanced"	"Detected in some"		"Horizontal cells: 1.7;Spermatocytes: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.0;SK-MEL-30: 1.2;WM-115: 1.1"															NA	NA						"unprognostic (1.99e-1)"	"unprognostic (8.54e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.28e-2)"	"unprognostic (3.05e-1)"	"unprognostic (7.08e-2)"	"unprognostic (9.29e-3)"	"unprognostic (4.11e-3)"	"unprognostic (7.20e-2)"	"unprognostic (3.18e-3)"	"unprognostic (3.12e-4)"	"unprognostic (9.54e-4)"	"unprognostic (6.86e-5)"	"unprognostic (5.34e-4)"	"unprognostic (2.88e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.14e-1)"	0.1	0.1	0.4	0.0	0.6	0.0	0.2	3.2	0.9	0.2	0.0	0.2	0.1	0.3	0.1	0.0	0.1	0.2	0.0	0.4	0.5	0.2	0.0	0.2	0.0	1.2	0.9	0.5	0.3	0.3	0.1	0.4	0.0	1.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.1	0.5	0.1	0.1	0.9	0.2	0.0	0.1	0.0	0.0	0.1	0.1	2.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.8	1.2	0.3	0.2	0.0	0.1	0.1	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	3.2	0.9	0.4	0.5	1.2	0.9	0.5	1.0	0.5	0.2	2.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.4	0.0	0.0	0.2	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1
PCDHA9	"KIAA0345, PCDH-ALPHA9"	ENSG00000204961	"Protocadherin alpha 9"	Q9Y5H5	5	140847772-141012347	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.2;testis: 1.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 2.9;Early spermatids: 1.7;Horizontal cells: 1.7;Rod photoreceptor cells: 1.7;Spermatocytes: 4.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebellum: 3.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"SCLC-21H: 7.1"															NA	NA						"unprognostic (1.53e-3)"	"unprognostic (1.13e-1)"		"unprognostic (7.54e-4)"	"unprognostic (1.28e-2)"			"unprognostic (4.65e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.20e-3)"	"unprognostic (6.49e-3)"	"unprognostic (1.31e-4)"	"unprognostic (1.82e-1)"	"unprognostic (8.79e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.19e-1)"		0.1	0.1	0.4	0.0	0.5	0.2	0.0	3.2	0.7	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.7	0.3	0.6	0.0	0.7	0.0	0.1	0.0	1.2	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.5	3.2	0.7	0.4	0.2	0.7	0.3	0.6	1.2	0.3	0.1	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.9	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.7	0.2	0.7	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.3	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	1.7	0.0	0.7	0.3	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PCDHB15	PCDH-BETA15	ENSG00000113248	"Protocadherin beta 15"	Q9Y5E8	5	141245395-141249365	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 4.3;Bipolar cells: 4.4;Early spermatids: 7.5;Endometrial stromal cells: 4.4;Fibroblasts: 3.7;Horizontal cells: 5.0;Skeletal myocytes: 4.2;Smooth muscle cells: 4.1;Spermatocytes: 4.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.2;LHCN-M2: 4.9;WM-115: 4.9"	"Low region specificity"	"Detected in all"							"HPA007172, CAB026471, HPA074676"	Uncertain		Approved	Mitochondria		NA	NA		250000	Mitochondria		"CAB026471: , HPA007172: AB_1079576, HPA074676: AB_2732263"	"unprognostic (1.39e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.37e-3)"	"unprognostic (1.75e-1)"	"unprognostic (2.06e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.87e-2)"	"unprognostic (7.58e-2)"	"unprognostic (7.01e-2)"	"unprognostic (6.00e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.59e-1)"	3.0	1.4	1.8	2.6	2.1	0.0	2.6	4.3	2.5	5.7	0.3	3.0	0.5	6.9	2.5	1.4	5.0	2.1	4.2	1.9	1.7	2.0	1.1	3.8	0.7	3.0	2.3	2.0	7.4	3.4	0.9	3.6	1.5	2.5	2.4	0.9	2.0	1.7	2.1	1.3	1.2	1.8	4.1	2.1	2.5	2.1	5.4	2.3	0.3	2.8	1.4	0.5	3.6	3.2	2.4	0.2	0.0	6.2	0.7	1.5	1.6	0.1	0.4	1.2	0.1	0.3	0.0	0.3	0.0	1.2	0.9	1.6	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.9	0.2	0.2	0.0	0.0	0.7	1.3	0.0	0.2	1.6	0.3	0.0	0.0	1.0	4.9	0.0	0.0	0.1	1.5	0.0	0.0	0.2	0.7	0.0	0.4	0.1	0.3	0.8	0.3	0.3	1.6	0.8	0.3	0.0	0.0	0.6	0.6	2.2	0.0	0.1	0.8	0.0	0.8	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.1	4.3	2.5	1.9	1.7	3.0	2.3	2.0	2.5	2.1	2.3	2.4	4.3	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	4.4	0.2	0.3	1.4	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	7.5	0.2	4.4	2.4	0.0	0.0	0.0	1.5	0.0	3.7	0.5	0.2	0.0	0.6	1.4	0.0	0.1	5.0	0.0	0.0	0.0	0.0	0.0	2.3	0.6	0.0	1.8	0.0	0.0	1.3	0.0	0.0	0.0	0.9	0.1	3.4	0.0	0.1	0.0	0.7	0.1	0.8	0.0	4.2	4.1	4.8	0.7	0.2	0.6	0.0	0.1	0.5	0.1	0.3
PCDHB5	"DKFZp586B0217, PCDH-BETA5"	ENSG00000113209	"Protocadherin beta 5"	Q9Y5E4	5	141135206-141138615	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Bipolar cells: 5.2;Early spermatids: 8.2;Muller glia cells: 5.0;Spermatocytes: 13.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 18.7;GAMG: 13.9;NTERA-2: 17.7;RH-30: 14.0;SCLC-21H: 16.4;SuSa: 21.7;T-47d: 17.6;U-138 MG: 32.4;U-2 OS: 14.1;WM-115: 14.7"	"Low region specificity"	"Detected in many"							"HPA013191, HPA067473"	Approved		Approved	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"HPA013191: AB_1855059, HPA067473: "	"unprognostic (2.21e-1)"	"unprognostic (4.71e-2)"	"unprognostic (4.05e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.84e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.06e-3)"	"unprognostic (6.65e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.55e-3)"	1.5	1.6	2.3	0.4	1.7	0.0	1.6	1.3	3.3	3.4	0.0	1.1	0.2	4.2	3.6	0.8	2.9	1.8	1.8	2.8	1.8	2.4	0.7	1.7	0.2	2.5	1.3	1.3	5.9	4.7	2.7	3.2	0.4	1.5	2.9	0.3	2.4	2.2	2.1	1.1	0.6	0.6	2.2	1.5	0.7	1.0	3.2	1.6	0.4	2.6	0.6	0.1	1.6	1.3	2.3	0.0	1.0	18.7	0.3	1.3	0.8	0.2	0.4	0.1	0.3	0.3	0.0	0.0	0.0	9.6	0.0	13.9	0.0	9.8	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.3	0.0	1.0	0.7	0.0	0.0	0.1	3.8	0.9	0.0	0.7	0.1	0.0	0.0	0.1	0.0	17.7	0.0	0.0	0.0	14.0	0.0	0.0	0.0	16.4	0.5	0.0	0.2	6.1	21.7	17.6	4.3	0.0	32.4	14.1	5.3	0.0	0.0	0.0	0.0	1.7	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	1.7	1.3	3.3	2.8	1.8	2.5	1.3	1.3	1.5	1.5	1.6	2.3	1.9	0.0	0.0	0.0	0.0	0.0	1.5	0.8	0.6	5.2	0.9	2.2	1.1	1.5	1.8	1.8	0.0	0.0	0.0	0.0	0.0	2.5	8.2	0.5	4.3	1.1	0.0	0.0	0.0	3.6	0.0	1.5	0.0	0.2	0.0	0.5	0.4	0.4	0.0	3.3	0.0	0.0	0.0	0.0	0.0	3.8	3.1	0.1	0.0	0.0	0.0	5.0	0.0	0.0	0.0	2.2	0.0	4.5	0.0	1.1	0.0	0.5	0.1	0.7	0.0	2.1	2.7	13.0	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.6
PCDHB6	PCDH-BETA6	ENSG00000113211	"Protocadherin beta 6"	Q9Y5E3	5	141150057-141153287	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	5	"Spermatocytes: 7.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 16.6;SH-SY5Y: 7.1;T-47d: 5.4;U-2197: 7.6;WM-115: 10.5"	"Low region specificity"	"Detected in many"							"HPA029566, HPA075308"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA029566: AB_10601385, HPA075308: "	"unprognostic (3.25e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.81e-1)"	"unprognostic (8.05e-2)"	"unprognostic (7.65e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.73e-3)"	"unprognostic (9.64e-3)"	"unprognostic (8.62e-2)"	"unprognostic (1.54e-3)"	"unprognostic (2.28e-2)"	"unprognostic (6.33e-2)"	"prognostic unfavorable (5.52e-4)"	"unprognostic (8.60e-4)"	"unprognostic (2.31e-2)"	"unprognostic (7.08e-3)"	"unprognostic (6.52e-2)"	0.7	0.7	0.9	0.2	0.9	0.0	1.1	0.5	1.6	1.1	0.0	0.6	0.0	1.9	1.1	0.2	1.0	0.3	0.7	1.5	0.4	0.4	0.1	0.7	0.1	0.8	0.6	0.8	1.3	0.5	1.9	1.0	0.4	0.8	0.5	0.1	0.9	0.7	0.3	0.4	0.7	0.3	0.9	0.6	0.2	0.4	1.9	0.7	0.1	0.4	0.3	0.1	0.7	0.7	1.3	0.0	0.4	0.3	0.1	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	16.6	0.2	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.3	7.1	0.0	0.1	3.7	0.4	5.4	2.3	0.0	0.6	1.2	7.6	0.0	0.0	0.0	0.0	3.8	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.9	0.5	1.6	1.5	0.4	0.8	0.6	0.8	0.8	0.6	0.7	1.3	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.6	0.4	0.6	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.1	1.0	0.7	0.0	0.0	0.0	0.8	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.2	0.0	1.5	0.8	7.6	0.1	0.0	0.4	0.0	0.0	0.2	0.0	0.0
PCDHB7	PCDH-BETA7	ENSG00000113212	"Protocadherin beta 7"	Q9Y5E2	5	141172644-141176383	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Early spermatids: 38.4;Late spermatids: 27.3;Spermatocytes: 24.5"	"Cancer enriched"	"Detected in many"	5	"glioma: 5.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.9;EFO-21: 4.8;U-138 MG: 3.2;U-2197: 9.6;U-87 MG: 3.3;WM-115: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059271	Approved					NA	NA					"HPA059271: AB_2683962"	"unprognostic (2.13e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.95e-2)"	"unprognostic (3.69e-4)"	"unprognostic (1.04e-2)"	"unprognostic (2.78e-2)"	"unprognostic (8.42e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.57e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.83e-3)"	"unprognostic (2.35e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.78e-4)"	1.7	0.7	0.5	0.9	0.6	0.0	2.0	0.8	1.7	2.9	0.0	1.3	0.4	4.6	1.6	0.3	2.6	1.5	1.4	1.0	2.1	0.9	0.3	2.1	0.2	1.7	0.8	0.3	2.3	0.4	0.3	2.4	0.2	1.1	1.1	0.4	1.4	0.6	1.0	0.4	0.6	0.8	3.1	0.8	0.7	0.7	2.0	0.4	0.2	1.0	0.6	0.2	1.3	1.5	1.0	0.0	0.0	0.4	0.4	3.9	1.9	0.0	0.2	0.5	0.1	0.1	0.0	0.1	0.0	4.8	0.5	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.0	1.4	1.0	0.3	0.0	0.8	0.0	2.1	0.0	0.7	3.2	0.6	9.6	0.1	0.0	0.0	0.0	3.3	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.8	1.7	1.0	2.1	1.7	0.8	0.3	1.1	0.8	0.4	1.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	4.9	0.2	0.5	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	38.4	0.3	2.4	1.1	0.0	0.0	0.0	0.4	0.0	2.1	0.0	0.1	0.0	0.0	1.8	0.0	0.1	1.7	0.0	0.0	6.1	0.0	0.0	27.3	0.9	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.3	6.6	3.4	2.1	24.5	0.7	0.0	0.9	0.1	0.0	0.3	0.0	0.0
PCDHB8	"PCDH-BETA8, PCDH3I"	ENSG00000120322	"Protocadherin beta 8"	Q9UN66	5	141177790-141180539	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"Early spermatids: 5.0;Spermatocytes: 6.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 20.9;T-47d: 31.4;U-138 MG: 12.1;U-2197: 34.2"									HPA057773	Uncertain					NA	NA					"HPA057773: AB_2683525"	"unprognostic (1.16e-3)"	"unprognostic (1.56e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.56e-2)"	"unprognostic (2.02e-2)"	"unprognostic (5.72e-3)"	"unprognostic (5.82e-4)"	"unprognostic (3.54e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.95e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.11e-2)"	"unprognostic (8.09e-2)"	"unprognostic (3.12e-2)"	"unprognostic (6.30e-4)"	0.8	0.5	0.1	0.2	0.4	0.0	0.5	0.2	1.8	0.6	0.0	0.3	0.1	1.3	0.7	0.3	0.5	0.6	0.6	1.0	0.6	0.4	0.1	0.6	0.0	0.6	0.3	0.0	0.9	0.6	1.0	0.8	0.2	0.3	0.4	0.2	0.8	0.3	0.3	0.1	0.4	0.1	0.7	0.1	0.2	0.2	1.1	0.2	0.0	0.3	0.3	0.0	0.3	0.3	1.0	0.0	0.0	0.1	1.3	3.8	2.4	0.2	0.2	7.7	0.0	0.1	0.0	0.0	0.0	20.9	0.1	7.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.3	0.2	0.4	0.0	0.0	1.3	0.0	0.3	0.1	1.7	6.2	0.2	0.0	0.0	0.0	0.0	0.5	0.1	8.4	0.0	0.1	0.0	6.0	1.6	0.1	0.0	1.1	0.0	31.4	0.0	0.9	12.1	6.0	34.2	0.0	0.0	0.0	0.0	3.6	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	1.8	1.0	0.6	0.6	0.3	0.0	0.3	0.1	0.2	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	6.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1
PCID2	FLJ11305	ENSG00000126226	"PCI domain containing 2"	Q5JVF3	13	113177536-113208715	"Predicted intracellular proteins"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 204.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069107, HPA073074"	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	Yes			"Nucleoplasm, Nucleoli"		"HPA069107: AB_2686088, HPA073074: AB_2686568"	"unprognostic (2.53e-2)"	"unprognostic (2.94e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (7.80e-5)"	"unprognostic (1.73e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (4.24e-6)"	"unprognostic (1.41e-2)"	"unprognostic (5.41e-3)"	"unprognostic (1.45e-1)"	"unprognostic (6.28e-2)"	22.2	29.2	17.1	15.9	17.8	15.6	23.1	19.5	18.9	26.9	18.5	23.0	12.2	23.2	23.2	19.4	26.1	17.2	38.0	17.2	17.5	18.3	24.0	18.8	26.0	16.9	17.2	17.4	34.0	24.1	19.3	22.8	15.7	17.5	24.9	18.6	10.8	24.0	19.4	29.3	18.6	20.3	22.0	17.2	24.9	24.6	45.7	17.9	24.7	21.0	24.7	23.2	24.1	22.6	19.2	62.9	26.3	39.1	34.7	70.2	52.3	27.4	47.2	70.7	64.4	59.1	51.9	57.7	50.2	30.7	64.5	81.6	38.8	62.9	42.8	71.2	44.3	62.1	64.8	68.1	45.9	70.0	110.4	25.5	43.3	46.6	40.4	71.1	51.4	51.3	68.5	50.4	19.9	73.6	30.3	59.4	77.9	38.9	115.1	33.2	53.4	43.4	48.0	58.8	31.3	52.0	31.9	29.5	72.2	55.9	39.3	39.9	133.4	33.5	19.0	68.7	27.9	36.2	30.4	30.4	70.4	65.3	74.1	44.2	28.2	25.5	20.0	68.9	34.4	81.6	39.7	58.0	72.5	26.0	39.5	52.2	54.6	3.9	22.6	33.2	24.8	64.7	54.7	17.1	17.8	19.5	18.9	17.2	17.5	16.9	17.2	17.4	17.5	17.2	17.9	19.2	26.5	19.2	16.7	16.3	28.4	21.5	29.1	37.8	17.6	23.6	25.5	32.3	27.8	21.5	23.7	14.7	16.7	30.2	38.5	7.8	27.4	22.8	52.8	26.8	35.7	26.2	7.8	32.8	43.6	13.8	24.7	33.8	18.8	21.7	10.8	39.0	18.9	18.4	20.2	37.0	33.7	15.6	16.2	18.2	14.0	18.1	41.3	17.2	16.0	26.2	24.0	19.0	38.1	25.1	40.4	18.1	15.8	40.6	16.8	46.3	13.6	23.6	30.4	23.8	19.7	37.4	30.9	204.4	72.7	17.6	24.7	31.1	43.7	33.0	20.1	25.3
PCM1	PTC4	ENSG00000078674	"Pericentriolar material 1"	Q15154	8	17922840-18027975	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 528.5;Spermatocytes: 569.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023370, HPA023374, CAB058695"	Enhanced		Supported	"Centriolar satellite,Cytosol"		NA	NA			"Centriolar satellite"	Cytosol	"CAB058695: AB_2665588, HPA023370: AB_1855072, HPA023374: AB_1855073"	"unprognostic (1.52e-2)"	"unprognostic (1.77e-2)"	"unprognostic (6.54e-3)"	"unprognostic (3.35e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.74e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.76e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.60e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.45e-1)"	29.8	31.6	33.6	28.4	42.3	52.6	43.5	44.6	37.2	39.6	40.1	33.2	22.0	39.6	42.0	28.4	44.5	31.0	36.7	32.9	37.9	32.2	39.6	33.9	41.8	36.2	35.1	27.2	47.4	40.2	53.0	31.3	35.5	37.4	33.8	27.7	77.3	35.4	32.5	106.1	30.6	29.8	30.9	35.9	33.7	28.2	155.6	34.0	57.4	49.4	85.6	37.6	31.3	26.4	48.6	64.0	66.8	100.5	133.4	55.2	57.0	51.7	52.6	64.4	54.9	61.3	45.4	37.0	83.0	35.3	52.8	47.2	45.0	64.8	48.3	93.0	27.6	25.1	142.7	46.2	93.1	61.6	63.7	35.1	50.3	50.6	63.9	70.3	47.9	64.1	84.9	98.4	62.6	67.9	32.0	136.8	103.3	82.7	52.8	19.1	81.0	90.1	30.0	45.3	87.1	76.6	57.6	56.5	30.5	82.1	42.8	48.2	91.0	57.8	49.6	40.5	61.3	45.0	26.6	62.9	72.5	41.8	68.3	52.0	31.5	7.2	18.7	13.0	4.6	13.5	13.0	11.6	15.1	7.3	13.1	12.9	13.2	7.6	13.9	10.0	17.8	13.1	5.6	33.6	42.3	44.6	37.2	32.9	37.9	36.2	35.1	27.2	37.4	35.9	34.0	48.6	91.6	128.2	154.9	187.7	109.3	33.8	66.3	44.4	75.7	196.1	74.1	72.0	249.4	62.9	117.2	86.5	350.3	50.9	145.9	33.6	29.4	73.0	528.5	275.2	130.4	86.5	71.2	115.5	219.9	59.0	33.6	100.4	55.0	132.5	142.1	103.9	64.6	50.8	43.3	129.5	211.8	45.7	61.1	61.3	39.7	301.3	92.2	83.6	55.2	162.1	82.8	145.8	132.8	208.6	243.1	58.9	36.0	97.8	84.7	45.8	45.6	25.9	282.1	234.9	124.9	173.8	92.7	569.3	177.1	65.4	38.2	60.5	122.5	92.1	50.6	47.2
PDE6D	JBTS22	ENSG00000156973	"Phosphodiesterase 6D"	O43924	2	231732433-231786272	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"		"Ciliopathy, Joubert syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 211.9;Late spermatids: 147.9;Spermatocytes: 236.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037433, HPA037434"	Uncertain					NA	NA					"HPA037433: AB_2675475, HPA037434: AB_10672490"	"unprognostic (1.95e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.72e-3)"	"unprognostic (7.07e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.48e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.75e-2)"	"prognostic unfavorable (4.02e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (4.97e-4)"	16.9	28.3	43.0	16.4	46.1	14.7	16.5	47.0	51.1	18.2	37.3	18.2	13.5	17.7	15.0	16.4	15.7	14.4	17.8	43.8	44.9	18.1	15.5	15.3	23.5	45.2	45.8	41.9	13.5	13.3	23.7	25.2	23.2	45.4	13.8	17.8	70.2	14.3	17.8	13.8	16.4	15.8	22.2	45.3	19.0	16.3	28.1	45.3	32.7	14.2	16.8	24.2	18.1	16.5	49.4	26.3	20.3	37.0	28.2	43.7	36.1	15.7	27.0	44.6	40.8	56.9	8.1	24.5	21.4	22.7	23.2	74.9	20.4	22.3	30.2	52.6	63.5	26.4	31.2	12.4	13.0	20.2	20.6	17.2	25.5	26.4	39.8	30.4	27.5	44.1	68.3	9.1	23.5	27.5	52.0	67.7	64.4	28.6	39.6	28.1	45.7	17.0	32.9	42.8	19.5	36.4	32.6	23.0	19.4	46.3	36.1	17.5	43.0	19.5	26.5	7.3	57.9	21.4	57.9	26.3	52.6	27.4	38.6	42.5	84.4	48.2	68.4	46.3	48.7	36.3	50.4	46.0	47.3	49.3	55.5	31.7	44.3	42.0	34.4	64.9	55.8	84.4	43.1	43.0	46.1	47.0	51.1	43.8	44.9	45.2	45.8	41.9	45.4	45.3	45.3	49.4	20.8	0.0	8.7	18.3	19.5	13.8	12.4	23.6	21.1	14.7	13.3	17.7	13.1	12.8	15.8	12.9	16.7	16.4	18.2	10.2	25.4	23.1	211.9	6.8	9.2	19.6	17.4	15.8	13.4	23.9	21.9	14.7	13.3	6.5	14.5	7.3	19.2	5.0	18.9	11.8	18.1	10.0	14.2	14.4	15.1	147.9	13.1	17.5	23.2	16.9	24.6	22.0	17.5	48.7	34.0	26.0	14.9	12.4	17.0	10.5	11.2	18.4	11.8	29.0	19.7	10.7	24.9	236.8	65.1	20.3	14.2	13.5	18.5	11.5	10.5	11.0
PDHA2	PDHAL	ENSG00000163114	"Pyruvate dehydrogenase E1 subunit alpha 2"	P29803	4	95840093-95841464	"Citric acid cycle related proteins, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	607	"testis: 60.7"	"Group enriched"	"Detected in some"	71	"Early spermatids: 426.6;Late spermatids: 288.3;Spermatocytes: 229.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA047487, HPA047864, HPA063053"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA047487: AB_2680066, HPA047864: AB_2680190, HPA063053: AB_2684931"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	426.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	288.3	4.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	229.6	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PEX3		ENSG00000034693	"Peroxisomal biogenesis factor 3"	P56589	6	143450805-143490616	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Peroxisome biogenesis"		"Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 80.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042830, HPA058006"	Supported		Approved	Nucleoplasm,Peroxisomes		NA	NA			"Nucleoplasm, Peroxisomes"		"HPA042830: AB_10794918, HPA058006: AB_2683576"	"unprognostic (3.52e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.16e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.16e-1)"	"prognostic favorable (3.80e-4)"	"unprognostic (1.87e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.12e-1)"	8.7	38.7	4.2	7.6	5.2	3.3	11.9	4.9	5.6	10.1	6.7	7.0	6.0	9.9	12.6	18.0	9.7	7.3	12.7	4.7	5.0	18.5	24.6	8.0	8.9	4.2	4.3	4.3	10.8	6.8	24.7	9.0	9.4	4.4	11.8	6.3	10.0	10.7	11.3	11.7	12.3	7.5	9.0	3.3	7.3	9.8	12.3	4.0	8.4	15.7	9.6	9.6	9.0	13.5	7.8	21.4	4.6	11.0	21.1	17.8	15.6	12.2	17.8	13.8	23.7	28.3	31.5	12.8	31.7	21.1	17.4	27.8	17.3	14.4	23.9	30.8	19.4	16.5	22.8	10.2	20.0	15.0	38.7	9.6	18.1	16.6	22.4	17.2	10.3	13.0	18.5	21.1	15.7	24.0	14.1	20.2	15.3	6.1	12.6	18.2	15.3	22.2	14.0	28.0	9.2	15.3	5.3	23.0	19.3	14.7	9.5	10.2	12.7	10.3	16.7	15.9	26.9	20.9	10.7	16.4	36.1	21.1	26.0	13.3	12.9	6.3	6.4	15.5	10.1	17.2	23.2	16.3	15.5	9.9	18.6	21.1	20.7	1.0	15.6	13.4	10.6	21.2	9.8	4.2	5.2	4.9	5.6	4.7	5.0	4.2	4.3	4.3	4.4	3.3	4.0	7.8	13.1	16.0	14.4	23.8	19.7	26.6	12.7	19.2	14.8	14.5	9.9	11.8	14.8	5.7	19.0	9.2	4.2	41.7	9.0	4.1	19.6	12.3	12.6	15.2	10.4	12.0	6.0	5.9	61.0	9.5	11.6	13.5	10.2	13.1	25.3	9.6	13.6	20.5	11.5	16.8	67.4	5.4	16.2	7.6	6.6	4.9	13.7	6.0	8.8	28.1	8.0	15.4	10.3	40.7	59.6	9.6	2.3	11.3	18.1	6.6	8.2	28.8	27.2	12.1	6.6	12.2	13.6	80.0	18.5	20.2	34.8	58.7	13.7	20.9	7.6	8.5
PFDN4	"C-1, C1, PFD4"	ENSG00000101132	"Prefoldin subunit 4"	Q9NQP4	20	54208087-54228052	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024055	Approved					NA	NA		220000			"HPA024055: AB_1855236"	"unprognostic (2.38e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.11e-1)"	"unprognostic (5.18e-3)"	"unprognostic (2.95e-2)"	"prognostic unfavorable (9.40e-4)"	"prognostic unfavorable (7.66e-5)"	"unprognostic (7.87e-3)"	"unprognostic (3.38e-1)"	"unprognostic (2.33e-2)"	"unprognostic (7.44e-3)"	"unprognostic (8.58e-2)"	"prognostic unfavorable (1.47e-10)"	"unprognostic (9.43e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.57e-2)"	5.6	6.2	14.2	4.9	14.4	5.4	6.0	14.0	19.2	5.9	12.5	3.5	2.0	8.1	5.8	5.4	4.7	5.9	14.4	14.5	15.1	6.4	4.0	3.9	6.8	14.9	15.6	14.2	7.9	3.7	5.9	2.6	6.7	15.2	5.4	4.3	3.4	4.1	5.2	8.9	4.4	2.8	6.3	14.4	3.2	2.3	7.7	14.9	4.8	6.9	8.3	4.9	5.8	2.7	15.6	9.9	3.4	11.6	3.8	8.1	19.4	11.5	9.2	7.1	21.8	9.6	12.6	9.9	7.2	30.1	10.4	12.6	8.4	13.3	11.9	36.7	7.2	10.0	6.1	13.1	42.6	10.5	12.5	6.8	10.3	16.8	9.4	17.3	11.3	13.8	8.9	11.6	8.2	20.0	38.8	12.8	29.5	14.1	6.2	16.5	9.9	4.1	13.2	18.7	12.7	13.6	14.4	11.2	30.3	31.9	10.5	9.4	25.4	6.9	15.5	18.8	21.8	20.8	5.1	8.1	11.0	15.4	11.0	13.7	3.6	5.4	2.6	4.4	5.8	6.2	6.0	5.9	5.3	7.8	5.2	6.1	5.7	0.8	7.6	5.5	8.6	12.5	5.0	14.2	14.4	14.0	19.2	14.5	15.1	14.9	15.6	14.2	15.2	14.4	14.9	15.6	46.7	28.9	32.9	6.2	47.3	91.1	86.4	190.5	59.7	16.5	67.6	82.2	73.6	52.9	68.7	40.5	0.0	124.4	53.2	45.5	107.6	147.5	196.9	67.6	53.5	65.3	71.2	77.2	14.7	137.9	147.1	66.6	19.9	82.1	43.1	52.1	84.6	71.6	95.3	13.5	14.6	56.7	85.5	104.3	104.8	35.7	78.9	46.8	62.2	8.4	172.5	41.7	52.5	12.1	11.9	145.8	68.5	68.1	35.1	69.0	42.7	135.4	66.6	15.7	105.2	55.5	64.6	181.4	92.8	57.3	88.5	93.4	53.6	48.5	66.5	76.7
PFN4		ENSG00000176732	"Profilin family member 4"	Q8NHR9	2	24114809-24123464	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	27	"testis: 81.7"	"Group enriched"	"Detected in some"	6	"Early spermatids: 491.1;Spermatocytes: 319.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (4.20e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.56e-4)"	"unprognostic (1.25e-1)"	"unprognostic (3.82e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.74e-2)"	"unprognostic (8.97e-3)"	"unprognostic (1.77e-5)"	"unprognostic (2.55e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.10e-2)"	0.8	0.6	1.5	0.2	1.0	0.3	1.3	1.2	1.6	0.7	0.9	0.4	0.2	0.9	2.0	0.8	1.7	0.6	1.2	0.9	0.8	1.2	0.3	0.8	0.5	1.2	1.0	1.0	1.9	0.4	1.0	1.2	0.5	1.9	0.9	0.6	3.0	0.7	0.7	1.0	0.6	0.4	0.4	0.4	0.7	0.3	81.7	0.8	0.4	2.0	0.5	0.7	0.4	0.6	1.0	2.0	1.0	0.4	1.8	1.9	1.9	0.7	0.6	0.3	0.6	0.4	0.4	2.1	1.2	0.3	0.0	2.3	0.2	0.0	0.2	0.2	1.5	0.0	0.1	0.5	0.0	1.1	0.3	0.1	2.4	1.2	0.5	1.2	0.4	0.3	1.3	0.4	1.1	1.0	1.4	0.3	0.6	0.4	0.0	1.3	0.4	1.0	0.0	1.0	0.2	1.1	1.6	0.7	0.2	0.6	0.7	2.1	0.4	0.9	0.9	0.7	0.1	0.7	1.7	1.7	1.1	1.6	0.1	1.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	1.5	1.0	1.2	1.6	0.9	0.8	1.2	1.0	1.0	1.9	0.4	0.8	1.0	0.3	0.0	1.1	0.7	0.2	0.3	0.6	0.4	0.0	0.8	0.9	0.6	2.4	0.0	0.3	0.0	0.0	0.4	0.2	0.1	3.9	0.5	491.1	4.6	0.9	1.1	0.0	0.0	1.3	1.4	0.7	0.7	0.0	0.7	0.0	1.7	0.4	0.8	1.0	1.7	1.7	0.2	0.0	0.0	0.0	66.9	6.5	0.7	0.0	0.0	0.0	1.1	0.0	0.5	1.4	0.8	0.0	1.9	0.1	0.3	0.1	2.0	4.3	1.0	0.0	0.5	0.5	319.1	3.6	0.0	0.6	0.3	0.1	0.8	0.2	0.4
PHOSPHO2	MGC22679	ENSG00000144362	"Phosphatase, orphan 2"	Q8TCD6	2	169694454-169701708	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 158.7;Spermatocytes: 68.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034726, HPA034727"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA034726: AB_10602191, HPA034727: AB_2674302"	"unprognostic (1.98e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.39e-3)"	"unprognostic (1.30e-2)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (3.82e-6)"	"unprognostic (4.31e-2)"	"unprognostic (2.11e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.31e-1)"	"prognostic favorable (9.53e-4)"	"unprognostic (4.10e-1)"	"unprognostic (2.60e-1)"	"unprognostic (6.12e-2)"	"unprognostic (7.53e-2)"	5.1	2.9	2.0	2.4	1.7	2.9	10.7	3.9	1.7	4.8	2.8	5.9	6.5	5.3	4.3	3.2	6.0	4.0	2.4	1.6	2.2	5.6	3.7	3.3	3.0	1.2	1.4	1.2	6.1	5.2	7.3	4.7	3.0	1.6	13.1	5.9	7.3	8.6	4.8	3.5	3.5	6.4	3.1	1.4	2.6	4.8	13.8	1.8	3.0	9.9	1.6	3.0	3.8	2.8	1.7	6.6	1.8	4.6	6.2	8.5	2.7	17.8	2.8	1.9	4.3	4.7	6.3	4.9	6.4	6.1	2.1	8.9	5.0	6.2	3.4	3.5	9.5	7.0	6.4	6.1	11.0	5.6	5.3	5.6	4.9	6.3	4.9	6.5	3.6	3.9	8.9	10.8	6.4	2.7	6.0	3.7	6.8	6.0	4.2	2.3	3.6	2.8	5.1	6.8	19.6	19.1	6.5	5.8	3.1	6.8	5.5	8.4	3.2	2.3	4.7	4.3	4.2	3.1	6.2	6.0	5.7	5.5	3.2	5.1	0.1	0.7	1.0	3.3	0.9	4.6	6.5	3.6	3.2	0.9	8.8	4.7	4.6	1.3	9.8	0.9	4.2	4.4	1.4	2.0	1.7	3.9	1.7	1.6	2.2	1.2	1.4	1.2	1.6	1.4	1.8	1.7	6.1	3.2	3.6	0.0	6.8	2.5	10.3	5.4	2.8	8.7	15.2	11.0	4.1	5.7	4.7	3.7	6.2	8.8	2.5	7.0	9.8	7.6	158.7	10.6	5.0	4.3	15.0	6.9	0.0	11.1	9.3	6.9	15.3	3.3	0.0	5.7	2.5	3.7	2.8	6.7	0.0	6.6	12.2	0.6	1.6	35.9	4.7	2.0	3.6	0.0	1.0	6.4	1.0	0.0	0.0	6.4	6.8	4.9	3.8	6.5	12.7	12.2	13.4	10.2	0.0	6.7	9.3	68.9	13.9	4.5	4.3	5.5	5.7	8.8	7.5	5.5
PIAS2	"ARIP3, miz, PIASX-ALPHA, PIASX-BETA, ZMIZ4"	ENSG00000078043	"Protein inhibitor of activated STAT 2"	O75928	18	46803218-46920160	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 67.9"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 521.4;Late spermatids: 519.5;Spermatocytes: 238.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068792	Enhanced		Supported	Nucleoplasm		Yes	No			Nucleoplasm		"HPA068792: AB_2686037"	"unprognostic (9.59e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.05e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.77e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.92e-2)"	"prognostic unfavorable (1.27e-4)"	"unprognostic (1.71e-1)"	4.6	5.4	6.8	4.1	8.9	7.4	5.1	17.7	10.5	4.7	6.8	4.9	2.9	5.1	7.5	3.7	4.6	4.6	6.9	8.2	8.2	6.5	6.0	4.4	6.2	5.8	8.2	7.3	5.0	4.2	11.9	5.7	4.0	8.9	6.6	7.1	11.0	5.6	4.5	16.3	7.7	4.2	4.8	4.1	6.0	4.6	67.9	7.2	4.6	8.3	10.3	5.2	4.1	4.4	8.6	13.7	5.5	6.1	8.7	6.0	7.5	2.9	7.0	5.6	6.0	5.5	6.5	5.1	13.7	3.7	5.3	6.1	4.5	12.3	7.5	8.5	6.6	4.6	8.5	5.4	7.7	5.9	14.3	5.8	7.7	4.5	5.3	5.6	9.7	5.5	11.9	6.4	3.5	12.0	7.4	8.2	8.3	6.7	2.5	3.5	15.0	13.1	0.1	5.5	10.4	11.7	9.0	6.4	4.1	4.7	6.8	6.1	6.3	6.9	12.8	5.5	4.5	5.3	10.1	5.4	17.7	9.5	15.1	12.8	0.7	1.7	1.2	2.0	1.3	1.3	1.6	1.8	2.4	2.0	3.0	2.5	2.1	1.0	1.9	1.3	2.1	1.9	0.8	6.8	8.9	17.7	10.5	8.2	8.2	5.8	8.2	7.3	8.9	4.1	7.2	8.6	26.3	19.2	21.9	60.4	25.0	20.6	19.9	15.2	23.9	57.7	21.8	13.2	30.7	12.8	12.6	25.8	89.6	2.6	32.8	18.1	19.6	13.5	521.4	16.6	25.4	26.0	28.5	16.6	137.9	8.9	2.3	20.6	19.4	15.9	14.5	48.4	34.2	22.3	28.1	32.0	134.9	18.0	16.2	50.3	15.7	519.5	33.5	24.2	12.4	73.1	34.7	21.9	40.2	133.7	94.0	7.9	17.1	35.0	30.3	28.4	11.8	23.1	13.9	36.0	6.6	42.5	18.2	238.7	72.4	24.7	15.3	1.4	19.2	35.6	25.5	18.0
PIH1D2		ENSG00000150773	"PIH1 domain containing 2"	Q8WWB5	11	112063218-112074274	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 67.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 425.9;Endometrial ciliated cells: 68.8;Late spermatids: 157.5;Respiratory ciliated cells: 115.3;Spermatocytes: 215.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"T-47d: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039496			Uncertain	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA039496: AB_10959385"	"unprognostic (8.74e-2)"	"unprognostic (6.64e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.01e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.43e-3)"	"unprognostic (5.82e-2)"	"unprognostic (9.05e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.81e-3)"	"unprognostic (1.59e-1)"	"unprognostic (6.08e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.12e-1)"	0.8	1.0	2.7	0.5	1.7	0.4	2.0	2.2	1.8	1.8	8.0	0.8	0.5	1.7	4.8	1.2	15.0	1.6	1.1	1.8	5.5	3.9	0.7	2.9	0.4	3.6	3.7	1.1	1.2	1.1	4.2	3.3	0.7	3.0	0.9	0.8	12.5	1.3	1.4	1.1	1.2	0.4	0.6	3.7	0.3	1.0	67.1	1.9	0.6	5.4	0.4	0.4	0.8	0.8	2.4	1.9	1.1	3.1	1.6	0.7	0.8	2.3	0.7	2.2	1.8	2.3	3.0	6.4	0.9	2.4	1.8	2.5	2.6	0.6	1.8	1.9	0.9	2.1	1.3	1.4	1.6	1.3	1.8	0.3	1.2	2.3	4.7	2.6	1.6	0.9	1.3	2.0	0.6	1.3	0.7	0.7	2.5	1.0	1.0	1.6	1.1	2.0	2.6	5.6	0.9	3.6	1.0	2.9	0.5	1.0	0.7	8.0	0.5	0.1	1.6	1.4	0.8	0.6	0.4	0.3	1.3	1.9	0.1	0.9	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.7	1.7	2.2	1.8	1.8	5.5	3.6	3.7	1.1	3.0	3.7	1.9	2.4	1.4	6.4	0.5	10.1	0.0	0.6	1.6	7.8	1.8	2.6	1.9	2.2	3.1	5.7	9.9	3.7	2.1	0.9	0.0	0.5	15.6	3.8	425.9	68.8	2.8	1.3	3.0	0.0	5.1	2.3	0.7	1.5	0.0	2.6	1.3	1.5	1.1	0.2	0.7	1.7	5.8	0.5	10.2	0.3	0.4	157.5	2.8	0.8	3.6	1.9	0.6	5.6	0.0	4.0	3.9	1.6	0.4	1.5	0.0	0.6	0.2	10.4	115.3	16.9	0.0	0.7	3.3	215.5	8.4	0.4	1.0	0.3	0.6	1.6	0.4	0.9
PKD2L2	TRPP5	ENSG00000078795	"Polycystin 2 like 2, transient receptor potential cation channel"	Q9NZM6	5	137887968-137942747	"Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 8.2"	"Group enriched"	"Detected in many"	5	"Early spermatids: 42.7;Spermatocytes: 52.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HeLa: 2.2;Karpas-707: 2.6;U-266/70: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA041903, HPA043634"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA041903: AB_2677734, HPA043634: AB_2678591"	"unprognostic (7.53e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.59e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.40e-4)"	"unprognostic (1.64e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.00e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.22e-1)"	0.4	0.9	1.2	0.5	1.9	1.5	0.2	2.9	1.2	0.1	0.2	0.1	0.3	0.3	0.7	0.4	0.3	0.4	1.2	0.9	0.9	0.2	0.1	0.2	0.9	0.6	0.6	0.9	0.3	0.8	0.1	0.3	0.2	1.3	0.4	0.2	1.1	0.5	0.0	2.3	0.5	0.2	0.1	0.2	0.7	0.4	8.2	1.2	0.1	0.7	0.8	0.2	0.1	0.2	3.2	0.7	0.5	0.1	0.0	0.1	0.2	0.7	0.2	0.0	0.0	0.0	0.0	1.4	1.0	1.5	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.4	0.6	2.2	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.3	0.2	1.4	0.7	2.6	0.0	0.2	0.5	1.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	1.0	0.4	0.4	0.6	0.1	0.4	0.3	0.2	0.2	0.2	0.4	0.7	0.2	0.5	2.0	1.6	0.1	1.0	0.2	0.8	5.3	0.9	1.8	1.0	0.6	0.5	1.5	0.8	0.7	0.5	1.9	1.0	0.9	4.1	1.0	0.6	2.0	0.6	0.6	1.2	1.9	2.9	1.2	0.9	0.9	0.6	0.6	0.9	1.3	0.2	1.2	3.2	0.6	3.2	2.2	4.6	4.7	2.2	1.8	0.6	7.4	2.4	0.5	0.4	1.7	0.0	0.9	0.0	0.0	0.4	1.6	0.6	0.0	0.1	42.7	1.5	1.3	1.3	0.0	0.8	5.0	0.0	0.2	1.5	0.5	1.8	1.3	0.5	1.4	0.4	0.3	3.3	5.6	0.0	2.0	0.6	1.9	8.2	0.6	1.3	3.6	1.9	0.1	0.9	1.0	3.5	6.1	0.1	0.0	0.4	1.7	1.5	0.1	0.3	0.0	4.1	0.0	3.2	1.1	52.3	3.1	2.6	1.1	0.1	3.1	0.8	0.2	0.8
PKDREJ		ENSG00000130943	"Polycystin family receptor for egg jelly"	Q9NTG1	22	46255663-46263343	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"testis: 3.4"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 1.8;Cone photoreceptor cells: 4.2;Early spermatids: 2.5;Horizontal cells: 1.7;Late spermatids: 2.4;Spermatocytes: 8.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA034587	Enhanced					NA	NA					"HPA034587: AB_10670570"	"unprognostic (9.48e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.11e-2)"	"unprognostic (5.06e-4)"	"unprognostic (1.13e-1)"	"unprognostic (2.99e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.59e-1)"	"unprognostic (6.17e-3)"	"unprognostic (3.41e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.37e-1)"	0.1	0.1	0.0	0.0	0.3	0.1	0.1	0.2	0.2	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.2	0.2	0.0	0.1	0.0	0.4	0.1	0.1	0.2	0.1	0.1	0.1	0.6	0.2	0.0	0.1	0.0	0.1	3.4	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.4	0.1	0.0	0.1	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.1	0.4	0.2	0.0	0.4	0.1	0.2	0.4	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.2	0.0	0.0	1.8	4.2	0.0	0.0	0.2	0.0	0.0	2.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.4	0.0	0.0	0.0	2.4	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	8.4	0.8	0.3	0.6	0.0	0.0	0.0	0.3	0.0
PLA2G6	"iPLA2, iPLA2beta, NBIA2, PARK14, PNPLA9"	ENSG00000184381	"Phospholipase A2 group VI"	O60733	22	38111495-38214778	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Chemotaxis, Lipid metabolism, Phospholipid metabolism"	"Calmodulin-binding, Hydrolase"	"Disease variant, Dystonia, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 28.5;Spermatocytes: 44.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 3.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 39.1;HMC-1: 25.6;U-266/70: 20.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001171	Approved		Approved	"Centriolar satellite,Cytosol"		NA	NA			"Centriolar satellite, Cytosol"		"HPA001171: AB_1079145"	"unprognostic (5.26e-2)"	"prognostic favorable (7.29e-4)"	"unprognostic (8.74e-2)"	"unprognostic (6.27e-2)"	"unprognostic (3.83e-1)"	"unprognostic (3.70e-3)"	"unprognostic (8.67e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.37e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.48e-1)"	"prognostic favorable (1.55e-4)"	18.5	22.4	13.7	4.7	14.9	12.3	19.6	14.0	20.4	23.2	11.1	10.8	9.3	17.9	10.7	10.3	26.4	13.3	9.4	12.8	12.3	24.0	13.4	10.5	8.6	15.8	13.7	11.5	24.5	16.2	6.7	17.9	4.2	18.0	25.1	2.9	8.4	16.1	9.3	10.8	16.4	12.6	3.5	13.9	17.3	13.3	42.5	13.8	11.8	52.2	4.5	4.7	13.4	14.5	24.2	0.8	1.3	2.6	6.3	8.0	5.5	9.8	0.9	1.0	0.5	1.2	3.2	2.4	5.9	6.7	1.3	0.9	3.5	2.2	2.5	0.3	9.2	11.1	39.1	3.4	3.5	3.1	2.6	25.6	13.3	3.7	2.3	4.6	6.6	0.8	11.7	8.0	13.3	0.7	3.1	8.5	3.0	3.4	2.7	1.3	6.5	1.2	6.1	2.8	5.9	7.1	1.9	1.9	3.1	6.7	3.9	4.1	2.4	0.6	2.1	4.5	0.9	0.6	20.6	2.7	4.0	4.0	3.2	2.0	1.4	0.1	0.0	1.0	0.0	0.7	0.5	1.0	1.5	0.4	0.3	0.4	1.2	0.6	3.7	0.2	1.3	1.6	0.7	13.7	14.9	14.0	20.4	12.8	12.3	15.8	13.7	11.5	18.0	13.9	13.8	24.2	5.6	3.2	2.7	19.9	4.6	3.1	3.5	4.0	4.6	9.9	7.4	6.5	2.0	4.3	5.0	12.9	4.2	3.3	11.1	11.3	0.0	2.1	28.5	9.5	4.4	3.1	11.4	7.4	6.4	1.0	2.7	3.3	11.2	8.7	0.0	10.6	3.6	3.5	1.7	15.2	5.9	8.6	2.0	1.0	0.8	18.3	5.9	2.1	1.8	4.7	2.3	4.9	8.2	4.5	25.2	1.1	12.6	3.8	4.7	2.9	21.9	1.9	7.6	7.5	6.6	2.6	3.4	44.5	7.7	4.1	3.4	4.9	6.6	6.8	8.4	2.1
PNMA1	MA1	ENSG00000176903	"PNMA family member 1"	Q8ND90	14	73711783-73714384	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 84.2;Peritubular cells: 84.7;Spermatocytes: 87.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							"HPA003817, HPA015007"	Enhanced		Supported	"Nucleoplasm,Focal adhesion sites,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Focal adhesion sites"	"HPA003817: AB_1079646, HPA015007: AB_1855502"	"unprognostic (2.82e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.96e-1)"	"prognostic unfavorable (7.49e-5)"	"prognostic unfavorable (3.00e-5)"	"unprognostic (2.90e-1)"	"unprognostic (5.35e-2)"	"unprognostic (3.63e-1)"	"unprognostic (5.58e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.67e-3)"	"unprognostic (2.04e-3)"	"unprognostic (4.17e-2)"	"unprognostic (2.23e-3)"	"prognostic unfavorable (4.51e-5)"	35.8	30.5	72.4	20.5	85.1	8.9	20.8	61.2	89.8	36.0	37.7	44.5	14.1	46.7	55.1	23.6	38.5	24.8	23.5	78.2	86.3	28.1	4.9	15.6	16.6	67.6	65.4	78.4	53.9	9.3	8.0	53.5	21.6	67.0	49.2	16.7	60.5	11.0	90.1	12.1	9.6	25.1	52.7	66.5	19.3	26.2	71.6	74.7	19.1	18.7	10.5	12.6	42.0	26.8	74.2	48.2	42.8	72.3	54.1	53.1	56.0	29.9	49.8	27.8	44.5	32.5	40.6	29.2	1.1	33.8	60.7	42.4	31.6	56.0	29.4	45.7	45.7	34.7	27.2	35.8	30.7	56.8	15.3	41.6	49.8	35.1	53.4	33.5	87.4	68.1	28.7	23.9	29.3	61.2	117.6	30.5	37.1	21.8	24.6	149.0	47.5	45.0	1.1	58.8	1.5	85.4	65.5	87.5	19.9	40.4	43.6	97.0	25.6	66.5	89.3	71.7	54.9	41.1	25.7	42.9	14.2	88.3	21.4	30.3	2.9	1.8	4.7	8.5	3.5	5.8	2.8	10.9	8.7	3.9	3.1	10.4	10.0	1.6	5.6	5.3	0.6	14.2	7.3	72.4	85.1	61.2	89.8	78.2	86.3	67.6	65.4	78.4	67.0	66.5	74.7	74.2	13.1	6.4	3.0	21.9	8.8	3.8	6.8	5.0	6.2	48.6	7.0	7.5	19.9	2.8	4.1	14.7	12.5	7.5	10.4	6.7	15.6	10.1	84.2	32.2	30.6	13.5	18.7	3.0	31.4	6.7	11.3	20.5	14.3	10.2	16.5	16.6	20.0	1.6	15.6	58.9	28.9	5.4	14.2	6.8	25.9	57.6	32.6	18.8	19.6	12.2	14.1	65.2	10.3	17.1	21.7	30.2	1.4	84.7	10.9	7.4	1.6	26.6	23.1	49.1	72.3	31.2	44.1	87.2	44.4	4.7	3.8	6.0	20.0	43.8	2.5	3.7
POLD3	"KIAA0039, P66, P68, PPP1R128"	ENSG00000077514	"DNA polymerase delta 3, accessory subunit"	Q15054	11	74493851-74669117	"Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA excision, DNA repair, DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA058846	Enhanced		Supported	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA058846: AB_2683833"	"unprognostic (3.68e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.05e-3)"	"unprognostic (3.28e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.49e-1)"	"prognostic unfavorable (9.17e-4)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (5.48e-4)"	"unprognostic (3.99e-3)"	"unprognostic (1.54e-3)"	"unprognostic (9.21e-3)"	"prognostic unfavorable (7.90e-6)"	"unprognostic (7.92e-3)"	"unprognostic (2.65e-1)"	"unprognostic (9.11e-2)"	"unprognostic (1.23e-1)"	8.0	6.3	6.9	14.7	6.5	10.2	11.2	6.5	7.3	10.6	7.6	17.3	15.9	16.6	12.1	13.0	16.4	15.0	8.9	6.2	6.6	45.0	7.2	11.6	14.6	5.4	5.8	5.4	16.2	11.5	7.9	4.7	11.6	6.0	8.4	18.1	15.1	6.9	10.2	7.7	11.7	14.6	15.4	5.7	11.5	15.6	19.8	5.6	15.8	15.1	12.6	15.4	12.8	7.5	7.8	32.2	28.6	43.6	29.8	13.2	22.5	30.9	42.7	23.9	43.7	37.0	37.8	40.8	45.7	30.9	20.5	25.3	41.2	36.3	28.0	54.6	34.5	23.3	29.1	44.3	12.8	9.5	56.4	25.3	10.0	17.3	51.1	27.3	13.8	17.1	39.8	26.7	35.5	25.6	25.3	63.4	25.3	26.4	95.3	29.1	60.0	109.4	37.9	20.2	30.6	29.0	19.5	50.7	25.3	49.7	26.2	29.5	35.7	16.4	42.9	30.8	48.8	34.2	24.8	56.6	102.4	24.5	35.1	33.2	7.3	22.6	15.9	9.2	18.5	9.1	10.1	11.7	8.2	17.7	8.0	11.6	9.6	19.4	10.8	19.0	5.2	13.7	13.0	6.9	6.5	6.5	7.3	6.2	6.6	5.4	5.8	5.4	6.0	5.7	5.6	7.8	14.8	12.8	20.0	13.1	9.7	5.9	7.0	11.4	12.5	12.3	10.5	12.8	7.8	7.2	17.7	9.2	8.4	19.7	11.1	17.9	5.9	17.2	28.3	24.8	17.1	14.2	5.4	24.2	20.1	32.1	26.7	13.1	16.8	14.4	19.0	20.9	8.2	4.9	15.6	23.5	15.3	12.7	12.2	12.9	7.2	23.1	12.5	16.9	3.6	15.0	25.3	15.3	9.2	6.6	18.7	17.4	13.4	8.6	11.4	11.4	10.7	39.1	45.2	19.1	6.6	13.7	12.4	60.3	37.7	11.2	5.4	13.0	11.8	10.0	19.9	10.5
POLI	"RAD30B, RAD3OB"	ENSG00000101751	"DNA polymerase iota"	Q9UNA4	18	54269517-54321266	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, DNA synthesis"	"DNA-binding, DNA-directed DNA polymerase, Mutator protein, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 117.4;Spermatocytes: 80.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012000, HPA064696"	Enhanced		Supported	"Nuclear speckles,Cytoplasmic bodies"		NA	NA			"Nuclear speckles"	"Cytoplasmic bodies"	"HPA012000: AB_1847786, HPA064696: AB_2685325"	"unprognostic (1.64e-1)"	"unprognostic (5.79e-3)"	"unprognostic (9.72e-3)"	"unprognostic (4.92e-2)"	"unprognostic (3.04e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.04e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.30e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.52e-2)"	"unprognostic (6.99e-2)"	21.4	9.3	8.0	7.2	10.8	7.1	18.3	8.1	9.3	13.9	5.9	8.0	7.9	15.2	14.6	7.2	11.4	9.7	10.8	6.3	9.0	14.5	7.6	10.1	9.6	9.9	8.5	5.9	16.8	13.5	16.0	11.6	14.9	9.0	14.2	8.7	25.6	8.3	14.7	6.3	7.2	6.6	11.6	10.0	9.5	9.8	38.3	8.4	14.7	31.6	5.6	8.4	9.5	8.8	13.6	12.0	4.3	31.4	19.1	10.3	20.1	10.2	9.7	20.6	10.9	18.0	3.2	11.1	5.6	3.1	14.2	11.1	9.6	7.4	11.1	12.2	13.7	3.7	7.1	5.2	8.3	16.9	11.4	5.5	21.9	16.4	9.5	19.6	24.5	23.4	9.1	4.9	15.6	18.3	9.6	8.2	9.9	10.8	3.0	4.7	5.1	6.4	14.1	12.3	15.9	14.6	14.9	6.9	6.0	10.1	20.2	22.1	5.1	11.3	20.4	5.5	3.1	8.2	12.6	3.0	7.9	14.5	10.0	15.1	4.0	6.3	6.7	4.6	3.5	4.3	5.1	4.8	4.8	6.1	6.5	7.0	4.0	3.9	4.9	3.7	4.8	6.1	3.9	8.0	10.8	8.1	9.3	6.3	9.0	9.9	8.5	5.9	9.0	10.0	8.4	13.6	8.7	25.6	16.4	24.5	5.0	2.5	8.0	9.1	10.8	15.3	12.1	10.0	10.5	2.8	9.6	5.5	10.4	33.5	4.7	1.8	9.8	9.0	117.4	14.4	12.3	8.0	6.1	5.0	16.5	6.2	16.6	11.0	9.2	10.3	13.3	13.9	8.9	6.1	9.2	3.3	20.3	4.7	8.2	5.9	2.5	25.4	19.9	6.2	7.2	26.2	8.2	18.7	7.2	28.6	43.5	6.2	2.6	18.0	3.3	4.7	3.7	15.6	20.6	23.6	32.9	13.9	9.6	80.1	31.4	4.9	2.6	27.9	6.4	11.7	4.3	3.1
POLL		ENSG00000166169	"DNA polymerase lambda"	Q9UGP5	10	101578882-101588270	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, DNA synthesis"	"DNA-binding, DNA-directed DNA polymerase, Lyase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076828			Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA076828: "	"unprognostic (3.71e-3)"	"unprognostic (6.93e-3)"	"unprognostic (1.73e-2)"	"unprognostic (2.47e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.86e-1)"	"unprognostic (1.64e-3)"	16.4	22.6	15.3	12.5	15.9	12.9	19.8	14.0	19.1	20.3	15.6	20.8	17.0	19.6	22.8	18.2	22.3	15.7	19.0	15.8	14.2	24.9	27.1	15.8	17.1	16.1	14.4	15.9	26.5	46.0	21.5	28.7	13.9	15.4	26.2	17.2	17.6	20.9	15.5	34.7	16.0	18.8	14.4	12.0	22.9	27.9	41.8	14.9	7.5	26.3	18.4	17.3	21.1	17.9	15.6	23.5	21.0	16.2	23.0	16.2	30.0	22.7	15.3	26.4	22.9	23.9	15.5	27.8	5.7	23.5	13.9	12.6	28.8	18.4	22.6	18.4	20.8	24.8	18.1	23.1	17.7	29.8	19.0	16.2	27.5	30.3	25.0	51.8	64.1	24.7	11.1	20.4	19.2	14.7	18.8	0.0	20.8	8.6	13.0	12.4	0.1	14.6	9.9	19.2	14.1	11.2	16.6	9.4	15.7	26.5	23.8	47.3	11.0	13.5	8.1	16.4	9.8	16.8	28.4	15.3	8.9	17.5	16.6	6.3	0.6	9.2	1.3	6.5	6.6	10.6	8.4	7.4	6.8	11.6	6.8	11.7	8.0	1.0	9.5	6.7	0.2	10.2	7.6	15.3	15.9	14.0	19.1	15.8	14.2	16.1	14.4	15.9	15.4	12.0	14.9	15.6	7.5	6.4	12.9	13.7	11.4	3.7	6.7	9.7	7.4	16.9	14.7	19.0	8.6	11.5	7.4	7.3	47.9	16.9	7.5	9.1	5.9	9.6	25.2	7.3	7.5	7.6	13.1	25.9	10.4	21.5	9.8	9.6	20.9	6.6	14.0	20.9	8.6	10.9	11.2	21.9	7.9	13.6	18.3	17.7	6.0	51.6	14.0	9.6	10.6	2.8	18.0	10.1	13.4	8.5	9.9	13.7	9.2	11.3	10.9	6.5	13.7	11.6	7.2	24.0	13.1	10.8	9.6	35.5	11.0	8.4	2.0	11.5	9.4	14.4	15.6	5.6
POM121L12	DKFZp564N2472	ENSG00000221900	"POM121 transmembrane nucleoporin like 12"	Q8N7R1	7	53035633-53036925	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	134	"testis: 13.4"	"Cell type enriched"	"Detected in some"	8	"Spermatocytes: 11.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA027836	Enhanced					NA	NA					"HPA027836: AB_10669592"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
POM121L2	POM121-L	ENSG00000158553	"POM121 transmembrane nucleoporin like 2"	Q96KW2	6	27285903-27312170	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	77	"testis: 8.4"	"Cell type enriched"	"Detected in single"	6	"Spermatocytes: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA046150	Uncertain					NA	NA					"HPA046150: AB_10960993"		"unprognostic (2.45e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.22e-1)"				"unprognostic (1.43e-2)"		"unprognostic (5.88e-3)"				"unprognostic (3.48e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.51e-2)"	"unprognostic (2.03e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
POMT1	LGMD2K	ENSG00000130714	"Protein O-mannosyltransferase 1"	Q9Y6A1	9	131502789-131523806	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 64.5;Spermatocytes: 71.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065252			Uncertain	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA065252: AB_2685445"	"unprognostic (2.00e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.67e-1)"	"unprognostic (7.97e-2)"	"unprognostic (5.35e-3)"	"unprognostic (1.14e-1)"	"unprognostic (9.76e-3)"	"unprognostic (2.84e-1)"	"prognostic favorable (3.90e-5)"	"unprognostic (8.36e-2)"	"prognostic favorable (4.68e-5)"	"unprognostic (2.41e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.12e-1)"	14.8	21.1	16.4	7.7	16.4	6.6	16.3	17.8	20.9	20.3	14.1	22.9	9.0	17.2	7.3	15.3	18.6	9.4	22.3	23.9	15.8	25.5	24.6	15.8	8.4	15.9	16.2	16.3	25.8	26.1	15.6	31.5	9.8	15.9	28.6	6.6	8.1	20.2	8.7	33.1	17.5	20.1	7.2	14.0	22.4	20.6	64.2	16.4	7.2	19.1	13.5	5.4	16.6	17.3	15.4	9.8	17.4	10.5	26.4	19.3	13.5	24.5	12.1	17.0	21.3	14.1	15.8	14.7	2.5	16.9	26.4	8.6	24.1	17.3	16.6	5.9	16.2	21.6	4.2	28.5	7.8	23.1	13.1	10.5	10.8	10.0	12.3	5.0	17.6	15.1	16.4	13.4	15.6	23.2	27.6	15.8	25.2	6.7	9.6	21.1	15.7	13.8	24.6	18.1	1.5	15.0	14.1	25.1	26.8	13.0	5.8	31.4	17.7	20.9	13.8	2.2	28.6	10.3	7.3	7.0	5.2	8.7	29.1	13.0	0.0	2.8	3.4	5.2	3.0	7.7	1.9	5.0	5.3	4.0	2.6	4.8	3.6	0.6	3.2	2.9	2.4	5.2	4.0	16.4	16.4	17.8	20.9	23.9	15.8	15.9	16.2	16.3	15.9	14.0	16.4	15.4	5.9	9.6	16.0	18.6	7.1	4.5	4.9	7.2	5.7	13.2	7.8	8.6	9.7	10.0	8.7	12.9	8.4	20.8	6.5	12.9	1.9	10.7	64.5	9.6	7.3	8.0	7.8	1.3	21.5	6.7	12.9	9.0	9.2	9.9	2.5	15.1	11.0	10.1	10.8	21.9	25.9	8.4	10.2	5.4	5.9	33.0	8.7	5.6	5.4	15.9	7.5	12.3	5.2	18.6	11.1	8.1	6.0	10.1	6.8	4.9	14.2	7.5	6.8	16.6	6.6	7.5	7.2	71.6	9.6	5.7	3.0	17.5	9.0	6.2	9.1	2.6
POT1	"DKFZp586D211, hPot1"	ENSG00000128513	"Protection of telomeres 1"	Q9NUX5	7	124822386-124929983	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 41.5;Oligodendrocytes: 66.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068538			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA068538: AB_2686001"	"unprognostic (1.39e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.04e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.38e-3)"	"unprognostic (7.88e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.48e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.75e-2)"	"unprognostic (4.77e-3)"	"unprognostic (7.42e-2)"	5.6	5.7	3.4	5.8	3.9	4.2	10.5	4.0	3.8	8.0	4.2	5.7	4.6	9.6	6.2	4.5	8.1	6.1	6.3	3.5	4.1	9.8	10.0	6.1	8.9	4.0	4.1	2.8	10.2	5.3	9.8	6.4	7.0	4.2	7.1	6.4	9.9	3.9	6.7	3.3	4.1	4.2	7.3	4.2	8.2	5.8	13.9	3.6	13.1	13.1	4.5	9.7	7.8	4.5	6.4	24.0	6.9	14.0	9.9	9.2	16.2	10.3	12.1	14.9	14.3	19.7	7.3	25.9	24.4	8.5	11.1	23.6	9.5	14.8	15.0	21.7	21.4	17.5	18.9	10.3	3.2	15.4	22.6	12.4	13.1	13.6	12.8	21.8	14.5	16.6	10.1	38.1	51.9	15.0	4.1	29.8	12.5	17.4	13.2	14.1	19.1	14.0	27.5	9.9	9.8	13.9	16.6	18.7	19.8	15.6	20.3	8.0	12.3	8.4	14.3	5.5	19.1	17.1	23.2	27.0	39.8	20.4	23.6	22.7	0.6	2.2	1.0	2.3	2.3	4.3	3.2	2.6	3.0	2.5	2.5	4.3	3.0	0.4	3.7	1.8	2.2	2.8	1.9	3.4	3.9	4.0	3.8	3.5	4.1	4.0	4.1	2.8	4.2	4.2	3.6	6.4	9.7	6.4	4.1	36.9	10.1	4.6	6.7	5.5	13.1	9.2	7.1	7.1	8.8	8.6	3.6	12.9	10.4	7.0	8.0	1.5	19.6	5.0	19.3	4.3	6.9	7.1	9.0	16.0	34.7	4.5	8.0	6.9	8.2	4.2	3.8	9.4	7.1	10.5	6.3	8.4	41.5	4.0	2.0	10.9	7.0	8.3	8.7	8.7	16.0	24.4	5.6	12.6	4.1	37.2	66.8	3.8	1.7	4.5	7.6	2.8	0.8	11.2	4.9	10.0	0.0	5.4	6.3	35.2	14.4	7.6	2.6	4.5	8.5	4.8	4.9	3.5
POTEB3		ENSG00000278522	"POTE ankyrin domain family member B3"	A0JP26	15	21405401-21440499	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	9	"testis: 5.7"	"Cell type enriched"	"Detected in single"	5	"Spermatocytes: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 1.5;RPMI-8226: 1.9"															NA	NA																							0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.3	0.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.7	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.2	0.3	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.4	0.0	0.1	0.0	0.2	0.4	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.5	0.8	0.0	0.1	0.0	0.9	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.5	0.1	0.1	0.1	0.2	0.0	0.2	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
POTEC	"A26B2, CT104.6, DKFZp686J0529, POTE-18, POTE18"	ENSG00000183206	"POTE ankyrin domain family member C"	B2RU33	18	14507339-14543585	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	26	"testis: 2.5"	"Cell type enriched"	"Detected in some"	8	"Spermatocytes: 40.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA						"unprognostic (1.63e-1)"									"unprognostic (9.88e-2)"				"unprognostic (8.05e-2)"	"unprognostic (1.64e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	2.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	40.1	4.9	0.0	0.0	0.3	0.0	0.0	0.1	0.1
POTEG	"A26C2, CT104.4, POTE-14, POTE14, POTE14alpha"	ENSG00000187537	"POTE ankyrin domain family member G"	Q6S5H5	14	19402486-19434341	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"prostate: 1.1"	"Cell type enhanced"	"Detected in single"		"Spermatocytes: 1.1"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 0.5"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"																	NA	NA						"unprognostic (4.01e-1)"				"unprognostic (1.51e-1)"	"unprognostic (6.00e-2)"		"unprognostic (1.17e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.69e-2)"		"unprognostic (1.05e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.29e-1)"		"unprognostic (2.50e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	7.6	15.0	4.7	11.1	3.5	2.9	4.1	4.5	10.6	2.7	3.1	5.0	7.6	3.7	11.3	2.9	7.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1
POTEH	"A26C3, ACTBL1, CT104.7, POTE22"	ENSG00000198062	"POTE ankyrin domain family member H"	Q6S545	22	15690026-15721631	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	19	"prostate: 2.2;testis: 1.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	28	"prostate cancer: 1.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA						"unprognostic (4.66e-2)"											"unprognostic (1.02e-1)"						0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
POTEI	POTE2beta	ENSG00000196834	"POTE ankyrin domain family member I"	P0CG38	2	130459455-130509707	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"brain: 3.7;prostate: 2.5;testis: 3.3"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 2.3;Breast myoepithelial cells: 1.5;Cardiomyocytes: 1.9;Prostatic glandular cells: 1.9;Spermatocytes: 5.8;Spermatogonia: 1.6"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"spinal cord: 3.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.6;BEWO: 1.4;K-562: 2.0;MCF7: 1.2;RPMI-8226: 1.2;U-2 OS: 3.7;U-266/70: 1.2"									"HPA041264, HPA041271, HPA043260"	Uncertain					NA	NA					"HPA041264: AB_2677383, HPA041271: AB_2677386, HPA043260: AB_2678396"	"unprognostic (2.52e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.49e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.62e-1)"		"unprognostic (3.82e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.99e-1)"	"unprognostic (8.59e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.22e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.38e-2)"	0.0	0.0	0.5	0.0	0.4	0.0	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.6	0.0	0.0	0.0	0.0	1.4	1.0	0.0	0.0	0.1	0.0	0.1	0.1	0.6	2.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	3.7	0.0	0.2	3.3	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.1	1.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.3	0.0	1.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.3	0.5	0.0	0.0	0.0	3.7	0.1	0.0	1.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.2	0.1	0.1	0.6	1.4	1.0	0.0	0.6	3.7	0.9	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	2.3	1.5	1.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.9	1.1	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.1	0.7	0.0	0.0	0.0	0.2	5.8	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2
POTEJ	POTE2beta	ENSG00000222038	"POTE ankyrin domain family member J"	P0CG39	2	130611440-130658037	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"Spermatocytes: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA041264, HPA041271, HPA043260"	Uncertain					NA	NA					"HPA041264: AB_2677383, HPA041271: AB_2677386, HPA043260: AB_2678396"	"unprognostic (8.11e-2)"	"unprognostic (6.24e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.55e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.07e-2)"		"unprognostic (5.44e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.30e-1)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.1	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
POU5F2	"FLJ25680, SPRM-1"	ENSG00000248483	"POU domain class 5, transcription factor 2"	Q8N7G0	5	93733220-93741600	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.9;testis: 1.9"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 16.8;Rod photoreceptor cells: 14.4;Spermatocytes: 22.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"U-2 OS: 1.4"	"Not detected"	"Not detected"							HPA077615	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA077615: "	"unprognostic (1.07e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.03e-1)"	"unprognostic (9.17e-3)"	"unprognostic (3.72e-2)"	"unprognostic (5.87e-3)"	"unprognostic (4.58e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.84e-1)"	"unprognostic (6.16e-9)"	"unprognostic (1.87e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.44e-3)"	0.0	0.0	0.6	0.1	0.9	0.4	0.2	1.9	1.0	0.0	0.3	0.1	0.2	0.1	0.2	0.0	0.0	0.1	0.0	0.5	0.5	0.1	0.1	0.0	0.2	0.8	0.6	0.4	0.1	0.0	0.0	0.0	0.1	0.9	0.1	0.1	1.0	0.1	0.1	0.1	0.4	0.2	0.0	0.4	0.1	0.2	1.9	1.0	0.1	0.2	0.0	0.1	0.0	0.0	1.8	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.1	0.2	0.2	0.2	0.0	0.2	0.2	0.1	0.2	0.1	0.1	0.1	0.0	0.2	0.2	0.3	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.3	0.2	0.0	0.1	0.3	0.3	0.2	0.1	0.0	0.1	0.1	0.2	0.1	0.1	1.4	0.2	0.1	0.2	0.1	0.2	0.1	0.2	0.1	0.3	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.4	0.2	0.0	0.1	0.2	0.0	0.6	0.9	1.9	1.0	0.5	0.5	0.8	0.6	0.4	0.9	0.4	1.0	1.8	2.3	3.2	2.2	0.0	4.3	2.2	2.6	1.8	0.0	10.7	2.8	1.5	0.4	1.5	1.0	1.8	6.2	1.0	4.7	1.3	0.0	1.6	2.7	3.0	3.2	2.5	3.0	3.2	0.0	0.9	0.9	2.1	1.1	3.3	8.2	5.8	2.5	0.9	1.1	16.8	0.0	0.3	0.0	2.4	6.2	7.6	4.7	2.4	1.8	0.0	3.3	2.9	11.3	0.0	0.0	2.1	1.2	1.5	1.8	2.1	1.8	0.5	2.1	14.4	0.0	3.4	1.8	22.3	2.3	0.7	2.7	0.5	4.8	4.6	1.2	2.3
PPP1R1C	Inhibitor-1-like	ENSG00000150722	"Protein phosphatase 1 regulatory inhibitor subunit 1C"	Q8WVI7	2	181954241-182131398	"Predicted intracellular proteins"	"Cell cycle, Cell division"	"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"heart muscle: 21.3"	"Group enriched"	"Detected in many"	4	"Early spermatids: 168.5;Late spermatids: 219.8;Spermatocytes: 145.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA055043			Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	NA			Nucleoplasm	"Nucleoli, Golgi apparatus"	"HPA055043: AB_2797251"	"unprognostic (1.70e-1)"	"unprognostic (3.15e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.08e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.77e-2)"	"unprognostic (6.57e-2)"	"unprognostic (6.59e-3)"	"unprognostic (1.13e-1)"	"unprognostic (7.98e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.00e-3)"	"unprognostic (7.68e-2)"	"unprognostic (3.07e-2)"	"unprognostic (9.75e-3)"	0.0	0.0	0.2	0.0	0.2	0.0	0.0	1.5	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	21.3	0.4	0.9	0.0	0.8	0.1	0.0	0.7	0.6	0.1	0.0	0.3	0.0	0.4	0.0	1.5	1.0	0.0	1.8	0.1	0.0	3.7	0.1	0.0	0.0	0.2	0.0	0.2	0.3	0.1	0.7	0.0	3.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.5	0.5	0.4	0.9	0.7	0.6	0.1	1.5	0.2	0.1	0.4	0.1	12.8	8.7	6.2	0.0	0.3	0.6	1.2	2.8	1.1	0.3	0.3	40.6	17.2	8.1	3.7	0.0	3.1	0.0	0.5	1.9	2.5	168.5	1.7	0.1	0.6	6.1	0.0	1.1	11.0	6.6	2.4	4.6	0.8	0.0	0.0	0.0	18.5	0.6	0.0	19.4	0.4	10.2	0.8	0.0	219.8	5.9	0.3	3.6	1.9	3.6	12.0	0.0	3.5	0.7	23.1	0.1	0.7	0.0	0.3	0.0	0.7	1.6	1.7	0.0	0.4	0.8	145.1	2.6	1.3	0.3	2.5	0.0	0.8	0.6	1.0
PPP2R1B	"PP2A-Abeta, PR65B"	ENSG00000137713	"Protein phosphatase 2 scaffold subunit Abeta"	P30154	11	111726908-111766389	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 172.1"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 306.1;Late spermatids: 160.7;Spermatocytes: 135.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 173.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004034, HPA018908"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"CAB004034: AB_490763, HPA018908: AB_1855655"	"unprognostic (8.37e-2)"	"unprognostic (3.87e-2)"	"unprognostic (4.84e-3)"	"unprognostic (3.27e-3)"	"unprognostic (3.43e-1)"	"unprognostic (4.93e-2)"	"prognostic favorable (3.80e-4)"	"unprognostic (4.58e-1)"	"unprognostic (8.20e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.25e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.30e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.22e-1)"	59.0	10.6	10.9	14.2	17.1	16.3	21.7	18.3	12.4	13.1	15.7	14.9	14.0	8.8	8.1	12.8	8.1	13.5	6.4	10.9	14.7	14.7	172.1	8.9	12.2	14.0	13.6	9.3	13.4	33.5	13.1	10.8	9.3	14.2	7.8	14.9	8.6	9.7	6.1	9.7	9.6	15.3	7.9	11.4	6.3	22.5	54.5	13.3	16.0	10.7	9.0	14.2	12.3	7.4	20.7	38.4	25.1	35.6	24.2	34.9	18.7	35.8	37.2	25.9	27.0	24.6	86.0	39.3	48.3	27.1	24.1	25.6	35.4	53.4	30.5	34.3	33.7	16.6	47.2	14.5	37.8	17.3	55.7	36.1	21.5	18.1	30.6	22.2	19.1	33.8	49.7	58.3	62.3	30.1	12.4	60.8	22.6	43.8	41.4	27.3	45.9	23.6	58.6	40.2	41.9	11.6	31.4	33.1	30.2	6.1	38.3	35.0	20.6	36.7	31.3	37.8	15.6	23.9	6.6	17.4	173.8	11.1	63.9	40.7	6.1	10.1	10.4	13.0	11.7	12.7	10.0	12.9	12.1	14.9	12.5	11.2	12.0	2.6	15.3	11.4	6.4	15.0	12.2	10.9	17.1	18.3	12.4	10.9	14.7	14.0	13.6	9.3	14.2	11.4	13.3	20.7	21.2	19.2	10.5	63.3	11.0	14.3	11.0	12.0	18.2	5.4	14.1	8.5	3.2	15.7	13.4	12.9	8.4	13.5	11.0	23.8	13.7	18.7	306.1	29.6	13.4	20.2	15.6	32.4	23.8	22.9	20.3	12.3	15.3	46.1	8.2	34.3	9.3	89.4	9.5	1.7	14.5	11.5	22.4	5.8	9.2	160.7	6.5	7.5	8.8	17.8	8.9	9.9	7.2	26.2	49.1	23.6	9.0	7.5	9.0	10.9	16.2	17.6	16.8	11.0	13.1	14.5	14.4	135.9	20.8	12.0	14.6	17.6	11.0	9.7	13.9	15.0
PPP2R3C	"C14orf10, FLJ20644, G4-1, G5PR"	ENSG00000092020	"Protein phosphatase 2 regulatory subunit B''gamma"	Q969Q6	14	35085467-35122517	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cone-rod dystrophy, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 489.7;Late spermatids: 233.5;Spermatocytes: 239.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040835, HPA058834"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		No	No			Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA040835: AB_10794152, HPA058834: AB_2683831"	"unprognostic (1.41e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.32e-3)"	"unprognostic (5.33e-2)"	"unprognostic (9.73e-2)"	"unprognostic (1.10e-3)"	"unprognostic (3.05e-1)"	"unprognostic (7.85e-2)"	"unprognostic (9.48e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.15e-3)"	"unprognostic (8.55e-2)"	"unprognostic (8.29e-2)"	20.1	15.6	25.5	24.1	26.8	43.2	17.3	26.2	41.9	18.2	25.6	18.8	21.2	16.4	16.6	12.6	14.1	18.7	23.1	25.4	28.1	14.5	16.2	17.9	31.3	27.3	26.7	24.8	16.0	10.3	17.1	17.7	18.9	27.3	17.3	20.5	15.6	13.6	14.2	25.1	7.0	22.7	21.2	27.2	24.6	16.4	72.3	26.0	26.7	12.5	25.9	26.1	22.5	10.4	29.5	41.2	21.8	41.7	33.9	32.4	54.5	29.6	33.0	32.0	41.0	48.0	18.1	32.2	47.2	13.4	33.9	15.5	17.6	20.0	13.8	60.5	47.8	19.3	26.2	11.9	65.2	43.3	51.2	51.7	41.9	14.4	29.0	19.7	24.0	55.7	26.2	25.7	46.3	57.4	28.4	46.4	43.1	37.1	27.4	24.3	50.2	27.1	32.8	15.8	24.1	39.9	37.5	41.7	27.6	57.8	19.9	17.9	57.0	47.9	41.3	17.3	36.0	34.9	44.8	52.4	92.8	22.8	47.9	48.1	66.5	41.6	86.9	23.4	52.5	27.0	31.0	24.8	29.5	36.1	33.1	22.0	26.9	76.9	33.1	42.7	16.3	40.8	34.0	25.5	26.8	26.2	41.9	25.4	28.1	27.3	26.7	24.8	27.3	27.2	26.0	29.5	35.5	16.0	24.7	32.7	40.2	11.5	23.3	31.7	9.6	15.9	18.8	14.7	26.3	17.2	25.8	20.2	4.2	19.4	48.1	29.1	33.2	31.2	489.7	23.1	28.1	33.8	31.2	69.7	28.3	36.1	26.2	26.5	19.9	21.7	33.7	31.3	34.6	22.8	61.3	8.4	30.4	26.8	32.6	49.7	36.3	233.5	28.3	42.6	28.4	24.4	71.5	28.7	46.4	36.2	58.8	49.2	22.3	30.5	37.4	24.8	37.8	43.2	25.1	21.5	32.9	24.0	43.1	239.2	58.6	19.6	13.5	34.8	45.2	36.2	24.6	30.5
PPP3R2	PPP3RL	ENSG00000188386	"Protein phosphatase 3 regulatory subunit B, beta"	Q96LZ3	9	101591604-101595021	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	153	"testis: 81.5"	"Group enriched"	"Detected in some"	38	"Early spermatids: 399.2;Late spermatids: 198.3;Spermatocytes: 600.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA047157	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA047157: AB_2679960"												"unprognostic (8.81e-2)"			"unprognostic (2.65e-1)"			0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	81.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.5	0.2	0.1	0.3	0.2	0.3	0.5	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	399.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	198.3	10.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.1	0.2	600.6	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRKACG	PKACg	ENSG00000165059	"Protein kinase cAMP-activated catalytic subunit gamma"	P22612	9	69012504-69014113	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	151	"testis: 24.8"	"Group enriched"	"Detected in some"	27	"Early spermatids: 71.0;Late spermatids: 88.4;Spermatocytes: 41.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB004530, HPA071185"	Supported		Uncertain	"Cytokinetic bridge,Cytosol"		Yes	NA			Cytosol	"Cytokinetic bridge"	"CAB004530: AB_628137, HPA071185: AB_2686356"					"unprognostic (2.74e-1)"									"unprognostic (3.61e-2)"	"unprognostic (7.22e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	88.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.3	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1
PRKRIP1	"C114, FLJ13902, KRBOX3"	ENSG00000128563	"PRKR interacting protein 1"	Q9H875	7	102363872-102426676	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051146	Uncertain		Supported	"Actin filaments,Cytosol"		NA	NA			"Actin filaments"	Cytosol	"HPA051146: AB_2681361"	"unprognostic (4.78e-3)"	"unprognostic (7.23e-3)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (8.25e-2)"	"unprognostic (2.99e-3)"	"unprognostic (3.15e-2)"	"unprognostic (1.99e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.57e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.61e-3)"	"unprognostic (9.79e-3)"	"prognostic unfavorable (4.39e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.88e-1)"	"prognostic favorable (1.94e-4)"	12.2	16.4	13.7	7.2	13.7	16.7	12.9	16.6	18.0	15.4	12.6	12.9	8.7	13.8	3.5	11.8	14.3	5.7	9.7	13.7	14.1	15.5	12.2	9.7	12.6	14.5	14.0	13.3	14.8	11.7	11.7	15.5	7.1	14.7	15.6	3.7	4.2	12.2	6.9	12.4	18.4	12.5	5.1	13.0	18.4	13.6	19.2	13.9	12.2	14.6	7.5	7.7	13.7	13.2	14.6	17.0	12.4	11.8	17.3	5.4	7.7	17.6	13.1	9.0	21.1	17.8	20.3	14.7	17.6	20.3	11.2	15.0	19.2	9.0	12.9	10.7	20.1	19.1	7.3	12.3	11.9	13.3	10.3	10.3	5.5	12.4	16.2	10.9	11.3	10.7	19.9	21.1	26.3	13.1	33.7	34.4	46.7	18.3	15.1	14.7	24.8	11.5	27.5	11.3	7.2	13.5	25.9	19.5	29.2	20.1	11.8	15.1	20.0	12.7	21.6	26.0	23.3	20.5	36.0	26.7	31.6	18.3	18.4	29.4	3.8	10.1	18.3	11.5	10.0	10.7	14.0	11.5	12.9	7.8	13.0	14.2	12.4	20.7	12.9	13.6	14.1	9.6	10.0	13.7	13.7	16.6	18.0	13.7	14.1	14.5	14.0	13.3	14.7	13.0	13.9	14.6	23.4	32.1	21.8	0.0	31.4	13.4	19.0	14.8	20.5	23.1	21.1	19.3	23.8	14.3	23.0	16.5	31.3	27.5	31.7	13.7	31.3	24.8	77.8	29.6	26.0	21.4	16.3	21.8	0.0	25.1	26.7	21.3	16.3	32.0	22.8	27.1	15.0	14.1	27.6	23.5	0.0	13.8	8.2	13.8	16.9	92.5	17.1	19.2	12.4	0.0	22.1	25.3	20.6	0.0	0.0	29.5	9.8	16.6	28.6	22.4	14.6	26.6	27.1	21.5	32.9	29.2	27.0	88.4	47.6	20.8	17.6	41.9	30.4	24.2	12.0	19.4
PRPF18	hPrp18	ENSG00000165630	"Pre-mRNA processing factor 18"	Q99633	10	13586939-13630859	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 105.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA037599, HPA047950"	Supported		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA037599: AB_10795137, HPA047950: AB_2680221"	"unprognostic (5.82e-2)"	"unprognostic (7.86e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.20e-2)"	"unprognostic (3.00e-2)"	"unprognostic (6.36e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (6.12e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.93e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.09e-2)"	"unprognostic (1.63e-1)"	14.7	16.0	8.8	14.5	10.1	43.4	19.8	12.7	10.5	12.9	9.3	16.2	17.0	14.1	28.4	15.9	11.8	15.7	14.5	9.0	9.1	20.9	22.1	15.0	18.4	9.5	9.3	7.2	13.1	17.1	18.8	10.8	17.5	9.9	14.4	18.3	10.2	14.4	13.1	23.4	14.1	16.6	15.2	9.1	13.8	15.1	19.0	9.5	25.3	23.8	22.4	19.9	16.6	12.4	10.5	29.5	21.7	18.9	16.4	25.9	24.7	23.5	33.6	16.6	35.9	34.2	20.8	43.8	24.4	18.3	31.1	16.3	23.8	25.1	27.8	41.3	36.3	24.9	28.4	18.5	16.3	30.7	22.6	32.9	19.4	44.3	31.3	15.4	21.9	35.3	35.0	29.9	32.1	33.1	30.5	42.2	15.6	17.8	29.0	10.7	29.8	22.8	30.6	23.9	12.6	13.2	32.7	26.6	18.8	29.1	23.0	29.0	36.6	30.2	22.2	26.1	36.5	25.5	31.2	35.8	34.8	32.8	27.9	15.4	27.2	27.3	36.5	27.7	25.1	24.0	26.9	24.8	23.9	27.4	25.8	26.4	32.6	40.3	39.7	37.4	23.3	33.5	16.8	8.8	10.1	12.7	10.5	9.0	9.1	9.5	9.3	7.2	9.9	9.1	9.5	10.5	24.5	19.2	22.4	14.7	32.8	45.6	24.0	35.7	25.0	13.5	22.6	15.0	9.4	30.0	32.9	22.0	10.4	30.5	28.7	21.1	41.1	30.9	29.8	27.5	22.8	21.1	12.6	25.9	27.0	29.1	40.4	18.9	19.4	22.0	27.1	10.5	16.4	28.4	26.0	21.9	25.3	21.8	46.8	20.7	18.0	16.5	17.7	19.4	24.9	18.7	29.7	20.2	36.0	28.1	29.3	33.7	28.9	13.2	27.1	16.2	30.2	50.6	31.8	21.7	19.7	20.8	18.3	105.8	41.1	17.1	46.9	41.7	33.2	11.6	19.0	25.8
PRPS1L1	"PRPS3, PRPSL"	ENSG00000229937	"Phosphoribosyl pyrophosphate synthetase 1 like 1"	P21108	7	18026770-18027846	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Nucleotide biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	318	"testis: 31.8"	"Group enriched"	"Detected in some"	7	"Early spermatids: 71.0;Spermatocytes: 129.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051269			Uncertain	Vesicles		NA	NA			Vesicles		"HPA051269: "					"unprognostic (2.39e-2)"									"unprognostic (3.18e-2)"	"unprognostic (1.11e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	6.6	0.0	1.1	129.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRPSAP2	PAP41	ENSG00000141127	"Phosphoribosyl pyrophosphate synthetase associated protein 2"	O60256	17	18840085-18931287	"Predicted intracellular proteins"	"Nucleotide biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SuSa: 274.7"	"Low region specificity"	"Detected in all"							HPA021881	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		84000	"Nucleoplasm, Cytosol"		"HPA021881: AB_1855782"	"unprognostic (1.34e-1)"	"unprognostic (7.25e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.25e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (3.71e-4)"	"unprognostic (4.57e-2)"	"unprognostic (8.98e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.08e-2)"	10.5	18.0	22.4	21.6	25.9	23.8	16.3	39.9	25.5	14.8	19.1	20.8	26.5	21.4	18.0	16.8	21.2	21.6	19.2	25.2	25.2	30.2	21.6	18.5	51.7	27.1	24.7	21.6	26.0	16.1	21.2	22.2	14.0	27.0	16.6	24.7	46.7	14.7	14.6	10.4	20.9	20.9	17.5	26.3	19.7	23.3	32.0	26.1	30.8	26.8	10.9	57.8	15.0	14.5	39.1	40.6	44.2	63.1	46.1	26.8	16.2	64.4	30.4	23.7	38.8	35.7	56.2	19.3	104.3	30.7	26.4	38.4	49.2	75.0	38.4	42.2	47.4	60.1	32.8	37.0	46.8	37.5	21.0	29.1	19.5	24.7	49.2	36.6	39.2	36.5	57.0	49.4	17.0	34.5	45.5	45.4	23.9	45.8	80.3	29.0	63.0	103.4	46.4	24.4	25.7	37.7	47.7	45.4	18.5	48.5	274.7	49.7	31.0	24.8	15.8	31.5	53.8	38.7	26.9	34.8	43.5	33.3	30.0	33.1	23.2	23.2	28.5	25.9	23.5	29.4	43.7	32.9	27.2	31.9	40.4	46.0	34.5	9.5	36.9	26.1	21.4	36.3	30.0	22.4	25.9	39.9	25.5	25.2	25.2	27.1	24.7	21.6	27.0	26.3	26.1	39.1	16.6	16.0	31.7	21.5	31.7	15.8	19.7	26.9	16.5	38.5	14.2	18.2	10.2	25.8	18.6	11.0	29.2	12.4	22.6	12.3	27.4	23.4	54.3	14.6	13.0	18.3	26.5	23.5	17.6	22.1	37.9	14.8	16.3	13.1	46.3	18.4	18.9	17.6	24.5	16.8	21.5	17.6	16.2	14.0	11.0	67.9	14.0	19.5	12.4	14.0	24.6	26.3	19.6	27.2	37.8	21.1	14.8	13.5	48.0	20.3	21.5	32.2	25.3	34.4	19.7	13.7	14.3	69.8	54.0	19.5	20.9	14.0	23.8	24.7	21.3	15.6
PSMG1	"c21-LRP, DSCR2, LRPC21, PAC1"	ENSG00000183527	"Proteasome assembly chaperone 1"	O95456	21	39174769-39183488	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 40.6"	"Group enriched"	"Detected in all"	4	"Early spermatids: 673.8;Spermatocytes: 544.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA057193, HPA070225"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"		No	No			"Nucleoplasm, Golgi apparatus, Cytosol"		"HPA057193: AB_2683363, HPA070225: AB_2686236"	"unprognostic (1.52e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.10e-1)"	"unprognostic (9.38e-2)"	"unprognostic (5.06e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.66e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.99e-2)"	"prognostic unfavorable (3.58e-5)"	"unprognostic (2.84e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.32e-2)"	"unprognostic (4.17e-3)"	7.3	9.9	3.5	9.2	4.4	17.5	6.9	2.9	6.0	7.3	2.3	10.6	9.0	7.9	4.8	11.9	6.5	5.4	8.3	4.9	4.0	9.8	16.0	5.7	9.0	2.4	2.6	3.3	7.2	10.9	5.2	8.1	7.8	3.1	5.6	10.0	4.9	7.4	3.3	13.9	7.0	8.3	5.1	1.9	6.3	7.1	40.6	3.2	6.3	10.9	5.7	6.3	7.9	7.4	4.3	104.0	34.7	23.5	32.9	12.3	15.1	65.0	55.3	25.9	44.8	28.2	66.6	26.9	113.7	28.9	17.1	38.1	28.5	40.3	30.3	30.2	48.9	61.6	209.6	52.4	83.6	21.9	101.0	40.4	18.9	24.6	46.2	46.5	9.8	24.9	47.0	160.4	61.9	27.2	58.2	63.0	54.7	82.2	38.9	53.5	99.6	29.8	115.8	19.1	30.4	77.6	22.7	70.4	39.1	57.4	4.0	36.6	51.4	26.7	50.1	16.8	66.7	79.9	46.4	79.3	96.8	42.0	170.4	38.6	10.6	6.8	3.9	10.5	9.0	12.3	12.0	14.7	12.4	12.2	10.6	11.5	10.3	0.6	7.5	9.1	11.3	13.7	7.9	3.5	4.4	2.9	6.0	4.9	4.0	2.4	2.6	3.3	3.1	1.9	3.2	4.3	23.7	6.4	17.6	5.2	17.8	136.0	44.1	68.6	43.9	14.2	31.3	39.0	24.8	22.8	39.9	20.2	4.2	108.9	12.6	14.7	66.5	50.8	673.8	20.8	36.5	26.3	29.9	63.3	7.5	49.7	118.6	31.8	18.8	21.6	36.1	26.2	18.9	32.7	59.5	8.4	8.0	45.7	69.2	17.7	35.5	88.4	31.7	25.0	46.2	3.7	24.4	18.0	12.3	3.5	5.9	32.4	20.0	33.1	31.7	41.5	30.6	89.4	20.8	19.7	26.3	29.5	31.3	544.1	98.7	51.7	97.7	54.5	20.1	54.7	56.9	27.9
PSMG2	"CLAST3, HCCA3, HsT1707, MDS003, MGC15092, PAC2, TNFSF5IP1"	ENSG00000128789	"Proteasome assembly chaperone 2"	Q969U7	18	12658043-12725740	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 537.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 436.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041517, HPA046741"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA041517: AB_2677530, HPA046741: AB_2679780"	"unprognostic (2.28e-2)"	"unprognostic (9.44e-3)"	"unprognostic (9.68e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.40e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.09e-4)"	"unprognostic (5.91e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.73e-1)"	"unprognostic (9.04e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.82e-2)"	"unprognostic (6.75e-3)"	63.3	50.7	46.6	45.2	46.8	92.7	65.8	50.0	55.2	52.3	47.1	56.3	48.7	49.5	68.1	64.0	48.1	53.7	47.8	46.4	49.0	57.7	66.2	44.7	65.6	47.9	47.8	45.5	61.1	56.3	31.3	32.0	53.3	47.5	42.9	61.0	25.3	46.9	48.4	51.3	55.0	48.2	53.4	49.1	44.1	54.1	90.5	47.3	68.2	50.1	39.8	64.2	64.4	52.5	52.2	82.6	51.3	58.2	74.0	100.1	142.5	75.0	81.3	115.7	131.1	147.8	89.1	84.6	90.6	64.6	86.2	108.3	49.8	93.7	99.9	112.2	48.6	52.4	50.1	43.0	101.8	100.7	170.7	78.7	116.8	76.0	80.7	107.6	81.3	92.5	78.7	77.4	112.9	102.4	83.0	109.9	226.1	46.2	436.4	67.8	78.8	87.5	130.2	121.0	106.3	69.6	52.5	77.5	88.1	78.1	56.3	75.8	136.2	63.5	148.9	203.3	131.3	89.4	101.1	142.9	111.1	90.1	88.5	63.3	84.9	89.3	87.6	65.3	95.1	77.6	70.3	84.0	74.8	80.5	62.5	74.6	72.2	30.9	73.9	111.6	65.7	108.2	91.7	46.6	46.8	50.0	55.2	46.4	49.0	47.9	47.8	45.5	47.5	49.1	47.3	52.2	96.1	51.3	50.1	42.7	76.4	91.0	98.8	145.2	80.8	25.1	81.4	99.2	36.0	82.9	80.9	82.8	22.9	183.0	80.9	70.8	154.6	110.5	537.7	59.8	75.8	83.9	68.6	97.2	50.1	110.8	140.3	99.3	59.1	53.3	60.9	74.9	101.7	53.1	147.6	25.2	50.3	87.8	54.9	133.0	88.7	140.8	134.2	100.2	72.9	26.2	130.7	63.8	50.4	34.7	38.5	103.2	84.2	97.0	67.1	126.1	120.6	193.8	68.7	21.4	85.5	78.4	89.8	344.9	216.8	119.5	90.1	186.3	78.8	122.3	103.6	130.7
PSTK	"C10orf89, MGC35392"	ENSG00000179988	"Phosphoseryl-tRNA kinase"	Q8IV42	10	122954381-122997513	"Enzymes, Predicted intracellular proteins"	"Protein biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 31.3;Spermatocytes: 37.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037780, HPA037781"	Approved		Approved	"Nucleoli,Nuclear bodies,Actin filaments"		No	No			"Actin filaments"	"Nucleoli, Nuclear bodies"	"HPA037780: AB_2675662, HPA037781: AB_10670530"	"unprognostic (8.95e-3)"	"unprognostic (5.51e-3)"	"unprognostic (1.37e-1)"	"unprognostic (7.39e-4)"	"unprognostic (5.21e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.60e-2)"	"unprognostic (5.92e-4)"	"unprognostic (3.55e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.22e-3)"	"unprognostic (7.10e-3)"	"unprognostic (2.39e-1)"	"unprognostic (4.50e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.02e-2)"	"unprognostic (5.55e-4)"	0.9	2.3	1.1	0.6	1.3	6.2	3.0	1.3	2.2	1.9	0.2	1.6	1.9	1.9	3.5	1.6	2.0	0.7	1.7	1.3	1.3	2.0	4.2	1.0	0.9	1.6	1.4	1.3	1.3	2.1	1.1	2.6	1.3	2.4	2.0	1.5	0.5	1.9	1.1	3.5	1.6	1.0	1.9	1.2	1.1	1.3	3.2	1.2	1.8	2.4	1.0	1.2	1.4	1.3	2.7	4.1	3.4	1.7	0.8	1.6	3.2	2.1	2.0	3.5	3.0	3.7	4.6	3.4	4.4	3.9	2.5	2.0	2.3	0.7	3.1	3.4	2.4	8.7	2.7	1.2	4.0	4.3	6.7	3.6	3.3	5.2	2.9	5.2	2.7	2.3	3.9	4.3	6.0	4.3	6.6	2.0	3.9	3.3	1.6	4.3	4.5	3.0	4.4	4.3	2.6	1.6	2.1	3.9	3.8	5.3	1.4	1.8	0.4	3.1	2.8	2.6	1.2	4.5	2.6	1.6	5.8	2.4	4.3	0.9	0.0	5.0	6.0	7.4	3.1	8.8	6.2	5.7	7.0	6.7	5.9	7.5	7.7	0.6	6.8	3.6	6.7	3.8	5.3	1.1	1.3	1.3	2.2	1.3	1.3	1.6	1.4	1.3	2.4	1.2	1.2	2.7	3.0	9.6	7.3	14.4	4.6	4.5	5.0	11.0	5.2	8.3	7.1	11.7	5.9	10.0	7.5	5.5	8.4	7.7	8.0	1.6	9.8	4.6	31.3	5.7	5.2	3.2	4.2	3.4	18.8	6.3	3.1	6.0	1.5	11.6	2.5	8.1	3.6	6.3	4.8	5.0	20.3	2.6	14.2	2.1	4.3	5.4	5.3	3.0	5.4	4.7	6.1	8.8	5.2	12.5	29.4	3.7	3.8	5.7	3.3	3.5	3.0	7.7	8.3	11.4	0.0	5.6	8.6	37.5	20.6	5.5	4.7	9.6	6.9	10.8	4.3	3.5
PWP1	IEF-SSP-9502	ENSG00000136045	"PWP1 homolog, endonuclein"	Q13610	12	107685799-107713162	"Predicted intracellular proteins"	"Ribosome biogenesis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038708			Approved	"Nucleoli rim,Golgi apparatus"		Yes	No			"Nucleoli rim"	"Golgi apparatus"	"HPA038708: AB_2676163"	"unprognostic (7.06e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (9.65e-4)"	"prognostic unfavorable (1.40e-5)"	"unprognostic (1.97e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (2.00e-1)"	"unprognostic (6.95e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.10e-2)"	28.9	21.1	19.2	26.7	20.1	32.2	34.1	20.0	23.8	24.5	28.4	25.0	17.9	30.6	25.0	29.0	24.9	20.6	17.5	19.5	20.6	30.7	32.5	21.6	32.3	18.8	19.0	19.2	33.1	26.0	33.2	18.0	29.8	21.3	25.4	26.2	27.2	24.6	27.8	23.1	28.7	21.9	32.6	18.9	23.9	23.3	30.3	19.6	33.5	26.1	17.8	37.7	31.7	24.7	20.3	71.0	86.9	51.8	49.4	70.9	77.2	68.5	72.9	81.9	100.8	84.8	88.5	32.9	108.8	38.4	112.9	68.4	60.7	70.8	77.0	99.2	54.7	80.6	82.9	50.5	103.2	72.7	101.8	56.9	70.2	69.1	93.5	83.0	79.0	119.8	66.0	110.8	29.8	109.1	78.3	71.6	99.3	62.0	64.8	141.2	58.3	61.2	101.4	62.7	98.3	58.4	46.9	59.6	42.4	104.1	64.8	75.3	49.7	94.9	76.7	38.9	63.0	84.1	42.5	62.8	84.9	34.3	55.3	68.7	29.4	20.8	16.2	41.7	27.8	37.8	68.5	40.6	43.9	35.0	64.1	34.5	47.9	6.6	44.2	34.4	47.3	48.6	29.7	19.2	20.1	20.0	23.8	19.5	20.6	18.8	19.0	19.2	21.3	18.9	19.6	20.3	44.1	41.7	38.1	13.7	80.1	48.4	52.3	70.6	36.5	50.4	41.0	41.3	22.1	25.8	48.9	27.6	37.5	69.1	48.4	14.6	58.7	69.7	24.4	34.5	47.3	52.0	21.0	52.2	15.6	63.0	74.5	51.6	30.5	35.8	57.6	41.5	43.5	52.0	46.2	33.7	19.0	31.9	26.4	34.3	28.0	11.1	50.4	33.2	30.2	4.7	75.2	41.4	38.1	15.1	16.7	68.0	19.8	44.0	46.0	50.2	24.5	70.8	42.8	46.2	26.3	41.8	50.9	124.3	79.2	41.9	49.7	45.7	44.0	45.8	34.1	40.5
PXYLP1	"ACPL2, FLJ23751"	ENSG00000155893	"2-phosphoxylose phosphatase 1"	Q8TE99	3	141228726-141367753	"Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 149.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 196.8;Late spermatids: 131.1;Spermatocytes: 95.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017243	Uncertain				"Intracellular and membrane"	NA	NA					"HPA017243: AB_1844509"	"unprognostic (9.55e-2)"	"unprognostic (3.48e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.45e-2)"	"unprognostic (8.04e-3)"	"unprognostic (4.05e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.95e-2)"	"unprognostic (5.07e-3)"	"unprognostic (4.67e-2)"	"unprognostic (1.29e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.56e-2)"	"unprognostic (8.17e-3)"	4.3	6.3	6.1	4.3	7.1	5.1	8.4	2.5	14.9	7.4	0.7	5.5	5.6	8.8	149.5	2.7	6.5	8.3	13.9	6.4	13.0	7.5	5.1	4.9	9.2	3.1	3.8	6.0	8.7	9.3	16.3	7.5	18.3	2.5	10.2	5.7	18.4	6.7	29.2	2.9	4.6	6.5	7.2	3.6	5.3	5.0	9.0	3.3	53.8	5.9	2.0	10.0	7.0	4.7	7.1	5.3	5.5	23.3	18.5	9.0	7.7	5.6	3.6	9.0	9.1	12.5	9.2	1.8	0.3	4.9	8.2	1.9	1.2	24.7	2.3	8.7	17.4	16.3	1.9	7.5	7.4	19.2	4.8	1.0	7.3	10.4	2.8	1.0	11.3	0.6	17.8	0.9	2.1	4.1	4.5	25.8	6.0	9.7	13.2	3.1	3.5	13.6	3.2	6.5	22.8	10.1	17.8	9.3	2.9	7.6	4.2	9.7	2.8	1.1	11.6	6.9	8.0	3.5	4.9	0.4	0.7	10.7	6.5	10.4	15.2	6.0	9.4	13.4	4.0	8.6	0.7	7.5	8.9	5.3	0.5	21.6	17.6	3.8	19.3	2.0	1.9	4.3	8.9	6.1	7.1	2.5	14.9	6.4	13.0	3.1	3.8	6.0	2.5	3.6	3.3	7.1	1.1	9.6	8.7	14.0	2.2	0.0	4.6	0.0	6.2	3.3	9.5	6.7	7.6	2.8	1.8	46.0	6.2	2.1	3.4	2.1	0.0	3.2	196.8	1.0	9.3	1.4	4.2	4.4	41.3	3.7	8.2	7.9	1.1	1.8	2.5	5.4	1.4	3.8	0.7	6.7	31.8	3.9	0.0	1.8	0.0	131.1	20.2	2.0	0.0	1.0	3.5	8.0	3.1	32.6	6.5	3.0	8.6	15.1	2.7	7.6	4.2	11.7	2.9	5.2	13.1	6.6	4.2	95.9	13.8	2.2	0.0	1.1	4.9	0.9	4.7	6.6
RAE1	"Gle2, Mnrp41"	ENSG00000101146	"Ribonucleic acid export 1"	P78406	20	57351223-57379211	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 103.9"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 113.6;Spermatocytes: 256.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048795			Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA048795: AB_2680523"	"unprognostic (1.20e-1)"	"unprognostic (5.98e-2)"	"unprognostic (4.55e-2)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (3.23e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (2.12e-7)"	"unprognostic (1.88e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.50e-3)"	"unprognostic (3.88e-2)"	"unprognostic (7.48e-2)"	"unprognostic (3.55e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.01e-1)"	13.4	14.0	18.4	13.7	20.0	50.9	17.2	19.4	19.2	15.4	18.3	14.4	12.0	16.8	18.3	20.7	17.6	9.0	12.4	19.1	19.4	13.0	16.6	10.1	21.0	16.9	17.9	18.8	16.4	10.9	19.2	13.4	14.7	17.5	12.5	16.4	20.2	12.9	15.2	15.1	22.6	13.7	16.4	17.6	17.1	12.9	103.9	20.9	29.4	12.2	15.9	26.8	14.6	16.1	19.8	43.5	52.6	52.8	29.3	30.1	29.0	46.1	33.9	47.2	172.2	70.3	166.1	33.8	69.2	46.8	52.8	63.8	56.6	101.6	88.3	142.1	20.8	45.2	47.0	46.0	74.9	59.0	57.1	41.3	41.3	74.0	75.8	83.1	29.1	49.9	47.2	84.8	32.5	53.0	114.8	88.3	53.2	32.9	86.3	93.3	47.6	49.4	46.0	37.3	45.5	55.2	47.6	58.4	129.4	61.0	41.2	71.5	54.0	29.7	70.6	63.0	41.7	57.7	34.9	83.9	81.8	48.3	36.1	35.6	21.2	42.0	77.0	27.0	36.8	32.9	31.2	26.0	26.8	32.3	28.1	33.9	30.7	36.2	24.7	37.9	23.8	24.6	40.4	18.4	20.0	19.4	19.2	19.1	19.4	16.9	17.9	18.8	17.5	17.6	20.9	19.8	17.5	19.2	16.7	8.5	21.0	17.2	16.3	42.0	15.9	15.9	12.6	19.3	10.4	11.5	24.1	18.4	14.6	52.8	20.8	11.6	27.4	30.3	113.6	16.5	16.7	17.9	6.6	18.7	10.2	14.3	39.3	18.6	12.2	15.3	38.0	25.6	11.0	13.5	38.3	3.3	9.5	15.2	18.3	59.5	14.5	63.9	21.8	33.5	10.6	14.0	40.0	19.9	27.8	5.5	13.1	22.2	24.3	22.6	15.9	14.0	10.1	20.6	24.1	17.9	19.7	11.6	19.9	256.9	83.1	19.2	21.0	70.5	24.2	34.9	20.1	16.2
RANBP3		ENSG00000031823	"RAN binding protein 3"	Q9H6Z4	19	5916139-5978142	"Cancer-related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 86.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043375, HPA043389"	Enhanced		Enhanced	Nucleoplasm		NA	NA		17000	Nucleoplasm		"HPA043375: AB_10959889, HPA043389: AB_10963696"	"unprognostic (1.81e-1)"	"unprognostic (1.18e-3)"	"unprognostic (3.61e-1)"	"prognostic favorable (1.22e-5)"	"unprognostic (4.24e-2)"	"unprognostic (1.42e-3)"	"unprognostic (5.44e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.08e-1)"	"prognostic favorable (4.14e-4)"	"unprognostic (2.27e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.91e-1)"	"unprognostic (5.15e-2)"	"prognostic favorable (8.14e-4)"	"unprognostic (1.06e-2)"	24.6	40.7	28.0	24.2	26.2	21.7	24.9	26.8	33.9	30.4	22.3	36.8	22.4	35.4	10.7	26.8	29.2	18.0	34.2	27.8	26.2	24.8	24.6	25.4	26.7	29.7	31.4	24.8	28.4	29.8	20.9	32.3	16.9	28.8	32.5	12.3	19.5	25.8	23.1	36.9	28.8	27.9	19.2	27.7	30.3	32.2	45.0	28.4	26.5	26.1	21.5	18.0	36.9	28.1	28.1	73.8	50.4	42.3	47.6	31.2	31.3	30.0	45.9	43.1	52.7	56.7	64.9	25.4	69.0	50.4	35.8	33.1	44.8	38.2	44.8	32.0	71.0	62.3	37.1	38.8	77.6	33.7	54.9	52.2	30.9	30.4	33.0	37.3	24.5	38.9	37.0	68.4	63.6	30.3	30.7	91.8	26.6	77.6	31.8	64.3	67.0	40.6	63.3	34.3	56.3	46.4	52.1	41.1	42.9	41.1	24.7	32.7	41.0	40.6	44.2	32.2	78.2	68.4	65.4	72.1	59.2	55.9	68.0	55.6	14.5	23.1	29.2	23.2	23.2	24.1	17.6	22.7	23.5	23.4	24.5	19.5	25.8	26.0	17.9	24.3	22.3	32.1	24.5	28.0	26.2	26.8	33.9	27.8	26.2	29.7	31.4	24.8	28.8	27.7	28.4	28.1	14.0	25.6	26.6	9.8	18.4	12.2	20.5	27.1	9.6	16.7	12.0	10.2	16.4	18.6	19.9	7.3	25.0	29.2	18.6	16.9	43.0	28.8	59.5	14.3	12.6	19.2	13.2	8.6	9.4	20.8	29.5	17.1	17.3	15.4	17.7	14.1	9.3	10.8	25.0	23.5	11.7	20.2	32.6	14.9	16.8	73.3	16.8	16.5	21.4	8.4	31.5	21.9	25.7	13.6	17.5	22.7	11.4	24.8	21.7	18.8	20.2	21.0	21.4	20.8	19.7	13.5	15.8	86.8	40.8	10.4	11.8	35.4	20.6	19.1	15.1	23.0
RARS2	"DALRD2, dJ382I10.6, MGC14993, MGC23778, PRO1992, RARSL"	ENSG00000146282	"Arginyl-tRNA synthetase 2, mitochondrial"	Q5T160	6	87513938-87589987	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Neurodegeneration, Pontocerebellar hypoplasia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039987, HPA042645"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA039987: AB_2676786, HPA042645: AB_2678097"	"unprognostic (1.49e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.03e-2)"	"unprognostic (6.98e-2)"	"unprognostic (9.27e-2)"	"unprognostic (5.41e-2)"	"unprognostic (6.61e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.08e-3)"	"unprognostic (8.28e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.56e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.89e-2)"	"unprognostic (5.73e-2)"	"unprognostic (7.16e-3)"	23.0	39.9	11.0	15.9	12.2	19.5	21.5	15.2	11.7	21.3	18.6	21.0	18.0	22.0	18.7	17.9	19.8	19.2	22.9	11.0	12.6	19.1	28.2	18.5	16.9	11.8	11.9	10.8	18.7	24.2	21.6	17.7	22.4	12.4	19.0	22.9	26.2	20.9	13.7	22.7	18.7	22.7	21.7	11.2	18.7	19.4	25.6	12.4	18.6	20.7	19.5	19.1	20.8	18.3	16.1	19.8	19.1	45.1	49.8	44.6	47.5	31.9	46.6	54.2	30.8	38.6	36.6	21.6	25.0	26.9	47.4	32.0	26.7	37.9	25.8	43.2	18.0	36.0	25.7	24.4	58.7	56.1	30.7	21.3	48.9	24.6	26.4	33.1	44.5	41.0	25.7	59.6	24.4	46.8	35.2	10.0	32.8	29.2	42.3	20.0	19.9	45.9	22.2	38.5	40.1	40.8	54.7	24.8	12.1	33.1	38.2	22.5	45.8	28.1	21.2	16.8	22.8	38.4	25.6	45.1	21.1	32.2	31.8	36.6	18.8	17.8	22.7	16.1	18.6	19.0	15.1	20.4	15.1	15.6	16.2	19.9	16.9	11.9	18.6	20.7	17.9	27.9	15.4	11.0	12.2	15.2	11.7	11.0	12.6	11.8	11.9	10.8	12.4	11.2	12.4	16.1	34.4	19.2	15.6	30.0	21.2	17.3	35.4	51.3	12.5	13.9	17.3	16.8	19.9	10.0	37.8	11.0	20.9	31.0	18.1	14.6	45.0	32.9	95.3	23.5	29.3	22.8	9.0	7.4	46.8	46.9	45.5	28.3	12.8	20.3	18.3	27.9	23.6	15.5	20.5	6.7	59.0	23.5	44.7	13.5	14.1	50.6	25.4	15.0	19.6	38.4	22.6	13.6	19.6	56.3	63.9	37.6	21.2	24.0	20.7	30.8	57.2	32.9	24.2	20.3	26.3	18.9	30.0	61.8	33.7	14.1	18.0	39.5	20.6	51.4	27.0	33.9
RASGEF1C	FLJ35841	ENSG00000146090	"RasGEF domain family member 1C"	Q8N431	5	180100795-180209211	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 20.6;testis: 5.8"	"Cell type enriched"	"Detected in some"	9	"Microglial cells: 188.3"	"Cancer enhanced"	"Detected in some"		"glioma: 2.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.2;HEK 293: 1.7;MCF7: 2.2;SCLC-21H: 7.6;U-2 OS: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028242	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA028242: AB_10602294"	"unprognostic (2.21e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.75e-4)"	"unprognostic (4.65e-2)"	"unprognostic (4.04e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.02e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.65e-4)"	"unprognostic (5.89e-2)"	"unprognostic (8.25e-3)"	"unprognostic (3.70e-1)"	"unprognostic (1.77e-2)"	0.2	0.2	3.7	0.2	12.9	0.0	0.4	20.6	8.6	1.0	0.0	2.4	0.1	0.0	0.1	0.3	0.5	0.3	0.8	6.7	2.5	0.1	0.0	0.0	0.0	6.8	4.1	6.9	0.1	0.1	0.0	0.1	0.1	7.5	0.9	0.2	0.3	1.1	0.9	0.0	0.5	0.8	0.1	4.5	0.0	0.7	5.8	2.9	0.0	1.2	0.0	0.0	0.7	1.1	7.3	0.0	0.0	0.2	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.0	2.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	2.4	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	12.9	20.6	8.6	6.7	2.5	6.8	4.1	6.9	7.5	4.5	2.9	7.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.2	1.8	1.1	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	3.4	0.2	0.0	0.5	0.0	0.0	20.2	0.0	0.6	0.1	0.0	0.5	0.0	1.5	0.0	0.0	0.1	0.0	12.5	0.0	0.0	0.0	0.0	3.8	0.0	0.1	0.0	188.3	0.0	0.2	0.0	15.1	19.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	16.7	1.0	0.0	0.0	1.9	0.0	0.5	0.0	0.0
RBMXL2	"HNRNPG-T, HNRPGT"	ENSG00000170748	"RBMX like 2"	O75526	11	7088998-7091148	"Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	168	"testis: 36.1"	"Group enriched"	"Detected in some"	8	"Early spermatids: 157.6;Late spermatids: 160.6;Spermatocytes: 205.3"	"Cancer enriched"	"Detected in single"	133	"testis cancer: 6.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA038912, HPA051842"	Enhanced					NA	NA					"HPA038912: AB_10670913, HPA051842: AB_2681634"		"unprognostic (3.73e-1)"			"unprognostic (2.24e-1)"							"unprognostic (5.47e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.24e-1)"	"unprognostic (8.28e-2)"	"unprognostic (3.77e-2)"		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	36.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	157.6	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	160.6	3.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	205.3	20.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0
RDH14	"PAN2, SDR7C4"	ENSG00000240857	"Retinol dehydrogenase 14"	Q9HBH5	2	18554723-18560679	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056686, HPA078577"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA056686: AB_2683209, HPA078577: "	"unprognostic (5.79e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.03e-2)"	"unprognostic (1.99e-2)"	"unprognostic (8.71e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.83e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.32e-2)"	"unprognostic (3.69e-2)"	14.0	14.6	11.9	8.4	12.1	5.5	12.7	12.2	12.5	9.8	15.9	13.8	11.7	14.3	12.3	9.9	12.0	9.5	27.2	11.8	11.9	14.1	18.7	11.9	12.6	12.1	11.8	12.0	10.0	14.2	18.9	11.4	13.1	12.7	13.4	10.5	8.4	10.8	11.1	28.4	9.6	11.5	12.1	12.2	11.5	14.8	11.5	12.4	12.6	11.2	27.3	9.5	15.6	10.3	12.8	28.6	8.9	7.3	6.0	21.8	22.9	24.7	16.8	17.7	15.2	15.0	6.9	14.6	28.2	9.7	10.3	19.7	15.3	10.8	19.9	17.6	15.6	28.8	10.8	10.6	21.4	18.6	13.7	14.1	17.5	19.9	14.8	22.9	21.2	14.2	11.2	19.9	9.2	25.2	9.2	11.8	23.7	19.9	21.9	24.1	16.5	20.1	12.1	29.9	18.4	11.2	19.3	9.3	20.4	25.8	15.4	10.1	7.2	14.4	21.5	13.1	16.6	20.6	26.0	23.1	20.8	15.1	9.0	17.1	1.4	1.4	6.5	3.3	1.7	5.5	7.3	3.9	4.9	1.9	11.6	5.5	4.5	0.5	3.1	1.7	6.1	5.1	1.3	11.9	12.1	12.2	12.5	11.8	11.9	12.1	11.8	12.0	12.7	12.2	12.4	12.8	21.7	16.0	12.8	0.0	36.1	24.5	31.0	27.9	31.3	23.5	20.1	24.5	55.6	32.9	20.9	16.5	6.2	44.6	34.8	20.6	31.3	37.8	27.4	27.4	19.7	19.4	13.2	18.7	0.0	35.3	50.3	38.5	20.4	19.7	12.7	16.4	20.3	30.0	24.2	15.2	0.0	27.1	20.3	17.2	14.6	13.6	66.8	15.4	23.2	0.0	23.2	31.3	29.9	0.0	0.0	27.0	36.3	44.8	15.6	45.1	23.3	38.1	18.8	22.4	32.9	28.5	29.6	79.5	30.6	18.9	18.6	45.7	27.1	30.9	29.2	27.3
REC114	"C15orf60, CT147, FLJ27520, FLJ36860, FLJ44083, LOC283677"	ENSG00000183324	"REC114 meiotic recombination protein"	Q7Z4M0	15	73443164-73560013	"Predicted intracellular proteins"	"DNA recombination, Meiosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"testis: 39.5"	"Group enriched"	"Detected in some"	5	"Early spermatids: 184.0;Spermatocytes: 143.4"	"Cancer enriched"	"Detected in single"	11	"testis cancer: 1.3"	"Region enhanced"	"Detected in single"		"cerebellum: 1.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-266/84: 1.0"	"Region enhanced"	"Detected in many"		"olfactory bulb: 6.1"	"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.64e-1)"	"unprognostic (1.14e-1)"				"unprognostic (1.12e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.97e-1)"	"unprognostic (8.06e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.53e-7)"	"unprognostic (1.33e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.74e-1)"	0.0	0.0	0.2	0.0	0.1	0.0	0.0	1.1	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	1.1	0.4	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	184.0	0.1	0.0	0.2	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	25.1	3.1	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	143.4	29.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RFPL3	RNF120	ENSG00000128276	"Ret finger protein like 3"	O75679	22	32354885-32361161	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 25.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 2.6;Spermatocytes: 2.0;Spermatogonia: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.6;NB-4: 2.2;U-266/70: 2.5;U-266/84: 2.6"									"HPA048320, HPA072380"			Approved	"Nuclear speckles,Plasma membrane"		NA	NA			"Nuclear speckles"	"Plasma membrane"	"HPA048320: AB_2680356, HPA072380: AB_2686515"	"unprognostic (1.63e-1)"				"unprognostic (9.90e-2)"			"unprognostic (1.10e-1)"		"unprognostic (1.05e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.25e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.32e-2)"		0.1	0.1	0.0	0.2	0.1	1.4	0.0	0.4	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.0	0.1	0.1	0.6	0.1	0.2	0.0	0.5	0.7	0.0	0.1	0.1	0.2	0.3	0.0	2.4	0.5	0.0	0.5	1.3	0.3	0.0	0.0	0.7	0.1	25.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.0	0.4	1.0	0.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	1.0	0.5	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.8	0.0	0.8	0.0	0.4	0.6	2.2	0.1	0.1	0.0	1.1	0.2	0.3	0.0	0.2	0.8	0.1	0.0	0.2	0.6	0.2	0.0	0.2	0.0	0.0	0.4	0.1	0.0	2.5	2.6	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.1	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0
RIOK1	"AD034, bA288G3.1, FLJ30006, RRP10"	ENSG00000124784	"RIO kinase 1"	Q9BRS2	6	7389793-7418037	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ribosome biogenesis"	"Hydrolase, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017866, HPA051446"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"HPA017866: AB_2669670, HPA051446: AB_2681488"	"unprognostic (2.33e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (3.41e-5)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (3.45e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (5.85e-5)"	"unprognostic (2.33e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.12e-3)"	"unprognostic (2.59e-2)"	12.2	9.4	4.3	10.9	4.3	20.8	11.1	5.0	5.4	10.1	4.1	8.0	6.6	10.6	5.3	11.5	8.3	7.6	8.1	4.4	4.6	6.5	7.9	7.2	14.1	4.6	4.6	3.7	11.0	10.2	7.4	4.7	11.5	4.6	8.1	8.7	7.4	7.1	8.2	11.6	9.1	6.3	10.9	4.4	9.5	7.0	20.1	4.5	15.8	7.3	10.4	16.0	15.0	7.6	4.9	20.4	11.7	18.3	45.8	27.0	22.6	28.7	25.6	16.6	22.1	18.5	33.1	10.0	51.8	43.3	19.7	19.4	20.3	45.7	19.5	29.0	35.8	49.6	28.3	18.3	39.4	23.0	81.5	37.5	17.2	27.2	24.1	50.4	11.5	20.1	38.6	72.1	12.3	21.0	26.7	56.8	50.2	39.6	36.3	26.1	42.9	23.3	56.6	13.8	19.9	60.8	30.4	20.8	13.3	41.6	48.4	18.9	28.4	19.9	24.4	18.9	17.5	38.3	17.1	33.0	75.7	7.7	44.0	38.7	12.0	11.5	9.0	14.9	15.6	18.0	21.5	15.4	15.9	20.5	23.0	17.8	19.2	2.3	26.7	14.0	17.3	16.2	11.3	4.3	4.3	5.0	5.4	4.4	4.6	4.6	4.6	3.7	4.6	4.4	4.5	4.9	22.2	6.4	26.4	5.5	27.5	52.8	32.3	29.5	38.1	10.0	18.9	22.0	22.8	4.3	35.2	7.3	10.4	34.1	25.3	9.9	3.9	15.9	74.8	14.9	28.4	24.8	7.2	17.9	10.2	11.7	34.7	29.8	16.8	19.1	33.6	13.4	19.2	10.2	22.6	5.0	12.0	17.4	20.3	11.2	25.1	12.5	19.9	19.7	17.8	11.2	15.1	8.9	6.2	13.0	8.4	12.2	8.2	19.9	27.0	33.7	7.1	9.3	20.9	13.7	19.7	33.8	23.9	58.9	75.4	33.7	64.8	27.9	29.0	23.9	16.9	23.8
RLN2	"bA12D24.1.1, bA12D24.1.2, H2, RLXH2"	ENSG00000107014	"Relaxin 2"	P04090	9	5299864-5304716	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 5.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 13.0;Muller glia cells: 9.6;Spermatocytes: 17.3;Syncytiotrophoblasts: 13.5"	"Group enriched"	"Detected in some"	5	"breast cancer: 2.0;prostate cancer: 6.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	26	"gdT-cell: 1.4;MAIT T-cell: 4.2;memory B-cell: 1.9;memory CD4 T-cell: 2.8;memory CD8 T-cell: 2.3;naive B-cell: 1.4;naive CD4 T-cell: 4.0;naive CD8 T-cell: 3.0;NK-cell: 3.5;T-reg: 1.3"	"Group enriched"	"Detected in many"	33	"B-cells: 1.9;NK-cells: 3.5;T-cells: 4.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 5.6;HEL: 21.9;T-47d: 6.1;U-266/84: 10.2"														"Secreted to blood"	NA	NA	24400	10000				"unprognostic (1.63e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.84e-1)"	"unprognostic (2.03e-2)"	"unprognostic (9.99e-2)"		"unprognostic (1.48e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.91e-3)"	"unprognostic (2.50e-3)"	"unprognostic (9.18e-2)"	"unprognostic (1.74e-6)"	"unprognostic (2.36e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.88e-2)"	"unprognostic (8.41e-4)"	0.4	0.0	0.4	1.4	0.4	0.3	2.3	0.5	0.7	0.4	0.4	0.5	0.0	0.5	0.3	0.3	5.2	0.2	0.5	0.4	0.5	1.5	0.0	0.7	2.8	0.5	0.4	0.3	0.1	0.5	4.2	3.0	0.6	0.6	4.0	0.4	3.0	0.3	0.6	0.0	0.4	0.5	0.2	0.4	0.9	0.5	2.8	0.5	2.8	0.8	0.2	2.3	0.2	0.1	0.4	3.0	0.4	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.5	1.0	0.3	1.6	5.6	0.4	0.0	0.0	0.9	0.0	2.8	0.7	4.4	2.0	21.9	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.1	0.2	0.0	0.5	0.0	0.0	0.2	0.1	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.0	0.6	2.7	3.0	0.0	0.6	0.1	0.2	6.1	0.1	0.2	0.0	0.5	0.0	0.1	1.3	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	4.2	1.9	2.8	2.3	0.0	1.4	4.0	3.0	0.0	3.5	0.0	0.0	1.3	0.8	0.4	0.4	0.5	0.7	0.4	0.5	0.5	0.4	0.3	0.6	0.4	0.5	0.4	0.8	3.2	0.6	0.3	2.6	0.5	2.3	1.5	1.2	1.5	3.8	3.0	1.9	1.5	1.2	1.8	0.0	6.3	1.3	0.1	7.9	2.8	13.0	3.3	0.3	0.8	3.6	1.7	0.4	1.5	2.3	0.4	0.5	0.3	0.0	0.6	0.0	0.0	0.6	3.3	0.9	1.7	2.0	0.0	0.0	5.3	0.6	0.1	0.0	1.0	0.8	9.6	4.1	0.0	0.9	0.8	0.2	0.4	0.5	1.0	0.1	1.4	5.0	1.7	0.0	0.6	0.4	17.3	5.1	1.4	1.3	13.5	3.4	0.0	1.5	0.5
RNF113B	"RNF161, ZNF183L1"	ENSG00000139797	"Ring finger protein 113B"	Q8IZP6	13	98175785-98177269	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	72	"testis: 47.4"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 40.8;Late spermatids: 18.9;Spermatocytes: 106.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"													NA	NA									"unprognostic (3.69e-1)"				"unprognostic (2.22e-1)"		"unprognostic (1.78e-1)"		"unprognostic (4.10e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.75e-1)"	"unprognostic (7.48e-2)"		"unprognostic (1.92e-3)"	0.0	0.2	0.6	0.0	0.6	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.1	0.1	0.0	0.0	0.4	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	47.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.6	0.6	0.0	0.4	0.6	0.3	0.4	0.2	0.4	0.2	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.8	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.9	1.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	106.4	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RNF114	"PSORS12, ZNF313"	ENSG00000124226	"Ring finger protein 114"	Q9Y508	20	49936336-49953885	"Enzymes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 167.4"	"Group enriched"	"Detected in all"	6	"Early spermatids: 1500.7;Late spermatids: 923.4;Spermatocytes: 558.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 561.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021184	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA021184: AB_1859185"	"unprognostic (8.38e-2)"	"unprognostic (3.56e-2)"	"unprognostic (5.62e-2)"	"prognostic unfavorable (8.10e-6)"	"unprognostic (1.56e-1)"	"unprognostic (2.96e-1)"	"prognostic unfavorable (3.11e-4)"	"unprognostic (2.50e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.99e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.54e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (3.01e-4)"	"unprognostic (1.36e-2)"	31.9	32.3	43.9	30.0	47.7	52.0	31.5	46.7	45.5	35.7	41.5	45.4	43.2	29.0	33.1	31.1	35.0	29.0	35.8	40.5	45.5	49.0	49.4	38.2	39.7	47.8	46.6	38.9	39.4	52.7	30.4	28.3	35.3	46.6	34.2	40.4	16.8	41.4	34.4	84.0	24.4	41.1	25.7	48.1	52.9	36.2	167.4	46.1	39.5	38.3	53.3	37.6	29.2	28.9	50.2	83.9	80.5	42.9	43.7	84.3	57.8	118.0	73.0	86.2	153.2	64.4	241.7	67.6	39.9	142.9	40.1	91.6	66.3	62.5	74.7	90.6	73.5	44.3	51.5	50.1	173.2	73.3	95.3	59.5	51.5	68.8	58.4	39.9	52.6	36.8	69.7	98.0	46.7	45.5	281.0	82.6	98.0	42.3	67.4	114.3	85.7	45.5	73.6	83.4	67.9	63.2	45.4	88.8	561.6	118.5	45.4	149.7	86.6	47.8	134.6	62.3	71.6	87.0	93.6	107.1	79.2	76.4	63.2	76.1	112.2	97.8	86.1	48.1	92.5	53.1	63.9	52.6	48.6	75.3	71.2	61.6	50.2	100.5	57.8	112.5	61.9	68.9	92.7	43.9	47.7	46.7	45.5	40.5	45.5	47.8	46.6	38.9	46.6	48.1	46.1	50.2	47.1	48.1	53.7	13.4	69.9	107.2	127.8	103.4	63.2	24.4	50.7	55.8	46.1	41.5	101.4	69.9	12.5	91.3	61.0	61.7	72.4	107.5	1500.7	72.2	36.3	55.3	60.4	45.4	22.8	101.1	77.4	61.9	41.3	71.4	45.0	31.9	46.1	63.7	110.6	40.4	24.4	79.5	42.7	76.6	146.5	923.4	70.5	66.0	71.2	27.2	96.3	38.0	56.7	10.6	26.2	92.1	77.9	59.8	81.9	122.5	96.4	120.9	75.8	22.6	39.5	45.5	59.2	558.0	138.4	45.8	87.1	124.8	69.2	46.5	80.4	113.3
RNF126	FLJ20552	ENSG00000070423	"Ring finger protein 126"	Q9BV68	19	647526-663233	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043050	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA043050: AB_10794768"	"unprognostic (2.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.09e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.68e-2)"	"unprognostic (9.96e-3)"	"unprognostic (7.04e-3)"	"unprognostic (3.39e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.67e-2)"	21.1	23.6	8.0	16.2	9.0	22.0	21.9	6.6	17.2	17.6	0.9	25.6	21.8	20.9	2.7	42.6	19.3	4.6	24.3	9.7	6.9	20.7	40.6	19.4	14.2	9.5	7.8	8.8	16.9	23.2	6.9	20.3	8.8	9.7	20.4	4.9	4.4	21.2	7.0	62.1	45.1	27.4	4.9	5.8	30.8	24.5	49.8	8.0	10.1	14.8	12.9	5.9	21.8	24.2	12.7	79.7	26.5	21.0	30.6	4.8	6.7	38.5	40.6	15.0	22.5	21.2	52.1	26.9	64.2	25.9	16.5	8.9	51.7	12.6	30.0	6.2	43.8	98.8	32.7	24.5	47.0	18.2	64.9	46.0	11.3	22.9	18.5	14.3	9.0	20.6	51.8	68.5	63.4	12.0	62.9	67.7	35.0	62.4	22.5	50.6	48.9	18.1	102.0	17.0	43.6	52.0	42.1	30.1	39.8	42.4	7.2	25.3	51.5	28.6	40.6	30.6	62.1	71.1	112.3	59.5	77.6	52.1	39.2	43.0	3.7	14.7	12.3	25.1	18.4	21.1	23.9	23.1	24.7	19.0	25.5	17.7	16.6	3.7	27.7	22.6	21.5	28.3	14.8	8.0	9.0	6.6	17.2	9.7	6.9	9.5	7.8	8.8	9.7	5.8	8.0	12.7	34.2	12.8	7.4	9.1	66.9	137.9	61.2	44.3	45.5	31.4	35.7	39.6	27.6	27.1	23.2	9.2	16.7	72.8	74.8	60.9	54.8	60.6	146.4	20.2	17.8	31.0	21.7	37.8	11.9	75.6	139.2	29.3	40.2	22.7	14.7	23.1	22.9	22.9	43.2	32.0	9.9	39.3	26.4	26.7	58.9	36.8	21.5	32.9	42.7	3.7	47.5	32.7	112.3	7.1	15.7	136.2	70.0	19.5	76.5	98.2	68.1	40.8	14.8	24.6	59.2	22.0	40.5	153.6	65.3	74.4	144.8	88.1	60.7	43.2	58.1	87.0
RNF20	"BRE1, BRE1A, FLJ11189, FLJ20382, hBRE1, KAIA2779"	ENSG00000155827	"Ring finger protein 20"	Q5VTR2	9	101533853-101563344	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 76.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012478, HPA051773"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB012478: , HPA051773: AB_2681604"	"unprognostic (7.02e-2)"	"unprognostic (2.21e-1)"	"unprognostic (9.04e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.01e-1)"	"unprognostic (5.47e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.60e-1)"	"prognostic favorable (1.64e-6)"	"unprognostic (2.72e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.32e-1)"	"unprognostic (9.54e-3)"	18.0	18.0	22.4	16.4	25.4	15.0	19.2	23.7	23.9	17.1	22.6	17.9	11.2	19.2	19.4	21.8	20.0	14.2	26.7	21.6	26.7	21.5	15.9	16.5	18.7	24.6	24.6	20.3	21.7	21.5	28.3	10.4	14.7	24.7	21.1	17.0	30.7	16.9	18.0	29.9	17.5	12.4	19.0	24.1	17.8	14.6	32.8	23.5	20.0	23.7	25.1	21.2	15.2	15.1	28.1	25.8	64.2	36.4	40.0	43.8	34.4	31.0	44.1	35.3	43.1	37.6	39.2	26.8	56.8	23.2	34.3	36.0	64.0	42.6	37.5	44.1	59.7	19.8	30.5	55.9	39.7	32.2	53.0	35.2	34.0	39.4	38.2	49.2	32.4	25.7	20.7	29.5	32.5	47.4	33.6	41.4	14.0	80.5	57.8	32.3	39.4	125.7	28.3	17.8	24.5	38.7	48.6	62.1	32.9	36.1	36.3	29.7	24.7	36.6	39.8	39.7	28.6	37.3	35.1	118.0	30.4	35.1	19.6	49.2	24.5	15.2	23.7	20.4	20.3	15.5	15.3	16.7	15.4	14.6	12.4	17.3	16.4	15.7	17.1	30.0	9.2	14.7	13.4	22.4	25.4	23.7	23.9	21.6	26.7	24.6	24.6	20.3	24.7	24.1	23.5	28.1	15.9	25.6	31.2	10.7	16.8	6.4	9.7	13.7	17.1	32.4	11.6	11.4	49.5	8.6	23.9	22.0	6.2	16.7	10.2	17.9	5.9	18.3	54.5	20.3	18.5	18.7	24.6	22.3	16.3	13.8	11.5	16.9	10.2	11.5	22.1	19.7	11.7	18.1	16.4	43.7	18.7	12.1	16.2	27.4	4.3	21.4	18.0	20.0	10.6	8.4	31.4	31.4	33.0	11.1	21.9	11.0	13.0	23.7	13.1	9.3	10.1	11.5	28.5	26.5	32.9	21.8	17.5	76.0	16.7	18.3	5.8	7.7	16.1	15.4	15.3	6.4
RNF25	"AO7, FLJ13906"	ENSG00000163481	"Ring finger protein 25"	Q96BH1	2	218663892-218672002	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036420, HPA036421"	Uncertain		Approved	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Actin filaments"	"HPA036420: AB_2675114, HPA036421: AB_10669604"	"unprognostic (3.22e-2)"	"unprognostic (7.85e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (6.58e-4)"	"unprognostic (3.58e-2)"	"unprognostic (2.67e-2)"	"unprognostic (3.46e-1)"	"unprognostic (2.04e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.44e-1)"	"unprognostic (6.69e-2)"	11.0	11.6	17.9	8.9	18.1	7.3	11.1	17.9	21.1	12.3	16.5	10.4	6.2	12.8	16.0	11.8	12.5	10.9	14.0	18.0	18.8	9.3	11.2	10.5	14.6	17.9	18.0	17.5	14.6	11.6	15.3	11.5	11.5	18.1	11.9	8.3	7.1	11.1	14.1	15.1	14.7	8.0	13.8	18.0	10.4	9.5	14.4	18.4	15.3	14.3	17.3	12.0	14.1	9.8	18.5	18.8	20.4	22.1	24.6	27.6	17.5	20.4	27.3	43.5	58.0	53.6	32.4	13.2	11.6	17.6	42.3	35.2	19.5	22.1	33.9	31.0	16.4	27.3	22.7	21.3	34.6	33.6	19.3	20.6	33.9	30.9	55.5	44.7	21.4	31.0	40.9	27.4	24.3	41.1	45.3	20.6	20.4	32.9	16.2	23.4	23.2	15.5	15.9	36.3	21.8	19.5	23.8	18.1	17.2	28.4	21.9	20.6	25.6	26.6	40.2	20.5	19.2	31.1	23.7	13.7	23.5	33.4	19.1	25.7	58.6	21.5	32.6	26.0	21.3	24.8	25.7	25.7	27.2	17.1	30.4	29.0	23.2	17.1	30.5	25.2	15.0	25.9	24.8	17.9	18.1	17.9	21.1	18.0	18.8	17.9	18.0	17.5	18.1	18.0	18.4	18.5	4.2	0.0	0.5	5.2	7.8	6.2	4.8	16.3	6.8	7.7	3.4	3.7	4.0	10.0	8.9	1.8	8.4	12.3	4.5	7.4	15.6	12.3	16.8	6.3	8.1	7.6	1.2	2.1	6.2	12.9	9.7	7.5	9.7	4.8	7.0	5.9	8.9	7.1	13.2	5.0	5.8	5.5	8.2	5.0	4.0	5.3	7.2	5.5	8.8	2.8	8.9	7.9	9.2	3.5	4.9	12.7	9.6	12.8	8.5	3.8	7.2	14.8	8.2	5.0	26.3	5.6	9.2	19.3	12.8	5.9	6.8	10.0	8.0	8.5	6.1	3.6
RNFT1	PTD016	ENSG00000189050	"Ring finger protein, transmembrane 1"	Q5M7Z0	17	59952240-59964761	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 65.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 174.8;Spermatocytes: 256.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013739			Approved	Nucleoli		NA	NA			Nucleoli		"HPA013739: AB_1856382"	"unprognostic (1.61e-1)"	"unprognostic (2.83e-1)"	"prognostic favorable (6.57e-4)"	"unprognostic (3.04e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.08e-2)"	"prognostic favorable (7.48e-4)"	"unprognostic (5.42e-2)"	"unprognostic (3.45e-1)"	"unprognostic (8.26e-3)"	"unprognostic (9.44e-3)"	"unprognostic (1.19e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.05e-1)"	"prognostic favorable (2.57e-4)"	"unprognostic (2.60e-1)"	6.5	7.2	1.4	6.5	1.5	5.7	4.2	1.7	1.6	4.1	2.0	6.1	8.1	2.6	11.4	3.4	2.7	4.1	3.5	1.4	1.5	5.0	17.5	6.7	6.7	1.9	1.6	1.1	2.6	5.6	7.0	1.7	6.2	1.5	4.5	7.1	1.6	4.8	2.2	3.6	3.2	7.1	4.4	1.6	4.0	3.7	65.5	1.7	5.0	5.5	2.2	7.5	7.4	1.8	1.6	7.1	3.2	3.5	4.4	12.6	8.3	6.3	8.6	5.5	8.1	9.3	9.5	2.7	10.9	14.2	8.1	16.0	8.0	11.7	6.9	11.9	9.7	11.2	9.2	7.2	9.3	8.0	13.3	13.1	9.6	3.9	7.0	3.3	3.7	7.7	3.0	23.7	6.3	6.1	8.5	6.0	6.2	1.2	10.9	7.6	7.6	24.1	5.7	5.5	4.9	2.0	3.8	12.0	3.0	17.2	4.9	14.3	25.8	4.8	12.6	11.1	7.2	7.7	9.3	26.4	6.0	8.8	7.7	6.5	32.5	17.3	31.4	7.6	21.8	10.7	14.3	7.2	8.8	15.5	8.8	9.1	8.3	8.6	13.9	28.0	9.9	9.9	11.9	1.4	1.5	1.7	1.6	1.4	1.5	1.9	1.6	1.1	1.5	1.6	1.7	1.6	12.5	0.0	7.4	5.5	23.3	11.3	14.5	15.1	9.6	9.5	13.4	10.2	6.3	4.3	12.4	9.2	20.9	36.1	23.2	17.0	5.9	14.0	174.8	12.5	9.3	7.5	4.2	13.3	24.7	14.4	36.4	16.6	12.8	8.4	19.0	24.5	13.2	29.5	44.5	18.5	19.7	7.6	12.2	24.5	16.6	77.3	9.0	26.6	17.8	23.4	35.1	4.9	16.5	14.6	8.0	13.3	25.0	11.7	14.1	9.3	17.2	10.4	23.0	8.6	19.7	8.2	11.0	256.4	44.2	15.8	9.7	28.9	16.8	12.5	11.4	10.2
ROPN1	"CT91, ODF6, ROPN1A, ropporin"	ENSG00000065371	"Rhophilin associated tail protein 1"	Q9HAT0	3	123968521-123992178	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 160.1"	"Group enriched"	"Detected in some"	9	"Early spermatids: 1370.6;Late spermatids: 629.0;Spermatocytes: 355.0"	"Cancer enriched"	"Detected in some"	4	"melanoma: 3.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"SK-MEL-30: 28.7"	"Low region specificity"	"Detected in single"							HPA052530	Supported					NA	NA					"HPA052530: AB_2681861"	"unprognostic (1.75e-5)"			"unprognostic (2.24e-1)"	"unprognostic (4.77e-2)"	"unprognostic (7.66e-2)"			"unprognostic (1.72e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.13e-1)"			"unprognostic (2.08e-2)"	"unprognostic (8.35e-4)"			0.0	0.0	0.2	0.0	0.1	0.0	20.7	0.1	0.2	0.0	0.0	0.5	0.0	0.0	3.6	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.5	0.3	6.1	0.0	0.1	1.5	0.1	0.0	0.0	0.0	0.0	160.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	28.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.0	0.1	0.2	0.1	0.2	0.2	0.0	0.1	0.3	0.6	0.0	0.0	0.0	0.1	0.8	0.0	0.1	0.0	0.0	49.4	81.7	7.8	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	1370.6	0.2	0.0	1.4	2.4	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	629.0	8.7	1.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	355.0	5.7	0.0	0.0	0.0	0.4	0.0	0.5	0.0
RPL10L		ENSG00000165496	"Ribosomal protein L10 like"	Q96L21	14	46651010-46651781	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	33	"testis: 92.7"	"Group enriched"	"Detected in some"	17	"Early spermatids: 581.2;Late spermatids: 224.4;Spermatocytes: 310.1"	"Cancer enriched"	"Detected in single"	15	"testis cancer: 6.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	43	"U-2 OS: 41.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA011311	Uncertain		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"		"HPA011311: AB_1856431"	"unprognostic (7.36e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.92e-2)"	"unprognostic (4.18e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.92e-1)"	"unprognostic (8.70e-4)"	"unprognostic (4.69e-2)"	"unprognostic (5.27e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.44e-2)"		0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	92.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	41.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	10.4	0.3	0.0	0.0	0.0	0.1	1.3	0.0	0.2	0.0	0.0	0.2	0.0	2.2	0.0	0.0	581.2	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.3	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	1.5	0.0	0.3	19.2	224.4	6.2	0.9	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.2	0.0	6.6	0.1	0.1	0.1	0.0	6.6	2.9	20.8	310.1	14.7	0.0	18.8	0.3	2.4	0.2	2.0	4.3
RPL26L1	RPL26P1	ENSG00000037241	"Ribosomal protein L26 like 1"	Q9UNX3	5	172958729-172969771	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 408.0;Spermatocytes: 316.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA030449	Approved		Approved	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA030449: AB_10602125"	"unprognostic (3.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.39e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (2.04e-3)"	"unprognostic (2.45e-1)"	"unprognostic (7.51e-2)"	"unprognostic (5.86e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.17e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.14e-3)"	25.3	46.2	30.5	29.2	31.7	39.4	27.6	32.0	39.4	23.5	29.3	24.7	25.4	28.7	38.0	37.8	26.8	22.3	38.2	32.8	33.1	42.2	48.3	22.3	34.7	31.8	31.0	30.7	25.9	25.1	34.8	30.5	24.0	33.1	25.7	26.5	18.0	24.8	29.2	38.1	21.3	22.0	26.2	31.5	27.0	26.4	91.9	31.5	34.3	29.8	28.3	29.3	30.7	25.7	32.1	129.8	114.7	101.9	140.8	68.9	72.3	131.7	120.6	70.6	170.5	151.1	141.1	135.3	96.6	301.5	166.6	181.6	82.1	170.1	239.8	156.4	124.1	220.9	71.6	122.8	174.5	135.1	105.7	60.8	91.0	99.2	176.1	122.3	69.1	99.2	93.6	100.3	79.0	123.1	286.6	129.5	165.6	65.2	59.7	180.5	93.3	157.5	128.4	101.0	80.1	102.0	62.7	110.6	100.2	167.6	64.7	122.8	111.5	105.4	193.2	109.0	114.3	92.5	70.3	119.0	182.3	152.6	130.2	117.6	25.4	86.6	39.9	33.1	80.5	42.7	50.4	40.4	46.1	99.5	38.1	32.9	42.0	42.9	39.5	72.2	68.1	55.8	55.7	30.5	31.7	32.0	39.4	32.8	33.1	31.8	31.0	30.7	33.1	31.5	31.5	32.1	41.5	41.7	32.8	4.6	29.8	48.8	56.9	191.3	32.5	18.8	50.2	61.8	45.5	41.5	82.7	58.8	18.8	111.6	28.7	36.2	181.9	119.0	408.0	98.4	70.0	47.7	40.2	49.2	4.5	113.0	124.5	45.3	29.6	70.6	26.6	60.2	41.4	132.1	115.0	15.2	5.2	48.6	93.6	48.6	51.9	79.9	37.9	45.6	51.6	2.8	93.5	61.7	49.4	2.0	5.0	138.0	38.6	41.0	59.2	67.9	48.2	216.2	92.4	20.2	19.7	35.6	56.1	316.7	178.6	70.5	52.8	78.9	28.9	81.1	59.1	57.7
RPL39L	RPL39L1	ENSG00000163923	"Ribosomal protein L39 like"	Q96EH5	3	187120948-187180908	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	10	"testis: 212.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 545.6;Late spermatids: 245.5;Spermatocytes: 785.0;Spermatogonia: 161.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA047105	Approved					NA	NA					"HPA047105: AB_2679933"	"unprognostic (1.01e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (6.05e-4)"	"prognostic unfavorable (1.30e-6)"	"unprognostic (6.94e-2)"	"unprognostic (9.75e-3)"	"unprognostic (1.66e-3)"	"unprognostic (8.02e-2)"	"prognostic favorable (1.94e-4)"	"unprognostic (1.19e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.27e-3)"	"unprognostic (9.51e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.21e-3)"	"unprognostic (2.60e-1)"	7.7	3.0	9.9	8.0	9.8	19.5	12.9	12.6	12.1	11.2	8.4	9.9	3.4	8.8	4.6	9.0	12.1	3.7	9.8	9.6	9.9	5.6	4.6	5.5	13.3	9.3	8.1	8.4	4.8	20.4	6.0	4.8	6.0	9.8	9.9	4.6	6.8	8.4	7.2	2.2	11.7	6.3	8.2	6.5	7.1	6.9	212.2	8.9	16.6	4.0	2.3	14.2	8.6	10.8	12.8	213.2	67.3	22.4	35.9	10.2	15.3	20.9	56.6	44.0	51.0	54.8	5.6	33.3	78.7	203.7	32.7	98.2	64.7	56.4	10.8	77.5	136.5	9.1	1.5	69.7	1.3	19.3	18.7	20.3	12.7	8.2	42.2	35.9	38.9	52.6	95.4	42.8	90.3	19.4	62.7	2.1	66.0	162.8	65.0	122.7	69.5	31.0	58.9	17.0	4.8	54.6	56.8	47.3	120.2	138.0	94.1	118.8	55.4	24.8	1.4	59.6	48.5	59.2	118.6	138.1	153.4	30.8	69.9	117.0	6.1	10.7	2.6	25.1	10.4	12.3	33.1	25.1	22.5	10.8	22.7	17.2	26.1	2.2	16.5	7.3	12.2	47.5	30.9	9.9	9.8	12.6	12.1	9.6	9.9	9.3	8.1	8.4	9.8	6.5	8.9	12.8	3.0	3.2	7.1	2.3	21.0	25.0	37.0	32.5	19.4	3.4	30.4	35.9	48.4	14.3	10.7	3.7	0.0	26.0	9.1	3.3	7.9	13.0	545.6	16.4	14.7	8.1	0.0	8.8	1.8	2.6	95.7	16.8	5.1	9.2	7.0	21.1	23.6	50.4	40.3	6.7	1.6	4.5	16.2	19.1	25.5	245.5	21.8	9.9	23.2	1.0	4.3	16.6	34.0	3.0	1.3	10.5	2.2	11.7	27.2	31.6	0.7	2.3	10.2	2.2	6.6	8.5	26.4	785.0	161.7	12.7	21.2	14.9	16.0	14.5	8.4	30.4
RPUSD3	MGC29784	ENSG00000156990	"RNA pseudouridine synthase D3"	Q6P087	3	9837849-9844602	"Predicted intracellular proteins"	"mRNA processing"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 100.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 249.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037551, HPA037552"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA037551: AB_2675538, HPA037552: AB_10672600"	"unprognostic (1.57e-1)"	"unprognostic (8.88e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (1.73e-5)"	"unprognostic (1.31e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.17e-3)"	"unprognostic (2.02e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.94e-2)"	"unprognostic (8.83e-2)"	18.4	29.1	25.5	13.3	25.9	21.5	19.9	24.8	31.5	19.4	22.3	24.1	17.7	21.7	14.9	32.6	20.2	8.8	33.7	27.0	24.9	24.7	31.0	16.2	17.5	24.1	24.8	26.5	18.0	24.7	26.3	20.4	16.8	25.5	20.1	16.7	15.6	20.0	17.6	73.3	27.3	20.3	16.8	21.9	21.1	23.0	54.7	25.7	15.4	16.1	48.6	21.5	24.4	21.1	26.5	30.5	44.8	33.6	21.7	55.1	40.5	249.3	25.9	36.7	41.9	44.3	39.4	30.6	52.4	31.6	29.0	61.7	25.6	75.2	46.3	33.2	40.7	78.9	69.8	39.6	42.5	43.1	43.5	42.3	50.0	63.3	48.9	56.5	34.2	55.9	69.3	52.7	35.4	41.9	72.0	59.6	78.9	36.4	44.4	66.3	41.5	27.5	88.5	46.2	23.0	25.9	21.5	32.6	41.0	69.9	47.9	70.3	46.3	33.6	16.7	30.0	29.8	38.4	52.3	67.4	70.0	35.1	81.3	39.5	35.4	51.0	26.5	44.1	38.2	45.7	50.3	41.4	42.3	46.8	41.9	46.3	41.7	12.3	84.9	26.7	45.0	64.9	41.5	25.5	25.9	24.8	31.5	27.0	24.9	24.1	24.8	26.5	25.5	21.9	25.7	26.5	11.8	19.2	9.6	10.1	19.5	8.0	21.4	27.8	13.1	22.8	17.1	21.5	25.4	21.5	20.8	14.7	20.9	44.3	19.8	16.4	46.9	31.1	80.3	6.9	13.7	15.8	13.2	24.6	9.9	31.6	48.6	16.3	15.8	9.7	21.0	20.1	22.1	28.3	39.1	11.8	10.6	17.0	12.2	14.7	7.3	59.5	21.5	15.2	16.0	3.7	27.2	20.6	54.6	8.0	6.3	25.8	20.6	21.4	18.8	19.5	28.1	55.4	12.9	22.2	6.6	13.3	17.2	100.7	20.6	22.3	12.8	17.2	20.5	33.9	28.6	16.2
RSPH6A	"RSHL1, RSP4, RSP6, RSPH4B"	ENSG00000104941	"Radial spoke head 6 homolog A"	Q9H0K4	19	45795713-45815308	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 29.9"	"Group enriched"	"Detected in some"	4	"Early spermatids: 80.7;Spermatocytes: 49.0"	"Cancer enriched"	"Detected in single"	5	"thyroid cancer: 1.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"RPMI-8226: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA045382	Enhanced					NA	NA					"HPA045382: AB_10959735"	"unprognostic (1.99e-1)"	"unprognostic (3.23e-1)"		"unprognostic (6.55e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.72e-3)"		"unprognostic (4.16e-4)"	"unprognostic (2.33e-1)"	"unprognostic (5.89e-2)"		"unprognostic (1.72e-2)"	"unprognostic (7.84e-5)"	"unprognostic (1.38e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.99e-3)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.9	0.1	0.0	2.8	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	80.7	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	13.5	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	49.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0
RTF1	KIAA0252	ENSG00000137815	"RTF1 homolog, Paf1/RNA polymerase II complex component"	Q92541	15	41408408-41483563	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006714, CAB079946, CAB079947"	Supported		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			Nucleoplasm	Cytosol	"CAB079946: , CAB079947: , HPA006714: AB_1079855"	"unprognostic (1.10e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.87e-2)"	"unprognostic (5.36e-2)"	"unprognostic (4.21e-1)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.69e-2)"	"unprognostic (8.22e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.50e-2)"	17.9	23.4	25.4	19.0	26.9	45.6	22.7	27.6	43.0	24.5	19.9	20.7	19.4	25.3	19.7	21.6	17.2	20.5	24.8	26.9	23.7	19.2	20.1	19.6	28.4	21.6	22.2	25.3	29.7	16.8	37.2	11.5	24.7	23.0	23.6	22.6	26.6	16.8	23.1	49.9	26.1	20.0	26.5	19.9	24.0	21.0	30.1	23.1	29.1	29.7	35.1	25.2	23.3	17.7	25.2	32.0	20.6	66.5	54.2	37.0	43.4	31.2	41.8	46.8	56.0	46.5	40.4	19.8	30.2	33.0	43.9	24.9	55.3	38.9	34.8	47.6	46.2	36.1	63.5	45.2	30.4	25.8	57.2	35.5	31.4	34.3	30.0	30.1	41.6	45.8	54.0	49.2	34.0	46.5	24.2	55.1	35.1	35.9	39.6	28.0	59.0	51.8	28.9	36.5	67.5	34.0	44.9	37.6	47.4	19.0	35.9	38.9	54.5	37.9	54.6	34.4	54.8	46.5	38.9	65.0	49.6	39.4	53.5	34.1	5.4	3.1	6.9	3.4	2.1	3.1	6.9	3.3	2.9	2.2	5.3	4.0	3.2	8.5	6.2	2.7	5.5	4.3	1.1	25.4	26.9	27.6	43.0	26.9	23.7	21.6	22.2	25.3	23.0	19.9	23.1	25.2	118.0	128.2	80.1	23.8	109.0	145.0	98.7	120.4	102.4	213.5	152.6	129.7	94.3	111.5	89.7	123.2	93.8	168.3	117.1	129.6	164.4	103.0	333.7	103.9	162.6	116.4	87.8	85.0	40.3	110.5	119.1	103.5	71.9	126.2	91.2	127.9	129.5	193.2	95.5	148.0	43.6	145.4	109.9	86.7	94.4	348.5	145.1	83.0	108.5	15.9	116.1	106.2	128.8	16.6	23.5	127.0	105.1	159.9	104.1	141.9	112.6	186.4	70.7	188.2	85.5	115.4	146.9	198.3	59.9	83.4	163.0	219.3	113.0	126.1	133.2	99.2
RTP1	"MGC35450, Z3CXXC1"	ENSG00000175077	"Receptor transporter protein 1"	P59025	3	187197486-187201462	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 2.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 3.3;Late spermatids: 1.9;Spermatocytes: 4.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	32	"SuSa: 4.0;T-47d: 2.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"									NA	NA									"unprognostic (2.90e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.29e-1)"		"unprognostic (1.91e-1)"				"unprognostic (2.63e-1)"			"unprognostic (2.89e-1)"			0.0	0.0	1.2	0.0	1.3	0.0	0.0	0.3	1.1	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	2.3	0.0	0.0	0.0	0.0	0.5	1.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	2.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.3	0.3	1.1	0.9	2.3	0.5	1.0	0.8	0.4	0.4	2.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RWDD2A	"dJ747H23.2, MGC13523, RWDD2"	ENSG00000013392	"RWD domain containing 2A"	Q9UIY3	6	83193357-83198935	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 52.3;Spermatocytes: 65.2"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 11.6"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030105, HPA030106, HPA030107"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA030105: AB_10599826, HPA030106: AB_10600896, HPA030107: AB_10601009"	"unprognostic (2.51e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.19e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.60e-1)"	"prognostic favorable (3.82e-5)"	"prognostic favorable (1.38e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.59e-2)"	2.8	6.9	7.0	2.1	7.2	0.5	3.2	6.4	8.1	3.1	6.1	2.7	2.5	3.3	9.4	1.7	3.8	4.6	4.5	6.8	7.5	4.5	6.0	2.9	2.5	5.9	5.9	7.0	4.0	9.7	4.0	5.7	2.5	6.1	11.6	2.5	4.7	6.1	4.7	2.3	2.0	2.8	3.3	5.7	2.9	3.9	9.0	7.7	1.8	6.2	4.0	2.7	2.6	1.8	6.7	2.1	1.9	4.4	8.3	5.2	3.7	3.0	4.8	10.1	3.5	4.2	2.8	1.1	1.6	3.8	5.8	8.0	2.1	3.7	2.8	5.4	2.0	3.8	1.9	3.0	6.2	8.0	0.5	1.5	4.9	4.6	4.4	9.2	11.5	6.6	4.5	3.1	2.8	4.3	3.1	0.7	1.5	1.5	1.9	1.9	2.4	9.1	1.0	7.4	2.4	1.5	5.3	2.9	4.5	4.4	6.3	2.8	2.9	7.1	2.4	1.5	3.5	2.1	6.2	2.7	0.9	2.8	0.8	2.9	0.3	0.9	0.0	1.2	0.8	1.8	1.9	1.7	1.7	1.0	1.0	2.2	2.1	0.3	0.4	2.2	3.5	2.2	1.0	7.0	7.2	6.4	8.1	6.8	7.5	5.9	5.9	7.0	6.1	5.7	7.7	6.7	2.4	0.0	6.7	9.8	4.2	3.7	3.6	5.3	3.4	5.6	3.7	3.2	5.4	2.8	3.3	1.8	0.0	7.7	3.9	2.4	5.9	8.9	52.3	4.8	4.5	3.5	5.4	0.4	10.8	9.1	3.3	6.5	3.6	4.0	0.0	7.0	5.0	6.8	5.0	1.7	11.2	6.1	8.2	1.6	2.5	14.8	9.0	2.2	8.8	3.7	3.8	11.0	0.0	13.6	4.5	5.8	2.5	6.0	11.2	8.7	4.1	13.3	4.9	5.0	6.6	7.0	5.2	65.2	10.5	1.2	2.4	5.7	2.9	6.3	3.4	2.8
SAYSD1	"C6orf64, FLJ11101"	ENSG00000112167	"SAYSVFN motif domain containing 1"	Q9NPB0	6	39104063-39115186	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 55.9"	"Group enriched"	"Detected in many"	4	"Early spermatids: 136.1;Late spermatids: 63.2;Spermatocytes: 223.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007959		Approved	Supported	Vesicles		NA	NA			Vesicles		"HPA007959: AB_1078359"	"unprognostic (2.65e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.56e-1)"	"unprognostic (9.90e-3)"	"unprognostic (1.96e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.82e-3)"	"unprognostic (5.08e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.79e-1)"	"unprognostic (9.78e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.00e-3)"	8.4	8.0	8.7	6.6	9.1	7.6	10.6	8.9	10.4	8.4	8.5	8.5	10.0	8.5	11.2	7.5	8.7	7.0	7.9	8.7	9.1	9.5	10.2	7.1	10.4	8.5	8.8	8.2	8.8	11.2	7.7	6.4	6.8	8.7	9.3	7.8	6.9	12.7	8.2	7.1	7.5	9.5	6.9	8.3	7.6	7.8	55.9	8.7	17.2	8.8	7.1	9.5	7.3	6.9	10.1	14.8	9.4	8.3	9.9	13.4	17.7	8.6	6.7	7.3	7.9	8.3	13.6	10.2	13.4	9.4	8.8	11.2	9.9	7.3	6.3	8.3	8.5	13.2	8.8	5.5	11.9	10.9	10.1	12.7	12.3	15.4	3.1	7.8	5.6	7.4	19.9	15.1	7.9	9.0	20.4	16.1	16.6	7.2	9.7	4.8	2.3	10.1	5.4	16.7	10.3	23.3	9.4	11.6	10.0	10.9	6.6	16.4	13.1	9.7	10.4	7.5	3.2	8.8	0.2	4.3	16.2	6.0	14.4	7.8	10.6	10.8	24.9	14.0	15.1	16.0	16.4	15.2	12.8	11.4	18.5	21.0	17.9	5.2	15.8	15.8	9.0	22.2	12.1	8.7	9.1	8.9	10.4	8.7	9.1	8.5	8.8	8.2	8.7	8.3	8.7	10.1	19.3	3.2	6.0	4.6	11.4	15.4	13.2	29.1	8.6	6.4	26.4	21.8	18.8	21.5	17.0	18.4	8.4	33.1	8.3	10.5	17.6	22.9	136.1	22.8	14.0	11.2	8.4	13.5	3.2	21.8	32.7	16.8	4.6	19.0	8.2	13.8	6.4	23.3	26.8	6.7	4.2	16.5	2.0	13.9	15.7	63.2	20.5	13.2	12.4	0.0	11.9	15.5	12.3	9.0	6.3	15.9	9.7	19.2	5.3	22.6	21.8	28.3	19.2	4.1	6.6	13.1	17.3	223.6	14.5	11.6	16.6	12.3	12.8	10.2	20.1	14.9
SCCPDH	"CGI-49, NET11"	ENSG00000143653	"Saccharopine dehydrogenase (putative)"	Q8NBX0	1	246724409-246768137	"Metabolic proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 1380.7;Spermatocytes: 822.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	20	"basophil: 872.9"	"Lineage enriched"	"Detected in all"	26	"granulocytes: 872.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050775, HPA076030"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA050775: AB_2681231, HPA076030: "	"unprognostic (4.25e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.83e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.60e-1)"	"unprognostic (2.70e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.93e-2)"	26.9	54.2	38.8	14.5	46.8	36.0	23.8	53.3	43.6	22.8	41.1	27.0	34.7	26.4	17.8	9.4	31.9	21.8	33.1	38.0	46.3	50.3	159.5	21.2	13.6	64.8	48.4	36.5	22.6	19.0	36.8	24.4	24.0	62.7	39.7	27.0	32.0	15.5	26.2	61.2	24.3	34.9	24.2	66.5	11.6	28.3	160.9	49.8	20.3	33.8	55.2	10.7	82.3	12.1	94.6	55.3	53.2	37.7	22.8	44.5	55.7	0.5	42.3	58.8	70.1	58.3	32.7	150.6	29.3	53.8	49.0	38.9	17.7	32.4	12.6	71.6	40.8	11.9	49.6	46.9	65.9	41.6	97.1	40.7	37.6	5.9	47.4	4.8	65.7	76.4	60.0	62.9	0.1	70.9	13.5	101.6	122.6	56.5	29.6	41.7	83.8	48.5	0.3	216.6	128.2	42.7	48.0	57.3	2.5	39.0	20.2	42.1	99.6	49.8	32.1	28.5	78.7	110.5	138.0	51.1	17.4	54.7	130.2	43.3	872.9	24.3	44.1	18.1	22.2	22.4	11.2	5.4	15.7	10.7	9.4	7.1	22.0	6.4	34.1	15.4	18.2	4.0	17.1	38.8	46.8	53.3	43.6	38.0	46.3	64.8	48.4	36.5	62.7	66.5	49.8	94.6	25.0	6.4	11.5	25.8	8.0	30.1	40.6	54.6	1.8	31.2	42.4	17.5	38.0	55.8	40.5	152.6	18.8	41.4	14.6	42.4	31.3	67.2	1380.7	72.7	39.4	23.6	44.9	54.7	23.7	69.0	17.4	35.7	32.6	111.9	57.2	49.2	22.5	187.8	89.4	6.7	20.5	27.4	52.9	45.7	13.7	245.6	47.5	29.7	48.0	10.3	20.3	67.4	18.6	27.2	37.3	75.2	27.8	47.4	8.3	49.2	138.4	69.7	79.4	39.2	19.7	36.7	39.4	822.3	76.2	5.6	68.5	84.6	17.0	42.8	55.0	201.9
SEC22A	SEC22L2	ENSG00000121542	"SEC22 homolog A, vesicle trafficking protein"	Q96IW7	3	123201927-123274136	"Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 67.5;Inhibitory neurons: 67.5;Oligodendrocytes: 75.0;Spermatocytes: 75.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.94e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.96e-1)"	"unprognostic (8.25e-3)"	"unprognostic (2.16e-1)"	"unprognostic (9.04e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.91e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.66e-3)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (1.46e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.25e-1)"	10.1	11.4	6.2	8.2	7.1	4.6	11.0	8.9	7.1	9.9	6.7	9.0	6.8	9.7	8.8	12.4	9.7	9.0	7.9	7.4	8.1	10.3	13.0	9.2	10.4	6.6	6.9	7.1	10.7	10.2	9.6	11.4	10.2	7.4	9.0	9.6	10.0	9.6	7.4	6.1	13.8	8.6	11.7	6.5	9.9	8.5	21.7	6.9	10.3	10.0	5.6	13.2	9.0	10.0	8.2	40.4	12.5	20.2	15.6	27.1	25.4	20.2	35.3	22.2	20.4	28.8	10.3	22.0	20.9	25.8	19.9	23.8	30.5	16.0	20.8	34.0	9.1	13.6	14.1	11.7	9.0	24.7	18.3	11.6	18.2	27.2	19.4	18.7	20.5	27.6	18.3	9.4	17.4	20.6	17.6	17.0	13.5	7.1	29.2	25.0	12.9	21.5	21.2	18.6	11.0	14.6	11.3	20.8	14.5	21.0	14.6	30.2	22.5	12.6	17.8	19.5	29.4	21.5	11.4	11.4	34.6	26.5	20.5	27.3	19.3	19.9	16.7	24.1	19.3	29.8	18.7	24.7	26.4	19.9	15.7	26.3	22.0	2.9	28.9	19.5	19.2	27.6	16.9	6.2	7.1	8.9	7.1	7.4	8.1	6.6	6.9	7.1	7.4	6.5	6.9	8.2	10.5	3.2	12.1	39.8	13.9	8.4	17.9	29.7	10.8	7.5	7.9	7.4	5.6	17.2	20.4	7.3	4.2	27.5	7.3	6.1	9.8	17.8	30.5	4.7	9.0	9.8	7.8	8.6	67.5	10.4	19.5	12.5	12.2	6.4	7.0	11.6	12.1	9.0	13.6	1.7	67.5	9.4	10.2	5.0	8.0	16.5	12.2	7.8	5.4	56.2	11.7	6.7	9.2	59.3	75.0	11.3	4.6	6.8	18.4	9.9	5.7	9.5	11.1	7.6	19.7	8.8	12.3	75.6	17.0	12.1	9.5	44.1	12.9	11.2	6.8	10.9
SEC22C	"MGC13261, MGC5373, SEC22L3"	ENSG00000093183	"SEC22 homolog C, vesicle trafficking protein"	Q9BRL7	3	42547969-42601080	"Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031242			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA031242: "	"unprognostic (1.68e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.67e-1)"	"unprognostic (9.37e-3)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (3.04e-5)"	"unprognostic (1.15e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.57e-1)"	"prognostic favorable (1.35e-7)"	"unprognostic (2.59e-1)"	"unprognostic (3.30e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.41e-3)"	32.5	23.6	40.5	14.2	44.0	36.8	33.5	42.7	44.2	28.3	36.9	26.3	32.2	30.1	27.6	17.4	27.5	19.1	24.2	37.5	42.1	26.2	16.5	33.4	19.2	44.3	44.1	37.6	29.6	29.9	26.6	26.8	19.5	44.5	37.7	15.7	25.8	23.5	26.2	22.4	18.9	32.9	26.5	43.2	20.6	28.5	27.7	42.8	18.4	24.4	26.4	16.5	25.9	23.3	51.8	24.0	22.2	35.9	30.5	72.4	68.1	7.6	43.8	46.7	46.1	47.9	15.5	37.9	24.5	17.6	50.1	28.2	12.6	24.1	39.8	40.7	32.8	28.5	41.7	40.0	21.0	55.4	19.2	39.5	38.3	53.1	51.4	62.5	46.5	51.1	38.7	37.0	46.5	45.8	16.6	27.1	22.3	19.8	16.0	31.9	11.7	21.4	22.9	40.6	21.1	18.5	27.8	30.9	28.0	34.5	26.5	48.4	20.9	42.9	35.1	27.8	63.8	43.1	36.8	55.6	23.5	41.7	26.6	34.0	11.7	11.5	22.0	13.2	9.0	19.6	11.5	17.6	16.3	10.8	9.4	14.9	13.2	7.1	10.2	9.3	11.3	16.3	10.1	40.5	44.0	42.7	44.2	37.5	42.1	44.3	44.1	37.6	44.5	43.2	42.8	51.8	31.4	25.6	27.6	27.1	23.2	15.0	18.3	25.3	25.0	16.6	31.6	29.6	18.8	24.3	17.2	11.0	29.2	20.5	28.1	1.9	41.1	29.7	61.2	17.5	19.5	30.5	9.0	48.2	18.9	32.9	20.3	31.8	21.9	12.7	49.4	25.1	32.2	14.5	31.3	26.9	18.4	4.9	32.6	19.0	14.4	15.0	32.6	17.6	40.9	21.5	35.5	39.2	24.7	12.5	44.1	28.8	1.0	42.9	23.0	24.0	36.9	29.6	19.4	39.9	39.5	26.6	31.1	96.9	49.8	11.3	10.2	10.5	34.6	20.3	6.6	9.4
SERPINE3		ENSG00000253309	"Serpin family E member 3"	A8MV23	13	51335773-51364735	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.6;pancreas: 1.3;retina: 1.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 1.6;Early spermatids: 2.6;Excitatory neurons: 2.3;Inhibitory neurons: 1.9;Oligodendrocyte precursor cells: 2.5;Oligodendrocytes: 2.5;Spermatocytes: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HeLa: 1.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"spinal cord: 1.3"	"HPA051904, HPA055804"	Uncertain				"Secreted in other tissues"	NA	NA					"HPA051904: AB_2681659, HPA055804: AB_2682928"	"unprognostic (1.60e-1)"	"unprognostic (6.17e-2)"	"unprognostic (9.66e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.52e-2)"	"unprognostic (8.54e-3)"	"unprognostic (2.67e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.94e-6)"	"unprognostic (1.29e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.31e-2)"	0.3	0.1	0.1	0.2	0.3	0.0	0.1	1.6	0.9	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.2	0.3	0.5	0.1	0.1	0.2	0.0	0.3	1.5	0.5	0.2	0.1	1.3	0.0	0.1	0.0	1.1	0.1	0.0	1.8	0.1	0.0	0.0	0.9	0.7	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.2	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	1.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.6	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.5	0.0	0.0	0.0	0.3	0.6	0.8	0.2	0.5	0.0	0.3	0.1	0.2	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.6	0.9	0.5	0.1	1.5	0.5	0.2	1.1	0.0	0.3	0.6	0.2	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	2.6	0.2	0.2	0.1	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.5	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.1	2.9	0.0	0.9	0.0	0.0	0.5	0.7	0.0	0.0
SETD3	"C14orf154, FLJ23027"	ENSG00000183576	"SET domain containing 3, actin histidine methyltransferase"	Q86TU7	14	99397748-99480889	"Enzymes, Predicted intracellular proteins"		"Actin-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 206.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003591, HPA003639"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA003591: AB_1079930, HPA003639: AB_1079931"	"unprognostic (6.82e-2)"	"unprognostic (2.66e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (6.46e-4)"	"unprognostic (1.04e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.29e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.42e-1)"	"prognostic favorable (1.89e-15)"	"unprognostic (6.81e-2)"	"unprognostic (3.21e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.62e-3)"	39.1	26.9	55.2	25.5	54.7	23.8	30.4	52.4	57.1	29.4	48.6	42.2	36.7	26.5	84.2	36.9	47.0	29.6	79.8	53.3	50.5	97.0	47.6	37.7	24.3	52.0	50.6	45.9	22.2	38.0	40.4	21.8	43.0	51.3	36.2	38.3	65.0	58.3	42.0	175.6	31.8	37.7	39.8	51.3	28.6	29.3	85.8	53.1	24.7	53.8	119.2	25.0	36.6	24.6	55.8	39.9	44.6	33.1	31.7	37.6	42.0	117.1	49.4	37.4	50.3	51.1	43.5	65.7	38.8	39.5	55.6	39.5	50.4	40.8	55.2	79.6	38.5	22.0	35.3	27.8	40.2	46.9	53.6	51.2	29.6	71.3	44.7	64.8	37.9	63.4	57.2	28.3	56.9	56.3	74.7	56.6	57.9	19.9	98.5	50.7	34.1	67.8	32.0	72.6	48.4	58.9	27.4	44.3	45.4	38.4	59.7	61.6	46.2	56.6	22.6	31.5	153.8	38.2	40.6	49.3	42.1	42.6	52.5	35.3	7.6	18.1	24.9	17.7	21.5	20.6	11.4	15.0	16.6	22.4	8.9	12.3	15.4	10.8	20.6	19.2	14.1	12.2	14.8	55.2	54.7	52.4	57.1	53.3	50.5	52.0	50.6	45.9	51.3	51.3	53.1	55.8	31.1	25.6	44.5	43.1	16.9	24.3	18.6	14.4	21.6	26.0	22.8	17.1	83.0	18.6	24.8	25.8	27.1	61.9	37.3	37.2	33.2	24.7	206.6	29.9	24.9	29.1	21.7	11.3	47.7	28.0	45.4	22.2	17.3	30.7	32.9	7.5	22.9	27.5	35.8	18.5	43.6	28.2	14.2	29.7	23.2	121.0	19.0	35.9	10.6	52.5	27.9	47.6	60.8	38.2	36.8	25.7	20.3	21.1	23.6	26.1	30.1	101.5	28.1	39.5	6.6	25.3	23.0	130.4	73.0	25.0	32.4	30.0	27.9	9.2	30.5	20.8
SETD4	"C21orf18, C21orf27"	ENSG00000185917	"SET domain containing 4"	Q9NVD3	21	36034541-36079389	"Predicted intracellular proteins"	"Inflammatory response"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 54.3;Spermatocytes: 63.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA024073, HPA035405"	Approved		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA024073: AB_1856755, HPA035405: AB_2674612"	"unprognostic (4.23e-1)"	"unprognostic (5.67e-2)"	"unprognostic (6.98e-2)"	"unprognostic (5.73e-2)"	"unprognostic (1.98e-1)"	"unprognostic (8.05e-3)"	"unprognostic (7.86e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.17e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.60e-3)"	"unprognostic (1.15e-3)"	"unprognostic (1.99e-1)"	"unprognostic (8.09e-3)"	"unprognostic (3.30e-2)"	"unprognostic (1.28e-2)"	8.3	9.4	9.4	6.9	9.4	8.5	9.2	9.1	10.1	10.2	13.7	9.3	11.5	9.7	11.2	11.0	10.8	7.9	10.2	9.1	8.5	9.7	7.3	8.5	8.8	9.0	8.5	8.9	9.8	7.8	10.0	9.0	9.1	9.5	10.3	9.5	9.7	10.1	7.9	9.9	13.7	9.4	11.0	8.0	8.5	10.0	23.3	9.2	11.2	10.2	8.9	11.0	10.0	10.7	11.8	13.3	9.2	13.6	17.3	6.5	7.9	21.9	17.1	15.0	17.3	11.5	19.2	11.5	7.1	11.9	7.8	13.3	9.7	10.3	10.2	15.0	12.7	12.4	19.2	16.2	12.6	15.9	18.3	10.7	8.3	17.2	11.7	15.0	9.8	13.1	9.6	25.5	12.7	10.7	14.3	12.3	26.3	28.2	11.3	11.6	18.2	10.0	17.3	18.9	9.3	11.2	17.9	17.4	18.5	17.6	11.7	16.3	15.2	11.0	15.0	5.6	9.4	15.9	20.3	31.7	11.2	15.6	24.9	13.2	5.9	12.5	11.3	8.1	10.0	9.0	16.2	10.3	8.8	14.6	13.2	7.3	8.6	9.5	11.0	10.2	15.6	13.0	7.7	9.4	9.4	9.1	10.1	9.1	8.5	9.0	8.5	8.9	9.5	8.0	9.2	11.8	9.7	9.6	7.0	11.1	10.8	12.1	11.3	18.6	15.4	13.3	9.0	8.9	9.2	7.2	13.7	9.2	31.3	16.3	13.4	7.9	5.9	12.7	54.3	16.8	10.9	9.3	3.6	7.2	17.4	8.2	9.6	10.4	8.6	8.7	11.4	17.0	7.5	5.5	10.6	3.3	19.2	13.4	26.4	6.9	5.1	10.4	9.6	5.0	10.6	4.7	8.0	7.6	14.4	19.6	19.8	10.0	9.4	10.1	6.2	11.2	20.7	10.3	23.8	21.0	6.6	8.9	9.0	63.1	20.8	13.2	9.1	9.4	8.1	14.8	11.3	11.3
SF3B2	"Cus1, SAP145, SF3b1, SF3b145"	ENSG00000087365	"Splicing factor 3b subunit 2"	Q13435	11	66050729-66069308	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045028	Supported		Enhanced	"Nuclear speckles"		NA	NA		130000	"Nuclear speckles"		"HPA045028: AB_10965174"	"unprognostic (1.48e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.45e-2)"	"unprognostic (3.29e-1)"	"unprognostic (9.86e-2)"	"unprognostic (7.10e-2)"	"prognostic unfavorable (6.43e-5)"	"unprognostic (8.43e-2)"	"unprognostic (4.69e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (3.51e-5)"	"unprognostic (4.03e-2)"	"unprognostic (3.56e-1)"	"unprognostic (5.14e-2)"	"unprognostic (2.60e-2)"	111.7	96.8	120.4	81.2	129.3	145.9	109.9	123.2	140.6	122.6	126.1	96.4	71.4	112.5	96.3	97.4	113.3	55.7	94.5	123.9	123.6	107.5	112.9	105.2	99.8	126.0	123.5	117.1	137.3	138.6	89.6	138.2	81.2	124.4	100.1	77.7	97.4	92.0	74.5	109.0	116.4	99.3	80.7	122.8	114.8	103.8	146.4	127.1	110.5	116.2	55.1	114.9	109.2	105.6	140.4	226.9	177.3	189.0	178.9	184.3	163.5	153.1	168.4	210.5	234.9	176.8	149.8	188.9	212.5	185.7	186.7	249.5	202.9	263.2	177.8	208.8	170.2	143.5	223.3	164.2	245.5	187.8	229.7	171.5	137.9	174.0	242.5	287.8	171.3	172.7	180.5	215.2	348.7	191.4	309.8	257.5	343.2	196.1	166.2	163.9	235.6	162.9	299.0	192.3	186.0	147.8	218.0	165.9	175.9	257.0	136.3	217.2	147.1	156.7	206.9	178.0	229.0	194.3	267.5	337.0	270.8	229.6	151.6	191.9	152.1	96.2	167.9	135.3	117.2	131.1	106.8	120.3	128.2	98.5	110.2	116.7	116.8	130.2	116.3	160.1	78.8	131.8	147.5	120.4	129.3	123.2	140.6	123.9	123.6	126.0	123.5	117.1	124.4	122.8	127.1	140.4	86.5	128.2	131.0	18.6	144.3	111.3	148.9	165.9	129.1	94.9	69.1	65.0	68.5	98.7	141.5	66.2	89.6	195.9	131.8	114.3	92.0	172.2	278.2	119.5	103.2	104.4	82.5	113.6	19.2	214.8	183.7	117.6	95.8	92.0	120.8	119.0	80.7	72.4	124.9	107.7	19.3	112.4	130.2	103.6	115.0	78.5	120.2	103.8	65.8	10.3	195.6	122.1	155.5	12.1	28.9	158.9	96.3	130.1	198.3	136.6	101.1	108.1	214.7	109.4	78.9	106.1	153.7	220.1	172.0	103.2	99.0	186.6	145.5	118.7	122.3	130.8
SFMBT1	"DKFZp434L243, RU1, SFMBT"	ENSG00000163935	"Scm like with four mbt domains 1"	Q9UHJ3	3	52903572-53046750	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 46.0"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 136.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036152, HPA064564"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA036152: AB_2674972, HPA064564: AB_2685288"	"unprognostic (2.78e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (1.69e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.39e-2)"	"unprognostic (6.79e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.57e-2)"	"unprognostic (3.57e-3)"	"unprognostic (7.15e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.19e-2)"	"unprognostic (3.55e-2)"	3.2	2.5	2.6	5.6	3.2	6.9	5.8	5.4	3.3	3.6	3.7	7.4	4.8	2.4	5.1	6.6	5.4	3.6	7.3	2.9	3.8	6.4	7.9	4.2	7.6	3.0	3.0	2.0	1.4	9.1	12.0	5.3	4.7	3.1	3.7	7.7	6.4	7.5	2.8	13.1	5.2	5.3	3.5	2.7	4.0	6.4	46.0	3.0	5.2	5.9	8.8	8.6	5.1	3.1	3.4	25.6	6.8	10.9	19.8	2.3	1.7	22.3	5.5	5.2	16.3	20.1	14.1	21.5	13.2	6.3	3.4	17.8	2.1	11.0	7.0	19.7	23.8	6.9	11.0	14.9	6.4	3.7	17.4	10.9	1.6	10.1	11.2	7.5	1.8	3.0	14.8	3.8	18.9	5.4	8.0	11.1	7.0	5.7	9.7	7.2	9.8	10.2	7.3	2.2	27.1	12.8	8.1	23.6	9.6	11.8	1.2	6.3	16.0	1.9	7.2	16.2	12.5	17.2	9.0	34.1	27.3	6.6	7.1	12.4	1.3	1.5	9.1	2.5	0.7	3.3	6.2	3.9	2.3	0.6	5.2	3.6	4.0	2.4	2.9	0.7	0.7	1.9	1.9	2.6	3.2	5.4	3.3	2.9	3.8	3.0	3.0	2.0	3.1	2.7	3.0	3.4	2.5	9.6	9.4	42.7	22.7	11.6	8.6	5.1	9.6	15.4	11.7	6.2	17.0	10.0	6.0	1.8	45.9	10.0	7.3	11.0	7.9	8.2	56.2	5.1	3.5	4.1	6.0	16.0	37.1	13.4	8.7	6.2	10.7	5.1	8.9	8.2	3.6	16.8	6.5	8.4	47.3	8.3	0.0	6.7	7.9	58.5	2.1	6.9	0.0	46.9	3.6	6.2	17.5	60.3	41.8	9.4	6.9	7.5	11.5	9.1	6.0	7.6	11.1	23.2	6.6	5.2	4.2	136.6	27.0	9.8	8.7	5.3	14.4	8.4	12.2	5.3
SH3GLB1	"Bif-1, CGI-61, KIAA0491, PPP1R70"	ENSG00000097033	"SH3 domain containing GRB2 like, endophilin B1"	Q9Y371	1	86704570-86748184	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, Autophagy"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 634.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 301.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004650, HPA015608, HPA019900"	Enhanced		Supported	Cytosol		NA	NA		28000	Cytosol		"CAB004650: AB_425966, HPA015608: AB_1845355, HPA019900: AB_1845356"	"unprognostic (1.72e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.52e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (2.90e-5)"	"unprognostic (8.34e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.29e-1)"	"prognostic unfavorable (2.53e-4)"	"unprognostic (1.56e-1)"	"unprognostic (4.04e-3)"	"unprognostic (7.70e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.69e-1)"	107.5	38.4	20.9	55.8	23.4	66.8	56.6	22.7	25.6	39.6	19.3	54.2	48.9	36.2	31.3	80.1	28.1	47.4	73.5	20.0	28.8	40.8	45.3	49.4	41.3	26.3	21.9	19.0	24.4	64.5	41.6	30.6	58.0	24.8	34.6	58.5	39.3	56.9	36.5	173.4	35.5	47.4	50.7	25.1	46.9	36.6	110.4	21.3	34.4	38.9	99.3	52.3	64.4	42.1	28.4	78.1	28.1	44.2	40.4	180.1	155.1	72.2	115.1	114.5	106.8	112.3	81.4	63.3	39.7	72.0	143.5	132.9	44.5	39.4	75.0	101.2	86.1	28.1	94.7	39.2	87.1	108.7	51.5	92.4	111.8	85.5	118.3	128.7	114.5	171.4	41.7	36.0	108.5	145.1	23.1	46.7	32.7	43.0	56.8	47.6	53.1	184.6	29.7	92.3	132.2	47.9	34.7	64.8	82.4	140.8	65.2	32.7	51.8	151.4	102.2	61.9	129.3	96.5	56.8	56.3	58.6	50.8	52.1	63.5	153.0	59.0	66.5	43.0	64.5	42.4	36.8	40.2	43.8	45.5	35.3	19.1	34.3	301.4	62.4	77.0	43.8	65.4	49.5	20.9	23.4	22.7	25.6	20.0	28.8	26.3	21.9	19.0	24.8	25.1	21.3	28.4	192.0	83.3	65.6	39.2	75.0	89.6	119.5	124.1	44.3	31.2	96.9	69.1	157.0	60.1	104.0	55.2	52.1	84.3	145.7	182.0	86.1	145.2	634.6	86.3	104.5	135.4	86.6	64.4	49.9	169.8	203.4	99.7	45.9	110.0	113.5	61.0	157.1	79.4	143.7	16.8	50.5	130.3	128.1	149.2	99.4	236.9	70.2	116.0	81.8	40.3	163.7	71.9	124.6	46.8	65.2	201.7	173.4	85.0	123.9	103.4	108.8	134.0	90.2	55.4	78.9	146.7	111.7	403.5	86.3	100.6	118.1	101.9	90.4	57.1	87.4	199.8
SHCBP1L	C1orf14	ENSG00000157060	"SHC binding and spindle associated 1 like"	Q9BZQ2	1	182899865-182953525	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1157	"testis: 115.6"	"Group enriched"	"Detected in some"	6	"Early spermatids: 593.7;Spermatocytes: 593.1"	"Cancer enhanced"	"Detected in single"		"cervical cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA036124, HPA036125, HPA064821"	Enhanced					NA	NA					"HPA036124: AB_2674953, HPA036125: AB_10671834, HPA064821: AB_2685360"		"unprognostic (1.29e-3)"								"unprognostic (1.03e-1)"				"unprognostic (1.01e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.44e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	115.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	593.7	0.1	0.1	0.6	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	86.9	6.8	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.1	0.1	593.1	16.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1
SIGLECL1	"C19orf75, FLJ40235, SIGLEC23P, SIGLECP7"	ENSG00000179213	"SIGLEC family like 1"	Q8N7X8	19	51246348-51269330	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	73	"testis: 22.7"	"Group enriched"	"Detected in some"	8	"Early spermatids: 46.6;Late spermatids: 65.9;Spermatocytes: 73.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA079471	Enhanced					NA	NA					"HPA079471: "															"unprognostic (5.41e-2)"			0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	22.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	65.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	73.5	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC25A19	"DNC, MCPHA, MUP1, TPC"	ENSG00000125454	"Solute carrier family 25 member 19"	Q9HC21	17	75272981-75289510	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 82.2;Langerhans cells: 160.3;Spermatocytes: 79.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021936			Supported	Mitochondria		NA	NA			Mitochondria		"HPA021936: "	"unprognostic (2.28e-1)"	"unprognostic (7.05e-3)"	"unprognostic (8.21e-2)"	"prognostic unfavorable (8.72e-5)"	"unprognostic (2.31e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (1.21e-7)"	"unprognostic (6.71e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.85e-1)"	"unprognostic (7.72e-2)"	"unprognostic (1.77e-3)"	"unprognostic (2.71e-3)"	"unprognostic (3.58e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.13e-1)"	9.3	31.5	11.4	16.2	12.1	8.1	6.5	13.0	13.4	6.8	11.9	9.5	9.5	6.8	2.5	8.6	6.3	6.2	10.0	11.8	13.7	8.6	8.9	11.8	23.1	15.0	12.5	11.9	6.2	8.8	8.2	4.8	12.2	13.5	6.2	8.9	3.2	6.3	3.8	14.6	5.0	8.6	7.1	12.7	14.7	11.0	33.3	13.8	8.6	6.1	16.9	18.9	11.7	5.7	14.6	28.3	34.8	6.2	18.4	13.6	7.0	20.0	18.1	7.0	20.3	20.5	59.8	17.4	89.8	12.8	6.4	17.7	24.7	43.5	20.9	25.3	26.5	70.5	41.1	40.4	58.4	11.5	58.7	44.9	6.1	11.6	31.5	25.2	4.7	33.9	44.9	51.0	41.9	6.5	59.3	61.8	59.3	13.5	55.3	67.8	47.4	19.8	85.1	14.1	19.7	60.7	15.3	19.3	51.4	22.2	10.2	32.1	47.3	12.0	12.1	24.1	23.5	49.0	102.7	53.4	95.8	9.5	66.9	15.5	0.3	21.0	2.3	16.2	25.2	16.6	36.3	12.7	15.4	24.9	29.7	14.2	14.7	1.7	10.0	14.8	31.0	17.7	14.5	11.4	12.1	13.0	13.4	11.8	13.7	15.0	12.5	11.9	13.5	12.7	13.8	14.6	5.1	6.4	6.7	3.3	27.6	15.2	10.8	6.0	2.8	1.2	5.4	7.5	0.6	2.8	6.1	7.3	2.1	7.5	13.3	8.6	23.5	6.5	18.0	5.6	8.7	6.7	3.0	11.1	3.1	5.3	82.2	8.6	9.7	3.5	11.4	2.7	2.5	2.9	44.1	3.3	3.5	6.2	4.1	9.5	160.3	24.1	3.1	31.5	24.9	4.7	38.8	1.6	11.3	2.0	2.4	5.1	8.6	3.4	26.5	14.1	6.5	6.4	3.9	6.0	6.6	5.9	10.0	79.6	11.9	7.9	12.9	8.9	12.5	11.4	11.0	9.7
SLC25A2	ORNT2	ENSG00000120329	"Solute carrier family 25 member 2"	Q9BXI2	5	141302635-141304049	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	24	"testis: 6.6"	"Group enriched"	"Detected in some"	21	"Early spermatids: 18.2;Late spermatids: 12.0;Spermatocytes: 27.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042146	Uncertain					NA	NA					"HPA042146: AB_2677874"	"unprognostic (1.55e-1)"	"unprognostic (3.53e-1)"	"unprognostic (4.63e-2)"	"unprognostic (4.30e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.72e-3)"	"unprognostic (2.81e-1)"		"unprognostic (2.62e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.82e-10)"	"unprognostic (2.56e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.14e-1)"	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	6.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	27.6	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0
SLC25A31	"ANT4, DKFZP434N1235"	ENSG00000151475	"Solute carrier family 25 member 31"	Q9H0C2	4	127730400-127774292	"Predicted membrane proteins, Transporters"	"Antiport, Differentiation, Spermatogenesis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	271	"testis: 47.7"	"Cell type enriched"	"Detected in some"	8	"Spermatocytes: 198.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA015064, HPA016841, HPA046835, HPA071684"	Uncertain		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA015064: AB_1847691, HPA016841: AB_1847690, HPA046835: AB_2679831, HPA071684: AB_2686431"					"unprognostic (8.15e-2)"									"unprognostic (1.62e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.32e-1)"		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	47.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	13.5	3.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	198.2	23.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC25A33	"BMSC-MCP, MGC4399, PNC1"	ENSG00000171612	"Solute carrier family 25 member 33"	Q9BSK2	1	9539465-9585173	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 27.7"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 422.0;Late spermatids: 559.8;Spermatocytes: 358.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.8"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049982	Uncertain					NA	NA					"HPA049982: AB_2680981"	"unprognostic (1.61e-1)"	"prognostic favorable (4.86e-4)"	"unprognostic (2.94e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.75e-2)"	"unprognostic (5.18e-2)"	"prognostic favorable (7.02e-4)"	"unprognostic (1.88e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.59e-2)"	"unprognostic (2.77e-1)"	"unprognostic (4.55e-3)"	"unprognostic (7.27e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.25e-2)"	"unprognostic (3.77e-2)"	11.4	3.4	11.9	2.7	12.5	9.1	6.0	15.1	13.9	2.5	11.2	4.6	2.2	3.0	12.8	2.9	3.0	3.7	4.8	11.5	14.9	10.1	12.7	2.7	3.4	13.9	14.4	10.5	2.8	3.7	4.0	5.7	1.4	13.3	4.1	3.7	11.2	5.4	2.0	18.3	2.2	2.6	2.7	14.2	2.3	4.5	13.5	14.5	3.5	5.2	27.7	3.6	4.1	2.3	14.3	6.9	3.1	8.7	13.4	7.0	4.0	5.6	6.5	6.1	10.8	9.5	6.9	5.2	19.8	7.8	5.4	11.3	2.8	22.2	4.3	13.3	15.3	13.9	19.5	4.2	27.5	15.1	19.6	14.8	4.8	7.5	10.8	5.2	2.6	6.4	14.5	19.2	10.0	6.1	7.2	12.5	13.4	10.7	12.5	7.3	16.5	9.2	12.8	6.9	3.8	15.1	9.7	7.3	22.2	20.0	7.5	8.2	14.2	2.8	6.8	9.0	9.2	8.4	11.8	23.6	33.5	4.9	21.6	8.4	2.8	0.3	0.1	0.5	0.4	0.3	0.8	0.4	0.3	0.6	0.3	0.6	0.7	0.4	0.5	0.4	0.5	0.0	0.1	11.9	12.5	15.1	13.9	11.5	14.9	13.9	14.4	10.5	13.3	14.2	14.5	14.3	25.7	3.2	13.1	59.1	34.4	51.5	107.3	4.2	69.4	15.1	60.0	39.5	9.3	37.1	6.8	9.2	52.1	14.0	32.9	22.5	199.6	11.5	422.0	38.1	19.0	19.9	66.3	8.2	12.3	15.1	38.6	27.2	30.1	39.8	23.6	9.5	11.4	55.8	21.3	10.1	18.2	27.5	6.1	9.2	66.8	559.8	9.9	30.7	32.0	5.6	11.7	195.3	9.2	13.6	13.7	11.5	14.4	10.1	20.4	94.7	6.6	29.5	8.0	53.3	6.6	41.5	37.0	358.5	115.1	42.6	35.8	39.3	22.7	16.7	32.4	96.2
SLC25A35	FLJ40217	ENSG00000125434	"Solute carrier family 25 member 35"	Q3KQZ1	17	8287763-8295400	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 20.9;Syncytiotrophoblasts: 17.4"	"Cancer enhanced"	"Detected in all"		"endometrial cancer: 14.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051720	Uncertain		Approved	Vesicles,Mitochondria		NA	NA			"Vesicles, Mitochondria"		"HPA051720: AB_2681584"	"unprognostic (4.73e-2)"	"unprognostic (1.36e-3)"	"unprognostic (1.21e-2)"	"prognostic favorable (3.37e-7)"	"unprognostic (1.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.52e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.30e-2)"	"unprognostic (8.96e-3)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.14e-6)"	"unprognostic (5.31e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (1.91e-5)"	5.7	8.4	3.1	5.0	3.9	6.1	8.6	3.9	4.4	8.7	4.3	7.4	6.1	13.5	7.7	5.5	7.2	5.2	4.6	3.0	3.9	14.3	4.7	6.9	5.1	4.5	3.9	2.2	2.9	12.3	6.1	12.9	4.2	5.3	8.7	5.4	4.6	6.5	5.3	2.2	4.0	7.8	4.1	3.7	9.0	12.7	24.7	4.0	5.3	9.2	1.5	3.5	6.1	5.0	4.2	5.0	13.5	2.4	10.0	7.5	2.9	5.5	3.2	2.8	3.4	3.7	1.6	12.4	5.8	3.3	3.7	7.1	11.0	2.8	3.8	1.9	3.2	3.6	4.8	11.1	1.9	2.7	0.7	12.8	5.9	2.1	6.5	1.2	2.5	5.4	6.8	1.4	2.0	2.9	2.7	5.3	2.7	0.8	3.4	4.4	5.8	1.6	2.6	2.6	12.6	1.2	3.0	9.2	5.4	4.1	2.4	12.2	3.6	7.6	2.3	1.7	5.6	2.7	4.3	2.9	2.1	5.9	8.6	6.1	4.1	5.6	7.6	4.0	8.8	3.3	1.9	3.7	4.3	5.7	3.6	1.3	2.5	1.1	2.8	6.5	3.0	4.1	2.5	3.1	3.9	3.9	4.4	3.0	3.9	4.5	3.9	2.2	5.3	3.7	4.0	4.2	3.1	0.0	5.4	5.2	3.6	0.8	1.5	1.4	2.8	4.3	6.3	4.1	1.0	5.7	1.8	11.0	8.4	9.2	2.1	3.8	11.7	2.8	3.8	10.2	1.9	2.8	9.0	4.6	0.5	7.1	2.3	3.0	5.1	10.6	5.1	1.3	1.8	2.8	6.7	1.7	0.7	3.0	2.0	6.4	1.5	5.5	1.5	4.2	0.0	4.7	5.8	7.9	3.1	1.0	2.5	3.2	6.0	1.2	3.7	1.9	2.4	7.3	2.0	9.0	0.0	1.1	1.2	20.9	0.8	1.9	0.3	17.4	3.2	9.1	3.1	1.9
SLC26A8		ENSG00000112053	"Solute carrier family 26 member 8"	Q96RN1	6	35943516-36024868	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Differentiation, Ion transport, Meiosis, Spermatogenesis, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"testis: 44.4"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 54.1;Excitatory neurons: 15.8;Inhibitory neurons: 12.1;Late spermatids: 12.0;Spermatocytes: 64.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in single"	11	"neutrophil: 2.3"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA038081	Enhanced					NA	NA					"HPA038081: AB_10670653"	"unprognostic (8.18e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.07e-3)"	"unprognostic (2.93e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.78e-1)"	"unprognostic (4.63e-6)"	"unprognostic (7.14e-2)"	"unprognostic (4.24e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.24e-8)"	0.1	0.1	0.7	0.3	0.6	4.8	0.1	0.9	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	1.2	0.0	0.1	0.3	0.0	1.0	0.8	0.9	0.0	0.1	0.0	0.2	0.1	1.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.3	1.0	0.0	44.4	1.0	0.0	0.2	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.7	0.6	0.9	0.8	0.5	1.2	1.0	0.8	0.9	1.3	0.3	1.0	0.9	0.1	3.2	1.1	2.0	0.0	0.4	0.4	0.1	0.0	0.3	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	54.1	0.4	0.2	0.3	0.0	0.0	15.8	0.0	0.0	0.3	0.0	0.8	0.0	0.1	0.4	0.8	0.1	0.0	12.1	0.0	0.0	1.2	0.4	12.0	0.9	0.5	1.8	1.0	0.9	0.0	0.0	0.5	1.0	0.1	0.0	0.4	0.1	0.4	0.3	0.1	0.3	0.3	0.0	0.7	0.1	64.8	0.8	0.0	0.1	0.3	0.3	0.0	0.0	0.2
SLC2A14	"GLUT14, SLC2A3P3"	ENSG00000173262	"Solute carrier family 2 member 14"	Q8TDB8	12	7812512-7891148	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Spermatogenesis, Sugar transport, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"testis: 82.0"	"Cell type enriched"	"Detected in many"	5	"Spermatocytes: 65.7"	"Cancer enriched"	"Detected in single"	35	"testis cancer: 7.1"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.7;neutrophil: 3.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 18.4;CACO-2: 31.0;SuSa: 35.5"									HPA006539	Supported		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA006539: AB_1078984"	"unprognostic (2.52e-1)"	"unprognostic (4.74e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.82e-3)"	"unprognostic (8.62e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.91e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.46e-4)"	"unprognostic (3.92e-2)"	"unprognostic (3.41e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.22e-2)"	0.6	5.7	0.8	0.3	1.1	6.3	0.9	4.2	1.2	0.2	1.5	0.9	0.2	0.3	0.2	1.5	0.4	0.9	0.7	1.7	0.7	0.6	3.0	0.5	0.6	0.3	0.4	1.0	2.7	6.7	0.0	0.4	1.1	1.8	1.3	0.5	1.4	0.1	0.1	0.5	0.7	0.5	0.5	0.0	0.3	0.2	82.0	1.1	0.2	0.2	0.1	0.2	1.0	0.3	1.0	0.4	1.5	0.7	0.4	0.3	0.8	18.4	0.2	0.0	0.0	0.5	31.0	0.2	0.1	0.8	0.0	0.3	0.2	0.1	0.0	0.0	0.7	0.2	3.3	1.2	8.1	0.1	2.0	4.5	0.0	0.2	0.2	0.0	0.1	0.0	1.1	3.6	0.8	0.0	0.7	0.4	1.6	3.6	0.1	0.0	0.2	0.1	1.1	0.0	0.5	0.6	0.2	0.5	0.7	0.1	35.5	0.1	2.7	0.5	0.1	3.0	0.5	0.5	3.0	1.3	0.6	0.9	0.1	0.6	3.7	0.4	1.0	0.6	0.1	0.6	0.3	0.5	0.4	0.2	0.3	0.3	0.4	3.4	0.6	0.1	0.2	1.0	0.2	0.8	1.1	4.2	1.2	1.7	0.7	0.3	0.4	1.0	1.8	0.0	1.1	1.0	2.1	0.0	1.1	0.0	0.9	0.6	0.0	0.0	0.0	0.1	0.1	0.3	2.4	0.0	0.0	0.0	4.2	0.4	0.5	0.1	0.0	0.0	8.9	0.1	1.3	3.2	0.0	6.9	1.9	1.5	1.5	1.9	0.0	0.2	9.5	6.4	5.3	0.5	0.2	0.0	2.2	0.0	0.0	2.5	12.2	5.4	0.3	1.4	1.8	1.9	0.0	0.1	0.0	0.5	0.4	0.3	5.7	2.6	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.2	2.7	65.7	3.1	0.0	0.1	0.4	3.6	4.2	0.1	0.0
SLC35E4		ENSG00000100036	"Solute carrier family 35 member E4"	Q6ICL7	22	30635781-30669016	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 23.0"	"Group enriched"	"Detected in many"	4	"Early spermatids: 122.2;Late spermatids: 108.6;Spermatocytes: 55.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 22.8;U-2197: 21.0;U-87 MG: 22.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049558	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA049558: AB_2680817"	"unprognostic (2.09e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.01e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.03e-4)"	"unprognostic (5.71e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.45e-7)"	"unprognostic (2.77e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.24e-2)"	"unprognostic (8.05e-3)"	2.4	1.8	3.8	1.4	4.6	1.5	2.2	2.7	6.7	2.5	0.4	3.1	1.0	3.5	1.3	2.9	2.5	1.1	2.9	4.0	3.6	1.6	0.5	2.1	0.8	4.6	4.5	3.7	1.9	1.7	1.7	2.3	0.4	4.9	2.3	1.7	1.6	2.1	1.3	11.2	5.1	1.8	1.4	2.2	1.9	3.5	23.0	4.4	0.4	1.6	2.8	0.5	3.1	2.8	7.3	10.0	4.3	1.6	3.2	4.3	10.9	0.9	6.4	5.6	4.3	4.0	0.3	2.6	0.7	3.4	6.6	6.1	6.2	2.8	3.7	2.2	22.8	3.1	0.1	3.3	0.3	6.1	0.4	2.7	3.5	1.6	17.3	5.4	6.8	14.9	0.8	0.9	2.8	6.8	2.8	0.4	1.9	1.9	2.9	16.2	1.8	3.2	0.3	2.0	0.8	8.7	3.4	6.6	2.8	3.2	0.7	2.0	0.7	20.0	18.2	5.8	21.0	6.2	0.8	0.9	0.3	22.3	0.3	4.9	0.6	0.6	0.1	0.2	0.8	0.4	0.0	0.6	0.9	1.1	0.1	0.5	0.5	0.2	0.6	0.7	0.3	0.7	0.3	3.8	4.6	2.7	6.7	4.0	3.6	4.6	4.5	3.7	4.9	2.2	4.4	7.3	5.7	0.0	1.5	2.6	2.7	14.5	2.5	1.9	8.0	10.6	2.0	3.7	1.9	0.0	1.2	1.8	22.9	0.1	4.8	5.4	0.0	3.4	122.2	6.0	4.9	9.1	2.4	0.8	4.2	2.3	0.5	3.7	2.6	2.0	1.3	4.1	4.2	0.3	1.8	11.8	4.9	4.4	2.0	1.2	7.7	108.6	3.4	8.0	3.6	4.7	2.5	17.2	1.0	2.5	9.2	2.5	11.1	3.8	3.1	1.7	1.2	0.4	5.7	10.5	0.0	3.9	5.0	55.1	3.8	4.2	19.0	0.1	4.9	2.4	5.0	2.1
SLC39A3	ZIP3	ENSG00000141873	"Solute carrier family 39 member 3"	Q9BRY0	19	2732204-2740028	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 101.1"	"Group enriched"	"Detected in all"	4	"Early spermatids: 302.1;Late spermatids: 433.3;Spermatocytes: 185.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-937: 409.6"	"Low region specificity"	"Detected in all"							"HPA042139, HPA058526"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA042139: AB_10793875, HPA058526: AB_2683743"	"unprognostic (1.81e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (9.76e-5)"	"unprognostic (2.26e-1)"	"unprognostic (2.44e-2)"	"unprognostic (9.88e-3)"	"unprognostic (1.01e-1)"	"unprognostic (6.03e-2)"	"unprognostic (3.66e-2)"	"unprognostic (4.37e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.75e-3)"	"unprognostic (9.22e-3)"	"unprognostic (6.58e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.80e-2)"	18.0	27.2	19.7	14.9	20.3	46.7	17.6	17.7	22.7	19.8	13.7	18.2	16.9	25.3	30.7	17.5	23.4	15.4	22.1	22.8	16.9	19.6	33.1	16.4	19.3	19.4	18.1	20.3	13.6	20.8	35.0	27.4	12.4	19.6	19.5	14.5	10.3	21.5	18.0	23.1	14.7	16.6	23.2	16.3	22.9	17.5	101.1	20.7	22.0	20.6	24.9	16.3	22.5	14.5	18.5	53.3	44.1	32.5	80.3	66.1	45.0	30.6	38.6	46.5	71.3	72.4	47.8	35.0	32.2	23.6	68.2	56.3	42.9	50.2	52.7	44.3	0.4	37.1	144.4	31.4	48.9	72.1	123.2	209.5	40.6	83.3	53.1	43.3	25.6	36.9	61.8	162.8	147.6	48.6	35.2	61.4	99.0	34.6	48.8	59.4	81.4	20.9	100.7	34.1	42.7	44.1	40.3	33.9	24.4	82.4	20.9	42.4	162.7	22.4	49.5	27.0	75.6	56.4	38.7	66.6	32.6	37.4	409.6	59.7	41.1	36.0	67.9	35.9	35.6	30.1	53.3	30.5	29.2	48.9	53.7	24.5	29.2	16.7	29.7	34.1	83.9	21.2	35.2	19.7	20.3	17.7	22.7	22.8	16.9	19.4	18.1	20.3	19.6	16.3	20.7	18.5	18.1	3.2	2.8	2.6	31.6	10.3	16.6	37.1	2.2	19.2	25.5	23.6	7.8	24.3	22.6	7.3	8.4	37.5	16.8	20.2	17.6	50.7	302.1	17.8	16.4	21.8	24.0	57.6	5.0	61.8	56.3	18.4	10.7	13.3	24.8	24.2	21.8	31.0	64.9	48.8	5.9	19.7	32.6	25.7	12.9	433.3	21.5	39.3	24.9	4.7	26.7	33.5	26.8	6.6	5.6	46.9	25.8	27.8	12.9	33.3	23.0	23.6	17.6	22.0	26.3	14.0	23.6	185.8	29.7	10.5	9.8	26.4	14.5	29.4	25.6	17.6
SLC6A16	NTT5	ENSG00000063127	"Solute carrier family 6 member 16"	Q9GZN6	19	49289638-49325215	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 95.1"	"Group enriched"	"Detected in many"	8	"Early spermatids: 125.9;Late spermatids: 46.8;Spermatocytes: 153.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 18.2;SuSa: 9.9"	"Not detected"	"Not detected"							HPA076812			Supported	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA076812: AB_2686816"	"unprognostic (1.98e-1)"	"unprognostic (7.15e-3)"	"unprognostic (6.39e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.83e-3)"	"unprognostic (7.89e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.10e-1)"	"unprognostic (8.93e-2)"	"unprognostic (4.18e-2)"	4.0	2.0	4.4	2.9	2.5	4.5	3.2	1.7	2.8	4.5	15.2	3.0	1.2	4.1	2.4	1.7	5.8	2.3	2.2	2.4	3.1	5.5	10.0	5.0	7.4	4.5	4.0	1.9	7.0	6.9	0.9	1.6	3.2	5.0	5.0	1.1	5.0	1.5	2.9	1.0	2.2	3.8	1.9	3.5	4.7	3.5	95.1	2.3	2.3	3.2	0.5	5.5	3.6	3.5	3.3	0.0	7.3	18.2	6.5	0.3	2.8	3.3	0.9	1.5	0.6	2.0	0.2	0.6	8.5	1.1	0.8	0.3	0.3	2.0	0.3	2.2	1.3	2.1	0.7	0.7	1.7	1.4	0.6	3.0	2.8	1.1	1.4	1.0	5.2	1.6	1.5	1.7	1.1	2.4	1.6	0.5	0.3	6.4	0.3	0.9	0.3	4.4	1.6	1.0	0.0	0.2	0.4	2.9	0.1	0.6	9.9	2.9	0.3	9.3	1.4	6.7	4.2	0.0	4.0	4.6	7.5	0.1	2.0	0.4	0.2	0.3	2.6	1.6	1.2	1.5	4.5	0.5	1.6	0.4	2.2	1.4	0.9	1.9	1.8	2.1	1.1	0.9	1.3	4.4	2.5	1.7	2.8	2.4	3.1	4.5	4.0	1.9	5.0	3.5	2.3	3.3	4.4	0.0	1.1	3.6	5.8	1.5	0.9	0.4	2.2	8.6	1.7	1.7	1.5	2.8	0.1	1.8	2.1	0.0	1.7	0.1	11.7	0.8	125.9	2.3	1.6	3.9	0.0	0.0	4.1	0.6	0.0	1.7	0.0	1.5	1.3	0.3	2.2	5.5	0.9	0.0	8.1	0.1	0.0	1.4	1.8	46.8	3.7	0.8	5.4	12.2	1.2	0.5	5.2	2.5	1.7	0.2	0.0	3.4	1.5	0.5	0.0	0.3	11.3	1.2	0.0	1.7	4.9	153.5	8.3	0.3	1.3	0.0	1.1	1.8	0.1	0.3
SLC6A2	"NAT1, NET, NET1, SLC6A5"	ENSG00000103546	"Solute carrier family 6 member 2"	P23975	16	55655604-55706192	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 21.9;brain: 77.2"	"Group enriched"	"Detected in some"	4	"Early spermatids: 4.3;Extravillous trophoblasts: 10.6;Late spermatids: 4.4;Spermatocytes: 11.5;Syncytiotrophoblasts: 5.6"	"Cancer enhanced"	"Detected in some"		"liver cancer: 1.9"	"Group enriched"	"Detected in many"	12	"midbrain: 40.2;pons: 77.2;white matter: 20.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	29	"SH-SY5Y: 489.1"	"Region enriched"	"Detected in some"	4	"pons and medulla: 7.8"	"Region enriched"	"Detected in single"	19	"pons: 13.8"	"HPA004057, HPA076311, CAB078195"	Enhanced	Supported	Approved	Mitochondria,Cytosol		NA	NA			Cytosol	Mitochondria	"CAB078195: AB_2665806, HPA004057: AB_1080012, HPA076311: AB_2732307"	"unprognostic (9.58e-3)"	"unprognostic (5.48e-2)"		"unprognostic (1.26e-4)"	"unprognostic (4.07e-1)"	"unprognostic (4.16e-1)"	"unprognostic (8.38e-2)"	"unprognostic (2.97e-2)"	"unprognostic (3.29e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.02e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.43e-2)"	0.7	21.9	0.8	0.0	0.1	0.0	0.8	0.0	1.2	2.4	0.0	0.2	0.1	5.4	0.2	0.2	0.5	0.1	0.0	0.1	0.1	0.4	0.4	0.1	0.0	3.7	40.2	0.1	0.1	0.0	0.5	0.0	12.7	77.2	0.2	0.3	0.0	1.9	0.6	0.0	13.5	0.2	0.8	0.2	0.0	0.1	6.3	0.3	0.1	0.0	0.0	0.1	0.2	0.5	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	5.2	3.7	489.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	1.2	0.1	0.1	3.7	40.2	0.1	77.2	0.2	0.3	20.9	1.8	0.0	0.0	0.0	0.0	1.5	0.2	0.4	0.0	0.0	0.3	0.1	0.8	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.3	0.1	0.0	0.3	0.0	0.0	0.0	0.0	10.6	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.5	4.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	11.5	0.3	0.0	0.4	5.6	0.0	0.0	0.0	0.1
SLC9B1	"NHA1, NHEDC1"	ENSG00000164037	"Solute carrier family 9 member B1"	Q4ZJI4	4	102885048-103019719	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Fertilization, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"testis: 40.8"	"Group enriched"	"Detected in many"	4	"Early spermatids: 177.8;Late spermatids: 106.0;Spermatocytes: 224.8"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA058971, HPA065520"			Supported	"Centriolar satellite,Mitochondria"		NA	NA			Mitochondria	"Centriolar satellite"	"HPA058971: AB_2683865, HPA065520: AB_2685502"	"unprognostic (4.87e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.26e-4)"	"unprognostic (2.53e-1)"	"unprognostic (3.39e-1)"	"unprognostic (5.06e-4)"	"unprognostic (5.85e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.07e-3)"	"unprognostic (7.68e-2)"	"unprognostic (3.03e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.66e-5)"	"unprognostic (5.78e-2)"	1.0	0.8	2.1	0.6	2.7	0.6	0.5	2.3	2.4	0.4	0.1	0.4	0.7	1.3	2.2	0.3	0.6	1.5	0.8	1.5	2.0	0.6	0.2	0.5	1.0	2.7	2.6	1.1	1.4	1.2	0.7	0.5	0.8	3.2	0.9	0.7	1.8	0.2	0.7	0.2	1.9	0.5	0.6	3.2	0.9	0.4	40.8	2.5	1.1	1.0	0.0	1.1	0.8	0.2	4.4	0.1	0.0	0.9	1.5	1.9	1.4	0.3	0.3	0.4	0.0	0.1	0.0	0.1	0.7	0.2	0.8	0.3	0.0	0.7	0.4	0.6	1.5	0.9	1.2	1.0	0.0	0.0	0.4	0.2	0.2	0.4	0.0	0.8	0.4	0.5	2.0	0.5	0.8	0.7	0.6	0.4	1.0	0.4	0.2	0.0	1.3	0.8	0.2	0.4	0.2	0.9	2.3	0.2	0.3	1.1	0.6	0.2	0.8	0.3	0.4	0.1	0.5	0.5	2.5	1.9	0.7	0.5	0.4	1.0	0.2	0.2	0.0	0.4	0.1	0.5	0.5	0.3	0.6	0.2	0.5	1.5	0.9	0.1	0.1	0.1	0.6	0.6	0.2	2.1	2.7	2.3	2.4	1.5	2.0	2.7	2.6	1.1	3.2	3.2	2.5	4.4	1.3	3.2	1.5	26.1	3.4	1.3	0.5	1.8	1.8	1.8	1.0	0.6	0.9	1.5	0.4	0.0	16.7	0.6	1.1	0.2	1.9	0.3	177.8	0.8	1.1	1.7	0.0	0.4	6.0	0.4	0.4	2.3	0.0	0.6	0.0	1.9	1.4	0.2	1.3	3.3	8.3	0.1	6.1	3.9	3.1	106.0	5.3	1.3	1.8	4.7	1.5	2.5	1.0	24.1	40.5	1.1	0.0	3.0	1.8	0.9	0.4	0.9	0.2	5.0	0.0	6.4	1.8	224.8	9.5	0.7	0.6	0.5	2.9	2.0	0.3	0.6
SLC9C1	"NHE, SLC9A10"	ENSG00000172139	"Solute carrier family 9 member C1"	Q4G0N8	3	112140898-112294227	"Predicted membrane proteins, Transporters"	"Antiport, Differentiation, Ion transport, Sodium transport, Spermatogenesis, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"skin 1: 2.1;testis: 8.1"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 4.1;Early spermatids: 3.3;Excitatory neurons: 4.3;Oligodendrocyte precursor cells: 5.0;Oligodendrocytes: 5.1;Spermatocytes: 15.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.21e-2)"	"unprognostic (3.63e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.57e-3)"	"unprognostic (9.56e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.65e-2)"	"unprognostic (8.32e-2)"	"unprognostic (5.89e-2)"	"unprognostic (9.62e-3)"	"unprognostic (3.25e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.1	8.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	1.3	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	3.3	1.0	0.1	2.5	0.0	0.0	4.3	0.0	0.3	0.2	1.1	0.6	0.0	0.2	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	2.8	0.0	0.0	0.0	5.0	5.1	0.1	0.1	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.1	15.2	0.4	0.0	0.0	0.4	0.0	0.4	0.1	0.1
SLCO6A1	"CT48, MGC26949, OATP6A1, OATPY"	ENSG00000205359	"Solute carrier organic anion transporter family member 6A1"	Q86UG4	5	102371774-102499016	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	109	"testis: 30.5"	"Group enriched"	"Detected in some"	5	"Early spermatids: 168.8;Spermatocytes: 127.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			HPA054126	Enhanced					NA	NA					"HPA054126: AB_2682390"		"unprognostic (1.17e-1)"			"unprognostic (2.59e-1)"	"unprognostic (4.37e-2)"		"unprognostic (4.65e-1)"		"unprognostic (1.84e-1)"					"unprognostic (2.60e-2)"		"unprognostic (6.70e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	168.8	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	26.0	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	127.7	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLTM	"FLJ13213, Met"	ENSG00000137776	"SAFB like transcription modulator"	Q9NWH9	15	58879050-58933679	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040256, HPA040381"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA040256: AB_10674990, HPA040381: AB_2676953"	"unprognostic (2.36e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.52e-3)"	"unprognostic (9.65e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.44e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.10e-3)"	"unprognostic (8.03e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.69e-1)"	"unprognostic (5.71e-2)"	"unprognostic (3.24e-3)"	31.5	21.7	30.3	31.8	32.5	58.3	29.8	38.8	33.1	29.9	29.1	29.9	30.2	27.8	20.9	38.8	28.1	24.0	27.2	28.6	30.1	31.0	35.2	28.5	43.1	31.4	32.0	26.1	29.8	25.1	36.3	28.6	21.2	32.0	29.4	32.4	45.3	30.8	24.5	46.5	35.3	33.7	26.0	30.9	38.4	39.2	28.0	32.2	57.8	34.4	44.0	44.5	34.1	31.5	33.3	77.8	84.1	72.0	36.6	48.1	36.2	60.6	55.1	64.3	49.9	48.2	58.4	45.7	144.6	50.5	50.8	54.4	67.9	72.3	62.9	68.7	93.7	46.4	105.4	91.8	44.7	42.0	83.8	78.1	34.1	61.0	52.8	44.1	30.4	46.9	66.0	95.5	81.7	58.2	56.1	84.1	64.6	80.9	46.3	40.5	63.6	65.4	70.1	60.2	99.8	58.9	50.8	57.0	55.1	57.8	79.3	44.0	90.1	48.6	60.2	88.5	66.3	74.6	57.3	123.1	105.5	47.6	101.7	61.5	67.9	30.3	44.4	45.2	29.5	46.1	53.5	36.0	39.3	31.2	47.3	39.2	35.6	42.8	47.0	37.7	53.6	36.5	22.7	30.3	32.5	38.8	33.1	28.6	30.1	31.4	32.0	26.1	32.0	30.9	32.2	33.3	92.5	153.8	161.2	61.4	125.8	96.9	100.2	85.6	107.0	116.3	77.3	66.0	107.8	64.3	122.8	106.7	98.0	73.5	155.9	88.4	78.2	98.4	100.8	110.5	99.0	94.7	73.4	115.7	67.7	115.7	160.1	94.3	99.4	119.1	118.9	75.3	63.9	104.1	63.9	119.5	67.3	94.4	59.0	88.6	73.0	120.8	86.3	108.8	78.2	72.1	121.0	84.9	126.7	74.4	141.8	131.1	76.5	88.4	140.0	92.4	57.4	90.6	103.9	145.3	72.3	106.6	95.6	215.1	85.2	100.0	104.6	112.5	134.9	78.0	94.0	125.6
SLU7	9G8	ENSG00000164609	"SLU7 homolog, splicing factor"	O95391	5	160401641-160421711	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035907, HPA058120"	Uncertain		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			Nucleoplasm	"Nuclear speckles"	"HPA035907: AB_10671717, HPA058120: AB_2683612"	"unprognostic (3.70e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.86e-2)"	"unprognostic (9.96e-3)"	"unprognostic (8.01e-2)"	"unprognostic (3.52e-1)"	"unprognostic (3.38e-3)"	"unprognostic (3.76e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.93e-1)"	"unprognostic (7.69e-2)"	"prognostic favorable (1.98e-4)"	"unprognostic (2.65e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.25e-1)"	22.3	23.4	28.2	19.7	28.9	49.0	27.7	29.6	46.9	21.3	24.9	21.0	17.1	20.1	26.1	22.1	18.1	18.9	26.1	29.3	28.6	24.6	24.6	23.5	27.5	27.7	28.0	27.0	21.5	16.5	24.8	11.0	21.3	29.2	21.4	21.1	29.7	25.0	19.9	32.9	22.8	21.6	18.4	26.8	28.1	23.6	27.5	28.1	30.7	32.5	33.3	31.6	21.7	12.3	30.6	24.5	29.6	26.0	36.2	33.4	35.1	33.1	33.9	49.3	35.9	43.8	40.1	29.1	39.5	34.2	36.6	36.9	27.0	22.9	37.7	45.2	65.1	33.0	29.4	39.0	26.2	33.7	49.8	34.9	38.1	34.3	33.8	38.1	37.7	25.7	35.3	26.7	36.0	33.2	21.5	24.7	32.1	18.6	25.2	26.5	21.4	53.4	40.4	31.6	37.8	30.9	42.7	40.1	35.6	62.2	21.6	47.7	46.4	32.7	34.5	18.2	26.1	36.3	40.1	48.8	34.9	51.2	33.1	33.4	49.9	22.2	39.2	26.7	24.9	25.5	30.0	25.2	27.2	20.2	26.1	27.2	26.7	54.2	33.9	36.5	21.6	29.4	22.8	28.2	28.9	29.6	46.9	29.3	28.6	27.7	28.0	27.0	29.2	26.8	28.1	30.6	42.7	67.3	67.8	9.8	53.7	44.7	39.9	55.5	24.5	70.2	25.7	26.3	71.4	24.3	57.1	25.8	25.0	38.1	70.9	34.1	50.9	52.2	126.2	43.0	41.6	44.1	39.5	68.8	19.8	55.8	39.7	43.0	17.9	51.3	46.3	34.7	35.3	24.6	38.4	57.2	18.3	34.7	54.9	47.3	57.3	34.3	47.8	46.9	65.8	20.6	65.8	61.6	64.9	9.0	15.2	50.5	45.3	47.4	33.1	40.0	39.8	39.5	62.0	49.4	46.0	49.6	50.1	88.9	54.6	27.4	41.5	94.1	52.0	41.9	27.8	52.5
SMIM19	C8orf40	ENSG00000176209	"Small integral membrane protein 19"	Q96E16	8	42541155-42555195	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011145, HPA074830"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA011145: AB_1078360, HPA074830: "	"unprognostic (2.12e-2)"	"unprognostic (2.33e-3)"	"unprognostic (4.01e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.68e-3)"	"unprognostic (7.04e-3)"	"unprognostic (1.76e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.67e-2)"	"prognostic favorable (1.74e-6)"	"unprognostic (5.10e-2)"	"unprognostic (9.70e-3)"	"unprognostic (9.64e-2)"	"unprognostic (2.93e-3)"	48.9	57.5	37.4	18.6	37.8	32.7	65.5	38.3	44.6	30.0	38.0	42.1	30.3	32.8	80.7	33.5	57.5	28.1	58.4	38.0	38.6	77.6	138.0	31.7	37.2	36.9	37.8	37.2	42.5	69.1	36.5	27.1	23.5	37.2	32.2	35.0	21.3	63.2	30.4	122.9	44.8	39.2	25.3	38.2	33.5	46.6	44.3	37.4	37.0	74.1	74.8	34.2	36.7	30.2	39.9	38.9	28.5	61.0	52.6	35.9	43.2	19.9	29.9	40.2	23.4	27.8	6.8	84.4	42.4	12.2	25.1	57.0	27.2	31.8	19.2	24.3	33.8	26.3	35.9	17.9	15.5	73.9	25.7	9.0	35.4	16.1	19.6	62.7	45.3	21.5	49.1	28.8	94.5	23.7	38.0	18.8	39.0	72.1	90.4	19.5	21.1	43.4	72.4	60.7	28.5	12.7	46.0	30.0	32.2	93.1	32.6	68.0	48.2	27.3	14.7	12.5	40.8	19.6	88.7	53.8	56.9	62.2	40.9	39.6	92.2	42.3	31.4	46.3	34.0	56.5	71.3	59.6	57.0	65.1	68.3	55.6	54.3	15.3	80.7	28.8	107.2	78.2	40.0	37.4	37.8	38.3	44.6	38.0	38.6	36.9	37.8	37.2	37.2	38.2	37.4	39.9	53.1	22.4	45.9	5.9	43.0	45.8	63.5	89.8	70.6	25.2	89.9	108.8	75.7	88.6	66.2	33.1	6.2	90.1	58.6	36.2	201.5	67.9	183.9	109.6	26.0	43.9	16.3	45.6	12.7	126.8	62.9	65.5	43.3	54.8	40.0	52.3	47.8	142.5	78.3	23.5	13.4	74.4	61.1	45.9	51.0	77.5	69.0	47.3	92.5	11.2	64.0	66.7	42.2	10.6	14.6	85.5	69.5	59.5	29.0	53.3	161.9	228.2	110.9	14.3	26.3	67.6	50.7	131.3	48.6	58.4	49.6	47.2	43.3	76.4	74.8	63.2
SNRPA1	"Lea1, U2A'"	ENSG00000131876	"Small nuclear ribonucleoprotein polypeptide A'"	P09661	15	101281510-101295282	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045622, HPA048499"	Supported		Supported	"Nucleoplasm,Nuclear speckles,Nuclear bodies"		NA	NA		48000	Nucleoplasm	"Nuclear speckles, Nuclear bodies"	"HPA045622: AB_2679394, HPA048499: AB_2680421"	"unprognostic (2.73e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.09e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (8.56e-5)"	"unprognostic (5.80e-2)"	"unprognostic (1.66e-3)"	"prognostic favorable (8.83e-5)"	"unprognostic (4.74e-2)"	"unprognostic (6.77e-3)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.06e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.37e-2)"	19.2	18.4	11.8	35.8	12.4	68.7	21.1	14.2	15.5	14.8	15.0	30.9	24.6	15.6	33.3	34.0	18.7	12.8	24.4	13.3	13.6	23.3	25.7	19.7	43.7	12.6	12.4	12.1	13.8	22.4	18.4	14.0	30.6	12.7	16.4	31.1	15.7	23.3	12.7	19.9	17.8	30.4	19.5	12.4	25.5	23.4	38.1	12.9	37.8	18.5	12.5	52.3	26.5	18.3	13.6	175.5	119.5	112.7	57.4	31.3	25.6	111.3	158.2	72.8	139.2	105.1	255.8	150.7	192.9	89.2	107.8	109.0	101.7	170.2	113.1	148.1	98.0	262.5	151.4	196.7	137.3	24.0	175.1	103.7	21.0	83.0	89.0	111.3	30.9	90.9	147.1	216.1	175.8	86.5	194.6	177.6	185.7	144.5	232.0	100.1	174.5	121.7	194.8	103.3	450.2	88.6	92.7	97.2	109.0	125.1	117.1	105.2	136.4	66.2	74.1	141.0	86.8	160.3	143.5	464.8	378.9	59.9	162.9	89.3	3.8	36.6	21.5	55.7	47.2	55.3	53.0	57.7	56.1	58.0	47.4	46.6	59.0	6.8	48.5	44.0	54.7	68.9	39.0	11.8	12.4	14.2	15.5	13.3	13.6	12.6	12.4	12.1	12.7	12.4	12.9	13.6	41.5	19.2	54.6	16.3	71.6	65.6	73.4	141.6	70.6	37.8	41.8	52.6	30.5	18.6	80.3	36.8	12.5	124.3	69.6	37.4	68.4	94.6	96.2	52.7	42.5	47.2	27.0	61.4	30.9	109.0	154.1	51.5	27.0	55.6	65.8	37.7	21.4	35.5	67.0	37.0	29.2	44.2	126.1	24.1	39.2	22.4	34.8	36.4	42.7	13.1	76.4	39.6	47.4	16.6	28.6	95.3	41.8	28.6	76.1	142.3	78.7	87.1	89.2	34.9	13.1	37.9	67.1	192.9	65.9	68.3	50.6	112.3	68.1	42.3	52.4	101.6
SNRPC	"U1-C, Yhc1"	ENSG00000124562	"Small nuclear ribonucleoprotein polypeptide C"	P09234	6	34757505-34773857	"Plasma proteins, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 384.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034338, HPA042419, HPA055490"	Supported		Enhanced	Nucleoplasm		NA	NA		320000	Nucleoplasm		"CAB034338: AB_2295245, HPA042419: AB_2677989, HPA055490: AB_2682833"	"unprognostic (1.84e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.32e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.93e-2)"	"prognostic unfavorable (5.65e-4)"	"unprognostic (1.48e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.16e-3)"	"unprognostic (7.71e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (8.20e-5)"	"unprognostic (4.39e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.62e-2)"	71.1	74.5	67.0	68.4	71.7	178.2	74.8	71.6	85.2	65.9	72.4	78.9	73.8	84.2	63.7	86.2	85.5	49.4	167.0	68.7	70.4	85.2	92.8	63.1	102.5	70.6	68.4	67.0	75.7	87.7	78.9	58.0	74.1	71.5	66.4	66.3	40.0	75.9	55.9	163.3	67.5	76.2	65.9	71.8	85.3	82.5	125.4	72.8	116.5	76.0	126.1	96.1	74.5	67.1	76.2	332.8	203.2	260.7	331.6	137.7	134.7	199.0	186.6	204.9	367.9	308.6	349.6	128.4	373.9	239.1	235.0	255.6	156.0	398.7	279.1	297.8	247.6	420.0	287.7	158.7	493.4	240.1	371.2	171.0	167.3	266.4	372.5	264.1	144.9	237.0	354.4	471.2	205.0	270.4	280.8	443.8	592.0	282.4	493.9	245.8	295.2	219.4	350.5	242.0	140.9	316.9	229.9	167.3	167.0	422.3	167.7	256.0	541.5	157.4	219.8	258.3	181.0	460.4	228.5	645.6	522.4	101.2	629.7	381.1	122.8	165.7	133.4	127.2	200.4	149.4	233.5	156.2	148.4	196.1	210.7	168.3	153.9	30.3	163.3	238.6	207.6	235.7	245.6	67.0	71.7	71.6	85.2	68.7	70.4	70.6	68.4	67.0	71.5	71.8	72.8	76.2	43.6	121.8	107.9	5.2	70.5	44.0	76.0	178.6	72.8	25.9	47.4	64.4	229.3	82.9	131.3	68.0	25.0	239.8	69.0	49.1	189.8	148.4	185.6	74.2	58.0	74.3	90.7	73.2	11.1	156.8	213.9	72.3	51.5	63.7	80.4	83.6	71.4	101.1	232.2	28.6	10.1	92.6	118.0	77.3	55.1	83.8	55.3	75.4	64.0	1.9	158.2	96.6	123.6	8.5	14.6	149.3	66.7	41.8	116.6	70.0	96.0	214.6	127.4	41.4	65.7	49.0	82.8	384.6	99.7	83.8	44.8	113.3	70.7	86.3	109.6	67.8
SNUPN	"RNUT1, SNURPORTIN-1, Snurportin1"	ENSG00000169371	"Snurportin 1"	O95149	15	75598083-75626469	"Predicted intracellular proteins"	Transport	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 137.1;Spermatocytes: 93.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005004	Approved					NA	NA					"CAB005004: AB_425829"	"unprognostic (2.37e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.36e-2)"	"unprognostic (8.73e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.76e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.99e-3)"	"unprognostic (9.07e-2)"	"unprognostic (9.97e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.14e-2)"	18.4	16.1	20.8	15.7	21.9	13.9	23.8	20.9	26.5	20.6	21.3	17.0	15.0	19.1	20.4	14.4	23.9	13.6	16.6	22.4	21.6	20.3	22.3	15.1	20.3	19.8	20.6	21.1	26.5	12.8	21.2	12.2	15.3	20.3	16.6	17.6	13.3	20.0	17.7	35.0	16.8	15.5	24.7	19.3	17.4	15.9	34.6	20.3	22.3	21.1	30.8	21.2	18.2	15.7	21.5	26.1	34.1	30.4	21.6	42.1	46.8	23.2	26.1	38.5	44.2	47.8	25.4	62.6	47.4	35.7	34.0	36.6	29.9	60.3	38.3	34.5	27.3	56.1	56.4	29.3	16.4	40.6	39.4	37.3	44.6	37.3	32.8	41.0	40.1	42.4	36.8	36.8	30.9	45.4	9.0	38.5	38.7	40.6	42.7	19.5	48.7	23.7	46.7	39.7	13.6	28.5	19.9	11.4	38.7	68.9	37.5	33.0	73.8	27.9	35.3	32.8	19.4	23.3	21.9	43.7	69.8	38.7	59.6	47.0	10.3	39.5	12.2	47.4	37.7	57.3	34.7	48.9	45.8	47.7	41.1	63.2	53.0	6.7	36.9	40.1	47.0	42.1	41.0	20.8	21.9	20.9	26.5	22.4	21.6	19.8	20.6	21.1	20.3	19.3	20.3	21.5	19.1	12.8	14.5	7.8	13.1	13.3	10.4	30.5	18.2	19.0	18.7	21.5	11.7	14.3	16.8	9.2	12.5	28.7	19.2	10.3	54.8	23.1	137.1	14.9	23.6	14.4	16.2	14.1	9.0	19.3	38.5	25.2	10.7	12.8	12.7	20.4	17.2	18.5	24.7	13.5	8.2	12.4	14.2	17.7	17.3	60.3	31.4	19.1	19.6	7.5	24.2	18.3	25.7	3.0	7.6	14.7	10.5	29.3	9.9	11.5	17.6	34.1	15.1	20.4	19.7	16.6	14.5	93.2	14.6	15.0	10.9	11.9	16.2	27.3	18.1	5.7
SNX14	RGS-PX2	ENSG00000135317	"Sorting nexin 14"	Q9Y5W7	6	85505496-85594156	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"		"Disease variant, Mental retardation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 173.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017639	Approved		Supported	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA017639: AB_1857345"	"unprognostic (1.16e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.52e-2)"	"unprognostic (5.23e-2)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (1.92e-2)"	"unprognostic (3.45e-2)"	"unprognostic (4.60e-1)"	"unprognostic (1.57e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.87e-3)"	"unprognostic (4.72e-3)"	27.5	40.2	42.2	23.2	42.6	31.7	42.1	46.5	61.4	31.1	50.0	40.1	30.1	23.7	57.8	24.5	28.4	28.5	24.6	42.1	48.4	54.9	70.2	40.0	32.8	42.2	43.3	42.9	27.0	44.0	47.5	36.5	36.5	44.9	33.5	35.4	47.6	28.1	31.1	16.5	28.8	32.0	22.6	42.2	37.7	45.7	87.8	44.3	19.1	40.8	13.0	29.0	35.5	24.9	45.8	46.1	27.3	44.5	64.9	98.3	71.6	46.0	58.0	78.5	44.2	67.5	49.0	75.4	60.3	69.8	74.4	85.9	60.7	30.5	58.8	69.4	53.3	18.0	66.1	36.4	75.1	80.9	62.4	65.0	63.0	43.7	52.0	51.6	81.1	79.4	23.2	67.7	50.4	96.9	52.1	4.4	117.0	18.3	72.1	31.1	26.2	90.6	29.1	107.1	82.7	19.8	44.5	35.0	76.6	56.3	57.9	47.9	108.9	71.6	35.4	21.8	44.1	60.3	50.4	87.0	22.8	71.3	72.2	71.8	36.7	21.5	33.0	19.9	33.6	14.7	13.3	13.4	18.1	26.2	14.7	12.0	15.0	9.9	22.9	40.9	7.9	16.7	15.7	42.2	42.6	46.5	61.4	42.1	48.4	42.2	43.3	42.9	44.9	42.2	44.3	45.8	28.5	93.0	47.2	76.4	25.3	14.7	18.7	32.8	15.9	36.4	23.3	15.1	16.9	15.7	39.1	22.0	56.3	50.4	32.6	30.7	5.9	31.7	87.1	37.3	22.2	26.9	31.8	13.2	115.2	41.6	31.9	23.1	37.8	32.5	31.6	36.0	26.0	28.7	35.4	15.2	124.4	26.1	65.1	37.7	22.3	21.6	19.6	33.4	28.4	63.7	43.1	26.1	41.2	85.5	91.0	34.4	22.0	29.3	23.8	15.7	31.9	25.1	58.9	40.7	19.7	26.2	33.0	173.0	14.9	15.9	14.8	56.5	26.4	26.5	28.6	17.7
SPAG6	"CFAP194, CT141, FAP194, PF16, Repro-SA-1"	ENSG00000077327	"Sperm associated antigen 6"	O75602	10	22345445-22454224	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 31.6;choroid plexus: 51.7;fallopian tube: 49.4;testis: 97.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 228.6;Endometrial ciliated cells: 73.2;Respiratory ciliated cells: 266.4;Spermatocytes: 372.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	29	"U-937: 105.6"	"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in many"		"midbrain: 11.1"	HPA038440	Enhanced					NA	NA					"HPA038440: AB_10671742"	"unprognostic (5.02e-2)"	"unprognostic (9.52e-2)"		"unprognostic (8.94e-6)"	"unprognostic (2.21e-1)"	"unprognostic (2.51e-2)"	"unprognostic (4.91e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.38e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.78e-4)"	0.0	0.0	17.0	0.0	4.2	0.4	1.7	5.5	2.2	1.3	51.7	0.0	0.0	0.2	0.4	0.0	49.4	0.0	0.1	2.6	31.6	0.3	0.1	7.1	0.1	15.0	14.2	0.3	0.1	0.3	1.8	14.7	0.0	9.9	1.0	0.0	5.8	0.0	0.0	0.0	0.2	0.0	0.0	22.2	0.0	0.0	97.1	6.6	0.4	0.1	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.9	2.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	3.6	0.0	0.0	0.0	0.3	0.0	2.5	0.0	0.0	0.0	0.0	0.1	1.7	0.8	0.2	0.0	105.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	17.0	4.2	5.5	2.2	2.6	31.6	15.0	14.2	0.3	9.9	22.2	6.6	11.0	0.0	0.0	4.8	0.0	0.1	0.1	0.1	14.0	0.0	0.2	0.5	0.3	0.6	0.0	24.5	0.0	0.0	0.1	0.2	0.1	1.9	0.3	228.6	73.2	0.4	0.2	0.0	0.0	7.1	0.0	0.0	0.7	0.0	1.0	1.3	0.0	0.0	0.0	0.0	0.0	3.1	0.0	16.2	0.0	0.2	51.4	5.0	0.5	1.8	4.7	0.0	0.3	0.0	0.5	6.0	0.4	0.0	4.9	0.3	1.8	0.0	1.4	266.4	1.2	0.0	0.0	3.7	372.6	4.8	0.0	0.1	0.0	0.5	0.1	0.0	0.1
SPATA16	NYD-SP12	ENSG00000144962	"Spermatogenesis associated 16"	Q9BXB7	3	172889357-173141235	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	601	"testis: 60.0"	"Group enriched"	"Detected in some"	49	"Early spermatids: 288.6;Late spermatids: 129.3;Spermatocytes: 192.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA037884	Enhanced					NA	NA					"HPA037884: AB_2675717"															"unprognostic (3.60e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	288.6	0.0	0.0	0.2	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	129.3	4.1	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	192.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPATA22	NYD-SP20	ENSG00000141255	"Spermatogenesis associated 22"	Q8NHS9	17	3440019-3513852	"Predicted intracellular proteins"	Meiosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	53	"testis: 232.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 293.3;Late spermatids: 207.8;Spermatocytes: 1047.6"	"Cancer enriched"	"Detected in single"	10	"testis cancer: 3.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"K-562: 7.7;TIME: 10.9"	"Not detected"	"Not detected"													NA	NA						"unprognostic (4.09e-2)"				"unprognostic (9.31e-2)"	"unprognostic (2.54e-2)"		"unprognostic (7.07e-2)"	"unprognostic (9.05e-2)"		"unprognostic (1.98e-2)"		"unprognostic (6.79e-4)"	"unprognostic (4.33e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.27e-1)"		1.1	0.6	0.7	0.2	1.3	0.1	1.1	0.7	1.1	0.5	0.0	0.2	0.2	0.4	0.2	0.3	0.5	0.1	0.4	0.7	0.7	0.4	0.2	0.3	0.3	1.4	1.2	0.6	0.2	0.2	2.8	0.2	3.6	1.1	0.3	0.0	0.2	0.2	0.1	0.6	0.1	0.3	0.2	0.6	0.6	0.2	232.3	2.2	0.2	0.2	0.3	0.0	0.3	0.2	4.3	0.0	0.0	0.1	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.2	0.1	0.2	0.0	0.1	0.7	1.3	0.7	1.1	0.7	0.7	1.4	1.2	0.6	1.1	0.6	2.2	4.3	0.3	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.6	0.0	0.0	0.0	0.0	3.7	0.2	0.0	0.0	0.0	293.3	0.1	0.2	0.7	0.0	0.0	4.5	0.0	17.3	0.7	0.0	0.1	0.0	0.1	0.0	0.1	1.1	0.0	1.2	0.1	0.0	0.6	0.3	207.8	14.3	0.9	0.0	0.0	0.0	0.0	0.0	1.5	45.8	0.0	0.0	8.6	0.0	0.0	0.0	0.2	0.0	0.0	13.1	0.9	0.4	1047.6	58.8	0.0	0.1	1.2	0.1	0.2	0.0	0.0
SPATA4	"CFAP178, FAP178, SPEF1B, TSARG2"	ENSG00000150628	"Spermatogenesis associated 4"	Q8NEY3	4	176184579-176195585	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"testis: 140.8"	"Group enriched"	"Detected in some"	12	"Early spermatids: 1074.2;Late spermatids: 496.7;Spermatocytes: 460.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	9	"basophil: 1.2"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"GAMG: 1.4;U-87 MG: 2.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA019220	Enhanced					NA	NA					"HPA019220: AB_1857420"	"unprognostic (1.97e-3)"	"unprognostic (6.08e-2)"		"unprognostic (2.83e-1)"	"unprognostic (8.50e-3)"	"unprognostic (3.17e-2)"		"unprognostic (1.87e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.09e-3)"	"unprognostic (9.77e-2)"	"unprognostic (4.38e-6)"	"unprognostic (1.89e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.59e-1)"	0.0	0.4	1.6	0.0	0.9	0.1	0.6	0.9	1.0	0.3	1.2	0.3	0.0	0.3	3.6	0.1	8.8	0.2	0.4	0.7	1.4	2.3	0.0	1.2	0.0	1.5	1.3	0.6	0.2	0.4	0.4	1.0	0.0	1.1	0.2	0.0	2.3	0.3	0.5	1.1	0.1	0.1	0.2	1.3	0.0	0.1	140.8	0.8	0.0	1.7	0.4	0.0	0.1	0.0	0.8	0.0	0.3	0.0	0.0	0.1	0.4	0.0	0.2	0.3	0.1	0.3	0.2	0.2	0.0	0.0	0.2	1.4	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.9	0.3	0.3	0.4	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.3	0.0	0.3	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	2.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.6	0.9	0.9	1.0	0.7	1.4	1.5	1.3	0.6	1.1	1.3	0.8	0.8	0.0	0.0	0.5	0.3	0.0	0.0	0.1	2.2	0.0	0.5	1.0	1.4	0.5	0.0	3.2	0.0	0.0	0.0	0.0	0.0	5.9	0.5	1074.2	20.0	0.3	0.7	0.0	0.0	1.1	0.0	0.0	0.2	2.0	0.4	0.0	0.4	0.0	0.0	0.1	0.0	1.0	0.0	2.0	0.0	0.0	496.7	11.5	1.3	0.0	0.0	0.0	1.9	0.0	1.0	0.5	1.5	0.0	8.2	0.0	0.1	0.0	10.7	52.3	3.1	0.0	0.5	1.3	460.1	11.3	0.0	0.0	0.0	0.1	0.5	0.1	0.1
SPDYA	"Ringo3, SPDY1, SPY1"	ENSG00000163806	"Speedy/RINGO cell cycle regulator family member A"	Q5MJ70	2	28782517-28850611	"Predicted intracellular proteins"	"Cell cycle, DNA damage"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"testis: 32.8"	"Group enriched"	"Detected in many"	4	"Early spermatids: 58.8;Spermatocytes: 225.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 2.6;THP-1: 2.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035162, HPA066214"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA035162: AB_2674501, HPA066214: AB_2685636"	"unprognostic (3.41e-2)"	"unprognostic (3.20e-3)"	"unprognostic (2.45e-1)"	"unprognostic (3.53e-2)"	"unprognostic (4.21e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.10e-4)"	"unprognostic (3.04e-3)"	"unprognostic (1.95e-2)"	"unprognostic (6.54e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.66e-13)"	"unprognostic (8.56e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.55e-5)"	0.7	0.9	0.2	0.2	0.3	0.6	0.7	0.3	0.4	1.6	0.0	0.8	0.5	0.7	0.0	0.9	1.0	0.5	0.8	0.3	0.0	1.2	1.4	0.7	0.5	0.1	0.0	0.2	1.5	0.8	0.0	1.4	0.2	0.3	1.7	0.0	1.0	0.7	0.0	0.3	1.6	0.9	0.0	0.1	1.8	0.8	32.8	0.1	0.0	1.2	0.0	0.0	0.8	1.0	0.2	0.4	0.2	0.7	1.6	0.0	0.0	0.8	0.4	0.0	0.1	0.0	0.4	0.3	0.3	0.5	0.0	0.4	1.0	0.1	0.0	0.1	0.2	0.4	0.3	1.0	1.3	0.0	0.5	0.7	0.1	0.0	0.1	0.2	0.3	0.0	0.3	0.2	0.6	0.3	0.2	0.1	2.6	0.2	0.1	0.1	0.3	1.2	0.4	0.5	0.3	0.5	0.3	0.8	1.0	0.3	0.7	0.3	2.5	0.1	1.2	1.0	0.6	0.6	0.3	0.7	0.7	0.3	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.3	0.4	0.3	0.0	0.1	0.0	0.2	0.3	0.1	0.1	0.2	4.5	3.2	0.5	6.5	2.6	0.3	1.0	0.4	0.6	0.8	3.7	3.8	0.6	0.0	1.4	1.8	6.2	0.1	2.1	2.1	0.0	0.7	58.8	9.9	2.7	1.4	0.0	0.4	9.0	0.5	0.2	1.9	4.1	12.2	2.5	0.8	1.8	0.1	0.4	0.0	6.0	0.0	0.0	0.3	3.1	29.1	2.5	6.7	0.0	1.9	0.8	0.1	0.0	9.0	6.0	0.8	0.3	2.2	2.9	1.2	0.5	0.1	1.6	1.4	6.6	9.0	1.7	225.0	9.6	1.8	0.1	0.5	3.8	0.5	0.5	2.1
SPESP1	SP-ESP	ENSG00000258484	"Sperm equatorial segment protein 1"	Q6UW49	15	68818221-68946811	"Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 73.8"	"Group enriched"	"Detected in many"	4	"Early spermatids: 400.4;Spermatocytes: 455.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 17.8;BJ hTERT+ SV40 Large T+ RasG12V: 18.6;HBF TERT88: 21.7;HMC-1: 13.4;OE19: 15.9;RPTEC TERT1: 26.8;SCLC-21H: 19.9;WM-115: 31.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA045936, HPA051040"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted in male reproductive system"	NA	NA		52000	"Nucleoplasm, Vesicles"	Cytosol	"HPA045936: AB_2679504, HPA051040: AB_2681322"	"unprognostic (1.14e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.73e-3)"	"unprognostic (9.82e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.96e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.40e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.67e-2)"	2.2	3.4	1.1	0.9	1.1	0.4	2.2	1.1	1.5	1.1	0.9	1.4	1.2	1.5	6.4	2.6	1.9	3.6	2.8	1.0	1.2	1.8	1.2	1.1	0.8	1.3	1.2	0.8	3.4	1.9	4.8	1.2	13.0	1.2	3.5	1.1	2.9	1.9	2.9	1.6	1.0	0.9	1.2	1.3	1.3	1.6	73.8	1.1	1.0	1.9	2.0	0.7	2.4	0.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	17.8	18.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	21.7	5.0	0.0	0.0	0.0	0.0	6.3	0.0	13.4	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	2.9	0.0	0.0	3.3	15.9	0.0	0.0	1.4	0.0	26.8	0.2	19.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	31.6	1.1	1.3	0.4	0.2	1.1	0.5	0.5	0.4	0.3	0.8	0.3	0.3	0.5	0.5	0.2	0.8	0.4	0.4	0.5	1.1	1.1	1.1	1.5	1.0	1.2	1.3	1.2	0.8	1.2	1.3	1.1	1.5	5.1	0.0	0.0	0.0	0.2	1.9	3.0	23.7	1.8	1.0	2.7	4.1	4.1	1.5	4.0	7.3	4.2	92.3	0.3	0.2	1.9	2.1	400.4	3.9	3.4	3.6	1.8	0.8	0.0	2.7	7.2	5.5	0.0	2.0	0.0	1.7	2.2	1.8	7.8	0.0	0.0	0.9	6.1	2.1	3.3	90.3	21.1	1.2	5.4	0.0	1.0	5.3	0.0	0.0	0.0	0.9	0.0	8.6	0.0	3.3	0.0	3.9	6.3	5.6	46.0	3.4	4.2	455.0	88.7	1.1	2.3	62.1	0.5	11.1	0.2	1.5
SPINK2	HUSI-II	ENSG00000128040	"Serine peptidase inhibitor Kazal type 2"	P20155	4	56809860-56821742	"Disease related genes, Human disease related genes, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"epididymis: 5356.9"	"Group enriched"	"Detected in many"	10	"Early spermatids: 1217.2;Late spermatids: 1399.4;Spermatocytes: 1989.6"	"Group enriched"	"Detected in some"	5	"lung cancer: 1.3;testis cancer: 4.6;thyroid cancer: 2.4"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	7	"NK-cell: 146.4"	"Lineage enriched"	"Detected in many"	7	"NK-cells: 146.4"	"Cell line enriched"	"Detected in some"	4	"U-266/70: 90.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB020824, HPA026813"	Enhanced				"Secreted to blood"	NA	NA					"CAB020824: , HPA026813: AB_1857446"	"unprognostic (5.56e-3)"	"unprognostic (3.60e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.60e-1)"		"prognostic favorable (2.82e-4)"	"unprognostic (9.83e-2)"	"unprognostic (6.62e-2)"	"unprognostic (9.40e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.10e-3)"	"unprognostic (3.18e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.87e-2)"	0.5	0.1	0.2	1.1	0.2	13.6	1.4	0.1	0.7	0.7	1.5	2.8	1.9	0.3	5356.9	0.2	0.3	0.1	3.8	0.2	0.3	0.2	0.2	0.2	4.8	0.3	0.4	0.2	0.4	0.1	0.0	4.2	0.0	0.3	3.6	2.1	0.0	2.0	242.9	1.8	0.5	3.1	0.3	0.2	1.8	3.1	348.8	0.3	3.9	0.6	2.3	4.9	0.5	4.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.0	1.2	0.1	0.1	0.0	2.5	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.7	2.9	18.0	0.5	0.0	0.0	0.0	0.0	4.5	0.0	6.0	0.3	3.0	0.0	0.0	0.2	0.7	0.0	0.4	0.0	0.0	0.0	0.2	0.0	90.5	0.4	0.0	0.0	0.0	0.0	4.4	0.0	1.1	0.5	0.1	0.6	9.1	5.1	5.4	1.4	10.5	11.1	21.6	0.9	146.4	0.0	0.8	0.3	5.4	0.2	0.2	0.1	0.7	0.2	0.3	0.3	0.4	0.2	0.3	0.2	0.3	0.2	0.2	0.0	0.0	0.0	7.2	2.0	14.2	1.8	1.8	0.0	0.2	0.6	3.4	0.0	0.2	0.0	0.0	0.0	2.5	1.4	0.0	0.0	1217.2	0.2	0.1	1.6	1.8	32.4	0.3	0.0	0.3	0.8	0.5	0.2	1.3	0.3	0.0	0.0	0.1	0.0	0.2	10.4	0.0	0.0	3.6	1399.4	37.9	2.5	12.4	0.0	1.6	1.5	1.0	0.0	0.1	0.0	13.1	24.5	35.2	9.5	0.4	0.3	0.3	0.0	13.1	0.4	1.9	1989.6	149.9	0.1	0.3	0.0	16.8	0.0	2.6	2.6
SPRYD7	"C13orf1, CLLD6"	ENSG00000123178	"SPRY domain containing 7"	Q5W111	13	49912702-49936490	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Alveolar cells type 1: 131.4;Spermatocytes: 167.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043934	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA043934: AB_10960545"	"unprognostic (1.83e-2)"	"prognostic unfavorable (8.48e-6)"	"unprognostic (2.57e-1)"	"unprognostic (4.95e-2)"	"unprognostic (4.45e-1)"	"unprognostic (1.87e-3)"	"unprognostic (3.54e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.05e-1)"	"unprognostic (3.12e-3)"	"unprognostic (3.34e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.06e-2)"	5.3	8.7	10.2	3.9	11.6	3.3	5.7	9.6	13.9	4.4	6.7	7.6	6.3	4.4	5.4	7.7	4.7	3.2	11.7	11.5	11.8	8.5	10.8	10.2	3.2	10.2	9.9	11.2	5.4	5.6	9.5	6.1	6.3	11.1	6.5	6.6	12.4	4.7	5.0	24.1	6.1	7.3	5.3	8.9	4.0	7.0	9.0	11.0	2.6	6.8	15.5	3.7	5.7	5.5	12.4	10.1	8.5	5.4	6.0	6.5	9.2	12.3	19.5	9.1	13.5	7.7	15.5	8.1	9.8	6.1	14.4	11.1	8.5	12.1	18.1	18.7	16.3	10.9	10.5	6.5	10.9	22.1	25.4	7.2	8.0	20.0	11.8	23.0	8.4	8.4	5.5	12.0	8.6	31.6	6.2	0.9	11.9	2.1	15.3	9.6	4.7	9.1	6.0	14.1	7.6	4.5	5.6	5.7	12.8	9.8	6.8	11.9	15.7	10.8	12.2	6.8	11.3	19.8	5.3	8.8	7.5	9.5	10.2	14.0	0.7	2.0	1.7	2.0	2.3	4.1	5.3	1.9	2.6	2.5	4.3	1.5	2.3	0.4	6.8	4.6	1.7	3.1	1.8	10.2	11.6	9.6	13.9	11.5	11.8	10.2	9.9	11.2	11.1	8.9	11.0	12.4	23.7	131.4	32.8	22.2	17.0	20.3	23.3	64.1	21.1	29.4	17.2	20.1	60.1	21.5	32.1	12.9	8.4	38.8	11.2	42.4	52.8	32.1	118.5	25.9	20.0	21.5	23.4	6.5	35.5	25.8	45.0	21.4	15.3	13.3	17.7	12.5	19.2	52.1	27.9	23.5	33.3	21.4	26.4	7.6	13.9	24.3	21.1	14.1	23.2	24.4	14.6	21.6	12.3	24.6	60.1	37.2	23.6	20.3	12.4	23.9	34.5	82.1	26.6	30.7	6.6	20.1	29.8	167.1	56.9	33.8	31.0	39.8	11.9	27.7	22.2	10.4
SPSB2	"GRCC9, SSB-2"	ENSG00000111671	"SplA/ryanodine receptor domain and SOCS box containing 2"	Q99619	12	6870935-6889358	"Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 40.2"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 38.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 43.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055225	Approved					NA	NA					"HPA055225: AB_2682746"	"unprognostic (1.13e-1)"	"unprognostic (3.66e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.33e-1)"	"unprognostic (8.14e-2)"	"prognostic unfavorable (2.62e-4)"	"unprognostic (3.05e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.77e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.39e-2)"	5.3	11.3	6.7	5.9	6.5	6.2	5.9	9.6	9.9	7.7	6.0	6.9	5.0	8.0	3.4	7.3	7.7	6.4	4.5	6.0	7.2	13.5	6.8	12.5	7.4	6.7	6.5	5.4	5.1	8.7	4.6	7.6	2.4	7.0	7.2	2.3	4.3	7.8	6.2	5.2	8.2	7.5	3.0	6.6	9.4	7.7	9.8	6.3	8.5	12.2	1.7	3.6	7.5	6.6	7.8	9.4	43.6	4.2	6.5	9.7	4.6	8.3	9.7	11.0	8.4	4.0	19.9	35.8	3.2	4.5	8.4	6.1	8.8	10.3	5.5	1.2	21.4	3.5	11.0	13.7	7.8	14.7	5.0	10.5	4.9	7.8	11.1	9.8	6.9	5.7	12.6	7.1	4.3	8.7	13.7	10.0	5.8	17.1	12.6	13.2	9.3	5.5	6.4	16.7	6.4	1.8	5.3	6.7	13.0	10.4	12.3	3.9	8.5	4.8	8.4	13.2	8.8	10.3	5.7	9.2	4.1	9.3	9.6	12.0	0.1	8.4	24.0	12.1	9.9	14.2	11.8	11.9	9.9	9.3	13.2	13.5	12.1	6.8	7.0	12.1	17.3	13.6	8.3	6.7	6.5	9.6	9.9	6.0	7.2	6.7	6.5	5.4	7.0	6.6	6.3	7.8	4.2	28.9	19.9	2.0	7.1	2.5	3.7	7.5	2.2	5.3	8.5	4.4	3.3	7.2	9.4	20.2	2.1	5.8	4.4	11.1	33.2	13.3	16.8	18.6	5.3	5.5	9.5	6.6	0.5	10.7	4.5	5.8	3.6	8.9	8.2	2.5	7.5	4.7	11.5	6.7	0.9	10.8	0.0	7.6	3.9	8.9	9.6	8.1	0.0	1.9	13.4	9.4	17.5	1.0	1.8	9.0	6.6	9.1	2.2	7.6	15.6	40.2	19.5	14.3	6.6	6.5	6.3	29.0	9.2	4.1	4.8	7.7	8.5	10.2	7.8	3.4
SPSB4	SSB-4	ENSG00000175093	"SplA/ryanodine receptor domain and SOCS box containing 4"	Q96A44	3	141051347-141148611	"Predicted intracellular proteins"	"Biological rhythms, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.8;pancreas: 7.1;pituitary gland: 3.0;testis: 2.9"	"Group enriched"	"Detected in some"	4	"Early spermatids: 23.6;Late spermatids: 11.7;Oligodendrocyte precursor cells: 41.7;Spermatocytes: 22.1"	"Group enriched"	"Detected in some"	5	"glioma: 4.6;testis cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 12.5;NTERA-2: 3.5;RH-30: 4.2;SH-SY5Y: 3.6;U-2 OS: 2.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA062793			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA062793: AB_2732689"	"unprognostic (5.07e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.23e-3)"	"prognostic favorable (3.72e-4)"	"unprognostic (7.49e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.46e-4)"	"unprognostic (9.80e-3)"	0.3	0.3	1.1	0.0	0.9	0.0	0.1	0.8	1.3	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.3	1.9	0.3	0.0	0.4	0.0	2.8	2.0	0.2	0.0	7.1	0.2	3.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.0	1.6	1.1	0.0	2.9	1.1	0.2	0.0	0.0	0.0	0.1	0.1	1.1	0.0	0.0	12.5	0.2	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.4	0.9	0.0	3.5	0.0	0.0	0.0	4.2	0.6	0.0	0.0	1.1	3.6	0.0	0.0	0.0	2.0	0.2	0.3	0.0	0.0	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.9	0.8	1.3	0.3	1.9	2.8	2.0	0.2	1.6	1.6	1.1	1.1	0.4	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.1	4.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	23.6	0.0	0.1	0.1	0.0	0.0	2.8	0.5	0.0	3.2	0.0	0.0	0.0	0.4	0.4	0.1	0.2	0.0	5.6	0.0	0.0	5.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.7	0.3	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.4	22.1	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
SRP19		ENSG00000153037	"Signal recognition particle 19"	P09132	5	112861188-112898371	"Predicted intracellular proteins, Transporters"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029272, HPA057315"	Approved		Supported	"Nuclear bodies,Cytosol"		NA	NA			Cytosol	"Nuclear bodies"	"HPA029272: AB_10600910, HPA057315: "	"unprognostic (4.77e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.60e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.98e-3)"	"unprognostic (5.55e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.62e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (3.72e-10)"	"unprognostic (1.82e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.69e-3)"	28.6	32.8	22.4	29.2	23.4	79.9	29.3	22.5	25.6	21.7	21.1	23.9	24.8	25.5	38.6	29.6	22.2	23.3	25.4	23.3	23.7	25.6	48.5	24.6	38.7	22.0	22.4	22.8	18.0	42.0	25.6	40.8	28.9	22.8	32.9	27.4	14.7	29.8	18.1	34.2	24.0	23.6	30.5	21.2	30.2	26.0	20.4	23.6	36.3	40.3	24.1	40.3	29.0	22.5	24.1	60.1	40.7	49.3	78.6	45.2	52.4	118.7	82.0	51.8	69.2	82.3	68.0	45.8	62.3	55.0	53.2	110.0	39.0	54.6	84.5	82.2	66.0	88.8	55.1	80.5	80.6	72.4	44.7	58.5	61.2	80.5	64.9	95.6	45.5	64.7	67.1	41.9	72.3	59.5	70.1	72.6	79.0	51.1	60.5	61.6	45.6	44.3	94.4	68.6	75.5	56.1	49.6	66.4	42.4	40.3	56.5	64.7	63.2	52.1	57.1	48.6	57.3	98.3	85.2	111.4	107.9	55.4	75.4	60.3	66.7	34.1	43.6	49.3	37.3	60.9	54.9	55.0	52.7	39.9	45.8	46.3	52.4	48.1	50.9	41.3	86.8	72.2	36.3	22.4	23.4	22.5	25.6	23.3	23.7	22.0	22.4	22.8	22.8	21.2	23.6	24.1	64.7	80.1	49.9	17.9	60.6	86.4	74.8	102.2	9.1	15.6	75.1	85.9	52.0	41.5	87.8	44.1	20.9	80.0	120.2	29.6	103.7	96.4	38.9	76.0	85.0	53.4	119.0	52.2	26.7	103.2	125.0	55.9	16.3	80.4	73.5	54.6	35.7	65.3	84.5	13.5	24.6	67.6	79.3	53.3	53.8	24.0	38.8	56.6	51.6	21.5	87.8	30.7	90.6	21.6	41.1	130.4	38.9	39.5	65.7	107.5	33.5	117.1	74.1	24.6	26.3	40.8	58.3	157.4	44.7	22.6	87.8	148.2	71.3	54.2	41.2	112.7
STAM2	Hbp	ENSG00000115145	"Signal transducing adaptor molecule 2"	O75886	2	152116801-152175763	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 147.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 16.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035528, HPA035529"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			Vesicles	"Nucleoplasm, Cytosol"	"HPA035528: AB_10601606, HPA035529: AB_10672868"	"unprognostic (1.53e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.16e-2)"	"unprognostic (2.76e-2)"	"unprognostic (3.15e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.03e-2)"	9.8	10.0	7.8	7.9	8.6	3.2	12.6	8.0	9.0	11.0	8.6	10.3	9.4	11.0	8.8	9.1	12.9	9.4	9.7	7.0	8.1	14.8	11.0	10.8	8.8	8.1	8.3	6.4	11.1	8.9	12.9	6.5	10.4	8.4	13.0	11.0	11.2	12.0	9.0	5.9	10.8	9.3	10.2	8.2	8.3	11.8	12.7	8.1	8.6	14.4	7.8	9.0	10.8	6.7	10.3	8.3	7.9	7.2	8.8	18.5	22.0	7.7	16.8	19.4	10.7	13.6	7.8	7.8	10.8	13.1	24.2	9.4	8.3	8.0	15.6	17.1	13.3	6.3	7.8	5.1	11.8	21.2	11.5	14.6	16.9	14.6	20.0	26.8	15.5	11.7	7.2	5.1	7.5	22.2	8.1	6.1	8.9	4.5	6.1	11.2	4.9	8.9	5.9	16.7	14.1	3.8	5.9	9.3	8.2	14.1	8.0	11.1	10.5	15.3	23.7	7.6	18.8	10.3	6.1	6.7	6.8	17.9	9.2	13.2	16.8	3.4	4.6	1.7	4.6	1.6	1.7	1.8	1.9	2.7	2.0	1.5	1.9	8.6	2.6	7.1	3.2	2.2	1.6	7.8	8.6	8.0	9.0	7.0	8.1	8.1	8.3	6.4	8.4	8.2	8.1	10.3	17.6	25.6	33.5	39.2	10.9	13.8	12.0	16.4	15.9	10.6	17.9	11.6	30.5	7.2	28.9	16.5	16.7	7.4	14.7	22.1	23.5	13.9	147.8	37.2	25.5	15.1	8.3	13.5	43.8	14.2	14.6	22.7	27.0	22.2	27.1	14.8	17.5	16.0	16.7	1.7	39.7	20.2	20.3	20.0	13.0	64.4	15.8	16.9	14.2	32.8	19.6	14.7	8.2	51.8	61.0	21.2	18.2	15.4	10.9	14.3	13.9	14.8	55.6	11.6	26.3	18.0	16.1	54.1	20.1	13.5	13.2	20.2	9.3	18.2	13.5	16.1
STK31	"SgK396, TDRD8"	ENSG00000196335	"Serine/threonine kinase 31"	Q9BXU1	7	23710203-23832513	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	60	"testis: 64.6"	"Group enriched"	"Detected in some"	5	"Spermatocytes: 161.5;Spermatogonia: 75.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"CACO-2: 20.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA023194, HPA072896"	Enhanced					NA	NA					"HPA023194: AB_1857590, HPA072896: "	"unprognostic (4.25e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.98e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.42e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.29e-6)"	"unprognostic (7.83e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.65e-1)"	0.1	0.1	0.3	0.0	0.4	0.0	0.2	1.0	0.4	0.1	0.1	0.1	0.3	0.1	0.0	0.3	0.2	0.1	0.0	0.2	0.3	0.2	0.3	0.4	0.0	0.5	0.3	0.1	0.2	0.4	0.0	0.1	0.0	0.6	0.2	0.0	0.2	0.2	0.0	0.0	0.2	0.3	0.0	0.2	0.2	0.4	64.6	0.4	0.1	0.2	0.0	0.0	0.1	0.1	0.5	0.2	0.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	20.5	2.3	0.0	2.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	1.0	0.4	0.2	0.3	0.5	0.3	0.1	0.6	0.2	0.4	0.5	0.4	3.2	1.1	2.9	0.3	0.1	0.2	0.5	0.0	2.0	1.0	0.1	0.6	1.5	2.8	0.0	0.0	0.6	0.1	0.3	0.0	0.2	21.1	0.6	0.0	0.4	1.2	0.0	2.9	0.6	0.1	0.6	2.0	0.2	0.0	0.3	0.0	0.5	0.2	0.0	4.6	0.4	2.0	0.0	0.0	19.6	3.4	0.5	0.0	2.8	0.0	1.0	0.0	2.5	12.7	0.4	5.3	3.0	0.5	0.3	0.8	0.1	4.3	1.2	0.0	0.6	0.1	161.5	75.0	0.0	0.1	0.5	0.5	0.1	0.5	0.5
STON1-GTF2A1L	SALF	ENSG00000068781	"STON1-GTF2A1L readthrough"		2	48529925-48776517	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in many"	5	"brain: 13.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 8.4;Excitatory neurons: 2.9;Late spermatids: 2.2;Oligodendrocyte precursor cells: 12.1;Spermatocytes: 8.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 2.1;ASC TERT1: 2.0;HSkMC: 1.4;hTERT-RPE1: 3.6;SuSa: 7.3"									HPA005715	Uncertain					NA	NA					"HPA005715: AB_1080113"	"unprognostic (5.66e-3)"	"unprognostic (8.85e-2)"	"unprognostic (1.18e-3)"		"unprognostic (8.26e-2)"	"unprognostic (5.08e-2)"		"unprognostic (3.53e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.59e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.46e-2)"	2.2	0.3	2.2	0.8	1.7	0.0	0.3	3.0	0.9	1.6	2.0	2.3	0.2	2.1	0.5	1.3	1.3	2.1	0.2	0.3	1.7	0.6	0.0	0.4	0.0	6.7	2.8	0.0	1.8	0.0	0.0	0.1	0.8	6.8	0.8	0.9	2.1	0.0	0.9	0.0	0.0	0.4	2.5	4.8	0.5	1.0	0.5	1.6	0.1	0.1	0.0	0.0	2.6	0.4	13.1	0.0	0.0	0.8	0.0	2.1	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.1	1.4	0.1	0.0	0.0	3.6	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.7	3.0	0.9	0.3	1.7	6.7	2.8	0.0	6.8	4.8	1.6	13.1	0.2	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.2	0.0	0.0	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	1.9	0.0	0.4	0.0	12.1	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	8.2	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2
STYX		ENSG00000198252	"Serine/threonine/tyrosine interacting protein"	Q8WUJ0	14	52730166-52774989	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 117.1;Late spermatids: 92.5;Spermatocytes: 73.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040290	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA040290: AB_10963686"	"unprognostic (5.24e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.22e-1)"	"unprognostic (9.56e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.91e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.57e-3)"	"unprognostic (6.89e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.48e-2)"	"unprognostic (6.84e-3)"	9.5	3.7	3.8	8.9	4.9	5.8	7.7	5.2	4.4	5.6	3.6	6.0	5.8	6.9	4.7	9.1	4.7	5.8	8.8	3.2	4.0	5.9	26.9	5.9	14.1	5.0	5.0	2.9	6.9	5.9	4.9	2.2	9.6	5.0	6.4	6.5	3.9	5.8	5.9	11.5	8.2	5.7	7.0	4.6	9.2	6.7	11.0	4.4	9.5	5.7	13.0	12.5	7.5	4.9	6.1	14.4	7.8	10.5	12.7	17.5	24.9	20.0	16.9	12.6	12.1	12.2	11.3	10.3	17.7	14.1	16.0	10.2	11.1	13.1	13.8	21.3	16.0	5.0	9.1	8.3	15.0	14.5	14.5	11.5	17.9	16.4	16.0	16.4	10.9	22.2	15.7	11.0	16.6	16.9	19.9	16.3	9.5	12.7	16.1	15.9	13.6	14.1	10.5	15.8	16.1	2.4	7.0	17.3	11.5	11.4	14.6	28.1	14.5	20.8	21.1	13.4	23.1	10.7	6.1	8.8	10.8	6.8	9.6	18.3	7.7	4.4	3.7	5.6	6.1	7.4	6.1	9.2	7.6	4.8	3.8	10.6	8.2	2.2	4.9	5.8	3.6	10.8	5.6	3.8	4.9	5.2	4.4	3.2	4.0	5.0	5.0	2.9	5.0	4.6	4.4	6.1	15.2	6.4	9.2	6.2	18.3	16.6	10.7	10.2	9.6	5.1	14.1	8.0	23.1	8.6	11.4	5.5	6.2	13.8	19.7	7.6	13.7	12.4	117.1	9.1	10.9	16.0	4.8	15.6	7.7	18.2	32.8	11.8	11.2	8.9	20.8	5.9	16.1	54.7	15.4	5.0	7.6	6.1	8.2	21.2	20.4	92.5	9.6	20.2	3.6	10.3	27.6	8.7	15.5	6.6	15.9	14.5	7.9	11.3	16.2	19.6	8.1	12.0	14.6	6.9	26.3	8.7	19.6	73.1	25.7	16.9	19.6	21.1	25.6	5.9	8.2	13.6
SULT6B1		ENSG00000138068	"Sulfotransferase family 6B member 1"	Q6IMI4	2	37167820-37196598	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 1.6;testis: 2.4"	"Group enriched"	"Detected in some"	8	"Early spermatids: 3.5;Late spermatids: 1.8;Spermatocytes: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"WM-115: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"									NA	NA										"unprognostic (1.86e-1)"										"unprognostic (8.98e-2)"			0.0	0.0	0.4	0.0	0.2	0.3	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	1.6	0.2	0.1	0.3	0.3	0.1	0.2	0.1	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SUPT20H	"bA421P11.4, C13orf19, FAM48A, P38IP, SPT20"	ENSG00000102710	"SPT20 homolog, SAGA complex component"	Q8NEM7	13	37009312-37059713	"Predicted intracellular proteins"	"Autophagy, Gastrulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 56.8"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 145.7;Spermatocytes: 316.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038906, HPA038907"	Uncertain		Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA038906: AB_10673482, HPA038907: AB_10697401"	"unprognostic (4.04e-1)"	"unprognostic (9.67e-3)"	"unprognostic (2.97e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.81e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.46e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.55e-3)"	"unprognostic (2.30e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.21e-3)"	10.1	9.2	7.9	12.4	8.7	19.4	10.1	10.1	12.8	13.3	9.8	13.7	7.6	13.5	8.9	10.4	15.4	10.7	12.2	7.8	9.1	9.6	6.5	11.9	14.0	9.1	8.4	7.8	13.2	7.5	9.9	9.9	13.7	9.2	11.5	11.4	11.1	9.0	12.6	14.7	9.2	10.7	16.3	8.1	13.5	9.9	56.8	8.5	23.9	9.3	11.5	16.0	13.7	10.6	10.2	13.8	16.7	52.0	29.5	19.2	26.1	21.7	36.4	22.6	40.8	29.4	28.0	26.3	27.3	14.7	29.4	45.3	23.4	32.6	37.7	54.2	38.1	29.5	82.9	11.7	30.6	36.9	33.9	35.4	19.9	23.1	37.0	63.2	24.9	49.3	36.7	27.5	6.9	47.9	20.5	47.6	23.7	32.7	31.9	18.8	38.2	36.3	5.9	30.6	21.5	9.7	26.1	23.4	20.9	26.0	41.3	15.1	29.8	29.8	16.5	14.4	19.4	31.1	11.5	12.3	26.8	18.8	19.9	31.7	18.9	16.1	22.6	18.9	21.1	16.7	12.9	18.0	17.0	15.3	14.1	20.6	19.7	28.1	19.3	20.4	11.9	21.7	15.2	7.9	8.7	10.1	12.8	7.8	9.1	9.1	8.4	7.8	9.2	8.1	8.5	10.2	25.9	22.4	29.6	34.9	29.0	13.5	16.1	18.8	19.4	36.0	20.3	22.6	16.4	14.3	28.1	31.3	35.5	32.4	26.4	13.1	21.5	24.7	145.7	48.5	35.6	21.4	31.2	33.9	41.8	14.5	31.0	23.3	25.0	25.3	45.5	60.2	23.2	9.8	19.6	21.9	47.7	20.4	26.4	18.2	16.8	29.4	34.2	22.6	7.2	54.4	33.2	17.3	37.0	45.2	60.1	21.6	14.9	33.4	25.4	19.6	17.9	17.6	40.5	34.4	32.9	20.1	27.8	316.0	74.2	23.3	9.9	26.4	34.5	69.4	19.9	15.7
SWT1	"C1orf26, FLJ20121, HsSwt1"	ENSG00000116668	"SWT1 RNA endoribonuclease homolog"	Q5T5J6	1	185157080-185291781	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"testis: 38.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 150.8;Late spermatids: 52.7;Oligodendrocytes: 55.2;Spermatocytes: 54.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 14.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 18.4;U-266/84: 15.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024214, HPA027334"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA024214: AB_1845642, HPA027334: AB_1845643"	"unprognostic (2.67e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.65e-1)"	"unprognostic (4.26e-2)"	"unprognostic (3.17e-3)"	"unprognostic (8.41e-3)"	"unprognostic (5.71e-3)"	"unprognostic (9.26e-3)"	"unprognostic (7.37e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.28e-1)"	"prognostic favorable (5.63e-4)"	"unprognostic (1.97e-1)"	"unprognostic (4.19e-2)"	"unprognostic (4.50e-2)"	"unprognostic (4.35e-2)"	3.3	3.3	4.5	3.0	5.6	9.1	4.2	4.7	4.2	3.8	4.2	3.4	4.9	4.3	4.4	2.7	2.9	3.8	3.7	3.2	5.0	4.8	3.3	3.5	2.8	5.2	5.3	2.8	6.4	9.3	4.4	2.4	5.6	5.2	4.7	3.3	5.5	6.5	3.1	2.9	3.0	3.8	3.2	4.8	3.1	4.9	38.6	4.8	5.0	5.2	4.6	3.0	3.3	2.8	7.4	2.1	1.8	5.0	2.7	8.1	6.2	4.2	2.1	3.6	2.6	3.9	1.5	1.7	2.1	4.1	1.6	2.6	1.8	3.1	2.8	3.3	5.6	2.1	2.2	1.2	2.0	4.0	0.7	1.8	4.6	2.8	2.8	2.5	4.4	6.3	4.2	4.8	10.2	2.7	0.7	2.5	1.9	5.4	5.5	1.0	1.9	4.5	5.2	2.5	1.3	1.0	7.7	1.7	2.6	7.2	11.7	2.9	1.4	3.0	3.4	2.2	3.2	1.3	18.4	15.2	0.8	3.8	1.3	1.3	14.2	1.9	2.8	1.5	1.8	2.8	2.3	3.1	2.3	1.2	3.3	2.9	2.2	5.6	0.8	4.3	1.1	6.1	1.1	4.5	5.6	4.7	4.2	3.2	5.0	5.2	5.3	2.8	5.2	4.8	4.8	7.4	7.1	3.2	1.1	37.2	4.0	1.0	2.0	1.4	2.8	4.3	5.0	3.4	7.3	2.8	3.2	5.5	4.2	3.2	2.2	5.1	0.0	2.9	150.8	5.3	4.4	4.9	0.0	8.2	25.5	2.7	6.8	5.5	4.6	4.9	2.5	4.5	7.9	3.8	3.7	8.4	32.3	3.6	0.0	5.7	1.9	52.7	4.7	3.1	1.8	21.5	3.8	2.6	4.1	31.7	55.2	2.1	7.8	5.7	5.7	2.4	4.4	5.3	2.4	5.4	0.0	4.3	5.7	54.3	11.5	3.0	0.6	6.7	3.6	2.3	2.9	2.3
SYCE3	C22orf41	ENSG00000217442	"Synaptonemal complex central element protein 3"	A1L190	22	50551112-50562919	"Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	46	"testis: 143.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 497.2;Late spermatids: 99.0;Spermatocytes: 508.0;Spermatogonia: 182.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.0;Karpas-707: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA047813			Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	NA			"Nucleoplasm, Nucleoli, Golgi apparatus"		"HPA047813: AB_2797234"	"unprognostic (2.55e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.06e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.98e-3)"	"unprognostic (1.68e-2)"	"unprognostic (4.05e-2)"	"unprognostic (3.43e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.20e-2)"	0.4	1.1	1.6	0.5	1.6	0.3	1.1	1.6	3.1	0.4	1.4	0.7	0.2	0.0	1.6	0.5	1.2	1.0	0.2	1.5	1.8	2.7	1.8	0.6	0.5	1.7	1.9	1.4	0.0	0.4	0.6	1.3	0.3	1.9	0.5	0.1	1.4	0.5	0.1	0.1	0.4	0.2	0.0	1.5	0.2	0.4	143.2	1.7	0.8	1.7	0.0	0.3	0.5	0.2	1.8	0.2	0.4	0.1	0.1	0.3	0.3	0.2	0.3	0.0	0.1	0.0	0.0	5.0	0.2	1.7	0.0	1.0	0.0	0.5	0.5	0.0	0.0	0.2	0.0	0.4	0.0	2.1	0.0	0.9	1.3	1.1	0.2	0.8	0.2	0.0	1.0	0.0	4.1	0.2	1.8	0.0	0.0	0.2	2.1	0.0	0.0	0.0	2.3	0.6	1.5	0.4	1.3	0.0	1.2	0.9	0.2	1.2	1.0	0.0	0.4	0.4	0.0	0.0	1.0	0.2	0.7	0.5	0.1	0.1	0.0	0.7	0.8	0.0	0.6	0.1	0.0	0.0	0.0	1.1	0.2	0.0	0.1	4.3	0.0	0.5	0.0	0.0	0.1	1.6	1.6	1.6	3.1	1.5	1.8	1.7	1.9	1.4	1.9	1.5	1.7	1.8	0.3	0.0	0.0	0.0	0.1	0.1	0.4	3.7	2.8	0.8	5.6	5.6	0.5	2.8	2.1	1.8	0.0	5.9	0.1	0.4	3.9	1.7	497.2	2.7	0.4	0.7	0.0	0.0	0.1	0.6	3.2	0.2	0.0	2.0	0.0	0.0	0.7	3.2	1.7	0.0	0.1	0.1	4.1	1.2	0.0	99.0	10.8	0.8	0.0	0.0	2.9	1.2	0.0	0.0	0.2	0.9	0.1	7.2	0.0	0.6	0.4	7.6	4.7	0.8	46.0	0.0	0.7	508.0	182.4	0.8	0.1	3.7	0.1	0.0	0.2	0.8
SYPL1	SYPL	ENSG00000008282	"Synaptophysin like 1"	Q16563	7	106090505-106112576	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 633.6;Spermatocytes: 536.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014141	Approved					NA	NA					"HPA014141: AB_1857716"	"unprognostic (8.88e-2)"	"unprognostic (8.10e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.47e-1)"	"unprognostic (4.76e-2)"	"unprognostic (4.61e-2)"	"unprognostic (8.74e-2)"	"unprognostic (9.15e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.32e-1)"	"prognostic favorable (1.25e-9)"	"unprognostic (2.09e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.17e-1)"	79.4	70.7	42.7	49.6	56.4	51.6	99.3	63.4	63.0	94.3	43.4	79.8	61.0	101.0	89.7	148.4	105.0	70.7	74.0	41.2	54.2	128.3	67.2	67.5	86.7	76.8	58.9	37.2	72.7	54.8	126.8	26.5	84.8	72.7	97.7	77.8	13.1	137.0	120.9	151.0	94.8	58.7	110.3	70.9	60.3	82.4	98.5	53.5	57.3	118.5	102.5	122.4	108.5	95.5	96.0	187.1	85.3	44.9	74.4	188.8	142.9	65.0	115.0	128.3	105.8	128.5	58.5	323.6	187.0	150.9	144.2	179.5	154.9	72.4	186.0	174.8	51.6	85.5	82.6	49.5	57.4	148.0	140.7	65.5	107.5	236.7	111.1	142.8	140.9	147.9	69.5	85.5	0.4	212.7	161.3	149.3	167.1	49.8	214.5	112.6	18.4	75.7	97.7	224.4	300.4	22.1	50.1	111.3	266.4	115.6	106.8	81.6	111.0	133.2	210.3	107.3	226.0	132.4	82.1	102.2	193.7	92.6	239.8	121.0	66.9	39.8	44.8	13.6	37.9	28.2	130.3	36.3	27.3	32.5	125.1	53.5	34.3	15.2	71.3	31.2	31.3	33.9	40.9	42.7	56.4	63.4	63.0	41.2	54.2	76.8	58.9	37.2	72.7	70.9	53.5	96.0	186.9	54.5	63.4	27.1	238.6	171.7	285.3	326.6	252.6	8.9	111.5	70.4	69.7	181.6	172.9	187.6	16.7	211.6	45.9	51.6	113.5	167.0	633.6	96.6	57.3	153.3	37.8	81.2	8.4	107.5	144.7	125.1	88.7	87.7	91.4	47.9	152.4	96.5	90.5	20.2	7.6	82.7	175.0	83.4	95.3	170.3	95.1	69.4	145.9	16.9	39.4	103.9	15.5	8.5	70.8	130.0	66.2	94.0	23.8	213.6	61.0	221.4	131.2	12.8	157.8	76.3	144.4	536.4	126.3	309.0	173.0	184.0	79.5	113.6	101.1	271.8
TBC1D15	"DKFZp761D0223, FLJ12085"	ENSG00000121749	"TBC1 domain family member 15"	Q8TC07	12	71839707-71927248	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 160.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013388, HPA015592"	Supported		Supported	Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"		"HPA013388: AB_2199233, HPA015592: AB_1857789"	"unprognostic (3.87e-2)"	"prognostic favorable (7.06e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.63e-2)"	"unprognostic (6.13e-3)"	"unprognostic (2.96e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.07e-2)"	"unprognostic (2.18e-1)"	"prognostic favorable (5.34e-4)"	"unprognostic (5.73e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.78e-1)"	27.1	26.1	11.7	15.9	14.5	42.6	25.6	13.8	17.1	21.2	11.2	14.7	15.6	21.5	13.2	16.4	15.3	21.8	15.4	11.0	13.0	22.9	30.9	21.6	22.7	15.0	13.0	10.5	22.5	24.0	23.2	14.5	23.6	14.8	18.0	15.0	14.2	22.8	13.1	43.8	17.9	18.0	18.4	14.3	22.0	17.3	18.7	12.5	25.1	28.1	25.7	20.0	18.0	15.0	20.4	21.0	20.3	17.1	18.4	35.2	38.8	25.6	20.8	58.5	30.6	39.7	13.9	18.4	26.9	14.0	21.6	21.9	13.7	22.3	15.7	32.6	23.1	18.0	23.5	17.0	12.3	29.9	33.1	17.1	35.0	20.5	23.1	39.3	39.7	26.9	25.7	27.9	16.0	25.4	15.3	24.9	25.3	37.4	19.2	17.4	17.9	19.1	29.3	23.3	18.6	18.9	17.3	29.5	25.9	26.2	23.7	26.5	23.1	25.3	23.9	10.6	26.5	14.4	38.1	36.1	35.5	14.3	22.6	21.8	2.6	5.7	7.8	6.1	5.5	6.8	4.3	7.5	5.8	5.1	4.2	9.5	8.6	11.7	5.7	8.1	2.8	10.8	5.4	11.7	14.5	13.8	17.1	11.0	13.0	15.0	13.0	10.5	14.8	14.3	12.5	20.4	83.4	48.1	69.3	42.4	34.7	58.6	33.6	23.8	25.6	33.7	30.2	25.5	24.8	24.3	38.5	18.4	10.4	20.4	43.1	18.3	13.7	29.3	160.8	38.1	40.4	53.3	13.8	27.8	60.3	25.5	15.5	44.5	17.3	82.0	34.1	30.8	79.2	35.6	24.0	52.2	57.7	22.0	20.3	54.2	41.8	26.7	34.8	46.0	32.0	35.6	27.5	29.9	16.5	45.2	85.7	25.1	11.0	32.7	33.9	39.9	21.5	39.8	49.8	25.6	19.7	58.2	35.7	76.9	24.5	18.1	68.5	38.3	39.2	38.8	15.0	37.1
TBK1	NAK	ENSG00000183735	"TANK binding kinase 1"	Q9UHD2	12	64452090-64502114	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Amyotrophic lateral sclerosis, Disease variant, Glaucoma, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045797, HPA060211"	Uncertain		Enhanced	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA045797: AB_2679457, HPA060211: AB_2684222"	"unprognostic (4.73e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (3.48e-4)"	"unprognostic (1.69e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (4.20e-6)"	"unprognostic (4.35e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.26e-2)"	"unprognostic (9.56e-3)"	11.3	15.5	6.1	10.2	6.1	17.1	11.5	5.7	6.9	9.9	5.7	10.2	15.2	11.0	6.7	11.4	9.6	10.2	9.5	5.9	5.6	11.9	17.5	13.0	14.7	6.5	7.1	5.9	9.6	7.6	11.7	9.8	13.8	6.2	10.7	8.5	6.3	10.3	9.1	18.6	8.6	11.5	10.9	5.6	13.5	10.3	23.7	6.8	6.9	8.6	15.0	13.0	16.1	10.3	7.2	23.3	24.2	11.1	10.6	24.7	26.1	29.0	22.9	37.6	22.5	21.1	14.9	12.4	31.5	21.4	26.8	34.4	19.0	19.4	20.0	26.4	29.5	17.1	33.0	15.3	19.1	30.2	35.2	36.4	18.5	19.1	23.1	23.6	42.3	32.4	11.0	27.9	38.7	31.6	27.0	0.9	17.0	29.9	22.9	13.8	14.9	15.3	31.8	25.1	36.9	9.8	14.7	33.3	36.0	23.5	23.5	33.1	24.9	25.9	20.2	18.1	14.9	24.0	25.4	54.3	30.3	28.1	18.6	26.1	41.8	10.1	24.3	13.9	17.7	16.3	12.8	10.1	15.2	12.2	10.1	2.8	8.7	17.8	26.6	15.5	2.1	13.6	10.0	6.1	6.1	5.7	6.9	5.9	5.6	6.5	7.1	5.9	6.2	5.6	6.8	7.2	23.7	19.2	20.5	28.4	21.6	11.0	25.7	20.1	15.4	17.0	14.9	9.1	10.9	8.6	23.4	22.0	10.4	28.8	30.0	14.1	11.7	19.3	34.5	19.2	17.9	28.6	17.3	18.3	50.5	23.6	32.6	21.3	15.3	30.2	43.1	17.5	16.8	17.1	20.2	18.5	42.2	10.5	12.2	23.0	30.2	29.2	19.3	31.1	14.2	46.9	31.4	12.7	33.0	39.2	52.3	16.9	10.9	20.7	25.6	43.7	13.6	12.3	20.8	16.3	26.3	22.4	18.7	68.9	12.7	14.0	14.9	92.6	27.1	11.5	10.1	41.6
TBL2	"DKFZP43N024, WBSCR13, WS-betaTRP"	ENSG00000106638	"Transducin beta like 2"	Q9Y4P3	7	73567537-73578791	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 44.6"	"Group enriched"	"Detected in all"	7	"Early spermatids: 398.2;Late spermatids: 515.4;Spermatocytes: 345.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007477, HPA051533"			Supported	Cytosol	"Secreted in male reproductive system"	NA	NA			Cytosol		"HPA007477: AB_1080214, HPA051533: AB_2681523"	"unprognostic (9.04e-2)"	"unprognostic (6.61e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.76e-2)"	"prognostic unfavorable (4.93e-4)"	"unprognostic (2.24e-3)"	"unprognostic (7.50e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (1.88e-5)"	"unprognostic (1.59e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.31e-1)"	4.8	9.2	2.1	5.3	2.1	1.6	4.2	3.3	5.4	4.6	2.8	4.7	5.5	4.5	8.4	5.4	4.3	2.7	3.9	2.3	2.1	4.2	6.0	5.6	1.9	2.1	2.1	2.2	4.8	16.6	5.6	3.2	4.4	2.5	4.4	5.6	4.0	11.1	4.3	2.9	4.9	4.4	4.6	2.1	3.2	6.5	44.6	2.1	2.3	4.9	1.5	3.2	3.6	4.5	2.2	22.1	27.5	8.7	12.6	19.9	18.2	10.2	26.9	18.4	9.3	17.1	40.9	22.0	18.4	5.4	21.7	19.5	15.9	18.2	9.5	19.4	6.8	10.8	6.6	11.8	26.3	28.5	13.3	22.4	11.4	15.0	28.7	22.1	16.7	10.2	2.4	26.0	12.6	14.7	20.2	13.2	10.7	8.7	23.8	18.1	8.6	14.6	38.8	10.5	16.0	8.4	14.3	25.8	65.8	16.9	10.1	17.2	5.7	18.7	17.1	8.8	17.1	25.7	25.8	18.0	20.0	23.3	15.3	21.3	16.8	11.1	4.9	6.3	7.3	5.9	3.0	5.0	5.2	13.6	4.1	5.9	3.7	1.4	8.8	7.4	10.2	6.5	8.1	2.1	2.1	3.3	5.4	2.3	2.1	2.1	2.1	2.2	2.5	2.1	2.1	2.2	8.6	25.6	9.3	3.3	8.1	4.6	14.5	17.3	4.0	10.8	10.8	6.3	4.7	11.5	13.5	5.5	8.4	45.2	6.5	12.7	1.9	26.1	398.2	11.3	14.9	12.6	9.5	6.3	4.1	30.1	54.6	17.3	7.7	11.6	14.0	13.9	10.0	14.7	27.4	3.3	4.5	16.8	6.1	9.4	3.8	515.4	23.6	17.5	7.2	4.7	17.3	8.1	10.3	4.5	4.1	22.6	13.7	26.7	19.9	17.1	14.6	5.1	9.8	13.4	6.6	13.8	15.1	345.8	27.9	7.8	3.7	43.4	5.0	17.0	15.8	9.0
TBP	"GTF2D1, SCA17, TFIID"	ENSG00000112592	"TATA-box binding protein"	P20226	6	170554302-170572870	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	DNA-binding	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 88.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009442, HPA049805"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB009442: AB_632480, HPA049805: AB_2680890"	"unprognostic (2.86e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.90e-2)"	"unprognostic (4.55e-3)"	"unprognostic (7.10e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (1.51e-7)"	"unprognostic (1.46e-1)"	"unprognostic (4.28e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.05e-1)"	10.1	10.6	10.2	9.7	10.4	15.7	10.5	11.5	15.2	10.3	9.6	11.5	8.6	12.7	8.2	11.4	11.8	8.3	9.0	11.2	10.3	10.3	11.6	9.8	14.1	11.7	10.3	9.3	12.9	11.8	9.4	9.3	10.9	11.1	10.6	8.6	9.0	10.3	7.7	12.9	10.8	12.0	9.7	9.5	15.0	11.8	34.9	10.4	12.0	10.6	10.7	12.3	10.7	10.8	13.0	12.9	14.0	24.4	31.2	12.5	14.2	23.0	20.5	15.6	19.9	21.1	28.9	12.7	27.1	16.4	16.7	28.6	18.9	31.6	16.8	21.2	31.5	23.2	27.6	16.6	26.1	18.1	32.7	23.1	13.8	19.2	22.9	25.8	16.3	15.9	37.2	49.7	16.5	18.3	19.3	32.8	31.8	24.5	27.3	11.0	28.6	20.0	23.8	14.5	6.5	10.4	24.9	24.1	17.8	16.0	20.7	12.4	40.7	17.6	13.5	19.1	22.2	32.0	24.4	35.1	42.3	18.5	27.0	21.9	67.4	30.8	39.8	37.8	32.2	44.4	52.9	36.7	38.6	30.2	49.9	47.3	40.0	44.4	35.0	45.4	42.6	37.2	21.8	10.2	10.4	11.5	15.2	11.2	10.3	11.7	10.3	9.3	11.1	9.5	10.4	13.0	8.4	9.6	6.9	6.8	16.5	5.5	5.3	11.6	20.5	7.5	8.3	7.4	9.9	15.7	10.0	12.9	8.4	15.8	10.5	6.2	3.9	6.6	26.9	7.8	9.3	9.5	7.2	17.5	13.7	4.7	13.5	9.2	7.7	10.7	1.3	13.0	13.2	8.0	10.1	0.0	12.8	7.5	22.4	14.0	5.3	7.7	10.8	9.8	1.8	10.3	8.5	5.4	6.2	11.1	16.2	6.6	7.9	10.5	18.7	8.5	8.2	8.9	7.2	6.7	13.1	6.6	11.1	88.1	17.4	18.3	6.7	13.5	11.1	10.1	8.0	6.7
TBPL1	"STUD, TLF, TLP, TRF2"	ENSG00000028839	"TATA-box binding protein like 1"	P62380	6	133952170-133990432	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 127.8"	"Group enriched"	"Detected in all"	5	"Early spermatids: 407.5;Spermatocytes: 557.4;Syncytiotrophoblasts: 244.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071810, HPA071813"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA071810: AB_2686451, HPA071813: AB_2686452"	"unprognostic (2.21e-3)"	"unprognostic (1.95e-2)"	"unprognostic (5.11e-2)"	"unprognostic (6.67e-3)"	"prognostic favorable (7.22e-4)"	"unprognostic (5.16e-3)"	"prognostic unfavorable (7.91e-5)"	"unprognostic (1.19e-1)"	"unprognostic (3.94e-2)"	"unprognostic (4.66e-2)"	"prognostic favorable (7.23e-4)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (4.14e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.82e-1)"	"unprognostic (8.16e-2)"	11.2	11.8	15.3	12.2	20.2	37.9	10.6	20.2	21.0	10.5	13.6	11.8	13.4	12.4	8.2	11.8	13.2	11.9	12.0	19.7	18.6	8.7	13.9	9.8	21.5	14.9	14.2	16.4	12.7	8.2	10.5	11.8	15.0	16.5	12.3	14.4	15.2	9.2	12.4	6.5	8.9	13.0	11.2	12.6	12.7	11.8	127.8	18.6	20.0	16.9	9.3	17.0	15.2	9.9	19.6	16.5	19.6	43.9	28.5	32.6	33.3	24.5	29.9	31.5	39.1	51.1	23.0	13.0	49.8	20.2	24.1	43.8	21.2	28.0	32.3	46.8	38.3	35.9	87.8	11.5	25.5	33.0	46.4	32.8	20.8	32.2	43.8	47.1	30.7	37.6	43.3	129.3	33.4	28.1	37.0	39.2	27.8	49.2	23.6	25.1	26.7	26.4	19.5	23.2	14.3	56.5	56.2	17.7	23.2	37.8	36.9	10.5	18.5	34.4	22.5	32.4	50.0	33.6	27.2	31.5	32.8	37.7	30.0	27.4	133.1	31.7	81.8	62.7	33.3	69.8	67.6	53.1	67.1	29.8	60.2	50.6	59.5	74.8	52.5	38.3	35.4	60.5	64.0	15.3	20.2	20.2	21.0	19.7	18.6	14.9	14.2	16.4	16.5	12.6	18.6	19.6	35.6	6.4	12.2	10.7	43.2	70.7	27.0	46.7	46.1	22.8	29.8	34.2	12.8	28.6	21.1	7.3	18.8	40.7	59.1	16.8	29.4	29.1	407.5	20.6	17.1	40.8	71.0	51.4	35.3	25.2	69.7	30.8	36.7	14.8	40.0	13.5	22.9	11.2	24.4	15.2	25.2	26.5	48.8	14.8	43.2	75.1	21.1	38.3	32.0	22.5	21.3	23.3	42.2	27.2	27.7	31.4	24.2	18.4	35.2	39.7	17.9	28.4	28.2	12.3	19.7	27.3	35.1	557.4	72.8	36.7	65.8	244.9	50.0	11.0	24.3	37.6
TCFL5	"bHLHe82, CHA, E2BP-1, Figlb"	ENSG00000101190	"Transcription factor like 5"	Q9UL49	20	62841005-62861822	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 69.5;testis: 74.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 23.6;Oligodendrocytes: 32.4;Spermatocytes: 64.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA055223, HPA076419"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA055223: AB_2682745, HPA076419: "	"unprognostic (4.05e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (3.24e-4)"	"unprognostic (2.78e-1)"	"unprognostic (2.72e-3)"	"unprognostic (3.95e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.88e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.77e-2)"	"unprognostic (4.89e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.01e-2)"	6.8	4.4	59.9	5.0	61.2	4.9	7.5	56.2	64.2	7.3	43.2	6.6	3.7	6.6	7.5	7.0	6.7	5.9	6.6	50.1	53.6	5.6	5.6	4.2	6.2	59.8	62.4	46.7	9.6	5.7	10.0	4.8	5.8	63.1	5.5	4.3	8.9	5.8	7.0	5.8	13.7	4.9	6.4	63.8	5.0	4.8	74.6	58.6	11.9	18.5	7.3	6.2	7.2	5.4	69.5	23.4	6.9	14.9	17.6	31.1	31.3	13.3	14.9	20.1	28.5	15.6	16.9	14.1	11.8	16.7	13.2	15.1	25.0	15.1	16.8	24.7	8.3	12.7	9.9	20.9	25.3	12.2	14.4	11.4	11.6	24.2	8.1	16.4	12.1	12.9	17.9	11.1	4.4	13.3	28.1	63.4	18.0	9.8	19.2	21.7	34.8	25.9	16.8	7.6	6.8	21.3	11.5	26.2	10.4	41.3	10.5	17.9	26.5	14.1	22.4	14.6	19.7	17.7	11.0	8.0	9.9	13.6	17.6	12.7	0.1	0.3	0.6	0.6	0.3	0.4	0.2	0.4	0.4	0.2	0.2	0.4	0.3	0.5	0.2	0.3	0.4	0.4	0.1	59.9	61.2	56.2	64.2	50.1	53.6	59.8	62.4	46.7	63.1	63.8	58.6	69.5	8.9	0.0	1.5	4.9	3.3	10.5	1.6	1.6	0.6	10.2	4.6	5.0	4.7	5.7	1.3	7.3	6.2	0.6	3.7	1.3	1.9	1.4	23.6	2.7	6.9	6.6	2.4	1.7	10.6	1.2	0.9	5.2	1.5	2.7	0.0	7.8	3.3	3.8	1.0	8.4	7.4	2.5	2.0	4.0	6.2	9.4	7.8	2.4	3.6	3.7	2.1	12.8	1.0	10.1	32.4	1.0	1.8	7.2	0.9	1.5	1.2	2.2	1.8	6.9	0.0	4.8	4.1	64.6	8.9	2.1	14.2	0.3	2.5	5.8	2.3	1.3
TCP10L2	bA517H2.3	ENSG00000166984	"T-complex 10 like 2, pseudogene"	B9ZVM9	6	167146414-167196913	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"epididymis: 1.3;testis: 1.1"	"Group enriched"	"Detected in some"	13	"Early spermatids: 11.7;Late spermatids: 10.8;Spermatocytes: 39.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB034197, HPA044709"	Uncertain					NA	NA					"CAB034197: AB_2202388, HPA044709: AB_10961410"			"unprognostic (5.07e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.35e-1)"		"unprognostic (2.52e-1)"			"unprognostic (1.24e-1)"	"unprognostic (1.12e-1)"		"unprognostic (5.40e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.19e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	11.7	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	39.5	0.5	0.0	0.0	0.0	0.2	0.0	0.3	0.0
TDRD10	DKFZp434M202	ENSG00000163239	"Tudor domain containing 10"	Q5VZ19	1	154502219-154548147	"Cancer-related genes, Predicted intracellular proteins"		RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 56.0"	"Group enriched"	"Detected in some"	5	"Early spermatids: 61.8;Late spermatids: 89.0;Spermatocytes: 103.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 3.0;TIME: 1.4"					"Not detected"	"Not detected"			HPA054327			Approved	Vesicles		NA	NA			Vesicles		"HPA054327: AB_2682452"	"unprognostic (1.30e-1)"	"unprognostic (6.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.33e-3)"	"unprognostic (9.69e-3)"	"unprognostic (5.80e-3)"	"unprognostic (2.99e-1)"	"unprognostic (5.97e-3)"	"unprognostic (2.44e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.00e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.34e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (8.04e-5)"	"unprognostic (1.62e-1)"	9.1	4.5	3.3	0.5	3.2	0.1	6.9	2.7	3.8	4.7	3.5	2.8	0.7	4.2	2.3	2.5	6.6	1.6	7.1	3.0	3.0	3.4	4.5	8.1	0.8	3.0	3.1	2.7	10.2	0.9	0.9	2.6	1.7	2.9	3.9	1.3	0.1	1.8	1.2	1.9	2.3	3.5	1.8	2.7	9.0	1.9	56.0	3.3	0.5	11.1	1.4	0.4	3.9	3.7	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	3.2	2.7	3.8	3.0	3.0	3.0	3.1	2.7	2.9	2.7	3.3	3.0	10.0	3.2	6.7	4.9	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.5	1.3	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.8	0.0	0.1	8.2	0.0	0.0	0.3	0.0	0.0	2.1	0.0	0.0	1.3	0.7	6.1	0.4	0.4	0.0	0.5	0.0	0.0	4.0	2.1	89.0	2.5	1.0	0.0	6.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.4	103.7	16.5	0.1	0.3	0.0	0.0	0.1	0.0	0.0
TFIP11	"DKFZP434B194, Spp382, TIP39"	ENSG00000100109	"Tuftelin interacting protein 11"	Q9UBB9	22	26491225-26512505	"Plasma proteins, Predicted intracellular proteins"	"Biomineralization, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 67.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027085			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA027085: AB_1857964"	"unprognostic (1.53e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.87e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.86e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.01e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.46e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.62e-1)"	13.6	13.1	11.7	16.5	12.4	63.4	12.7	14.9	13.3	11.6	11.5	12.8	13.0	12.5	10.5	14.9	13.2	12.7	16.1	12.2	11.7	14.1	19.5	14.1	25.1	11.2	11.5	11.6	12.5	16.8	13.1	10.5	14.6	12.3	12.5	12.7	13.5	11.1	10.7	42.2	20.4	13.6	13.2	10.9	17.9	12.0	26.8	12.1	20.3	16.3	21.7	24.9	14.9	10.9	13.6	22.9	26.4	22.3	24.6	34.7	20.6	21.5	26.4	34.5	41.8	39.1	19.8	16.1	44.4	16.6	33.9	27.6	32.8	32.1	26.3	30.3	32.3	30.4	27.4	16.4	20.2	31.4	63.6	33.2	25.9	34.9	40.0	30.9	22.3	32.6	22.4	37.4	38.9	28.2	28.2	29.2	33.8	21.4	32.2	21.9	43.6	34.6	38.8	24.2	22.4	16.7	24.0	31.9	22.7	32.8	21.4	18.7	27.7	31.6	35.2	56.8	22.4	25.6	29.8	41.8	86.6	27.8	24.6	26.8	68.7	28.4	50.1	37.2	31.3	35.1	37.9	33.0	35.2	26.1	42.9	30.9	28.4	44.9	36.3	44.1	16.4	44.5	33.0	11.7	12.4	14.9	13.3	12.2	11.7	11.2	11.5	11.6	12.3	10.9	12.1	13.6	11.3	9.6	9.7	11.4	17.8	16.8	11.2	13.2	22.2	9.7	7.5	6.3	3.5	17.2	12.3	12.9	8.4	17.9	20.7	14.8	13.7	15.1	67.9	12.2	9.2	13.3	16.2	20.2	7.1	20.7	14.4	7.8	9.2	12.6	8.2	11.9	13.2	10.8	13.3	15.2	7.2	11.2	6.1	6.2	7.8	12.3	11.1	10.4	7.2	4.7	12.3	7.7	19.6	6.0	6.5	25.3	8.4	9.8	18.6	7.6	11.4	9.3	14.1	6.9	0.0	10.1	10.6	43.6	19.4	14.2	16.8	19.4	17.4	11.6	10.7	10.9
THTPA	THTPASE	ENSG00000259431	"Thiamine triphosphatase"	Q9BU02	14	23555988-23560271	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 54.8;Spermatocytes: 57.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028876	Approved		Uncertain	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA028876: AB_10600731"	"unprognostic (3.50e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.13e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (1.70e-9)"	"unprognostic (3.47e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.62e-2)"	"unprognostic (5.40e-2)"	13.7	17.7	28.6	10.5	37.7	8.2	11.1	28.0	31.3	9.5	28.4	10.4	14.3	12.2	15.2	8.6	15.0	9.7	14.9	30.3	27.7	14.0	11.4	9.6	10.7	31.6	27.5	32.1	12.7	11.5	19.9	11.2	6.8	27.9	16.2	10.7	13.3	17.4	14.1	23.8	7.0	9.9	11.9	26.6	10.8	10.8	20.3	28.6	11.1	11.6	20.9	10.3	10.3	7.3	29.5	3.9	24.1	11.4	12.4	26.3	14.6	6.3	11.2	9.7	10.7	10.5	4.9	15.9	7.2	9.5	13.1	12.1	11.8	12.1	13.8	7.8	15.9	13.7	10.2	16.9	13.3	13.0	9.1	8.7	20.6	10.2	16.4	12.0	22.9	13.0	11.6	7.7	15.9	15.7	11.6	14.6	3.7	4.1	20.9	20.1	9.9	7.9	13.4	18.9	7.6	22.1	10.6	10.8	22.0	6.6	6.6	14.9	4.4	10.9	7.0	7.4	14.5	6.5	18.9	12.2	4.4	7.3	4.2	10.9	13.7	16.0	8.7	9.8	12.0	9.8	10.2	7.2	7.6	14.7	15.3	11.7	10.2	1.7	8.3	16.1	18.7	6.4	10.9	28.6	37.7	28.0	31.3	30.3	27.7	31.6	27.5	32.1	27.9	26.6	28.6	29.5	8.1	6.4	7.5	16.6	14.5	0.0	7.8	0.0	6.8	27.4	12.0	10.7	0.1	8.6	3.7	7.3	8.4	11.0	9.2	7.2	54.8	14.5	21.9	6.7	9.2	6.2	6.1	3.4	11.8	12.4	5.1	9.9	9.2	6.7	23.5	7.7	7.1	10.8	18.4	8.4	23.1	7.5	0.0	7.9	0.0	23.0	11.5	9.8	0.0	4.7	9.9	33.4	14.4	15.1	37.0	8.2	9.6	7.5	11.3	9.3	15.2	38.9	2.9	11.6	13.1	13.2	7.7	57.5	8.3	9.5	0.0	6.7	9.3	14.2	7.7	5.9
THUMPD3	DKFZP434F091	ENSG00000134077	"THUMP domain containing 3"	Q9BV44	3	9362971-9386791	"Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 270.0;Late spermatids: 145.3;Spermatocytes: 183.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036170, HPA036171"	Approved		Enhanced	Nucleoli,Cytosol		No	No			Cytosol	Nucleoli	"HPA036170: AB_10671836, HPA036171: AB_2674985"	"unprognostic (2.13e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.74e-3)"	"unprognostic (4.25e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (1.25e-7)"	"unprognostic (6.54e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.19e-2)"	"prognostic favorable (1.03e-4)"	"unprognostic (1.41e-1)"	"unprognostic (4.53e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.59e-2)"	14.6	15.7	10.2	15.2	11.7	33.3	18.2	12.9	11.6	18.2	12.9	19.3	17.0	16.5	16.8	21.1	14.9	13.7	24.8	10.2	13.9	20.2	23.6	14.3	19.0	12.1	11.0	9.2	14.8	15.6	26.0	12.2	15.2	12.3	19.7	19.2	22.2	16.0	18.1	27.1	13.7	14.4	14.5	12.3	14.4	14.2	59.9	11.3	18.5	23.3	26.7	17.8	16.5	9.7	14.9	40.0	53.0	36.4	18.7	46.5	44.4	146.3	47.2	38.3	47.1	35.8	40.2	41.0	41.0	35.8	43.5	74.1	26.0	66.4	48.3	47.9	45.6	39.1	51.0	51.2	35.3	44.8	66.0	35.3	36.2	53.7	55.7	58.1	38.0	31.5	65.1	80.2	58.2	62.9	55.3	78.9	27.2	69.3	44.0	50.1	49.4	62.7	57.9	29.7	60.4	15.5	48.9	39.6	27.5	43.5	37.2	45.2	42.1	22.8	45.0	38.9	54.9	53.1	73.1	186.7	129.2	55.0	60.5	65.7	19.1	17.8	17.6	20.5	23.4	26.2	17.2	17.6	21.9	20.8	20.0	28.0	21.5	3.6	17.7	29.0	20.5	18.4	14.1	10.2	11.7	12.9	11.6	10.2	13.9	12.1	11.0	9.2	12.3	12.3	11.3	14.9	14.9	25.6	21.8	10.1	14.0	10.7	29.3	42.6	16.5	21.6	19.5	23.2	45.3	17.2	34.6	22.0	16.7	34.7	13.1	10.0	52.8	39.2	270.0	19.2	26.8	14.9	3.0	9.7	9.7	29.4	28.4	22.3	12.2	20.9	28.4	21.9	13.2	25.3	27.4	38.7	13.2	15.5	38.7	14.8	6.8	145.3	20.5	18.0	12.4	9.4	20.2	31.4	18.6	18.1	12.5	28.2	9.8	25.9	16.2	32.6	10.9	32.6	20.1	35.2	6.6	28.5	24.5	183.5	52.9	18.9	12.9	27.5	18.4	49.2	20.0	20.9
TIMM23	TIM23	ENSG00000265354	"Translocase of inner mitochondrial membrane 23"	O14925	10	45972489-46003742	"Predicted membrane proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 148.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA031408	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA031408: AB_10600828"	"unprognostic (4.09e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.15e-2)"	"prognostic unfavorable (2.77e-5)"	"unprognostic (1.74e-1)"	"unprognostic (3.90e-2)"	"prognostic favorable (6.79e-4)"	"unprognostic (4.41e-2)"	"unprognostic (7.30e-2)"	"unprognostic (3.24e-1)"	"unprognostic (7.78e-2)"	"unprognostic (5.54e-2)"	"unprognostic (7.20e-2)"	"unprognostic (2.21e-1)"	39.3	50.5	49.6	35.8	50.7	66.9	38.7	52.1	63.4	28.4	55.7	40.5	57.0	27.1	62.5	43.4	28.3	32.0	85.7	50.7	53.1	60.1	74.8	26.8	36.7	52.3	53.1	48.4	20.7	32.5	50.9	35.3	35.5	53.4	34.9	40.3	43.2	32.7	37.2	129.7	35.9	38.0	38.0	50.5	25.8	33.1	81.3	51.4	40.4	43.7	135.7	45.8	53.5	27.3	55.3	162.6	167.5	108.7	110.3	88.5	82.4	106.1	130.6	156.1	155.6	164.0	212.8	125.4	144.1	105.7	138.6	111.3	136.1	168.0	139.9	153.3	108.0	165.6	92.1	120.8	231.7	142.2	173.1	98.7	99.4	122.3	133.4	188.0	64.7	146.1	123.0	166.0	78.8	138.7	162.7	155.5	239.0	131.7	119.0	51.8	118.6	105.0	105.5	177.6	111.8	127.3	117.0	72.8	159.4	132.8	83.8	168.7	102.1	108.1	74.8	130.6	96.8	188.9	83.6	148.9	203.2	139.3	246.7	63.9	54.8	98.1	54.3	73.1	131.1	75.7	82.1	70.0	79.1	111.2	79.8	62.5	69.5	22.8	79.1	118.6	92.2	85.8	129.5	49.6	50.7	52.1	63.4	50.7	53.1	52.3	53.1	48.4	53.4	50.5	51.4	55.3	13.3	9.6	22.2	10.7	19.4	21.9	18.1	32.7	15.9	14.3	16.0	11.9	97.5	30.0	24.4	12.9	8.4	42.1	17.0	16.1	45.0	40.4	101.5	26.6	20.8	18.3	10.2	43.3	19.1	30.1	47.7	24.8	20.9	23.8	27.8	14.2	13.2	27.3	34.5	0.0	18.6	16.5	36.7	16.0	15.8	35.0	17.7	18.9	23.2	12.2	29.3	23.0	20.6	14.6	19.6	36.7	14.7	11.7	36.0	20.3	22.3	61.0	26.9	10.4	6.6	13.1	26.0	148.7	48.4	38.7	21.6	35.6	16.6	17.0	25.6	22.4
TKTL2	"DKFZP434L1717, FLJ32975"	ENSG00000151005	"Transketolase like 2"	Q9H0I9	4	163471095-163473754	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	375	"testis: 58.3"	"Group enriched"	"Detected in some"	26	"Early spermatids: 76.3;Late spermatids: 40.8;Spermatocytes: 156.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (2.19e-1)"	"unprognostic (1.55e-1)"			"unprognostic (8.62e-2)"			"unprognostic (2.05e-2)"		"unprognostic (2.90e-1)"	"unprognostic (2.21e-1)"		"unprognostic (7.72e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.15e-2)"			0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	58.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	76.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.8	3.4	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	156.6	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMA16	"C4orf43, FLJ11184"	ENSG00000198498	"Translation machinery associated 16 homolog"	Q96EY4	4	163494442-163520539	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 165.6;Late spermatids: 179.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041571, HPA052688"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA041571: AB_10794381, HPA052688: AB_2681916"	"unprognostic (6.02e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.92e-3)"	"prognostic unfavorable (2.70e-5)"	"prognostic unfavorable (4.40e-4)"	"unprognostic (2.30e-3)"	"unprognostic (1.33e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (7.70e-4)"	"unprognostic (6.98e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.56e-2)"	16.5	12.0	4.5	18.0	5.1	12.6	18.1	5.7	6.8	10.9	5.3	13.2	11.1	15.9	7.0	14.5	11.5	10.0	9.3	4.8	4.9	12.2	13.7	9.0	22.2	5.1	5.0	4.2	17.0	14.9	9.6	5.3	14.1	5.4	11.9	11.9	5.8	14.5	10.0	9.7	14.5	10.1	13.1	5.0	16.2	12.9	26.9	4.9	19.3	11.7	7.6	20.1	14.0	10.9	6.2	49.1	24.1	43.0	37.3	20.1	32.6	41.3	56.3	29.8	34.2	28.5	23.4	65.4	108.1	22.7	34.0	27.0	25.2	54.6	43.0	43.0	58.1	42.6	154.3	23.3	41.3	39.6	120.2	46.7	22.6	40.0	27.1	36.4	29.5	34.5	39.4	55.1	79.9	39.7	47.2	74.9	68.4	45.6	28.4	43.0	67.7	38.3	68.9	26.2	23.8	22.5	35.2	36.8	46.3	43.4	25.7	30.3	51.3	59.3	23.5	46.0	22.9	61.2	55.8	75.8	124.7	47.3	64.0	72.3	11.7	37.0	3.5	18.4	58.8	26.1	55.6	32.4	23.5	42.3	51.7	29.8	26.1	1.3	35.3	48.4	74.8	31.3	19.4	4.5	5.1	5.7	6.8	4.8	4.9	5.1	5.0	4.2	5.4	5.0	4.9	6.2	25.7	22.4	31.2	3.3	51.2	32.9	36.3	52.0	29.6	15.4	42.9	40.5	37.6	47.1	31.7	33.1	4.2	53.8	25.6	16.4	64.6	53.2	165.6	19.0	61.4	30.0	30.5	28.8	8.8	71.0	92.3	37.9	15.3	17.9	29.1	41.6	36.0	55.6	36.4	15.2	7.3	37.5	20.3	43.3	23.4	179.2	55.6	25.4	26.6	6.5	44.4	15.8	16.5	11.6	11.0	54.9	30.6	32.0	30.0	57.8	11.9	71.7	19.0	14.3	39.5	30.4	33.7	103.9	42.1	28.5	39.6	30.5	24.1	43.7	44.0	28.9
TMBIM4	"CGI-119, GAAP, LFG4, S1R, ZPRO"	ENSG00000155957	"Transmembrane BAX inhibitor motif containing 4"	Q9HC24	12	66135846-66170072	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA077642			Supported	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA077642: AB_2686849"	"unprognostic (5.41e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.19e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.69e-2)"	"unprognostic (5.62e-2)"	"unprognostic (7.18e-3)"	"unprognostic (8.51e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.36e-1)"	"unprognostic (9.93e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.68e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.20e-3)"	80.4	89.4	26.6	76.0	32.8	62.1	82.2	33.0	30.0	67.9	44.3	91.3	60.0	61.6	69.2	63.2	66.3	70.8	71.4	26.3	42.7	94.8	110.6	77.4	75.1	37.0	31.5	22.9	57.2	104.4	105.6	40.4	74.8	37.2	73.4	70.9	40.0	90.1	74.4	47.2	52.6	70.3	59.0	34.6	75.0	94.2	85.9	31.8	63.7	98.8	62.1	56.5	80.7	43.2	40.7	49.1	62.4	39.7	72.8	131.4	122.7	41.9	74.4	129.1	56.7	45.8	32.8	78.7	45.6	86.3	105.2	42.6	78.9	20.1	65.7	36.6	74.5	27.3	87.7	30.0	38.6	66.6	106.9	109.2	86.9	92.8	27.7	31.1	79.0	87.2	51.8	65.9	160.3	94.3	79.5	41.1	37.5	47.4	76.1	63.3	21.5	26.5	50.8	126.8	80.3	20.1	47.6	84.5	154.5	102.3	34.2	146.3	146.7	106.0	69.1	25.9	50.5	44.8	82.7	48.5	32.2	94.8	103.7	84.1	420.7	372.7	371.6	136.0	381.4	137.9	205.9	139.7	139.4	256.2	196.6	157.9	139.1	662.3	135.3	434.3	171.7	159.8	483.9	26.6	32.8	33.0	30.0	26.3	42.7	37.0	31.5	22.9	37.2	34.6	31.8	40.7	232.8	150.6	147.2	34.0	131.3	0.0	64.1	0.0	84.2	47.8	202.2	152.1	37.0	0.0	66.2	244.6	45.9	137.0	128.2	191.4	103.7	213.8	330.6	116.2	96.4	114.5	74.7	32.0	15.8	338.1	116.9	140.7	85.1	105.8	179.0	72.7	0.0	0.0	210.7	45.4	25.2	172.4	0.0	0.0	0.0	143.8	104.4	193.2	0.0	62.8	205.5	114.1	123.6	42.7	77.0	202.9	176.9	91.0	126.8	87.9	128.9	214.5	99.1	65.9	59.2	67.8	75.7	391.0	40.8	112.5	0.0	130.8	99.3	142.7	182.2	62.8
TMEM202	FLJ27523	ENSG00000187806	"Transmembrane protein 202"	A6NGA9	15	72398302-72408367	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	124	"testis: 12.4"	"Group enriched"	"Detected in some"	34	"Early spermatids: 67.6;Late spermatids: 58.5;Spermatocytes: 61.2"	"Cancer enriched"	"Detected in single"	11	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"									NA	NA																				"unprognostic (1.31e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	61.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMEM217	"C6orf128, dJ355M6.2"	ENSG00000172738	"Transmembrane protein 217"	Q8N7C4	6	37212178-37258155	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 9.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 20.5;Exocrine glandular cells: 16.0;Pancreatic endocrine cells: 15.9;Spermatocytes: 55.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 7.7;HUVEC TERT2: 6.4;TIME: 17.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045432, HPA071187"			Approved	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA045432: AB_2732519, HPA071187: AB_2732174"	"unprognostic (7.78e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.29e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.40e-2)"	"unprognostic (3.51e-2)"	"unprognostic (4.23e-4)"	"unprognostic (8.22e-2)"	"unprognostic (2.18e-1)"	"unprognostic (5.62e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.33e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.59e-1)"	0.7	3.1	0.9	0.7	1.0	2.8	0.5	1.1	1.7	0.3	0.9	0.3	1.1	0.3	1.6	1.6	0.7	1.2	0.3	0.9	1.2	0.6	1.0	0.7	0.4	0.9	0.9	1.0	0.3	2.7	1.3	0.1	0.3	1.0	0.3	0.4	0.7	1.2	0.1	0.1	1.0	0.4	0.4	0.9	0.2	0.2	9.2	1.0	0.7	0.7	0.0	0.3	2.2	0.1	1.1	0.7	0.0	0.5	0.4	0.3	2.1	0.3	2.2	3.9	1.9	5.5	1.7	1.3	0.1	0.8	0.5	2.4	1.2	0.7	0.6	2.0	0.7	1.1	7.7	1.7	0.9	0.9	0.2	3.7	1.4	1.7	5.0	0.5	1.0	6.4	0.8	2.5	0.0	0.9	0.9	0.5	3.2	0.6	0.0	0.3	1.0	0.2	0.2	2.1	0.8	0.6	0.3	0.4	0.4	1.0	0.9	0.1	0.4	17.6	1.8	0.5	0.2	0.4	0.5	0.7	1.9	0.3	1.7	0.4	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.1	0.2	0.2	0.1	0.0	0.1	0.1	0.1	0.9	1.0	1.1	1.7	0.9	1.2	0.9	0.9	1.0	1.0	0.9	1.0	1.1	2.6	0.0	0.6	2.9	0.7	2.5	8.9	2.6	0.6	0.8	3.9	1.8	0.2	1.5	3.9	1.8	0.0	0.8	1.3	3.4	3.9	15.0	20.5	8.3	1.3	3.3	1.8	0.0	2.9	16.0	0.6	3.8	2.0	5.6	5.7	1.4	0.4	0.1	0.9	3.3	2.1	0.4	2.0	0.6	6.3	14.9	0.6	2.8	1.8	0.0	0.0	6.4	0.0	1.5	3.0	15.9	1.1	0.0	0.5	6.9	0.8	1.1	5.0	0.5	0.0	4.1	1.8	55.0	0.8	3.4	3.0	1.1	1.1	1.5	1.0	13.9
TMEM225	"PMP22CD, PPP1R154, SPATA47"	ENSG00000204300	"Transmembrane protein 225"	Q6GV28	11	123882920-123885670	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	188	"testis: 22.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 113.4;Late spermatids: 28.0;Spermatocytes: 80.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																			"unprognostic (3.38e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	113.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	80.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMPRSS12	"CT151, MGC57341"	ENSG00000186452	"Transmembrane serine protease 12"	Q86WS5	12	50842920-50887884	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	50	"testis: 21.8"	"Group enriched"	"Detected in some"	8	"Early spermatids: 44.7;Spermatocytes: 121.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.04e-1)"	"unprognostic (9.09e-2)"		"unprognostic (3.03e-2)"		"unprognostic (7.25e-3)"		"unprognostic (1.70e-1)"		"unprognostic (1.39e-1)"	"unprognostic (3.88e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.65e-3)"	"unprognostic (1.03e-2)"	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.4	0.2	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	21.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.7	0.0	0.3	0.5	0.2	0.0	0.0	0.8	0.5	0.1	0.0	0.1	1.8	0.0	0.9	0.1	0.0	0.0	0.0	44.7	0.1	0.0	0.0	0.0	0.0	0.6	0.0	1.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	9.7	4.1	0.1	1.8	0.0	0.0	0.0	0.0	2.0	0.6	0.0	0.0	0.7	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.1	121.7	2.4	0.0	0.3	0.7	0.0	0.0	0.0	0.1
TNPO3	"IPO12, LGMD1F, MTR10A, TRN-SR, TRN-SR2"	ENSG00000064419	"Transportin 3"	Q9Y5L0	7	128954180-129055173	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039555, HPA041537"	Approved		Enhanced	Vesicles		NA	NA			Vesicles		"HPA039555: AB_10672000, HPA041537: AB_2677539"	"unprognostic (5.76e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (3.29e-5)"	"unprognostic (1.86e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.93e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.26e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.24e-2)"	16.3	17.0	17.1	19.5	17.8	34.6	15.8	19.1	18.8	14.2	16.8	18.5	16.6	15.8	17.9	21.3	16.3	13.1	15.5	17.0	19.5	19.3	23.1	16.2	23.6	17.5	17.6	16.0	20.6	15.2	21.2	10.1	14.9	18.5	16.7	20.3	16.6	15.6	18.2	32.8	18.2	16.7	19.6	18.0	17.8	19.9	26.6	18.7	30.3	23.1	27.3	29.1	18.8	15.3	20.7	59.1	65.3	49.7	84.3	47.3	40.5	42.3	51.8	45.0	47.4	55.5	53.7	52.9	73.3	23.6	55.7	89.7	42.3	101.6	49.8	67.6	61.3	45.0	54.0	52.2	42.2	45.0	99.8	44.2	38.1	49.7	57.9	51.4	41.4	59.9	59.5	124.7	51.3	61.2	43.7	86.9	73.4	142.6	64.4	59.7	61.0	46.3	60.0	48.0	54.6	61.5	48.7	55.2	25.7	58.3	71.4	29.0	61.3	45.2	59.7	29.4	71.1	71.5	65.3	54.6	99.3	86.3	100.5	106.1	26.7	14.1	22.0	16.4	17.3	14.6	16.1	13.3	14.8	16.1	15.5	13.0	15.2	15.5	14.5	23.9	7.7	15.1	11.7	17.1	17.8	19.1	18.8	17.0	19.5	17.5	17.6	16.0	18.5	18.0	18.7	20.7	20.4	16.0	16.7	30.7	31.4	6.8	15.6	5.7	27.3	23.4	20.3	13.8	21.4	20.0	11.6	18.4	22.9	24.7	26.9	20.4	7.9	23.2	41.4	19.1	17.7	18.8	11.5	38.5	45.8	24.8	37.2	17.4	22.4	27.7	10.8	30.5	19.6	27.9	27.8	37.0	46.8	22.2	2.0	25.7	9.5	25.4	16.8	24.9	8.8	31.9	44.4	13.6	17.5	37.7	47.5	30.3	17.7	17.7	28.5	17.6	21.7	18.7	13.1	21.7	13.1	18.5	19.4	76.3	31.8	32.5	8.2	35.0	23.5	33.1	24.8	30.4
TOE1	hCaf1z	ENSG00000132773	"Target of EGR1, exonuclease"	Q96GM8	1	45340052-45343973	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 36.6;Spermatocytes: 51.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053775, HPA069119"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA053775: AB_2682259, HPA069119: AB_2686090"	"unprognostic (7.20e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.15e-3)"	"unprognostic (1.90e-2)"	"unprognostic (3.33e-1)"	"prognostic favorable (9.05e-4)"	"prognostic unfavorable (6.12e-9)"	"unprognostic (4.67e-2)"	"unprognostic (4.84e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.03e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (2.71e-4)"	"prognostic favorable (9.98e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.08e-1)"	4.9	5.1	4.6	6.0	4.6	8.1	5.5	4.7	6.1	3.8	4.5	6.9	6.7	6.7	8.5	3.7	5.5	3.5	3.7	4.5	5.1	4.7	5.5	5.1	8.0	4.9	4.7	4.7	6.2	4.8	7.5	3.3	6.9	4.9	5.1	8.2	4.1	5.3	5.0	3.0	4.0	5.1	6.6	4.9	5.9	5.7	11.9	4.9	9.1	7.1	2.4	8.4	5.5	3.3	4.8	15.8	9.1	16.5	15.7	7.6	5.9	23.9	15.6	12.9	26.6	24.7	16.7	9.6	29.9	12.1	16.2	23.4	15.9	21.0	22.5	21.3	19.6	17.3	36.0	21.9	15.6	7.3	23.7	17.2	8.8	4.8	28.4	17.8	9.4	19.5	22.5	28.4	19.6	18.9	14.6	34.8	18.4	31.1	20.6	14.2	24.9	24.5	13.6	11.5	28.7	13.9	13.4	14.5	36.3	27.5	25.7	9.8	33.2	14.6	12.6	23.3	19.1	29.7	15.0	19.4	19.9	14.8	26.5	14.7	20.0	5.8	6.2	7.3	6.9	8.4	5.9	6.3	7.3	6.0	8.4	6.4	7.0	0.6	4.1	6.1	5.2	8.6	5.1	4.6	4.6	4.7	6.1	4.5	5.1	4.9	4.7	4.7	4.9	4.9	4.9	4.8	6.5	6.4	4.8	2.3	12.4	1.8	6.3	8.8	4.6	10.7	4.5	5.0	1.8	7.2	8.1	7.3	12.5	36.6	9.2	9.2	7.9	5.4	13.9	2.1	6.2	9.0	3.0	14.1	2.5	6.2	13.8	6.6	4.6	3.4	11.4	10.5	8.6	5.0	9.3	8.4	2.7	7.3	8.2	3.5	2.6	9.4	6.8	6.2	3.6	1.9	12.3	13.1	9.2	2.0	2.1	3.4	10.7	6.4	7.0	6.5	8.8	7.9	4.7	18.3	13.1	8.0	7.1	51.7	18.9	3.8	1.4	22.7	9.0	10.2	6.9	4.6
TP53RK	"BUD32, C20orf64, dJ101A2.2, Nori-2p, prpk, TPRKB"	ENSG00000172315	"TP53 regulating kinase"	Q96S44	20	46684365-46689444	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 214.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 212.4;SK-MEL-30: 90.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004688, HPA015837"	Approved					NA	NA					"CAB004688: AB_426116, HPA015837: AB_1855776"	"unprognostic (9.45e-2)"	"unprognostic (3.73e-1)"	"unprognostic (9.76e-2)"	"prognostic unfavorable (6.70e-5)"	"unprognostic (4.41e-2)"	"unprognostic (2.63e-1)"	"prognostic unfavorable (6.27e-5)"	"unprognostic (9.16e-3)"	"unprognostic (6.11e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.36e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.74e-2)"	6.2	7.8	5.9	7.4	5.6	6.4	9.0	4.9	6.2	7.0	2.9	6.6	4.8	7.1	4.7	8.9	6.4	5.7	5.0	5.2	5.8	6.9	7.0	5.8	11.3	5.4	5.7	5.3	6.3	5.5	7.5	6.2	6.0	5.4	8.0	6.1	6.5	7.1	6.2	6.8	9.0	5.9	6.9	4.4	7.1	7.0	12.2	6.5	13.4	8.1	5.3	12.0	10.7	6.8	6.8	12.7	8.7	17.9	15.9	18.5	15.1	16.6	17.7	16.3	22.7	16.4	24.7	8.0	32.2	26.1	14.6	20.3	19.6	23.1	20.3	19.6	7.9	12.0	31.0	8.4	22.4	24.3	20.2	212.4	20.3	24.2	15.8	15.4	10.6	15.3	12.7	21.5	13.1	19.6	19.1	31.0	35.5	14.6	18.1	29.8	17.9	16.2	19.1	15.2	14.1	21.6	11.5	21.3	42.1	90.7	9.3	15.4	21.8	15.7	26.3	15.5	17.5	19.8	14.5	19.6	24.7	15.2	15.2	12.6	36.6	16.1	28.4	16.9	15.8	19.5	19.9	18.2	19.4	16.7	19.3	19.9	17.1	2.7	22.5	14.6	25.4	25.5	17.4	5.9	5.6	4.9	6.2	5.2	5.8	5.4	5.7	5.3	5.4	4.4	6.5	6.8	12.6	9.6	13.1	5.2	14.3	50.7	54.8	45.9	39.9	9.4	22.8	21.2	7.0	18.6	27.7	9.2	12.5	42.6	23.9	10.4	27.4	28.9	214.7	13.3	25.6	17.5	13.1	16.2	5.0	23.8	73.6	29.1	23.4	14.2	22.9	14.6	11.0	12.2	25.8	15.2	4.7	16.5	32.6	14.4	28.5	49.9	22.1	13.1	37.4	4.7	17.9	8.1	21.6	6.0	6.0	34.7	4.9	16.1	8.4	62.6	15.5	31.1	18.0	10.4	6.6	8.8	26.1	87.6	15.6	35.2	61.8	88.7	19.4	26.8	13.1	59.9
TPRKB	"CGI-121, CGI121"	ENSG00000144034	"TP53RK binding protein"	Q9Y3C4	2	73729104-73737400	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"tRNA processing"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 259.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035712	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA035712: AB_10669674"	"unprognostic (1.11e-1)"	"unprognostic (2.41e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.21e-3)"	"unprognostic (4.96e-2)"	"unprognostic (3.16e-3)"	"unprognostic (3.01e-3)"	"unprognostic (5.10e-3)"	"unprognostic (6.06e-2)"	"unprognostic (2.68e-3)"	"unprognostic (5.66e-2)"	"unprognostic (8.45e-3)"	"unprognostic (1.82e-1)"	"unprognostic (5.03e-2)"	22.2	23.3	13.7	22.5	14.3	70.8	43.1	16.6	17.3	32.9	14.6	36.9	39.0	30.5	36.2	31.3	55.3	20.4	30.2	14.0	14.6	35.8	39.6	17.5	37.3	15.0	14.3	13.5	36.4	26.9	18.6	12.8	22.8	15.1	25.3	34.2	16.3	31.3	19.2	68.8	25.9	35.8	29.4	14.8	22.5	25.1	52.2	14.1	37.4	21.5	51.4	34.0	26.5	25.4	15.1	106.1	73.3	73.4	85.5	27.2	37.6	62.2	73.5	40.0	72.2	54.2	110.8	66.0	67.0	54.0	38.2	130.7	62.6	60.6	77.6	116.0	53.4	79.2	135.7	49.8	90.6	26.6	198.3	72.8	27.2	43.6	76.4	76.3	37.4	76.9	114.7	119.8	105.1	75.5	56.4	142.5	130.6	94.9	130.5	93.9	83.6	211.6	93.8	67.2	89.8	69.1	83.1	53.1	79.5	105.6	59.8	58.7	78.6	48.5	62.4	104.7	113.6	182.6	69.1	127.6	176.9	55.9	131.2	78.4	32.5	18.2	29.1	16.5	28.5	26.4	23.9	23.6	22.3	22.1	20.9	27.0	25.5	13.1	24.6	21.5	30.1	25.4	15.8	13.7	14.3	16.6	17.3	14.0	14.6	15.0	14.3	13.5	15.1	14.8	14.1	15.1	56.3	32.1	39.8	7.2	43.1	53.2	66.8	123.0	38.7	15.0	51.8	94.9	63.5	50.1	70.6	22.0	4.2	81.3	39.7	64.0	88.0	95.4	138.9	50.2	42.7	81.9	33.6	62.1	8.6	184.9	107.9	45.1	17.9	43.4	48.7	51.3	148.2	44.3	86.7	8.4	8.7	71.2	71.2	55.6	60.0	28.9	59.0	52.1	33.8	2.8	65.0	36.6	64.9	10.1	8.3	110.7	76.9	52.3	35.6	47.8	103.4	154.9	54.4	21.8	52.6	61.7	46.2	259.3	87.8	44.8	53.0	45.6	42.8	53.9	85.4	58.2
TPTE2	TPIP	ENSG00000132958	"Transmembrane phosphoinositide 3-phosphatase and tensin homolog 2"	Q6XPS3	13	19422877-19536762	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	8	"testis: 7.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 4.9;Early spermatids: 9.8;Excitatory neurons: 4.6;Inhibitory neurons: 6.3;Microglial cells: 3.7;Oligodendrocyte precursor cells: 7.5;Oligodendrocytes: 3.6;Spermatocytes: 14.8;Spermatogonia: 3.9"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HDLM-2: 4.8;Karpas-707: 1.3"									HPA068342			Approved	"Endoplasmic reticulum,Cytosol"		NA	NA			Cytosol	"Endoplasmic reticulum"	"HPA068342: AB_2685976"	"unprognostic (2.50e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.33e-3)"		"unprognostic (1.90e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.40e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.05e-12)"	"unprognostic (1.04e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.44e-1)"	"unprognostic (5.00e-3)"	0.0	0.1	0.4	0.1	0.5	0.0	0.1	0.7	0.9	0.0	0.4	0.1	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.2	0.6	0.5	0.4	0.0	0.0	0.0	0.1	0.1	0.7	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.5	0.2	0.1	7.6	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.8	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.7	0.9	0.5	0.5	0.6	0.5	0.4	0.7	0.5	0.5	0.8	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.1	0.0	0.1	0.0	0.0	4.6	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.7	0.0	0.1	0.0	6.3	0.0	0.0	0.3	0.0	1.5	0.3	0.0	0.0	3.7	0.1	0.5	0.0	7.5	3.6	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.1	14.8	3.9	0.0	0.1	0.1	0.1	0.1	0.0	0.2
TRIM37	"KIAA0898, MUL, POB1, TEF3"	ENSG00000108395	"Tripartite motif containing 37"	O94972	17	58982638-59106921	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Ubl conjugation pathway"	"Repressor, Transferase"	"Dwarfism, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 62.9"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 129.2;Excitatory neurons: 96.7;Inhibitory neurons: 105.2;Late spermatids: 88.8;Spermatocytes: 133.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 30.4"	"Group enriched"	"Detected in all"	5	"granulocytes: 30.4;T-cells: 8.3"	"Cell line enriched"	"Detected in all"	4	"MCF7: 242.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021911	Uncertain					NA	NA					"HPA021911: AB_10964487"	"unprognostic (4.07e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (4.99e-6)"	"unprognostic (7.83e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.10e-3)"	"unprognostic (4.79e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.46e-1)"	"unprognostic (4.27e-2)"	"unprognostic (3.04e-2)"	8.9	12.4	14.6	9.5	20.4	6.8	8.2	26.5	32.0	8.0	7.1	7.9	6.8	8.8	10.8	8.4	9.8	9.0	11.6	19.0	19.3	7.7	8.3	8.9	9.1	21.2	17.2	18.5	6.2	7.7	8.7	10.4	9.5	26.2	9.5	7.1	33.2	5.9	9.3	11.2	7.5	6.2	10.9	10.8	8.7	6.6	62.9	20.6	12.2	13.4	12.8	8.4	9.1	6.5	28.2	21.4	33.3	21.9	27.5	20.5	19.0	35.3	24.0	36.9	25.3	41.4	19.6	14.4	21.1	36.1	25.3	43.3	19.0	31.5	17.7	40.5	41.8	30.4	32.6	28.9	27.1	36.1	16.8	15.8	15.4	16.1	32.5	40.8	25.8	33.0	19.1	25.4	29.7	24.9	242.4	34.0	9.5	31.5	28.9	22.0	15.0	57.1	13.7	24.0	29.7	51.7	29.9	24.8	10.2	23.2	26.4	30.4	7.8	25.9	39.5	47.6	36.5	27.6	30.5	48.5	18.5	26.8	17.5	18.7	30.4	3.7	4.5	7.2	2.7	6.7	3.6	4.7	4.6	4.0	3.9	4.0	5.4	5.3	3.4	2.8	3.0	8.3	3.1	14.6	20.4	26.5	32.0	19.0	19.3	21.2	17.2	18.5	26.2	10.8	20.6	28.2	10.3	9.6	11.0	44.4	13.2	7.9	6.0	6.5	15.4	19.7	13.2	12.2	24.1	7.2	15.6	9.2	33.3	15.1	7.8	12.0	3.9	10.3	129.2	30.8	13.8	13.7	12.0	12.8	96.7	5.6	10.6	14.0	11.7	13.5	10.8	18.0	12.1	18.9	8.7	45.4	105.2	7.2	16.2	9.1	6.9	88.8	9.9	9.3	12.4	18.7	7.2	19.9	5.2	36.2	43.5	10.2	11.3	17.7	15.1	9.9	3.3	9.7	29.1	38.8	13.1	10.9	17.3	133.1	45.0	14.0	6.3	17.8	14.7	19.7	9.1	6.8
TRIM61	RNF35	ENSG00000183439	"Tripartite motif containing 61"	Q5EBN2	4	164954446-164977668	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Early spermatids: 34.5;Late spermatids: 14.0;Spermatocytes: 50.1"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 15.1;SuSa: 10.2;U-266/70: 17.2"	"Not detected"	"Not detected"							HPA049109	Uncertain		Approved	"Nucleoli fibrillar center,Endoplasmic reticulum"		NA	NA			"Nucleoli fibrillar center, Endoplasmic reticulum"		"HPA049109: AB_2680636"	"unprognostic (2.05e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.24e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.98e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.92e-1)"	"unprognostic (9.77e-5)"	"unprognostic (4.61e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.32e-2)"	2.1	3.6	1.9	2.2	2.4	3.7	1.3	2.2	2.5	2.9	0.6	1.4	1.9	1.5	2.2	1.0	3.6	2.9	3.0	1.9	2.7	1.0	1.1	2.3	3.2	2.5	2.1	1.9	5.0	1.4	1.2	1.0	1.7	2.3	1.8	1.4	2.8	0.9	2.0	0.9	1.1	1.4	2.2	1.5	2.1	1.3	8.9	2.5	2.6	5.7	1.4	2.9	2.3	0.2	2.8	0.9	0.8	2.0	2.1	1.1	1.1	1.2	4.2	1.3	0.9	0.8	0.7	1.4	0.9	1.1	5.3	1.0	1.0	1.4	1.5	0.9	1.6	0.8	1.6	1.5	0.9	15.1	1.6	1.4	9.0	1.3	3.7	1.4	8.5	0.8	1.3	1.8	3.6	0.8	1.0	1.4	1.0	6.5	1.0	0.7	1.4	1.1	1.2	0.6	2.6	1.7	1.1	1.0	1.5	1.2	10.2	0.5	1.6	0.9	2.7	1.8	0.9	1.7	17.2	8.2	2.3	1.0	0.9	1.9	5.4	1.4	0.1	2.9	1.2	3.3	3.5	1.8	3.3	1.5	5.8	4.4	3.6	0.3	8.0	1.1	4.1	0.8	1.4	1.9	2.4	2.2	2.5	1.9	2.7	2.5	2.1	1.9	2.3	1.5	2.5	2.8	0.2	0.0	3.3	1.0	3.8	0.3	1.2	0.4	0.0	1.1	0.1	0.1	2.3	0.0	0.2	3.7	4.2	0.3	2.3	0.0	0.0	0.3	34.5	0.4	2.1	0.9	0.0	1.3	1.9	0.7	0.0	1.6	0.5	0.1	0.0	4.8	0.0	0.4	1.1	1.7	1.4	0.0	0.0	0.6	0.7	14.0	1.2	0.9	0.0	0.0	1.7	2.7	1.0	3.5	4.3	0.1	0.1	1.5	6.4	0.6	0.0	3.7	0.1	0.4	0.0	1.5	1.3	50.1	3.7	0.2	0.0	0.3	2.2	2.8	0.0	0.6
TRIM69	"RNF36, Trif, TRIMLESS"	ENSG00000185880	"Tripartite motif containing 69"	Q86WT6	15	44728988-44767829	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 35.3"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 213.2;Late spermatids: 93.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"T-reg: 4.2"	"Lineage enriched"	"Detected in single"	7	"T-cells: 4.2"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.4;U-266/70: 8.2;U-266/84: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA028894	Enhanced					NA	NA					"HPA028894: AB_10603136"	"unprognostic (4.82e-3)"	"unprognostic (1.23e-2)"	"unprognostic (4.10e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.75e-2)"	"unprognostic (4.20e-1)"	"unprognostic (9.27e-2)"	"unprognostic (4.95e-2)"	"unprognostic (6.49e-2)"	"unprognostic (3.53e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.72e-2)"	"prognostic favorable (2.26e-5)"	"unprognostic (4.79e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.49e-2)"	0.8	0.8	4.9	0.4	5.0	0.2	0.8	4.5	7.2	0.9	4.3	1.2	0.4	0.6	0.4	0.7	0.8	0.5	2.4	4.9	4.8	1.3	1.6	1.3	0.9	5.0	4.8	5.0	0.8	0.4	0.3	1.5	0.2	5.0	0.9	0.6	0.7	0.8	0.2	6.0	0.9	1.3	0.6	4.7	2.4	0.7	35.3	4.8	0.5	0.6	6.1	1.2	0.7	0.8	5.5	0.1	0.1	0.2	0.6	0.2	0.7	0.0	0.1	0.3	0.8	1.3	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.4	1.7	0.0	0.2	0.1	0.0	0.7	0.0	0.1	0.9	0.6	0.1	0.1	1.1	0.2	0.7	0.0	2.4	0.2	0.0	0.0	0.1	0.1	0.4	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.2	8.2	2.3	1.4	0.2	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.6	0.6	0.8	0.9	0.0	0.0	0.2	0.6	0.1	0.0	0.2	0.0	4.2	0.1	4.9	5.0	4.5	7.2	4.9	4.8	5.0	4.8	5.0	5.0	4.7	4.8	5.5	41.8	6.4	5.1	9.4	22.1	21.3	21.3	8.0	12.0	10.8	9.3	9.1	60.2	8.6	11.0	9.2	4.2	6.1	20.4	16.5	41.1	42.1	213.2	9.0	12.2	22.2	4.2	5.7	16.0	16.0	4.2	17.8	13.7	10.6	14.0	10.5	11.4	5.1	36.3	23.5	9.8	7.5	8.2	25.4	39.7	93.9	9.3	22.6	12.4	1.0	52.7	21.2	20.6	9.5	1.7	14.8	13.4	11.7	21.9	11.4	18.6	27.0	8.8	4.2	6.6	27.0	19.7	78.8	1.7	25.0	41.2	1.5	25.6	5.1	7.0	52.5
TRMT12	"FLJ20772, Trm12, TYW2"	ENSG00000183665	"TRNA methyltransferase 12 homolog"	Q53H54	8	124450820-124462150	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"tRNA processing"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 73.1"	"Low region specificity"	"Detected in all"							HPA023939	Approved		Approved	Nucleoplasm,Mitochondria		No	No			Nucleoplasm	Mitochondria	"HPA023939: AB_1848793"	"unprognostic (2.54e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.75e-2)"	"prognostic unfavorable (2.99e-5)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (6.89e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.72e-3)"	"unprognostic (3.39e-2)"	"unprognostic (2.40e-1)"	"prognostic unfavorable (9.25e-4)"	"unprognostic (1.04e-2)"	6.0	5.9	5.5	5.5	5.5	3.1	8.8	4.7	7.2	6.6	5.2	5.7	4.6	6.5	6.1	5.7	7.7	4.4	5.8	6.4	5.0	7.6	6.0	6.0	6.5	4.5	4.2	5.4	5.0	5.2	8.6	4.8	5.5	4.6	7.0	6.6	8.2	7.8	6.2	9.8	5.3	5.0	8.2	3.8	5.6	5.7	6.5	5.3	8.4	8.9	10.0	6.8	6.7	4.4	5.2	14.8	12.6	10.3	8.1	19.0	9.7	2.5	9.1	10.6	13.1	11.2	7.7	10.0	14.9	12.3	9.4	8.5	10.1	14.7	14.9	15.4	14.8	11.2	14.4	12.8	2.6	14.8	0.0	11.2	12.1	19.6	12.9	16.2	3.8	11.1	15.4	20.4	10.1	8.2	73.1	17.2	6.1	0.0	33.9	11.5	5.4	6.9	9.9	12.1	15.7	17.3	13.8	13.4	49.5	19.5	8.7	14.1	6.1	8.9	9.1	23.8	6.8	10.4	10.4	15.6	5.8	8.2	5.0	7.5	0.4	3.5	3.8	2.3	2.9	3.0	2.1	3.2	2.5	2.8	2.8	3.9	3.9	1.3	3.1	3.3	0.8	2.1	2.4	5.5	5.5	4.7	7.2	6.4	5.0	4.5	4.2	5.4	4.6	3.8	5.3	5.2	4.9	9.6	7.5	2.0	11.2	5.2	6.1	3.5	7.4	5.6	5.5	4.7	3.9	7.2	2.2	3.7	16.7	7.3	8.4	4.2	5.9	5.6	18.6	6.3	4.9	5.7	3.0	1.7	1.5	6.2	5.4	4.5	6.6	3.6	9.5	7.7	4.2	5.4	5.1	8.4	1.8	4.4	4.1	4.1	2.5	21.0	4.1	5.2	5.4	1.0	8.1	4.0	9.2	1.0	1.2	4.3	3.9	6.0	8.4	4.8	3.9	8.2	7.6	8.2	0.0	8.2	6.5	14.2	5.8	4.7	4.3	4.9	6.3	7.9	4.9	4.6
TRMT1L	C1orf25	ENSG00000121486	"TRNA methyltransferase 1 like"	Q7Z2T5	1	185118101-185157072	"Metabolic proteins, Predicted intracellular proteins"	"Behavior, tRNA processing"	"Methyltransferase, RNA-binding, Transferase, tRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 73.0;Spermatocytes: 103.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026728	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA026728: AB_1845641"	"unprognostic (1.07e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.55e-3)"	"unprognostic (2.96e-1)"	"unprognostic (1.46e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.38e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.32e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.44e-2)"	"unprognostic (9.45e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.26e-1)"	6.9	8.7	8.3	8.5	9.6	5.8	7.7	10.3	9.8	7.9	10.1	7.7	8.6	7.3	9.5	7.0	10.7	7.1	12.2	8.1	8.9	13.2	14.6	7.5	10.9	9.3	9.4	7.6	11.5	5.0	12.2	7.0	8.3	9.2	7.7	7.3	9.0	5.7	8.2	21.0	4.8	7.1	7.0	9.3	10.7	7.2	27.9	9.0	10.3	10.5	18.8	12.0	7.1	5.6	12.9	12.4	22.3	15.1	11.3	21.8	20.0	21.5	11.7	10.5	15.7	16.4	20.4	23.1	13.5	28.5	8.1	24.0	15.6	25.7	15.3	15.4	16.1	11.2	13.0	15.9	20.9	15.2	19.3	20.6	9.6	20.3	16.1	16.1	16.6	17.5	17.9	34.5	18.0	18.9	10.5	14.7	11.2	24.9	25.3	4.6	17.1	21.7	21.6	15.2	13.5	13.4	12.0	22.8	22.0	16.2	34.2	22.4	10.7	16.9	14.3	11.4	9.9	15.8	28.7	41.5	21.3	9.4	16.8	14.0	24.0	10.6	21.9	7.5	14.7	8.1	12.3	9.9	9.3	13.3	18.1	12.3	9.7	12.3	12.8	19.2	5.5	14.2	9.2	8.3	9.6	10.3	9.8	8.1	8.9	9.3	9.4	7.6	9.2	9.3	9.0	12.9	8.2	12.8	15.6	24.2	18.0	2.7	8.1	11.6	7.4	8.7	6.9	6.5	29.5	11.5	15.1	16.5	8.4	16.3	10.0	8.9	27.4	12.2	73.0	22.4	8.9	11.7	6.1	29.0	19.8	6.0	9.9	12.0	10.7	8.2	8.8	14.5	11.0	25.0	13.0	3.3	19.6	9.2	12.2	17.5	6.2	25.0	12.5	13.7	1.8	20.6	16.3	9.6	6.2	18.6	36.8	7.6	10.9	12.0	10.7	5.9	9.6	23.9	44.2	8.6	0.0	11.0	9.6	103.8	32.0	9.7	2.4	11.4	10.7	13.6	8.3	5.3
TSGA10	"CEP4L, CT79"	ENSG00000135951	"Testis specific 10"	Q9BZW7	2	98997261-99154964	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 52.0"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 458.9;Late spermatids: 294.2;Oligodendrocytes: 144.9;Spermatocytes: 206.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036879			Approved	Cytosol		NA	NA			Cytosol		"HPA036879: AB_10671715"	"unprognostic (1.71e-3)"	"unprognostic (6.68e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.95e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.15e-5)"	"unprognostic (2.32e-1)"	"unprognostic (2.82e-6)"	"unprognostic (1.06e-2)"	"unprognostic (9.91e-3)"	"unprognostic (9.79e-2)"	"unprognostic (8.37e-4)"	1.1	1.0	3.2	0.7	1.8	0.7	1.4	2.1	1.9	1.3	3.2	0.9	1.0	1.1	1.6	0.6	12.7	1.1	0.1	1.8	1.7	2.0	0.5	1.7	1.0	3.3	2.8	1.3	0.6	1.7	1.6	2.5	0.4	2.7	1.0	1.3	2.6	1.1	0.6	0.1	1.9	0.6	0.3	3.4	0.8	1.4	52.0	2.0	1.1	3.1	0.2	0.8	0.6	0.4	3.8	0.8	0.2	1.2	0.5	0.6	0.7	0.9	0.0	0.1	0.3	0.2	0.2	0.8	0.7	0.2	0.0	0.5	0.2	0.2	0.2	0.3	1.0	0.8	0.1	0.0	0.3	0.0	0.5	1.7	0.9	1.0	0.1	0.1	0.7	0.0	0.9	0.0	0.0	0.6	0.2	0.2	0.4	0.1	0.3	0.2	0.3	0.1	0.2	4.2	0.7	1.7	0.2	0.9	0.7	0.2	1.3	0.2	0.3	0.4	0.2	0.4	0.0	0.1	0.6	0.3	0.3	0.3	1.0	0.4	0.1	0.2	0.2	0.6	0.0	0.7	0.7	0.7	0.8	0.0	0.8	1.1	0.7	0.0	1.0	0.0	0.4	0.7	0.3	3.2	1.8	2.1	1.9	1.8	1.7	3.3	2.8	1.3	2.7	3.4	2.0	3.8	3.1	3.2	9.2	35.3	13.3	3.6	10.3	8.6	6.2	19.3	13.9	15.4	7.1	17.2	14.5	23.9	29.2	9.7	5.6	4.7	25.4	8.4	458.9	80.6	4.5	4.0	15.5	8.6	73.4	10.5	4.3	5.8	8.6	10.9	5.1	5.3	4.2	7.1	4.6	20.2	57.9	6.7	12.2	3.1	1.4	294.2	11.1	5.1	1.8	23.4	4.5	21.1	15.5	27.6	144.9	4.7	12.2	9.8	8.1	7.8	8.0	12.9	107.9	36.6	6.6	5.7	6.2	206.8	36.6	5.6	4.4	9.3	8.9	5.9	8.4	7.9
TSPAN10	OCSP	ENSG00000182612	"Tetraspanin 10"		17	81637171-81648749	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 12.9;Horizontal cells: 13.5"	"Cancer enriched"	"Detected in many"	15	"melanoma: 32.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 17.8;U-138 MG: 6.0;U-87 MG: 7.6"	"Region enriched"	"Detected in single"	4	"olfactory bulb: 1.3"	"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.81e-2)"	"unprognostic (3.67e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.08e-3)"	"unprognostic (3.74e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.59e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.43e-2)"	"unprognostic (7.31e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.58e-1)"	0.5	1.2	0.1	0.2	0.0	0.0	0.7	0.2	0.2	0.9	0.5	0.2	0.1	0.7	0.4	0.8	0.7	0.3	0.2	0.0	0.3	0.9	0.9	0.3	0.9	0.1	0.1	0.0	0.8	0.7	0.6	0.3	0.5	0.1	1.2	0.0	0.0	0.9	0.3	0.0	1.3	0.3	0.0	0.1	0.4	0.3	1.3	0.1	0.3	0.6	0.0	0.2	0.3	0.5	0.1	1.8	1.9	0.2	0.2	0.5	0.6	0.2	1.8	5.7	2.7	1.5	0.6	3.0	0.7	0.6	1.7	1.5	0.0	0.1	0.4	0.3	0.6	3.4	0.0	0.4	0.4	0.4	0.0	1.0	0.6	0.7	3.2	0.1	5.8	0.0	0.7	0.0	0.2	2.7	0.2	0.1	0.4	0.2	0.0	2.8	1.3	0.0	0.0	0.2	0.5	0.0	1.2	3.1	0.4	17.8	1.5	3.4	0.4	0.1	6.0	1.9	0.5	1.6	0.0	0.0	0.0	7.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1	3.0	3.2	7.3	0.7	2.1	0.0	2.6	0.0	0.6	2.5	5.1	6.3	1.8	4.3	2.5	12.9	4.2	2.1	1.1	1.7	9.8	3.6	0.9	3.4	2.1	2.9	0.0	0.8	0.5	2.4	6.2	3.2	1.5	4.4	7.6	3.3	3.6	1.5	10.0	13.5	0.5	1.2	0.0	1.6	0.0	2.1	1.5	2.3	0.0	2.8	0.0	5.4	0.0	0.5	1.7	0.9	0.1	1.2	0.0	1.7	1.1	4.5	3.6	5.0	0.0	3.6	1.7	5.7	5.8	1.2	0.0	1.4	1.3	8.6	1.1	1.3
TTC30A	"FAP259, FLJ13946, IFT70A"	ENSG00000197557	"Tetratricopeptide repeat domain 30A"	Q86WT1	2	177612999-177618742	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 50.1;Respiratory ciliated cells: 29.0;Spermatocytes: 51.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											"HPA051714, HPA052100, HPA052487"	Supported		Approved	Nucleoplasm,Centrosome		NA	NA			"Nucleoplasm, Centrosome"		"HPA051714: AB_2681583, HPA052100: AB_2681726, HPA052487: AB_2681848"	"unprognostic (7.75e-2)"	"unprognostic (3.83e-3)"	"unprognostic (2.16e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.79e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.41e-1)"	"unprognostic (4.67e-3)"	"unprognostic (6.07e-2)"	2.2	1.8	2.8	1.2	2.1	0.4	4.3	2.3	2.1	3.0	3.6	2.6	1.7	3.2	7.9	1.6	6.3	2.3	3.4	1.9	2.6	5.0	2.9	2.6	1.3	2.6	2.4	1.6	2.5	3.3	5.7	2.1	0.9	2.6	2.9	2.5	8.3	3.2	2.9	1.5	1.2	1.7	2.7	2.9	1.2	2.8	10.0	2.1	1.7	7.2	1.2	1.3	1.2	0.6	2.8	5.1	2.9	2.8	0.0	5.7	4.7	2.1	2.4	7.1	4.3	4.5	0.9	3.6	1.1	4.6	4.3	5.8	4.2	1.9	5.4	4.7	0.3	1.6	1.0	1.4	1.3	2.3	1.2	1.1	2.9	3.5	2.4	0.9	4.1	2.0	2.5	0.7	0.5	3.0	2.6	4.0	2.4	1.6	1.8	1.0	2.5	7.5	0.5	5.4	1.3	9.2	6.2	2.2	4.2	2.6	6.6	2.4	1.3	1.8	2.6	1.5	2.9	2.0	1.9	1.9	0.3	6.6	0.1	2.6	0.0	0.3	0.4	0.0	0.4	0.0	0.0	0.0	0.1	0.3	0.1	0.5	0.2	0.1	0.0	0.3	0.1	0.2	0.2	2.8	2.1	2.3	2.1	1.9	2.6	2.6	2.4	1.6	2.6	2.9	2.1	2.8	2.3	9.6	3.1	1.6	1.2	0.8	0.8	3.6	1.8	3.0	3.8	2.4	3.6	2.8	4.7	7.3	2.1	1.0	0.4	5.0	1.9	5.5	50.1	10.8	3.1	2.0	7.2	0.4	1.2	4.0	0.7	3.2	1.5	1.6	0.0	2.8	3.6	3.8	0.8	16.8	1.6	2.5	8.2	0.6	0.4	10.9	2.1	0.8	1.8	0.0	0.3	10.6	0.0	0.5	1.0	2.9	1.0	2.2	1.2	1.1	1.7	4.7	29.0	11.7	0.0	4.1	2.1	51.7	4.3	2.8	0.4	0.3	0.9	4.1	1.9	0.3
TTI2	"C8orf41, FLJ23263"	ENSG00000129696	"TELO2 interacting protein 2"	Q6NXR4	8	33473386-33513185	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 40.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023523, HPA029823"	Approved		Enhanced	Centrosome		NA	NA			Centrosome		"HPA023523: AB_1845776, HPA029823: AB_10602337"	"unprognostic (6.30e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.34e-3)"	"unprognostic (5.86e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.13e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.64e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.27e-3)"	"unprognostic (1.07e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.94e-1)"	"unprognostic (9.35e-2)"	5.5	7.0	5.1	6.8	5.5	8.0	6.5	6.6	6.3	6.6	5.4	6.1	5.6	6.2	6.6	6.4	6.5	4.7	7.5	4.9	6.2	6.9	7.5	4.7	10.9	5.4	5.5	4.8	5.9	4.7	9.7	5.8	5.8	5.5	6.1	6.0	5.6	6.1	5.2	9.1	6.2	5.6	6.2	5.4	7.7	5.6	13.0	5.4	10.7	6.6	6.9	11.5	6.7	6.0	5.8	8.2	15.1	19.6	19.5	14.8	9.7	8.1	12.2	13.7	20.0	19.6	12.4	6.9	23.3	17.8	9.1	17.8	14.2	31.2	14.3	17.6	10.6	10.0	14.5	8.4	12.9	15.9	13.1	13.4	8.2	17.9	14.9	13.3	12.1	17.7	30.2	21.7	17.9	14.1	16.8	39.0	13.2	25.9	23.0	10.4	26.0	15.6	11.1	11.2	8.9	23.5	12.3	11.8	10.9	14.8	17.7	11.2	10.4	10.7	12.4	10.9	13.0	12.0	9.6	10.0	34.2	12.1	13.0	13.5	19.9	20.9	35.8	24.2	24.5	23.6	18.6	21.1	23.3	19.4	22.9	24.1	21.5	23.0	23.3	27.5	14.0	25.2	19.8	5.1	5.5	6.6	6.3	4.9	6.2	5.4	5.5	4.8	5.5	5.4	5.4	5.8	5.6	6.4	4.8	5.9	8.3	5.4	7.8	7.7	8.0	6.3	3.9	3.4	0.7	1.5	8.7	7.3	20.9	9.9	5.0	3.5	3.9	9.4	21.9	7.4	9.3	7.0	3.0	15.4	4.7	9.2	9.5	6.1	3.6	7.2	3.8	8.1	3.6	5.5	9.3	6.7	5.0	6.2	6.1	5.5	3.1	4.2	6.8	5.4	5.4	3.7	10.8	6.1	5.2	3.5	5.7	6.3	2.2	7.5	5.2	7.5	5.6	7.7	8.5	11.5	6.6	6.2	5.5	40.4	10.5	5.0	8.1	8.8	6.0	7.7	5.6	4.9
TTK	"CT96, MPH1, MPS1, MPS1L1"	ENSG00000112742	"TTK protein kinase"	P33981	6	80003887-80042527	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 25.6;lymphoid tissue: 47.1;testis: 34.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 43.3;Erythroid cells: 23.1;Late spermatids: 21.4;Spermatocytes: 130.5;Spermatogonia: 33.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.2"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB010166, CAB013229"	Enhanced		Approved	Nucleoli,Cytosol		NA	Yes			"Nucleoli, Cytosol"		"CAB010166: AB_632567, CAB013229: AB_2533230"	"unprognostic (4.27e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (7.97e-2)"	"unprognostic (4.78e-2)"	"prognostic unfavorable (3.84e-10)"	"unprognostic (1.56e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.02e-3)"	"prognostic unfavorable (2.54e-4)"	"unprognostic (1.54e-1)"	"unprognostic (0.00e+0)"	"unprognostic (3.51e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.66e-1)"	0.7	0.8	0.0	4.2	0.1	25.6	2.2	0.1	0.3	0.7	0.0	4.9	4.0	1.0	0.1	4.8	0.6	0.5	0.1	0.1	0.1	0.2	0.5	0.8	8.2	0.1	0.2	0.0	0.2	0.2	0.3	0.0	3.9	0.2	0.8	5.9	1.8	0.7	0.1	0.0	3.7	4.1	1.7	0.1	1.4	3.4	34.6	0.1	47.1	0.4	0.1	9.1	1.2	1.4	0.4	39.9	23.4	68.2	56.4	3.1	9.5	38.5	44.9	27.4	64.2	77.8	32.1	29.6	58.5	34.1	19.5	66.9	50.0	60.7	27.6	88.6	53.4	49.3	54.1	29.4	26.5	0.2	64.4	33.9	1.2	2.8	45.0	28.6	9.6	36.9	80.6	60.2	58.5	55.2	29.5	37.0	46.4	40.4	35.4	27.9	32.7	124.4	24.4	16.3	25.2	46.8	27.4	26.6	28.3	16.3	36.6	26.6	48.3	15.4	28.8	28.5	18.8	72.9	13.1	47.1	32.4	10.3	58.9	25.1	0.0	0.0	0.3	0.1	0.0	0.1	0.2	0.2	0.4	0.0	0.7	0.0	0.1	0.0	0.3	0.0	0.0	1.2	0.2	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.2	0.0	0.2	0.1	0.1	0.4	0.3	3.2	1.1	0.0	1.4	1.3	0.6	2.6	0.0	0.2	0.9	0.5	0.6	0.0	2.3	0.0	2.1	9.8	0.8	2.2	3.9	0.4	43.3	3.1	1.6	1.1	1.8	23.1	0.2	0.2	15.0	2.1	2.6	2.3	1.3	13.9	0.7	0.2	6.5	0.0	0.2	3.0	4.1	2.6	1.2	21.4	0.9	1.9	0.0	0.0	5.2	0.2	1.0	0.0	0.1	0.6	0.2	0.7	5.1	0.4	0.3	0.1	3.0	1.6	6.6	0.1	1.7	130.5	33.0	8.5	0.3	3.7	1.1	0.5	5.6	1.6
TUBA3C	"bA408E5.3, TUBA2"	ENSG00000198033	"Tubulin alpha 3c"	P0DPH7	13	19173772-19181824	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	714	"testis: 408.0"	"Group enriched"	"Detected in some"	25	"Early spermatids: 703.3;Late spermatids: 250.4;Spermatocytes: 947.8;Spermatogonia: 255.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 2.7;testis cancer: 2.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	49	"HDLM-2: 107.5;U-2 OS: 256.9;U-266/70: 84.2;U-266/84: 109.7"									"HPA039247, HPA043684, HPA063394"	Uncertain		Supported	Microtubules		NA	Yes			Microtubules		"HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003"	"unprognostic (3.76e-3)"				"unprognostic (1.33e-1)"							"unprognostic (3.00e-1)"		"unprognostic (1.04e-1)"	"unprognostic (1.26e-1)"			0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	408.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.4	0.0	0.0	0.0	0.0	107.5	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.5	0.0	0.4	256.9	0.2	0.3	84.2	109.7	0.2	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	703.3	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	250.4	21.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.6	947.8	255.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0
TUBA3E		ENSG00000152086	"Tubulin alpha 3e"	Q6PEY2	2	130191745-130198439	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 176.6"	"Group enriched"	"Detected in some"	6	"Early spermatids: 259.8;Late spermatids: 109.4;Spermatocytes: 415.4;Spermatogonia: 172.3"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"BEWO: 4.2;U-2 OS: 2.7"									"HPA039247, HPA043684, HPA063394"	Uncertain		Supported	Microtubules		NA	NA			Microtubules		"HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003"	"unprognostic (1.02e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.81e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.21e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.65e-7)"	"unprognostic (1.39e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.02e-3)"	"unprognostic (8.94e-3)"	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.4	0.1	1.0	0.0	0.0	0.0	3.9	0.5	0.0	2.5	0.0	31.2	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.6	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	176.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.3	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	259.8	0.0	1.8	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	109.4	9.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	39.5	0.0	0.1	415.4	172.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1
TUSC1	"CCDC89B, TSG-9"	ENSG00000198680	"Tumor suppressor candidate 1"	Q2TAM9	9	25676389-25678440	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 164.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 38.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051426	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA051426: AB_2681481"	"unprognostic (9.84e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.11e-3)"	"unprognostic (9.41e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.79e-3)"	"unprognostic (1.72e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.85e-3)"	"unprognostic (9.14e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.89e-3)"	"unprognostic (2.88e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.21e-2)"	15.2	10.7	8.7	2.9	8.5	1.7	14.9	7.5	9.4	12.9	9.3	13.6	5.3	18.4	6.2	9.2	16.1	2.9	12.0	9.0	8.9	12.1	11.0	9.9	1.6	10.0	10.3	9.2	13.4	9.9	5.6	9.1	3.8	9.0	11.8	3.7	2.8	10.9	6.1	8.4	12.8	9.1	5.5	9.2	6.8	11.6	22.0	9.4	3.2	12.0	4.7	2.0	12.8	10.8	9.6	10.0	2.1	2.1	0.0	7.0	5.8	0.1	7.5	0.0	2.8	3.4	0.1	3.5	0.0	2.2	8.9	7.6	0.0	5.3	9.4	1.7	0.0	10.3	38.6	11.2	0.0	3.4	0.0	0.0	7.1	13.0	3.1	7.3	0.0	3.1	0.0	0.0	0.1	3.3	5.0	0.0	0.1	1.8	8.0	9.5	0.0	1.4	0.1	3.9	4.6	0.7	16.8	9.3	7.6	8.2	4.1	6.7	10.8	6.6	0.0	13.6	0.1	0.0	0.0	0.0	0.0	8.8	2.6	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	8.7	8.5	7.5	9.4	9.0	8.9	10.0	10.3	9.2	9.0	9.2	9.4	9.6	46.5	12.8	6.4	2.3	2.1	60.8	46.1	14.7	47.3	24.8	45.4	55.0	12.2	20.0	5.9	16.5	4.2	29.5	2.4	14.8	66.5	7.9	85.7	11.0	26.6	24.4	13.1	4.8	7.3	12.4	13.8	33.0	7.1	17.2	0.0	15.7	22.9	18.5	9.7	21.9	7.6	11.8	10.2	4.8	13.0	16.2	30.7	5.2	28.4	3.7	1.2	42.9	0.0	4.0	9.3	8.1	9.5	21.8	0.5	45.5	8.1	23.1	3.5	14.3	32.9	52.8	36.9	164.0	12.8	16.8	37.8	29.0	1.3	16.3	14.3	19.8
TYSND1	"MGC34695, NET41"	ENSG00000156521	"Trypsin like peroxisomal matrix peptidase 1"	Q2T9J0	10	70137981-70146700	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Early spermatids: 120.7;Late spermatids: 227.4;Spermatocytes: 124.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 27.5;PC-3: 41.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030304	Approved		Uncertain	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Nucleoplasm, Centrosome"	Cytosol	"HPA030304: AB_10670560"	"unprognostic (4.75e-3)"	"unprognostic (4.30e-2)"	"unprognostic (2.44e-2)"	"unprognostic (7.69e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.26e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.69e-2)"	5.7	6.1	1.3	1.9	1.2	0.9	5.5	1.7	1.9	5.1	1.0	4.1	3.3	4.1	0.6	11.9	4.5	0.6	2.8	1.1	0.9	5.1	6.5	2.8	1.8	2.1	0.9	1.6	4.2	6.3	1.3	3.4	1.3	1.3	5.8	0.6	0.2	5.7	1.5	3.3	11.3	5.0	0.3	0.5	5.4	3.9	14.3	1.0	1.2	4.7	0.5	0.9	4.8	6.6	1.4	16.0	10.2	0.8	6.2	1.0	0.9	3.7	2.2	1.4	2.0	1.8	6.2	9.6	13.8	6.0	0.5	0.6	27.5	1.0	3.9	0.4	8.9	9.5	0.7	2.9	3.3	2.4	1.2	0.1	2.0	7.6	1.7	3.1	1.2	1.4	4.9	0.1	4.3	0.8	6.3	5.3	5.6	3.3	3.5	41.7	8.9	2.6	6.2	0.9	2.6	7.4	3.8	6.7	14.8	6.1	0.2	9.4	1.1	2.6	2.5	1.7	4.8	8.7	14.9	9.9	7.0	2.9	6.2	1.8	0.0	0.8	0.7	3.8	1.2	2.4	3.0	2.2	2.8	0.9	3.3	3.0	2.6	0.3	2.0	0.7	0.7	2.6	1.4	1.3	1.2	1.7	1.9	1.1	0.9	2.1	0.9	1.6	1.3	0.5	1.0	1.4	6.1	9.6	5.3	4.9	12.6	14.3	14.5	13.3	14.8	6.9	14.8	16.9	4.2	27.1	7.8	11.0	0.0	35.2	15.5	14.6	17.6	7.8	120.7	5.5	6.8	6.3	14.3	5.0	6.7	9.5	9.8	7.5	5.1	6.3	13.4	9.3	6.8	16.5	12.1	0.0	6.0	12.1	16.2	10.7	6.6	227.4	9.3	8.2	12.4	6.5	6.1	7.0	12.3	11.6	5.5	5.5	11.6	7.9	7.5	14.5	19.2	16.5	3.9	4.4	6.6	6.9	6.1	124.7	12.5	22.4	18.5	16.7	14.0	10.6	21.0	8.8
UBE2J2	"NCUBE2, Ubc6p"	ENSG00000160087	"Ubiquitin conjugating enzyme E2 J2"	Q8N2K1	1	1253909-1273864	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway, Unfolded protein response"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 261.9;Late spermatids: 452.3;Spermatocytes: 261.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (9.39e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.88e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.67e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.60e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (2.09e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.46e-2)"	30.6	36.6	23.7	24.8	21.7	23.0	30.0	24.8	26.5	30.0	20.6	35.8	23.4	34.2	12.3	44.4	33.1	16.7	34.0	23.0	20.8	35.2	46.2	30.3	25.8	22.9	21.6	20.1	29.8	36.0	20.3	35.5	20.0	23.6	32.4	16.1	15.0	31.1	15.2	51.3	39.5	35.0	19.5	23.0	45.0	37.5	106.0	22.5	24.1	29.7	21.5	22.9	30.8	29.6	25.6	70.0	30.3	40.4	39.6	31.9	32.1	31.6	50.8	44.3	73.0	53.5	54.3	50.2	37.4	52.6	50.4	40.0	49.6	42.6	55.0	57.5	64.5	68.8	58.2	64.3	47.9	62.9	56.1	50.6	31.1	30.1	58.1	42.2	39.6	53.3	52.1	80.0	38.7	43.2	38.1	82.4	63.8	45.3	47.3	67.7	74.3	40.8	63.8	37.9	25.3	140.9	73.9	38.5	80.4	89.8	36.9	42.9	62.2	36.5	44.8	40.9	53.0	56.2	79.2	88.9	114.3	58.9	83.5	36.8	83.4	36.5	69.3	33.7	37.0	31.3	37.1	35.4	35.3	36.1	32.5	32.7	32.5	54.0	39.7	38.7	34.5	42.4	29.5	23.7	21.7	24.8	26.5	23.0	20.8	22.9	21.6	20.1	23.6	23.0	22.5	25.6	32.8	9.6	17.3	18.9	34.0	42.7	51.7	71.4	23.9	31.3	28.5	29.5	18.9	32.9	40.8	29.5	8.4	71.7	53.3	44.0	56.7	70.9	261.9	25.3	28.5	34.3	17.5	45.6	12.8	93.2	71.5	34.5	33.1	25.3	16.5	32.6	31.8	30.3	52.1	23.5	14.3	35.6	54.9	31.1	41.2	452.3	37.6	31.7	40.9	12.2	44.3	33.2	70.0	8.5	16.4	105.4	33.8	37.6	50.9	76.6	54.4	73.2	23.4	29.9	32.9	29.8	40.1	261.0	100.6	38.3	43.8	87.3	35.7	40.6	40.7	61.8
UBIAD1	"SCCD, TERE1"	ENSG00000120942	"UbiA prenyltransferase domain containing 1"	Q9Y5Z9	1	11273198-11296049	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"Menaquinone biosynthesis, Ubiquinone biosynthesis"	"Prenyltransferase, Transferase"	"Corneal dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044862			Approved	Vesicles		NA	NA			Vesicles		"HPA044862: AB_2679117"	"unprognostic (1.79e-2)"	"unprognostic (2.26e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.95e-3)"	"unprognostic (7.55e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.63e-1)"	"prognostic favorable (6.80e-5)"	"unprognostic (3.00e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.25e-1)"	7.0	7.6	5.2	7.7	7.4	7.7	8.4	6.6	6.1	6.5	2.2	7.1	5.6	8.5	6.1	5.9	9.7	4.6	8.3	4.9	5.5	6.5	10.1	6.2	10.3	7.2	7.2	5.0	11.6	10.9	10.0	5.8	6.5	6.7	7.2	6.8	8.1	7.0	6.6	17.8	7.5	6.5	7.9	6.9	7.2	7.3	9.3	6.6	12.1	7.8	13.9	10.6	8.2	5.7	9.9	14.5	14.1	11.0	21.3	8.0	7.4	14.8	15.6	12.7	16.4	14.9	16.4	13.1	28.5	15.6	11.1	15.4	19.5	28.1	18.7	19.9	20.0	24.1	19.1	14.5	22.0	14.5	29.5	15.9	11.2	24.9	22.2	26.3	8.7	12.2	25.8	23.1	22.9	11.2	14.8	19.1	14.7	13.3	27.1	20.7	18.0	24.6	34.6	12.7	9.5	13.6	14.5	16.6	16.3	21.5	4.5	12.1	15.3	10.2	14.4	15.5	15.1	20.5	18.6	27.9	52.4	9.2	38.3	18.3	11.5	12.8	19.5	24.3	17.5	27.3	45.3	32.5	24.8	16.9	42.1	48.5	33.3	3.9	20.5	15.6	21.1	33.8	22.2	5.2	7.4	6.6	6.1	4.9	5.5	7.2	7.2	5.0	6.7	6.9	6.6	9.9	9.4	9.6	14.6	4.2	19.6	15.4	16.7	11.2	22.2	11.9	13.3	13.7	8.3	11.5	18.1	5.5	8.4	10.6	17.5	7.4	11.7	10.8	34.1	6.3	9.6	9.5	4.9	13.3	4.2	13.3	14.7	11.4	13.3	9.6	7.0	11.3	7.9	19.7	8.7	13.5	6.5	11.1	14.2	8.2	14.1	23.1	12.5	9.5	5.4	4.7	7.1	9.5	14.4	9.0	11.1	11.0	5.3	10.9	14.2	15.0	5.8	8.6	8.9	15.8	0.0	20.2	10.4	24.7	15.7	15.7	12.6	18.9	14.4	12.0	14.1	10.3
UFSP2	"C4orf20, FLJ11200"	ENSG00000109775	"UFM1 specific peptidase 2"	Q9NUQ7	4	185399537-185425979	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 190.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039985, HPA043298"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA039985: AB_10794206, HPA043298: AB_10795037"	"unprognostic (8.87e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.19e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.56e-1)"	"prognostic favorable (1.07e-8)"	"unprognostic (1.92e-1)"	"unprognostic (8.12e-2)"	"unprognostic (9.36e-3)"	"unprognostic (6.70e-3)"	21.4	25.1	21.2	9.6	21.5	5.8	24.5	25.3	24.3	21.8	27.3	17.2	13.1	20.1	28.4	26.1	17.9	15.8	32.4	22.1	23.5	37.6	24.3	17.3	12.0	21.0	21.1	17.7	31.6	19.8	24.0	10.1	14.1	21.1	19.9	15.4	56.9	20.4	19.4	48.9	21.8	12.1	20.4	21.1	14.7	17.7	21.2	22.1	14.4	26.1	40.9	16.2	16.3	10.2	25.5	17.5	11.9	28.8	24.3	25.8	25.6	15.3	20.3	20.5	19.3	19.3	18.4	23.2	17.9	9.0	19.7	14.7	16.1	20.4	32.2	17.4	21.8	12.4	11.8	13.0	23.3	30.2	15.3	12.3	14.7	26.8	16.5	16.7	26.7	35.7	21.9	24.8	34.3	28.2	16.3	22.0	16.4	8.7	11.8	16.7	20.2	11.5	20.4	31.9	11.4	18.6	14.8	11.3	25.6	23.1	17.6	15.4	13.6	27.3	9.5	16.8	7.5	17.2	34.6	14.8	9.5	30.5	11.0	25.3	10.8	12.3	7.6	21.2	10.4	25.7	22.0	21.7	24.1	14.1	15.4	23.2	22.9	0.7	21.5	11.1	19.9	20.6	12.5	21.2	21.5	25.3	24.3	22.1	23.5	21.0	21.1	17.7	21.1	21.1	22.1	25.5	33.8	6.4	23.9	14.7	30.1	22.0	28.7	35.1	33.0	47.6	20.9	25.5	27.0	15.7	31.1	20.2	66.7	26.0	23.4	8.3	111.6	28.3	190.5	16.4	28.9	24.1	19.3	24.0	12.2	33.1	29.7	34.2	20.4	19.2	29.7	21.9	21.8	17.3	27.2	18.5	17.8	18.6	28.5	22.1	18.8	52.9	35.4	18.5	35.6	12.2	17.3	71.8	21.6	23.6	33.2	19.7	14.6	42.2	53.0	15.4	22.2	100.9	23.7	87.9	65.7	31.8	38.9	89.3	56.7	22.6	18.9	41.9	27.1	35.6	14.8	19.6
UPF3A	"HUPF3A, RENT3A, UPF3"	ENSG00000169062	"UPF3A regulator of nonsense mediated mRNA decay"	Q9H1J1	13	114281601-114305817	"Predicted intracellular proteins"	"mRNA transport, Nonsense-mediated mRNA decay, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 480.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018325, HPA061316"	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"HPA018325: AB_1858638, HPA061316: AB_2684477"	"unprognostic (9.08e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.16e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.80e-3)"	"unprognostic (1.44e-1)"	"prognostic favorable (7.09e-5)"	"unprognostic (1.39e-3)"	"unprognostic (1.52e-2)"	"unprognostic (2.34e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.76e-1)"	"prognostic favorable (3.71e-4)"	15.5	20.2	14.7	15.2	15.1	18.1	16.6	20.2	18.6	17.5	10.2	15.9	18.2	18.9	8.3	13.4	18.6	11.8	13.0	13.9	14.8	13.4	10.4	12.2	17.2	18.1	15.5	12.6	15.6	19.9	13.8	17.2	11.3	18.4	16.5	11.2	11.7	16.6	14.7	24.0	15.8	16.0	11.4	15.5	16.4	16.9	46.7	15.4	18.1	30.5	7.6	10.9	15.5	14.4	18.5	55.9	15.9	35.3	31.7	16.4	28.1	22.3	42.0	30.0	26.4	29.1	24.4	19.4	54.0	11.9	19.6	17.8	29.3	17.2	14.1	32.6	39.8	33.7	47.0	50.9	27.1	28.3	81.7	20.3	19.1	28.1	17.8	20.5	27.7	21.2	14.0	29.0	24.7	26.6	16.7	33.8	22.1	46.7	36.8	15.9	43.2	19.8	31.7	23.4	17.5	39.1	43.3	33.6	51.3	31.3	23.6	37.6	72.7	27.5	27.8	46.0	15.5	26.6	53.4	39.3	74.5	51.7	46.7	23.3	3.0	5.6	4.8	6.8	4.7	5.2	13.2	7.0	7.2	6.5	9.7	7.1	6.7	0.9	11.9	6.1	16.9	10.8	4.3	14.7	15.1	20.2	18.6	13.9	14.8	18.1	15.5	12.6	18.4	15.5	15.4	18.5	104.8	67.3	61.5	88.5	64.2	68.7	57.8	57.2	76.8	85.3	80.6	84.3	22.8	52.9	60.8	58.8	83.4	65.0	75.3	32.1	103.7	54.3	205.8	148.7	101.2	78.1	57.5	51.9	84.7	71.2	45.2	69.7	42.8	65.4	55.6	57.7	63.9	72.6	45.7	79.1	114.7	50.5	79.3	44.9	46.1	96.8	100.6	53.8	55.2	59.0	51.1	74.2	83.4	188.5	130.9	52.6	34.0	87.6	81.1	59.1	36.0	69.8	96.0	72.3	85.5	77.5	56.4	480.3	172.4	82.4	71.9	40.5	64.3	111.8	62.2	46.7
USP29		ENSG00000131864	"Ubiquitin specific peptidase 29"	Q9HBJ7	19	57119138-57131926	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.2;testis: 5.0"	"Group enriched"	"Detected in some"	8	"Collecting duct cells: 1.8;Early spermatids: 2.2;Spermatocytes: 5.1;Spermatogonia: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA076515	Enhanced					NA	NA					"HPA076515: "															"unprognostic (1.32e-1)"			0.1	0.0	1.1	0.0	0.7	1.8	0.0	2.1	0.8	0.0	1.1	0.1	0.1	0.2	0.0	0.2	0.1	0.2	0.5	1.2	1.1	0.1	0.1	0.2	0.4	1.6	0.9	0.7	0.3	1.3	0.0	0.0	0.2	1.5	0.1	0.1	0.6	0.7	0.0	0.3	1.4	0.0	0.0	1.3	0.2	0.4	5.0	0.9	0.0	0.3	0.0	0.1	0.3	0.0	2.2	0.0	0.2	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.9	0.2	0.0	0.0	0.3	0.0	0.5	0.2	0.3	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.1	0.3	0.2	0.0	0.2	0.0	0.6	0.5	0.2	0.1	0.1	0.1	0.3	0.2	0.3	0.4	0.3	0.1	0.0	0.0	0.4	0.1	0.3	0.1	0.2	0.0	1.3	0.3	0.3	0.2	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	1.1	0.3	0.1	0.6	0.1	0.2	1.1	0.7	2.1	0.8	1.2	1.1	1.6	0.9	0.7	1.5	1.3	0.9	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2
USP5	IsoT	ENSG00000111667	"Ubiquitin specific peptidase 5"	P45974	12	6852148-6866632	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006756	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		1200000	"Nucleoplasm, Cytosol"		"HPA006756: AB_1080534"	"unprognostic (2.19e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.57e-1)"	"unprognostic (4.71e-2)"	"unprognostic (8.90e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.02e-3)"	27.3	38.2	19.4	26.9	26.3	23.0	19.6	15.0	38.2	22.6	2.7	31.6	25.5	31.8	17.6	38.6	26.2	18.6	33.3	23.7	25.9	20.3	23.3	20.7	29.5	28.4	24.3	21.9	19.5	17.9	41.7	28.0	25.6	33.5	26.7	22.4	15.8	20.2	29.9	67.2	48.5	26.3	35.8	14.7	21.4	23.1	41.3	29.5	36.9	26.9	42.9	29.7	30.1	24.4	39.0	88.1	135.7	88.4	100.4	59.0	53.9	113.4	93.0	70.9	109.2	78.8	129.4	84.9	105.7	47.6	98.5	86.5	75.2	98.6	92.7	69.5	198.6	84.0	97.1	105.5	71.0	45.8	88.5	97.2	55.6	52.9	94.8	64.9	72.9	94.8	41.7	85.4	40.9	91.1	97.4	132.9	44.4	172.8	89.3	56.5	103.4	115.5	73.5	62.9	84.5	48.5	97.4	63.5	96.3	41.1	110.6	38.3	72.4	92.4	91.5	109.1	70.4	117.6	49.0	124.5	163.8	102.1	55.3	91.3	5.4	19.3	8.3	24.3	25.1	23.1	15.0	21.7	20.8	28.4	13.9	20.1	20.9	1.3	17.6	24.4	20.5	19.9	27.7	19.4	26.3	15.0	38.2	23.7	25.9	28.4	24.3	21.9	33.5	14.7	29.5	39.0	11.3	9.6	13.1	7.5	14.0	11.6	11.4	18.0	8.6	18.7	13.1	10.8	9.5	17.2	11.5	22.0	60.5	45.9	14.8	21.5	11.7	28.1	14.7	10.6	14.7	15.3	16.7	19.4	11.5	20.5	30.7	16.6	10.2	13.7	14.7	29.6	11.4	22.2	28.4	40.4	11.9	19.3	14.2	13.0	7.4	19.2	23.0	10.9	16.0	9.4	32.4	16.0	13.4	6.0	11.9	20.2	17.4	33.8	14.1	10.3	22.5	18.5	7.9	16.2	32.9	13.3	17.2	51.7	25.6	17.6	15.5	52.8	15.4	27.6	27.5	7.9
USP8	"HumORF8, KIAA0055, SPG59, UBPY"	ENSG00000138592	"Ubiquitin specific peptidase 8"	P40818	15	50424380-50514421	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Cushing syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050215	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA050215: AB_2681054"	"unprognostic (5.81e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.99e-2)"	"prognostic favorable (1.29e-5)"	"unprognostic (4.89e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.58e-1)"	20.5	19.0	10.9	21.3	10.7	27.8	19.8	14.1	13.4	20.7	16.1	21.7	27.0	19.3	10.5	20.9	18.6	16.5	15.2	8.8	13.2	27.2	28.3	19.6	19.1	14.4	11.8	6.6	20.1	17.6	45.4	10.6	20.5	11.6	17.1	21.0	22.4	20.0	17.4	17.7	14.3	24.6	18.6	11.2	18.9	22.7	32.3	11.6	21.1	25.6	22.9	24.5	20.2	12.7	12.8	30.6	35.8	23.7	41.1	32.3	44.3	31.0	45.7	43.9	35.7	40.4	19.5	17.7	28.8	35.0	43.5	46.6	57.8	28.8	28.3	39.9	27.2	19.3	52.9	31.9	27.3	35.9	34.3	34.4	32.4	36.2	26.0	55.8	37.0	36.3	23.3	28.4	36.8	32.9	45.9	26.6	12.0	28.5	32.6	17.1	24.1	39.1	45.8	29.5	61.3	29.1	23.8	42.5	55.9	57.4	48.9	35.8	36.9	45.0	41.1	24.1	122.7	52.7	28.5	69.8	32.4	30.6	65.6	40.1	114.6	27.7	50.1	21.4	26.1	22.1	37.3	22.9	23.3	22.7	34.3	24.0	21.2	47.9	22.1	35.0	20.5	20.0	16.0	10.9	10.7	14.1	13.4	8.8	13.2	14.4	11.8	6.6	11.6	11.2	11.6	12.8	63.5	96.1	130.8	36.2	101.8	28.9	40.7	47.3	35.9	54.5	41.7	40.0	69.8	51.5	72.7	47.8	68.8	59.0	92.7	79.5	25.4	53.7	153.7	91.5	79.7	53.8	53.3	36.8	41.0	51.3	45.4	55.8	58.1	65.6	86.7	48.5	51.0	56.6	45.4	33.7	44.3	68.7	36.7	73.2	38.2	28.4	53.7	77.6	40.9	46.9	85.3	45.5	72.1	34.7	46.1	57.3	58.2	61.7	87.1	51.0	88.9	49.9	114.9	74.2	46.0	108.2	56.2	140.5	54.8	39.6	41.5	105.2	72.6	77.1	64.8	55.3
VPS50	"CCDC132, DKFZp313I2429, FLJ20097, KIAA1861, VPS54L"	ENSG00000004766	"VPS50 subunit of EARP/GARPII complex"	Q96JG6	7	93232340-93361123	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026679	Approved		Uncertain	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA026679: AB_1846135"	"unprognostic (2.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.12e-2)"	"unprognostic (7.43e-2)"	"unprognostic (4.97e-2)"	"prognostic unfavorable (7.21e-5)"	"unprognostic (1.05e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.69e-1)"	"unprognostic (5.17e-2)"	"prognostic favorable (1.35e-6)"	"unprognostic (2.08e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.35e-1)"	7.1	9.1	3.8	3.4	5.2	2.6	8.2	5.7	5.5	7.3	4.7	8.8	2.0	8.3	4.2	9.2	6.9	2.7	7.0	4.5	4.4	7.2	6.2	6.1	4.9	4.3	4.4	4.4	7.7	7.8	6.0	7.8	4.8	4.8	6.5	5.3	5.2	8.9	3.2	12.1	8.8	8.2	3.5	4.4	9.6	7.9	6.6	4.2	4.3	7.4	5.0	4.8	8.0	7.9	5.5	6.5	2.2	2.6	5.0	8.2	7.9	6.3	5.5	5.0	9.1	6.1	5.5	9.0	5.5	5.1	4.2	13.6	3.6	10.4	7.0	11.3	5.8	4.6	14.6	3.1	2.4	4.9	3.4	4.5	3.8	8.7	9.9	9.5	5.9	11.5	3.9	10.2	8.2	11.3	4.7	5.3	4.6	6.2	8.7	5.9	3.5	6.3	8.1	5.1	2.9	3.7	7.8	4.8	13.5	4.4	7.5	6.3	2.8	5.8	12.4	4.4	16.3	4.5	3.3	8.0	9.1	6.9	6.1	6.8	3.1	3.2	2.1	2.6	3.5	4.6	2.4	2.7	2.7	4.5	2.4	2.0	2.5	1.1	1.4	2.5	2.8	2.9	2.0	3.8	5.2	5.7	5.5	4.5	4.4	4.3	4.4	4.4	4.8	4.4	4.2	5.5	10.9	12.8	11.3	0.0	13.5	0.0	3.4	0.0	6.8	14.1	11.7	6.3	0.0	2.8	5.0	5.5	16.7	7.5	11.0	5.5	3.9	6.2	27.9	7.6	10.8	7.9	2.4	10.8	0.0	5.5	11.7	6.4	11.2	8.2	7.6	12.6	9.7	6.1	10.7	10.1	0.0	7.1	0.0	13.7	0.0	14.2	9.0	10.0	0.0	0.0	9.4	10.3	6.2	0.0	0.0	6.9	9.4	7.2	10.2	2.7	6.1	8.3	5.8	14.3	6.6	11.2	6.3	18.1	12.8	7.9	0.0	9.4	8.5	13.9	5.1	2.8
WBP11	"BUG13, CFAP90, FAP90, NPWBP, PPP1R165, SIPP1"	ENSG00000084463	"WW domain binding protein 11"	Q9Y2W2	12	14784582-14803486	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA039710, HPA040037, HPA046403, HPA049126"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA039710: AB_2676638, HPA040037: AB_10796115, HPA046403: AB_2679654, HPA049126: AB_2680644"	"unprognostic (4.40e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.15e-2)"	"prognostic unfavorable (9.40e-4)"	"unprognostic (5.67e-3)"	"unprognostic (3.30e-2)"	"unprognostic (2.68e-1)"	"unprognostic (9.69e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.96e-3)"	"unprognostic (6.11e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.09e-2)"	22.5	23.6	14.3	22.6	15.7	66.3	21.0	14.7	17.5	18.0	14.2	19.6	16.3	22.6	17.6	20.0	24.3	18.4	31.4	15.2	16.2	20.2	23.3	20.6	27.6	14.8	14.9	13.6	25.0	21.2	25.3	13.4	25.3	15.2	22.0	22.4	21.5	21.4	18.2	39.1	23.5	18.9	22.4	13.6	23.1	18.9	39.3	16.0	26.3	24.5	33.2	29.8	21.7	16.9	15.2	52.1	45.3	53.0	102.4	34.7	32.9	95.6	41.8	35.0	62.3	62.3	83.9	63.2	64.1	26.7	38.0	53.0	42.4	82.3	55.3	76.5	114.6	54.5	94.3	48.1	52.0	34.8	89.6	50.1	32.2	43.7	69.8	52.0	33.6	50.2	59.5	61.3	33.7	50.1	50.1	84.0	48.7	171.9	35.4	29.0	70.7	84.3	40.6	45.3	70.8	28.3	57.6	55.8	46.3	44.9	123.8	24.6	58.2	37.8	43.7	66.1	38.9	72.8	29.2	43.8	116.6	45.7	43.6	59.3	12.3	14.0	12.7	18.8	19.4	20.8	18.3	18.1	19.1	13.2	16.9	20.9	19.6	8.7	19.2	20.6	9.6	21.3	13.7	14.3	15.7	14.7	17.5	15.2	16.2	14.8	14.9	13.6	15.2	13.6	16.0	15.2	56.8	57.7	61.0	10.1	79.3	54.9	86.9	49.7	41.5	43.7	53.5	40.6	108.6	54.3	60.7	36.8	47.9	57.8	87.2	36.6	43.0	62.5	98.5	70.1	66.8	52.5	39.5	72.6	17.5	59.5	93.3	62.2	32.6	56.7	106.3	41.0	45.0	48.6	46.6	43.7	16.2	37.8	32.6	44.3	42.1	58.4	45.4	56.7	35.6	9.4	104.6	49.6	74.2	13.0	23.0	52.8	22.3	32.7	64.0	64.1	34.0	53.8	78.7	54.1	59.2	79.3	81.3	207.5	140.4	43.5	55.7	75.9	84.8	42.9	42.6	68.1
WDR48	"KIAA1449, P80, SPG60"	ENSG00000114742	"WD repeat domain 48"	Q8TAF3	3	39052013-39096671	"Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 104.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038421, HPA058015"	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA038421: AB_10670780, HPA058015: AB_2683580"	"unprognostic (1.95e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.78e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.34e-3)"	"unprognostic (6.14e-3)"	"unprognostic (9.87e-3)"	"unprognostic (8.02e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.14e-2)"	"prognostic favorable (1.63e-7)"	"unprognostic (2.41e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.69e-2)"	14.2	15.6	21.1	13.5	22.5	35.4	17.8	20.5	25.9	17.8	17.7	14.5	15.3	20.2	14.2	14.1	15.8	13.3	16.4	21.6	22.2	21.6	16.2	14.0	17.8	21.2	21.2	20.8	21.3	16.3	22.2	4.5	20.9	21.4	16.1	15.3	18.0	15.5	21.1	11.6	14.2	15.3	17.1	21.6	16.3	14.3	48.3	22.2	27.0	25.1	17.3	19.6	17.0	6.4	24.3	11.6	16.4	32.9	23.6	23.8	27.2	14.4	14.4	20.6	17.6	22.5	11.5	12.7	27.8	10.0	20.2	15.7	13.8	30.3	18.7	20.5	70.3	38.8	26.1	22.8	19.0	10.8	18.8	13.7	18.1	21.2	19.0	21.9	31.9	21.8	20.1	30.7	27.8	16.3	9.9	24.6	20.1	36.3	16.8	19.8	9.6	17.3	24.1	21.9	24.2	24.1	29.0	14.7	29.8	25.4	29.0	15.6	26.7	18.8	15.9	12.0	14.7	16.2	30.2	48.6	22.7	18.5	16.9	15.5	13.3	6.0	7.5	9.2	7.9	9.1	9.4	10.6	10.7	8.7	10.9	10.7	9.3	8.0	15.1	13.0	7.2	12.6	8.9	21.1	22.5	20.5	25.9	21.6	22.2	21.2	21.2	20.8	21.4	21.6	22.2	24.3	27.0	16.0	22.0	45.4	26.6	17.6	13.3	9.2	20.5	21.6	18.1	16.6	23.2	7.2	15.5	11.0	16.7	15.9	26.0	14.4	17.6	13.9	77.2	20.2	28.5	20.6	22.1	17.9	35.3	12.4	12.2	18.0	9.7	29.7	24.1	25.5	16.1	13.0	8.6	21.9	37.0	13.7	4.1	11.4	15.9	71.9	18.6	16.2	14.2	26.2	19.8	23.6	13.4	38.7	41.1	12.0	12.9	16.6	20.9	21.9	17.3	13.4	17.8	17.9	26.3	21.9	19.2	104.5	59.9	16.7	21.2	21.5	25.7	23.0	12.3	19.5
WDR5	"CFAP89, SWD3"	ENSG00000196363	"WD repeat domain 5"	P61964	9	134135365-134159968	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 152.7;Spermatocytes: 99.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047182			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047182: AB_2679971"	"unprognostic (9.28e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.05e-3)"	"unprognostic (2.26e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.31e-3)"	"unprognostic (4.63e-2)"	"unprognostic (7.06e-2)"	"unprognostic (5.91e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.88e-2)"	16.6	18.5	16.5	14.1	17.2	20.5	16.8	19.7	21.2	16.9	15.6	19.3	17.8	18.9	9.0	25.1	19.1	8.3	17.6	17.2	16.9	17.0	34.3	15.5	16.3	15.5	16.4	17.3	22.1	27.9	13.6	25.6	14.8	18.0	19.1	13.8	9.1	18.2	12.8	34.1	22.3	19.6	13.7	14.2	20.2	20.8	39.0	16.8	17.9	17.8	18.4	18.1	18.6	16.4	17.3	43.6	52.4	49.0	56.1	26.1	28.7	77.4	43.0	28.3	57.5	39.1	61.3	34.9	68.8	26.7	35.2	50.5	105.9	66.9	44.1	46.6	46.4	45.6	39.7	85.6	49.9	27.9	90.0	40.2	27.7	41.0	43.1	52.6	23.7	38.7	67.5	75.3	37.6	40.5	116.1	77.4	73.6	62.3	98.3	65.2	83.4	99.2	65.2	28.3	42.0	81.7	42.5	64.8	50.2	29.7	32.5	69.1	78.3	33.9	58.7	53.8	54.5	70.5	19.6	40.0	74.0	34.1	60.4	48.2	0.9	9.3	1.6	6.7	6.0	6.6	4.6	6.6	6.9	10.0	5.8	6.8	5.4	0.8	4.9	5.1	8.3	6.4	7.1	16.5	17.2	19.7	21.2	17.2	16.9	15.5	16.4	17.3	18.0	14.2	16.8	17.3	8.2	9.6	8.6	10.7	11.8	11.9	14.9	7.0	16.5	9.6	13.6	12.8	9.5	11.5	5.0	5.5	22.9	27.4	8.9	9.1	9.8	14.7	152.7	8.6	14.4	9.6	6.6	17.5	16.4	20.9	42.5	12.2	15.3	10.0	8.9	17.6	5.3	21.9	19.1	8.4	16.6	13.7	8.2	6.3	9.8	41.4	11.5	10.9	5.4	11.2	10.0	6.8	10.3	10.1	14.3	16.7	9.7	11.7	26.6	30.4	17.6	10.2	3.9	7.4	6.6	9.7	10.9	99.9	42.3	25.6	16.3	17.8	9.7	32.5	22.2	18.0
WDR53	"MGC12928, MGC64882"	ENSG00000185798	"WD repeat domain 53"	Q7Z5U6	3	196554177-196568674	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 74.7"	"Group enriched"	"Detected in many"	9	"Early spermatids: 313.9;Late spermatids: 118.8;Spermatocytes: 135.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016420	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA016420: AB_1858812"	"unprognostic (3.29e-2)"	"unprognostic (4.24e-3)"	"unprognostic (9.89e-2)"	"unprognostic (2.29e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.71e-2)"	"prognostic unfavorable (1.57e-6)"	"unprognostic (4.49e-2)"	"prognostic unfavorable (3.09e-4)"	"unprognostic (2.57e-1)"	"unprognostic (2.10e-3)"	"unprognostic (4.48e-3)"	"unprognostic (8.01e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.97e-1)"	7.8	7.4	9.9	7.0	10.7	14.8	9.1	10.9	11.8	7.2	10.5	7.6	4.4	8.2	11.1	9.1	7.1	6.4	7.5	10.1	11.1	7.3	10.0	7.0	10.7	10.3	10.2	9.6	7.1	6.0	10.1	6.8	6.4	11.7	7.3	7.2	8.9	7.1	6.2	13.2	11.8	8.0	7.4	9.9	10.9	7.3	74.7	10.3	12.2	7.2	12.7	12.0	7.3	7.7	11.9	39.4	8.5	14.6	13.6	15.0	13.2	23.8	20.1	16.2	23.0	21.7	22.8	20.2	18.9	66.4	13.0	21.2	22.3	18.9	18.4	28.8	30.0	16.3	19.4	21.2	14.6	18.5	26.9	14.3	10.7	25.9	20.6	22.2	11.4	18.7	23.6	18.8	34.5	17.7	36.4	22.5	27.5	19.5	25.7	24.4	26.5	25.3	40.5	12.8	13.4	15.0	15.2	15.0	20.8	32.2	19.8	53.0	24.2	17.2	18.9	18.0	21.5	40.6	29.5	63.8	56.6	12.7	34.2	19.4	13.1	5.5	15.7	8.8	4.7	14.1	7.8	12.2	8.5	4.7	7.5	10.2	6.1	4.7	7.4	7.8	6.2	16.5	5.0	9.9	10.7	10.9	11.8	10.1	11.1	10.3	10.2	9.6	11.7	9.9	10.3	11.9	3.9	0.0	2.8	6.8	3.8	4.2	3.2	8.1	2.8	3.7	3.4	3.4	5.6	2.8	5.8	3.7	0.0	5.7	3.5	1.7	5.9	5.0	313.9	3.3	3.5	4.7	0.0	7.4	5.5	4.2	6.1	3.9	0.5	2.7	9.5	3.2	3.9	2.5	4.3	3.3	4.8	1.6	10.2	3.8	3.0	118.8	5.0	3.9	5.4	10.3	7.3	4.0	4.1	6.0	7.1	3.7	1.9	3.4	3.7	2.9	1.5	5.0	3.1	2.8	19.7	4.0	5.5	135.6	13.9	3.5	4.7	4.7	6.3	4.1	2.7	2.6
WDR87	NYD-SP11	ENSG00000171804	"WD repeat domain 87"	Q6ZQQ6	19	37884823-37906677	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	47	"testis: 17.1"	"Group enriched"	"Detected in some"	5	"Early spermatids: 33.1;Spermatocytes: 114.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"									NA	NA						"unprognostic (6.37e-3)"	"unprognostic (1.26e-2)"		"unprognostic (5.59e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.00e-1)"		"unprognostic (1.89e-2)"	"unprognostic (2.60e-1)"	"unprognostic (4.22e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.78e-8)"	"unprognostic (1.19e-1)"	"unprognostic (2.42e-1)"	"unprognostic (5.48e-2)"	"unprognostic (4.12e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	33.1	0.2	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	13.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	114.8	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WDR88	PQWD	ENSG00000166359	"WD repeat domain 88"	Q6ZMY6	19	33132090-33175799	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 8.9"	"Group enriched"	"Detected in some"	5	"Early spermatids: 31.3;Late spermatids: 15.9;Spermatocytes: 24.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041916, HPA050336"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA041916: AB_10804121, HPA050336: AB_2681093"	"unprognostic (1.02e-1)"	"unprognostic (9.40e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.33e-4)"	"unprognostic (5.14e-2)"	"unprognostic (7.98e-2)"	"unprognostic (8.44e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-4)"	"unprognostic (3.40e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.43e-2)"	"unprognostic (6.67e-2)"	0.2	0.4	0.3	0.9	0.8	0.9	0.1	0.8	0.7	0.1	0.0	0.2	0.6	0.3	0.0	0.6	0.2	0.5	0.9	0.5	0.3	0.3	0.1	0.2	1.2	0.4	0.3	0.4	0.8	0.8	0.0	0.2	0.2	0.5	0.4	0.0	1.5	0.8	0.0	0.2	0.7	0.7	0.0	0.1	0.6	0.3	8.9	0.3	0.0	1.0	0.0	0.0	0.2	0.0	0.6	0.5	1.1	0.7	1.3	0.3	0.0	1.0	0.4	0.0	0.1	0.0	0.5	1.1	1.3	0.6	0.0	0.8	0.4	0.0	0.1	0.0	2.8	0.4	1.3	1.0	0.2	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	3.2	0.9	1.4	0.0	1.7	0.5	0.6	0.5	0.4	0.4	1.1	0.4	0.2	0.0	0.6	1.9	1.9	1.3	0.6	0.3	0.9	1.6	1.0	0.7	0.3	1.0	0.6	0.2	1.2	0.9	0.7	0.2	2.1	0.5	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.0	0.2	0.1	0.1	0.1	0.5	0.1	0.1	0.0	0.0	0.3	0.8	0.8	0.7	0.5	0.3	0.4	0.3	0.4	0.5	0.1	0.3	0.6	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.3	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	15.9	0.3	0.0	0.0	1.9	0.0	0.0	0.0	2.5	4.6	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	24.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WRAP73	WDR8	ENSG00000116213	"WD repeat containing, antisense to TP73"	Q9P2S5	1	3630767-3652761	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026893	Uncertain					NA	NA					"HPA026893: AB_10603459"	"unprognostic (3.34e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.12e-1)"	"unprognostic (9.44e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.40e-3)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (2.35e-2)"	"unprognostic (1.02e-2)"	"unprognostic (6.19e-2)"	"prognostic favorable (3.49e-4)"	"unprognostic (5.31e-2)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.00e-3)"	13.4	14.4	10.6	10.8	11.6	24.1	13.5	12.1	16.2	14.1	11.0	14.7	14.0	14.3	8.0	15.8	13.5	9.1	13.1	10.6	10.8	13.7	13.6	13.4	17.8	11.3	11.0	10.1	14.1	18.3	10.2	17.7	9.7	11.6	13.7	9.1	8.5	13.6	7.9	16.4	13.0	18.2	8.9	10.6	21.6	16.9	16.0	11.6	14.5	14.8	9.7	14.2	14.0	13.6	12.4	30.5	17.4	17.0	33.1	22.4	14.3	16.8	14.9	14.6	24.8	21.5	27.5	39.4	33.5	27.5	19.0	20.2	22.6	50.0	29.8	12.8	59.3	75.8	19.1	23.7	31.3	24.0	22.5	29.2	13.2	20.7	20.1	25.6	13.8	22.2	39.7	31.8	19.9	18.1	27.2	47.6	33.7	23.5	30.4	36.7	29.3	24.5	17.9	13.1	12.6	43.7	61.1	17.3	23.5	43.1	14.4	23.3	35.9	17.9	19.1	19.1	32.6	21.7	27.0	34.7	68.7	9.8	45.8	8.6	57.3	23.4	70.3	21.7	22.5	21.6	22.2	22.7	21.1	24.3	22.4	19.9	21.0	28.8	24.2	33.3	20.5	27.3	19.3	10.6	11.6	12.1	16.2	10.6	10.8	11.3	11.0	10.1	11.6	10.6	11.6	12.4	15.4	3.2	13.4	12.1	18.3	7.0	10.8	22.3	12.0	23.5	8.7	9.4	7.9	10.0	12.9	14.7	35.5	21.3	21.0	15.4	13.7	13.1	12.1	11.3	9.4	11.2	10.3	5.9	9.0	14.2	12.5	12.0	14.3	8.7	4.5	14.8	10.0	7.0	18.3	42.1	7.9	13.8	16.2	11.9	6.8	25.7	12.5	13.5	12.4	9.4	14.8	17.6	15.5	6.0	10.3	16.6	7.8	9.8	16.5	14.2	30.3	9.4	14.2	26.9	6.6	9.8	15.3	38.1	15.8	12.3	6.8	14.5	20.3	15.4	13.0	9.6
YBEY	C21orf57	ENSG00000182362	"YbeY metalloendoribonuclease"	P58557	21	46286342-46297751	"Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"testis: 79.5"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 376.6;Late spermatids: 276.0;Spermatocytes: 273.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 85.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016593, HPA018162"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA016593: AB_1845698, HPA018162: AB_1845699"	"prognostic favorable (5.54e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.43e-2)"	"unprognostic (7.24e-3)"	"unprognostic (4.81e-1)"	"unprognostic (2.78e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.51e-2)"	"unprognostic (7.50e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.64e-3)"	10.9	13.1	14.8	5.4	16.0	5.9	13.6	16.4	18.0	11.9	14.0	14.7	11.6	10.1	14.5	9.8	10.2	8.8	13.5	14.3	16.0	13.5	18.4	7.9	11.5	16.0	15.5	13.3	12.7	17.2	11.9	11.9	6.0	16.8	12.9	12.2	7.5	13.8	8.2	16.6	15.9	16.3	4.3	16.0	11.1	11.1	79.5	15.6	11.0	9.5	12.9	14.4	8.9	9.3	17.7	24.4	21.1	17.7	21.5	13.2	50.0	17.2	16.4	24.3	15.8	19.2	11.2	4.0	30.7	13.9	17.0	8.4	7.9	7.7	7.5	14.3	29.3	29.9	8.9	13.9	4.4	37.7	10.1	1.0	34.8	31.9	12.5	25.9	20.7	10.5	15.2	21.6	36.0	18.6	20.7	19.9	13.2	51.5	9.3	21.7	41.4	8.4	59.6	32.5	11.2	13.0	22.6	22.3	10.0	46.6	5.8	5.1	8.8	12.8	15.1	5.6	12.2	10.8	44.4	85.2	53.8	27.5	11.1	9.3	27.7	9.1	7.3	13.2	10.4	13.2	32.7	16.3	16.9	10.5	24.9	15.8	18.2	3.2	21.3	12.5	24.1	26.6	10.3	14.8	16.0	16.4	18.0	14.3	16.0	16.0	15.5	13.3	16.8	16.0	15.6	17.7	16.9	3.2	7.4	12.1	35.2	46.3	38.4	49.6	45.5	14.4	44.7	46.1	21.6	21.5	23.1	18.4	8.4	17.5	33.3	45.1	64.6	36.4	376.6	31.4	31.2	22.3	32.0	13.7	7.9	77.2	27.9	27.6	28.5	17.9	11.4	20.5	26.4	50.5	25.2	16.8	13.5	55.5	30.5	37.8	45.8	276.0	40.7	24.6	39.2	7.5	27.7	21.3	40.2	11.6	18.4	47.9	58.4	24.5	36.9	28.1	103.4	65.6	20.6	20.8	6.6	21.1	19.5	273.7	31.8	31.2	60.5	9.6	30.2	32.5	55.6	36.8
YBX1	"BP-8, CSDA2, CSDB, DBPB, MDR-NF1, NSEP-1, NSEP1, YB-1, YB1"	ENSG00000065978	"Y-box binding protein 1"	P67809	1	42682418-42703805	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, Mitogen, Repressor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 2058.3"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 8388.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB005875, HPA040304, HPA057159"	Supported		Supported	"Endoplasmic reticulum,Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		1600000	Cytosol	"Endoplasmic reticulum, Vesicles, Plasma membrane"	"CAB005875: AB_2219278, HPA040304: AB_10795364, HPA057159: AB_2683355"	"unprognostic (8.59e-2)"	"unprognostic (5.16e-2)"	"unprognostic (9.27e-3)"	"unprognostic (2.68e-3)"	"unprognostic (7.76e-2)"	"unprognostic (8.03e-3)"	"prognostic unfavorable (9.87e-10)"	"unprognostic (2.80e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.79e-3)"	"unprognostic (7.51e-2)"	"unprognostic (5.52e-2)"	"prognostic unfavorable (3.59e-7)"	"unprognostic (3.66e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.25e-1)"	536.8	256.6	143.6	426.2	150.6	871.4	404.5	154.0	159.0	324.8	167.8	527.1	368.2	409.6	213.1	368.0	339.9	211.6	740.6	138.6	181.9	316.7	312.4	399.7	411.2	173.9	151.9	119.5	314.3	268.9	134.9	123.2	244.2	173.8	310.5	381.8	395.2	272.7	221.5	2058.3	291.3	369.2	341.8	163.7	370.3	408.4	789.7	165.6	356.7	284.4	1144.0	385.3	505.7	335.1	202.6	1552.8	761.5	1020.4	1232.7	991.0	908.1	1200.2	971.5	768.9	1116.6	875.8	1034.6	1253.7	1630.6	1157.5	825.2	495.5	870.2	1162.6	1230.5	1103.9	1087.8	1278.0	1596.4	1491.9	1343.8	786.7	2214.4	1320.7	812.6	1092.3	1094.5	1365.7	630.0	950.3	1271.9	1823.0	720.6	1104.0	837.7	2816.5	2464.6	2902.1	755.0	1006.4	1789.6	1972.5	1938.2	1176.7	933.8	1731.6	1298.5	893.7	1294.0	2038.3	1096.8	443.2	5002.2	862.6	945.4	1748.6	1371.1	2209.3	1213.7	1670.6	2004.8	910.4	1750.3	1049.9	15.3	48.4	69.9	42.9	107.1	52.9	69.4	51.8	43.3	77.4	61.2	44.0	45.9	9.0	35.1	124.2	58.6	69.7	34.1	143.6	150.6	154.0	159.0	138.6	181.9	173.9	151.9	119.5	173.8	163.7	165.6	202.6	701.7	173.1	230.9	16.3	818.3	1397.7	1265.9	419.7	747.3	247.8	569.7	564.5	1072.3	441.8	355.5	325.5	150.1	753.9	678.4	620.6	1457.6	1013.6	8388.7	363.5	695.5	755.1	587.8	2244.2	16.2	886.6	1998.9	687.6	461.3	427.0	383.1	489.1	483.3	480.1	1708.7	121.1	27.1	930.2	354.0	1656.0	2342.9	3743.4	751.2	1307.6	905.4	19.7	1171.0	463.8	744.6	23.6	32.7	858.2	975.1	806.1	981.0	1935.1	993.3	1169.8	196.2	602.4	466.8	754.8	1083.7	3245.2	425.5	1113.5	1302.5	481.5	635.6	811.4	1257.7	1697.8
YBX2	"Contrin, CSDA3, MSY2"	ENSG00000006047	"Y-box binding protein 2"	Q9Y2T7	17	7288263-7294639	"Predicted intracellular proteins, Transcription factors"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	119	"testis: 555.4"	"Group enriched"	"Detected in some"	18	"Early spermatids: 346.9;Late spermatids: 427.3;Spermatocytes: 234.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 4.8;MCF7: 8.7;SH-SY5Y: 3.2;SK-BR-3: 3.9;T-47d: 12.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"CAB012332, HPA053904, HPA056744"	Enhanced					NA	NA					"CAB012332: AB_776541, HPA053904: AB_2682302, HPA056744: AB_2683223"	"unprognostic (1.76e-2)"	"unprognostic (4.62e-3)"	"unprognostic (3.99e-2)"	"prognostic unfavorable (6.50e-5)"	"unprognostic (9.80e-4)"	"unprognostic (4.68e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.38e-4)"	"unprognostic (1.78e-2)"	"unprognostic (2.15e-1)"	"unprognostic (5.31e-1)"	"unprognostic (2.35e-2)"	2.9	0.1	0.3	0.1	0.4	0.2	3.2	0.2	1.1	2.2	0.0	4.6	1.0	1.3	0.0	2.1	2.3	0.0	1.3	0.6	0.2	1.1	1.9	0.1	0.0	0.8	0.3	0.2	0.3	0.3	0.3	0.5	0.0	0.5	1.4	0.4	0.0	1.2	0.8	2.0	1.4	4.0	0.5	0.2	0.1	1.2	555.4	0.6	0.0	1.1	0.1	0.0	1.0	1.0	0.6	0.0	0.0	0.0	0.8	0.0	0.0	1.5	0.0	0.0	0.0	0.0	4.8	2.3	0.0	2.4	0.0	0.0	0.4	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	8.7	0.3	0.4	1.5	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	3.2	1.3	3.9	0.3	2.0	12.6	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.2	1.1	0.6	0.2	0.8	0.3	0.2	0.5	0.2	0.6	0.6	0.6	0.0	0.0	0.3	0.0	0.6	0.1	0.1	0.0	0.2	2.8	3.3	4.4	0.0	0.3	1.8	0.0	0.2	0.5	18.0	0.0	0.1	346.9	0.7	0.1	0.7	4.8	0.0	0.5	0.2	0.4	0.4	0.0	0.4	0.0	0.0	0.0	1.5	0.1	0.0	0.1	8.2	0.0	0.0	0.0	427.3	6.8	0.7	3.6	0.0	0.0	0.8	0.0	0.0	0.1	0.0	9.9	6.8	0.0	0.3	10.0	0.4	0.3	0.5	0.0	0.4	1.2	234.3	12.0	1.8	0.9	0.1	0.1	0.1	15.2	1.1
YIPF2	"FinGER2, MGC3262"	ENSG00000130733	"Yip1 domain family member 2"	Q9BWQ6	19	10922185-10928681	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 159.1;Syncytiotrophoblasts: 174.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019902	Approved		Approved	"Golgi apparatus,Mitochondria"		No	No			"Golgi apparatus, Mitochondria"		"HPA019902: AB_1858925"	"unprognostic (1.27e-1)"	"unprognostic (8.56e-2)"	"unprognostic (2.90e-3)"	"unprognostic (8.38e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.93e-1)"	"unprognostic (7.65e-2)"	"unprognostic (4.30e-2)"	"unprognostic (5.62e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.92e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.00e-2)"	29.2	43.8	16.7	16.0	16.7	29.8	34.4	18.2	26.8	41.3	25.0	31.3	32.1	38.4	27.0	51.4	35.5	30.6	29.3	17.1	17.4	41.0	56.5	33.1	16.9	20.1	17.4	15.0	39.9	115.3	33.7	109.0	39.2	18.8	40.6	15.9	6.5	106.6	23.8	25.1	33.9	30.1	14.3	15.7	27.9	39.5	77.4	17.3	14.5	47.9	10.4	11.3	32.9	39.9	18.2	64.9	22.3	17.5	25.4	40.0	38.9	30.1	48.9	71.6	36.6	52.9	68.1	51.6	12.8	80.2	56.2	16.7	49.8	11.9	47.6	9.5	41.7	43.2	24.2	27.3	39.1	62.1	42.5	49.3	35.7	33.6	24.7	35.4	47.7	26.2	31.1	31.6	69.2	22.9	109.4	27.4	42.7	29.4	44.3	55.2	22.8	14.1	65.3	33.0	30.2	45.4	22.2	35.2	56.4	48.8	15.3	51.7	60.1	39.1	41.6	15.3	60.2	36.7	96.7	42.5	24.2	65.1	72.9	43.9	39.2	18.8	9.3	13.3	21.3	10.4	16.3	10.4	12.3	22.3	9.5	9.3	13.3	3.1	12.1	19.4	34.1	12.6	10.4	16.7	16.7	18.2	26.8	17.1	17.4	20.1	17.4	15.0	18.8	15.7	17.3	18.2	20.5	16.0	21.2	2.6	16.0	6.8	41.6	22.4	17.1	19.4	46.9	37.8	0.5	27.1	27.3	35.0	16.7	109.5	20.6	31.9	27.4	69.3	131.1	23.0	20.1	19.2	43.3	17.2	6.4	80.7	114.1	36.0	33.6	29.3	21.6	22.5	22.5	23.0	38.7	18.5	6.7	69.4	14.2	15.3	5.2	34.6	35.1	20.5	5.4	5.6	21.1	23.8	16.5	3.5	3.3	50.3	47.7	25.6	55.4	51.6	52.5	27.0	26.1	16.4	6.6	20.0	21.9	159.1	16.6	22.6	7.0	174.3	13.9	27.9	50.6	50.0
ZBED9	"Buster4, FLJ31087, KIAA1925, SCAND3, ZFP38-L, ZNF305P2, ZNF452"	ENSG00000232040	"Zinc finger BED-type containing 9"	Q6R2W3	6	28570535-28616212	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 8.8"	"Group enriched"	"Detected in many"	4	"Early spermatids: 27.2;Spermatocytes: 24.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 4.7;hTCEpi: 4.4;K-562: 8.3;U-266/84: 3.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007246	Uncertain		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	NA			Nucleoli	"Nucleoplasm, Golgi apparatus"	"HPA007246: AB_1080727"	"unprognostic (1.01e-1)"	"unprognostic (5.16e-5)"	"unprognostic (1.88e-1)"	"unprognostic (1.27e-4)"	"unprognostic (3.96e-2)"	"unprognostic (9.46e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.73e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.34e-3)"	"unprognostic (8.21e-3)"	"unprognostic (4.31e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.66e-3)"	"unprognostic (3.92e-2)"	"unprognostic (1.59e-1)"	0.1	0.5	0.6	0.1	0.7	0.1	0.9	1.7	0.8	0.9	0.1	0.4	0.2	0.6	3.1	0.2	1.2	0.2	0.3	0.6	0.6	0.8	1.2	0.5	0.1	0.3	0.4	0.5	1.7	0.8	0.9	0.7	0.6	0.6	1.4	0.5	1.5	0.7	1.9	0.0	0.2	0.2	0.3	0.1	0.0	0.3	8.8	0.4	0.4	1.7	0.0	0.2	0.2	0.3	0.7	1.1	1.2	1.2	0.0	0.0	0.0	1.3	0.2	0.0	0.2	0.7	0.0	0.7	0.0	4.7	0.1	2.4	0.6	0.0	1.3	0.2	0.0	3.0	0.2	0.8	1.1	0.7	0.0	0.0	0.6	4.4	0.1	2.1	0.7	0.0	0.0	8.3	0.0	0.0	0.9	0.0	0.0	1.1	0.0	0.6	0.4	0.5	0.0	1.3	1.3	1.2	2.8	0.0	1.2	0.0	1.6	0.0	0.3	0.0	0.0	1.3	0.0	0.8	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.7	1.7	0.8	0.6	0.6	0.3	0.4	0.5	0.6	0.1	0.4	0.7	0.0	0.0	3.2	0.3	0.2	0.0	0.9	0.0	2.2	1.6	1.5	0.8	1.9	2.8	0.6	0.0	2.1	2.8	0.0	1.0	1.9	1.7	27.2	1.1	0.3	0.3	1.2	0.0	5.2	1.3	1.5	0.3	0.0	1.1	0.0	1.7	0.0	1.9	0.4	0.0	5.7	1.4	0.0	0.0	0.0	5.4	2.5	0.1	0.0	0.0	0.1	1.1	0.0	1.0	0.2	0.4	0.8	0.0	0.0	0.9	0.5	0.6	0.7	1.5	0.0	0.2	0.2	24.9	3.5	1.3	0.0	1.0	0.0	0.2	1.2	0.6
ZBTB32	"FAXF, FAZF, Rog, TZFP, ZNF538"	ENSG00000011590	"Zinc finger and BTB domain containing 32"	Q9Y2Y4	19	35704558-35717038	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 49.4"	"Cell type enhanced"	"Detected in some"		"B-cells: 24.0;Early spermatids: 39.6;granulocytes: 17.7;Late spermatids: 73.0;Plasma cells: 25.6;Spermatocytes: 115.5"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"cerebellum: 1.5"	"Immune cell enhanced"	"Detected in some"		"memory B-cell: 10.5"	"Lineage enriched"	"Detected in many"	5	"B-cells: 10.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 4.3;hTEC/SVTERT24-B: 2.0;U-266/70: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA076730	Enhanced					NA	NA					"HPA076730: AB_2732320"	"unprognostic (2.11e-3)"	"unprognostic (1.08e-4)"	"unprognostic (3.87e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.04e-5)"	"unprognostic (2.59e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.01e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.02e-8)"	"unprognostic (2.44e-3)"	"unprognostic (2.25e-1)"	"unprognostic (6.26e-5)"	"unprognostic (1.94e-3)"	0.1	0.2	0.2	2.0	0.1	0.6	0.0	1.5	0.3	0.1	0.0	0.2	0.3	0.0	0.0	0.3	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.3	3.4	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.5	0.2	0.1	0.2	0.4	0.0	0.0	0.1	1.7	0.1	0.0	2.6	0.5	49.4	0.1	0.3	0.1	0.0	1.3	0.5	0.0	0.3	0.7	0.6	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.3	0.1	0.0	1.0	0.0	0.0	0.0	0.7	0.0	0.0	2.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.7	0.0	0.1	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.4	0.0	0.1	0.3	0.0	0.0	0.4	0.1	0.3	0.0	1.2	1.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	10.5	0.5	0.6	0.0	3.8	0.1	0.3	0.0	0.0	0.0	0.0	2.3	0.6	0.2	0.1	1.5	0.3	0.1	0.0	0.3	0.0	0.1	0.5	0.0	0.1	0.3	0.1	0.0	1.3	0.0	24.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	39.6	0.0	0.0	0.1	0.0	0.0	1.1	0.2	0.0	0.0	0.5	0.0	17.7	0.0	0.4	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.0	73.0	1.2	0.3	1.8	0.0	1.6	0.0	0.0	0.0	0.2	0.0	0.0	1.2	25.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	115.5	0.8	0.0	0.0	0.0	4.1	0.0	0.1	0.0
ZBTB48	"HKR3, TZAP, ZNF855"	ENSG00000204859	"Zinc finger and BTB domain containing 48"	P10074	1	6579994-6589280	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 61.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030417	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA030417: AB_10603145"	"unprognostic (6.66e-2)"	"prognostic favorable (1.04e-4)"	"unprognostic (7.15e-3)"	"unprognostic (9.05e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.71e-1)"	"unprognostic (8.15e-3)"	"unprognostic (6.43e-2)"	"unprognostic (1.70e-1)"	"prognostic favorable (5.19e-6)"	"unprognostic (7.73e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.91e-3)"	9.7	11.0	6.5	13.4	6.6	14.3	10.8	6.3	8.7	14.7	8.1	10.8	11.9	11.1	12.0	12.0	13.2	11.3	8.4	6.6	7.2	11.5	21.4	11.2	14.2	6.5	6.3	6.3	16.6	11.7	13.4	12.0	10.5	6.6	15.7	12.6	7.0	11.6	10.1	10.3	14.2	11.6	10.6	6.2	16.1	12.5	25.7	7.1	17.0	14.3	14.4	15.1	12.1	13.1	7.8	6.5	7.2	12.1	17.8	13.0	10.1	6.1	6.3	7.5	12.2	12.8	8.1	14.8	20.8	11.1	5.7	8.1	12.4	18.3	12.8	9.3	21.6	16.5	17.0	24.1	7.9	15.1	28.0	45.2	10.0	9.5	11.9	18.9	16.1	8.9	16.0	17.5	13.2	9.0	12.0	14.0	20.0	9.2	12.7	12.9	15.5	11.3	23.4	10.6	5.3	23.4	10.7	9.7	22.3	15.1	12.1	12.7	22.2	9.9	8.3	5.3	9.1	8.3	14.7	13.8	33.2	7.7	22.0	5.1	20.0	10.5	42.3	8.3	6.5	8.5	9.1	6.5	8.1	11.5	10.5	8.7	7.8	14.6	10.6	10.7	7.7	5.9	8.4	6.5	6.6	6.3	8.7	6.6	7.2	6.5	6.3	6.3	6.6	6.2	7.1	7.8	7.7	3.2	12.3	10.4	13.0	4.7	9.3	13.3	3.4	8.0	7.8	8.0	5.8	11.5	10.0	11.0	6.2	6.1	12.5	15.1	11.7	4.7	61.8	10.1	7.1	6.1	15.5	3.4	7.5	3.6	5.1	6.8	23.4	6.5	26.6	10.1	7.1	15.1	10.8	10.1	6.6	15.5	14.2	7.6	5.4	19.1	8.7	11.2	5.4	4.7	9.2	11.1	9.2	4.0	5.5	3.1	14.6	5.7	6.6	5.6	22.6	12.6	18.3	7.8	19.7	10.5	8.2	34.5	14.8	5.3	5.5	5.1	9.9	13.6	10.0	6.5
ZC2HC1C	"C14orf140, FAM164C"	ENSG00000119703	"Zinc finger C2HC-type containing 1C"	Q53FD0	14	75064109-75119502	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 24.1;testis: 55.8"	"Group enriched"	"Detected in many"	5	"Early spermatids: 165.2;Late spermatids: 195.1;Spermatocytes: 198.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 6.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA050928, HPA065062"	Enhanced		Approved	"Nuclear speckles,Mitochondria"		No	No			"Nuclear speckles"	Mitochondria	"HPA050928: AB_2681277, HPA065062: AB_2732728"	"unprognostic (8.01e-2)"	"unprognostic (2.01e-2)"	"unprognostic (9.61e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.97e-3)"	"unprognostic (6.00e-2)"	"unprognostic (8.94e-2)"	"unprognostic (1.20e-2)"	"unprognostic (3.71e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.26e-1)"	"prognostic favorable (4.63e-13)"	"unprognostic (4.69e-3)"	"unprognostic (7.37e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.81e-1)"	0.9	2.6	3.8	0.6	2.8	0.4	1.7	2.9	2.9	1.8	4.4	2.7	3.1	1.3	24.1	1.3	11.1	1.6	4.4	2.4	2.9	5.6	8.5	2.5	0.2	3.0	3.1	2.3	0.6	5.2	7.0	6.2	0.9	2.9	1.3	2.4	2.6	3.0	3.4	4.7	1.5	2.4	1.0	3.1	0.8	1.6	55.8	2.8	2.3	7.1	1.5	0.5	1.4	0.6	3.4	3.8	2.8	0.3	3.3	0.2	0.0	1.8	0.3	1.1	1.4	0.8	4.8	6.9	3.3	2.6	0.4	2.6	1.0	0.0	0.0	1.2	3.9	0.3	0.6	1.0	2.3	2.5	0.0	1.8	0.3	0.4	1.6	0.0	1.7	1.1	0.2	5.8	1.0	0.7	0.6	0.4	0.3	0.7	2.4	1.8	0.0	0.2	0.7	4.3	0.3	5.7	1.3	2.4	2.0	1.5	0.6	2.9	0.9	0.7	0.9	0.9	1.0	0.8	4.0	4.9	1.1	1.4	0.4	0.6	0.3	0.0	0.2	0.6	0.0	0.1	0.4	0.3	0.1	0.1	0.2	0.1	0.1	0.1	1.2	0.1	0.2	0.9	0.1	3.8	2.8	2.9	2.9	2.4	2.9	3.0	3.1	2.3	2.9	3.1	2.8	3.4	0.8	6.4	9.7	2.0	0.9	1.8	1.9	1.3	4.6	4.5	7.9	5.1	7.0	2.8	6.6	11.0	10.4	2.3	1.6	2.5	3.9	4.6	165.2	21.0	2.1	2.0	5.3	0.4	2.4	1.4	1.1	2.5	1.1	1.9	1.3	1.1	2.9	4.7	1.7	11.8	2.1	2.3	0.0	1.0	0.7	195.1	3.1	1.0	3.6	1.0	0.9	3.0	8.2	0.5	1.0	1.6	0.6	2.6	0.6	2.8	4.2	7.4	32.5	8.5	6.6	5.2	2.0	198.5	5.5	1.9	0.9	5.1	0.9	2.3	3.9	1.3
ZC3HC1	NIPA	ENSG00000091732	"Zinc finger C3HC-type containing 1"	Q86WB0	7	130018287-130051451	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019089, HPA024023"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA019089: AB_1858976, HPA024023: AB_1858977"	"unprognostic (7.14e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (3.36e-4)"	"unprognostic (1.89e-1)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (1.02e-6)"	"unprognostic (2.11e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.10e-3)"	"unprognostic (2.33e-1)"	"unprognostic (5.11e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.53e-1)"	8.4	12.5	10.9	7.4	10.9	4.7	8.5	10.7	11.4	9.0	11.3	8.6	5.4	9.3	8.7	7.5	8.4	5.8	15.3	10.7	11.7	11.9	14.2	6.4	10.7	11.2	11.1	10.7	9.4	7.6	11.7	7.6	8.5	10.8	8.3	7.3	5.8	7.1	7.1	33.0	6.4	7.6	11.6	10.7	12.6	8.7	15.8	11.3	10.5	7.4	29.4	10.7	9.2	7.6	11.2	15.2	24.8	30.3	35.1	17.2	15.5	20.6	19.5	23.5	36.5	36.3	29.7	25.5	34.2	13.7	24.4	48.5	13.4	40.1	29.2	35.0	22.7	34.2	24.1	21.4	29.1	27.7	27.4	22.9	18.4	21.2	38.1	24.2	20.1	39.5	28.9	73.7	11.7	35.5	26.5	33.2	51.9	62.5	26.0	28.0	31.0	23.6	29.5	37.0	10.7	19.3	34.3	27.5	39.4	30.7	42.9	17.3	28.6	17.6	24.2	11.5	20.5	32.8	22.9	36.8	44.7	37.8	34.9	41.2	34.5	24.6	23.8	26.0	29.4	29.5	39.3	26.6	27.5	31.2	37.1	35.2	27.7	2.0	29.5	28.3	18.6	30.8	24.6	10.9	10.9	10.7	11.4	10.7	11.7	11.2	11.1	10.7	10.8	10.7	11.3	11.2	5.2	6.4	2.3	12.4	8.8	1.5	5.4	16.0	11.4	6.1	4.3	5.8	13.5	4.3	7.5	7.3	0.0	19.2	4.8	2.3	17.6	12.8	3.3	3.1	5.5	8.6	3.6	5.2	13.8	9.7	16.9	8.1	4.1	2.6	4.5	12.4	11.4	9.1	9.0	6.7	15.7	4.2	16.2	5.0	3.0	5.2	8.7	4.3	1.8	9.4	11.6	6.9	9.2	11.6	12.4	8.9	7.7	6.4	9.1	2.3	2.6	22.1	8.9	5.9	0.0	7.4	8.3	42.0	22.9	5.0	1.7	7.4	7.0	9.4	4.9	2.2
ZCCHC14	"BDG29, MGC14139"	ENSG00000140948	"Zinc finger CCHC-type containing 14"	Q8WYQ9	16	87406246-87493024	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014122			Uncertain	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA014122: "	"unprognostic (2.04e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.99e-1)"	"unprognostic (6.74e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.46e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.88e-2)"	"prognostic favorable (1.47e-14)"	"unprognostic (1.06e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.13e-2)"	"unprognostic (2.83e-2)"	10.8	13.0	10.1	6.1	8.1	3.2	10.0	15.9	10.9	11.9	5.9	10.0	13.8	10.6	6.7	9.2	8.8	10.2	9.4	11.8	5.6	10.1	22.2	10.4	5.1	8.0	6.0	8.1	15.4	12.4	13.7	10.3	7.5	7.7	7.3	8.0	10.9	8.2	7.3	9.7	11.8	14.2	7.7	3.3	5.3	9.0	35.6	6.3	4.0	12.5	8.0	4.2	10.5	9.7	6.5	12.7	9.1	15.2	19.8	19.5	13.5	9.2	6.2	9.2	7.4	3.7	19.9	11.0	6.8	8.0	12.3	18.5	20.2	14.4	4.8	9.5	2.0	17.6	6.7	13.9	19.9	8.5	1.8	3.2	11.8	9.7	14.1	8.7	11.0	10.4	3.9	15.8	1.9	6.6	13.5	0.3	8.3	11.9	7.7	8.2	17.7	8.1	3.0	13.2	6.9	34.0	42.8	45.7	6.2	26.1	9.3	14.8	14.6	8.4	17.6	13.5	16.3	10.5	3.9	2.5	20.0	8.1	10.7	11.8	0.0	0.1	0.0	0.2	0.0	0.5	0.0	0.2	0.3	0.0	0.0	0.4	0.2	0.2	0.2	0.5	0.0	0.4	0.0	10.1	8.1	15.9	10.9	11.8	5.6	8.0	6.0	8.1	7.7	3.3	6.3	6.5	21.4	12.8	12.2	30.0	2.3	18.2	2.6	7.4	6.8	19.6	12.8	11.6	11.1	11.5	12.9	5.5	6.2	3.3	6.7	17.7	3.9	7.0	26.0	11.5	23.7	15.2	21.0	3.2	43.6	8.1	1.9	15.0	10.7	18.6	1.3	17.3	11.4	33.2	5.2	23.5	47.6	14.6	8.2	7.2	10.9	40.2	11.1	7.0	7.2	28.1	2.7	7.1	6.2	46.8	29.7	8.7	7.7	10.1	3.0	3.3	24.6	11.1	9.9	15.1	19.7	12.3	21.8	53.9	22.9	12.1	17.5	3.7	6.3	26.0	15.7	2.6
ZCCHC9	"DKFZp761J139, PPP1R41"	ENSG00000131732	"Zinc finger CCHC-type containing 9"	Q8N567	5	81301587-81313297	"Predicted intracellular proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 146.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038404	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA038404: AB_10672744"	"unprognostic (1.55e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.29e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.68e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.06e-1)"	13.6	12.5	9.8	16.0	9.7	10.9	13.6	10.8	13.5	15.6	10.9	14.3	15.0	15.6	16.5	14.7	12.7	14.5	10.8	9.6	10.8	18.0	33.6	11.3	19.2	10.2	10.0	9.7	17.4	11.9	13.1	13.9	19.3	10.0	15.6	15.1	14.1	10.6	11.1	15.0	16.4	18.9	14.7	9.7	13.4	13.0	15.0	10.3	17.9	12.7	11.7	18.4	16.5	13.6	11.3	26.6	18.5	44.5	23.7	37.5	35.3	59.7	39.2	46.3	29.5	40.8	41.0	35.8	24.6	15.8	19.8	51.1	19.4	35.6	35.8	46.9	55.3	33.5	25.4	21.0	48.4	44.2	32.6	20.3	27.6	30.7	25.3	62.7	22.9	25.3	26.5	43.1	23.4	30.8	36.3	54.0	48.7	32.4	14.9	23.7	31.9	57.0	36.4	23.4	26.5	21.6	20.5	31.1	18.4	146.5	32.1	23.0	51.7	17.6	18.5	22.6	33.2	43.4	33.2	36.5	37.7	32.7	46.7	40.3	12.6	10.8	11.3	10.5	14.9	13.2	12.8	14.0	12.8	13.3	11.1	13.3	13.8	10.6	10.8	13.6	15.1	17.4	6.5	9.8	9.7	10.8	13.5	9.6	10.8	10.2	10.0	9.7	10.0	9.7	10.3	11.3	15.9	9.6	18.6	10.4	18.2	9.1	12.5	25.8	14.2	18.0	14.5	17.1	12.3	37.1	19.3	31.3	14.6	28.0	17.3	15.0	31.3	22.4	68.4	22.6	31.5	17.9	7.8	12.8	15.0	20.4	53.8	23.9	14.8	18.8	13.3	13.3	29.6	61.7	36.7	26.9	19.3	23.3	16.2	14.2	16.5	19.1	32.6	19.9	3.6	13.1	33.2	22.0	35.0	12.1	14.2	30.2	27.4	29.0	17.6	13.8	44.8	67.1	28.1	28.2	19.7	16.2	18.8	75.6	38.2	14.0	9.2	23.0	19.8	22.3	21.6	12.6
ZCWPW2	ZCW2	ENSG00000206559	"Zinc finger CW-type and PWWP domain containing 2"	Q504Y3	3	28348721-28538122	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 10.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 35.6;Early spermatids: 95.0;Excitatory neurons: 33.7;Inhibitory neurons: 34.9;Oligodendrocyte precursor cells: 32.2;Oligodendrocytes: 31.7;Spermatocytes: 68.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035035, HPA039839"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA035035: AB_10602256, HPA039839: AB_2676708"	"unprognostic (1.11e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.59e-3)"	"unprognostic (6.53e-2)"	"unprognostic (6.09e-4)"	"unprognostic (3.21e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.10e-4)"	"unprognostic (1.06e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.38e-2)"	1.5	1.8	2.0	0.9	1.8	0.8	1.8	1.8	2.1	1.4	0.3	1.1	1.2	2.1	2.2	1.4	1.0	2.0	2.8	1.9	1.2	1.7	1.2	1.3	1.2	1.2	1.2	1.5	2.5	1.9	1.5	1.3	1.2	1.4	2.2	1.1	1.6	2.3	1.1	6.2	1.9	1.0	1.0	0.7	1.1	1.8	10.0	1.2	0.6	2.6	4.5	1.0	0.8	0.8	2.3	0.3	0.2	0.8	0.3	1.2	2.8	1.2	1.1	0.8	0.3	0.3	0.2	0.9	0.7	0.5	0.6	0.8	0.4	0.2	0.2	0.3	0.4	0.4	0.3	1.1	0.3	0.6	0.5	0.6	1.2	0.5	0.3	0.5	1.3	0.5	1.5	0.3	1.0	1.5	0.3	0.2	0.6	0.3	0.1	1.1	0.3	0.3	0.6	1.2	0.1	0.3	0.9	0.2	0.4	0.7	0.8	0.4	2.6	1.0	0.8	0.4	0.7	0.6	0.3	0.2	0.3	2.8	0.5	1.0	1.0	0.7	1.1	0.3	0.7	0.2	0.1	0.3	0.2	0.3	0.2	0.5	0.7	1.0	0.2	0.2	0.4	0.3	0.2	2.0	1.8	1.8	2.1	1.9	1.2	1.2	1.2	1.5	1.4	0.7	1.2	2.3	1.6	0.0	2.0	35.6	0.4	0.6	2.7	3.7	1.2	3.0	1.6	2.7	13.6	0.0	4.3	0.0	0.0	2.4	0.1	0.4	5.9	0.5	95.0	1.2	1.2	1.0	1.2	0.0	33.7	0.9	1.4	4.3	0.0	0.6	2.5	0.8	1.4	0.5	1.3	3.3	34.9	1.9	8.2	0.6	0.7	17.7	4.7	1.3	0.0	13.1	0.7	3.7	1.0	32.2	31.7	0.6	0.3	4.9	0.3	1.1	0.6	2.6	1.7	2.0	0.0	4.4	4.5	68.7	5.8	1.1	1.6	1.2	0.6	1.3	0.7	1.3
ZFP64	"dJ548G19.1, dJ831D17.1, FLJ10734, FLJ12628, ZNF338"	ENSG00000020256	"ZFP64 zinc finger protein"	Q9NTW7	20	52051663-52204308	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035112, HPA058387"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA035112: AB_10672859, HPA058387: AB_2683702"	"unprognostic (3.86e-2)"	"unprognostic (8.84e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.61e-3)"	"unprognostic (9.22e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (9.86e-7)"	"unprognostic (4.68e-2)"	"unprognostic (5.49e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.35e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.38e-2)"	4.2	4.9	4.1	5.7	5.1	5.3	4.7	4.3	5.3	5.7	2.4	6.3	6.7	5.7	4.2	7.1	6.7	5.4	4.9	4.7	3.4	4.7	5.3	4.6	6.7	4.5	2.9	4.5	7.9	5.7	7.2	4.7	4.4	4.7	6.4	5.7	5.0	5.8	5.8	5.4	11.3	6.0	5.5	1.7	5.7	6.0	6.6	3.6	7.4	6.9	4.5	5.4	5.6	6.1	5.1	35.1	19.6	14.7	35.1	7.2	13.0	21.0	11.9	17.3	25.5	21.1	18.8	14.3	15.5	23.2	21.5	21.1	46.2	12.0	26.6	15.6	6.6	37.5	9.3	35.0	20.1	19.9	10.4	6.6	11.3	39.4	13.0	14.8	13.0	17.6	16.4	11.2	19.5	6.4	14.6	14.5	8.9	14.8	19.0	15.1	15.9	7.6	15.6	12.1	13.9	15.2	18.0	23.1	28.6	22.5	12.0	19.2	12.3	11.6	18.0	26.1	19.7	7.7	21.1	20.6	12.6	17.2	10.3	12.2	5.1	3.3	8.1	4.5	1.8	3.3	5.1	3.4	3.6	4.2	3.2	3.8	3.7	1.8	5.3	4.8	4.1	3.3	2.8	4.1	5.1	4.3	5.3	4.7	3.4	4.5	2.9	4.5	4.7	1.7	3.6	5.1	4.7	3.2	3.3	7.2	5.4	8.7	4.3	5.4	19.9	5.1	5.1	3.9	4.0	4.3	2.5	0.0	2.1	4.3	6.2	7.5	7.9	8.2	7.4	3.9	4.4	4.2	6.7	5.5	18.0	5.8	8.5	5.9	9.7	3.9	7.0	5.2	9.3	6.1	4.0	1.7	15.5	9.5	8.2	4.1	4.2	9.1	6.5	2.9	3.6	14.0	4.0	2.7	7.2	15.6	18.6	5.4	6.0	7.2	11.6	3.5	5.3	4.9	4.0	4.7	6.6	3.8	5.5	19.7	2.9	11.3	13.4	1.2	5.8	3.9	9.0	2.6
ZFPL1	"D11S750, MCG4"	ENSG00000162300	"Zinc finger protein like 1"	O95159	11	65084210-65088398	"Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014909, HPA017347"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA014909: AB_1859055, HPA017347: AB_1859056"	"unprognostic (2.03e-1)"	"unprognostic (5.79e-2)"	"unprognostic (6.08e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (9.12e-6)"	"unprognostic (1.19e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.63e-1)"	"unprognostic (7.34e-2)"	"prognostic favorable (2.73e-5)"	"unprognostic (1.88e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.34e-2)"	"unprognostic (6.94e-2)"	27.7	32.8	19.9	11.6	22.0	29.5	29.5	21.6	30.0	29.4	19.1	30.4	18.0	31.6	18.9	30.2	28.1	10.1	29.5	19.3	20.3	28.0	32.9	21.6	12.0	22.3	21.4	18.8	29.5	32.3	15.8	40.9	12.9	21.3	31.8	9.2	7.6	31.1	16.9	38.1	34.4	28.3	12.8	20.2	25.6	30.7	27.7	21.1	11.1	27.3	20.6	8.3	31.4	26.8	23.1	60.3	41.1	25.4	26.5	22.3	31.5	40.5	26.0	33.8	31.8	25.2	27.5	40.9	19.5	51.2	39.5	31.0	30.8	15.0	34.4	11.1	27.7	25.0	20.0	29.3	54.3	48.0	14.8	27.0	29.7	45.2	24.0	40.6	20.2	31.2	30.4	24.3	29.4	23.9	83.1	25.6	35.8	17.2	19.9	35.7	23.3	14.5	53.7	25.0	27.9	27.6	22.3	21.5	41.8	63.5	12.1	61.7	25.4	30.1	21.2	35.0	47.2	21.4	19.4	21.0	24.0	33.2	14.6	41.2	77.1	19.7	42.2	15.1	21.4	16.3	18.0	14.0	15.9	20.0	20.1	15.3	13.8	27.3	23.8	21.2	19.6	26.1	12.0	19.9	22.0	21.6	30.0	19.3	20.3	22.3	21.4	18.8	21.3	20.2	21.1	23.1	22.6	12.8	18.4	6.8	16.1	11.0	29.6	45.0	19.4	20.4	27.4	27.1	4.4	21.5	35.3	12.9	4.2	49.9	19.0	49.6	58.7	39.4	18.6	24.1	17.9	17.9	22.8	14.5	6.4	47.9	47.1	19.4	25.0	29.6	9.5	30.0	16.4	20.7	32.1	23.5	6.1	40.1	32.6	15.7	11.9	47.0	20.5	12.8	17.8	3.7	25.0	39.2	18.6	5.0	23.7	44.0	44.4	20.3	29.5	29.8	55.0	32.6	25.8	19.5	19.7	17.5	27.5	35.7	18.3	24.4	12.5	68.3	13.6	17.0	37.5	36.1
ZKSCAN4	"FLJ32136, P1P373C6, p373c6.1, ZNF307, ZNF427, ZSCAN36"	ENSG00000187626	"Zinc finger with KRAB and SCAN domains 4"	Q969J2	6	28241697-28252269	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 27.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA009637	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA009637: AB_2668244"	"unprognostic (4.29e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.01e-2)"	"unprognostic (4.23e-3)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (1.90e-6)"	"prognostic favorable (5.04e-4)"	"unprognostic (8.73e-3)"	"unprognostic (1.80e-2)"	"unprognostic (7.20e-2)"	"unprognostic (5.13e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.07e-2)"	"unprognostic (9.70e-2)"	"unprognostic (7.36e-3)"	2.5	2.8	1.6	2.0	1.7	1.0	2.6	2.8	2.0	3.3	1.6	2.8	2.0	3.5	2.0	2.5	2.7	1.4	2.0	1.6	1.5	2.4	3.0	2.0	3.4	1.8	1.7	1.7	3.2	2.3	2.3	2.2	2.1	2.0	2.7	2.0	2.3	2.9	1.9	1.6	2.8	3.6	1.5	1.5	8.7	2.5	9.0	1.7	4.1	2.4	1.6	3.3	3.0	2.9	1.8	1.4	1.0	2.8	4.7	3.2	3.1	2.6	1.8	2.9	2.6	2.9	1.6	1.2	3.9	3.3	2.1	1.6	1.6	2.9	2.3	2.7	1.8	3.1	3.3	2.5	2.2	2.2	6.6	2.9	3.4	2.8	2.3	2.3	3.3	2.7	3.4	3.1	0.8	2.2	1.4	4.4	6.9	2.2	0.6	1.9	3.4	3.9	2.5	1.6	1.1	4.3	3.1	1.5	2.0	3.3	2.5	1.7	3.0	2.2	2.9	1.7	1.7	1.8	2.5	2.6	1.8	1.0	6.5	1.7	2.8	1.9	2.2	1.9	1.6	2.2	1.8	1.8	1.8	3.2	1.7	2.7	2.6	2.5	2.4	1.9	4.2	1.8	1.4	1.6	1.7	2.8	2.0	1.6	1.5	1.8	1.7	1.7	2.0	1.5	1.7	1.8	1.7	0.0	0.5	2.6	2.2	0.4	0.5	1.0	1.2	1.1	1.5	1.4	1.3	2.8	2.7	1.8	2.1	3.9	3.9	2.2	0.0	2.7	9.8	1.3	3.2	2.2	3.5	3.8	7.9	2.0	2.8	2.5	3.1	1.4	2.5	4.2	2.5	1.0	4.5	1.7	6.5	1.5	0.0	10.7	1.8	6.9	2.8	2.9	1.8	7.5	2.6	2.2	3.1	2.5	3.9	1.7	4.9	3.8	1.3	0.4	2.3	1.7	0.4	1.7	0.0	1.6	1.6	27.4	2.4	1.6	0.3	1.1	2.1	3.5	2.3	0.3
ZKSCAN5	"ZFP95, ZNF914, ZSCAN37"	ENSG00000196652	"Zinc finger with KRAB and SCAN domains 5"	Q9Y2L8	7	99504662-99534700	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003201	Uncertain		Approved	"Intermediate filaments"		No	No			"Intermediate filaments"		"HPA003201: AB_10610701"	"unprognostic (2.47e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (7.59e-6)"	"unprognostic (1.12e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.35e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.18e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (3.42e-1)"	2.7	3.2	4.9	2.9	5.1	3.2	3.4	5.9	5.7	3.0	4.2	2.8	1.7	3.3	3.5	2.3	3.0	2.6	3.2	4.8	4.9	3.0	3.1	3.0	3.5	4.6	4.9	4.5	3.6	1.6	3.8	2.9	3.3	5.0	3.3	2.7	5.5	2.0	3.5	4.7	2.3	2.4	4.2	4.4	3.2	2.6	8.4	4.9	6.1	3.7	6.9	3.8	3.1	2.6	5.3	6.6	10.6	12.4	16.5	8.5	6.4	5.3	11.1	10.6	12.7	12.4	7.6	5.9	11.3	9.9	8.3	15.5	5.2	11.1	7.2	12.7	6.5	6.6	7.2	6.9	7.1	8.9	10.8	11.4	5.7	10.2	10.9	16.7	8.1	9.1	9.9	14.8	15.0	13.7	8.5	15.0	11.8	10.9	5.9	8.6	9.4	10.6	9.4	8.1	6.5	8.8	14.0	10.0	9.4	7.4	9.8	5.7	7.5	8.7	16.2	11.7	13.1	9.5	9.6	14.6	16.9	7.5	7.5	14.6	0.8	0.8	2.4	2.0	1.2	1.6	0.7	0.7	1.0	1.6	0.6	1.6	1.6	0.7	1.7	0.8	1.1	1.4	1.0	4.9	5.1	5.9	5.7	4.8	4.9	4.6	4.9	4.5	5.0	4.4	4.9	5.3	6.9	6.4	3.2	7.8	5.8	2.7	1.9	2.3	4.6	5.8	4.7	4.4	6.1	0.0	4.8	3.7	14.6	3.8	5.6	4.3	0.0	3.3	6.2	3.8	5.8	6.4	6.0	6.5	8.5	3.5	3.4	3.7	5.6	4.4	5.7	7.5	4.6	4.2	3.4	10.1	8.6	3.0	8.2	3.9	4.0	2.9	4.1	4.9	0.0	9.4	3.5	8.7	2.1	6.0	8.4	4.3	0.8	5.7	4.4	2.4	4.1	2.5	3.0	6.3	6.6	6.5	4.1	18.0	6.6	5.9	2.8	2.6	4.4	5.9	3.3	1.8
ZKSCAN7	"FLJ12738, ZNF167, ZNF448, ZNF64, ZSCAN39"	ENSG00000196345	"Zinc finger with KRAB and SCAN domains 7"	Q9P0L1	3	44555193-44594173	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 15.4;Late spermatids: 17.1;Oligodendrocyte precursor cells: 10.6;Spermatocytes: 10.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.0;NTERA-2: 3.1;SH-SY5Y: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048312, HPA049906, HPA071850"	Uncertain		Supported	"Nuclear speckles,Cytosol"		NA	NA			Cytosol	"Nuclear speckles"	"HPA048312: AB_2680352, HPA049906: AB_2680946, HPA071850: AB_2686458"	"unprognostic (3.31e-2)"	"unprognostic (4.49e-2)"	"unprognostic (7.25e-2)"	"unprognostic (5.78e-3)"	"unprognostic (3.41e-2)"	"unprognostic (1.21e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.31e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.22e-4)"	"unprognostic (5.91e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.83e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.54e-1)"	"unprognostic (7.17e-3)"	1.4	2.7	0.9	1.0	0.9	0.3	1.6	1.9	1.0	2.6	1.2	1.7	0.4	2.8	2.3	0.8	2.5	0.9	2.1	0.8	0.8	2.0	2.2	1.3	1.3	0.7	0.9	0.6	4.2	3.1	0.8	4.2	0.7	1.1	2.4	0.7	3.0	1.6	1.3	1.0	0.6	1.7	1.4	0.5	2.1	1.7	4.2	0.7	2.2	2.6	0.6	1.2	2.4	1.6	1.0	0.0	0.0	2.6	4.0	0.8	0.3	0.0	1.3	1.1	1.4	1.5	0.0	0.0	0.0	0.4	0.9	0.4	0.0	0.0	0.8	1.7	0.0	0.0	0.1	0.9	1.1	2.4	0.0	0.0	1.8	0.9	0.7	0.0	0.0	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	3.1	0.0	0.0	0.0	1.2	0.0	0.7	0.3	1.9	4.8	0.0	0.1	0.0	2.9	0.0	1.9	0.4	0.8	0.3	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.5	0.2	0.3	0.8	0.1	0.2	0.3	0.5	0.6	0.2	0.7	0.3	0.7	0.4	0.6	0.3	0.6	0.5	0.3	0.9	0.9	1.9	1.0	0.8	0.8	0.7	0.9	0.6	1.1	0.5	0.7	1.0	0.3	0.0	0.5	5.2	1.4	0.1	0.4	0.9	0.6	6.6	0.9	1.1	4.8	0.0	0.4	1.8	0.0	0.0	3.3	0.2	0.0	2.1	15.4	0.6	1.8	0.9	3.0	1.3	4.3	0.5	0.1	2.1	0.0	0.4	0.0	3.1	0.4	1.4	1.1	3.3	4.7	0.3	0.0	0.3	0.4	17.1	0.9	0.7	0.0	1.0	1.4	3.8	6.2	10.6	6.4	0.9	0.0	2.6	0.4	0.5	0.4	1.3	0.3	4.2	0.0	1.0	1.1	10.8	3.6	0.5	0.4	0.1	1.0	2.9	0.6	0.2
ZMYND12	DKFZp434N2435	ENSG00000066185	"Zinc finger MYND-type containing 12"	Q9H0C1	1	42430329-42456253	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 17.2;testis: 29.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 164.2;Late spermatids: 71.4;Respiratory ciliated cells: 40.0;Spermatocytes: 95.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 2.6;SK-MEL-30: 2.2;WM-115: 1.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (4.54e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.20e-1)"	"unprognostic (6.43e-3)"	"unprognostic (2.53e-3)"	"unprognostic (8.13e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.79e-3)"	"unprognostic (7.23e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.87e-2)"	"prognostic favorable (1.11e-5)"	"unprognostic (1.76e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.45e-1)"	1.0	2.3	4.8	0.2	4.0	0.2	2.2	4.5	5.7	2.1	5.1	1.2	1.0	1.3	9.5	0.3	17.2	1.8	2.3	3.6	5.7	9.4	7.0	1.9	0.4	5.1	4.9	3.5	1.9	3.4	2.3	3.4	0.5	4.9	2.3	1.1	4.1	1.0	2.2	1.8	0.7	0.4	0.9	5.0	0.9	1.6	29.0	4.7	0.6	5.0	2.5	0.3	1.0	0.3	4.6	0.0	0.0	0.2	0.8	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.8	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.4	0.0	0.0	0.1	0.0	0.5	0.4	0.0	0.5	2.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.4	1.7	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.7	0.2	0.1	0.0	0.3	4.8	4.0	4.5	5.7	3.6	5.7	5.1	4.9	3.5	4.9	5.0	4.7	4.6	0.4	3.2	2.7	4.6	0.5	0.0	0.8	2.6	0.0	0.9	2.5	1.8	3.7	7.2	4.3	7.3	0.0	1.5	0.3	0.6	15.6	1.0	164.2	26.3	1.0	0.5	0.0	1.3	1.6	0.5	1.3	1.3	4.1	1.8	0.0	1.1	0.4	3.8	2.6	0.0	1.7	1.5	6.1	2.6	0.0	71.4	2.5	3.7	3.6	2.8	0.8	3.5	1.0	1.0	1.6	0.1	0.3	2.2	0.8	0.5	0.9	18.4	40.0	2.8	0.0	1.0	0.5	95.9	5.4	0.8	0.3	0.7	0.4	1.9	0.7	1.1
ZNF143	"pHZ-1, SBF, STAF"	ENSG00000166478	"Zinc finger protein 143"	P52747	11	9460319-9528524	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Sertoli cells: 59.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003263, HPA003264, HPA074818"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Golgi apparatus,Vesicles"		NA	NA			Nucleoplasm	"Nuclear bodies, Golgi apparatus, Vesicles"	"HPA003263: AB_1080672, HPA003264: , HPA074818: AB_2686715"	"unprognostic (2.30e-2)"	"unprognostic (2.12e-2)"	"unprognostic (5.51e-2)"	"unprognostic (9.72e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (1.76e-5)"	"unprognostic (4.87e-3)"	"unprognostic (2.57e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (1.20e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.06e-2)"	"unprognostic (7.55e-2)"	9.0	6.1	10.5	11.5	10.5	18.7	9.7	17.7	10.0	9.8	10.6	8.5	9.5	10.6	14.5	9.9	10.1	8.4	9.4	8.4	13.0	8.7	9.7	9.2	15.8	10.6	9.5	7.1	13.8	7.7	7.9	7.2	10.5	11.5	8.8	10.0	16.2	8.9	8.0	17.5	10.3	8.3	9.6	11.5	11.2	7.8	17.0	9.8	19.1	14.7	11.6	14.2	11.3	8.5	15.6	20.0	18.8	23.4	15.2	18.9	17.4	21.5	21.8	17.3	16.4	17.9	26.7	24.3	19.6	9.7	17.7	14.0	22.5	23.1	17.3	24.5	20.0	27.7	18.5	27.7	18.7	15.6	25.9	17.8	15.3	20.4	22.2	19.4	21.4	16.3	17.9	20.5	23.3	18.3	17.1	24.1	10.6	26.3	23.0	19.9	21.4	21.2	12.3	14.7	24.0	16.1	15.8	24.0	16.0	14.3	20.6	14.9	14.6	15.6	21.4	15.3	15.1	19.6	11.5	21.6	33.4	13.8	14.8	12.5	39.1	24.6	57.3	28.0	24.9	25.0	23.0	24.6	22.9	20.9	18.2	22.8	19.6	45.1	19.4	28.2	10.1	29.7	19.6	10.5	10.5	17.7	10.0	8.4	13.0	10.6	9.5	7.1	11.5	11.5	9.8	15.6	17.9	6.4	12.1	6.2	14.7	26.6	34.1	12.1	17.6	9.3	8.7	13.2	15.5	7.2	10.3	5.5	8.4	10.0	17.1	10.1	3.9	12.5	20.3	18.7	14.9	13.0	6.6	25.4	8.1	11.5	16.2	14.5	9.7	16.3	14.0	7.7	6.8	7.6	9.9	5.0	7.4	6.9	14.2	8.3	22.0	10.0	11.8	15.8	10.6	12.2	16.3	15.5	17.5	7.5	9.8	14.1	7.7	6.8	15.4	20.1	6.3	7.7	15.0	14.3	59.2	18.3	16.7	50.5	21.3	12.8	23.4	18.3	18.1	7.3	7.9	26.9
ZNF174	ZSCAN8	ENSG00000103343	"Zinc finger protein 174"	Q15697	16	3401215-3409364	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009656, HPA070692"	Approved		Supported	"Nucleoli fibrillar center,Nuclear bodies"		NA	NA			"Nucleoli fibrillar center"	"Nuclear bodies"	"HPA009656: AB_1080679, HPA070692: "	"unprognostic (4.33e-2)"	"unprognostic (6.81e-3)"	"unprognostic (2.08e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.94e-3)"	"unprognostic (5.19e-2)"	"unprognostic (2.03e-3)"	"unprognostic (6.39e-3)"	"unprognostic (2.41e-1)"	"unprognostic (4.25e-3)"	"unprognostic (2.06e-3)"	"unprognostic (4.35e-2)"	"unprognostic (6.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.83e-1)"	6.0	7.1	7.2	5.6	8.0	4.0	6.9	7.8	9.2	8.0	6.5	8.9	6.2	9.6	11.6	6.1	10.9	5.7	10.1	7.2	7.8	6.6	6.7	5.5	8.2	8.1	7.8	7.0	12.8	5.9	14.2	9.4	5.1	8.4	8.9	7.2	10.0	8.0	11.0	10.0	7.2	6.5	10.4	7.4	7.3	6.9	9.6	7.9	9.6	7.6	10.7	8.5	9.1	6.9	9.1	7.1	11.6	13.1	14.9	15.8	11.3	8.4	6.1	16.2	14.2	12.7	8.8	12.3	23.0	9.3	11.9	12.7	10.1	12.4	11.0	13.1	14.0	11.7	12.2	11.2	11.4	11.3	14.5	13.9	13.3	12.6	11.9	11.9	13.6	11.7	16.8	18.9	10.8	14.7	12.2	14.7	12.4	13.9	10.5	14.2	19.8	14.3	19.3	10.0	3.6	12.0	9.1	12.7	14.1	11.0	12.2	13.7	15.4	9.1	10.4	10.8	8.3	8.5	12.9	14.9	19.5	5.6	9.1	10.1	17.4	6.4	27.0	9.6	7.5	9.1	10.3	10.0	11.0	7.9	8.0	12.0	8.9	7.8	8.5	5.1	4.2	10.2	7.6	7.2	8.0	7.8	9.2	7.2	7.8	8.1	7.8	7.0	8.4	7.4	7.9	9.1	4.3	3.2	2.0	4.9	4.1	1.9	1.4	2.6	6.2	6.4	3.3	4.3	5.3	4.3	1.8	0.0	6.2	6.1	5.6	3.0	3.9	5.0	7.1	5.4	4.4	5.2	3.6	5.5	3.4	4.3	3.8	4.7	1.5	2.5	1.3	4.9	2.9	3.5	4.5	3.3	4.3	2.2	8.2	2.5	0.9	4.0	8.7	2.6	3.6	1.0	2.4	7.7	8.2	3.5	10.6	4.0	5.0	9.8	4.6	2.2	4.7	4.7	1.6	8.8	0.0	4.7	4.0	15.1	10.3	4.7	1.8	2.9	4.0	5.8	3.4	0.8
ZNF177		ENSG00000188629	"Zinc finger protein 177"	Q13360	19	9363020-9382617	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Early spermatids: 12.7;Late spermatids: 7.6;Spermatocytes: 5.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NB-4: 11.4"					"Low region specificity"	"Detected in all"			HPA003141	Uncertain					NA	NA					"HPA003141: AB_1859102"	"unprognostic (1.66e-1)"			"unprognostic (2.88e-1)"	"unprognostic (8.86e-3)"			"unprognostic (1.74e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.32e-3)"	"unprognostic (5.11e-2)"	"unprognostic (3.80e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.97e-2)"	3.1	4.9	9.2	0.9	9.0	0.5	3.7	10.8	11.8	6.9	7.9	3.9	0.7	5.7	8.2	1.2	6.6	1.4	4.5	9.2	8.7	5.2	2.7	2.9	1.3	8.8	8.3	9.0	8.1	2.3	2.7	7.5	1.9	9.2	5.8	1.7	10.0	2.2	3.0	1.3	1.9	2.6	2.7	7.9	4.1	2.5	10.5	8.5	2.9	5.1	1.6	1.0	3.9	3.4	9.8	0.4	0.6	6.1	3.8	2.8	3.0	2.1	1.1	0.8	1.6	2.3	0.3	0.2	0.4	3.3	0.7	2.1	0.2	1.3	1.1	2.5	1.2	6.0	2.0	0.6	0.5	1.6	2.1	4.2	1.2	2.4	0.9	3.2	4.9	0.8	5.1	0.1	4.1	2.4	0.0	3.4	11.4	1.1	0.1	1.9	2.2	2.0	0.5	1.2	3.1	4.8	1.1	1.8	0.1	0.9	4.6	1.2	4.0	0.7	1.7	1.2	3.5	1.8	0.2	0.0	1.8	0.6	1.7	1.7	0.6	0.0	0.4	0.4	0.1	0.2	0.2	0.0	0.4	0.4	0.0	0.4	0.2	0.3	0.8	0.0	0.2	0.1	0.2	9.2	9.0	10.8	11.8	9.2	8.7	8.8	8.3	9.0	9.2	7.9	8.5	9.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	2.0	0.0	0.0	7.6	0.6	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	5.2	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0
ZNF233	FLJ38032	ENSG00000159915	"Zinc finger protein 233"	A6NK53	19	44259880-44275317	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 14.4"	"Group enriched"	"Detected in some"	4	"Early spermatids: 40.9;Spermatocytes: 38.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 6.9;U-266/84: 7.6"									HPA020975	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA020975: AB_1859145"	"unprognostic (2.26e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.78e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.72e-2)"	"unprognostic (7.37e-3)"	"unprognostic (2.77e-2)"	"unprognostic (9.07e-3)"	"unprognostic (1.48e-1)"	"unprognostic (4.20e-3)"	"unprognostic (1.65e-1)"	"unprognostic (6.28e-3)"	"unprognostic (6.88e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.71e-4)"	"unprognostic (1.55e-1)"	0.4	1.1	1.6	1.1	1.9	1.8	1.5	2.6	2.9	0.7	0.2	2.3	0.9	0.4	1.6	0.6	1.3	0.9	3.2	1.6	1.0	1.2	0.5	0.6	1.4	1.6	0.3	1.5	0.6	0.8	1.7	3.2	1.3	1.7	2.7	1.3	4.9	0.9	1.0	1.7	1.7	1.0	0.4	0.3	1.3	1.1	14.4	0.6	1.5	1.9	0.6	0.6	0.9	0.4	3.3	0.4	1.8	2.0	1.9	2.2	0.4	0.5	0.7	0.6	0.7	1.2	1.5	2.1	0.6	1.9	0.6	1.1	0.6	0.0	0.5	0.8	0.3	2.4	1.0	2.5	1.7	1.5	0.7	0.8	0.5	0.3	0.5	1.3	2.9	0.9	0.7	0.8	3.8	0.1	0.7	0.6	0.5	2.1	0.4	0.3	1.2	0.2	0.8	0.4	1.2	2.8	4.4	0.7	0.5	1.3	3.7	3.5	1.0	0.3	0.6	0.4	0.4	0.4	6.9	7.6	1.2	3.0	0.5	0.9	1.5	0.3	0.2	0.5	0.3	0.4	0.9	0.4	0.3	0.1	1.3	0.6	0.7	0.7	1.1	0.3	1.3	0.7	0.1	1.6	1.9	2.6	2.9	1.6	1.0	1.6	0.3	1.5	1.7	0.3	0.6	3.3	0.5	0.0	0.5	2.6	0.4	0.0	0.2	0.2	0.0	3.7	1.1	0.4	4.6	0.0	0.3	0.0	0.0	0.5	0.2	0.3	0.0	0.6	40.9	1.3	0.3	0.9	1.2	0.4	9.0	0.0	0.1	0.6	0.5	0.5	0.0	0.7	0.0	0.0	0.6	0.0	7.9	0.2	2.0	0.0	0.0	8.5	0.6	0.1	0.0	1.0	0.0	1.9	0.0	4.5	5.7	0.1	0.1	0.7	0.0	0.5	0.8	0.0	0.4	4.0	0.0	0.6	0.4	38.6	1.9	0.0	0.0	0.0	0.3	1.1	0.4	0.1
ZNF287	"ZKSCAN13, ZSCAN45"	ENSG00000141040	"Zinc finger protein 287"	Q9HBT7	17	16546954-16569204	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 16.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SuSa: 16.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029290	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA029290: AB_10603465"	"unprognostic (4.74e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.99e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.19e-1)"	"prognostic favorable (5.28e-5)"	"unprognostic (5.69e-3)"	"unprognostic (5.74e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.87e-1)"	2.5	3.4	1.3	2.0	2.1	0.7	3.2	4.3	2.0	3.1	0.3	1.6	0.8	2.7	4.0	2.0	2.8	2.1	4.9	1.7	1.4	2.9	0.3	2.3	2.7	1.7	1.6	1.4	4.2	2.2	6.8	3.5	1.5	1.9	3.1	1.9	5.0	1.7	3.6	3.0	3.1	1.5	3.0	1.0	2.6	2.4	2.7	1.4	2.6	3.7	4.5	2.9	2.4	1.6	2.6	3.9	7.0	6.1	6.4	4.0	7.8	1.5	3.2	5.7	6.0	7.5	1.3	2.8	1.7	3.5	5.2	4.1	6.1	3.7	5.7	7.3	2.7	3.1	0.0	0.5	0.0	5.0	0.0	5.6	5.8	3.8	2.6	3.8	5.8	3.7	7.9	0.4	0.0	8.9	3.5	5.5	0.2	1.3	3.3	3.3	0.0	6.8	0.2	3.5	1.9	3.5	5.8	10.2	1.3	4.1	16.5	4.8	0.6	3.0	3.8	2.0	5.0	4.3	3.1	2.4	0.0	5.5	0.0	4.7	0.1	0.6	0.5	8.0	0.7	6.8	10.9	8.6	8.1	2.9	7.7	9.3	9.4	0.1	6.7	3.1	1.8	7.0	4.4	1.3	2.1	4.3	2.0	1.7	1.4	1.7	1.6	1.4	1.9	1.0	1.4	2.6	2.3	3.2	1.7	4.6	4.2	0.6	1.5	6.0	2.2	3.7	1.4	1.8	10.0	1.5	4.9	0.0	4.2	0.2	3.3	0.1	5.9	5.2	3.0	1.8	2.3	3.8	2.4	0.4	7.2	9.1	0.7	4.0	2.0	0.9	7.0	3.5	1.8	0.1	1.3	16.8	8.4	0.6	0.0	1.0	0.9	2.9	2.1	1.1	0.0	1.0	1.0	3.8	4.1	8.0	9.2	4.6	0.2	3.4	0.8	0.6	0.1	2.3	7.2	3.7	6.6	2.6	3.1	12.6	5.9	1.7	1.4	0.0	4.3	6.3	0.9	0.7
ZNF35	"HF.10, HF10, Zfp105"	ENSG00000169981	"Zinc finger protein 35"	P13682	3	44648732-44660791	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 30.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051859, HPA054738"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA051859: AB_2681642, HPA054738: AB_2682588"	"unprognostic (1.54e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.91e-3)"	"unprognostic (9.91e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.01e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.69e-2)"	"unprognostic (9.08e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.60e-3)"	"unprognostic (3.30e-1)"	3.5	2.7	2.6	1.6	2.6	1.9	3.2	3.0	2.6	3.1	1.7	3.6	1.3	4.3	2.8	4.0	2.9	1.7	3.7	2.5	2.6	2.7	2.0	2.8	1.4	2.8	2.6	2.1	2.3	2.8	2.0	3.5	1.5	2.6	3.5	1.6	2.5	3.1	2.1	3.8	3.3	2.9	3.2	2.5	3.1	3.3	7.2	2.4	1.3	3.1	2.3	2.4	3.6	3.3	3.1	3.2	2.4	6.2	8.0	4.0	3.2	1.1	3.9	5.4	6.7	6.4	4.3	1.4	2.8	1.7	5.4	2.9	2.2	0.3	5.6	6.9	0.1	2.2	9.3	4.3	0.2	3.6	9.3	6.8	3.3	4.1	6.0	5.3	3.3	5.4	0.0	6.3	2.6	7.4	1.9	0.2	3.0	13.9	2.3	6.7	0.1	6.6	4.9	3.6	9.0	3.4	8.8	4.9	3.0	0.8	5.1	8.0	5.7	5.7	7.1	5.2	3.9	7.8	7.1	11.8	1.6	6.1	4.5	5.6	0.0	1.7	0.7	0.9	1.9	0.6	1.5	0.2	1.0	1.8	1.9	0.4	0.5	0.1	2.3	1.8	0.7	0.1	1.0	2.6	2.6	3.0	2.6	2.5	2.6	2.8	2.6	2.1	2.6	2.5	2.4	3.1	6.6	6.4	8.7	6.8	5.3	2.8	3.9	3.0	1.8	4.9	4.8	3.4	3.2	2.8	3.3	1.8	0.0	0.3	3.7	2.8	1.9	8.1	10.2	2.2	4.2	9.3	2.4	3.8	7.5	8.7	0.1	5.8	2.6	3.5	0.0	5.7	5.0	1.5	3.8	6.7	8.5	2.4	10.2	2.8	1.4	6.5	1.2	3.2	1.8	4.7	3.6	4.4	7.2	8.0	11.2	10.3	3.3	4.5	4.0	4.3	2.0	3.8	3.4	6.4	0.0	4.8	5.5	30.7	11.7	3.0	2.8	0.4	2.6	5.7	3.0	3.3
ZNF354A	"EZNF, HKL1, KID-1, KID1, TCF17"	ENSG00000169131	"Zinc finger protein 354A"	O60765	5	178711512-178730659	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 49.6"	"Low region specificity"	"Detected in all"							HPA052043	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Nucleoli"	Cytosol	"HPA052043: AB_2681706"	"unprognostic (2.79e-1)"	"unprognostic (3.44e-2)"	"unprognostic (7.06e-3)"	"unprognostic (1.78e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.66e-3)"	"prognostic favorable (8.28e-4)"	"unprognostic (4.06e-2)"	"unprognostic (4.55e-2)"	"prognostic unfavorable (3.45e-6)"	"unprognostic (8.71e-2)"	"unprognostic (4.13e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-2)"	8.0	5.3	8.8	7.8	8.3	9.5	8.4	8.3	9.4	8.8	8.0	10.6	4.4	8.6	7.6	7.0	8.8	5.8	7.0	8.8	7.9	10.5	4.8	8.2	8.4	8.2	8.4	8.5	7.6	11.2	8.2	6.5	8.5	8.2	9.8	5.8	8.6	6.4	8.5	7.6	7.6	8.2	8.1	7.8	12.7	8.0	10.5	8.5	8.5	10.9	8.2	8.9	10.0	8.4	8.8	7.6	5.8	12.0	31.9	20.4	16.4	49.6	8.6	11.4	11.7	12.5	8.7	12.5	10.1	11.1	7.9	21.5	14.9	4.5	37.6	17.8	13.7	13.8	3.1	8.0	1.1	15.4	0.0	8.3	12.9	22.9	10.3	20.8	15.1	11.3	13.5	2.5	0.0	17.2	15.4	15.5	10.2	10.5	7.0	15.0	11.6	2.1	6.5	10.9	7.6	13.1	14.3	10.9	12.3	17.0	15.7	10.1	14.9	8.8	13.2	8.6	7.5	7.4	3.3	7.2	6.3	0.5	2.3	16.9	4.5	6.0	15.6	4.9	4.0	6.1	5.4	4.3	5.5	5.4	3.5	4.8	3.6	15.8	6.1	4.1	2.0	4.4	3.6	8.8	8.3	8.3	9.4	8.8	7.9	8.2	8.4	8.5	8.2	7.8	8.5	8.8	10.7	12.8	7.4	8.8	7.5	5.0	11.7	14.1	4.0	9.0	8.2	9.3	6.6	4.3	11.3	7.3	14.6	12.8	12.6	3.7	13.7	11.3	18.8	5.9	9.0	9.0	4.8	7.8	18.6	7.6	14.6	9.5	3.6	5.7	6.3	14.3	4.6	1.5	8.9	6.7	10.9	2.7	8.2	7.7	8.2	4.7	6.8	8.2	10.6	10.3	7.6	9.2	16.5	12.5	13.3	7.2	1.4	10.5	3.2	10.7	4.1	17.0	9.5	10.5	6.6	10.1	9.4	36.2	12.0	4.8	5.5	12.2	9.2	10.9	4.3	7.7
ZNF416	FLJ20557	ENSG00000083817	"Zinc finger protein 416"	Q9BWM5	19	57571566-57578911	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 8.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA063318			Approved	"Nuclear bodies,Cytosol"		No	No			Cytosol	"Nuclear bodies"	"HPA063318: AB_2684983"	"unprognostic (1.40e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.57e-3)"	"unprognostic (3.66e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.54e-2)"	"unprognostic (6.62e-3)"	"unprognostic (5.37e-2)"	"prognostic favorable (1.20e-5)"	"unprognostic (1.31e-1)"	"unprognostic (2.62e-1)"	"unprognostic (8.03e-3)"	"unprognostic (1.70e-1)"	2.1	2.3	2.5	1.6	2.9	2.6	3.8	4.4	3.7	2.8	2.2	2.0	1.4	2.4	3.9	3.2	3.4	1.9	2.7	2.6	2.5	2.6	2.1	2.5	2.8	2.1	2.4	2.5	4.5	1.4	4.4	2.0	2.9	2.7	2.7	2.1	3.8	2.2	3.1	2.6	4.9	1.7	2.8	2.1	2.8	2.1	4.3	2.6	4.0	3.6	3.0	4.1	2.4	2.5	2.8	3.2	3.1	6.5	5.2	3.9	5.6	4.3	3.2	5.8	6.2	4.0	2.2	1.7	2.2	2.3	4.1	4.5	1.2	3.8	5.5	7.6	3.5	15.5	5.3	3.5	1.8	7.0	4.7	3.3	5.6	5.6	3.9	8.2	4.9	4.3	5.3	0.7	1.7	8.4	1.3	9.9	2.2	7.7	3.8	5.7	4.9	9.7	4.8	4.3	6.8	4.7	5.3	5.8	3.0	2.9	7.3	2.7	5.6	3.2	6.7	3.2	2.2	4.8	5.4	9.5	5.9	1.5	3.1	4.1	1.1	2.6	1.9	4.3	1.9	7.7	6.6	5.9	6.3	4.1	10.4	8.0	5.8	0.8	9.0	1.7	3.7	2.9	3.7	2.5	2.9	4.4	3.7	2.6	2.5	2.1	2.4	2.5	2.7	2.1	2.6	2.8	1.1	0.0	0.5	1.3	2.9	1.7	1.6	1.6	1.2	3.5	1.6	1.8	1.8	1.5	1.6	0.0	0.0	2.1	1.0	0.6	3.9	2.8	5.0	0.9	0.9	1.8	0.0	3.6	1.5	0.9	0.8	1.1	1.5	1.1	2.5	2.6	0.7	1.2	1.7	8.4	1.4	1.1	0.0	1.0	0.6	2.0	0.9	0.6	0.0	1.0	0.5	3.2	3.1	3.0	0.2	1.4	1.2	0.7	0.8	1.3	1.1	1.3	0.6	2.8	6.6	1.5	1.2	3.1	4.1	1.3	2.4	1.9	1.3	2.4	0.9	2.2
ZNF473	"DKFZP434N043, HZFP100, KIAA1141"	ENSG00000142528	"Zinc finger protein 473"	Q8WTR7	19	50025714-50053414	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 42.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 88.9;Late spermatids: 23.3;Spermatocytes: 64.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA004191, HPA073309"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA004191: AB_2667168, HPA073309: AB_2686594"	"unprognostic (7.47e-3)"	"unprognostic (3.57e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.27e-1)"	"unprognostic (8.00e-3)"	"prognostic unfavorable (3.72e-4)"	"unprognostic (1.31e-3)"	"unprognostic (6.44e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.70e-2)"	"unprognostic (3.22e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.93e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.08e-1)"	3.8	2.9	5.4	2.9	5.0	4.3	4.6	5.9	6.4	3.6	8.1	3.1	2.9	3.8	4.0	3.6	7.4	3.2	2.9	6.2	5.1	3.6	3.3	3.5	3.6	5.1	5.5	4.1	4.5	4.7	4.4	5.4	3.0	5.5	4.8	3.0	6.2	2.4	4.0	4.1	3.7	2.5	4.9	4.9	6.8	3.1	42.8	5.5	4.1	4.6	4.7	4.6	3.2	2.4	7.2	14.4	9.6	14.7	12.4	5.7	6.6	8.3	13.2	7.9	18.4	17.2	18.4	9.5	22.2	5.0	7.7	6.8	10.8	18.4	8.8	23.4	15.6	18.0	22.5	8.8	9.3	6.6	16.3	13.1	6.8	16.1	19.3	25.2	7.6	6.2	13.1	32.1	19.3	9.4	6.2	13.0	7.8	10.4	22.4	15.1	15.8	20.5	9.8	6.1	15.6	12.1	13.9	18.6	10.1	8.9	10.0	9.4	14.7	3.0	25.7	13.1	5.2	13.4	8.9	22.8	18.4	6.1	12.7	21.0	2.0	5.0	2.9	6.3	7.3	6.6	11.7	6.3	7.7	5.0	10.0	7.8	10.0	4.4	2.5	3.4	5.3	3.9	4.2	5.4	5.0	5.9	6.4	6.2	5.1	5.1	5.5	4.1	5.5	4.9	5.5	7.2	2.8	0.0	1.7	0.3	4.6	4.6	2.9	1.9	6.8	0.7	2.9	2.8	2.2	0.0	1.7	0.0	0.0	2.3	1.5	2.3	3.9	2.4	88.9	5.6	5.1	3.8	1.8	5.2	3.1	3.2	3.2	3.5	7.7	4.0	0.0	3.8	6.8	1.7	2.2	0.0	3.1	3.7	2.0	1.3	1.7	23.3	3.7	2.0	1.8	1.9	3.2	1.7	2.1	1.5	2.8	3.4	3.0	3.8	4.1	4.1	1.6	1.7	10.4	4.3	13.1	3.5	2.7	64.7	20.5	4.8	4.7	1.9	3.5	3.5	2.4	2.1
ZNF485		ENSG00000198298	"Zinc finger protein 485"	Q8NCK3	10	43606419-43617904	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 8.9;Spermatocytes: 19.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA059356	Uncertain					NA	NA					"HPA059356: AB_2683988"	"prognostic unfavorable (5.24e-4)"	"unprognostic (1.34e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.12e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.40e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.56e-3)"	"unprognostic (4.12e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.46e-6)"	"unprognostic (8.45e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.41e-2)"	1.2	1.7	2.3	2.2	2.9	0.7	3.8	2.5	2.8	1.7	2.0	2.1	1.7	2.3	1.7	1.9	2.7	1.1	1.4	2.1	2.6	1.4	1.8	1.3	3.4	2.7	2.7	2.3	3.9	4.1	1.5	1.0	1.0	3.0	2.6	2.0	1.8	1.9	1.8	3.1	3.9	1.6	1.6	2.2	2.3	2.4	4.0	2.6	2.1	1.9	2.5	3.4	1.8	1.7	3.6	3.3	2.4	1.9	7.1	3.7	4.3	0.1	3.6	1.0	4.0	5.6	6.8	5.1	11.1	3.7	1.4	1.6	3.3	4.2	3.5	6.5	4.9	3.3	0.1	3.0	3.1	2.8	1.8	5.2	3.1	5.8	2.5	4.7	1.8	1.6	1.9	10.4	0.2	7.9	5.4	5.8	5.4	9.7	5.2	3.0	3.1	1.3	2.6	3.6	3.1	7.0	5.5	1.7	5.9	2.2	2.9	9.7	3.8	2.2	2.9	4.3	4.4	5.8	7.3	8.5	2.2	0.6	2.7	2.8	0.1	1.9	0.9	4.3	3.8	6.7	6.0	5.5	4.8	2.6	4.8	9.2	5.7	0.3	13.8	1.3	1.5	4.8	3.3	2.3	2.9	2.5	2.8	2.1	2.6	2.7	2.7	2.3	3.0	2.2	2.6	3.6	1.2	0.0	1.1	0.3	2.4	0.6	1.8	1.7	2.8	1.7	2.0	2.3	2.6	1.5	1.8	0.0	0.0	0.9	1.5	0.7	3.9	2.0	8.9	0.6	2.2	1.0	0.0	2.5	2.1	2.0	0.9	1.3	0.5	0.6	0.0	2.5	1.4	1.3	1.5	1.7	2.7	1.9	0.0	0.6	0.4	4.6	0.6	1.1	0.0	1.0	1.0	0.6	2.1	2.0	3.4	1.7	2.1	1.2	0.6	1.6	0.2	1.6	0.2	0.6	0.0	2.4	1.1	19.9	4.7	2.6	0.6	0.3	2.1	2.6	2.4	0.9
ZNF546	"MGC43537, ZNF49"	ENSG00000187187	"Zinc finger protein 546"	Q86UE3	19	39984134-40021038	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 13.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 36.0;Oligodendrocytes: 20.1;Spermatocytes: 57.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA030838			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA030838: AB_10603332"	"unprognostic (4.38e-6)"	"unprognostic (3.29e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.69e-2)"	"unprognostic (6.10e-2)"	"unprognostic (7.18e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.73e-2)"	"unprognostic (8.20e-3)"	"unprognostic (4.99e-2)"	"unprognostic (2.03e-3)"	"unprognostic (2.70e-1)"	"unprognostic (5.69e-3)"	"unprognostic (2.23e-1)"	"unprognostic (6.46e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.58e-5)"	1.8	2.8	1.3	0.7	1.7	0.5	1.9	1.7	1.5	2.2	1.4	1.8	0.4	1.7	0.9	1.0	2.2	0.5	2.3	1.2	0.8	1.9	3.7	1.3	0.9	1.3	1.1	1.0	3.0	1.9	1.2	2.8	0.8	1.4	2.1	0.6	2.4	1.4	1.1	2.5	1.0	1.8	1.4	0.9	3.2	1.5	13.7	1.2	1.0	2.4	1.4	1.1	2.1	1.7	2.7	0.1	2.2	0.8	1.2	1.9	1.1	0.1	0.8	1.2	0.8	1.3	0.1	0.3	1.1	0.9	0.6	0.3	0.0	0.4	0.1	1.3	1.0	1.5	1.4	1.7	0.7	1.0	1.5	0.9	1.1	0.4	0.5	1.3	1.1	1.2	2.0	1.7	2.9	1.0	0.3	0.5	0.3	0.2	0.1	0.2	0.7	0.8	0.5	0.5	0.2	0.5	0.7	0.5	0.0	0.5	0.8	0.3	0.7	0.5	0.3	0.6	0.1	0.5	1.9	2.2	0.2	0.6	0.5	0.4	0.7	0.4	0.8	1.0	0.7	0.7	0.8	0.7	0.6	0.8	0.6	1.3	1.2	0.3	0.8	0.3	0.2	0.9	0.3	1.3	1.7	1.7	1.5	1.2	0.8	1.3	1.1	1.0	1.4	0.9	1.2	2.7	3.1	0.0	4.6	7.8	3.9	0.5	1.0	0.8	2.8	8.4	2.4	1.9	6.8	2.8	1.1	3.7	12.5	1.4	4.1	0.6	1.9	1.4	36.0	2.5	4.5	4.0	0.0	1.7	9.9	0.4	0.2	4.9	0.5	1.5	0.0	6.3	4.6	3.0	1.8	1.7	11.7	0.5	2.0	1.9	0.5	7.4	4.4	2.0	0.0	8.4	1.5	4.8	3.1	8.5	20.1	0.3	0.4	4.1	1.9	0.8	2.4	3.5	4.1	7.9	0.0	6.2	2.6	57.8	5.4	1.0	0.0	0.3	2.3	4.8	0.6	0.7
ZNF548	FLJ32932	ENSG00000188785	"Zinc finger protein 548"	Q8NEK5	19	57389850-57402992	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 55.6"									HPA066042	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA066042: AB_2685602"	"prognostic favorable (7.85e-4)"	"unprognostic (4.61e-2)"	"unprognostic (5.53e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.05e-3)"	"unprognostic (1.61e-2)"	"unprognostic (6.77e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.86e-3)"	"unprognostic (5.85e-2)"	13.8	6.9	5.8	17.1	6.2	26.5	12.4	12.0	11.5	8.0	6.8	9.0	6.9	10.9	6.9	8.2	10.3	11.4	9.7	7.1	7.4	6.5	6.8	12.1	24.0	5.7	4.9	5.7	11.9	6.9	8.6	7.1	8.5	6.2	7.8	8.2	12.7	7.1	7.2	7.6	10.4	14.7	11.7	4.3	19.1	7.3	6.5	5.8	13.5	11.9	5.5	18.1	8.5	7.8	7.6	7.5	6.8	12.1	8.7	5.7	6.2	2.5	5.4	8.0	8.4	14.0	1.7	20.5	7.4	3.4	4.3	5.6	3.3	5.1	5.9	7.6	3.5	17.4	7.7	55.6	8.8	4.1	8.1	16.3	7.2	8.5	8.0	11.7	8.1	4.2	15.1	0.5	0.1	7.6	2.0	12.8	3.1	3.4	0.2	7.6	15.6	13.3	10.1	4.4	12.7	7.5	9.1	6.6	3.5	4.0	10.2	7.6	6.1	6.9	10.0	9.7	3.3	9.8	18.7	13.1	10.3	6.9	4.5	10.1	1.3	1.5	2.6	4.0	1.7	5.6	3.9	3.7	5.2	3.1	8.4	5.5	5.8	1.4	5.1	2.2	2.6	7.0	2.6	5.8	6.2	12.0	11.5	7.1	7.4	5.7	4.9	5.7	6.2	4.3	5.8	7.6	10.2	3.2	6.7	4.6	9.5	6.6	4.9	4.3	4.6	5.0	9.1	7.1	5.7	7.2	4.0	7.3	6.2	4.4	8.9	1.9	3.9	4.4	12.7	5.3	4.4	9.1	6.0	1.7	3.0	2.4	2.9	5.9	2.0	4.5	9.5	7.6	11.0	8.4	4.2	1.7	3.9	3.8	4.1	4.8	2.9	5.1	5.6	4.3	0.0	1.9	3.2	6.3	8.2	4.0	4.6	2.5	1.1	4.1	8.8	3.5	3.3	2.7	5.8	9.4	0.0	7.7	7.8	11.7	7.1	4.5	5.7	4.4	9.4	4.2	2.3	2.2
ZNF555	MGC26707	ENSG00000186300	"Zinc finger protein 555"	Q8NEP9	19	2841437-2860471	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 81.6;Late spermatids: 62.6;Spermatocytes: 27.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA053956, HPA055430"	Uncertain					NA	NA					"HPA053956: AB_2682321, HPA055430: AB_2682814"	"unprognostic (9.64e-3)"	"unprognostic (4.39e-3)"	"unprognostic (7.98e-2)"	"unprognostic (2.08e-3)"	"unprognostic (4.30e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.11e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.99e-3)"	"unprognostic (5.73e-2)"	"unprognostic (1.06e-7)"	"unprognostic (2.44e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.86e-1)"	"unprognostic (9.66e-2)"	2.3	1.9	1.0	1.5	1.7	2.8	4.0	2.8	2.4	3.0	0.6	2.2	1.4	3.8	3.0	3.3	3.2	1.4	3.0	1.4	1.2	3.0	2.3	2.2	2.4	2.0	1.6	0.9	6.0	2.7	3.3	1.9	3.9	1.8	2.9	1.8	5.6	2.3	3.5	2.7	2.0	1.7	2.2	1.4	2.8	2.2	5.8	1.6	2.5	4.1	4.7	3.0	2.7	2.4	2.6	2.5	1.2	5.7	4.9	4.6	7.6	2.9	2.2	6.0	5.6	5.6	3.1	2.0	3.1	1.8	3.9	4.3	2.0	4.9	3.1	5.2	0.0	2.3	2.3	1.5	4.0	5.5	0.0	4.0	5.0	4.7	3.0	7.4	6.2	5.6	4.0	5.0	1.7	6.4	0.9	1.9	2.4	3.4	1.5	2.9	4.1	6.0	1.3	6.7	2.5	1.3	4.5	3.2	3.4	5.6	6.6	2.5	4.2	3.8	3.2	1.8	4.7	3.0	1.0	4.7	0.0	3.3	6.4	3.1	5.2	4.7	8.0	3.2	5.6	4.7	3.0	3.6	4.4	6.9	2.1	3.2	2.6	0.5	2.6	9.6	9.6	4.0	3.3	1.0	1.7	2.8	2.4	1.4	1.2	2.0	1.6	0.9	1.8	1.4	1.6	2.6	2.4	0.0	1.1	13.1	2.0	0.6	1.7	1.4	1.8	13.2	2.8	2.5	5.7	1.5	1.0	1.8	18.8	1.9	2.6	0.4	3.9	2.8	81.6	2.4	4.1	2.2	1.2	3.4	8.9	2.0	1.2	3.2	1.5	3.3	0.0	6.2	3.9	0.9	2.1	11.8	11.7	1.3	0.0	1.9	3.8	62.6	5.9	2.7	0.0	1.9	2.9	6.8	1.0	8.5	11.5	1.8	1.5	3.8	5.8	1.7	0.5	2.3	2.3	13.0	0.0	4.7	2.5	27.2	11.3	1.6	1.7	1.6	1.8	4.3	1.0	1.1
ZNF596		ENSG00000172748	"Zinc finger protein 596"	Q8TC21	8	232137-264703	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 18.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 60.1;Late spermatids: 20.4;Oligodendrocytes: 20.7;Spermatocytes: 63.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 11.4"					"Low region specificity"	"Detected in all"			HPA055463	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			"Nucleoli, Mitochondria"		"HPA055463: AB_2682821"	"unprognostic (3.30e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.90e-1)"	"unprognostic (9.07e-3)"	"unprognostic (9.68e-3)"	"unprognostic (2.10e-3)"	"unprognostic (1.74e-1)"	"unprognostic (4.84e-1)"	"unprognostic (1.70e-5)"	"unprognostic (6.37e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.51e-1)"	"unprognostic (4.53e-1)"	2.6	3.6	4.2	2.0	4.6	1.8	5.2	8.0	5.4	3.6	4.6	2.7	2.7	7.2	7.1	2.3	4.1	2.2	3.4	4.2	4.9	3.8	3.0	3.1	3.8	4.4	4.4	4.2	5.1	3.4	5.0	4.7	3.6	5.6	3.9	3.3	18.8	2.4	4.0	2.9	4.5	2.6	3.2	3.2	5.0	3.7	15.7	4.8	3.5	5.8	1.9	2.8	2.7	2.6	6.6	1.6	1.1	4.5	11.4	2.1	2.3	3.6	3.6	1.5	1.3	2.4	1.1	2.0	1.6	1.3	2.7	1.9	3.3	1.2	2.6	1.7	1.2	1.9	3.3	3.3	1.3	2.4	1.4	1.8	4.8	0.4	1.5	2.4	2.2	1.0	5.7	2.4	5.4	7.8	5.6	4.0	1.8	2.4	3.0	1.1	1.6	1.0	2.7	4.4	2.7	2.7	6.7	2.3	1.2	1.8	2.3	3.6	4.1	2.6	3.3	0.9	0.3	1.8	1.7	5.1	2.2	4.1	1.4	2.4	4.6	1.5	2.3	2.4	1.2	3.1	3.2	2.5	2.2	1.7	3.6	2.9	3.4	1.4	1.5	2.9	2.3	2.9	1.3	4.2	4.6	8.0	5.4	4.2	4.9	4.4	4.4	4.2	5.6	3.2	4.8	6.6	2.3	3.2	2.7	10.1	2.2	0.4	0.7	2.6	2.2	8.3	1.3	1.8	2.9	1.5	2.4	1.8	2.1	2.1	0.8	1.6	3.9	2.1	60.1	1.5	2.7	2.5	0.0	1.7	14.1	1.7	1.4	2.1	5.1	1.3	5.1	2.9	2.2	0.9	1.1	11.8	15.7	1.5	4.1	0.8	0.3	20.4	4.1	0.9	0.0	9.4	0.5	5.4	1.0	15.6	20.7	1.3	0.5	1.2	2.9	0.7	1.6	1.9	3.8	9.0	0.0	2.6	1.8	63.7	4.5	3.1	0.4	1.5	1.8	2.9	1.5	0.5
ZNF646	KIAA0296	ENSG00000167395	"Zinc finger protein 646"	O15015	16	31074422-31084196	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 25.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 24.8;Spermatocytes: 16.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 25.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042364, HPA066468"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane, Cytosol"		"HPA042364: AB_10794796, HPA066468: AB_2732746"	"unprognostic (1.61e-2)"	"unprognostic (2.18e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.18e-2)"	"unprognostic (4.66e-1)"	"unprognostic (6.20e-3)"	"prognostic unfavorable (1.28e-6)"	"unprognostic (3.23e-2)"	"unprognostic (4.21e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.16e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.16e-1)"	5.1	4.2	4.0	6.8	4.1	9.3	5.1	5.5	5.3	5.6	1.4	5.0	6.4	6.6	2.5	5.2	5.5	3.6	4.3	3.0	2.1	4.4	4.3	4.7	7.2	5.4	4.2	1.8	6.3	5.6	4.4	5.1	4.0	5.0	5.5	2.8	1.7	6.3	4.0	8.0	7.5	6.5	3.2	3.3	8.0	5.6	25.9	4.3	8.7	5.2	3.7	5.2	5.4	5.0	5.3	7.8	15.8	10.2	8.0	7.1	5.5	13.7	8.3	8.8	9.8	9.0	11.6	7.1	15.0	13.0	7.1	6.5	10.2	8.5	9.2	3.7	17.2	8.1	11.1	15.6	9.7	7.4	14.4	16.7	7.1	8.1	10.6	6.0	7.6	5.9	12.5	18.2	8.5	7.5	12.2	16.0	9.9	13.8	3.5	8.1	25.5	20.2	15.3	3.1	7.3	14.7	14.9	9.5	10.0	4.9	4.4	8.4	12.5	12.1	12.3	7.0	8.2	7.8	14.2	14.1	14.9	11.2	15.5	9.8	9.8	4.5	13.2	5.1	4.2	2.6	3.9	2.4	2.1	4.6	4.4	2.7	3.0	25.1	4.8	2.8	6.6	2.6	2.1	4.0	4.1	5.5	5.3	3.0	2.1	5.4	4.2	1.8	5.0	3.3	4.3	5.3	4.7	3.2	1.3	3.6	4.2	3.3	1.0	2.6	2.8	3.6	3.4	3.4	1.7	1.5	2.2	1.8	4.2	1.9	6.6	6.6	1.9	4.1	24.8	3.0	3.7	3.4	6.0	2.1	2.2	3.5	2.1	2.5	5.6	4.9	1.3	5.1	1.8	1.9	4.9	1.7	2.1	3.4	4.1	4.7	2.8	6.6	2.8	6.4	0.0	7.5	3.7	3.6	4.1	2.0	3.1	4.4	7.6	4.5	2.3	2.4	5.8	2.2	2.7	1.1	0.0	3.5	2.3	16.2	7.0	2.9	4.0	2.5	4.9	2.8	3.7	1.9
ZNF689	"FLJ90415, TIPUH1"	ENSG00000156853	"Zinc finger protein 689"	Q96CS4	16	30602558-30624012	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 19.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 53.0;Late spermatids: 52.0;Spermatocytes: 87.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054095, HPA055385"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		No	No			"Nucleoplasm, Nucleoli fibrillar center"		"HPA054095: AB_2682377, HPA055385: AB_2682801"	"unprognostic (5.62e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.73e-2)"	"unprognostic (7.73e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.38e-2)"	"unprognostic (5.83e-3)"	"unprognostic (2.26e-1)"	"prognostic favorable (9.89e-4)"	"unprognostic (3.21e-1)"	"unprognostic (1.58e-3)"	"unprognostic (3.93e-2)"	"unprognostic (5.23e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.69e-2)"	3.6	3.6	3.3	3.5	3.5	6.7	10.3	3.4	3.7	3.9	2.4	4.2	4.8	5.4	2.7	2.3	4.1	2.9	3.7	3.3	3.2	3.0	4.3	3.5	4.1	3.4	3.3	3.3	5.4	4.8	7.1	3.5	3.2	3.3	3.6	3.2	2.9	3.4	4.7	5.2	2.6	4.3	4.1	3.2	4.8	3.8	19.7	3.3	6.0	3.9	5.5	4.1	4.3	3.0	3.5	4.6	8.1	11.1	11.6	4.7	4.6	5.5	5.6	8.2	9.0	8.7	9.5	3.5	13.2	8.6	5.0	6.5	3.5	14.0	6.1	7.1	10.9	23.6	11.2	7.1	14.7	5.0	11.1	8.2	4.4	5.7	6.2	6.1	4.9	6.4	12.0	13.4	7.4	5.8	6.9	20.6	10.4	12.6	3.6	8.2	25.7	10.7	11.9	3.8	4.5	13.8	8.4	4.1	7.4	6.4	5.5	7.7	9.6	5.0	11.6	4.9	5.6	7.8	13.6	16.8	15.7	4.2	12.0	11.5	0.1	6.2	2.5	5.1	9.3	3.7	3.8	4.2	5.2	8.9	2.9	3.6	3.5	0.4	8.8	10.3	3.2	4.5	4.4	3.3	3.5	3.4	3.7	3.3	3.2	3.4	3.3	3.3	3.3	3.2	3.3	3.5	10.5	3.2	2.0	1.3	8.4	1.7	4.9	2.6	1.8	10.0	25.4	20.7	4.7	11.5	1.2	1.8	6.2	4.3	10.2	5.9	0.0	6.2	53.0	2.3	5.7	8.6	6.0	6.1	2.4	6.9	3.2	6.3	3.6	3.3	14.0	8.0	8.6	6.9	5.1	10.1	2.7	6.5	6.1	8.6	4.3	52.0	8.1	6.6	0.0	3.7	6.9	5.8	8.2	2.0	3.0	5.2	4.8	10.5	6.6	5.5	7.9	4.3	1.5	6.1	0.0	11.5	5.8	87.7	8.9	2.1	1.0	0.8	8.8	6.6	6.6	3.0
ZNF691	Zfp691	ENSG00000164011	"Zinc finger protein 691"	Q5VV52	1	42846573-42852477	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062527	Approved		Approved	Nucleoplasm,Nucleoli,Vesicles		NA	NA			Nucleoplasm	"Nucleoli, Vesicles"	"HPA062527: AB_2684791"	"unprognostic (4.34e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.32e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.50e-2)"	"prognostic unfavorable (7.33e-6)"	"unprognostic (1.40e-3)"	"unprognostic (2.65e-3)"	"unprognostic (5.12e-2)"	"prognostic favorable (6.25e-5)"	"unprognostic (1.24e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.05e-1)"	5.8	9.9	11.5	8.8	12.3	2.3	11.3	11.9	14.6	10.2	12.1	8.6	6.5	10.0	15.2	6.2	10.0	6.2	8.8	11.1	12.4	10.7	18.3	7.3	13.1	12.4	11.9	11.0	13.1	9.0	13.7	9.3	9.4	12.4	10.6	7.2	11.4	9.9	11.1	8.1	9.5	7.5	9.6	11.9	12.2	7.8	6.8	12.4	15.6	12.2	10.0	12.8	9.0	7.0	13.1	6.6	9.1	18.1	15.0	16.0	12.2	2.3	7.7	9.3	12.4	12.3	6.5	9.5	16.2	11.8	7.3	6.2	11.5	17.6	10.3	10.6	29.3	17.8	17.0	27.2	11.7	11.9	6.6	3.5	10.6	12.3	15.6	12.7	15.1	12.8	15.8	16.8	6.9	12.3	5.3	19.8	8.7	27.1	7.2	6.8	13.2	22.8	11.2	11.6	6.2	13.0	12.9	7.9	14.2	13.3	26.9	7.8	22.2	6.7	12.3	12.8	7.0	8.6	16.5	14.0	4.7	8.6	7.8	10.6	24.5	12.7	19.2	12.9	11.5	17.0	17.2	17.4	17.8	12.7	23.4	16.8	16.6	6.9	21.3	12.4	14.1	23.1	14.8	11.5	12.3	11.9	14.6	11.1	12.4	12.4	11.9	11.0	12.4	11.9	12.4	13.1	3.6	6.4	2.7	2.6	4.1	1.8	2.7	4.1	2.8	2.5	4.5	5.6	6.5	10.0	2.7	5.5	4.2	6.5	1.4	1.4	7.9	5.5	6.8	1.2	3.3	5.1	3.0	3.0	2.0	3.8	5.3	4.3	3.1	1.2	5.1	5.3	5.0	7.6	6.8	1.7	2.3	2.8	6.1	4.1	1.2	3.2	7.2	3.0	1.8	3.7	3.1	6.4	5.2	5.0	4.1	2.3	3.2	7.2	2.3	3.2	3.5	9.6	3.2	4.2	0.0	2.3	3.2	10.4	7.4	3.1	0.9	3.3	3.3	5.3	2.4	1.2
ZNF692	"AREBP, FLJ20531, Zfp692"	ENSG00000171163	"Zinc finger protein 692"	Q9BU19	1	248850006-248859144	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 52.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059337, HPA062792"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA059337: AB_2683984, HPA062792: AB_2684869"	"unprognostic (4.86e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.85e-3)"	"unprognostic (5.66e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.50e-2)"	"prognostic favorable (4.09e-4)"	"unprognostic (5.65e-3)"	"prognostic unfavorable (7.72e-9)"	"unprognostic (5.32e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.59e-1)"	"prognostic favorable (8.35e-5)"	11.5	16.6	33.4	4.8	34.2	7.5	16.4	34.6	48.9	26.3	32.3	18.5	5.2	17.2	8.3	23.4	25.5	5.0	16.4	33.3	33.1	24.0	21.9	12.6	6.2	35.0	33.9	33.6	27.8	28.4	7.5	29.3	4.2	36.0	35.2	3.6	8.6	17.9	5.4	17.8	17.1	16.8	3.9	32.8	23.7	19.8	39.2	33.8	7.0	24.9	4.7	4.5	21.4	21.0	35.0	7.1	6.4	6.1	14.7	4.7	2.5	26.4	6.1	1.9	6.2	4.0	8.2	9.8	8.8	11.7	2.3	2.5	9.5	9.1	8.8	3.9	12.6	5.7	9.9	17.8	2.2	3.5	11.4	8.3	3.2	10.2	6.8	17.5	5.8	5.9	11.1	21.1	6.2	2.9	3.8	5.9	23.7	12.2	17.1	13.1	19.3	3.6	16.9	11.9	4.5	11.7	8.8	6.3	10.1	12.2	2.3	13.1	18.5	4.5	2.7	5.0	2.7	8.0	17.0	11.3	5.8	6.2	14.9	4.7	0.0	1.5	1.4	3.6	1.1	3.3	3.0	2.9	4.0	3.1	2.3	4.1	3.0	3.3	8.1	1.0	2.5	3.5	2.0	33.4	34.2	34.6	48.9	33.3	33.1	35.0	33.9	33.6	36.0	32.8	33.8	35.0	7.8	9.6	8.6	27.1	10.7	9.6	12.5	19.0	11.4	15.3	16.8	18.7	5.4	7.2	10.8	11.0	22.9	12.8	10.3	10.0	5.9	7.6	14.3	6.1	7.0	6.7	8.3	22.7	20.6	4.0	10.4	8.1	15.8	6.8	5.7	15.9	2.9	6.2	6.5	11.8	19.7	12.3	12.2	6.0	5.5	7.8	10.2	5.4	16.0	10.3	6.1	8.3	9.2	8.5	23.5	5.7	5.2	7.2	6.6	17.3	11.6	4.1	10.8	13.6	0.0	8.4	8.0	52.7	15.4	11.0	8.0	6.2	11.3	9.5	14.3	10.0
ZNF821		ENSG00000102984	"Zinc finger protein 821"	O75541	16	71859680-71895336	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 21.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 143.0;Spermatocytes: 79.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 9.5;naive B-cell: 13.4;T-reg: 5.6"	"Group enriched"	"Detected in many"	9	"B-cells: 13.4;T-cells: 5.6"	"Cell line enhanced"	"Detected in many"		"AF22: 13.2;SCLC-21H: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036372, HPA042742"	Enhanced		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nucleoplasm, Nuclear speckles"		"HPA036372: AB_10669790, HPA042742: AB_2678140"	"unprognostic (3.16e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.12e-2)"	"prognostic favorable (1.20e-4)"	"unprognostic (1.69e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.72e-2)"	"unprognostic (5.25e-2)"	"unprognostic (3.04e-2)"	"prognostic favorable (4.27e-5)"	"unprognostic (2.83e-2)"	"prognostic favorable (6.32e-10)"	"unprognostic (1.82e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.02e-1)"	2.0	2.9	4.9	1.6	5.5	2.5	3.3	9.7	6.0	5.4	2.9	2.8	1.4	4.5	7.6	2.6	3.1	2.6	2.4	5.4	5.9	4.0	1.9	3.0	4.4	5.1	5.2	5.3	4.9	2.4	4.1	9.0	1.7	5.7	4.2	3.4	9.4	3.4	3.3	3.6	5.2	4.3	1.9	4.7	3.9	2.6	21.4	5.1	3.4	4.2	4.1	5.5	2.1	4.2	5.6	1.1	0.9	13.2	6.4	2.6	3.3	2.2	1.4	3.0	2.9	4.6	1.9	0.8	2.5	2.3	2.6	3.2	1.9	4.4	2.0	3.5	3.9	5.0	0.5	0.8	0.8	1.6	0.9	2.8	2.9	3.2	2.0	1.2	5.0	2.3	0.6	1.7	1.8	3.2	3.3	1.5	0.9	5.2	3.9	0.6	6.0	2.8	4.5	3.3	0.4	13.2	6.3	1.8	1.1	1.5	5.6	4.5	3.0	4.5	3.1	3.2	1.1	0.9	4.4	2.4	10.2	1.0	2.5	3.0	0.0	0.5	0.4	2.0	0.0	1.8	9.5	2.1	1.5	0.9	13.4	1.3	0.5	0.4	1.0	0.5	0.0	5.6	0.8	4.9	5.5	9.7	6.0	5.4	5.9	5.1	5.2	5.3	5.7	4.7	5.1	5.6	7.4	0.0	4.2	13.7	28.7	8.0	8.7	7.2	23.3	41.8	15.2	12.4	1.2	11.5	4.9	16.5	45.9	5.8	11.8	23.5	21.5	9.7	143.0	8.5	11.5	8.4	23.4	6.1	28.3	4.8	5.2	7.7	29.0	14.8	9.5	13.5	12.5	1.8	7.9	32.0	30.4	11.3	6.1	10.6	13.4	57.4	12.5	10.3	3.6	8.4	3.7	25.8	9.2	22.1	13.7	6.2	16.7	12.4	22.6	8.0	42.8	10.8	4.7	51.6	13.1	6.3	9.2	79.4	20.8	16.1	7.5	6.2	15.4	6.3	7.7	4.3
ZNF839	C14orf131	ENSG00000022976	"Zinc finger protein 839"	A8K0R7	14	102317377-102342702	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 27.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020434	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA020434: AB_10669862"	"unprognostic (7.83e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.28e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.73e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.10e-3)"	"prognostic favorable (4.57e-4)"	"unprognostic (2.40e-2)"	"prognostic favorable (5.00e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.21e-2)"	7.2	9.4	9.7	6.8	8.5	11.6	13.8	5.7	9.1	9.3	7.1	7.9	7.1	8.2	9.4	7.3	17.2	6.9	7.7	8.7	9.3	10.4	14.7	6.2	10.9	8.4	7.9	8.4	11.0	12.2	10.9	9.3	5.6	8.7	9.0	8.2	8.1	10.5	9.6	18.7	19.5	9.9	5.3	5.8	15.2	8.1	31.5	8.1	12.3	11.3	12.2	8.9	7.1	6.1	10.6	13.5	12.1	15.4	27.8	7.0	11.8	26.2	10.3	8.4	12.6	10.3	4.6	11.2	13.8	8.3	7.0	5.2	13.0	10.0	25.9	9.7	18.6	19.1	9.6	12.7	7.7	6.3	9.1	8.1	9.5	18.9	24.4	22.6	19.1	17.0	19.3	21.0	17.6	17.9	25.1	13.9	14.6	20.6	7.3	12.0	29.7	9.4	8.8	11.2	10.9	8.2	25.7	8.5	10.7	9.6	14.5	24.5	14.7	6.7	8.1	7.3	11.3	9.3	17.3	13.5	16.2	6.3	10.7	13.6	0.0	0.2	0.7	0.6	0.6	0.7	0.5	0.4	0.4	0.3	0.4	0.7	0.6	1.0	0.1	0.1	0.6	0.6	0.1	9.7	8.5	5.7	9.1	8.7	9.3	8.4	7.9	8.4	8.7	5.8	8.1	10.6	4.6	0.0	10.0	12.1	4.1	3.1	2.6	2.2	2.8	7.6	6.7	7.1	1.9	7.2	3.7	11.0	8.4	6.3	6.5	3.3	11.7	2.9	27.4	6.1	4.3	3.5	1.2	7.4	7.9	2.8	3.1	4.0	5.6	4.5	3.8	10.6	4.6	4.7	3.1	3.3	7.8	5.7	4.1	2.2	1.5	3.8	5.0	3.5	3.6	3.7	1.9	6.9	1.0	5.0	8.2	2.8	1.6	4.1	4.5	2.5	5.3	7.0	7.9	9.6	0.0	3.6	3.3	19.9	11.6	3.7	2.6	5.6	4.5	5.7	5.4	1.5
ZNF846		ENSG00000196605	"Zinc finger protein 846"	Q147U1	19	9751993-9793180	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 242.1;Late spermatids: 91.0;Spermatocytes: 177.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA034617, HPA034618"	Approved		Approved	"Actin filaments"		NA	NA			"Actin filaments"		"HPA034617: AB_10603942, HPA034618: AB_2674249"	"unprognostic (1.36e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.79e-2)"	"unprognostic (6.73e-2)"	"prognostic favorable (5.25e-8)"	"unprognostic (2.57e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.33e-3)"	"unprognostic (1.85e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.05e-3)"	7.2	6.7	9.4	6.3	9.4	4.6	7.1	7.1	9.2	8.1	7.2	7.2	4.3	11.2	9.7	9.3	8.5	9.8	7.9	8.0	8.0	5.0	4.7	7.0	8.2	10.6	8.6	7.3	13.0	3.9	7.4	5.6	6.4	10.2	11.9	7.2	7.4	7.2	18.9	5.5	8.1	5.3	10.7	9.7	6.5	6.6	14.1	8.9	8.1	7.3	5.7	6.4	13.2	9.0	9.9	3.8	0.8	11.6	2.8	12.8	16.4	2.6	5.8	4.0	4.1	8.2	2.1	3.1	1.5	2.3	6.9	4.8	1.4	0.8	4.5	4.5	3.4	2.5	8.6	0.3	3.1	4.6	0.8	8.9	16.9	5.9	3.1	2.4	9.4	3.4	4.6	1.5	0.0	4.4	1.5	3.1	7.2	1.7	3.1	4.8	4.5	0.9	0.4	5.2	14.6	1.8	3.5	3.1	0.3	4.4	4.0	1.9	6.0	1.8	3.3	2.4	2.8	0.5	6.5	7.3	8.3	0.4	1.1	2.9	1.1	2.1	1.3	1.7	1.7	3.5	4.2	2.6	4.3	6.9	5.2	2.0	4.2	0.8	2.2	1.2	4.5	3.3	1.6	9.4	9.4	7.1	9.2	8.0	8.0	10.6	8.6	7.3	10.2	9.7	8.9	9.9	4.4	9.6	5.4	18.3	4.7	7.9	15.0	14.5	20.5	1.7	7.3	10.0	6.8	5.7	11.9	0.0	2.1	1.6	5.5	5.4	9.8	6.5	242.1	6.4	7.7	5.1	1.2	4.8	25.8	4.9	2.1	7.8	5.1	4.5	5.1	7.8	5.7	5.4	7.5	0.0	13.7	4.9	6.1	13.9	9.1	91.0	6.8	10.2	7.2	41.2	9.2	3.2	1.0	14.6	14.6	7.0	3.9	9.1	3.7	7.3	3.1	6.1	12.5	2.4	6.6	3.7	8.2	177.1	8.6	8.0	8.8	1.2	5.2	7.8	4.1	16.4
ZNF879	DKFZp686E2433	ENSG00000234284	"Zinc finger protein 879"	B4DU55	5	179023804-179035064	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 12.5;Spermatocytes: 13.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 9.9;BEWO: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068608	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA068608: AB_2686010"	"unprognostic (3.20e-2)"	"unprognostic (5.24e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.49e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.61e-3)"	"unprognostic (5.83e-2)"	"unprognostic (8.80e-3)"	"unprognostic (3.19e-3)"	"unprognostic (6.04e-2)"	"unprognostic (5.69e-4)"	"unprognostic (1.07e-1)"	"unprognostic (4.61e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.79e-1)"	"unprognostic (4.72e-2)"	"unprognostic (5.17e-3)"	2.3	1.6	2.6	2.1	3.7	0.8	2.7	4.0	3.4	2.1	2.8	1.9	1.2	2.7	2.2	2.0	2.4	1.6	2.8	2.7	2.8	2.3	1.4	2.0	3.1	3.6	3.3	2.5	3.9	1.7	2.5	2.6	2.8	3.6	2.7	1.2	7.2	2.2	3.2	2.2	3.5	1.9	2.3	3.0	3.2	1.7	6.2	2.9	3.5	3.8	3.2	3.5	1.9	1.8	4.7	0.0	3.6	3.2	9.9	3.0	2.3	10.5	1.8	2.6	4.2	5.2	3.3	1.8	2.7	2.5	1.7	4.9	1.5	0.0	2.0	3.4	0.0	0.3	0.0	2.3	0.6	4.8	0.0	4.9	2.3	1.9	2.3	1.2	1.9	1.5	2.6	0.5	0.0	3.5	1.8	3.1	1.0	3.5	1.3	0.9	2.8	1.1	0.3	3.1	2.9	1.3	3.3	3.4	0.5	4.6	4.8	4.8	3.0	1.5	1.9	3.5	2.2	0.4	0.0	0.0	4.1	0.0	0.0	2.6	14.0	3.8	3.9	4.9	3.4	4.9	4.1	4.3	4.0	3.5	4.0	6.6	5.1	0.1	5.4	3.3	2.4	6.0	3.0	2.6	3.7	4.0	3.4	2.7	2.8	3.6	3.3	2.5	3.6	3.0	2.9	4.7	1.8	6.4	1.1	2.9	3.1	0.5	1.7	1.3	0.0	8.7	1.2	0.6	2.2	5.7	1.1	5.5	12.5	3.6	5.6	0.7	5.9	1.7	6.0	0.6	1.2	2.5	1.2	0.4	1.7	0.8	2.0	2.5	2.0	0.8	2.5	4.0	1.8	0.9	2.2	10.1	1.8	0.3	2.0	1.6	1.9	3.4	1.5	1.2	0.0	1.0	1.4	3.1	8.2	2.5	2.4	0.8	0.1	2.2	1.0	1.7	1.4	1.6	1.5	5.6	6.6	4.6	2.4	13.3	9.8	0.6	1.1	4.2	2.2	2.2	0.7	1.1
ZPBP	"SP38, ZPBP1"	ENSG00000042813	"Zona pellucida binding protein"	Q9BS86	7	49850421-50121329	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"testis: 144.4"	"Group enriched"	"Detected in some"	7	"Early spermatids: 973.0;Spermatocytes: 691.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA058673	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA058673: AB_2683794"	"unprognostic (1.16e-1)"							"unprognostic (6.46e-2)"		"unprognostic (7.80e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.15e-7)"		"unprognostic (9.49e-2)"	"unprognostic (2.34e-4)"		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	144.4	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	15.0	0.3	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	973.0	0.1	0.1	0.4	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	22.9	0.0	0.0	0.0	0.0	116.0	11.1	0.4	0.0	1.9	0.0	1.9	0.0	9.0	0.5	0.1	0.0	7.9	0.0	0.2	0.0	0.5	0.6	20.2	6.6	0.0	0.0	691.6	17.1	0.0	0.3	0.0	0.0	0.2	0.0	0.2
ZPBP2	"MGC41930, ZPBPL"	ENSG00000186075	"Zona pellucida binding protein 2"	Q6X784	17	39868202-39877896	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	100	"testis: 96.2"	"Group enriched"	"Detected in some"	5	"Early spermatids: 273.9;Spermatocytes: 598.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.3;U-698: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA027997, HPA053070"	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA027997: AB_1859488, HPA053070: AB_2682033"		"unprognostic (2.14e-2)"						"unprognostic (3.38e-1)"				"unprognostic (1.62e-1)"		"unprognostic (2.87e-1)"	"unprognostic (5.39e-1)"		"unprognostic (2.54e-3)"	0.1	0.1	0.4	0.3	0.3	0.3	0.2	0.8	0.7	0.1	0.2	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.2	0.4	0.3	0.0	0.2	0.1	0.7	0.2	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.4	0.1	0.1	0.6	0.1	0.1	0.4	0.3	0.1	0.0	0.1	0.3	0.2	96.2	0.3	0.1	0.1	0.1	0.9	0.1	0.0	0.7	0.0	0.0	0.4	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.2	0.0	1.3	0.1	0.2	0.1	0.0	0.2	0.1	0.2	0.3	0.6	0.1	0.2	0.0	0.1	0.2	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.3	0.4	0.3	0.3	0.2	0.4	1.0	0.1	0.1	0.4	0.1	0.0	0.2	0.1	0.5	0.1	0.0	0.2	0.1	0.1	0.2	0.0	0.4	0.1	4.9	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.8	0.7	0.4	0.3	0.2	0.1	0.2	0.4	0.1	0.3	0.7	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	273.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.2	7.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	598.2	19.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1
ZWILCH	"FLJ10036, KNTC1AP"	ENSG00000174442	"Zwilch kinetochore protein"	Q9H900	15	66504959-66550130	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 54.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 97.3;Late spermatids: 74.5;Spermatocytes: 167.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.10e-1)"	"unprognostic (9.99e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.79e-1)"	"unprognostic (4.83e-3)"	"unprognostic (3.32e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (2.90e-5)"	"prognostic unfavorable (7.34e-4)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (2.81e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.42e-1)"	3.8	2.2	3.2	8.5	2.9	10.4	6.7	2.7	3.1	4.9	3.9	8.8	5.5	6.3	6.3	6.7	4.0	5.9	2.7	3.1	3.2	4.7	5.4	5.3	11.7	3.6	2.7	2.4	6.0	3.2	2.6	2.4	7.3	3.1	4.6	10.0	3.8	3.4	3.7	3.3	7.9	5.5	6.3	3.4	5.6	5.6	54.4	3.2	14.3	3.9	3.1	14.2	5.5	4.1	3.9	38.1	48.5	58.0	51.5	13.6	24.0	31.3	58.8	35.6	69.4	76.5	39.4	32.2	81.6	26.3	38.6	57.7	92.6	156.4	42.2	83.9	41.7	31.9	59.5	63.9	31.3	4.9	41.4	32.0	9.9	10.7	71.2	51.8	21.4	44.8	34.3	57.4	43.2	54.7	38.2	36.7	25.2	111.7	75.2	31.0	41.9	72.1	59.6	24.9	42.6	34.5	37.5	32.1	41.4	50.6	66.1	32.9	27.6	30.0	63.2	68.7	37.6	87.2	21.6	92.6	85.0	42.9	94.5	53.5	4.0	2.1	3.6	4.3	4.2	3.7	4.3	4.3	4.1	2.1	4.1	2.8	4.0	2.5	5.0	5.4	2.2	4.5	2.2	3.2	2.9	2.7	3.1	3.1	3.2	3.6	2.7	2.4	3.1	3.4	3.2	3.9	6.1	3.2	4.6	1.3	7.5	11.1	6.4	8.4	4.0	5.1	5.8	4.2	1.5	5.7	8.7	1.8	0.0	14.1	7.0	5.3	3.9	8.2	97.3	5.9	6.6	6.5	4.8	31.5	5.2	6.5	25.1	6.7	10.7	7.8	15.2	9.6	3.9	4.7	12.5	0.0	4.3	10.3	12.2	4.1	8.4	74.5	7.5	7.4	5.4	2.8	7.4	1.5	7.2	2.5	2.7	8.1	2.1	5.3	15.0	4.6	2.0	2.8	5.2	3.7	26.3	3.1	6.4	167.9	43.1	11.2	8.5	12.9	8.3	4.8	10.1	6.9
